assays_assay_id,assays_assay_organism,assays_tid,assays_tissue_id,assays_assay_category,assays_src_id,assays_assay_test_type,assays_src_assay_id,assays_curated_by,assays_doc_id,assays_description,assays_assay_subcellular_fraction,assays_relationship_type,assays_assay_cell_type,assays_assay_type,assays_assay_strain,assays_chembl_id,assays_cell_id,assays_bao_format,assays_variant_id
7524,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,,A,,CHEMBL618647,,BAO_0000218,
7525,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,N,,A,,CHEMBL618648,,BAO_0000218,
7526,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,N,,A,,CHEMBL618649,,BAO_0000218,
7527,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,,A,,CHEMBL618650,,BAO_0000218,
7528,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,N,,A,,CHEMBL618651,,BAO_0000218,
7529,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,N,,A,,CHEMBL876497,,BAO_0000218,
7530,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,,A,,CHEMBL618652,,BAO_0000218,
7531,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,N,,A,,CHEMBL618653,,BAO_0000218,
7532,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,N,,A,,CHEMBL618654,,BAO_0000218,
7533,Rattus norvegicus,50597,,,1,,,Intermediate,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,N,,A,,CHEMBL618655,,BAO_0000218,
7534,Rattus norvegicus,50597,,,1,,,Intermediate,1465,Compound was tested for solubility in water,,N,,A,,CHEMBL618656,,BAO_0000218,
7535,,22229,,,1,,,Intermediate,5182,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,U,,P,,CHEMBL618657,,BAO_0000100,
7536,Rattus norvegicus,50597,,,1,,,Intermediate,17847,Solubility was determined,,N,,A,,CHEMBL618658,,BAO_0000218,
7537,Rattus norvegicus,50597,,,1,,,Intermediate,15339,solubility in water (ug/mL) at 37 degree C.,,N,,A,,CHEMBL618659,,BAO_0000218,
7538,Rattus norvegicus,50597,,,1,,,Intermediate,5202,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,N,,A,,CHEMBL618660,,BAO_0000218,
7539,Rattus norvegicus,50597,,,1,,,Intermediate,1088,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,N,,A,,CHEMBL618661,,BAO_0000218,
7540,Rattus norvegicus,50597,,,1,,,Intermediate,3169,Half life in rats,,N,,A,,CHEMBL873807,,BAO_0000218,
7541,Rattus norvegicus,50597,,,1,,,Intermediate,5353,Half life in Dawley rat,,N,,A,,CHEMBL618662,,BAO_0000218,
7542,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2864,Half life period after 3 mg/kg iv administration,,N,,A,,CHEMBL618663,,BAO_0000218,
7543,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2864,Half life period after 3 mg/kg iv administration in rat,,N,,A,,CHEMBL618664,,BAO_0000218,
7544,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2864,Half life period after 3 mg/kg iv administration in the rat,,N,,A,,CHEMBL618665,,BAO_0000218,
7545,Rattus norvegicus,50597,,,1,,,Intermediate,6362,Half life period in female Sprague-Dawley rats,,N,,A,,CHEMBL876498,,BAO_0000218,
7546,Rattus norvegicus,50597,,,1,,,Intermediate,6249,Half life period in rat,,N,,A,,CHEMBL618666,,BAO_0000218,
7547,Rattus norvegicus,50597,,,1,,,Intermediate,3169,Half-life in rats was determined,,N,,A,,CHEMBL620440,,BAO_0000218,
7548,Rattus norvegicus,50597,,,1,,,Intermediate,3169,Half-life in rats with metabolic oxidation,,N,,A,,CHEMBL620441,,BAO_0000218,
7549,Rattus norvegicus,50597,,,1,,,Intermediate,3169,Half-life in rats,,N,,A,,CHEMBL620442,,BAO_0000218,
7550,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,,A,,CHEMBL620443,,BAO_0000218,
7551,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,,A,,CHEMBL620444,,BAO_0000218,
7552,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,,A,,CHEMBL620445,,BAO_0000218,
7553,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,,A,,CHEMBL620446,,BAO_0000218,
7554,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2879,Biological half-life measured in plasma of rat,,N,,A,,CHEMBL620447,,BAO_0000218,
7555,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2879,Biological half-life measured in plasma of rat; 22-25,,N,,A,,CHEMBL621129,,BAO_0000218,
7556,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2879,Biological half-life measured in plasma of rat; 9-16,,N,,A,,CHEMBL621130,,BAO_0000218,
7557,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3184,Compound was evaluated for its half life when administered intravenously in rat,,N,,A,,CHEMBL873808,,BAO_0000218,
7558,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,N,,A,,CHEMBL876598,,BAO_0000218,
7559,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,429,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,N,,A,,CHEMBL621131,,BAO_0000218,
7560,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5656,Half life (T1/2) after oral administration in rat,,N,,A,,CHEMBL621132,,BAO_0000218,
7561,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4413,Half life of compound after iv administration of 20 mg/kg dose in rat,,N,,A,,CHEMBL621133,,BAO_0000218,
7562,Rattus norvegicus,50597,,,1,In vivo,,Expert,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL621312,,BAO_0000218,
7563,Rattus norvegicus,50597,,,1,,,Intermediate,17267,Half life of compound was determined in rat,,N,,A,,CHEMBL621313,,BAO_0000218,
7564,Rattus norvegicus,50597,178.0,,1,,,Intermediate,4727,Half life of compound was determined in rat blood,,N,,A,,CHEMBL621314,,BAO_0000218,
7565,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17651,Half life at 1 mg/kg was determined in rat,,N,,A,,CHEMBL621315,,BAO_0000218,
7566,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17651,Half life at 10 mg/kg was determined in rat,,N,,A,,CHEMBL621316,,BAO_0000218,
7567,Rattus norvegicus,50597,,,1,,,Intermediate,401,Half life in rats,,N,,A,,CHEMBL621317,,BAO_0000218,
7568,Rattus norvegicus,50597,,,1,,,Intermediate,4942,Half life in rats in hours,,N,,A,,CHEMBL621318,,BAO_0000218,
7569,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17735,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,,A,,CHEMBL621319,,BAO_0000218,
7570,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6056,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,N,,A,,CHEMBL621377,,BAO_0000218,
7571,Rattus norvegicus,50597,,,1,,,Intermediate,5213,Half life was determined,,N,,A,,CHEMBL621378,,BAO_0000218,
7572,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6616,Half life after i.v. administration,,N,,A,,CHEMBL876599,,BAO_0000218,
7573,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5937,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,N,,A,,CHEMBL621379,,BAO_0000218,
7574,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5819,Half life in rat plasma,,N,,A,,CHEMBL621380,,BAO_0000218,
7575,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5819,Half life in rat plasma; Not detected,,N,,A,,CHEMBL621381,,BAO_0000218,
7576,Rattus norvegicus,50597,,,1,,,Intermediate,6803,Half life in rats,,N,,A,,CHEMBL618515,,BAO_0000218,
7577,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Half life period of compound was determined after peroral administration,,N,,A,,CHEMBL618516,,BAO_0000218,
7578,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,N,,A,,CHEMBL618517,,BAO_0000218,
7579,Rattus norvegicus,50597,,,1,,,Intermediate,5948,Half life period in rat,,N,,A,,CHEMBL618518,,BAO_0000218,
7580,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1916,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,,A,,CHEMBL618519,,BAO_0000218,
7581,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,,A,,CHEMBL618698,,BAO_0000218,
7582,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,N,,A,,CHEMBL618862,,BAO_0000218,
7583,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4890,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL618863,,BAO_0000218,
7584,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,N,,A,,CHEMBL618864,,BAO_0000218,
7585,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4727,Half life time in rat the dose of 2 mg/kg,,N,,A,,CHEMBL618865,,BAO_0000218,
7586,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17509,Half-life 24 hr after 10 mg/kg iv administration in rats,,N,,A,,CHEMBL618866,,BAO_0000218,
7587,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17509,Half-life 24 hr after 2 mg/kg iv administration in rats,,N,,A,,CHEMBL618867,,BAO_0000218,
7588,Rattus norvegicus,50597,,,1,,,Intermediate,6597,Half-life consistent with the observed metabolic steady state in rats,,N,,A,,CHEMBL875828,,BAO_0000218,
7589,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17735,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,,A,,CHEMBL618868,,BAO_0000218,
7590,Rattus norvegicus,50597,,,1,,,Intermediate,6597,Half-life for oxidative metabolic stability was determined using male human,,N,,A,,CHEMBL618869,,BAO_0000218,
7591,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17670,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,N,,A,,CHEMBL618870,,BAO_0000218,
7592,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1696,Half-life in rat plasma,,N,,A,,CHEMBL618871,,BAO_0000218,
7593,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1742,Half-life in rat plasma was determined,,N,,A,,CHEMBL618872,,BAO_0000218,
7594,Rattus norvegicus,50597,,,1,,,Intermediate,17800,Half-life in rats was determined,,N,,A,,CHEMBL873816,,BAO_0000218,
7595,,22224,,,1,,,Autocuration,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,U,,A,,CHEMBL618873,,BAO_0000218,
7596,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 0.1 mg//kg,,U,,A,,CHEMBL621602,,BAO_0000019,
7597,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 0.3 mg/kg,,U,,A,,CHEMBL621603,,BAO_0000218,
7598,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 1 mg/kg,,U,,A,,CHEMBL621604,,BAO_0000218,
7599,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 10 mg/kg,,U,,A,,CHEMBL621605,,BAO_0000218,
7600,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 23.4 mg/kg,,U,,A,,CHEMBL621606,,BAO_0000218,
7601,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 3 mg/kg,,U,,A,,CHEMBL621607,,BAO_0000218,
7602,,22224,,,1,,,Autocuration,11954,Area under curve after oral dose of 3.87 mg/kg,,U,,A,,CHEMBL621608,,BAO_0000218,
7603,,22224,,,1,,,Autocuration,5237,Area under curve was determined,,U,,A,,CHEMBL621609,,BAO_0000019,
7604,,22224,,,1,,,Autocuration,4026,Area under curve at a dose of 10 mg/kg,,U,,A,,CHEMBL621610,,BAO_0000218,
7605,Rattus norvegicus,50597,,,1,,,Intermediate,5237,Area under curve was determined; ND=No data,,N,,A,,CHEMBL621611,,BAO_0000218,
7606,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL621612,,BAO_0000218,
7607,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,,A,,CHEMBL622308,,BAO_0000218,
7608,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622309,,BAO_0000218,
7609,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,,A,,CHEMBL622310,,BAO_0000218,
7610,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622311,,BAO_0000218,
7611,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,N,,A,,CHEMBL622312,,BAO_0000218,
7612,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622931,,BAO_0000218,
7613,Rattus norvegicus,50597,,,1,,,Intermediate,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,N,,A,,CHEMBL622932,,BAO_0000218,
7614,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622736,,BAO_0000218,
7615,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,,A,,CHEMBL622737,,BAO_0000218,
7616,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622738,,BAO_0000218,
7617,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,,A,,CHEMBL622739,,BAO_0000218,
7618,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622740,,BAO_0000218,
7619,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,N,,A,,CHEMBL622741,,BAO_0000218,
7620,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,,A,,CHEMBL622742,,BAO_0000218,
7621,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,N,,A,,CHEMBL622743,,BAO_0000218,
7622,Mus musculus,50594,1969.0,,1,,,Intermediate,11637,AUC in mice,,N,,A,,CHEMBL622744,,BAO_0000218,
7623,,22224,,,1,,,Autocuration,11149,Area under curve was measured from the graph obtained from concentration Vs time,,U,,A,,CHEMBL624134,,BAO_0000019,
7624,,22224,,,1,,,Autocuration,10016,Area under curve value of compound per hour after oral administration,,U,,A,,CHEMBL624135,,BAO_0000019,
7625,Rattus norvegicus,50597,,,1,,,Intermediate,17796,Area under curve was determined after oral administration in rats,,N,,A,,CHEMBL624136,,BAO_0000218,
7626,Rattus norvegicus,50597,,,1,,,Intermediate,17796,Area under curve was determined after oral administration in rats; No data,,N,,A,,CHEMBL624137,,BAO_0000218,
7627,Rattus norvegicus,50597,,,1,,,Intermediate,17796,Area under curve was determined after oral administration in rats;No data,,N,,A,,CHEMBL624320,,BAO_0000218,
7628,Canis lupus familiaris,50588,,,1,,,Intermediate,12923,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,,A,,CHEMBL624321,,BAO_0000218,
7629,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,,A,,CHEMBL624322,,BAO_0000218,
7630,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after iv dose of 5.06 in rats,,N,,A,,CHEMBL624323,,BAO_0000218,
7631,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,N,,A,,CHEMBL624324,,BAO_0000218,
7632,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,N,,A,,CHEMBL624325,,BAO_0000218,
7633,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,N,,A,,CHEMBL624326,,BAO_0000218,
7634,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,N,,A,,CHEMBL624327,,BAO_0000218,
7635,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,N,,A,,CHEMBL624328,,BAO_0000218,
7636,Canis lupus familiaris,50588,,,1,,,Intermediate,14169,Area under curve was determined in Dogs after peroral administration,,N,,A,,CHEMBL627848,,BAO_0000218,
7637,Rattus norvegicus,50597,,,1,,,Intermediate,14169,Area under curve was determined in Rats after peroral administration,,N,,A,,CHEMBL627849,,BAO_0000218,
7638,Rattus norvegicus,50597,,,1,,,Intermediate,14258,Area under curve was determined in carotid blood of rat when administered intradermally,,N,,A,,CHEMBL627850,,BAO_0000218,
7639,Rattus norvegicus,50597,,,1,,,Intermediate,14258,Area under curve was determined in portal blood of rat when administered intradermally,,N,,A,,CHEMBL627851,,BAO_0000218,
7640,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL627852,,BAO_0000218,
7641,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL627853,,BAO_0000218,
7642,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,,A,,CHEMBL627854,,BAO_0000218,
7643,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL627855,,BAO_0000218,
7644,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,,A,,CHEMBL627856,,BAO_0000218,
7645,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL875339,,BAO_0000218,
7646,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,N,,A,,CHEMBL627857,,BAO_0000218,
7647,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,N,,A,,CHEMBL627858,,BAO_0000218,
7648,Rattus norvegicus,50597,178.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,N,,A,,CHEMBL627859,,BAO_0000218,
7649,Rattus norvegicus,50597,955.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,N,,A,,CHEMBL627860,,BAO_0000218,
7650,Rattus norvegicus,50597,948.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,N,,A,,CHEMBL627019,,BAO_0000218,
7651,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,N,,A,,CHEMBL627020,,BAO_0000218,
7652,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,N,,A,,CHEMBL627021,,BAO_0000218,
7653,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,N,,A,,CHEMBL627022,,BAO_0000218,
7654,Rattus norvegicus,50597,,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,N,,A,,CHEMBL627023,,BAO_0000218,
7655,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,N,,A,,CHEMBL627024,,BAO_0000218,
7656,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,N,,A,,CHEMBL627025,,BAO_0000218,
7657,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,N,,A,,CHEMBL627026,,BAO_0000218,
7658,Rattus norvegicus,50597,178.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,N,,A,,CHEMBL627027,,BAO_0000218,
7659,Rattus norvegicus,50597,955.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,N,,A,,CHEMBL627028,,BAO_0000218,
7660,Rattus norvegicus,50597,948.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,N,,A,,CHEMBL627029,,BAO_0000218,
7661,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,N,,A,,CHEMBL627030,,BAO_0000218,
7662,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,N,,A,,CHEMBL627031,,BAO_0000218,
7663,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,N,,A,,CHEMBL627032,,BAO_0000218,
7664,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,N,,A,,CHEMBL627033,,BAO_0000218,
7665,Rattus norvegicus,50597,,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,N,,A,,CHEMBL627034,,BAO_0000218,
7666,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,N,,A,,CHEMBL627035,,BAO_0000218,
7667,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,N,,A,,CHEMBL627036,,BAO_0000218,
7668,Rattus norvegicus,50597,178.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,N,,A,,CHEMBL875340,,BAO_0000218,
7669,Rattus norvegicus,50597,948.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,N,,A,,CHEMBL627037,,BAO_0000218,
7670,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,N,,A,,CHEMBL627038,,BAO_0000218,
7671,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,N,,A,,CHEMBL627039,,BAO_0000218,
7672,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,N,,A,,CHEMBL627040,,BAO_0000218,
7673,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,N,,A,,CHEMBL624663,,BAO_0000218,
7674,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,N,,A,,CHEMBL625963,,BAO_0000218,
7675,Rattus norvegicus,50597,955.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,N,,A,,CHEMBL876799,,BAO_0000218,
7676,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,N,,A,,CHEMBL626133,,BAO_0000218,
7677,Rattus norvegicus,50597,,,1,,,Intermediate,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,N,,A,,CHEMBL626134,,BAO_0000218,
7678,Rattus norvegicus,50597,,,1,,,Intermediate,6295,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,,A,,CHEMBL626135,,BAO_0000218,
7679,Rattus norvegicus,50597,,,1,,,Intermediate,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,,A,,CHEMBL626136,,BAO_0000218,
7680,Rattus norvegicus,50597,,,1,,,Intermediate,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,N,,A,,CHEMBL626137,,BAO_0000218,
7681,Rattus norvegicus,50597,,,1,,,Intermediate,6295,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,,A,,CHEMBL626138,,BAO_0000218,
7682,Rattus norvegicus,50597,,,1,,,Intermediate,6296,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,,A,,CHEMBL626139,,BAO_0000218,
7683,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,,A,,CHEMBL626140,,BAO_0000218,
7684,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,,A,,CHEMBL626141,,BAO_0000218,
7685,Rattus norvegicus,50597,,,1,,,Intermediate,17686,C24h in rat p.o. at 20 mg/kg concentration,,N,,A,,CHEMBL626142,,BAO_0000218,
7686,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,,A,,CHEMBL627930,,BAO_0000218,
7687,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,N,,A,,CHEMBL627931,,BAO_0000218,
7688,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,N,,A,,CHEMBL627932,,BAO_0000218,
7689,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,N,,A,,CHEMBL627933,,BAO_0000218,
7690,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,N,,A,,CHEMBL627934,,BAO_0000218,
7691,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,N,,A,,CHEMBL627935,,BAO_0000218,
7692,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,N,,A,,CHEMBL627936,,BAO_0000218,
7693,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL627937,,BAO_0000218,
7694,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,,A,,CHEMBL627938,,BAO_0000218,
7695,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,N,,A,,CHEMBL627939,,BAO_0000218,
7696,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,N,,A,,CHEMBL627940,,BAO_0000218,
7697,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,,A,,CHEMBL627941,,BAO_0000218,
7698,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,,A,,CHEMBL876800,,BAO_0000218,
7699,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL627942,,BAO_0000218,
7700,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,,A,,CHEMBL627943,,BAO_0000218,
7701,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,N,,A,,CHEMBL627944,,BAO_0000218,
7702,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,N,,A,,CHEMBL627945,,BAO_0000218,
7703,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,N,,A,,CHEMBL628584,,BAO_0000218,
7704,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,N,,A,,CHEMBL628585,,BAO_0000218,
7705,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,N,,A,,CHEMBL628586,,BAO_0000218,
7706,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,N,,A,,CHEMBL628587,,BAO_0000218,
7707,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,N,,A,,CHEMBL628588,,BAO_0000218,
7708,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,N,,A,,CHEMBL628589,,BAO_0000218,
7709,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,N,,A,,CHEMBL625304,,BAO_0000218,
7710,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,N,,A,,CHEMBL625305,,BAO_0000218,
7711,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,N,,A,,CHEMBL625306,,BAO_0000218,
7712,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,N,,A,,CHEMBL625307,,BAO_0000218,
7713,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,N,,A,,CHEMBL625308,,BAO_0000218,
7714,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,N,,A,,CHEMBL627740,,BAO_0000218,
7715,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,N,,A,,CHEMBL627741,,BAO_0000218,
7716,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,,A,,CHEMBL627742,,BAO_0000218,
7717,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL627743,,BAO_0000218,
7718,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL627744,,BAO_0000218,
7719,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL627745,,BAO_0000218,
7720,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,,A,,CHEMBL627746,,BAO_0000218,
7721,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,,A,,CHEMBL627747,,BAO_0000218,
7722,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,N,,A,,CHEMBL876810,,BAO_0000218,
7723,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,N,,A,,CHEMBL627748,,BAO_0000218,
7724,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,,A,,CHEMBL627749,,BAO_0000218,
7725,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,,A,,CHEMBL627750,,BAO_0000218,
7726,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL618728,,BAO_0000218,
7727,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,,A,,CHEMBL618729,,BAO_0000218,
7728,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,N,,A,,CHEMBL618730,,BAO_0000218,
7729,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,N,,A,,CHEMBL618731,,BAO_0000218,
7730,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,N,,A,,CHEMBL618732,,BAO_0000218,
7731,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,N,,A,,CHEMBL618733,,BAO_0000218,
7732,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,N,,A,,CHEMBL618734,,BAO_0000218,
7733,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,N,,A,,CHEMBL618735,,BAO_0000218,
7734,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,N,,A,,CHEMBL876602,,BAO_0000218,
7735,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,N,,A,,CHEMBL618736,,BAO_0000218,
7736,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,N,,A,,CHEMBL618737,,BAO_0000218,
7737,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,N,,A,,CHEMBL618738,,BAO_0000218,
7738,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,N,,A,,CHEMBL618739,,BAO_0000218,
7739,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,N,,A,,CHEMBL618740,,BAO_0000218,
7740,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,,A,,CHEMBL618741,,BAO_0000218,
7741,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL618742,,BAO_0000218,
7742,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL618743,,BAO_0000218,
7743,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17752,Half-life from rat plasma at a single oral dose of 25 mg/kg,,N,,A,,CHEMBL618744,,BAO_0000218,
7744,Rattus norvegicus,50597,,,1,,,Intermediate,5610,Half-life in male rat,,N,,A,,CHEMBL618745,,BAO_0000218,
7745,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Half-life in rat after peroral administration at 10 mg/kg concentration,,N,,A,,CHEMBL620479,,BAO_0000218,
7746,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Half-life in rat after peroral administration at 5 mg/kg concentration,,N,,A,,CHEMBL620480,,BAO_0000218,
7747,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17771,Half-life in rat at a dose of 3 mg/kg,,N,,A,,CHEMBL620481,,BAO_0000218,
7748,Rattus norvegicus,50597,,,1,,,Intermediate,1974,Half-life was evaluated in rats,,N,,A,,CHEMBL620482,,BAO_0000218,
7749,Rattus norvegicus,50597,,,1,,,Intermediate,4239,Half-life was measured in rat,,N,,A,,CHEMBL876603,,BAO_0000218,
7750,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6681,Half-life period for the compound was determined in rats at 50 mg/kg dose,,N,,A,,CHEMBL620483,,BAO_0000218,
7751,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17752,Half-life period in rats after intravenous administration at 5 mg/kg,,N,,A,,CHEMBL620484,,BAO_0000218,
7752,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6046,Half-life period in rat at 10 mg/kg,,N,,A,,CHEMBL620485,,BAO_0000218,
7753,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,N,,A,,CHEMBL620486,,BAO_0000218,
7754,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,N,,A,,CHEMBL620487,,BAO_0000218,
7755,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,N,,A,,CHEMBL620488,,BAO_0000218,
7756,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4727,Half-life time in rat the dose of 2 mg/kg,,N,,A,,CHEMBL620489,,BAO_0000218,
7757,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1088,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,N,,A,,CHEMBL620490,,BAO_0000218,
7758,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5610,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,N,,A,,CHEMBL620491,,BAO_0000218,
7759,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,3032,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,N,,A,,CHEMBL876604,,BAO_0000218,
7760,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5199,Oral half life was determined,,N,,A,,CHEMBL620492,,BAO_0000218,
7761,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14941,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,N,,A,,CHEMBL620493,,BAO_0000218,
7762,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4408,Pharmacokinetic property (t1/2) in rat,,N,,A,,CHEMBL620494,,BAO_0000218,
7763,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2552,Plasma elimination half-life was determined,,N,,A,,CHEMBL620495,,BAO_0000218,
7764,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5199,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,,A,,CHEMBL620496,,BAO_0000218,
7765,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,Plasma half life was observed after intravenous administration in rat,,N,,A,,CHEMBL620497,,BAO_0000218,
7766,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1465,Plasma half-life was determined,,N,,A,,CHEMBL620498,,BAO_0000218,
7767,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1446,Plasma half-life following oral administration in Fisher rats,,N,,A,,CHEMBL620499,,BAO_0000218,
7768,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6824,Plasma half-life in rat,,N,,A,,CHEMBL620500,,BAO_0000218,
7769,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17533,Plasmatic Half-life after intravenous administration to rat,,N,,A,,CHEMBL873809,,BAO_0000218,
7770,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5979,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,N,,A,,CHEMBL620501,,BAO_0000218,
7771,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4689,Terminal half life after intravenous administration (1 mg/kg) in rat,,N,,A,,CHEMBL620502,,BAO_0000218,
7772,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4689,Terminal half life in Rat at a oral dose of 5 mg/kg,,N,,A,,CHEMBL620503,,BAO_0000218,
7773,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2463,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,N,,A,,CHEMBL620504,,BAO_0000218,
7774,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4883,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,N,,A,,CHEMBL876605,,BAO_0000218,
7775,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4883,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,N,,A,,CHEMBL620505,,BAO_0000218,
7776,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,plasma half life was observed after intravenous administration in rat,,N,,A,,CHEMBL873811,,BAO_0000218,
7777,Rattus norvegicus,50597,,,1,In vivo,,Expert,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL624016,,BAO_0000218,
7778,Rattus norvegicus,50597,,,1,,,Intermediate,4576,Half life of compound determined in rat,,N,,A,,CHEMBL624017,,BAO_0000218,
7779,Rattus norvegicus,50597,,,1,,,Intermediate,4576,Mean residence time determined in rat,,N,,A,,CHEMBL624018,,BAO_0000218,
7780,Rattus norvegicus,50597,,,1,,,Intermediate,4576,Plasma half life determined in rat,,N,,A,,CHEMBL624019,,BAO_0000218,
7781,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,4910,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,N,,A,,CHEMBL624020,,BAO_0000218,
7782,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4891,Compound was evaluated for pharmacokinetic parameter maximum time period,,N,,A,,CHEMBL624201,,BAO_0000218,
7783,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,N,,A,,CHEMBL872528,,BAO_0000218,
7784,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624202,,BAO_0000218,
7785,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624203,,BAO_0000218,
7786,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624350,,BAO_0000218,
7787,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL621320,,BAO_0000218,
7788,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,,A,,CHEMBL621321,,BAO_0000218,
7789,Rattus norvegicus,50597,,,1,,,Intermediate,4026,Maximum time (Tmax) required to reach Cmax in rats,,N,,A,,CHEMBL621322,,BAO_0000218,
7790,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4890,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL621323,,BAO_0000218,
7791,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6571,Maximum time of clearance of compound in rats after peroral administration,,N,,A,,CHEMBL621324,,BAO_0000218,
7792,Rattus norvegicus,50597,,,1,,,Intermediate,4727,Maximum time at the dose of 2 mg/kg in rat,,N,,A,,CHEMBL621325,,BAO_0000218,
7793,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17651,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,N,,A,,CHEMBL875837,,BAO_0000218,
7794,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17651,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,N,,A,,CHEMBL621326,,BAO_0000218,
7795,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14465,Tmax in Guinea pig (PO dose),,N,,A,,CHEMBL621327,,BAO_0000218,
7796,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14941,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,N,,A,,CHEMBL621328,,BAO_0000218,
7797,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5960,Pharmacokinetic parameter (Tmax) in rat,,N,,A,,CHEMBL621329,,BAO_0000218,
7798,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5022,Pharmacokinetic parameter (Tmax) was estimated,,N,,A,,CHEMBL621330,,BAO_0000218,
7799,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4408,Pharmacokinetic property (Tmax) in rat,,N,,A,,CHEMBL621331,,BAO_0000218,
7800,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5983,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,,A,,CHEMBL621332,,BAO_0000218,
7801,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4689,T max in Rat at a oral dose of 5 mg/kg,,N,,A,,CHEMBL621333,,BAO_0000218,
7802,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,T max was determined at 10 mg/kg po dose in rats,,N,,A,,CHEMBL621334,,BAO_0000218,
7803,Mus musculus,50594,,,1,,,Intermediate,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,,A,,CHEMBL621335,,BAO_0000218,
7804,Canis lupus familiaris,50588,,,1,,,Intermediate,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,N,,A,,CHEMBL621336,,BAO_0000218,
7805,Rattus norvegicus,50597,,,1,,,Intermediate,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,N,,A,,CHEMBL621337,,BAO_0000218,
7806,Canis lupus familiaris,50588,,,1,,,Intermediate,14599,Area under curve was measured after i.v. administration into Beagle dog.,,N,,A,,CHEMBL621338,,BAO_0000218,
7807,Canis lupus familiaris,50588,,,1,,,Intermediate,14599,Area under curve was measured after iv administration into Beagle dog,,N,,A,,CHEMBL875838,,BAO_0000218,
7808,Canis lupus familiaris,50588,,,1,,,Intermediate,14599,Area under curve was measured after po administration into Beagle dog,,N,,A,,CHEMBL621339,,BAO_0000218,
7809,Canis lupus familiaris,50588,,,1,,,Intermediate,14599,Area under curve was measured after po administration into Beagle dog.,,N,,A,,CHEMBL621340,,BAO_0000218,
7810,,22224,,,1,,,Autocuration,15675,Area under curve was measured at peroral dose of 3 mg/kg,,U,,A,,CHEMBL621341,,BAO_0000218,
7811,,22224,,,1,,,Autocuration,12706,Area under curve was measured by using concentration Vs time,,U,,A,,CHEMBL621342,,BAO_0000019,
7812,,22224,,,1,,,Autocuration,12706,Area under curve was measured by using concentration Vs time; not tested,,U,,A,,CHEMBL621343,,BAO_0000019,
7813,Mus musculus,50594,,,1,,,Intermediate,9750,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,N,,A,,CHEMBL621344,,BAO_0000218,
7814,Mus musculus,50594,,,1,,,Intermediate,9750,Area under curve(AUC) was measured in mice after oral administration.,,N,,A,,CHEMBL621345,,BAO_0000218,
7815,,22224,,,1,,,Autocuration,14691,Area under curve(AUC) value of the compound,,U,,A,,CHEMBL621346,,BAO_0000019,
7816,,22224,,,1,,,Autocuration,14691,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,U,,A,,CHEMBL621347,,BAO_0000218,
7817,Canis lupus familiaris,50588,,,1,,,Intermediate,14691,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,N,,A,,CHEMBL621348,,BAO_0000218,
7818,,22224,178.0,,1,,,Autocuration,2939,Area under curve(carotid artery) was determined by the availability in blood,,U,,A,,CHEMBL621349,,BAO_0000019,
7819,,22224,178.0,,1,,,Autocuration,2939,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,U,,A,,CHEMBL621350,,BAO_0000019,
7820,,22224,178.0,,1,,,Autocuration,2939,Area under curve(carotid artery) was determined by the availability in blood; No data,,U,,A,,CHEMBL875839,,BAO_0000019,
7821,,22224,178.0,,1,,,Autocuration,2939,Area under curve(portal vein) was determined by the availability in blood,,U,,A,,CHEMBL620211,,BAO_0000019,
7822,,22224,178.0,,1,,,Autocuration,2939,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,U,,A,,CHEMBL620212,,BAO_0000019,
7823,,22224,178.0,,1,,,Autocuration,2939,Area under curve(portal vein) was determined by the availability in blood; No data,,U,,A,,CHEMBL620213,,BAO_0000019,
7824,Macaca mulatta,50797,1969.0,,1,,,Intermediate,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,,A,,CHEMBL620214,,BAO_0000218,
7825,Macaca mulatta,50797,1969.0,,1,,,Intermediate,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,,A,,CHEMBL620215,,BAO_0000218,
7826,Macaca mulatta,50797,1969.0,,1,,,Intermediate,9552,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,N,,A,,CHEMBL620216,,BAO_0000218,
7827,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,N,,A,,CHEMBL620888,,BAO_0000218,
7828,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,N,,A,,CHEMBL620889,,BAO_0000218,
7829,,22224,1969.0,,1,,,Autocuration,9552,Area under plasma concentration vs time curve observed in rats for 0-3 h,,U,,A,,CHEMBL620890,,BAO_0000019,
7830,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,11911,Area under plasma time curve determined in male rat,,N,,A,,CHEMBL620891,,BAO_0000218,
7831,,22224,,,1,,,Autocuration,16618,Area under the MAP curve measured over 5 min.,,U,,A,,CHEMBL620892,,BAO_0000019,
7832,Mus musculus,50594,,,1,,,Intermediate,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,N,,A,,CHEMBL621079,,BAO_0000218,
7833,Mus musculus,50594,,,1,,,Intermediate,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,N,,A,,CHEMBL621080,,BAO_0000218,
7834,Canis lupus familiaris,50588,,,1,,,Intermediate,12836,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,N,,A,,CHEMBL621081,,BAO_0000218,
7835,Cricetinae,100712,,,1,,,Intermediate,12836,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,N,,A,,CHEMBL621082,,BAO_0000218,
7836,Rattus norvegicus,50597,,,1,,,Intermediate,12836,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,N,,A,,CHEMBL621083,,BAO_0000218,
7837,Canis lupus familiaris,50588,,,1,,,Intermediate,14339,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,N,,A,,CHEMBL621084,,BAO_0000218,
7838,Canis lupus familiaris,50588,,,1,,,Intermediate,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,N,,A,,CHEMBL621085,,BAO_0000218,
7839,Canis lupus familiaris,50588,,,1,,,Intermediate,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,N,,A,,CHEMBL621086,,BAO_0000218,
7840,Canis lupus familiaris,50588,,,1,,,Intermediate,10524,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,,A,,CHEMBL621087,,BAO_0000218,
7841,Canis lupus familiaris,50588,,,1,,,Intermediate,9994,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,N,,A,,CHEMBL622607,,BAO_0000218,
7842,Canis lupus familiaris,50588,,,1,,,Intermediate,11325,Serum AUC in marmosets (IV dose),,N,,A,,CHEMBL622608,,BAO_0000218,
7843,,22224,,,1,,,Autocuration,12536,Area under the curve after intravenous administration at a dose of 10 umol/kg,,U,,A,,CHEMBL624481,,BAO_0000019,
7844,,22224,,,1,,,Autocuration,12536,Area under the curve after intravenous administration at a dose of 2 umol/kg,,U,,A,,CHEMBL624482,,BAO_0000019,
7845,,22224,,,1,,,Autocuration,12536,Area under the curve after intravenous administration at a dose of 4 umol/kg,,U,,A,,CHEMBL624483,,BAO_0000019,
7846,,22224,,,1,,,Autocuration,12536,Area under the curve after intravenous administration at a dose of 40 umol/kg,,U,,A,,CHEMBL624484,,BAO_0000019,
7847,,22224,,,1,,,Autocuration,12536,Area under the curve after intravenous administration at a dose of 5 umol/kg,,U,,A,,CHEMBL624485,,BAO_0000019,
7848,Rattus norvegicus,50597,,,1,,,Intermediate,15556,Area under the curve for fumarate salt was evaluated in F344 Rats.,,N,,A,,CHEMBL624486,,BAO_0000218,
7849,,22224,,,1,,,Autocuration,2809,Area under the curve for the compound was calculated.,,U,,A,,CHEMBL624487,,BAO_0000019,
7850,,22224,,,1,,,Autocuration,9511,Area under the curve in concentration/ time,,U,,A,,CHEMBL624488,,BAO_0000019,
7851,Rattus norvegicus,50597,,,1,,,Intermediate,12818,Area under the curve administered intraintestinal in rats.,,N,,A,,CHEMBL624489,,BAO_0000218,
7852,Rattus norvegicus,50597,,,1,,,Intermediate,12818,Area under the curve administered intravenously in rats.,,N,,A,,CHEMBL625184,,BAO_0000218,
7853,,22224,,,1,,,Autocuration,15118,Area under the curve during intravenous administration,,U,,A,,CHEMBL625185,,BAO_0000019,
7854,,22224,,,1,,,Autocuration,15118,Area under the curve during intravenous administration; Not determined,,U,,A,,CHEMBL875954,,BAO_0000019,
7855,,22224,,,1,,,Autocuration,15118,Area under the curve during systemic administration,,U,,A,,CHEMBL625186,,BAO_0000019,
7856,,22224,,,1,,,Autocuration,15118,Area under the curve during systemic administration; Not determined,,U,,A,,CHEMBL625187,,BAO_0000019,
7857,,22224,,,1,,,Autocuration,2632,Area under the curve was calculated for the compound.,,U,,A,,CHEMBL625188,,BAO_0000019,
7858,Canis lupus familiaris,50588,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,N,,A,,CHEMBL625189,,BAO_0000218,
7859,Canis lupus familiaris,50588,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,N,,A,,CHEMBL625190,,BAO_0000218,
7860,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,N,,A,,CHEMBL621733,,BAO_0000218,
7861,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,N,,A,,CHEMBL621734,,BAO_0000218,
7862,Rattus norvegicus,50597,,,1,,,Intermediate,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,N,,A,,CHEMBL621735,,BAO_0000218,
7863,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17796,Clearance of the drug was measured in the plasma of rat; No data,,N,,A,,CHEMBL621736,,BAO_0000218,
7864,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5247,The pharmacokinetic parameter plasma clearance in vivo in rats,,N,,A,,CHEMBL621737,,BAO_0000218,
7865,Rattus norvegicus,50597,,,1,,,Intermediate,4727,Plasma clearance at the dose of 2 mg/kg in rat,,N,,A,,CHEMBL621738,,BAO_0000218,
7866,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,,A,,CHEMBL622806,,BAO_0000218,
7867,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,,A,,CHEMBL623519,,BAO_0000218,
7868,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,,A,,CHEMBL623520,,BAO_0000218,
7869,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17065,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,,A,,CHEMBL623521,,BAO_0000218,
7870,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17671,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,,A,,CHEMBL623522,,BAO_0000218,
7871,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6672,Clearance rate in rat,,N,,A,,CHEMBL623523,,BAO_0000218,
7872,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6673,Clearance rate in rat,,N,,A,,CHEMBL623690,,BAO_0000218,
7873,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL623691,,BAO_0000218,
7874,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL623692,,BAO_0000218,
7875,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL623693,,BAO_0000218,
7876,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL623694,,BAO_0000218,
7877,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4413,Clearance of compound after iv administration of 20 mg/kg dose in rat,,N,,A,,CHEMBL623695,,BAO_0000218,
7878,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,N,,A,,CHEMBL623696,,BAO_0000218,
7879,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,N,,A,,CHEMBL623697,,BAO_0000218,
7880,Macaca mulatta,22224,1969.0,,1,In vivo,,Intermediate,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,U,,A,,CHEMBL623698,,BAO_0000218,
7881,Rattus norvegicus,22224,1969.0,,1,In vivo,,Intermediate,5005,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,U,,A,,CHEMBL623699,,BAO_0000218,
7882,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15765,Mean (%CV) PK parameters for CL(mL/min/kg).,,N,,A,,CHEMBL623700,,BAO_0000218,
7883,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3747,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,N,,A,,CHEMBL623701,,BAO_0000218,
7884,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16366,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,N,,A,,CHEMBL623702,,BAO_0000218,
7885,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4199,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,N,,A,,CHEMBL623703,,BAO_0000218,
7886,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17267,Plasma clearance in rat was determined,,N,,A,,CHEMBL623704,,BAO_0000218,
7887,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Plasma clearance in rat after administration of 2 mg/kg iv,,N,,A,,CHEMBL623705,,BAO_0000218,
7888,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Plasma clearance in rat after administration of 2 mg/kg iv,,N,,A,,CHEMBL623706,,BAO_0000218,
7889,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,Plasma clearance was determined,,N,,A,,CHEMBL623707,,BAO_0000218,
7890,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5960,Plasma clearance in rat,,N,,A,,CHEMBL623708,,BAO_0000218,
7891,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5937,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,N,,A,,CHEMBL623709,,BAO_0000218,
7892,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5871,Plasma clearance in rat by iv administration,,N,,A,,CHEMBL623710,,BAO_0000218,
7893,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5874,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,N,,A,,CHEMBL623711,,BAO_0000218,
7894,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6504,Plasma clearance in rat p.o.,,N,,A,,CHEMBL623712,,BAO_0000218,
7895,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6803,Plasma clearance in rats,,N,,A,,CHEMBL623713,,BAO_0000218,
7896,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,Plasma clearance was determined; ND denotes no data,,N,,A,,CHEMBL623714,,BAO_0000218,
7897,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,Plasma clearance was determined; ND denotes not determined,,N,,A,,CHEMBL623715,,BAO_0000218,
7898,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1916,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,,A,,CHEMBL623716,,BAO_0000218,
7899,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5199,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,,A,,CHEMBL622980,,BAO_0000218,
7900,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16367,Plasma administration to rats,,N,,A,,CHEMBL622981,,BAO_0000218,
7901,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6362,Plasma clearance of the compound in female Sprague-Dawley rats,,N,,A,,CHEMBL622982,,BAO_0000218,
7902,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15662,Plasma clearance was observed after intravenous administration in rat,,N,,A,,CHEMBL622983,,BAO_0000218,
7903,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6215,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,N,,A,,CHEMBL622984,,BAO_0000218,
7904,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,N,,A,,CHEMBL622985,,BAO_0000218,
7905,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,plasma clearance was observed after intravenous administration in rat,,N,,A,,CHEMBL623631,,BAO_0000218,
7906,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4723,In vivo CL/F determined,,N,,A,,CHEMBL623632,,BAO_0000218,
7907,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,N,,A,,CHEMBL623633,,BAO_0000218,
7908,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,N,,A,,CHEMBL623634,,BAO_0000218,
7909,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5213,Compound was tested for the lower blood clearance in rat,,N,,A,,CHEMBL623635,,BAO_0000218,
7910,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4687,Evaluated for the low clearance in rat (in vivo),,N,,A,,CHEMBL621195,,BAO_0000218,
7911,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3371,Pharmacokinetic property (CLb)of the compound was determined in rat,,N,,A,,CHEMBL621196,,BAO_0000218,
7912,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4690,Rapid clearance after intravenous administration in rat was determined,,N,,A,,CHEMBL875287,,BAO_0000218,
7913,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5702,Clearance measured in rat,,N,,A,,CHEMBL621197,,BAO_0000218,
7914,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,740,Compound was evaluated for plasma clearance in rat,,N,,A,,CHEMBL621198,,BAO_0000218,
7915,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4853,Low plasma clearance was calculated in rat,,N,,A,,CHEMBL621199,,BAO_0000218,
7916,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5789,Pharmacokinetic property (Clp) in rat,,N,,A,,CHEMBL621200,,BAO_0000218,
7917,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,N,,A,,CHEMBL621201,,BAO_0000218,
7918,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,N,,A,,CHEMBL621202,,BAO_0000218,
7919,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,N,,A,,CHEMBL621203,,BAO_0000218,
7920,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Plasma clearance after IV dosing at 1 mg/kg in rat,,N,,A,,CHEMBL621204,,BAO_0000218,
7921,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,N,,A,,CHEMBL621205,,BAO_0000218,
7922,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL621206,,BAO_0000218,
7923,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,,A,,CHEMBL621207,,BAO_0000218,
7924,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,N,,A,,CHEMBL621208,,BAO_0000218,
7925,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,N,,A,,CHEMBL621209,,BAO_0000218,
7926,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,N,,A,,CHEMBL876484,,BAO_0000218,
7927,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,,A,,CHEMBL621210,,BAO_0000218,
7928,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL621211,,BAO_0000218,
7929,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,N,,A,,CHEMBL621212,,BAO_0000218,
7930,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,N,,A,,CHEMBL621213,,BAO_0000218,
7931,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,N,,A,,CHEMBL621214,,BAO_0000218,
7932,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,N,,A,,CHEMBL621215,,BAO_0000218,
7933,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,N,,A,,CHEMBL621216,,BAO_0000218,
7934,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,N,,A,,CHEMBL621217,,BAO_0000218,
7935,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,N,,A,,CHEMBL621218,,BAO_0000218,
7936,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,N,,A,,CHEMBL621219,,BAO_0000218,
7937,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,N,,A,,CHEMBL621220,,BAO_0000218,
7938,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,N,,A,,CHEMBL621221,,BAO_0000218,
7939,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,N,,A,,CHEMBL621222,,BAO_0000218,
7940,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,N,,A,,CHEMBL621223,,BAO_0000218,
7941,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,N,,A,,CHEMBL876485,,BAO_0000218,
7942,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,,A,,CHEMBL621224,,BAO_0000218,
7943,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL621225,,BAO_0000218,
7944,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL621226,,BAO_0000218,
7945,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL621227,,BAO_0000218,
7946,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,,A,,CHEMBL621228,,BAO_0000218,
7947,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,N,,A,,CHEMBL621229,,BAO_0000218,
7948,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,N,,A,,CHEMBL621230,,BAO_0000218,
7949,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,N,,A,,CHEMBL621231,,BAO_0000218,
7950,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,,A,,CHEMBL621232,,BAO_0000218,
7951,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,,A,,CHEMBL621233,,BAO_0000218,
7952,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL621234,,BAO_0000218,
7953,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,N,,A,,CHEMBL621235,,BAO_0000218,
7954,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,,A,,CHEMBL621236,,BAO_0000218,
7955,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL621237,,BAO_0000218,
7956,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL876486,,BAO_0000218,
7957,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,N,,A,,CHEMBL622436,,BAO_0000218,
7958,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,N,,A,,CHEMBL622437,,BAO_0000218,
7959,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,N,,A,,CHEMBL622438,,BAO_0000218,
7960,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,N,,A,,CHEMBL622439,,BAO_0000218,
7961,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,N,,A,,CHEMBL622440,,BAO_0000218,
7962,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL622441,,BAO_0000218,
7963,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,N,,A,,CHEMBL622442,,BAO_0000218,
7964,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL622443,,BAO_0000218,
7965,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,N,,A,,CHEMBL622444,,BAO_0000218,
7966,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,N,,A,,CHEMBL622445,,BAO_0000218,
7967,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,N,,A,,CHEMBL622446,,BAO_0000218,
7968,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,N,,A,,CHEMBL622447,,BAO_0000218,
7969,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL622448,,BAO_0000218,
7970,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,N,,A,,CHEMBL622449,,BAO_0000218,
7971,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,N,,A,,CHEMBL622450,,BAO_0000218,
7972,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,N,,A,,CHEMBL622451,,BAO_0000218,
7973,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,N,,A,,CHEMBL622452,,BAO_0000218,
7974,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,N,,A,,CHEMBL622453,,BAO_0000218,
7975,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,N,,A,,CHEMBL622454,,BAO_0000218,
7976,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,N,,A,,CHEMBL622455,,BAO_0000218,
7977,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,N,,A,,CHEMBL876024,,BAO_0000218,
7978,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,T max was determined at 3 mg/kg po dose in rats,,N,,A,,CHEMBL622456,,BAO_0000218,
7979,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL622457,,BAO_0000218,
7980,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL622458,,BAO_0000218,
7981,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,N,,A,,CHEMBL622459,,BAO_0000218,
7982,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,N,,A,,CHEMBL873343,,BAO_0000218,
7983,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,N,,A,,CHEMBL622460,,BAO_0000218,
7984,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4576,Time for maximum plasma concentration determined in rat,,N,,A,,CHEMBL622461,,BAO_0000218,
7985,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6681,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,N,,A,,CHEMBL622462,,BAO_0000218,
7986,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,N,,A,,CHEMBL622463,,BAO_0000218,
7987,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,N,,A,,CHEMBL622464,,BAO_0000218,
7988,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,N,,A,,CHEMBL622465,,BAO_0000218,
7989,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,N,,A,,CHEMBL622466,,BAO_0000218,
7990,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,N,,A,,CHEMBL622467,,BAO_0000218,
7991,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6824,Time of maximum plasma concentration in rat,,N,,A,,CHEMBL622468,,BAO_0000218,
7992,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,,A,,CHEMBL876025,,BAO_0000218,
7993,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,,A,,CHEMBL622469,,BAO_0000218,
7994,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,,A,,CHEMBL622470,,BAO_0000218,
7995,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15662,Time required to reach maximum concentration (Cmax) after oral administration in rat,,N,,A,,CHEMBL622471,,BAO_0000218,
7996,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1742,Time required to reach maximum concentration in rat plasma,,N,,A,,CHEMBL622472,,BAO_0000218,
7997,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2774,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,N,,A,,CHEMBL622473,,BAO_0000218,
7998,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,N,,A,,CHEMBL624282,,BAO_0000218,
7999,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,,A,,CHEMBL624283,,BAO_0000218,
8000,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,,A,,CHEMBL624284,,BAO_0000218,
8001,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1916,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,,A,,CHEMBL624285,,BAO_0000218,
8002,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16367,Time to reach Cmax after oral administration to rats,,N,,A,,CHEMBL624286,,BAO_0000218,
8003,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16366,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,N,,A,,CHEMBL624287,,BAO_0000218,
8004,Rattus norvegicus,50597,,,1,,,Intermediate,216,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,N,,A,,CHEMBL624288,,BAO_0000218,
8005,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6410,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,N,,A,,CHEMBL624289,,BAO_0000218,
8006,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6410,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,N,,A,,CHEMBL873344,,BAO_0000218,
8007,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6215,Tmax after peroral administration (10 mg/kg) was determined in rat,,N,,A,,CHEMBL619623,,BAO_0000218,
8008,Rattus norvegicus,50597,,,1,In vivo,,Expert,3598,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL621399,,BAO_0000218,
8009,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,N,,A,,CHEMBL621400,,BAO_0000218,
8010,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17670,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,N,,A,,CHEMBL621401,,BAO_0000218,
8011,Rattus norvegicus,50597,,,1,,,Intermediate,1465,Tmax was determined,,N,,A,,CHEMBL621402,,BAO_0000218,
8012,Rattus norvegicus,50597,,,1,,,Intermediate,2552,Tmax was determined,,N,,A,,CHEMBL621403,,BAO_0000218,
8013,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5656,Tmax after oral administration in rat,,N,,A,,CHEMBL621121,,BAO_0000218,
8014,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Tmax after peroral administration in rats at 2.4 uM/kg,,N,,A,,CHEMBL872525,,BAO_0000218,
8015,Rattus norvegicus,50597,,,1,,,Intermediate,5610,Tmax in male rat,,N,,A,,CHEMBL621122,,BAO_0000218,
8016,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6046,Tmax in rat at 10 mg/kg,,N,,A,,CHEMBL621123,,BAO_0000218,
8017,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5874,Tmax in rat by po administration at a dose of 40 mg/kg,,N,,A,,CHEMBL621124,,BAO_0000218,
8018,Rattus norvegicus,50597,,,1,,,Intermediate,17596,Tmax in rats,,N,,A,,CHEMBL621125,,BAO_0000218,
8019,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Tmax was measured in rats after peroral administration at 5 mg/kg,,N,,A,,CHEMBL621126,,BAO_0000218,
8020,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1908,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,N,,A,,CHEMBL621127,,BAO_0000218,
8021,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2959,Tmax value after administration of 20 mg/Kg oral dose in rat,,N,,A,,CHEMBL621128,,BAO_0000218,
8022,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6757,Tmax value at a dose of 10 mg/kg in male SD rats,,N,,A,,CHEMBL618263,,BAO_0000218,
8023,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6757,Tmax value at a dose of 100 mg/kg in male SD rats,,N,,A,,CHEMBL618264,,BAO_0000218,
8024,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6757,Tmax value at a dose of 50 mg/kg in male SD rats,,N,,A,,CHEMBL618265,,BAO_0000218,
8025,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4186,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,,A,,CHEMBL618266,,BAO_0000218,
8026,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15662,time required to reach maximum concentration (Cmax) after oral administration in rat,,N,,A,,CHEMBL618267,,BAO_0000218,
8027,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,N,,A,,CHEMBL618450,,BAO_0000218,
8028,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,N,,A,,CHEMBL618451,,BAO_0000218,
8029,Rattus norvegicus,50597,,,1,,,Intermediate,5546,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,,A,,CHEMBL618452,,BAO_0000218,
8030,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,3173,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,N,,A,,CHEMBL618453,,BAO_0000218,
8031,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,N,,A,,CHEMBL618454,,BAO_0000218,
8032,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,N,,A,,CHEMBL618455,,BAO_0000218,
8033,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4257,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,N,,A,,CHEMBL618456,,BAO_0000218,
8034,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6011,Compound distribution in rat tissues was determined,,N,,A,,CHEMBL618457,,BAO_0000218,
8035,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5472,Volume of distribution was evaluated in rat,,N,,A,,CHEMBL618458,,BAO_0000218,
8036,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,N,,A,,CHEMBL618459,,BAO_0000218,
8037,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,N,,A,,CHEMBL876733,,BAO_0000218,
8038,Canis lupus familiaris,50588,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,N,,A,,CHEMBL618460,,BAO_0000218,
8039,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,N,,A,,CHEMBL618461,,BAO_0000218,
8040,,22224,,,1,,,Autocuration,15469,Area under the curve was determined after oral administration (300 uM/Kg),,U,,A,,CHEMBL618462,,BAO_0000019,
8041,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,N,,A,,CHEMBL618463,,BAO_0000218,
8042,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,N,,A,,CHEMBL618464,,BAO_0000218,
8043,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,N,,A,,CHEMBL618465,,BAO_0000218,
8044,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,N,,A,,CHEMBL618466,,BAO_0000218,
8045,Rattus norvegicus,50597,,,1,,,Intermediate,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,N,,A,,CHEMBL618467,,BAO_0000218,
8046,Rattus norvegicus,50597,,,1,,,Intermediate,15372,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,,A,,CHEMBL618468,,BAO_0000218,
8047,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,N,,A,,CHEMBL618469,,BAO_0000218,
8048,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,N,,A,,CHEMBL618470,,BAO_0000218,
8049,,22224,,,1,,,Autocuration,14813,Plasma drug AUC in rat (PO dose),,U,,A,,CHEMBL618471,,BAO_0000218,
8050,Mus musculus,50594,,,1,,,Intermediate,15792,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,N,,A,,CHEMBL618472,,BAO_0000218,
8051,,22224,,,1,,,Autocuration,3579,Area under was determined at a dose of 30 mg/kg,,U,,A,,CHEMBL618473,,BAO_0000218,
8052,Mustela putorius furo,50506,,,1,,,Intermediate,12487,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,N,,A,,CHEMBL621699,,BAO_0000218,
8053,Rattus norvegicus,50597,,,1,,,Intermediate,12487,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,N,,A,,CHEMBL621700,,BAO_0000218,
8054,Rattus norvegicus,50597,,,1,,,Intermediate,12487,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,N,,A,,CHEMBL621701,,BAO_0000218,
8055,Mustela putorius furo,50506,,,1,,,Intermediate,12487,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,N,,A,,CHEMBL621702,,BAO_0000218,
8056,Canis lupus familiaris,50588,,,1,,,Intermediate,12487,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,N,,A,,CHEMBL621703,,BAO_0000218,
8057,Canis lupus familiaris,50588,,,1,,,Intermediate,12487,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,N,,A,,CHEMBL621704,,BAO_0000218,
8058,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,N,,A,,CHEMBL624259,,BAO_0000218,
8059,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,N,,A,,CHEMBL624260,,BAO_0000218,
8060,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,N,,A,,CHEMBL624430,,BAO_0000218,
8061,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,N,,A,,CHEMBL624431,,BAO_0000218,
8062,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,N,,A,,CHEMBL624432,,BAO_0000218,
8063,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,N,,A,,CHEMBL624433,,BAO_0000218,
8064,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,N,,A,,CHEMBL624434,,BAO_0000218,
8065,Rattus norvegicus,50597,,,1,,,Intermediate,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,N,,A,,CHEMBL624435,,BAO_0000218,
8066,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,N,,A,,CHEMBL618570,,BAO_0000218,
8067,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,A,,CHEMBL618571,,BAO_0000218,
8068,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,N,,A,,CHEMBL618572,,BAO_0000218,
8069,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,A,,CHEMBL618573,,BAO_0000218,
8070,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,N,,A,,CHEMBL619267,,BAO_0000218,
8071,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,A,,CHEMBL619431,,BAO_0000218,
8072,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,N,,A,,CHEMBL619432,,BAO_0000218,
8073,Mus musculus,50594,,,1,,,Intermediate,12745,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,A,,CHEMBL619433,,BAO_0000218,
8074,,22224,1969.0,,1,,,Autocuration,13298,AUC in mice after oral dose (50 mg/kg),,U,,A,,CHEMBL619434,,BAO_0000218,
8075,Mus musculus,50594,1977.0,,1,,,Intermediate,12226,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,N,,A,,CHEMBL619435,,BAO_0000218,
8076,,22224,1969.0,,1,,,Autocuration,12634,AUC (0-4 hr) ug/ml/h,,U,,A,,CHEMBL619436,,BAO_0000019,
8077,Rattus norvegicus,50597,,,1,,,Intermediate,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,N,,A,,CHEMBL619437,,BAO_0000218,
8078,,22224,,,1,,,Autocuration,13889,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,U,,A,,CHEMBL619438,,BAO_0000218,
8079,Mus musculus,50594,,,1,,,Intermediate,10018,Compound was evaluated for Area under curve in mice,,N,,A,,CHEMBL619439,,BAO_0000218,
8080,Rattus norvegicus,50597,,,1,,,Intermediate,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,,A,,CHEMBL619440,,BAO_0000218,
8081,,22224,,,1,,,Autocuration,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,U,,F,,CHEMBL619441,,BAO_0000218,
8082,Rattus norvegicus,50597,,,1,,,Intermediate,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,,A,,CHEMBL619442,,BAO_0000218,
8083,,22224,,,1,,,Autocuration,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,U,,A,,CHEMBL875156,,BAO_0000019,
8084,,22224,,,1,,,Autocuration,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,U,,A,,CHEMBL619443,,BAO_0000019,
8085,,22224,,,1,,,Autocuration,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,U,,A,,CHEMBL619444,,BAO_0000019,
8086,,22224,,,1,,,Autocuration,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,U,,A,,CHEMBL623464,,BAO_0000019,
8087,Mus musculus,50594,,,1,,,Intermediate,15115,Compound was evaluated for area under curve when administered through oral route in mouse,,N,,A,,CHEMBL623465,,BAO_0000218,
8088,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,N,,A,,CHEMBL623466,,BAO_0000218,
8089,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,N,,A,,CHEMBL623467,,BAO_0000218,
8090,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6249,Plasma clearance in rat,,N,,A,,CHEMBL623468,,BAO_0000218,
8091,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2463,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,N,,A,,CHEMBL622660,,BAO_0000218,
8092,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4969,Plasma clearance rate in Sprague-Dawley rats,,N,,A,,CHEMBL622661,,BAO_0000218,
8093,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17720,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,F,,CHEMBL622662,,BAO_0000218,
8094,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3457,Pharmacokinetic property (total body clearance) in rat,,N,,A,,CHEMBL622663,,BAO_0000218,
8095,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5983,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,N,,A,,CHEMBL622664,,BAO_0000218,
8096,Rattus norvegicus,50597,,,1,,,Intermediate,6295,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,,A,,CHEMBL622665,,BAO_0000218,
8097,Rattus norvegicus,50597,,,1,,,Intermediate,6296,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,,A,,CHEMBL622666,,BAO_0000218,
8098,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17686,Cl in rat i.v. at 2 mg/kg concentration,,N,,A,,CHEMBL621615,,BAO_0000218,
8099,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Clearance of compound after intravenous administration in rats at 24 uM/kg,,N,,A,,CHEMBL621616,,BAO_0000218,
8100,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5503,Clearance was determined,,N,,A,,CHEMBL621617,,BAO_0000218,
8101,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4368,Clearance by intravenous administration of 3.4 mg/kg in rat,,N,,A,,CHEMBL621618,,BAO_0000218,
8102,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6005,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,,A,,CHEMBL621619,,BAO_0000218,
8103,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5031,Clearance rate after i.v. administration in rats,,N,,A,,CHEMBL621620,,BAO_0000218,
8104,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4890,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL621786,,BAO_0000218,
8105,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,,A,,CHEMBL621787,,BAO_0000218,
8106,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5979,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,N,,A,,CHEMBL621788,,BAO_0000218,
8107,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5656,Clearance (Cl) after oral administration in rat,,N,,A,,CHEMBL621789,,BAO_0000218,
8108,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,N,,A,,CHEMBL621790,,BAO_0000218,
8109,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4839,Compound was tested for plasma clearance in rat,,N,,A,,CHEMBL621791,,BAO_0000218,
8110,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,5041,In vitro microsome metabolism clearance in rat was determined,Microsomes,N,,A,,CHEMBL621792,,BAO_0000218,
8111,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,5041,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Microsomes,N,,A,,CHEMBL621793,,BAO_0000218,
8112,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL621794,,BAO_0000218,
8113,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5496,In vivo plasma clearance was determined,,N,,A,,CHEMBL621795,,BAO_0000218,
8114,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5739,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,N,,A,,CHEMBL621796,,BAO_0000218,
8115,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,5676,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,N,Hepatocyte,A,,CHEMBL621797,401.0,BAO_0000218,
8116,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4239,Pharmacokinetic property (Plasma clearance) was measured in rat,,N,,A,,CHEMBL621798,,BAO_0000218,
8117,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5676,Pharmacokinetic property (clearance) in rat i.v.,,N,,A,,CHEMBL621799,,BAO_0000218,
8118,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1918,"Plasma Clearance was evaluated in rats, iv",,N,,A,,CHEMBL621800,,BAO_0000218,
8119,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17800,Plasma clearance (in vivo) in rats was determined,,N,,A,,CHEMBL621801,,BAO_0000218,
8120,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6056,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,N,,A,,CHEMBL621802,,BAO_0000218,
8121,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5496,Plasma clearance was determined,,N,,A,,CHEMBL618596,,BAO_0000218,
8122,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,N,,A,,CHEMBL618597,,BAO_0000218,
8123,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,N,,A,,CHEMBL618598,,BAO_0000218,
8124,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17752,Plasma clearance in rats,,N,,A,,CHEMBL618599,,BAO_0000218,
8125,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4576,Plasma clearance rate determined in rat,,N,,A,,CHEMBL618600,,BAO_0000218,
8126,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6011,Plasma clearance was determined in rat,,N,,A,,CHEMBL618601,,BAO_0000218,
8127,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5510,Plasma clearance was determined,,N,,A,,CHEMBL618602,,BAO_0000218,
8128,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5948,Plasma clearance value in rat,,N,,A,,CHEMBL618603,,BAO_0000218,
8129,Rattus norvegicus,50597,2107.0,,1,Ex vivo,,Intermediate,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,N,,A,,CHEMBL618604,,BAO_0000218,
8130,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4839,Clearance in rat,,N,,A,,CHEMBL618605,,BAO_0000218,
8131,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17686,Total body clearance in rat i.v. at 2 mg/kg concentration,,N,,A,,CHEMBL618606,,BAO_0000218,
8132,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6571,Clearance of compound in rats after intravenous administration,,N,,A,,CHEMBL618607,,BAO_0000218,
8133,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3364,Clearance after iv administration to rats,,N,,A,,CHEMBL618608,,BAO_0000218,
8134,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,N,,A,,CHEMBL618609,,BAO_0000218,
8135,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,N,,A,,CHEMBL618610,,BAO_0000218,
8136,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,N,,A,,CHEMBL618611,,BAO_0000218,
8137,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,N,,A,,CHEMBL618612,,BAO_0000218,
8138,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,N,,A,,CHEMBL618613,,BAO_0000218,
8139,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,N,,A,,CHEMBL621076,,BAO_0000218,
8140,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,N,,A,,CHEMBL621077,,BAO_0000218,
8141,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17670,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,N,,A,,CHEMBL621078,,BAO_0000218,
8142,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5970,Clearance in rat,,N,,A,,CHEMBL621251,,BAO_0000218,
8143,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6495,Clearance in rat after oral administration at 10 mg/kg,,N,,A,,CHEMBL621252,,BAO_0000218,
8144,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4590,Clearance in rat.,,N,,A,,CHEMBL621253,,BAO_0000218,
8145,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6193,Clearance rate following an oral dose of 20 mg/kg in rats,,N,,A,,CHEMBL621254,,BAO_0000218,
8146,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2832,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,N,,A,,CHEMBL621255,,BAO_0000218,
8147,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1052,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,N,,A,,CHEMBL621256,,BAO_0000218,
8148,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,N,,A,,CHEMBL621257,,BAO_0000218,
8149,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,N,,A,,CHEMBL621258,,BAO_0000218,
8150,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,N,,A,,CHEMBL621259,,BAO_0000218,
8151,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,N,,A,,CHEMBL621260,,BAO_0000218,
8152,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,N,,A,,CHEMBL876494,,BAO_0000218,
8153,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,N,,A,,CHEMBL621261,,BAO_0000218,
8154,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,N,,A,,CHEMBL621262,,BAO_0000218,
8155,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,N,,A,,CHEMBL621263,,BAO_0000218,
8156,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL621264,,BAO_0000218,
8157,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL621265,,BAO_0000218,
8158,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,N,,A,,CHEMBL621266,,BAO_0000218,
8159,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,N,,A,,CHEMBL621267,,BAO_0000218,
8160,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL621268,,BAO_0000218,
8161,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,N,,A,,CHEMBL621269,,BAO_0000218,
8162,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,N,,A,,CHEMBL621270,,BAO_0000218,
8163,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,N,,A,,CHEMBL621271,,BAO_0000218,
8164,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,N,,A,,CHEMBL621272,,BAO_0000218,
8165,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,N,,A,,CHEMBL621273,,BAO_0000218,
8166,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,N,,A,,CHEMBL621274,,BAO_0000218,
8167,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,N,,A,,CHEMBL876495,,BAO_0000218,
8168,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,N,,A,,CHEMBL621275,,BAO_0000218,
8169,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL621276,,BAO_0000218,
8170,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL621277,,BAO_0000218,
8171,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,N,,A,,CHEMBL621278,,BAO_0000218,
8172,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,N,,A,,CHEMBL621279,,BAO_0000218,
8173,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,N,,A,,CHEMBL621280,,BAO_0000218,
8174,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,N,,A,,CHEMBL621281,,BAO_0000218,
8175,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,N,,A,,CHEMBL621282,,BAO_0000218,
8176,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,N,,A,,CHEMBL621283,,BAO_0000218,
8177,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,N,,A,,CHEMBL621284,,BAO_0000218,
8178,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,N,,A,,CHEMBL621285,,BAO_0000218,
8179,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,N,,A,,CHEMBL621286,,BAO_0000218,
8180,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,N,,A,,CHEMBL623220,,BAO_0000218,
8181,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,N,,A,,CHEMBL623221,,BAO_0000218,
8182,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,N,,A,,CHEMBL876029,,BAO_0000218,
8183,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,N,,A,,CHEMBL623222,,BAO_0000218,
8184,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,N,,A,,CHEMBL623223,,BAO_0000218,
8185,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,N,,A,,CHEMBL621445,,BAO_0000218,
8186,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621446,,BAO_0000218,
8187,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621447,,BAO_0000218,
8188,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619681,,BAO_0000218,
8189,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619682,,BAO_0000218,
8190,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619683,,BAO_0000218,
8191,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619684,,BAO_0000218,
8192,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619685,,BAO_0000218,
8193,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619686,,BAO_0000218,
8194,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619687,,BAO_0000218,
8195,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619688,,BAO_0000218,
8196,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619689,,BAO_0000218,
8197,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619690,,BAO_0000218,
8198,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619691,,BAO_0000218,
8199,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6062,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,N,,A,,CHEMBL619692,,BAO_0000218,
8200,Rattus norvegicus,50597,,,1,,,Expert,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL619693,,BAO_0000218,
8201,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1908,Vc value after IV dose at a dose of 5 mg/kg in rats.,,N,,A,,CHEMBL619694,,BAO_0000218,
8202,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17596,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,N,,A,,CHEMBL619695,,BAO_0000218,
8203,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4891,Compound was evaluated for pharmacokinetic parameter volume of distribution,,N,,A,,CHEMBL619696,,BAO_0000218,
8204,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,740,Compound was evaluated for volume of distribution in rat,,N,,A,,CHEMBL619697,,BAO_0000218,
8205,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16366,Steady state volume distribution was determined; steady state(ss),,N,,A,,CHEMBL619698,,BAO_0000218,
8206,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3364,Steady state volume of distribution after iv administration to rats,,N,,A,,CHEMBL619699,,BAO_0000218,
8207,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2552,Steady state volume of distribution dosing at 3 mg/kg iv,,N,,A,,CHEMBL619700,,BAO_0000218,
8208,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,406,The compound was evaluated for volume of distribution in rat,,N,,A,,CHEMBL619701,,BAO_0000218,
8209,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12500,The compound was tested for volume of distribution in rat,,N,,A,,CHEMBL619702,,BAO_0000218,
8210,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12500,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,N,,A,,CHEMBL620335,,BAO_0000218,
8211,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5656,Volume distribution (VD) after oral administration in rat,,N,,A,,CHEMBL620336,,BAO_0000218,
8212,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17671,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,,A,,CHEMBL620337,,BAO_0000218,
8213,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1094,Volume distribution in rat,,N,,A,,CHEMBL620520,,BAO_0000218,
8214,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5833,Volume distribution in rat,,N,,A,,CHEMBL620521,,BAO_0000218,
8215,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Volume distribution in rat after peroral administration at 10 mg/kg,,N,,A,,CHEMBL875825,,BAO_0000218,
8216,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Volume distribution in rat after peroral administration at 5 mg/kg,,N,,A,,CHEMBL620522,,BAO_0000218,
8217,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6005,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,,A,,CHEMBL620523,,BAO_0000218,
8218,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1696,Volume of distribution in rat.,,N,,A,,CHEMBL620524,,BAO_0000218,
8219,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6672,Volume of distribution in rat,,N,,A,,CHEMBL620525,,BAO_0000218,
8220,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6673,Volume of distribution in rat,,N,,A,,CHEMBL620526,,BAO_0000218,
8221,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5871,Volume of distribution in rat by iv administration,,N,,A,,CHEMBL620527,,BAO_0000218,
8222,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6803,Volume of distribution in rats,,N,,A,,CHEMBL620528,,BAO_0000218,
8223,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5199,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,N,,A,,CHEMBL620529,,BAO_0000218,
8224,Rattus norvegicus,50597,,,1,,,Intermediate,4727,Volume distribution at the dose of 2 mg/kg in rat,,N,,A,,CHEMBL620530,,BAO_0000218,
8225,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16367,Steady state volume of distribution was determined,,N,,A,,CHEMBL620531,,BAO_0000218,
8226,Macaca mulatta,22224,,,1,In vivo,,Intermediate,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,U,,A,,CHEMBL620532,,BAO_0000218,
8227,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,U,,A,,CHEMBL620533,,BAO_0000218,
8228,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,U,,A,,CHEMBL620534,,BAO_0000218,
8229,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15765,Mean (%CV) PK parameters for Vdss(mL/kg).,,N,,A,,CHEMBL620535,,BAO_0000218,
8230,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,N,,A,,CHEMBL875826,,BAO_0000218,
8231,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,N,,A,,CHEMBL620536,,BAO_0000218,
8232,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,,A,,CHEMBL620537,,BAO_0000218,
8233,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,N,,A,,CHEMBL618526,,BAO_0000218,
8234,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5739,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,N,,A,,CHEMBL618527,,BAO_0000218,
8235,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5789,Pharmacokinetic property (Vdss) in rat,,N,,A,,CHEMBL618528,,BAO_0000218,
8236,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4239,Pharmacokinetic property (vdss) was measured in rat,,N,,A,,CHEMBL618529,,BAO_0000218,
8237,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,N,,A,,CHEMBL618530,,BAO_0000218,
8238,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6642,Volume of distribution in rat,,N,,A,,CHEMBL618531,,BAO_0000218,
8239,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5247,The pharmacokinetic parameter volume of distribution in vivo in rats,,N,,A,,CHEMBL618532,,BAO_0000218,
8240,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17720,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,F,,CHEMBL618533,,BAO_0000218,
8241,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17686,Vdss in rat i.v. at 2 mg/kg concentration,,N,,A,,CHEMBL618534,,BAO_0000218,
8242,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4689,Volume distribution after intravenous administration (1 mg/kg) in rat,,N,,A,,CHEMBL618535,,BAO_0000218,
8243,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,,A,,CHEMBL618536,,BAO_0000218,
8244,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,,A,,CHEMBL618537,,BAO_0000218,
8245,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Volume distribution at a dose of 10 uM/kg in rat was determined,,N,,A,,CHEMBL618538,,BAO_0000218,
8246,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4521,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,,A,,CHEMBL618539,,BAO_0000218,
8247,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6057,Volume distribution was calculated in rat,,N,,A,,CHEMBL618540,,BAO_0000218,
8248,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5510,Volume distribution was determined,,N,,A,,CHEMBL618541,,BAO_0000218,
8249,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2938,Volume of distribution after intravenous administration was evaluated in rat,,N,,A,,CHEMBL618542,,BAO_0000218,
8250,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,,A,,CHEMBL622544,,BAO_0000218,
8251,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,N,,A,,CHEMBL622545,,BAO_0000218,
8252,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,,A,,CHEMBL622546,,BAO_0000218,
8253,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,N,,A,,CHEMBL622547,,BAO_0000218,
8254,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5145,Volume of distribution in steady state was determined in rat,,N,,A,,CHEMBL622548,,BAO_0000218,
8255,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,N,,A,,CHEMBL622549,,BAO_0000218,
8256,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,,A,,CHEMBL622550,,BAO_0000218,
8257,Mus musculus,50594,,,1,,,Intermediate,15115,Compound was evaluated for area under curve when administered through oral route to mouse,,N,,A,,CHEMBL622551,,BAO_0000218,
8258,Rattus norvegicus,50597,,,1,,,Intermediate,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,,A,,CHEMBL622552,,BAO_0000218,
8259,Rattus norvegicus,50597,,,1,,,Intermediate,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,,A,,CHEMBL622553,,BAO_0000218,
8260,,22224,,,1,In vivo,,Autocuration,8267,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,U,,F,,CHEMBL622554,,BAO_0000218,
8261,Canis lupus familiaris,50588,,,1,,,Intermediate,8267,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,N,,A,,CHEMBL622555,,BAO_0000218,
8262,Mus musculus,50594,,,1,,,Intermediate,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,N,,A,,CHEMBL622556,,BAO_0000218,
8263,Mus musculus,50594,,,1,,,Intermediate,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,N,,A,,CHEMBL622557,,BAO_0000218,
8264,Mus musculus,50594,178.0,,1,,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,N,,A,,CHEMBL622558,,BAO_0000218,
8265,Mus musculus,50594,178.0,,1,,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,N,,A,,CHEMBL622559,,BAO_0000218,
8266,Canis lupus familiaris,50588,,,1,,,Intermediate,10754,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,N,,A,,CHEMBL622560,,BAO_0000218,
8267,Rattus norvegicus,50597,,,1,,,Intermediate,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,,A,,CHEMBL622561,,BAO_0000218,
8268,Rattus norvegicus,50597,,,1,,,Intermediate,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,N,,A,,CHEMBL622562,,BAO_0000218,
8269,Rattus norvegicus,50597,,,1,,,Intermediate,14681,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,,A,,CHEMBL622563,,BAO_0000218,
8270,,22224,,,1,,,Autocuration,13118,Concentration of compound in Central nervous system,,U,,A,,CHEMBL622564,,BAO_0000019,
8271,,22224,,,1,,,Autocuration,13118,Concentration of compound in Central nervous system; Not detectable,,U,,A,,CHEMBL622565,,BAO_0000019,
8272,Mus musculus,50594,,,1,,,Intermediate,13318,"Concentration of diester in the blood, following oral administration in mice",,N,,A,,CHEMBL622566,,BAO_0000218,
8273,Mus musculus,50594,,,1,,,Intermediate,13318,"Concentration of monoester in the blood, following oral administration in mice",,N,,A,,CHEMBL624515,,BAO_0000218,
8274,Mus musculus,50594,,,1,,,Intermediate,13318,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,N,,A,,CHEMBL624516,,BAO_0000218,
8275,,22224,,,1,,,Autocuration,15692,Evaluated for Pharmacokinetic property: Area under the curve,,U,,A,,CHEMBL624517,,BAO_0000019,
8276,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,N,,A,,CHEMBL624518,,BAO_0000218,
8277,Macaca fascicularis,100710,,,1,,,Intermediate,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,N,,A,,CHEMBL624519,,BAO_0000218,
8278,Macaca fascicularis,100710,,,1,,,Intermediate,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL624520,,BAO_0000218,
8279,Macaca fascicularis,100710,,,1,,,Intermediate,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL624521,,BAO_0000218,
8280,Macaca fascicularis,100710,,,1,,,Intermediate,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL624522,,BAO_0000218,
8281,Macaca fascicularis,100710,,,1,,,Intermediate,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL624523,,BAO_0000218,
8282,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,,A,,CHEMBL624409,,BAO_0000218,
8283,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,N,,A,,CHEMBL624410,,BAO_0000218,
8284,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,,A,,CHEMBL624411,,BAO_0000218,
8285,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,N,,A,,CHEMBL623531,,BAO_0000218,
8286,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,N,,A,,CHEMBL623532,,BAO_0000218,
8287,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,N,,A,,CHEMBL623533,,BAO_0000218,
8288,Macaca fascicularis,100710,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,,A,,CHEMBL623534,,BAO_0000218,
8289,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL623535,,BAO_0000218,
8290,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL623536,,BAO_0000218,
8291,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL623537,,BAO_0000218,
8292,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL623538,,BAO_0000218,
8293,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL623539,,BAO_0000218,
8294,Mus musculus,50594,,,1,,,Intermediate,14839,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,N,,A,,CHEMBL623540,,BAO_0000218,
8295,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,N,,A,,CHEMBL623541,,BAO_0000218,
8296,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,N,,A,,CHEMBL623542,,BAO_0000218,
8297,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,N,,A,,CHEMBL623543,,BAO_0000218,
8298,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,N,,A,,CHEMBL623544,,BAO_0000218,
8299,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,N,,A,,CHEMBL623545,,BAO_0000218,
8300,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,N,,A,,CHEMBL623546,,BAO_0000218,
8301,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5408,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL623547,,BAO_0000218,
8302,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6827,High i.v. clearance in Dawley rats,,N,,A,,CHEMBL623548,,BAO_0000218,
8303,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,17538,In vitro clearance in rat liver microsomes,Microsomes,N,,A,,CHEMBL623549,,BAO_0000218,
8304,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,6331,Intrinsic clearance in rat liver microsomes was determined,Microsomes,N,,A,,CHEMBL623550,,BAO_0000218,
8305,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,5948,Intrinsic clearance in rat hepatocytes was determined,,N,Hepatocyte,A,,CHEMBL875276,401.0,BAO_0000218,
8306,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4026,Plasma Clearance was determined,,N,,A,,CHEMBL621872,,BAO_0000218,
8307,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6647,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,N,,A,,CHEMBL621873,,BAO_0000218,
8308,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1696,Plasma clearance in rat.,,N,,A,,CHEMBL621874,,BAO_0000218,
8309,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6597,Plasma clearance in rats,,N,,A,,CHEMBL621875,,BAO_0000218,
8310,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,347,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,N,,A,,CHEMBL621876,,BAO_0000218,
8311,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16423,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,N,,A,,CHEMBL621877,,BAO_0000218,
8312,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2879,Plasma clearance was measured in rat,,N,,A,,CHEMBL621878,,BAO_0000218,
8313,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4883,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,,A,,CHEMBL621879,,BAO_0000218,
8314,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5328,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,N,,A,,CHEMBL621880,,BAO_0000218,
8315,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5160,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,N,,A,,CHEMBL621881,,BAO_0000218,
8316,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,,A,,CHEMBL621882,,BAO_0000218,
8317,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17651,Total clearance at 1 mg/kg was determined in rat,,N,,A,,CHEMBL875283,,BAO_0000218,
8318,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17651,Total clearance at 10 mg/kg was determined in rat,,N,,A,,CHEMBL621883,,BAO_0000218,
8319,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6596,Clearance in rat,,N,,A,,CHEMBL621884,,BAO_0000218,
8320,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4796,Plasma clearance rate determined in rats,,N,,A,,CHEMBL621885,,BAO_0000218,
8321,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6850,Clearance of compound in rat was evaluated,,N,,A,,CHEMBL621886,,BAO_0000218,
8322,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,N,,A,,CHEMBL621887,,BAO_0000218,
8323,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3371,Pharmacokinetic property (blood clearance) in rat,,N,,A,,CHEMBL621888,,BAO_0000218,
8324,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2083,Plasma clearance in rat,,N,,A,,CHEMBL621889,,BAO_0000218,
8325,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4942,Plasma clearance in rats,,N,,A,,CHEMBL621890,,BAO_0000218,
8326,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,6838,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Microsomes,N,,A,,CHEMBL621891,,BAO_0000218,
8327,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5353,Clearance in Dawley rat,,N,,A,,CHEMBL621892,,BAO_0000218,
8328,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Clearance rat,,N,,A,,CHEMBL621893,,BAO_0000218,
8329,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,N,,A,,CHEMBL621894,,BAO_0000218,
8330,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Clearance rat; Not determined,,N,,A,,CHEMBL621895,,BAO_0000218,
8331,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,N,,A,,CHEMBL875284,,BAO_0000218,
8332,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,,A,,CHEMBL618699,,BAO_0000218,
8333,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,,A,,CHEMBL618700,,BAO_0000218,
8334,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6211,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,N,,A,,CHEMBL618701,,BAO_0000218,
8335,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,N,,A,,CHEMBL876600,,BAO_0000218,
8336,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Clearance of compound in rat after 1 mg/kg i.v. administration,,N,,A,,CHEMBL618702,,BAO_0000218,
8337,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3341,Compound was evaluated for Hepatic clearance in rat,,N,,A,,CHEMBL618703,,BAO_0000218,
8338,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4891,In vivo clearance after 5 mg/kg dose,,N,,A,,CHEMBL618704,,BAO_0000218,
8339,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1094,Compound was tested for plasma clearance in rats,,N,,A,,CHEMBL618705,,BAO_0000218,
8340,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2938,Hepatic clearance after intravenous administration was evaluated in rat,,N,,A,,CHEMBL618706,,BAO_0000218,
8341,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17853,Lower clearance in rat (i.v.) at 0.5 mpk,,N,,A,,CHEMBL618707,,BAO_0000218,
8342,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6049,Pharmacokinetic parameter expressed as plasma clearance in rat,,N,,A,,CHEMBL618708,,BAO_0000218,
8343,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5789,Pharmacokinetic property (Clp) in rat,,N,,A,,CHEMBL618709,,BAO_0000218,
8344,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4514,Plasma clearance in Sprague-Dawley rats,,N,,A,,CHEMBL618710,,BAO_0000218,
8345,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6448,Plasma clearance (Clp) in rat,,N,,A,,CHEMBL618711,,BAO_0000218,
8346,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6062,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,N,,A,,CHEMBL618712,,BAO_0000218,
8347,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5710,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,N,,A,,CHEMBL618713,,BAO_0000218,
8348,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4709,Plasma clearance after intravenous administration of 1 mg/kg in rat,,N,,A,,CHEMBL618714,,BAO_0000218,
8349,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4521,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,,A,,CHEMBL618715,,BAO_0000218,
8350,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1742,Plasma clearance in rat was determined,,N,,A,,CHEMBL618716,,BAO_0000218,
8351,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6057,Plasma clearance measured in rat,,N,,A,,CHEMBL876601,,BAO_0000218,
8352,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6057,Plasma clearance was calculated in rat,,N,,A,,CHEMBL618717,,BAO_0000218,
8353,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5145,Plasma clearance in rat,,N,,A,,CHEMBL618718,,BAO_0000218,
8354,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5833,Plasma clearance in rat,,N,,A,,CHEMBL618719,,BAO_0000218,
8355,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6453,Plasma clearance in rat,,N,,A,,CHEMBL618720,,BAO_0000218,
8356,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6640,Plasma clearance in rat,,N,,A,,CHEMBL618721,,BAO_0000218,
8357,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6305,Plasma clearance in rats,,N,,A,,CHEMBL621477,,BAO_0000218,
8358,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6642,Plasma clearance in rat,,N,,A,,CHEMBL621478,,BAO_0000218,
8359,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5472,Plasma clearance was evaluated in rat,,N,,A,,CHEMBL621479,,BAO_0000218,
8360,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5472,Plasma clearance was evaluated in rat; Not tested,,N,,A,,CHEMBL621480,,BAO_0000218,
8361,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5144,Plasma clearance rate was determined for the compound in rat,,N,,A,,CHEMBL621481,,BAO_0000218,
8362,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,N,,A,,CHEMBL621482,,BAO_0000218,
8363,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,,A,,CHEMBL621483,,BAO_0000218,
8364,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,N,,A,,CHEMBL621484,,BAO_0000218,
8365,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621485,,BAO_0000218,
8366,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621486,,BAO_0000218,
8367,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621487,,BAO_0000218,
8368,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621488,,BAO_0000218,
8369,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621489,,BAO_0000218,
8370,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621490,,BAO_0000218,
8371,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621491,,BAO_0000218,
8372,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621492,,BAO_0000218,
8373,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621493,,BAO_0000218,
8374,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621494,,BAO_0000218,
8375,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621495,,BAO_0000218,
8376,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621496,,BAO_0000218,
8377,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621497,,BAO_0000218,
8378,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621498,,BAO_0000218,
8379,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL621499,,BAO_0000218,
8380,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL618634,,BAO_0000218,
8381,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL618635,,BAO_0000218,
8382,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL618636,,BAO_0000218,
8383,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619737,,BAO_0000218,
8384,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL619738,,BAO_0000218,
8385,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624329,,BAO_0000218,
8386,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624330,,BAO_0000218,
8387,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624331,,BAO_0000218,
8388,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624332,,BAO_0000218,
8389,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624333,,BAO_0000218,
8390,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624334,,BAO_0000218,
8391,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL624335,,BAO_0000218,
8392,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620016,,BAO_0000218,
8393,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620169,,BAO_0000218,
8394,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620170,,BAO_0000218,
8395,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620171,,BAO_0000218,
8396,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620172,,BAO_0000218,
8397,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620173,,BAO_0000218,
8398,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620174,,BAO_0000218,
8399,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620175,,BAO_0000218,
8400,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620176,,BAO_0000218,
8401,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,13950,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620177,,BAO_0000218,
8402,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620178,,BAO_0000218,
8403,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620179,,BAO_0000218,
8404,Rattus norvegicus,50597,,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620180,,BAO_0000218,
8405,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,N,,A,,CHEMBL620181,,BAO_0000218,
8406,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6571,Volume of distribution of compound in rats after intravenous administration,,N,,A,,CHEMBL620182,,BAO_0000218,
8407,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6453,Volume of distribution in rat,,N,,A,,CHEMBL620183,,BAO_0000218,
8408,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,N,,A,,CHEMBL620184,,BAO_0000218,
8409,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,,A,,CHEMBL620185,,BAO_0000218,
8410,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,,A,,CHEMBL620186,,BAO_0000218,
8411,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5353,Volume of distribution was determined in Dawley rat,,N,,A,,CHEMBL620187,,BAO_0000218,
8412,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,,A,,CHEMBL620188,,BAO_0000218,
8413,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Volume of distribution was reported in Sprague-Dawley rat,,N,,A,,CHEMBL620189,,BAO_0000218,
8414,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Volumes of distribution in rat after peroral administration,,N,,A,,CHEMBL620190,,BAO_0000218,
8415,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Volumes of distribution in rat after po administration,,N,,A,,CHEMBL620191,,BAO_0000218,
8416,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Volumes of distribution in rat after po administration; Not determined,,N,,A,,CHEMBL620192,,BAO_0000218,
8417,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5676,Pharmacokinetic property (Volume) in rat i.v.,,N,,A,,CHEMBL620193,,BAO_0000218,
8418,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,N,,A,,CHEMBL620194,,BAO_0000218,
8419,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17670,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,N,,A,,CHEMBL876730,,BAO_0000218,
8420,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6495,Volume distribution in rat after oral administration at 10 mg/kg,,N,,A,,CHEMBL620195,,BAO_0000218,
8421,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5408,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL620196,,BAO_0000218,
8422,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4883,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,,A,,CHEMBL620197,,BAO_0000218,
8423,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6647,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,N,,A,,CHEMBL620198,,BAO_0000218,
8424,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6495,Volume of distribution in rats,,N,,A,,CHEMBL620199,,BAO_0000218,
8425,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,N,,A,,CHEMBL620200,,BAO_0000218,
8426,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,N,,A,,CHEMBL620201,,BAO_0000218,
8427,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL620202,,BAO_0000218,
8428,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL620203,,BAO_0000218,
8429,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,N,,A,,CHEMBL620204,,BAO_0000218,
8430,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL620205,,BAO_0000218,
8431,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5960,Pharmacokinetic parameter (Vss) in rat,,N,,A,,CHEMBL624664,,BAO_0000218,
8432,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5676,Pharmacokinetic property (Volume) in rat i.v.,,N,,A,,CHEMBL624665,,BAO_0000218,
8433,Rattus norvegicus,50597,,,1,,,Intermediate,5948,Pharmacokinetic property (Vss) in rat,,N,,A,,CHEMBL624666,,BAO_0000218,
8434,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5979,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,N,,A,,CHEMBL624667,,BAO_0000218,
8435,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL624668,,BAO_0000218,
8436,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL624669,,BAO_0000218,
8437,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL624670,,BAO_0000218,
8438,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL624671,,BAO_0000218,
8439,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6448,Steady state volume distribution in rat,,N,,A,,CHEMBL624672,,BAO_0000218,
8440,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,N,,A,,CHEMBL624673,,BAO_0000218,
8441,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4576,Steady state volume of distribution determined in rat,,N,,A,,CHEMBL624674,,BAO_0000218,
8442,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,,A,,CHEMBL624675,,BAO_0000218,
8443,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,N,,A,,CHEMBL621728,,BAO_0000218,
8444,Rattus norvegicus,50597,,,1,,,Intermediate,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,N,,A,,CHEMBL621729,,BAO_0000218,
8445,Rattus norvegicus,50597,,,1,,,Intermediate,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,N,,A,,CHEMBL621730,,BAO_0000218,
8446,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Volume distribution in rat after administration of 2 mg/kg iv,,N,,A,,CHEMBL621731,,BAO_0000218,
8447,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Volume distribution in rat after administration of 2 mg/kg iv,,N,,A,,CHEMBL621732,,BAO_0000218,
8448,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,Volume in steady state distribution value was determined,,N,,A,,CHEMBL621908,,BAO_0000218,
8449,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,Volume in steady state distribution value was determined; ND denotes no data,,N,,A,,CHEMBL875347,,BAO_0000218,
8450,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,Volume in steady state distribution value was determined; ND denotes not determined,,N,,A,,CHEMBL621909,,BAO_0000218,
8451,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17065,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,,A,,CHEMBL621910,,BAO_0000218,
8452,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6597,Volume of distribution at steady state was evaluated in rats,,N,,A,,CHEMBL621911,,BAO_0000218,
8453,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15662,Volume of distribution at steady state was observed after intravenous administration in rat,,N,,A,,CHEMBL621912,,BAO_0000218,
8454,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6485,Volume of distribution in steady state was determined in rat,,N,,A,,CHEMBL621913,,BAO_0000218,
8455,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17655,Volume of distribution in steady state was determined in rat,,N,,A,,CHEMBL621914,,BAO_0000218,
8456,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6616,Volume of distribution after i.v. administration,,N,,A,,CHEMBL621915,,BAO_0000218,
8457,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,N,,A,,CHEMBL621916,,BAO_0000218,
8458,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,N,,A,,CHEMBL621917,,BAO_0000218,
8459,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,N,,A,,CHEMBL621918,,BAO_0000218,
8460,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (oxidized form) in spleen tissue,,N,,A,,CHEMBL621919,,BAO_0000218,
8461,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,N,,A,,CHEMBL621920,,BAO_0000218,
8462,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,N,,A,,CHEMBL621921,,BAO_0000218,
8463,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL622401,,BAO_0000218,
8464,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,N,,A,,CHEMBL875348,,BAO_0000218,
8465,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,N,,A,,CHEMBL622402,,BAO_0000218,
8466,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,N,,A,,CHEMBL622403,,BAO_0000218,
8467,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL622404,,BAO_0000218,
8468,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,N,,A,,CHEMBL622405,,BAO_0000218,
8469,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,N,,A,,CHEMBL622406,,BAO_0000218,
8470,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL622407,,BAO_0000218,
8471,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,N,,A,,CHEMBL622408,,BAO_0000218,
8472,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,N,,A,,CHEMBL622409,,BAO_0000218,
8473,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL622410,,BAO_0000218,
8474,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,N,,A,,CHEMBL622411,,BAO_0000218,
8475,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,N,,A,,CHEMBL627864,,BAO_0000218,
8476,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL627865,,BAO_0000218,
8477,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,N,,A,,CHEMBL627866,,BAO_0000218,
8478,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL627751,,BAO_0000218,
8479,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,N,,A,,CHEMBL627752,,BAO_0000218,
8480,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,N,,A,,CHEMBL627753,,BAO_0000218,
8481,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,N,,A,,CHEMBL627754,,BAO_0000218,
8482,Mus musculus,50594,,,1,,,Intermediate,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,N,,A,,CHEMBL627755,,BAO_0000218,
8483,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627756,,BAO_0000218,
8484,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627757,,BAO_0000218,
8485,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627758,,BAO_0000218,
8486,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627759,,BAO_0000218,
8487,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627760,,BAO_0000218,
8488,Mus musculus,50594,955.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627761,,BAO_0000218,
8489,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL876811,,BAO_0000218,
8490,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627762,,BAO_0000218,
8491,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627763,,BAO_0000218,
8492,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627764,,BAO_0000218,
8493,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627765,,BAO_0000218,
8494,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627766,,BAO_0000218,
8495,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627767,,BAO_0000218,
8496,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627768,,BAO_0000218,
8497,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL628422,,BAO_0000218,
8498,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL628423,,BAO_0000218,
8499,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,N,,A,,CHEMBL628424,,BAO_0000218,
8500,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,N,,A,,CHEMBL628425,,BAO_0000218,
8501,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4257,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,N,,A,,CHEMBL628426,,BAO_0000218,
8502,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,,A,,CHEMBL628427,,BAO_0000218,
8503,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5546,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,,A,,CHEMBL626938,,BAO_0000218,
8504,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6141,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,N,,A,,CHEMBL626939,,BAO_0000218,
8505,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,,A,,CHEMBL626940,,BAO_0000218,
8506,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,,A,,CHEMBL626941,,BAO_0000218,
8507,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Plasma clearance was reported in Sprague-Dawley rat,,N,,A,,CHEMBL626942,,BAO_0000218,
8508,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4689,Plasma clearance after intravenous administration (1 mg/kg) in rat,,N,,A,,CHEMBL876812,,BAO_0000218,
8509,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6848,Plasma clearance of compound in rats was evaluated,,N,,A,,CHEMBL626943,,BAO_0000218,
8510,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6848,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,N,,A,,CHEMBL626944,,BAO_0000218,
8511,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,N,,A,,CHEMBL626945,,BAO_0000218,
8512,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,,A,,CHEMBL626946,,BAO_0000218,
8513,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4956,Plasma clearance rate in Sprague-Dawley rats,,N,,A,,CHEMBL626856,,BAO_0000218,
8514,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5529,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,N,,A,,CHEMBL626857,,BAO_0000218,
8515,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,406,The compound was evaluated for plasma clearance in rat,,N,,A,,CHEMBL626858,,BAO_0000218,
8516,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17655,Total plasma clearance in rat,,N,,A,,CHEMBL627018,,BAO_0000218,
8517,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,3293,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,N,,A,,CHEMBL625331,,BAO_0000218,
8518,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,4075,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,N,,A,,CHEMBL625332,,BAO_0000218,
8519,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,C max was determined at 10 mg/kg po dose in rats,,N,,A,,CHEMBL877590,,BAO_0000218,
8520,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,C max was determined at 3 mg/kg po dose in rats,,N,,A,,CHEMBL625333,,BAO_0000218,
8521,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17594,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,N,,A,,CHEMBL625334,,BAO_0000218,
8522,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17594,Cmax after single intravenous bolus of 1 mg/kg in rats,,N,,A,,CHEMBL625335,,BAO_0000218,
8523,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4762,Cmax of compound at 5 mg/kg after po administration was determined in rat,,N,,A,,CHEMBL625336,,BAO_0000218,
8524,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17509,Cmax 24 hr after 10 mg/kg oral administration in rats,,N,,A,,CHEMBL625337,,BAO_0000218,
8525,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17509,Cmax 24 hr after 2 mg/kg oral administration in rats,,N,,A,,CHEMBL625338,,BAO_0000218,
8526,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,N,,A,,CHEMBL625339,,BAO_0000218,
8527,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Cmax in rat after administration of 2 mg/kg iv,,N,,A,,CHEMBL625340,,BAO_0000218,
8528,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Cmax in rat after administration of 2 mg/kg iv,,N,,A,,CHEMBL625341,,BAO_0000218,
8529,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3169,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,N,,A,,CHEMBL622687,,BAO_0000218,
8530,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6515,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,N,,A,,CHEMBL622688,,BAO_0000218,
8531,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11149,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,N,,A,,CHEMBL622689,,BAO_0000218,
8532,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,N,,A,,CHEMBL620295,,BAO_0000218,
8533,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17858,Cmax after 10 mg/kg oral administration in rat,,N,,A,,CHEMBL620296,,BAO_0000218,
8534,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,N,,A,,CHEMBL620297,,BAO_0000218,
8535,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Cmax after IV dosing at 1 mg/kg in rat; no data,,N,,A,,CHEMBL620298,,BAO_0000218,
8536,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4426,Cmax after oral administration at 20 mpk in rats,,N,,A,,CHEMBL620299,,BAO_0000218,
8537,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4426,Cmax after oral administration at 20 mpk in rats; Not performed.,,N,,A,,CHEMBL620300,,BAO_0000218,
8538,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4426,Cmax after oral administration at 20 mpk in rats d; Not performed.,,N,,A,,CHEMBL620301,,BAO_0000218,
8539,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5656,Cmax after oral administration in rat,,N,,A,,CHEMBL620302,,BAO_0000218,
8540,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Cmax after oral administration at a dose of 2 mg/kg in rat,,N,,A,,CHEMBL620303,,BAO_0000218,
8541,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Cmax after oral administration at a dose of 4 mg/kg in rat,,N,,A,,CHEMBL620304,,BAO_0000218,
8542,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6113,Cmax in rats after 20 mg/kg oral dose,,N,,A,,CHEMBL620305,,BAO_0000218,
8543,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Cmax after peroral administration in rats at 2.4 uM/kg,,N,,A,,CHEMBL620306,,BAO_0000218,
8544,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4756,Cmax at the dose of 2 mg/Kg administered perorally in rats,,N,,A,,CHEMBL620307,,BAO_0000218,
8545,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4756,Cmax at the dose of 5 mg/Kg administered perorally in rats,,N,,A,,CHEMBL620308,,BAO_0000218,
8546,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6402,Cmax by administering at 20 mg/kg p.o. in rats,,N,,A,,CHEMBL620309,,BAO_0000218,
8547,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5610,Cmax in male rat,,N,,A,,CHEMBL620310,,BAO_0000218,
8548,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5207,Cmax in rat,,N,,A,,CHEMBL620311,,BAO_0000218,
8549,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6011,Cmax in rat,,N,,A,,CHEMBL620312,,BAO_0000218,
8550,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6504,Cmax in rat,,N,,A,,CHEMBL620313,,BAO_0000218,
8551,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6046,Cmax in rat at 10 mg/kg,,N,,A,,CHEMBL620314,,BAO_0000218,
8552,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6504,Cmax in rat at the dose of 1 mg/kg i.v.,,N,,A,,CHEMBL620315,,BAO_0000218,
8553,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5874,Cmax in rat by po administration at a dose of 40 mg/kg,,N,,A,,CHEMBL620316,,BAO_0000218,
8554,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17686,Cmax in rat p.o. at 20 mg/kg concentration,,N,,A,,CHEMBL620317,,BAO_0000218,
8555,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5836,Cmax in rats,,N,,A,,CHEMBL620318,,BAO_0000218,
8556,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17596,Cmax in rats,,N,,A,,CHEMBL620319,,BAO_0000218,
8557,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16423,Cmax was evaluated after 20 uM/kg of peroral administration,,N,,A,,CHEMBL620320,,BAO_0000218,
8558,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Cmax was measured in rats after peroral administration at 3 mg/kg,,N,,A,,CHEMBL620321,,BAO_0000218,
8559,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1908,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,N,,A,,CHEMBL620322,,BAO_0000218,
8560,Rattus norvegicus,50597,,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620323,,BAO_0000218,
8561,Rattus norvegicus,50597,1870.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620324,,BAO_0000218,
8562,Rattus norvegicus,50597,1870.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620325,,BAO_0000218,
8563,Rattus norvegicus,50597,10000000.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620326,,BAO_0000218,
8564,Rattus norvegicus,50597,10000000.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620327,,BAO_0000218,
8565,Rattus norvegicus,50597,,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620328,,BAO_0000218,
8566,Rattus norvegicus,50597,,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620329,,BAO_0000218,
8567,Rattus norvegicus,50597,1891.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620330,,BAO_0000218,
8568,Rattus norvegicus,50597,1891.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL875286,,BAO_0000218,
8569,Rattus norvegicus,50597,,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620331,,BAO_0000218,
8570,Rattus norvegicus,50597,,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620332,,BAO_0000218,
8571,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620333,,BAO_0000218,
8572,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,A,,CHEMBL620334,,BAO_0000218,
8573,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL621015,,BAO_0000218,
8574,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL621016,,BAO_0000218,
8575,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL621191,,BAO_0000218,
8576,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL621192,,BAO_0000218,
8577,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL621193,,BAO_0000218,
8578,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL621194,,BAO_0000218,
8579,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL624204,,BAO_0000218,
8580,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL624205,,BAO_0000218,
8581,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL624206,,BAO_0000218,
8582,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL624207,,BAO_0000218,
8583,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL624208,,BAO_0000218,
8584,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL624209,,BAO_0000218,
8585,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL624210,,BAO_0000218,
8586,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL624211,,BAO_0000218,
8587,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL624212,,BAO_0000218,
8588,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL624213,,BAO_0000218,
8589,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL876611,,BAO_0000218,
8590,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL624214,,BAO_0000218,
8591,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL624215,,BAO_0000218,
8592,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL624216,,BAO_0000218,
8593,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL624217,,BAO_0000218,
8594,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL624218,,BAO_0000218,
8595,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL624219,,BAO_0000218,
8596,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL624220,,BAO_0000218,
8597,Rattus norvegicus,50597,178.0,,1,,,Intermediate,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL624221,,BAO_0000218,
8598,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL624222,,BAO_0000218,
8599,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL624223,,BAO_0000218,
8600,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL624224,,BAO_0000218,
8601,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL624225,,BAO_0000218,
8602,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,N,,A,,CHEMBL622420,,BAO_0000218,
8603,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5031,Volume of steady state distribution after i.v. administration in rats,,N,,A,,CHEMBL622421,,BAO_0000218,
8604,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6215,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,N,,A,,CHEMBL622422,,BAO_0000218,
8605,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17671,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,,A,,CHEMBL622423,,BAO_0000218,
8606,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17752,Vss was determined,,N,,A,,CHEMBL622424,,BAO_0000218,
8607,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6596,Vss in rat,,N,,A,,CHEMBL622425,,BAO_0000218,
8608,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16423,Vss was evaluated after 10 uM/kg of intra arterial administration,,N,,A,,CHEMBL876612,,BAO_0000218,
8609,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15662,volume of distribution at steady state was observed after intravenous administration in rat,,N,,A,,CHEMBL622426,,BAO_0000218,
8610,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6062,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,N,,A,,CHEMBL622427,,BAO_0000218,
8611,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5874,Pharmacokinetic (PK) parameter Vz in rat,,N,,A,,CHEMBL622428,,BAO_0000218,
8612,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4942,Volume distribution in rats,,N,,A,,CHEMBL622429,,BAO_0000218,
8613,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17796,Volume of distribution in rat; No data,,N,,A,,CHEMBL622430,,BAO_0000218,
8614,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4890,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL622431,,BAO_0000218,
8615,Rattus norvegicus,50597,2116.0,,1,,,Intermediate,15765,% absorption predicted from in vitro rat ileum transport studies,,N,,A,,CHEMBL622432,,BAO_0000218,
8616,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,N,,A,,CHEMBL622433,,BAO_0000218,
8617,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,N,,A,,CHEMBL622434,,BAO_0000218,
8618,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,N,,A,,CHEMBL622435,,BAO_0000218,
8619,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,N,,A,,CHEMBL618748,,BAO_0000218,
8620,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,N,,A,,CHEMBL618749,,BAO_0000218,
8621,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,N,,A,,CHEMBL618750,,BAO_0000218,
8622,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,N,,A,,CHEMBL618751,,BAO_0000218,
8623,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13569,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,N,,A,,CHEMBL618752,,BAO_0000218,
8624,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4576,Oral bioavailability in rat,,N,,A,,CHEMBL618753,,BAO_0000218,
8625,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,750,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,N,,A,,CHEMBL618754,,BAO_0000218,
8626,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,750,Oral bioavailability in rat,,N,,A,,CHEMBL618755,,BAO_0000218,
8627,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4590,Oral bioavailability in rat,,N,,A,,CHEMBL618756,,BAO_0000218,
8628,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1716,Oral bioavailability in rat,,N,,A,,CHEMBL618757,,BAO_0000218,
8629,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1974,Bioavailability in rat,,N,,A,,CHEMBL618758,,BAO_0000218,
8630,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4502,Oral bioavailability in rat (dose 30 mg/kg),,N,,A,,CHEMBL621088,,BAO_0000218,
8631,Rattus norvegicus,50597,,,1,,,Intermediate,3371,Pharmacokinetic property (cLogP) in rat,,N,,A,,CHEMBL621089,,BAO_0000218,
8632,Rattus norvegicus,50597,178.0,,1,,,Intermediate,9099,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,N,,F,,CHEMBL621090,,BAO_0000218,
8633,Rattus norvegicus,50597,178.0,,1,,,Intermediate,9099,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,N,,F,,CHEMBL621091,,BAO_0000218,
8634,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4590,Clearance in rat.,,N,,A,,CHEMBL876731,,BAO_0000218,
8635,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3184,Compound was evaluated for its clearance when administered intravenously in rat,,N,,A,,CHEMBL621092,,BAO_0000218,
8636,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16456,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,,A,,CHEMBL621093,,BAO_0000218,
8637,Rattus norvegicus,50597,,,1,,,Intermediate,4199,Blood: Brain distribution ratio is determined in rat,,N,,A,,CHEMBL621094,,BAO_0000218,
8638,Rattus norvegicus,50597,,,1,,,Intermediate,4199,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,N,,A,,CHEMBL621095,,BAO_0000218,
8639,Rattus norvegicus,50597,,,1,,,Intermediate,4199,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,N,,A,,CHEMBL621096,,BAO_0000218,
8640,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL621097,,BAO_0000218,
8641,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent dose excreted in 0-48 hours administered ip to male rat,,N,,F,,CHEMBL621098,,BAO_0000218,
8642,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621099,,BAO_0000218,
8643,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621100,,BAO_0000218,
8644,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL621101,,BAO_0000218,
8645,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621102,,BAO_0000218,
8646,Rattus norvegicus,50597,2037.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL876732,,BAO_0000218,
8647,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621103,,BAO_0000218,
8648,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621104,,BAO_0000218,
8649,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL621105,,BAO_0000218,
8650,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621106,,BAO_0000218,
8651,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621107,,BAO_0000218,
8652,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621108,,BAO_0000218,
8653,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621109,,BAO_0000218,
8654,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL621110,,BAO_0000218,
8655,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL621111,,BAO_0000218,
8656,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL622541,,BAO_0000218,
8657,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL622542,,BAO_0000218,
8658,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL622543,,BAO_0000218,
8659,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624412,,BAO_0000218,
8660,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624413,,BAO_0000218,
8661,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624414,,BAO_0000218,
8662,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624415,,BAO_0000218,
8663,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624416,,BAO_0000218,
8664,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624417,,BAO_0000218,
8665,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624418,,BAO_0000218,
8666,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624419,,BAO_0000218,
8667,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624420,,BAO_0000218,
8668,Mus musculus,50594,2385.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624421,,BAO_0000218,
8669,Mus musculus,50594,2385.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624422,,BAO_0000218,
8670,Mus musculus,50594,2385.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL624423,,BAO_0000218,
8671,Mus musculus,50594,2385.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL625123,,BAO_0000218,
8672,Mus musculus,50594,2385.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL625124,,BAO_0000218,
8673,Mus musculus,50594,2385.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL625125,,BAO_0000218,
8674,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL625126,,BAO_0000218,
8675,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626947,,BAO_0000218,
8676,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626948,,BAO_0000218,
8677,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626949,,BAO_0000218,
8678,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626950,,BAO_0000218,
8679,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626951,,BAO_0000218,
8680,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626952,,BAO_0000218,
8681,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626953,,BAO_0000218,
8682,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626954,,BAO_0000218,
8683,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626955,,BAO_0000218,
8684,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626956,,BAO_0000218,
8685,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626957,,BAO_0000218,
8686,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626958,,BAO_0000218,
8687,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626959,,BAO_0000218,
8688,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626960,,BAO_0000218,
8689,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL626961,,BAO_0000218,
8690,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627589,,BAO_0000218,
8691,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,17208,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,N,,A,,CHEMBL627590,,BAO_0000218,
8692,Mus musculus,50594,,,1,,,Intermediate,3132,Time taken for EC90 was determined when tested in mouse,,N,,A,,CHEMBL627591,,BAO_0000218,
8693,Mus musculus,50594,,,1,,,Intermediate,3132,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,N,,A,,CHEMBL627592,,BAO_0000218,
8694,Mus musculus,50594,,,1,In vivo,,Intermediate,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,N,,A,,CHEMBL627593,,BAO_0000218,
8695,Mus musculus,50594,,,1,,,Intermediate,5727,Half life in mice,,N,,A,,CHEMBL627594,,BAO_0000218,
8696,Mus musculus,50594,,,1,In vivo,,Intermediate,5302,Half life period in mouse after 10 mg/Kg dose,,N,,A,,CHEMBL876813,,BAO_0000218,
8697,Mus musculus,50594,,,1,In vivo,,Intermediate,5302,Half life period in mouse after 10 mg/kg dose,,N,,A,,CHEMBL627595,,BAO_0000218,
8698,Mus musculus,50594,,,1,In vivo,,Intermediate,6348,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,N,,A,,CHEMBL627596,,BAO_0000218,
8699,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5964,Cmax value at 5 mg/kg po was determined in rat,,N,,A,,CHEMBL627597,,BAO_0000218,
8700,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6078,Cmax value evaluated in rat,,N,,A,,CHEMBL627598,,BAO_0000218,
8701,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,5206,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,N,,A,,CHEMBL627599,,BAO_0000218,
8702,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2959,Cmax value after administration of 20 mg/Kg oral dose in rat,,N,,A,,CHEMBL627600,,BAO_0000218,
8703,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5964,Cmax value at 1 mg/kg po in rat,,N,,A,,CHEMBL627601,,BAO_0000218,
8704,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5964,Cmax value at 5 mg/kg po in rat,,N,,A,,CHEMBL627776,,BAO_0000218,
8705,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6757,Cmax value at a dose of 10 mg/kg in male SD rats,,N,,A,,CHEMBL627777,,BAO_0000218,
8706,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6757,Cmax value at a dose of 100 mg/kg in male SD rats,,N,,A,,CHEMBL627778,,BAO_0000218,
8707,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6757,Cmax value at a dose of 50 mg/kg in male SD rats,,N,,A,,CHEMBL627779,,BAO_0000218,
8708,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17617,Cmax value in rats at 10 mg/kg,,N,,A,,CHEMBL876814,,BAO_0000218,
8709,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1445,Cmax value was evaluated in rats at a dose of 20 mg/kg,,N,,A,,CHEMBL627780,,BAO_0000218,
8710,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6082,Cmax value was determined after peroral administration of 20 mg/kg in rat,,N,,A,,CHEMBL627781,,BAO_0000218,
8711,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,N,,A,,CHEMBL627782,,BAO_0000218,
8712,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5407,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,N,,A,,CHEMBL627783,,BAO_0000218,
8713,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2690,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,N,,A,,CHEMBL627784,,BAO_0000218,
8714,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,N,,A,,CHEMBL627785,,BAO_0000218,
8715,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,N,,A,,CHEMBL627786,,BAO_0000218,
8716,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4891,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,N,,A,,CHEMBL627787,,BAO_0000218,
8717,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,N,,A,,CHEMBL627788,,BAO_0000218,
8718,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,N,,A,,CHEMBL626579,,BAO_0000218,
8719,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,N,,A,,CHEMBL626580,,BAO_0000218,
8720,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3634,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,N,,A,,CHEMBL876815,,BAO_0000218,
8721,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,N,,A,,CHEMBL626581,,BAO_0000218,
8722,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,N,,A,,CHEMBL626582,,BAO_0000218,
8723,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,429,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,N,,A,,CHEMBL626583,,BAO_0000218,
8724,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL626205,,BAO_0000218,
8725,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL626206,,BAO_0000218,
8726,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL626207,,BAO_0000218,
8727,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL623882,,BAO_0000218,
8728,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,N,,A,,CHEMBL623883,,BAO_0000218,
8729,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,N,,A,,CHEMBL623884,,BAO_0000218,
8730,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,3032,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,N,,A,,CHEMBL623885,,BAO_0000218,
8731,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6295,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,N,,A,,CHEMBL623886,,BAO_0000218,
8732,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6619,Maximal concentration in rat was determined,,N,,A,,CHEMBL623887,,BAO_0000218,
8733,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6616,Maximal concentration after i.v. administration,,N,,A,,CHEMBL623888,,BAO_0000218,
8734,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,3249,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,N,,A,,CHEMBL623889,,BAO_0000218,
8735,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17791,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,N,,A,,CHEMBL623890,,BAO_0000218,
8736,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17791,Cmax in rat plasma after oral dose (50 mg/Kg),,N,,A,,CHEMBL623891,,BAO_0000218,
8737,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1360,Maximal plasma concentration was determined.,,N,,A,,CHEMBL623892,,BAO_0000218,
8738,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2552,Maximal plasma drug concentration was determined,,N,,A,,CHEMBL623893,,BAO_0000218,
8739,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6571,Maximal concentration in rats after peroral administration,,N,,A,,CHEMBL877616,,BAO_0000218,
8740,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Maximum concentration in rat after 2 mg/kg peroral administration,,N,,A,,CHEMBL623894,,BAO_0000218,
8741,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6567,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,N,,A,,CHEMBL623895,,BAO_0000218,
8742,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3031,Maximum concentration of compound in rat was evaluated.,,N,,A,,CHEMBL623896,,BAO_0000218,
8743,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3436,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL623897,,BAO_0000218,
8744,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3436,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL623898,,BAO_0000218,
8745,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2083,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,N,,A,,CHEMBL623899,,BAO_0000218,
8746,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3436,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL623900,,BAO_0000218,
8747,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,N,,A,,CHEMBL623901,,BAO_0000218,
8748,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1974,Maximum concentration was evaluated in rats,,N,,A,,CHEMBL623902,,BAO_0000218,
8749,Rattus norvegicus,50597,1359.0,,1,In vivo,,Intermediate,3307,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,N,,A,,CHEMBL623903,,BAO_0000218,
8750,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,3307,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,N,,A,,CHEMBL623904,,BAO_0000218,
8751,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1916,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,N,,A,,CHEMBL877617,,BAO_0000218,
8752,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1500,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,N,,A,,CHEMBL623905,,BAO_0000218,
8753,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1500,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,N,,A,,CHEMBL623906,,BAO_0000218,
8754,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4186,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,,A,,CHEMBL623907,,BAO_0000218,
8755,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL623908,,BAO_0000218,
8756,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL623909,,BAO_0000218,
8757,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL623910,,BAO_0000218,
8758,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL623911,,BAO_0000218,
8759,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL623912,,BAO_0000218,
8760,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL624616,,BAO_0000218,
8761,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL624617,,BAO_0000218,
8762,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL624618,,BAO_0000218,
8763,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL624619,,BAO_0000218,
8764,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL624794,,BAO_0000218,
8765,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL624795,,BAO_0000218,
8766,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL623921,,BAO_0000218,
8767,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL623922,,BAO_0000218,
8768,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL623923,,BAO_0000218,
8769,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL623924,,BAO_0000218,
8770,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL623925,,BAO_0000218,
8771,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL623926,,BAO_0000218,
8772,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL623927,,BAO_0000218,
8773,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL623928,,BAO_0000218,
8774,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL623929,,BAO_0000218,
8775,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL623930,,BAO_0000218,
8776,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL623931,,BAO_0000218,
8777,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL622165,,BAO_0000218,
8778,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL621249,,BAO_0000218,
8779,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL621250,,BAO_0000218,
8780,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL621448,,BAO_0000218,
8781,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL621449,,BAO_0000218,
8782,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL621450,,BAO_0000218,
8783,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL621451,,BAO_0000218,
8784,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL621452,,BAO_0000218,
8785,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL621453,,BAO_0000218,
8786,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL621454,,BAO_0000218,
8787,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL621455,,BAO_0000218,
8788,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL621456,,BAO_0000218,
8789,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL625145,,BAO_0000218,
8790,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL875847,,BAO_0000218,
8791,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL625146,,BAO_0000218,
8792,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL625147,,BAO_0000218,
8793,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL625148,,BAO_0000218,
8794,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL625149,,BAO_0000218,
8795,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL625150,,BAO_0000218,
8796,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL625151,,BAO_0000218,
8797,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL625152,,BAO_0000218,
8798,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL625153,,BAO_0000218,
8799,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL625154,,BAO_0000218,
8800,Rattus norvegicus,50597,955.0,,1,,,Intermediate,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL625155,,BAO_0000218,
8801,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL625156,,BAO_0000218,
8802,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624354,,BAO_0000218,
8803,Rattus norvegicus,50597,10000000.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624355,,BAO_0000218,
8804,Rattus norvegicus,50597,10000000.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624356,,BAO_0000218,
8805,Rattus norvegicus,50597,10000000.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624357,,BAO_0000218,
8806,Rattus norvegicus,50597,10000000.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624358,,BAO_0000218,
8807,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624359,,BAO_0000218,
8808,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624360,,BAO_0000218,
8809,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL624361,,BAO_0000218,
8810,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624362,,BAO_0000218,
8811,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624363,,BAO_0000218,
8812,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624364,,BAO_0000218,
8813,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624365,,BAO_0000218,
8814,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624366,,BAO_0000218,
8815,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624367,,BAO_0000218,
8816,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624368,,BAO_0000218,
8817,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL624369,,BAO_0000218,
8818,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL624370,,BAO_0000218,
8819,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625069,,BAO_0000218,
8820,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625070,,BAO_0000218,
8821,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626051,,BAO_0000218,
8822,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626052,,BAO_0000218,
8823,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL626053,,BAO_0000218,
8824,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626054,,BAO_0000218,
8825,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626055,,BAO_0000218,
8826,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626056,,BAO_0000218,
8827,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626057,,BAO_0000218,
8828,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625193,,BAO_0000218,
8829,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625194,,BAO_0000218,
8830,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625195,,BAO_0000218,
8831,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625196,,BAO_0000218,
8832,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL625197,,BAO_0000218,
8833,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625198,,BAO_0000218,
8834,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL627929,,BAO_0000218,
8835,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL627074,,BAO_0000218,
8836,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL627075,,BAO_0000218,
8837,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL627076,,BAO_0000218,
8838,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL627077,,BAO_0000218,
8839,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL627078,,BAO_0000218,
8840,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL627079,,BAO_0000218,
8841,Mus musculus,50594,,,1,In vivo,,Intermediate,4573,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,N,,A,,CHEMBL873824,,BAO_0000218,
8842,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,3132,Half life in mouse plasma was determined at dose 25 mg/kg,,N,,A,,CHEMBL627080,,BAO_0000218,
8843,Mus musculus,50594,,,1,,,Intermediate,17718,Half life was determined,,N,,A,,CHEMBL627081,,BAO_0000218,
8844,Mus musculus,50594,,,1,In vivo,,Intermediate,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,N,,A,,CHEMBL627082,,BAO_0000218,
8845,Mus musculus,50594,,,1,In vivo,,Intermediate,5961,Half-life in male mice after 1 mg/kg intravenous dose,,N,,A,,CHEMBL627083,,BAO_0000218,
8847,Mus musculus,50594,1969.0,,1,,,Intermediate,17731,Half life in mice plasma,,N,,A,,CHEMBL627085,,BAO_0000218,
8848,Mus musculus,50594,,,1,,,Intermediate,17592,Half life in mouse,,N,,A,,CHEMBL627086,,BAO_0000218,
8849,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,3132,Half life in mouse plasma at dose 25 mg/kg,,N,,A,,CHEMBL627087,,BAO_0000218,
8850,Mus musculus,50594,,,1,In vivo,,Intermediate,17729,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,N,,A,,CHEMBL627088,,BAO_0000218,
8851,Mus musculus,50594,,,1,In vivo,,Intermediate,17729,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,N,,A,,CHEMBL627089,,BAO_0000218,
8852,Mus musculus,50594,,,1,In vivo,,Intermediate,17729,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,N,,A,,CHEMBL627090,,BAO_0000218,
8853,Mus musculus,50594,,,1,In vivo,,Intermediate,3277,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,N,,A,,CHEMBL627091,,BAO_0000218,
8854,Mus musculus,50594,,,1,In vivo,,Intermediate,3760,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,N,,A,,CHEMBL627092,,BAO_0000218,
8855,Mus musculus,50594,,,1,In vivo,,Intermediate,3760,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,N,,A,,CHEMBL876785,,BAO_0000218,
8856,Mus musculus,50594,,,1,In vivo,,Intermediate,2862,Half-life by iv administration in mouse,,N,,A,,CHEMBL627093,,BAO_0000218,
8857,Mus musculus,50594,,,1,In vivo,,Intermediate,2862,Half-life by oral administration in mouse,,N,,A,,CHEMBL627094,,BAO_0000218,
8858,Mus musculus,50594,,,1,,,Intermediate,5980,Half-life in mice,,N,,A,,CHEMBL627095,,BAO_0000218,
8859,Mus musculus,50594,955.0,,1,,,Intermediate,6159,Half-life using mouse brain homogenate,,N,,A,,CHEMBL627096,,BAO_0000218,
8860,Mus musculus,50594,,,1,,,Intermediate,6254,Half-life was measured in mice,,N,,A,,CHEMBL627097,,BAO_0000218,
8861,Mus musculus,50594,,,1,In vivo,,Intermediate,6062,Half-life was measured in mouse after an iv dose of 1 mg/kg,,N,,A,,CHEMBL627098,,BAO_0000218,
8862,Mus musculus,50594,178.0,,1,,,Intermediate,1574,Half-life period was determined in mouse blood,,N,,A,,CHEMBL627099,,BAO_0000218,
8863,Mus musculus,50594,955.0,,1,,,Intermediate,56,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,N,,A,,CHEMBL627100,,BAO_0000218,
8864,Mus musculus,50594,1969.0,,1,,,Intermediate,993,Plasma half life in mouse,,N,,A,,CHEMBL627101,,BAO_0000218,
8865,Mus musculus,50594,,,1,,,Intermediate,6652,Stability of the peptide in the presence of mouse serum,,N,,A,,CHEMBL627102,,BAO_0000218,
8866,Mus musculus,50594,,,1,,,Intermediate,17852,Terminal half life of compound was determined in mouse,,N,,A,,CHEMBL627103,,BAO_0000218,
8867,Mus musculus,50594,,,1,In vivo,,Intermediate,2675,Terminal half life was evaluated in mice after intravenous administration,,N,,A,,CHEMBL627104,,BAO_0000218,
8868,Mus musculus,50594,,,1,In vivo,,Intermediate,2675,Terminal half life was evaluated in mice after oral administration,,N,,A,,CHEMBL627105,,BAO_0000218,
8869,Mus musculus,50594,,,1,,,Intermediate,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,N,,A,,CHEMBL876786,,BAO_0000218,
8870,Mus musculus,50594,,,1,,,Intermediate,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,N,,A,,CHEMBL873825,,BAO_0000218,
8871,Mus musculus,50594,,,1,,,Intermediate,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,N,,A,,CHEMBL627106,,BAO_0000218,
8872,Mus musculus,50594,,,1,In vivo,,Intermediate,14239,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,N,,A,,CHEMBL626336,,BAO_0000218,
8873,Mus musculus,50594,,,1,In vivo,,Intermediate,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,N,,A,,CHEMBL877462,,BAO_0000218,
8874,Mus musculus,50594,,,1,In vivo,,Intermediate,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,N,,A,,CHEMBL626337,,BAO_0000218,
8875,Mus musculus,50594,,,1,,,Intermediate,17734,Half life after intraperitoneal administration of 100 mg/kg in mice,,N,,A,,CHEMBL626338,,BAO_0000218,
8876,Mus musculus,50594,,,1,In vivo,,Intermediate,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,N,,A,,CHEMBL626339,,BAO_0000218,
8877,Mus musculus,50594,,,1,In vivo,,Intermediate,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,N,,A,,CHEMBL626340,,BAO_0000218,
8878,Mus musculus,50594,,,1,In vivo,,Intermediate,17728,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,N,,A,,CHEMBL625377,,BAO_0000218,
8879,Mus musculus,50594,,,1,In vivo,,Intermediate,17728,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,N,,A,,CHEMBL625378,,BAO_0000218,
8880,Mus musculus,50594,,,1,In vivo,,Intermediate,17728,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,N,,A,,CHEMBL625379,,BAO_0000218,
8881,Sus scrofa,22224,,,1,,,Autocuration,14294,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,U,,A,,CHEMBL625380,,BAO_0000251,
8882,Sus scrofa,22224,,,1,,,Autocuration,14294,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Microsomes,U,,A,,CHEMBL625381,,BAO_0000251,
8883,Sus scrofa,22224,,,1,,,Autocuration,6056,Stability to porcine renal DHP-I,,U,,A,,CHEMBL625382,,BAO_0000019,
8884,Sus scrofa,22224,,,1,In vivo,,Autocuration,1317,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,U,,A,,CHEMBL873828,,BAO_0000218,
8885,Sus scrofa,22224,,,1,In vivo,,Autocuration,1317,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,U,,A,,CHEMBL625383,,BAO_0000218,
8886,Sus scrofa,22224,,,1,,,Autocuration,5229,Half-life of the parent prodrug in porcine esterase solution,,U,,A,,CHEMBL625384,,BAO_0000019,
8887,Sus scrofa,22224,,,1,,,Autocuration,4231,"First order rate constant, k was determined in in pig liver Esterase",,U,,A,,CHEMBL625385,,BAO_0000019,
8888,Sus scrofa,22224,2107.0,,1,,,Autocuration,4231,Half life of the in pig liver Esterase,,U,,A,,CHEMBL625386,,BAO_0000221,
8889,Sus scrofa,22224,2107.0,,1,,,Autocuration,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,U,,A,,CHEMBL623571,,BAO_0000221,
8890,Sus scrofa,22224,2107.0,,1,,,Autocuration,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,U,,A,,CHEMBL623572,,BAO_0000221,
8891,Sus scrofa,22224,2107.0,,1,,,Autocuration,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,U,,A,,CHEMBL623573,,BAO_0000221,
8892,Sus scrofa,22224,2107.0,,1,,,Autocuration,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,U,,A,,CHEMBL623574,,BAO_0000221,
8893,Sus scrofa,22224,2107.0,,1,,,Autocuration,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,U,,A,,CHEMBL623575,,BAO_0000221,
8894,Sus scrofa,22224,2107.0,,1,,,Autocuration,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,U,,A,,CHEMBL623749,,BAO_0000221,
8895,Sus scrofa,22224,2107.0,,1,,,Autocuration,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,U,,A,,CHEMBL623750,,BAO_0000221,
8896,Sus scrofa,22224,2107.0,,1,In vitro,,Autocuration,889,Half-life in vitro in pig liver,,U,,A,,CHEMBL623751,,BAO_0000221,
8897,Sus scrofa,22224,2107.0,,1,,,Autocuration,1904,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,U,,A,,CHEMBL623752,,BAO_0000221,
8898,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4186,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,N,,A,,CHEMBL623753,,BAO_0000218,
8899,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2774,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,N,,A,,CHEMBL623754,,BAO_0000218,
8900,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1742,Maximum concentration in rat plasma was determined,,N,,A,,CHEMBL623755,,BAO_0000218,
8901,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3169,Maximum concentration in rats,,N,,A,,CHEMBL623756,,BAO_0000218,
8902,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3169,Maximum concentration in rats at 1-2 hours,,N,,A,,CHEMBL623757,,BAO_0000218,
8903,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2081,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,N,,A,,CHEMBL623758,,BAO_0000218,
8904,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,3307,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,N,,A,,CHEMBL623759,,BAO_0000218,
8905,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4727,Maximum concentration at the dose of 2 mg/kg in rat,,N,,A,,CHEMBL623760,,BAO_0000218,
8906,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6597,Maximum concentration was evaluated in rats,,N,,A,,CHEMBL623761,,BAO_0000218,
8907,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,N,,A,,CHEMBL623762,,BAO_0000218,
8908,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,N,,A,,CHEMBL877594,,BAO_0000218,
8909,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,N,,A,,CHEMBL623763,,BAO_0000218,
8910,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,N,,A,,CHEMBL623764,,BAO_0000218,
8911,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,N,,A,,CHEMBL623765,,BAO_0000218,
8912,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,N,,A,,CHEMBL623766,,BAO_0000218,
8913,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,N,,A,,CHEMBL623767,,BAO_0000218,
8914,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,N,,A,,CHEMBL623768,,BAO_0000218,
8915,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623769,,BAO_0000218,
8916,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623770,,BAO_0000218,
8917,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623771,,BAO_0000218,
8918,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623772,,BAO_0000218,
8919,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623773,,BAO_0000218,
8920,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623774,,BAO_0000218,
8921,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5978,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,N,,A,,CHEMBL623775,,BAO_0000218,
8922,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14465,Cmax in rat (PO dose),,N,,A,,CHEMBL623776,,BAO_0000218,
8923,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4723,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL622191,,BAO_0000218,
8924,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4723,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL622192,,BAO_0000218,
8925,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4576,Maximum plasma concentration determined in rat,,N,,A,,CHEMBL622193,,BAO_0000218,
8926,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,,A,,CHEMBL622194,,BAO_0000218,
8927,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,N,,A,,CHEMBL622195,,BAO_0000218,
8928,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6824,Maximum plasma concentration in rat,,N,,A,,CHEMBL622196,,BAO_0000218,
8929,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17065,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,,A,,CHEMBL622197,,BAO_0000218,
8930,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2932,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,N,,A,,CHEMBL622198,,BAO_0000218,
8931,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2932,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,N,,A,,CHEMBL622199,,BAO_0000218,
8932,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2879,Maximum plasma concentration of compound was measured in rat,,N,,A,,CHEMBL622200,,BAO_0000218,
8933,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2864,Maximum plasma concentration after 20 mg/kg oral administration in rat,,N,,A,,CHEMBL622201,,BAO_0000218,
8934,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16367,Maximum plasma concentration after oral administration to rats,,N,,A,,CHEMBL623990,,BAO_0000218,
8935,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17717,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,A,,CHEMBL623991,,BAO_0000218,
8936,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17717,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,N,,A,,CHEMBL623992,,BAO_0000218,
8937,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,A,,CHEMBL623993,,BAO_0000218,
8938,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,N,,A,,CHEMBL623994,,BAO_0000218,
8939,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,N,,F,,CHEMBL623995,,BAO_0000218,
8940,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,F,,CHEMBL623996,,BAO_0000218,
8941,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,N,,F,,CHEMBL623997,,BAO_0000218,
8942,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4516,Maximum plasma concentration dosed orally in rats,,N,,A,,CHEMBL623998,,BAO_0000218,
8943,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4516,Maximum plasma concentration dosed orally in rats after 6 hours,,N,,A,,CHEMBL623999,,BAO_0000218,
8944,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4516,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,N,,A,,CHEMBL624000,,BAO_0000218,
8945,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5199,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,N,,A,,CHEMBL624001,,BAO_0000218,
8946,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17538,Maximum plasma concentration in rat after po administration,,N,,A,,CHEMBL624002,,BAO_0000218,
8947,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6685,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,N,,A,,CHEMBL624003,,BAO_0000218,
8948,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6685,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,N,,A,,CHEMBL624004,,BAO_0000218,
8949,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL624005,,BAO_0000218,
8950,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL624006,,BAO_0000218,
8951,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL624007,,BAO_0000218,
8952,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL624008,,BAO_0000218,
8953,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL624009,,BAO_0000218,
8954,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL874387,,BAO_0000218,
8955,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL624010,,BAO_0000218,
8956,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL624011,,BAO_0000218,
8957,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL624012,,BAO_0000218,
8958,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL624013,,BAO_0000218,
8959,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL624736,,BAO_0000218,
8960,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL624737,,BAO_0000218,
8961,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL624738,,BAO_0000218,
8962,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL624739,,BAO_0000218,
8963,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL624740,,BAO_0000218,
8964,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL624896,,BAO_0000218,
8965,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL624897,,BAO_0000218,
8966,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL624108,,BAO_0000218,
8967,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL624109,,BAO_0000218,
8968,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL624110,,BAO_0000218,
8969,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL624111,,BAO_0000218,
8970,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL624112,,BAO_0000218,
8971,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL624113,,BAO_0000218,
8972,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL619709,,BAO_0000218,
8973,Rattus norvegicus,50597,948.0,,1,,,Intermediate,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL619710,,BAO_0000218,
8974,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL619711,,BAO_0000218,
8975,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL619712,,BAO_0000218,
8976,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL619713,,BAO_0000218,
8977,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL619714,,BAO_0000218,
8978,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL619715,,BAO_0000218,
8979,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL619716,,BAO_0000218,
8980,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL619717,,BAO_0000218,
8981,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL619718,,BAO_0000218,
8982,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL619719,,BAO_0000218,
8983,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL875329,,BAO_0000218,
8984,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL619720,,BAO_0000218,
8985,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL619721,,BAO_0000218,
8986,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL619722,,BAO_0000218,
8987,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL619723,,BAO_0000218,
8988,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL619724,,BAO_0000218,
8989,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL619725,,BAO_0000218,
8990,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL619726,,BAO_0000218,
8991,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL619727,,BAO_0000218,
8992,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL619728,,BAO_0000218,
8993,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL619729,,BAO_0000218,
8994,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL619730,,BAO_0000218,
8995,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL619731,,BAO_0000218,
8996,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL619732,,BAO_0000218,
8997,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL619733,,BAO_0000218,
8998,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL619734,,BAO_0000218,
8999,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL619735,,BAO_0000218,
9000,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL875330,,BAO_0000218,
9001,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL628465,,BAO_0000218,
9002,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL628466,,BAO_0000218,
9003,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL628467,,BAO_0000218,
9004,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL628468,,BAO_0000218,
9005,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL628469,,BAO_0000218,
9006,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL628470,,BAO_0000218,
9007,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL628471,,BAO_0000218,
9008,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL628472,,BAO_0000218,
9009,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625191,,BAO_0000218,
9010,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL625192,,BAO_0000218,
9011,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,A,,CHEMBL875337,,BAO_0000218,
9012,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626341,,BAO_0000218,
9013,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL626342,,BAO_0000218,
9014,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,A,,CHEMBL621943,,BAO_0000218,
9015,Rattus norvegicus,50597,,,1,,,Intermediate,3748,Half life in rats,,N,,A,,CHEMBL621944,,BAO_0000218,
9016,Rattus norvegicus,50597,,,1,,,Intermediate,15765,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,N,,A,,CHEMBL621945,,BAO_0000218,
9017,Rattus norvegicus,50597,,,1,,,Intermediate,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,N,,A,,CHEMBL621946,,BAO_0000218,
9018,Rattus norvegicus,50597,,,1,,,Intermediate,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,,A,,CHEMBL621947,,BAO_0000218,
9019,Rattus norvegicus,50597,,,1,,,Intermediate,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,N,,A,,CHEMBL621948,,BAO_0000218,
9020,Rattus norvegicus,50597,,,1,,,Intermediate,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,,A,,CHEMBL621949,,BAO_0000218,
9021,Rattus norvegicus,50597,,,1,,,Intermediate,5413,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,N,,A,,CHEMBL621950,,BAO_0000218,
9022,Rattus norvegicus,50597,,,1,,,Intermediate,5413,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,N,,A,,CHEMBL621951,,BAO_0000218,
9023,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,15272,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,N,,A,,CHEMBL621952,,BAO_0000218,
9024,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,4689,Stability (%) in rat liver microsomes,,N,,A,,CHEMBL621953,,BAO_0000218,
9025,Rattus norvegicus,50597,,,1,,,Intermediate,6057,Area under curve was calculated after intravenous administration,,N,,A,,CHEMBL621954,,BAO_0000218,
9026,Rattus norvegicus,50597,,,1,,,Intermediate,6057,Area under the curve was calculated after iv administration in rat,,N,,A,,CHEMBL621955,,BAO_0000218,
9027,Rattus norvegicus,50597,,,1,,,Intermediate,6057,Area under the curve was calculated in rat after peroral administration,,N,,A,,CHEMBL621956,,BAO_0000218,
9028,Rattus norvegicus,50597,,,1,,,Intermediate,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,,A,,CHEMBL621957,,BAO_0000218,
9029,Rattus norvegicus,50597,,,1,,,Intermediate,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,N,,A,,CHEMBL621958,,BAO_0000218,
9030,Rattus norvegicus,50597,,,1,,,Intermediate,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,N,,A,,CHEMBL621959,,BAO_0000218,
9031,Rattus norvegicus,50597,,,1,,,Intermediate,17853,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,N,,A,,CHEMBL621960,,BAO_0000218,
9032,Rattus norvegicus,50597,,,1,,,Intermediate,17853,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,N,,A,,CHEMBL621961,,BAO_0000218,
9033,Rattus norvegicus,50597,,,1,,,Intermediate,15765,p value of the compound,,N,,A,,CHEMBL621962,,BAO_0000218,
9034,Rattus norvegicus,50597,,,1,,,Intermediate,15765,p value of the compound,,N,,F,,CHEMBL876787,,BAO_0000218,
9035,Rattus norvegicus,50597,,,1,,,Intermediate,15765,p value of the compound,,N,,A,,CHEMBL621963,,BAO_0000218,
9036,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL622637,,BAO_0000218,
9037,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL622638,,BAO_0000218,
9038,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL626561,,BAO_0000218,
9039,Oryctolagus cuniculus,22224,,,1,,,Autocuration,7991,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,U,,F,,CHEMBL626562,,BAO_0000019,
9040,Oryctolagus cuniculus,22224,,,1,,,Autocuration,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,U,,A,,CHEMBL626563,,BAO_0000218,
9041,Oryctolagus cuniculus,22224,,,1,,,Autocuration,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,U,,A,,CHEMBL626564,,BAO_0000218,
9042,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,6253,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,U,,A,,CHEMBL626565,,BAO_0000218,
9043,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,6253,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,U,,A,,CHEMBL626566,,BAO_0000218,
9044,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,3615,Clearance rate in rabbits,,U,,A,,CHEMBL626567,,BAO_0000218,
9045,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,4059,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,,A,,CHEMBL626568,,BAO_0000218,
9046,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,,A,,CHEMBL626569,,BAO_0000218,
9047,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,,A,,CHEMBL626570,,BAO_0000218,
9048,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,5124,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,,A,,CHEMBL626571,,BAO_0000218,
9049,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,429,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,U,,A,,CHEMBL626572,,BAO_0000218,
9050,Oryctolagus cuniculus,22224,1969.0,,1,In vivo,,Autocuration,4059,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,,A,,CHEMBL626573,,BAO_0000218,
9051,Oryctolagus cuniculus,22224,2107.0,,1,,,Autocuration,9659,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Microsomes,U,,A,,CHEMBL626574,,BAO_0000251,
9052,Oryctolagus cuniculus,22224,2107.0,,1,,,Autocuration,9659,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Microsomes,U,,A,,CHEMBL626575,,BAO_0000251,
9053,Oryctolagus cuniculus,22224,,,1,,,Autocuration,3639,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,U,,A,,CHEMBL626576,,BAO_0000218,
9054,Oryctolagus cuniculus,22224,,,1,,,Autocuration,3639,Dose at which bioavailability of perorally administered compound was tested in rabbit,,U,,A,,CHEMBL626577,,BAO_0000218,
9055,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,3639,The compound was tested for its bioavailability in rabbit (by oral dosage).,,U,,A,,CHEMBL626578,,BAO_0000218,
9056,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,,A,,CHEMBL625263,,BAO_0000218,
9057,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,,A,,CHEMBL625264,,BAO_0000218,
9058,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,5124,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,,A,,CHEMBL625265,,BAO_0000218,
9059,Oryctolagus cuniculus,22224,,,1,,,Autocuration,14294,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,U,,A,,CHEMBL625266,,BAO_0000251,
9060,Oryctolagus cuniculus,22224,,,1,,,Autocuration,14294,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Microsomes,U,,A,,CHEMBL876796,,BAO_0000251,
9061,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,429,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,U,,A,,CHEMBL625267,,BAO_0000218,
9062,Oryctolagus cuniculus,22224,1969.0,,1,In vivo,,Autocuration,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,U,,A,,CHEMBL625268,,BAO_0000218,
9063,Oryctolagus cuniculus,22224,1969.0,,1,In vivo,,Autocuration,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,U,,A,,CHEMBL625269,,BAO_0000218,
9064,Oryctolagus cuniculus,22224,1969.0,,1,In vivo,,Autocuration,5124,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,U,,A,,CHEMBL624689,,BAO_0000218,
9065,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,429,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,U,,A,,CHEMBL624690,,BAO_0000218,
9066,Oryctolagus cuniculus,22224,1088.0,,1,,,Autocuration,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,U,,A,,CHEMBL624691,,BAO_0000218,
9067,Oryctolagus cuniculus,22224,1088.0,,1,,,Autocuration,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,U,,A,,CHEMBL624692,,BAO_0000218,
9068,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,4059,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,U,,A,,CHEMBL624693,,BAO_0000218,
9069,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,U,,A,,CHEMBL624694,,BAO_0000218,
9070,Oryctolagus cuniculus,22224,,,1,In vitro,,Autocuration,11672,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,U,,A,,CHEMBL877596,,BAO_0000221,
9071,Oryctolagus cuniculus,22224,,,1,,,Autocuration,12886,Time within which only 10% of the drug was degraded,,U,,A,,CHEMBL624695,,BAO_0000019,
9072,Oryctolagus cuniculus,22224,2107.0,,1,,,Autocuration,3853,Half life period in rabbit liver homogenate,,U,,A,,CHEMBL624696,,BAO_0000221,
9073,Oryctolagus cuniculus,22224,,,1,,,Autocuration,3615,Half life value in rabbits,,U,,A,,CHEMBL624697,,BAO_0000019,
9074,Oryctolagus cuniculus,22224,178.0,,1,In vivo,,Autocuration,6253,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,U,,A,,CHEMBL624698,,BAO_0000218,
9075,Oryctolagus cuniculus,22224,178.0,,1,In vivo,,Autocuration,6253,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,U,,A,,CHEMBL624699,,BAO_0000218,
9076,Oryctolagus cuniculus,22224,,,1,In vivo,,Autocuration,6077,Half-life period in rabbits following intravenous administration at 2 mg/kg,,U,,A,,CHEMBL624700,,BAO_0000218,
9077,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17617,AUC 0-8 hr value in rats at 10 mg/kg,,N,,A,,CHEMBL622903,,BAO_0000218,
9078,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17594,AUC after administration at 2000 mg/kg/day in rats,,N,,A,,CHEMBL622904,,BAO_0000218,
9079,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6149,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,N,,A,,CHEMBL622905,,BAO_0000218,
9080,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17260,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,,A,,CHEMBL622906,,BAO_0000218,
9081,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17260,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,,A,,CHEMBL622907,,BAO_0000218,
9082,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6644,AUC in rat after oral administration at 10.5 mg/kg dose,,N,,A,,CHEMBL622908,,BAO_0000218,
9083,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6644,AUC in rat after oral administration at 11.2 mg/kg dose,,N,,A,,CHEMBL622909,,BAO_0000218,
9084,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6644,AUC in rat after oral administration at 9.7 mg/kg dose,,N,,A,,CHEMBL622910,,BAO_0000218,
9085,Rattus norvegicus,50597,955.0,,1,,,Intermediate,6495,AUC in rat brain after oral administration at 10 mg/kg,,N,,A,,CHEMBL622911,,BAO_0000218,
9086,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6504,AUC in rat p.o.,,N,,A,,CHEMBL622912,,BAO_0000218,
9087,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17686,AUC in rat p.o. at 20 mg/kg concentration,,N,,A,,CHEMBL622913,,BAO_0000218,
9088,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6495,AUC in rat plasma after oral administration at 10 mg/kg,,N,,A,,CHEMBL622914,,BAO_0000218,
9089,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,216,AUC in rats,,N,,A,,CHEMBL622915,,BAO_0000218,
9090,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1908,AUC value after IV dose at a dose of 5 mg/kg in rats.,,N,,A,,CHEMBL622916,,BAO_0000218,
9091,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1908,AUC value after oral dose at a dose of 10 mg/kg in rats.,,N,,A,,CHEMBL622917,,BAO_0000218,
9092,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6685,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,,A,,CHEMBL622918,,BAO_0000218,
9093,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,216,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,N,,A,,CHEMBL622919,,BAO_0000218,
9094,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6049,Maximum plasma concentration was evaluated in rat,,N,,A,,CHEMBL622920,,BAO_0000218,
9095,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2463,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,,A,,CHEMBL622921,,BAO_0000218,
9096,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,N,,A,,CHEMBL622922,,BAO_0000218,
9097,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6681,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,N,,A,,CHEMBL622923,,BAO_0000218,
9098,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4890,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL877604,,BAO_0000218,
9099,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6410,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,N,,A,,CHEMBL622924,,BAO_0000218,
9100,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6410,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,N,,A,,CHEMBL622925,,BAO_0000218,
9101,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16366,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,N,,A,,CHEMBL622926,,BAO_0000218,
9102,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6227,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,N,,A,,CHEMBL623625,,BAO_0000218,
9103,Rattus norvegicus,50597,1969.0,,1,In vivo,,Expert,3598,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL623626,,BAO_0000218,
9104,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1465,Maximum plasma drug concentration was determined,,N,,A,,CHEMBL623627,,BAO_0000218,
9105,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4368,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,N,,A,,CHEMBL623628,,BAO_0000218,
9106,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,Mean peak plasma concentration was observed after intravenous administration in rat,,N,,A,,CHEMBL623629,,BAO_0000218,
9107,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,Mean peak plasma concentration was observed after oral administration in rat,,N,,A,,CHEMBL623630,,BAO_0000218,
9108,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5355,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,N,,A,,CHEMBL623804,,BAO_0000218,
9109,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5355,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL623805,,BAO_0000218,
9110,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,1567,Peak oral plasma concentration was determined in rats by oral administration,,N,,A,,CHEMBL623806,,BAO_0000218,
9111,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4026,Peak plasma concentration (Cmax) was determined,,N,,A,,CHEMBL623807,,BAO_0000218,
9112,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6193,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,N,,A,,CHEMBL623808,,BAO_0000218,
9113,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4026,Peak plasma concentration (Cmax) in rats,,N,,A,,CHEMBL623809,,BAO_0000218,
9114,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6485,Peak plasma concentration at 1 mg/kg peroral administration,,N,,A,,CHEMBL623810,,BAO_0000218,
9115,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17655,Peak plasma concentration in rat,,N,,A,,CHEMBL623811,,BAO_0000218,
9116,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14941,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,N,,A,,CHEMBL623812,,BAO_0000218,
9117,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5394,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,N,,A,,CHEMBL877605,,BAO_0000218,
9118,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4408,Pharmacokinetic property (Cmax) in rat,,N,,A,,CHEMBL623813,,BAO_0000218,
9119,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5983,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,,A,,CHEMBL623814,,BAO_0000218,
9120,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4878,Cmax in rat after 3mg/kg oral dose,,N,,A,,CHEMBL623815,,BAO_0000218,
9121,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5862,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,N,,A,Sprague-Dawley,CHEMBL623816,,BAO_0000218,
9122,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4517,Cmax in rats after 20 mg/kg oral dose,,N,,A,,CHEMBL623145,,BAO_0000218,
9123,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5932,Cmax in rat plasma after 30mg/kg oral dose,,N,,A,,CHEMBL623146,,BAO_0000218,
9124,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5436,Plasma concentration after oral administration of 100 mg/kg to rats,,N,,A,,CHEMBL623147,,BAO_0000218,
9125,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,,A,,CHEMBL623042,,BAO_0000218,
9126,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4950,Tested for the Cmax in rat at 10 mg/kg per orally,,N,,A,,CHEMBL623043,,BAO_0000218,
9127,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL623044,,BAO_0000218,
9128,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL623045,,BAO_0000218,
9129,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3360,Bioavailability as oral Cmax in rats at 30 mins,,N,,A,,CHEMBL623046,,BAO_0000218,
9130,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3360,Bioavailability as oral Cmax in rats at 6hr,,N,,A,,CHEMBL623226,,BAO_0000218,
9131,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15022,The maximum concentration of compound was measured at the dose of 100 umol/kg,,N,,A,,CHEMBL623227,,BAO_0000218,
9132,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15022,The maximum concentration of compound was measured at the dose of 300 umol/kg,,N,,A,,CHEMBL623228,,BAO_0000218,
9133,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15022,The maximum concentration of compound was measured at the dose of 30 umol/kg,,N,,A,,CHEMBL623229,,BAO_0000218,
9134,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5160,The maximum plasma levels for the compounds were determined by LC-MS.,,N,,A,,CHEMBL623230,,BAO_0000218,
9135,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,mean peak plasma concentration was observed after intravenous administration in rat,,N,,A,,CHEMBL623231,,BAO_0000218,
9136,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15662,mean peak plasma concentration was observed after oral administration in rat,,N,,A,,CHEMBL623232,,BAO_0000218,
9137,Rattus norvegicus,50597,,,1,,,Intermediate,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,N,,A,,CHEMBL623233,,BAO_0000218,
9138,Rattus norvegicus,50597,,,1,,,Intermediate,3535,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,N,,A,,CHEMBL623234,,BAO_0000218,
9139,Rattus norvegicus,50597,,,1,,,Intermediate,3535,Concentration in plasma (portal) following oral dose in rats at 1 hr,,N,,A,,CHEMBL623235,,BAO_0000218,
9140,Rattus norvegicus,50597,,,1,,,Intermediate,3535,Concentration in plasma (portal) following oral dose in rats at 2 hr,,N,,A,,CHEMBL623236,,BAO_0000218,
9141,Rattus norvegicus,50597,,,1,,,Intermediate,3535,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,N,,A,,CHEMBL623237,,BAO_0000218,
9142,Rattus norvegicus,50597,,,1,,,Intermediate,3535,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,N,,A,,CHEMBL623238,,BAO_0000218,
9143,Rattus norvegicus,50597,,,1,,,Intermediate,3535,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,N,,A,,CHEMBL623239,,BAO_0000218,
9144,Rattus norvegicus,22224,1969.0,,1,In vivo,,Intermediate,5005,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,U,,A,,CHEMBL623240,,BAO_0000218,
9145,Rattus norvegicus,50597,1898.0,,1,,,Intermediate,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,N,,A,,CHEMBL623241,,BAO_0000218,
9146,Rattus norvegicus,50597,1898.0,,1,,,Intermediate,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,N,,A,,CHEMBL623242,,BAO_0000218,
9147,Rattus norvegicus,50597,,,1,,,Intermediate,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,N,,A,,CHEMBL874394,,BAO_0000218,
9148,Rattus norvegicus,50597,,,1,,,Intermediate,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,N,,A,,CHEMBL623243,,BAO_0000218,
9149,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL623244,,BAO_0000218,
9150,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL623245,,BAO_0000218,
9151,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL623246,,BAO_0000218,
9152,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL623247,,BAO_0000218,
9153,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL623248,,BAO_0000218,
9154,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL623249,,BAO_0000218,
9155,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL625072,,BAO_0000218,
9156,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL625073,,BAO_0000218,
9157,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL625074,,BAO_0000218,
9158,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL625075,,BAO_0000218,
9159,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL625076,,BAO_0000218,
9160,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL625077,,BAO_0000218,
9161,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL625078,,BAO_0000218,
9162,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL874395,,BAO_0000218,
9163,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL625079,,BAO_0000218,
9164,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL625080,,BAO_0000218,
9165,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL625081,,BAO_0000218,
9166,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL625082,,BAO_0000218,
9167,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL625083,,BAO_0000218,
9168,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL625084,,BAO_0000218,
9169,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL625085,,BAO_0000218,
9170,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL625086,,BAO_0000218,
9171,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL625087,,BAO_0000218,
9172,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL625088,,BAO_0000218,
9173,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL622205,,BAO_0000218,
9174,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL622206,,BAO_0000218,
9175,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL622207,,BAO_0000218,
9176,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL622366,,BAO_0000218,
9177,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL622367,,BAO_0000218,
9178,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL875331,,BAO_0000218,
9179,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL622368,,BAO_0000218,
9180,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL622369,,BAO_0000218,
9181,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL622370,,BAO_0000218,
9182,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL622371,,BAO_0000218,
9183,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL622372,,BAO_0000218,
9184,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL622373,,BAO_0000218,
9185,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL622374,,BAO_0000218,
9186,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL622375,,BAO_0000218,
9187,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL622376,,BAO_0000218,
9188,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL622377,,BAO_0000218,
9189,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL622378,,BAO_0000218,
9190,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL622379,,BAO_0000218,
9191,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL622380,,BAO_0000218,
9192,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL622381,,BAO_0000218,
9193,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL622382,,BAO_0000218,
9194,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL622383,,BAO_0000218,
9195,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL875332,,BAO_0000218,
9196,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL622384,,BAO_0000218,
9197,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL622385,,BAO_0000218,
9198,Rattus norvegicus,50597,945.0,,1,,,Intermediate,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,,A,,CHEMBL622386,,BAO_0000218,
9199,Rattus norvegicus,50597,,,1,,,Intermediate,10839,The compound was tested for the plasma binding in rat,,N,,A,,CHEMBL622387,,BAO_0000218,
9200,Rattus norvegicus,50597,,,1,,,Intermediate,16459,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,N,,A,,CHEMBL622388,,BAO_0000218,
9201,Rattus norvegicus,50597,,,1,,,Intermediate,16459,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,N,,A,,CHEMBL622389,,BAO_0000218,
9202,Rattus norvegicus,50597,,,1,,,Intermediate,16459,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,N,,A,,CHEMBL622390,,BAO_0000218,
9203,Rattus norvegicus,50597,,,1,,,Intermediate,16459,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,N,,A,,CHEMBL622391,,BAO_0000218,
9204,Rattus norvegicus,50597,,,1,,,Intermediate,16459,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,N,,A,,CHEMBL622392,,BAO_0000218,
9205,Rattus norvegicus,50597,,,1,,,Intermediate,16459,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,N,,A,,CHEMBL622393,,BAO_0000218,
9206,Rattus norvegicus,50597,,,1,,,Intermediate,3278,Plasma level at 2 hr after administration of the compound,,N,,A,,CHEMBL622394,,BAO_0000218,
9207,Rattus norvegicus,50597,,,1,,,Intermediate,3278,plasma level at 2 hr after administration of the compound,,N,,A,,CHEMBL622395,,BAO_0000218,
9208,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 1 min,,N,,A,,CHEMBL622396,,BAO_0000218,
9209,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 10 min,,N,,A,,CHEMBL624894,,BAO_0000218,
9210,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 10 mins,,N,,A,,CHEMBL624895,,BAO_0000218,
9211,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 2 hr,,N,,A,,CHEMBL624058,,BAO_0000218,
9212,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 3 min,,N,,A,,CHEMBL624059,,BAO_0000218,
9213,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 3 mins,,N,,A,,CHEMBL624060,,BAO_0000218,
9214,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 5 min,,N,,A,,CHEMBL624061,,BAO_0000218,
9215,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,4684,Stability in rat serum measured as % recovery at 5 mins,,N,,A,,CHEMBL624062,,BAO_0000218,
9216,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16456,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,,A,,CHEMBL624063,,BAO_0000218,
9217,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16456,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,,A,,CHEMBL624064,,BAO_0000218,
9218,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,723,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,N,,A,,CHEMBL624065,,BAO_0000218,
9219,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,723,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,N,,A,,CHEMBL624066,,BAO_0000218,
9220,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5160,Half life tested in mature male rat at a dose of 30 mg/kg,,N,,A,,CHEMBL877490,,BAO_0000218,
9221,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4709,Half life after intravenous administration of 1 mg/kg in rat,,N,,A,,CHEMBL874442,,BAO_0000218,
9222,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5633,Half life period after administration (30 mg/kg) in rat,,N,,A,,CHEMBL626890,,BAO_0000218,
9223,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5302,Half life period in rat after 5 mg/Kg dose,,N,,A,,CHEMBL626891,,BAO_0000218,
9224,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5302,Half life period in rat after 5 mg/kg dose,,N,,A,,CHEMBL626892,,BAO_0000218,
9225,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Half life period was determined,,N,,A,,CHEMBL626893,,BAO_0000218,
9226,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Half life period was evaluated in rat,,N,,A,,CHEMBL626894,,BAO_0000218,
9227,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Half life period was evaluated in rat; 0.5-1.0,,N,,A,,CHEMBL626895,,BAO_0000218,
9228,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Half life period was evaluated in rat; 5.9-7.5,,N,,A,,CHEMBL626896,,BAO_0000218,
9229,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14512,Half-life in rat plasma,,N,,A,,CHEMBL626897,,BAO_0000218,
9230,Rattus norvegicus,50597,,,1,,,Intermediate,6230,Half-life time in rat was determined,,N,,A,,CHEMBL626898,,BAO_0000218,
9231,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3364,Terminal half-life after iv administration to rats,,N,,A,,CHEMBL626899,,BAO_0000218,
9232,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6874,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,N,,A,,CHEMBL626900,,BAO_0000218,
9233,Rattus norvegicus,50597,,,1,,,Intermediate,857,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,N,,A,,CHEMBL626901,,BAO_0000218,
9234,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,N,,A,,CHEMBL626902,,BAO_0000218,
9235,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,N,,A,,CHEMBL626903,,BAO_0000218,
9236,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5355,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,N,,A,,CHEMBL874443,,BAO_0000218,
9237,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5355,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL626904,,BAO_0000218,
9238,Rattus norvegicus,50597,,,1,,,Intermediate,6305,Half life in rats,,N,,A,,CHEMBL626905,,BAO_0000218,
9239,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,N,,A,,CHEMBL873830,,BAO_0000218,
9240,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,N,,A,,CHEMBL626906,,BAO_0000218,
9241,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,,A,,CHEMBL631076,,BAO_0000218,
9242,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2932,Biological half-life was measured in plasma of rats,,N,,A,,CHEMBL631077,,BAO_0000218,
9243,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17065,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,,A,,CHEMBL631078,,BAO_0000218,
9244,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15765,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,N,,A,,CHEMBL631079,,BAO_0000218,
9245,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2713,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,N,,A,,CHEMBL631080,,BAO_0000218,
9246,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,N,,A,,CHEMBL631081,,BAO_0000218,
9247,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,N,,A,,CHEMBL631239,,BAO_0000218,
9248,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,740,Compound was evaluated for plasma half life in rat,,N,,A,,CHEMBL631240,,BAO_0000218,
9249,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6597,AUC value at a dose of 5 mg/kg (p.o.) in rats,,N,,A,,CHEMBL631241,,BAO_0000218,
9250,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2959,AUC value after administration of 20 mg/Kg oral dose in rat,,N,,A,,CHEMBL631242,,BAO_0000218,
9251,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17594,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,N,,A,,CHEMBL631243,,BAO_0000218,
9252,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17596,AUC0-96 after administration at 50 mg/kg,,N,,A,,CHEMBL874444,,BAO_0000218,
9253,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,N,,A,,CHEMBL631244,,BAO_0000218,
9254,Rattus norvegicus,50597,,,1,,,Intermediate,3293,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,N,,A,,CHEMBL631245,,BAO_0000218,
9255,Rattus norvegicus,50597,,,1,,,Intermediate,6757,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,N,,A,,CHEMBL627162,,BAO_0000218,
9256,Rattus norvegicus,50597,,,1,,,Intermediate,6757,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,N,,A,,CHEMBL627163,,BAO_0000218,
9257,Rattus norvegicus,50597,,,1,,,Intermediate,6757,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,N,,A,,CHEMBL627164,,BAO_0000218,
9258,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,N,,A,,CHEMBL627165,,BAO_0000218,
9259,Rattus norvegicus,50597,,,1,,,Intermediate,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,N,,A,,CHEMBL627166,,BAO_0000218,
9260,Rattus norvegicus,50597,,,1,,,Intermediate,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,N,,A,,CHEMBL627167,,BAO_0000218,
9261,Rattus norvegicus,50597,,,1,,,Intermediate,4026,Area under curve (AUC) at a dose of 30 mg/kg in rats,,N,,A,,CHEMBL627822,,BAO_0000218,
9262,Rattus norvegicus,50597,,,1,,,Intermediate,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL627823,,BAO_0000218,
9263,Rattus norvegicus,50597,,,1,,,Intermediate,5355,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,N,,A,,CHEMBL627824,,BAO_0000218,
9264,Rattus norvegicus,50597,,,1,,,Intermediate,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,,A,,CHEMBL627825,,BAO_0000218,
9265,Rattus norvegicus,50597,,,1,,,Intermediate,5633,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,N,,A,,CHEMBL627826,,BAO_0000218,
9266,Rattus norvegicus,50597,,,1,,,Intermediate,1716,Area under curve (Pharmacokinetic property) was determined,,N,,A,,CHEMBL627827,,BAO_0000218,
9267,Rattus norvegicus,50597,,,1,,,Intermediate,1716,Area under curve (Pharmacokinetic property) of the compound; Not determined,,N,,A,,CHEMBL627828,,BAO_0000218,
9268,Rattus norvegicus,50597,,,1,,,Intermediate,4689,Area under curve after intravenous administration (1 mg/kg) in rat,,N,,A,,CHEMBL627829,,BAO_0000218,
9269,Rattus norvegicus,50597,,,1,,,Intermediate,4527,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,N,,A,,CHEMBL627830,,BAO_0000218,
9270,Rattus norvegicus,50597,,,1,,,Intermediate,4527,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,N,,A,,CHEMBL627831,,BAO_0000218,
9271,Rattus norvegicus,50597,,,1,,,Intermediate,15662,Area under curve in male SD rats was observed after oral administration in rat,,N,,A,,CHEMBL627832,,BAO_0000218,
9272,Rattus norvegicus,50597,,,1,,,Intermediate,4413,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,N,,A,,CHEMBL627833,,BAO_0000218,
9273,Rattus norvegicus,50597,,,1,,,Expert,3598,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL627834,,BAO_0000218,
9274,Rattus norvegicus,50597,,,1,,,Expert,3598,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL628004,,BAO_0000218,
9275,Rattus norvegicus,50597,,,1,,,Intermediate,5964,Area under curve at 5 mg/kg po was determined in rat,,N,,A,,CHEMBL628005,,BAO_0000218,
9276,Rattus norvegicus,50597,,,1,,,Intermediate,4689,Area under curve in Rat at a oral dose of 5 mg/kg,,N,,A,,CHEMBL628006,,BAO_0000218,
9277,Rattus norvegicus,50597,,,1,,,Intermediate,4186,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,,A,,CHEMBL628007,,BAO_0000218,
9278,Rattus norvegicus,50597,,,1,,,Intermediate,5510,Area under curve was determined,,N,,A,,CHEMBL625676,,BAO_0000218,
9279,Rattus norvegicus,50597,,,1,,,Intermediate,17858,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,N,,A,,CHEMBL631309,,BAO_0000218,
9280,Rattus norvegicus,50597,,,1,,,Intermediate,17804,Area under curve after intravenous administration at 3 mg/kg,,N,,A,,CHEMBL631310,,BAO_0000218,
9281,Rattus norvegicus,50597,,,1,,,Intermediate,6106,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,N,,A,,CHEMBL631311,,BAO_0000218,
9282,Rattus norvegicus,50597,,,1,,,Intermediate,5964,Area under curve at 4 hr in rat,,N,,A,,CHEMBL631312,,BAO_0000218,
9283,Rattus norvegicus,50597,,,1,,,Intermediate,4026,Area under curve at a dose of 30 mg/kg,,N,,A,,CHEMBL631313,,BAO_0000218,
9284,Rattus norvegicus,50597,,,1,,,Intermediate,4756,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,N,,A,,CHEMBL631314,,BAO_0000218,
9285,Rattus norvegicus,50597,,,1,,,Intermediate,4756,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,N,,A,,CHEMBL631315,,BAO_0000218,
9286,Rattus norvegicus,50597,,,1,,,Intermediate,5862,Area under curve for a 2-mpk po dose in SD rats,,N,,A,,CHEMBL631316,,BAO_0000218,
9287,Rattus norvegicus,50597,,,1,,,Intermediate,5862,Area under curve in SD rats,,N,,A,,CHEMBL631317,,BAO_0000218,
9288,Rattus norvegicus,50597,,,1,,,Intermediate,6644,Area under curve in rat after oral administration at 13 mg/kg dose,,N,,A,,CHEMBL874471,,BAO_0000218,
9289,Rattus norvegicus,50597,,,1,,,Intermediate,5871,Area under curve in rat by po administration at 0-24 hr,,N,,A,,CHEMBL631318,,BAO_0000218,
9290,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5919,Area under curve in rat plasma,,N,,A,,CHEMBL631319,,BAO_0000218,
9291,Rattus norvegicus,50597,,,1,,,Intermediate,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,N,,A,,CHEMBL631320,,BAO_0000218,
9292,Rattus norvegicus,50597,,,1,,,Intermediate,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,N,,A,,CHEMBL631321,,BAO_0000218,
9293,Rattus norvegicus,50597,,,1,,,Intermediate,10,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,N,,A,,CHEMBL631322,,BAO_0000218,
9294,Rattus norvegicus,50597,,,1,,,Intermediate,11149,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,N,,A,,CHEMBL631323,,BAO_0000218,
9295,Rattus norvegicus,50597,,,1,,,Intermediate,5302,Area under curve value in rat at a dose of 5 mg/kg,,N,,A,,CHEMBL631324,,BAO_0000218,
9296,Rattus norvegicus,50597,,,1,,,Intermediate,17796,Area under curve was determined after oral administration in rats,,N,,A,,CHEMBL631325,,BAO_0000218,
9297,Rattus norvegicus,50597,,,1,,,Intermediate,4890,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL631326,,BAO_0000218,
9298,Rattus norvegicus,50597,,,1,,,Intermediate,6011,Area under curve was determined after peroral administration in rat,,N,,A,,CHEMBL631327,,BAO_0000218,
9299,Rattus norvegicus,50597,,,1,,,Intermediate,5375,Area under curve was determined at a dose 30 mpk administered orally.,,N,,A,,CHEMBL631328,,BAO_0000218,
9300,Rattus norvegicus,50597,,,1,,,Intermediate,17764,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,N,,A,,CHEMBL631329,,BAO_0000218,
9301,Rattus norvegicus,50597,,,1,,,Intermediate,4368,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,N,,A,,CHEMBL627217,,BAO_0000218,
9302,Rattus norvegicus,50597,,,1,,,Intermediate,5610,Area under curve was determined in male rat,,N,,A,,CHEMBL626352,,BAO_0000218,
9303,Rattus norvegicus,50597,,,1,,,Intermediate,5833,Area under curve was determined in rat after PO administration,,N,,A,,CHEMBL626353,,BAO_0000218,
9304,Rattus norvegicus,50597,,,1,,,Intermediate,4257,Area under curve was determined in rat after a 3 mg/kg of oral dose,,N,,A,,CHEMBL626354,,BAO_0000218,
9305,Rattus norvegicus,50597,,,1,,,Intermediate,5937,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,N,,A,,CHEMBL626355,,BAO_0000218,
9306,Rattus norvegicus,50597,,,1,,,Intermediate,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,N,,A,,CHEMBL626356,,BAO_0000218,
9307,Rattus norvegicus,50597,,,1,,,Intermediate,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,N,,A,,CHEMBL626357,,BAO_0000218,
9308,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL626358,,BAO_0000218,
9309,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL626359,,BAO_0000218,
9310,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17771,Peak plasma concentration in rat at a dose of 3 mg/kg,,N,,A,,CHEMBL626360,,BAO_0000218,
9311,Rattus norvegicus,50597,,,1,,,Intermediate,1628,Plasma concentration at 2 hr in rats was evaluated.,,N,,A,,CHEMBL626361,,BAO_0000218,
9312,Rattus norvegicus,50597,,,1,,,Intermediate,1628,Plasma concentration at 2 hr in rats was evaluated; Not available,,N,,A,,CHEMBL626362,,BAO_0000218,
9313,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL626363,,BAO_0000218,
9314,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL626970,,BAO_0000218,
9315,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL626971,,BAO_0000218,
9316,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4910,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL626972,,BAO_0000218,
9317,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4910,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL626973,,BAO_0000218,
9318,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4910,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL626974,,BAO_0000218,
9319,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4910,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL874592,,BAO_0000218,
9320,Rattus norvegicus,50597,,,1,,,Intermediate,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,N,,A,,CHEMBL626975,,BAO_0000218,
9321,Rattus norvegicus,50597,,,1,,,Intermediate,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,N,,A,,CHEMBL626976,,BAO_0000218,
9322,Rattus norvegicus,50597,,,1,,,Intermediate,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,N,,A,,CHEMBL626977,,BAO_0000218,
9323,Rattus norvegicus,50597,,,1,,,Intermediate,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,N,,A,,CHEMBL626978,,BAO_0000218,
9324,Rattus norvegicus,50597,,,1,,,Intermediate,16427,PK study was carried to determine the relative absorption ranking in rat.,,N,,A,,CHEMBL626979,,BAO_0000218,
9325,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4689,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,N,,A,,CHEMBL626980,,BAO_0000218,
9326,Rattus norvegicus,50597,178.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,N,,A,,CHEMBL626981,,BAO_0000218,
9327,Rattus norvegicus,50597,178.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,N,,A,,CHEMBL626982,,BAO_0000218,
9328,Rattus norvegicus,50597,178.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,N,,A,,CHEMBL626983,,BAO_0000218,
9329,Rattus norvegicus,50597,178.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,N,,A,,CHEMBL622522,,BAO_0000218,
9330,Rattus norvegicus,50597,178.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,N,,A,,CHEMBL622523,,BAO_0000218,
9331,Rattus norvegicus,50597,178.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,N,,A,,CHEMBL622524,,BAO_0000218,
9332,Rattus norvegicus,50597,955.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,N,,A,,CHEMBL622525,,BAO_0000218,
9333,Rattus norvegicus,50597,955.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,N,,A,,CHEMBL622526,,BAO_0000218,
9334,Rattus norvegicus,50597,955.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,N,,A,,CHEMBL619849,,BAO_0000218,
9335,Rattus norvegicus,50597,955.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,N,,A,,CHEMBL619850,,BAO_0000218,
9336,Rattus norvegicus,50597,955.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,N,,A,,CHEMBL623864,,BAO_0000218,
9337,Rattus norvegicus,50597,955.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,N,,A,,CHEMBL623865,,BAO_0000218,
9338,Rattus norvegicus,50597,948.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,N,,A,,CHEMBL623866,,BAO_0000218,
9339,Rattus norvegicus,50597,948.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,N,,A,,CHEMBL623867,,BAO_0000218,
9340,Rattus norvegicus,50597,948.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,N,,A,,CHEMBL877615,,BAO_0000218,
9341,Rattus norvegicus,50597,948.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,N,,A,,CHEMBL623868,,BAO_0000218,
9342,Rattus norvegicus,50597,948.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,N,,A,,CHEMBL623869,,BAO_0000218,
9343,Rattus norvegicus,50597,948.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,N,,A,,CHEMBL623870,,BAO_0000218,
9344,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL623871,,BAO_0000218,
9345,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL623872,,BAO_0000218,
9346,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL622129,,BAO_0000218,
9347,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL622130,,BAO_0000218,
9348,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL622131,,BAO_0000218,
9349,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL622132,,BAO_0000218,
9350,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL622133,,BAO_0000218,
9351,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL622134,,BAO_0000218,
9352,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL622135,,BAO_0000218,
9353,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL622136,,BAO_0000218,
9354,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL622137,,BAO_0000218,
9355,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL622138,,BAO_0000218,
9356,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL623017,,BAO_0000218,
9357,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL623018,,BAO_0000218,
9358,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL623019,,BAO_0000218,
9359,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL623020,,BAO_0000218,
9360,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL623021,,BAO_0000218,
9361,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL623022,,BAO_0000218,
9362,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL623023,,BAO_0000218,
9363,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL623024,,BAO_0000218,
9364,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL623025,,BAO_0000218,
9365,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL620545,,BAO_0000218,
9366,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL620546,,BAO_0000218,
9367,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL620547,,BAO_0000218,
9368,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL620548,,BAO_0000218,
9369,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL620549,,BAO_0000218,
9370,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL620550,,BAO_0000218,
9371,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL620551,,BAO_0000218,
9372,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL620552,,BAO_0000218,
9373,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL620553,,BAO_0000218,
9374,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL620554,,BAO_0000218,
9375,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL875845,,BAO_0000218,
9376,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL620555,,BAO_0000218,
9377,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL620556,,BAO_0000218,
9378,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL620557,,BAO_0000218,
9379,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL620558,,BAO_0000218,
9380,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL620559,,BAO_0000218,
9381,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL622939,,BAO_0000218,
9382,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL622940,,BAO_0000218,
9383,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL622941,,BAO_0000218,
9384,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL622942,,BAO_0000218,
9385,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL622943,,BAO_0000218,
9386,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL622944,,BAO_0000218,
9387,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL622945,,BAO_0000218,
9388,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL622946,,BAO_0000218,
9389,Rattus norvegicus,50597,,,1,,,Intermediate,3341,Compound was evaluated for terminal half life in rat,,N,,A,,CHEMBL622947,,BAO_0000218,
9390,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,3634,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,N,,A,,CHEMBL622948,,BAO_0000218,
9391,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,3634,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,N,,A,,CHEMBL622949,,BAO_0000218,
9392,Rattus norvegicus,50597,,,1,,,Intermediate,4839,Compound was tested for its half life in rat,,N,,A,,CHEMBL622950,,BAO_0000218,
9393,Macaca mulatta,22224,1969.0,,1,In vivo,,Intermediate,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,U,,A,,CHEMBL622951,,BAO_0000218,
9394,Rattus norvegicus,22224,1969.0,,1,,,Intermediate,5005,Compound was tested for its plasma half life in Sprague Dawley rats,,U,,A,,CHEMBL622952,,BAO_0000366,
9395,Rattus norvegicus,22224,1969.0,,1,,,Intermediate,5005,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,U,,A,,CHEMBL622953,,BAO_0000366,
9396,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1094,Compound was tested for plasma half-life period in rat,,N,,A,,CHEMBL873818,,BAO_0000218,
9397,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5031,Elimination half life after i.v. administration of compound in rats,,N,,A,,CHEMBL622954,,BAO_0000218,
9398,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,N,,A,,CHEMBL622955,,BAO_0000218,
9399,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Elimination half-life after IV dosing at 1 mg/kg in rat,,N,,A,,CHEMBL875229,,BAO_0000218,
9400,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,N,,A,,CHEMBL622956,,BAO_0000218,
9401,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,N,,A,,CHEMBL622957,,BAO_0000218,
9402,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,,A,,CHEMBL622958,,BAO_0000218,
9403,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,,A,,CHEMBL622959,,BAO_0000218,
9404,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,,A,,CHEMBL622960,,BAO_0000218,
9405,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,,A,,CHEMBL622961,,BAO_0000218,
9406,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4687,Evaluated for the half life in rat (in vivo),,N,,A,,CHEMBL622962,,BAO_0000218,
9407,Rattus norvegicus,50597,,,1,,,Intermediate,6640,Hafl life in rat,,N,,A,,CHEMBL622963,,BAO_0000218,
9408,Rattus norvegicus,50597,,,1,,,Intermediate,6640,Hafl life rat,,N,,A,,CHEMBL622964,,BAO_0000218,
9409,Rattus norvegicus,50597,,,1,,,Intermediate,6641,Hafl life rat,,N,,A,,CHEMBL622965,,BAO_0000218,
9410,Rattus norvegicus,50597,,,1,,,Intermediate,6640,Hafl life rat; Not determined,,N,,A,,CHEMBL622966,,BAO_0000218,
9411,Rattus norvegicus,50597,,,1,,,Intermediate,6641,Hafl life rat; Not determined,,N,,A,,CHEMBL622967,,BAO_0000218,
9412,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,17411,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL622968,,BAO_0000218,
9413,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,17411,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL622969,,BAO_0000218,
9414,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,17411,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL875327,,BAO_0000218,
9415,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Half life in rat after 1 mg/kg i.v. administration,,N,,A,,CHEMBL628638,,BAO_0000218,
9416,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Half life in rat after 2 mg/kg peroral administration,,N,,A,,CHEMBL628639,,BAO_0000218,
9417,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17411,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL625840,,BAO_0000218,
9418,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4722,Half life of 10 mg/kg oral dose determined in rats,,N,,A,,CHEMBL625841,,BAO_0000218,
9419,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL625842,,BAO_0000218,
9420,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL625843,,BAO_0000218,
9421,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL625844,,BAO_0000218,
9422,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL873822,,BAO_0000218,
9423,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL625845,,BAO_0000218,
9424,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL627059,,BAO_0000218,
9425,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL627060,,BAO_0000218,
9426,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL627061,,BAO_0000218,
9427,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4762,Half life of compound at 5 mg/kg after po administration was determined in rat,,N,,A,,CHEMBL627709,,BAO_0000218,
9428,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5327,Half life of compound determined after intravenous administration to rat,,N,,A,,CHEMBL627710,,BAO_0000218,
9429,Rattus norvegicus,50597,,,1,,,Intermediate,4847,Half life of compound was determined in rat,,N,,A,,CHEMBL627711,,BAO_0000218,
9430,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,A,,CHEMBL627712,,BAO_0000218,
9431,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4723,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL627713,,BAO_0000218,
9432,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4723,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL627714,,BAO_0000218,
9433,Macaca fascicularis,22224,,,1,In vivo,,Intermediate,4256,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,U,,A,,CHEMBL627889,,BAO_0000218,
9434,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,4256,Half life determined in rat by intravenous administration,,U,,A,,CHEMBL627890,,BAO_0000218,
9435,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4722,Half life determined in rats after iv administration,,N,,A,,CHEMBL627891,,BAO_0000218,
9436,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6535,Half life in rat plasma after administration of 2 mg/kg iv,,N,,A,,CHEMBL627892,,BAO_0000218,
9437,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6535,Half life in rat plasma after administration of 2 mg/kg iv,,N,,A,,CHEMBL627893,,BAO_0000218,
9438,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1435,Half life in rat plasma was determined,,N,,A,,CHEMBL627894,,BAO_0000218,
9439,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1435,Half life in rat plasma was determined; NA means not applicable,,N,,A,,CHEMBL627895,,BAO_0000218,
9440,Rattus norvegicus,50597,,,1,,,Intermediate,5206,Half life in rat was tested,,N,,A,,CHEMBL627896,,BAO_0000218,
9441,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6080,Half life measured in rat plasma,,N,,A,,CHEMBL627897,,BAO_0000218,
9442,Rattus norvegicus,50597,,,1,,,Intermediate,4449,Half life recorded in rats,,N,,A,,CHEMBL627898,,BAO_0000218,
9443,Rattus norvegicus,50597,,,1,,,Intermediate,6057,Half life was calculated,,N,,A,,CHEMBL627899,,BAO_0000218,
9444,Rattus norvegicus,50597,,,1,,,Intermediate,6057,Half life was calculated in rat,,N,,A,,CHEMBL873823,,BAO_0000218,
9445,Rattus norvegicus,50597,,,1,,,Intermediate,3747,Half life was determined,,N,,A,,CHEMBL627900,,BAO_0000218,
9446,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17858,Half life after 10 mg/kg oral administration in rat,,N,,A,,CHEMBL627901,,BAO_0000218,
9447,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,N,,A,,CHEMBL627902,,BAO_0000218,
9448,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Half life after administering orally a dose of 30 mg/kg,,N,,A,,CHEMBL627903,,BAO_0000218,
9449,Rattus norvegicus,50597,,,1,,,Intermediate,5031,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,N,,A,,CHEMBL627904,,BAO_0000218,
9450,Rattus norvegicus,50597,,,1,,,Intermediate,4722,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,N,,A,,CHEMBL627905,,BAO_0000218,
9451,Rattus norvegicus,50597,,,1,,,Intermediate,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,N,,A,,CHEMBL627906,,BAO_0000218,
9452,Rattus norvegicus,50597,,,1,,,Intermediate,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,N,,A,,CHEMBL627907,,BAO_0000218,
9453,Rattus norvegicus,50597,,,1,,,Intermediate,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,N,,A,,CHEMBL876783,,BAO_0000218,
9454,Rattus norvegicus,50597,,,1,,,Intermediate,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,N,,A,,CHEMBL627908,,BAO_0000218,
9455,Rattus norvegicus,50597,,,1,,,Intermediate,17065,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,,A,,CHEMBL627909,,BAO_0000218,
9456,Rattus norvegicus,50597,,,1,,,Intermediate,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,N,,A,,CHEMBL627910,,BAO_0000218,
9457,Rattus norvegicus,50597,,,1,,,Intermediate,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,N,,A,,CHEMBL627911,,BAO_0000218,
9458,Rattus norvegicus,50597,,,1,,,Intermediate,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,N,,A,,CHEMBL627912,,BAO_0000218,
9459,Rattus norvegicus,50597,,,1,,,Intermediate,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,N,,A,,CHEMBL627913,,BAO_0000218,
9460,Rattus norvegicus,50597,,,1,,,Intermediate,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,N,,A,,CHEMBL627914,,BAO_0000218,
9461,Rattus norvegicus,50597,,,1,,,Intermediate,16423,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,N,,A,,CHEMBL627915,,BAO_0000218,
9462,Rattus norvegicus,50597,,,1,,,Intermediate,16423,Area under the curve was evaluated after 20 uM/kg of peroral administration,,N,,A,,CHEMBL627916,,BAO_0000218,
9463,Rattus norvegicus,50597,,,1,,,Intermediate,6062,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,N,,A,,CHEMBL627917,,BAO_0000218,
9464,Rattus norvegicus,50597,,,1,,,Intermediate,6056,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,N,,A,,CHEMBL627918,,BAO_0000218,
9465,Rattus norvegicus,50597,,,1,,,Intermediate,5182,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,N,,A,,CHEMBL627919,,BAO_0000218,
9466,Rattus norvegicus,50597,,,1,,,Intermediate,6410,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,N,,A,,CHEMBL627920,,BAO_0000218,
9467,Rattus norvegicus,50597,,,1,,,Intermediate,6410,Area under the curve was evaluated at an oral dose of 30 mg/kg,,N,,A,,CHEMBL627921,,BAO_0000218,
9468,Rattus norvegicus,50597,,,1,,,Intermediate,4723,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL627922,,BAO_0000218,
9469,Rattus norvegicus,50597,,,1,,,Intermediate,4723,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL876784,,BAO_0000218,
9470,Rattus norvegicus,50597,,,1,,,Intermediate,4723,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL627923,,BAO_0000218,
9471,Rattus norvegicus,50597,,,1,,,Intermediate,4723,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL626208,,BAO_0000218,
9472,Rattus norvegicus,50597,,,1,,,Intermediate,4723,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL626209,,BAO_0000218,
9473,Rattus norvegicus,50597,,,1,,,Intermediate,4723,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL626210,,BAO_0000218,
9474,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2463,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,,A,,CHEMBL627994,,BAO_0000218,
9475,Rattus norvegicus,50597,,,1,,,Intermediate,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,N,,A,,CHEMBL627995,,BAO_0000218,
9476,Rattus norvegicus,50597,,,1,,,Intermediate,4075,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,N,,A,,CHEMBL627996,,BAO_0000218,
9477,Rattus norvegicus,50597,,,1,,,Intermediate,5394,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,N,,A,,CHEMBL627997,,BAO_0000218,
9478,Rattus norvegicus,50597,,,1,,,Intermediate,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,N,,A,,CHEMBL627998,,BAO_0000218,
9479,Rattus norvegicus,50597,,,1,,,Intermediate,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,N,,A,,CHEMBL628640,,BAO_0000218,
9480,Rattus norvegicus,50597,,,1,,,Intermediate,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,N,,A,,CHEMBL628641,,BAO_0000218,
9481,Rattus norvegicus,50597,,,1,,,Intermediate,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,N,,A,,CHEMBL628642,,BAO_0000218,
9482,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),,N,,A,,CHEMBL628643,,BAO_0000218,
9483,Rattus norvegicus,50597,,,1,,,Intermediate,2591,Compound was tested for area under curve in rat,,N,,A,,CHEMBL628644,,BAO_0000218,
9484,Rattus norvegicus,50597,,,1,,,Intermediate,6567,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,N,,A,,CHEMBL628645,,BAO_0000218,
9485,Rattus norvegicus,50597,,,1,,,Intermediate,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,,A,,CHEMBL628646,,BAO_0000218,
9486,Rattus norvegicus,50597,,,1,,,Intermediate,5529,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,N,,A,,CHEMBL628647,,BAO_0000218,
9487,Rattus norvegicus,50597,,,1,,,Intermediate,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,,A,,CHEMBL628648,,BAO_0000218,
9488,Rattus norvegicus,50597,,,1,,,Intermediate,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,,A,,CHEMBL625358,,BAO_0000218,
9489,Rattus norvegicus,50597,,,1,,,Intermediate,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,,A,,CHEMBL625359,,BAO_0000218,
9490,Rattus norvegicus,50597,,,1,,,Intermediate,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,,A,,CHEMBL625360,,BAO_0000218,
9491,Rattus norvegicus,50597,,,1,,,Intermediate,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,N,,A,,CHEMBL625361,,BAO_0000218,
9492,Rattus norvegicus,50597,,,1,,,Intermediate,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,N,,A,,CHEMBL625362,,BAO_0000218,
9493,Rattus norvegicus,50597,,,1,,,Intermediate,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,N,,A,,CHEMBL625363,,BAO_0000218,
9494,Rattus norvegicus,50597,,,1,,,Intermediate,4796,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,,A,,CHEMBL625364,,BAO_0000218,
9495,Rattus norvegicus,50597,,,1,,,Intermediate,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL625365,,BAO_0000218,
9496,Rattus norvegicus,50597,,,1,,,Intermediate,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL625366,,BAO_0000218,
9497,Rattus norvegicus,50597,,,1,,,Intermediate,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL625367,,BAO_0000218,
9498,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,N,,A,,CHEMBL625368,,BAO_0000218,
9499,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,N,,A,,CHEMBL625369,,BAO_0000218,
9500,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,N,,A,,CHEMBL625370,,BAO_0000218,
9501,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,N,,A,,CHEMBL625371,,BAO_0000218,
9502,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,N,,A,,CHEMBL625372,,BAO_0000218,
9503,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,N,,A,,CHEMBL625373,,BAO_0000218,
9504,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,N,,A,,CHEMBL625374,,BAO_0000218,
9505,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,N,,A,,CHEMBL877593,,BAO_0000218,
9506,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,N,,A,,CHEMBL625375,,BAO_0000218,
9507,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,N,,A,,CHEMBL625376,,BAO_0000218,
9508,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,N,,A,,CHEMBL621973,,BAO_0000218,
9509,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,N,,A,,CHEMBL621974,,BAO_0000218,
9510,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,N,,A,,CHEMBL621975,,BAO_0000218,
9511,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,N,,A,,CHEMBL622166,,BAO_0000218,
9512,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,N,,A,,CHEMBL622167,,BAO_0000218,
9513,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,N,,A,,CHEMBL622168,,BAO_0000218,
9514,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,N,,A,,CHEMBL622169,,BAO_0000218,
9515,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,N,,A,,CHEMBL622170,,BAO_0000218,
9516,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,N,,A,,CHEMBL622171,,BAO_0000218,
9517,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,N,,A,,CHEMBL622172,,BAO_0000218,
9518,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,N,,A,,CHEMBL622173,,BAO_0000218,
9519,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,N,,A,,CHEMBL622174,,BAO_0000218,
9520,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,N,,A,,CHEMBL622175,,BAO_0000218,
9521,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,N,,A,,CHEMBL622176,,BAO_0000218,
9522,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,N,,A,,CHEMBL622177,,BAO_0000218,
9523,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,N,,A,,CHEMBL622178,,BAO_0000218,
9524,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,N,,A,,CHEMBL622179,,BAO_0000218,
9525,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,N,,A,,CHEMBL622180,,BAO_0000218,
9526,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL622181,,BAO_0000218,
9527,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL622182,,BAO_0000218,
9528,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL622183,,BAO_0000218,
9529,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL622184,,BAO_0000218,
9530,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL622185,,BAO_0000218,
9531,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL622186,,BAO_0000218,
9532,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL622187,,BAO_0000218,
9533,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL625002,,BAO_0000218,
9534,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL622090,,BAO_0000218,
9535,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL622091,,BAO_0000218,
9536,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL622092,,BAO_0000218,
9537,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL622093,,BAO_0000218,
9538,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL622094,,BAO_0000218,
9539,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL622095,,BAO_0000218,
9540,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL622264,,BAO_0000218,
9541,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL622265,,BAO_0000218,
9542,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL622266,,BAO_0000218,
9543,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL622267,,BAO_0000218,
9544,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL622268,,BAO_0000218,
9545,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL622269,,BAO_0000218,
9546,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL625071,,BAO_0000218,
9547,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL621621,,BAO_0000218,
9548,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL621622,,BAO_0000218,
9549,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL621623,,BAO_0000218,
9550,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL621624,,BAO_0000218,
9551,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL621625,,BAO_0000218,
9552,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL621626,,BAO_0000218,
9553,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL621627,,BAO_0000218,
9554,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL621628,,BAO_0000218,
9555,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL875328,,BAO_0000218,
9556,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL621629,,BAO_0000218,
9557,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL621630,,BAO_0000218,
9558,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL621631,,BAO_0000218,
9559,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL621632,,BAO_0000218,
9560,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL621633,,BAO_0000218,
9561,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL621634,,BAO_0000218,
9562,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL621635,,BAO_0000218,
9563,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL621636,,BAO_0000218,
9564,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL621637,,BAO_0000218,
9565,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL621638,,BAO_0000218,
9566,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL618883,,BAO_0000218,
9567,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,A,,CHEMBL618884,,BAO_0000218,
9568,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL628627,,BAO_0000218,
9569,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL628628,,BAO_0000218,
9570,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,A,,CHEMBL628629,,BAO_0000218,
9571,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Half life after administering orally a dose of 3 mg/kg,,N,,A,,CHEMBL628630,,BAO_0000218,
9572,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,N,,A,,CHEMBL628631,,BAO_0000218,
9573,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Half life after administering intravenously a dose of 1 mg/kg,,N,,A,,CHEMBL628632,,BAO_0000218,
9574,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,526,Half life after oral dosing in rats,,N,,A,,CHEMBL628633,,BAO_0000218,
9575,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,N,,A,,CHEMBL628634,,BAO_0000218,
9576,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4368,Half life by intravenous administration of 3.4 mg/kg in rat,,N,,A,,CHEMBL627789,,BAO_0000218,
9577,Rattus norvegicus,50597,,,1,,,Intermediate,3371,Half life in rat,,N,,A,,CHEMBL627790,,BAO_0000218,
9578,Rattus norvegicus,50597,,,1,,,Intermediate,6448,Half life in rat,,N,,A,,CHEMBL627791,,BAO_0000218,
9579,Rattus norvegicus,50597,,,1,,,Intermediate,6453,Half life in rat,,N,,A,,CHEMBL627792,,BAO_0000218,
9580,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4353,Half life in rat after intravenous administration of the compound,,N,,A,,CHEMBL627793,,BAO_0000218,
9581,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4353,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,N,,A,,CHEMBL627794,,BAO_0000218,
9582,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4353,Half life in rat after po administration of the compound,,N,,A,,CHEMBL627795,,BAO_0000218,
9583,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4353,Half life in rat after po administration of the compound; ND means Not determined,,N,,A,,CHEMBL627796,,BAO_0000218,
9584,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4353,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,N,,A,,CHEMBL875335,,BAO_0000218,
9585,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4353,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,N,,A,,CHEMBL627797,,BAO_0000218,
9586,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5789,Half life in rat i.v.,,N,,A,,CHEMBL627798,,BAO_0000218,
9587,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17686,Half life in rat i.v. at 2 mg/kg concentration,,N,,A,,CHEMBL627799,,BAO_0000218,
9588,Rattus norvegicus,50597,,,1,,,Intermediate,6495,Half life in rats,,N,,A,,CHEMBL627800,,BAO_0000218,
9589,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,484,Half life in rats after intravenous administration,,N,,A,,CHEMBL627801,,BAO_0000218,
9590,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6467,Half life in rats at the dose of 1.0 mpk by i.v. administration,,N,,A,,CHEMBL627802,,BAO_0000218,
9591,Rattus norvegicus,50597,,,1,,,Expert,6642,Half life in rat,,N,,A,,CHEMBL627803,,BAO_0000218,
9592,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16367,Half life was evaluated after intravenous administration to rats,,N,,A,,CHEMBL873820,,BAO_0000218,
9593,Rattus norvegicus,50597,,,1,,,Intermediate,1369,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,N,,A,,CHEMBL627804,,BAO_0000218,
9594,Rattus norvegicus,50597,,,1,,,Intermediate,5472,Half life was evaluated in rat,,N,,A,,CHEMBL627805,,BAO_0000218,
9595,Rattus norvegicus,50597,,,1,,,Intermediate,6049,Half life was evaluated in rat,,N,,A,,CHEMBL627806,,BAO_0000218,
9596,Rattus norvegicus,50597,,,1,,,Intermediate,5472,Half life was evaluated in rat; Not tested,,N,,A,,CHEMBL627107,,BAO_0000218,
9597,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16366,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,N,,A,,CHEMBL627108,,BAO_0000218,
9598,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,11149,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,N,,A,,CHEMBL627109,,BAO_0000218,
9599,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11149,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,N,,A,,CHEMBL627110,,BAO_0000218,
9600,Primates,22224,,,1,In vivo,,Intermediate,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,,U,,A,,CHEMBL627111,,BAO_0000218,
9601,Primates,22224,,,1,In vivo,,Intermediate,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,,U,,A,,CHEMBL627112,,BAO_0000218,
9602,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,2891,Half life was measured in rat at dose of 30 mg/kg by iv administration,,U,,A,,CHEMBL627113,,BAO_0000218,
9603,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,2891,Half life was measured in rat at dose of 30 mg/kg by po administration,,U,,A,,CHEMBL627114,,BAO_0000218,
9604,Rattus norvegicus,50597,,,1,,,Intermediate,4026,Half life (t1/2) was determined,,N,,A,,CHEMBL627115,,BAO_0000218,
9605,Rattus norvegicus,50597,,,1,,,Intermediate,4527,Half life period at a dose of 10 uM/kg in rat was determined,,N,,A,,CHEMBL627116,,BAO_0000218,
9606,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,N,,A,,CHEMBL627117,,BAO_0000218,
9607,Rattus norvegicus,50597,,,1,,,Intermediate,5503,Half life period was determined,,N,,A,,CHEMBL627118,,BAO_0000218,
9608,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4426,Half life period after intravenous administration at 20 mpk in rats,,N,,A,,CHEMBL627119,,BAO_0000218,
9609,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4426,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,N,,A,,CHEMBL627120,,BAO_0000218,
9610,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6109,Half life period after intravenous administration in rat,,N,,A,,CHEMBL626922,,BAO_0000218,
9611,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,,A,,CHEMBL626923,,BAO_0000218,
9612,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,,A,,CHEMBL626924,,BAO_0000218,
9613,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4755,Half life period in 80% rat plasma at 37 degree Centigrade,,N,,A,,CHEMBL626925,,BAO_0000218,
9614,Rattus norvegicus,50597,,,1,,,Intermediate,5862,Half life period in SD rats,,N,,A,,CHEMBL626926,,BAO_0000218,
9615,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,N,,A,,CHEMBL626927,,BAO_0000218,
9616,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,N,,A,,CHEMBL626928,,BAO_0000218,
9617,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,,A,,CHEMBL626929,,BAO_0000218,
9618,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,,A,,CHEMBL626930,,BAO_0000218,
9619,Rattus norvegicus,50597,,,1,,,Intermediate,5960,Half life period in rat,,N,,A,,CHEMBL626931,,BAO_0000218,
9620,Rattus norvegicus,50597,,,1,,,Intermediate,6103,Half life period in rat,,N,,A,,CHEMBL626932,,BAO_0000218,
9621,Rattus norvegicus,50597,,,1,,,Intermediate,6317,Half life period in rat,,N,,A,,CHEMBL626933,,BAO_0000218,
9622,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Half life period in rat after oral administration at 10.5 mg/kg dose,,N,,A,,CHEMBL873826,,BAO_0000218,
9623,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Half life period in rat after oral administration at 11.2 mg/kg dose,,N,,A,,CHEMBL626934,,BAO_0000218,
9624,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Half life period in rat after oral administration at 13 mg/kg dose,,N,,A,,CHEMBL626935,,BAO_0000218,
9625,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Half life period in rat after oral administration at 9.7 mg/kg dose,,N,,A,,CHEMBL626936,,BAO_0000218,
9626,Rattus norvegicus,50597,,,1,,,Intermediate,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL626937,,BAO_0000218,
9627,Rattus norvegicus,50597,,,1,,,Intermediate,6295,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,,A,,CHEMBL625906,,BAO_0000218,
9628,Rattus norvegicus,50597,,,1,,,Intermediate,6296,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,,A,,CHEMBL625907,,BAO_0000218,
9629,Rattus norvegicus,50597,,,1,,,Intermediate,16427,PK study was carried to determine AUC (area under curve) value in rat,,N,,A,,CHEMBL625908,,BAO_0000218,
9630,Rattus norvegicus,50597,,,1,,,Intermediate,16367,Pharmacokinetic parameter AUC after intravenous administration to rats,,N,,A,,CHEMBL625909,,BAO_0000218,
9631,Rattus norvegicus,50597,,,1,,,Intermediate,16367,Pharmacokinetic parameter AUC after oral administration to rats,,N,,A,,CHEMBL625910,,BAO_0000218,
9632,Rattus norvegicus,50597,,,1,,,Intermediate,16365,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,N,,A,,CHEMBL625911,,BAO_0000218,
9633,Rattus norvegicus,50597,,,1,,,Intermediate,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,N,,A,,CHEMBL625912,,BAO_0000218,
9634,Rattus norvegicus,50597,,,1,,,Intermediate,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,N,,A,,CHEMBL626538,,BAO_0000218,
9635,Rattus norvegicus,50597,,,1,,,Intermediate,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,N,,A,,CHEMBL876794,,BAO_0000218,
9636,Rattus norvegicus,50597,,,1,,,Intermediate,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,N,,A,,CHEMBL626539,,BAO_0000218,
9637,Rattus norvegicus,50597,,,1,,,Intermediate,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,N,,A,,CHEMBL626540,,BAO_0000218,
9638,Rattus norvegicus,50597,,,1,,,Intermediate,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,N,,A,,CHEMBL626541,,BAO_0000218,
9639,Rattus norvegicus,50597,,,1,,,Intermediate,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,N,,A,,CHEMBL626542,,BAO_0000218,
9640,Rattus norvegicus,50597,,,1,,,Intermediate,2792,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,N,,A,,CHEMBL626543,,BAO_0000218,
9641,Rattus norvegicus,50597,,,1,,,Intermediate,2792,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,N,,A,,CHEMBL626544,,BAO_0000218,
9642,Rattus norvegicus,50597,,,1,,,Intermediate,2792,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,N,,A,,CHEMBL626545,,BAO_0000218,
9643,Rattus norvegicus,50597,,,1,,,Intermediate,2792,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,N,,A,,CHEMBL626546,,BAO_0000218,
9644,Rattus norvegicus,50597,,,1,,,Intermediate,5334,Pharmacokinetic parameter area under curve was reported,,N,,A,,CHEMBL626547,,BAO_0000218,
9645,Rattus norvegicus,50597,,,1,,,Intermediate,4408,Pharmacokinetic property (AUC) in rat,,N,,A,,CHEMBL626548,,BAO_0000218,
9646,Rattus norvegicus,50597,,,1,,,Intermediate,5983,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,,A,,CHEMBL626549,,BAO_0000218,
9647,Rattus norvegicus,50597,,,1,,,Intermediate,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,N,,A,,CHEMBL626550,,BAO_0000218,
9648,Rattus norvegicus,50597,,,1,,,Intermediate,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,N,,A,,CHEMBL626551,,BAO_0000218,
9649,Rattus norvegicus,50597,,,1,,,Intermediate,5491,Pharmacokinetic property was determined,,N,,A,,CHEMBL623777,,BAO_0000218,
9650,Rattus norvegicus,50597,,,1,,,Intermediate,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,N,,A,,CHEMBL623778,,BAO_0000218,
9651,Rattus norvegicus,50597,,,1,,,Intermediate,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,N,,A,,CHEMBL623779,,BAO_0000218,
9652,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4199,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,,A,,CHEMBL623780,,BAO_0000218,
9653,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4199,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,N,,A,,CHEMBL622015,,BAO_0000218,
9654,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4199,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,N,,A,,CHEMBL622016,,BAO_0000218,
9655,Rattus norvegicus,50597,,,1,,,Intermediate,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,N,,A,,CHEMBL622017,,BAO_0000218,
9656,Rattus norvegicus,50597,,,1,,,Intermediate,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,N,,A,,CHEMBL622018,,BAO_0000218,
9657,Rattus norvegicus,50597,,,1,,,Intermediate,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,N,,A,,CHEMBL622019,,BAO_0000218,
9658,Rattus norvegicus,50597,,,1,,,Intermediate,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,N,,A,,CHEMBL622020,,BAO_0000218,
9659,Rattus norvegicus,50597,,,1,,,Intermediate,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,N,,A,,CHEMBL622021,,BAO_0000218,
9660,Rattus norvegicus,50597,,,1,,,Intermediate,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,N,,A,,CHEMBL622022,,BAO_0000218,
9661,Rattus norvegicus,50597,,,1,,,Intermediate,5327,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,N,,A,,CHEMBL622023,,BAO_0000218,
9662,Rattus norvegicus,50597,,,1,,,Intermediate,6681,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,N,,A,,CHEMBL622024,,BAO_0000218,
9663,Rattus norvegicus,50597,,,1,,,Intermediate,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,N,,A,,CHEMBL622693,,BAO_0000218,
9664,Rattus norvegicus,50597,,,1,,,Intermediate,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,N,,A,,CHEMBL622694,,BAO_0000218,
9665,Rattus norvegicus,50597,,,1,,,Intermediate,6685,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,,A,,CHEMBL622695,,BAO_0000218,
9666,Rattus norvegicus,50597,,,1,,,Intermediate,6685,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,,A,,CHEMBL622696,,BAO_0000218,
9667,Rattus norvegicus,50597,,,1,,,Intermediate,6685,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,N,,A,,CHEMBL622697,,BAO_0000218,
9668,Rattus norvegicus,50597,,,1,,,Intermediate,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,N,,A,,CHEMBL622874,,BAO_0000218,
9669,Rattus norvegicus,50597,,,1,,,Intermediate,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,N,,A,,CHEMBL622875,,BAO_0000218,
9670,Rattus norvegicus,50597,,,1,,,Intermediate,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,,A,,CHEMBL622876,,BAO_0000218,
9671,Rattus norvegicus,50597,,,1,,,Intermediate,4796,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,,A,,CHEMBL622877,,BAO_0000218,
9672,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,,A,,CHEMBL622878,,BAO_0000218,
9673,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4910,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,N,,A,,CHEMBL622879,,BAO_0000218,
9674,Rattus norvegicus,50597,,,1,,,Intermediate,4839,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,N,,A,,CHEMBL877602,,BAO_0000218,
9675,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL622880,,BAO_0000218,
9676,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL622881,,BAO_0000218,
9677,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL622882,,BAO_0000218,
9678,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL622883,,BAO_0000218,
9679,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,N,,A,,CHEMBL622884,,BAO_0000218,
9680,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,N,,A,,CHEMBL622885,,BAO_0000218,
9681,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,,A,,CHEMBL622886,,BAO_0000218,
9682,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,,A,,CHEMBL622887,,BAO_0000218,
9683,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,,A,,CHEMBL622888,,BAO_0000218,
9684,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622889,,BAO_0000218,
9685,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622890,,BAO_0000218,
9686,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622891,,BAO_0000218,
9687,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL877603,,BAO_0000218,
9688,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622892,,BAO_0000218,
9689,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622893,,BAO_0000218,
9690,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622894,,BAO_0000218,
9691,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622895,,BAO_0000218,
9692,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,8677,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,N,,A,,CHEMBL622896,,BAO_0000218,
9693,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622897,,BAO_0000218,
9694,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622898,,BAO_0000218,
9695,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622899,,BAO_0000218,
9696,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622900,,BAO_0000218,
9697,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624114,,BAO_0000218,
9698,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624115,,BAO_0000218,
9699,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624116,,BAO_0000218,
9700,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624117,,BAO_0000218,
9701,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624118,,BAO_0000218,
9702,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624119,,BAO_0000218,
9703,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624120,,BAO_0000218,
9704,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624121,,BAO_0000218,
9705,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624122,,BAO_0000218,
9706,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624123,,BAO_0000218,
9707,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624124,,BAO_0000218,
9708,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624125,,BAO_0000218,
9709,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624126,,BAO_0000218,
9710,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624127,,BAO_0000218,
9711,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624128,,BAO_0000218,
9712,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL624129,,BAO_0000218,
9713,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL624130,,BAO_0000218,
9714,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622340,,BAO_0000218,
9715,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622341,,BAO_0000218,
9716,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622342,,BAO_0000218,
9717,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622343,,BAO_0000218,
9718,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622344,,BAO_0000218,
9719,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622345,,BAO_0000218,
9720,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622346,,BAO_0000218,
9721,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622347,,BAO_0000218,
9722,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622348,,BAO_0000218,
9723,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622349,,BAO_0000218,
9724,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,A,,CHEMBL622350,,BAO_0000218,
9725,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,A,,CHEMBL622351,,BAO_0000218,
9726,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,A,,CHEMBL622352,,BAO_0000218,
9727,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,A,,CHEMBL622353,,BAO_0000218,
9728,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,A,,CHEMBL622354,,BAO_0000218,
9729,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,A,,CHEMBL622355,,BAO_0000218,
9730,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,A,,CHEMBL622356,,BAO_0000218,
9731,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,A,,CHEMBL622357,,BAO_0000218,
9732,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,A,,CHEMBL622358,,BAO_0000218,
9733,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,A,,CHEMBL622359,,BAO_0000218,
9734,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,A,,CHEMBL874393,,BAO_0000218,
9735,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL622872,,BAO_0000218,
9736,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL622873,,BAO_0000218,
9737,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL623047,,BAO_0000218,
9738,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,A,,CHEMBL623048,,BAO_0000218,
9739,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL623049,,BAO_0000218,
9740,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL623050,,BAO_0000218,
9741,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,A,,CHEMBL623051,,BAO_0000218,
9742,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL623052,,BAO_0000218,
9743,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL626343,,BAO_0000218,
9744,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,A,,CHEMBL626344,,BAO_0000218,
9745,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,A,,CHEMBL626345,,BAO_0000218,
9746,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,A,,CHEMBL626346,,BAO_0000218,
9747,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,A,,CHEMBL626347,,BAO_0000218,
9748,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,A,,CHEMBL626348,,BAO_0000218,
9749,Rattus norvegicus,50597,,,1,,,Intermediate,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,A,,CHEMBL626349,,BAO_0000218,
9750,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,F,,CHEMBL626350,,BAO_0000218,
9751,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,A,,CHEMBL626351,,BAO_0000218,
9752,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,A,,CHEMBL627650,,BAO_0000218,
9753,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,F,,CHEMBL627651,,BAO_0000218,
9754,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,A,,CHEMBL627652,,BAO_0000218,
9755,Rattus norvegicus,50597,,,1,,,Intermediate,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,A,,CHEMBL627653,,BAO_0000218,
9756,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,N,,A,,CHEMBL627654,,BAO_0000218,
9757,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,N,,A,,CHEMBL627835,,BAO_0000218,
9758,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,N,,A,,CHEMBL627836,,BAO_0000218,
9759,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,N,,A,,CHEMBL627837,,BAO_0000218,
9760,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,N,,A,,CHEMBL627838,,BAO_0000218,
9761,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,N,,A,,CHEMBL875338,,BAO_0000218,
9762,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,N,,A,,CHEMBL627839,,BAO_0000218,
9763,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,N,,A,,CHEMBL627840,,BAO_0000218,
9764,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,N,,A,,CHEMBL627841,,BAO_0000218,
9765,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,N,,A,,CHEMBL627842,,BAO_0000218,
9766,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,N,,A,,CHEMBL627843,,BAO_0000218,
9767,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,N,,A,,CHEMBL627844,,BAO_0000218,
9768,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,N,,A,,CHEMBL627845,,BAO_0000218,
9769,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5874,Half life period in rat by iv administration at a dose of 3 mg/kg,,N,,A,,CHEMBL627846,,BAO_0000218,
9770,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,N,,A,,CHEMBL627847,,BAO_0000218,
9771,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,N,,A,,CHEMBL873821,,BAO_0000218,
9772,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,,A,,CHEMBL626079,,BAO_0000218,
9773,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,,A,,CHEMBL626080,,BAO_0000218,
9774,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5491,Half life period was evaluated in rat plasma,,N,,A,,CHEMBL626081,,BAO_0000218,
9775,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5491,Half life period was evaluated in rat plasma; Not tested,,N,,A,,CHEMBL875344,,BAO_0000218,
9776,Rattus norvegicus,50597,,,1,,,Intermediate,1918,Half life period was evaluated in rats,,N,,A,,CHEMBL626082,,BAO_0000218,
9777,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1918,"Half life period was evaluated in rats, iv",,N,,A,,CHEMBL626250,,BAO_0000218,
9778,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6113,Half life period after intravenous administration at 5 mg/kg in rat,,N,,A,,CHEMBL626251,,BAO_0000218,
9779,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5546,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,,A,,CHEMBL626252,,BAO_0000218,
9780,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5553,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,N,,A,,CHEMBL626253,,BAO_0000218,
9781,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4188,Half life stability of compound was evaluated in rat plasma,,N,,A,,CHEMBL626254,,BAO_0000218,
9782,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6215,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,N,,A,,CHEMBL626255,,BAO_0000218,
9783,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6141,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,N,,A,,CHEMBL626256,,BAO_0000218,
9784,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,,A,,CHEMBL626257,,BAO_0000218,
9785,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,N,,A,,CHEMBL626258,,BAO_0000218,
9786,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5710,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,N,,A,,CHEMBL626259,,BAO_0000218,
9787,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5789,Half in rat i.v.,,N,,A,,CHEMBL626260,,BAO_0000218,
9788,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6011,Half period in rat after intravenous administration,,N,,A,,CHEMBL875345,,BAO_0000218,
9789,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17594,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,N,,A,,CHEMBL626261,,BAO_0000218,
9790,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,12357,Half-life measured in in vitro Cathepsin B assay in rat liver,,N,,A,,CHEMBL626262,,BAO_0000218,
9791,Rattus norvegicus,50597,,,1,,,Intermediate,5210,Half-life of compound was determined in rats,,N,,A,,CHEMBL626263,,BAO_0000218,
9792,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17596,Half-life at 10 mg/kg in rat upon intravenous administration,,N,,A,,CHEMBL625270,,BAO_0000218,
9793,Rattus norvegicus,50597,,,1,,,Intermediate,6672,Half-life determined in rat,,N,,A,,CHEMBL625271,,BAO_0000218,
9794,Rattus norvegicus,50597,,,1,,,Intermediate,6673,Half-life determined in rat,,N,,A,,CHEMBL625272,,BAO_0000218,
9795,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,4910,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,N,,A,,CHEMBL625273,,BAO_0000218,
9796,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,3741,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,N,,A,,CHEMBL625274,,BAO_0000218,
9797,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17671,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,,A,,CHEMBL625275,,BAO_0000218,
9798,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4910,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,N,,A,,CHEMBL625276,,BAO_0000218,
9799,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17537,Half-life in rat plasma,,N,,A,,CHEMBL625277,,BAO_0000218,
9800,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4965,Half-life in rat plasma was determined,,N,,A,,CHEMBL625278,,BAO_0000218,
9801,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17537,Half-life in rat plasma; Not tested,,N,,A,,CHEMBL625279,,BAO_0000218,
9802,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,6124,Half-life in rat serum,,N,,A,,CHEMBL625280,,BAO_0000218,
9803,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,6124,Half-life in rat serum; na is not available,,N,,A,,CHEMBL876797,,BAO_0000218,
9804,Rattus norvegicus,50597,,,1,,,Intermediate,6078,Half-life was calculated in rat,,N,,A,,CHEMBL625281,,BAO_0000218,
9805,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17668,Half-life was calculated in rat plasma,,N,,A,,CHEMBL873827,,BAO_0000218,
9806,Rattus norvegicus,50597,,,1,,,Intermediate,3185,Half-life was determined,,N,,A,,CHEMBL625282,,BAO_0000218,
9807,Rattus norvegicus,50597,,,1,,,Intermediate,4883,Half-life was determined,,N,,A,,CHEMBL625283,,BAO_0000218,
9808,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2959,Half-life after administration of 20 mg/Kg oral dose in rat,,N,,A,,CHEMBL625284,,BAO_0000218,
9809,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4029,Half-life after administration of 3.2 mg/kg intravenously in male rat,,N,,A,,CHEMBL625285,,BAO_0000218,
9810,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4029,Half-life after intravenous administration in female rat,,N,,A,,CHEMBL625286,,BAO_0000218,
9811,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4029,Half-life after intravenous administration in male rat,,N,,A,,CHEMBL625287,,BAO_0000218,
9812,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6180,Half-life after intravenous dose in rat,,N,,A,,CHEMBL625288,,BAO_0000218,
9813,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,1557,Half-life in a rat liver homogenate preparation,,N,,A,,CHEMBL625289,,BAO_0000218,
9814,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,12500,Half-life in plasma of rat,,N,,A,,CHEMBL625290,,BAO_0000218,
9815,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,12500,Half-life in plasma of rat at dose of 3-10 mgkg,,N,,A,,CHEMBL876798,,BAO_0000218,
9816,Rattus norvegicus,50597,,,1,,,Intermediate,5064,Half-life in rat,,N,,A,,CHEMBL625291,,BAO_0000218,
9817,Rattus norvegicus,50597,,,1,,,Intermediate,5145,Half-life in rat,,N,,A,,CHEMBL625292,,BAO_0000218,
9818,Rattus norvegicus,50597,,,1,,,Intermediate,5147,Half-life in rat,,N,,A,,CHEMBL625293,,BAO_0000218,
9819,Rattus norvegicus,50597,,,1,,,Intermediate,5833,Half-life in rat,,N,,A,,CHEMBL622832,,BAO_0000218,
9820,Rattus norvegicus,50597,,,1,,,Intermediate,6596,Half-life in rat,,N,,A,,CHEMBL622833,,BAO_0000218,
9821,Rattus norvegicus,50597,,,1,,,Intermediate,17655,Half-life in rat,,N,,A,,CHEMBL622834,,BAO_0000218,
9822,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6495,Half-life in rat after oral administration at 10 mg/kg,,N,,A,,CHEMBL622835,,BAO_0000218,
9823,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17538,Half-life in rat after po administration at a dose of 10 mg/kg,,N,,A,,CHEMBL622836,,BAO_0000218,
9824,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17538,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,N,,A,,CHEMBL622837,,BAO_0000218,
9825,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,10,Half-life in rat at 3 mg/kg dose administered intravenously,,N,,A,,CHEMBL622838,,BAO_0000218,
9826,Rattus norvegicus,50597,955.0,,1,,,Intermediate,17669,Half-life in rat brain homogenate,,N,,A,,CHEMBL622839,,BAO_0000218,
9827,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17065,Half-life in rat plasma,,N,,A,,CHEMBL622840,,BAO_0000218,
9828,Rattus norvegicus,50597,,,1,,,Intermediate,4333,Half-life in rats,,N,,A,,CHEMBL622841,,BAO_0000218,
9829,Rattus norvegicus,50597,,,1,,,Intermediate,6827,Half-life in Dawley rats,,N,,A,,CHEMBL622842,,BAO_0000218,
9830,Rattus norvegicus,50597,1969.0,,1,In vitro,,Intermediate,889,Half-life in vitro in rat plasma,,N,,A,,CHEMBL622843,,BAO_0000218,
9831,Rattus norvegicus,50597,1969.0,,1,In vitro,,Intermediate,889,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,N,,A,,CHEMBL622844,,BAO_0000218,
9832,Rattus norvegicus,50597,,,1,,,Intermediate,3747,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,N,,A,,CHEMBL622845,,BAO_0000218,
9833,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The area under the curve of compound was measured at the dose of 100 umol/kg,,N,,A,,CHEMBL622846,,BAO_0000218,
9834,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The area under the curve of compound was measured at the dose of 300 umol/kg,,N,,A,,CHEMBL622847,,BAO_0000218,
9835,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The area under the curve of compound was measured at the dose of 30 umol/kg,,N,,A,,CHEMBL622848,,BAO_0000218,
9836,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3360,Bioavailability as oral AUC in rats,,N,,A,,CHEMBL622849,,BAO_0000218,
9837,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5334,The plasma concentration versus time curve (AUC) was determined,,N,,A,,CHEMBL622850,,BAO_0000218,
9838,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL876807,,BAO_0000218,
9839,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL622851,,BAO_0000218,
9840,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL622852,,BAO_0000218,
9841,Rattus norvegicus,50597,,,1,,,Intermediate,6570,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,N,,A,,CHEMBL622853,,BAO_0000218,
9842,Rattus norvegicus,50597,,,1,,,Intermediate,6570,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,N,,A,,CHEMBL622854,,BAO_0000218,
9843,Rattus norvegicus,50597,,,1,,,Intermediate,17411,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,A,,CHEMBL622855,,BAO_0000218,
9844,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14941,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,N,,A,,CHEMBL622856,,BAO_0000218,
9845,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14941,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,N,,A,,CHEMBL622857,,BAO_0000218,
9846,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17538,AUC in rat after po administration at a dose of 10 mg/kg,,N,,A,,CHEMBL622858,,BAO_0000218,
9847,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17752,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,N,,A,,CHEMBL622859,,BAO_0000218,
9848,Rattus norvegicus,50597,,,1,,,Intermediate,17509,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,N,,A,,CHEMBL622860,,BAO_0000218,
9849,Rattus norvegicus,50597,,,1,,,Intermediate,17509,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,N,,A,,CHEMBL622861,,BAO_0000218,
9850,Rattus norvegicus,50597,,,1,,,Intermediate,17509,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,N,,A,,CHEMBL622862,,BAO_0000218,
9851,Rattus norvegicus,50597,,,1,,,Intermediate,17509,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,N,,A,,CHEMBL622863,,BAO_0000218,
9852,Rattus norvegicus,50597,,,1,,,Intermediate,17509,Area under curve value 6 hr after po administration in rat,,N,,A,,CHEMBL623817,,BAO_0000218,
9853,Rattus norvegicus,50597,,,1,,,Intermediate,17717,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,A,,CHEMBL623818,,BAO_0000218,
9854,Rattus norvegicus,50597,,,1,,,Intermediate,17717,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,N,,A,,CHEMBL623819,,BAO_0000218,
9855,Rattus norvegicus,50597,,,1,,,Intermediate,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,A,,CHEMBL623820,,BAO_0000218,
9856,Rattus norvegicus,50597,,,1,,,Intermediate,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,N,,A,,CHEMBL623821,,BAO_0000218,
9857,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6642,AUC normalized for dose (AUCN) in rat,,N,,A,,CHEMBL623822,,BAO_0000218,
9858,Rattus norvegicus,50597,,,1,,,Intermediate,6640,Area under curve in rat after p.o. administration,,N,,A,,CHEMBL623823,,BAO_0000218,
9859,Rattus norvegicus,50597,,,1,,,Intermediate,6641,Area under curve in rat after p.o. administration,,N,,A,,CHEMBL623824,,BAO_0000218,
9860,Rattus norvegicus,50597,,,1,,,Intermediate,6641,Area under curve in rat after p.o. administration; Not determined,,N,,A,,CHEMBL623825,,BAO_0000218,
9861,Rattus norvegicus,50597,,,1,,,Intermediate,6641,Area under curve in rat after peroral administration,,N,,A,,CHEMBL622070,,BAO_0000218,
9862,Rattus norvegicus,50597,,,1,,,Intermediate,3603,Area under curve (carotid artery) value of the compound,,N,,A,,CHEMBL622071,,BAO_0000218,
9863,Rattus norvegicus,50597,,,1,,,Intermediate,3550,Bioavailability expressed as the area under curve of rat carotid artery,,N,,A,,CHEMBL622072,,BAO_0000218,
9864,Rattus norvegicus,50597,,,1,,,Intermediate,15662,Area under curve in male SD rats was observed after intravenous administration in rat,,N,,A,,CHEMBL622073,,BAO_0000218,
9865,Rattus norvegicus,50597,,,1,,,Intermediate,17720,Area under curve of the compound was determined,,N,,A,,CHEMBL622074,,BAO_0000218,
9866,Rattus norvegicus,50597,,,1,,,Intermediate,5407,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,N,,A,,CHEMBL622075,,BAO_0000218,
9867,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17752,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,N,,A,,CHEMBL622076,,BAO_0000218,
9868,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17752,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,N,,A,,CHEMBL622077,,BAO_0000218,
9869,Rattus norvegicus,50597,,,1,,,Intermediate,3603,Area under curve (portal vein) value of the compound,,N,,A,,CHEMBL622078,,BAO_0000218,
9870,Rattus norvegicus,50597,,,1,,,Intermediate,3550,Bioavailability expressed as the area under curve of rat portal vein,,N,,A,,CHEMBL622079,,BAO_0000218,
9871,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17655,Area Under plasma concentration time curve in rat upon peroral administration,,N,,A,,CHEMBL622080,,BAO_0000218,
9872,Rattus norvegicus,50597,,,1,,,Intermediate,17582,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,N,,A,,CHEMBL877612,,BAO_0000218,
9873,Rattus norvegicus,50597,,,1,,,Intermediate,17582,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,N,,A,,CHEMBL622081,,BAO_0000218,
9874,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for oral bioavailability in rats,,N,,A,,CHEMBL622082,,BAO_0000218,
9875,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for oral bioavailability in rats after iv administration,,N,,A,,CHEMBL622083,,BAO_0000218,
9876,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for oral bioavailability in rats; 30-80,,N,,A,,CHEMBL622084,,BAO_0000218,
9877,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for oral bioavailability in rats; 50-60,,N,,A,,CHEMBL622085,,BAO_0000218,
9878,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for oral bioavailability in rats; no data,,N,,A,,CHEMBL622086,,BAO_0000218,
9879,Rattus norvegicus,50597,,,1,,,Intermediate,17791,Compound was evaluated for oral bioavailability in rats; peptide,,N,,A,,CHEMBL622087,,BAO_0000218,
9880,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,N,,A,,CHEMBL622088,,BAO_0000218,
9881,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,N,,A,,CHEMBL622089,,BAO_0000218,
9882,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,N,,A,,CHEMBL623685,,BAO_0000218,
9883,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,N,,A,,CHEMBL623686,,BAO_0000218,
9884,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL623687,,BAO_0000218,
9885,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL623688,,BAO_0000218,
9886,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL623689,,BAO_0000218,
9887,Rattus norvegicus,50597,945.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622485,,BAO_0000218,
9888,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622486,,BAO_0000218,
9889,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL877613,,BAO_0000218,
9890,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622487,,BAO_0000218,
9891,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622488,,BAO_0000218,
9892,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8677,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,N,,A,,CHEMBL622489,,BAO_0000218,
9893,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,,A,,CHEMBL622490,,BAO_0000218,
9894,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,,A,,CHEMBL622491,,BAO_0000218,
9895,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,6899,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,N,,A,,CHEMBL622492,,BAO_0000218,
9896,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,,A,,CHEMBL622493,,BAO_0000218,
9897,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,,A,,CHEMBL622494,,BAO_0000218,
9898,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8677,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,,A,,CHEMBL622495,,BAO_0000218,
9899,Rattus norvegicus,50597,,,1,,,Intermediate,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,N,,A,,CHEMBL622496,,BAO_0000218,
9900,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,,A,,CHEMBL622497,,BAO_0000218,
9901,Rattus norvegicus,50597,,,1,,,Intermediate,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,N,,A,,CHEMBL622498,,BAO_0000218,
9902,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,N,,A,,CHEMBL624918,,BAO_0000218,
9903,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,N,,A,,CHEMBL624919,,BAO_0000218,
9904,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat blood after 5 min of administration,,N,,A,,CHEMBL624920,,BAO_0000218,
9905,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat blood after 5 min of administration.,,N,,A,,CHEMBL624921,,BAO_0000218,
9906,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat brain after 5 min of administration,,N,,A,,CHEMBL624922,,BAO_0000218,
9907,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat heart after 5 min of administration,,N,,A,,CHEMBL624923,,BAO_0000218,
9908,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat heart after 5 min of administration.,,N,,A,,CHEMBL624924,,BAO_0000218,
9909,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat kidney after 5 min of administration,,N,,A,,CHEMBL624925,,BAO_0000218,
9910,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat kidney after 5 min of administration.,,N,,A,,CHEMBL624926,,BAO_0000218,
9911,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat liver after 5 min of administration,,N,,A,,CHEMBL624927,,BAO_0000218,
9912,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat liver after 5 min of administration.,,N,,A,,CHEMBL874402,,BAO_0000218,
9913,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat lung after 5 min of administration,,N,,A,,CHEMBL624928,,BAO_0000218,
9914,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat lung after 5 min of administration.,,N,,A,,CHEMBL624929,,BAO_0000218,
9915,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat muscle after 5 min of administration,,N,,A,,CHEMBL624930,,BAO_0000218,
9916,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10839,Biodistribution of compound in rat muscle after 5 min of administration.,,N,,A,,CHEMBL624931,,BAO_0000218,
9917,Rattus norvegicus,50597,948.0,,1,,,Intermediate,4043,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624932,,BAO_0000218,
9918,Rattus norvegicus,50597,948.0,,1,,,Intermediate,4043,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624933,,BAO_0000218,
9919,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,4043,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624934,,BAO_0000218,
9920,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,4043,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624935,,BAO_0000218,
9921,Rattus norvegicus,50597,,,1,,,Intermediate,4043,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624936,,BAO_0000218,
9922,Rattus norvegicus,50597,,,1,,,Intermediate,4043,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624937,,BAO_0000218,
9923,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,4043,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624938,,BAO_0000218,
9924,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,4043,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624939,,BAO_0000218,
9925,Rattus norvegicus,50597,,,1,,,Intermediate,4043,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL624940,,BAO_0000218,
9926,Rattus norvegicus,50597,,,1,,,Intermediate,4043,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,A,,CHEMBL874403,,BAO_0000218,
9927,Rattus norvegicus,50597,,,1,,,Intermediate,1446,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,N,,A,,CHEMBL624941,,BAO_0000218,
9928,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,N,,A,,CHEMBL624942,,BAO_0000218,
9929,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,N,,A,,CHEMBL624943,,BAO_0000218,
9930,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5765,% Bioavailability after 1 day of the drug administration in rats,,N,,A,,CHEMBL624944,,BAO_0000218,
9931,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5765,% Bioavailability after 4 day of the drug administration in rats,,N,,A,,CHEMBL624945,,BAO_0000218,
9932,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4257,Absolute bioavailability was evaluated in rat,,N,,A,,CHEMBL624946,,BAO_0000218,
9933,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,N,,A,,CHEMBL624947,,BAO_0000218,
9934,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,N,,A,,CHEMBL624948,,BAO_0000218,
9935,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,N,,A,,CHEMBL624949,,BAO_0000218,
9936,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,N,,A,,CHEMBL622025,,BAO_0000218,
9937,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,N,,A,,CHEMBL622026,,BAO_0000218,
9938,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,N,,A,,CHEMBL622027,,BAO_0000218,
9939,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,N,,A,,CHEMBL622028,,BAO_0000218,
9940,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,N,,A,,CHEMBL622029,,BAO_0000218,
9941,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,N,,A,,CHEMBL622208,,BAO_0000218,
9942,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,N,,A,,CHEMBL622209,,BAO_0000218,
9943,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,N,,A,,CHEMBL622210,,BAO_0000218,
9944,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,N,,A,,CHEMBL622211,,BAO_0000218,
9945,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,N,,A,,CHEMBL622212,,BAO_0000218,
9946,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,N,,A,,CHEMBL622213,,BAO_0000218,
9947,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,N,,A,,CHEMBL874404,,BAO_0000218,
9948,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,N,,A,,CHEMBL620452,,BAO_0000218,
9949,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,N,,A,,CHEMBL620453,,BAO_0000218,
9950,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,N,,A,,CHEMBL620454,,BAO_0000218,
9951,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,N,,A,,CHEMBL624067,,BAO_0000218,
9952,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,N,,A,,CHEMBL624068,,BAO_0000218,
9953,Rattus norvegicus,50597,992.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,N,,A,,CHEMBL624069,,BAO_0000218,
9954,Rattus norvegicus,50597,992.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,N,,A,,CHEMBL624070,,BAO_0000218,
9955,Rattus norvegicus,50597,992.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,N,,A,,CHEMBL624071,,BAO_0000218,
9956,Rattus norvegicus,50597,995.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,N,,A,,CHEMBL624072,,BAO_0000218,
9957,Rattus norvegicus,50597,995.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,N,,A,,CHEMBL624073,,BAO_0000218,
9958,Rattus norvegicus,50597,995.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,N,,A,,CHEMBL624788,,BAO_0000218,
9959,Rattus norvegicus,50597,995.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,N,,A,,CHEMBL624789,,BAO_0000218,
9960,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,N,,A,,CHEMBL624790,,BAO_0000218,
9961,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,N,,A,,CHEMBL624791,,BAO_0000218,
9962,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,N,,A,,CHEMBL624792,,BAO_0000218,
9963,Rattus norvegicus,50597,,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,N,,A,,CHEMBL624793,,BAO_0000218,
9964,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,N,,A,,CHEMBL877491,,BAO_0000218,
9965,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,N,,A,,CHEMBL624957,,BAO_0000218,
9966,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,N,,A,,CHEMBL624958,,BAO_0000218,
9967,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,N,,A,,CHEMBL624959,,BAO_0000218,
9968,Rattus norvegicus,50597,,,1,,,Intermediate,11977,Dissociation constant was determined,,N,,A,,CHEMBL624960,,BAO_0000218,
9969,Rattus norvegicus,50597,,,1,,,Intermediate,14941,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,N,,A,,CHEMBL624961,,BAO_0000218,
9970,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL624962,,BAO_0000218,
9971,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL624963,,BAO_0000218,
9972,Rattus norvegicus,50597,,,1,,,Intermediate,4755,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,N,,A,,CHEMBL624964,,BAO_0000218,
9973,Rattus norvegicus,50597,,,1,,,Intermediate,589,LogP value was evaluated in the in situ rat gut perfusion assay,,N,,A,,CHEMBL624965,,BAO_0000218,
9974,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,,A,,CHEMBL624966,,BAO_0000218,
9975,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5031,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,N,,A,,CHEMBL624967,,BAO_0000218,
9976,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,N,,A,,CHEMBL624968,,BAO_0000218,
9977,Rattus norvegicus,50597,,,1,,,Intermediate,17720,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,A,,CHEMBL624969,,BAO_0000218,
9978,Rattus norvegicus,50597,,,1,,,Expert,2862,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,N,,F,,CHEMBL624970,,BAO_0000218,
9979,Rattus norvegicus,50597,,,1,,,Intermediate,16423,Half-life was evaluated after 10 uM/kg of intra arterial administration,,N,,A,,CHEMBL624971,,BAO_0000218,
9980,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16423,Half-life was evaluated after 20 uM/kg of peroral administration,,N,,A,,CHEMBL624972,,BAO_0000218,
9981,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6005,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,N,,A,,CHEMBL624973,,BAO_0000218,
9982,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2938,Half-life was evaluated in plasma of rat,,N,,A,,CHEMBL624974,,BAO_0000218,
9983,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,N,,A,,CHEMBL624975,,BAO_0000218,
9984,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,N,,A,,CHEMBL877492,,BAO_0000218,
9985,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6062,Half-life was measured in rat after an iv dose of 1 mg/kg,,N,,A,,CHEMBL624976,,BAO_0000218,
9986,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6571,Half-life period of compound in rats after peroral administration,,N,,A,,CHEMBL624977,,BAO_0000218,
9987,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,3136,Half-life period of compound was measured in rat plasma.,,N,,A,,CHEMBL626848,,BAO_0000218,
9988,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,3136,Half-life period of compound was measured in rat plasma; ND is not determined,,N,,A,,CHEMBL626849,,BAO_0000218,
9989,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,3136,Half-life period of compound was measured in rat plasma; not determined,,N,,A,,CHEMBL626850,,BAO_0000218,
9990,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4521,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,,A,,CHEMBL626851,,BAO_0000218,
9991,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5871,Half-life period in rat by iv administration,,N,,A,,CHEMBL626852,,BAO_0000218,
9992,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6077,Half-life period in rats following intravenous administration at 2 mg/kg,,N,,A,,CHEMBL626853,,BAO_0000218,
9993,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,,A,,CHEMBL626854,,BAO_0000218,
9994,Rattus norvegicus,50597,,,1,,,Intermediate,5144,Half-life period was determined for the compound in rat,,N,,A,,CHEMBL627486,,BAO_0000218,
9995,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4498,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,N,,A,,CHEMBL627487,,BAO_0000218,
9996,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4498,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,N,,A,,CHEMBL627488,,BAO_0000218,
9997,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1908,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,N,,A,,CHEMBL627489,,BAO_0000218,
9998,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6211,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,N,,A,,CHEMBL627490,,BAO_0000218,
9999,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5529,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,N,,A,,CHEMBL873829,,BAO_0000218,
10000,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Half-life was determined in rat at a dose of 1 mpk i.v.,,N,,A,,CHEMBL627655,,BAO_0000218,
10001,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,N,,A,,CHEMBL625994,,BAO_0000218,
10002,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,N,,A,,CHEMBL625995,,BAO_0000218,
10003,Rattus norvegicus,50597,,,1,,,Intermediate,5207,Half-life in rat,,N,,A,,CHEMBL625996,,BAO_0000218,
10004,Rattus norvegicus,50597,1969.0,,1,In vitro,,Intermediate,530,In vitro half life in rat plasma,,N,,A,,CHEMBL625850,,BAO_0000218,
10005,Rattus norvegicus,50597,1969.0,,1,In vitro,,Intermediate,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,N,,A,,CHEMBL625851,,BAO_0000218,
10006,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,3219,In vitro half life in rat,,N,,A,,CHEMBL625852,,BAO_0000218,
10007,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6109,In vivo half life period after intravenous administration in rat,,N,,A,,CHEMBL625853,,BAO_0000218,
10008,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,N,,A,,CHEMBL625854,,BAO_0000218,
10009,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,,A,,CHEMBL874450,,BAO_0000218,
10010,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL625855,,BAO_0000218,
10011,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL625856,,BAO_0000218,
10012,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL625857,,BAO_0000218,
10013,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL873831,,BAO_0000218,
10014,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17853,Longer half-life in rat (i.v.) at 0.5 mpk,,N,,A,,CHEMBL625858,,BAO_0000218,
10015,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17853,Longer half-life in rat (p.o.) at 2.0 mpk,,N,,A,,CHEMBL625859,,BAO_0000218,
10016,Rattus norvegicus,50597,,,1,,,Intermediate,3457,Pharmacokinetic property (half life) in rat,,N,,A,,CHEMBL625860,,BAO_0000218,
10017,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,N,,A,,CHEMBL625861,,BAO_0000218,
10018,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,N,,A,,CHEMBL625862,,BAO_0000218,
10019,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,N,,A,,CHEMBL625863,,BAO_0000218,
10020,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,N,,A,,CHEMBL625864,,BAO_0000218,
10021,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5739,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,N,,A,,CHEMBL625865,,BAO_0000218,
10022,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15765,Pharmacokinetic half time was determined intravenously in rats.,,N,,A,,CHEMBL625866,,BAO_0000218,
10023,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,6567,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,N,,A,,CHEMBL625867,,BAO_0000218,
10024,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,2448,Plasma half life of hydrolysis of the compound,,N,,A,,CHEMBL625868,,BAO_0000218,
10025,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5423,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,N,,A,,CHEMBL625869,,BAO_0000218,
10026,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4853,Plasma half life period was calculated in rat,,N,,A,,CHEMBL874451,,BAO_0000218,
10027,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4514,Plasma half-life in Sprague-Dawley rats,,N,,A,,CHEMBL625870,,BAO_0000218,
10028,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4514,Plasma half-life in Sprague-Dawley rats; Not determined,,N,,A,,CHEMBL625871,,BAO_0000218,
10029,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1500,Plasma half-life in rats,,N,,A,,CHEMBL625872,,BAO_0000218,
10030,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,1500,Plasma half-life in rats; <MQL,,N,,A,,CHEMBL625873,,BAO_0000218,
10031,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5334,Plasma half-life period (0-8 h) was determined,,N,,A,,CHEMBL625874,,BAO_0000218,
10032,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5334,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,N,,A,,CHEMBL625875,,BAO_0000218,
10033,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,N,,A,,CHEMBL625876,,BAO_0000218,
10034,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,N,,A,,CHEMBL631258,,BAO_0000218,
10035,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,N,,A,,CHEMBL631259,,BAO_0000218,
10036,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,N,,A,,CHEMBL631260,,BAO_0000218,
10037,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,N,,A,,CHEMBL631261,,BAO_0000218,
10038,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,N,,A,,CHEMBL631262,,BAO_0000218,
10039,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7768,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,N,,A,,CHEMBL631263,,BAO_0000218,
10040,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,N,,A,,CHEMBL631264,,BAO_0000218,
10041,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,N,,A,,CHEMBL631265,,BAO_0000218,
10042,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,N,,A,,CHEMBL631266,,BAO_0000218,
10043,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,N,,A,,CHEMBL631267,,BAO_0000218,
10044,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,N,,A,,CHEMBL631268,,BAO_0000218,
10045,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,N,,A,,CHEMBL631269,,BAO_0000218,
10046,Rattus norvegicus,50597,,,1,,,Intermediate,7768,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,N,,A,,CHEMBL631270,,BAO_0000218,
10047,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,,A,,CHEMBL631271,,BAO_0000218,
10048,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,N,,A,,CHEMBL631272,,BAO_0000218,
10049,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,N,,A,,CHEMBL631273,,BAO_0000218,
10050,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,N,,A,,CHEMBL631274,,BAO_0000218,
10051,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,N,,A,,CHEMBL631275,,BAO_0000218,
10052,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,N,,A,,CHEMBL626984,,BAO_0000218,
10053,Rattus norvegicus,50597,948.0,,1,,,Intermediate,7768,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,N,,A,,CHEMBL626985,,BAO_0000218,
10054,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,,A,,CHEMBL626986,,BAO_0000218,
10055,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,N,,A,,CHEMBL626987,,BAO_0000218,
10056,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,N,,A,,CHEMBL626988,,BAO_0000218,
10057,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,N,,A,,CHEMBL626989,,BAO_0000218,
10058,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,N,,A,,CHEMBL626990,,BAO_0000218,
10059,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,N,,A,,CHEMBL626991,,BAO_0000218,
10060,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7768,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,N,,A,,CHEMBL626992,,BAO_0000218,
10061,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,N,,A,,CHEMBL626993,,BAO_0000218,
10062,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,N,,A,,CHEMBL874593,,BAO_0000218,
10063,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,N,,A,,CHEMBL626994,,BAO_0000218,
10064,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,N,,A,,CHEMBL626995,,BAO_0000218,
10065,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,N,,A,,CHEMBL626190,,BAO_0000218,
10066,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,N,,A,,CHEMBL626191,,BAO_0000218,
10067,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,7768,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,N,,A,,CHEMBL626364,,BAO_0000218,
10068,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,N,,A,,CHEMBL626365,,BAO_0000218,
10069,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,N,,A,,CHEMBL626366,,BAO_0000218,
10070,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,N,,A,,CHEMBL626367,,BAO_0000218,
10071,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,N,,A,,CHEMBL626368,,BAO_0000218,
10072,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,N,,A,,CHEMBL626369,,BAO_0000218,
10073,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,N,,A,,CHEMBL626370,,BAO_0000218,
10074,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4498,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,N,,A,,CHEMBL626371,,BAO_0000218,
10075,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4498,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,N,,A,,CHEMBL626372,,BAO_0000218,
10076,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3603,Bioavailability after a dose of 10 mg/kg p.o.,,N,,A,,CHEMBL626373,,BAO_0000218,
10077,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6215,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,N,,A,,CHEMBL626374,,BAO_0000218,
10078,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5710,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,N,,A,,CHEMBL626375,,BAO_0000218,
10079,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5710,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,N,,A,,CHEMBL626376,,BAO_0000218,
10080,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5676,Bioavailability in rat po was determined,,N,,A,,CHEMBL626377,,BAO_0000218,
10081,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17667,Bioavailability of compound at 10 mg/kg in rat after oral administration,,N,,A,,CHEMBL626378,,BAO_0000218,
10082,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17667,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,N,,A,,CHEMBL626379,,BAO_0000218,
10083,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,,A,,CHEMBL626380,,BAO_0000218,
10084,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,,A,,CHEMBL626381,,BAO_0000218,
10085,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17267,Bioavailability in rat,,N,,A,,CHEMBL626382,,BAO_0000218,
10086,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6362,Bioavailability in rat (Sprague-Dawley) (female),,N,,A,,CHEMBL626383,,BAO_0000218,
10087,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17671,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,N,,A,,CHEMBL874652,,BAO_0000218,
10088,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17671,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,N,,A,,CHEMBL626384,,BAO_0000218,
10089,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4333,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,N,,A,,CHEMBL626385,,BAO_0000218,
10090,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6077,Bioavailability in rat at an oral dose of 2 mg/kg,,N,,A,,CHEMBL626386,,BAO_0000218,
10091,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3278,Bioavailability in rat,,N,,A,,CHEMBL626387,,BAO_0000218,
10092,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5964,Bioavailability in rat,,N,,A,,CHEMBL626388,,BAO_0000218,
10093,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4884,Bioavailability in rat,,N,,A,,CHEMBL626389,,BAO_0000218,
10094,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4905,Bioavailability in rat,,N,,A,,CHEMBL626390,,BAO_0000218,
10095,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4884,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,N,,A,,CHEMBL626391,,BAO_0000218,
10096,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6850,Bioavailability in rat,,N,,A,,CHEMBL626392,,BAO_0000218,
10097,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2864,Oral bioavailability in rat,,N,,A,,CHEMBL626393,,BAO_0000218,
10098,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5780,Bioavailability was determined in rat,,N,,A,,CHEMBL623026,,BAO_0000218,
10099,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1465,Bioavailability,,N,,A,,CHEMBL623027,,BAO_0000218,
10100,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5199,Bioavailability,,N,,A,,CHEMBL623028,,BAO_0000218,
10101,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5765,Bioavailability in rat after 1 day dosing,,N,,A,,CHEMBL623029,,BAO_0000218,
10102,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5765,Bioavailability in rat after 4 day dosing,,N,,A,,CHEMBL623030,,BAO_0000218,
10103,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,N,,A,,CHEMBL623031,,BAO_0000218,
10104,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,N,,A,,CHEMBL623032,,BAO_0000218,
10105,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,N,,A,,CHEMBL623033,,BAO_0000218,
10106,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6518,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,N,,A,,CHEMBL623034,,BAO_0000218,
10107,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2083,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,N,,A,,CHEMBL623035,,BAO_0000218,
10108,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17260,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,,A,,CHEMBL623036,,BAO_0000218,
10109,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4956,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,N,,A,,CHEMBL623037,,BAO_0000218,
10110,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4368,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,N,,A,,CHEMBL623038,,BAO_0000218,
10111,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17752,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,N,,A,,CHEMBL874385,,BAO_0000218,
10112,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1446,Bioavailability in rat (Fisher) (fasted),,N,,A,,CHEMBL623039,,BAO_0000218,
10113,Primates,22224,,,1,In vivo,,Intermediate,2891,Bioavailability in monkey after po administration of 10 mg/kg dose,,U,,A,,CHEMBL623040,,BAO_0000218,
10114,Primates,22224,,,1,In vivo,,Intermediate,2891,Oral bioavailability in monkey (dose 10 mg/kg),,U,,A,,CHEMBL623041,,BAO_0000218,
10115,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6672,Bioavailability in rat,,N,,A,,CHEMBL623741,,BAO_0000218,
10116,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6673,Bioavailability in rat,,N,,A,,CHEMBL623742,,BAO_0000218,
10117,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17655,Bioavailability in rat,,N,,A,,CHEMBL623743,,BAO_0000218,
10118,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17796,Bioavailability in rat,,N,,A,,CHEMBL623744,,BAO_0000218,
10119,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17853,Bioavailability in rat (dose 2.0 mg/kg p.o.),,N,,A,,CHEMBL623745,,BAO_0000218,
10120,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4521,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,N,,A,,CHEMBL623746,,BAO_0000218,
10121,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4940,Oral bioavailability in rat (dose 5 mg/kg p.o.),,N,,A,,CHEMBL623747,,BAO_0000218,
10122,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,2891,Bioavailability in rat after po administration of 30 mg/kg dose,,U,,A,,CHEMBL623748,,BAO_0000218,
10123,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,2891,Bioavailability in rat after po administration of 30 mg/kg dose,,U,,A,,CHEMBL623916,,BAO_0000218,
10124,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4521,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,N,,A,,CHEMBL623917,,BAO_0000218,
10125,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17686,Bioavailability in rat (dose 2 mg/kg i.v.),,N,,A,,CHEMBL623918,,BAO_0000218,
10126,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17796,Bioavailability in rat,,N,,A,,CHEMBL874386,,BAO_0000218,
10127,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17796,Bioavailability in rat; Only traces detected in rat plasma,,N,,A,,CHEMBL623919,,BAO_0000218,
10128,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5064,Bioavailability in rat,,N,,A,,CHEMBL623920,,BAO_0000218,
10129,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5147,Bioavailability upon oral administration of compound,,N,,A,,CHEMBL623148,,BAO_0000218,
10130,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1916,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,N,,A,,CHEMBL623149,,BAO_0000218,
10131,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6049,Bioavailability in rat,,N,,A,,CHEMBL623150,,BAO_0000218,
10132,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,N,,A,,CHEMBL623151,,BAO_0000218,
10133,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,N,,A,,CHEMBL623152,,BAO_0000218,
10134,Rattus norvegicus,50597,,,1,,,Expert,2862,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,N,,F,,CHEMBL623153,,BAO_0000218,
10135,Rattus norvegicus,50597,,,1,,,Expert,2862,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,N,,F,,CHEMBL623154,,BAO_0000218,
10136,Rattus norvegicus,50597,,,1,,,Intermediate,4194,In vitro and metabolic stability was determined,,N,,A,,CHEMBL623155,,BAO_0000218,
10137,Rattus norvegicus,50597,,,1,,,Intermediate,4194,In vitro metabolic stability in rat hepatocytes,,N,,A,,CHEMBL623156,,BAO_0000218,
10138,Rattus norvegicus,50597,,,1,,,Intermediate,5486,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,N,,A,,CHEMBL623157,,BAO_0000218,
10139,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,17582,Metabolic rate for compound was observed in rat hepatocytes,,N,Hepatocyte,A,,CHEMBL623158,401.0,BAO_0000218,
10140,Rattus norvegicus,50597,,,1,,,Intermediate,5600,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,N,,A,,CHEMBL623159,,BAO_0000218,
10141,Rattus norvegicus,50597,,,1,,,Intermediate,14294,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,N,,A,,CHEMBL874390,,BAO_0000218,
10142,Rattus norvegicus,50597,,,1,,,Intermediate,14294,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,N,,A,,CHEMBL623160,,BAO_0000218,
10143,Rattus norvegicus,50597,,,1,,,Intermediate,14294,Metabolism of compound in rat S9 microsomes; Trace,,N,,A,,CHEMBL623161,,BAO_0000218,
10144,Rattus norvegicus,50597,,,1,,,Intermediate,17847,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,N,,A,,CHEMBL623162,,BAO_0000218,
10145,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,N,,A,,CHEMBL623163,,BAO_0000218,
10146,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,N,,A,,CHEMBL623164,,BAO_0000218,
10147,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,N,,A,,CHEMBL623165,,BAO_0000218,
10148,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,N,,A,,CHEMBL623166,,BAO_0000218,
10149,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,N,,A,,CHEMBL624983,,BAO_0000218,
10150,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,N,,A,,CHEMBL624984,,BAO_0000218,
10151,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,N,,A,,CHEMBL624985,,BAO_0000218,
10152,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,N,,A,,CHEMBL622970,,BAO_0000218,
10153,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,N,,A,,CHEMBL622971,,BAO_0000218,
10154,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,N,,A,,CHEMBL622972,,BAO_0000218,
10155,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,N,,A,,CHEMBL622973,,BAO_0000218,
10156,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,N,,A,,CHEMBL622974,,BAO_0000218,
10157,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,N,,A,,CHEMBL622975,,BAO_0000218,
10158,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,N,,A,,CHEMBL622976,,BAO_0000218,
10159,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,N,,A,,CHEMBL622977,,BAO_0000218,
10160,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,,A,,CHEMBL624351,,BAO_0000218,
10161,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,,A,,CHEMBL624352,,BAO_0000218,
10162,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,,A,,CHEMBL624353,,BAO_0000218,
10163,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,,A,,CHEMBL622397,,BAO_0000218,
10164,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,N,,A,,CHEMBL622398,,BAO_0000218,
10165,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,N,,A,,CHEMBL622399,,BAO_0000218,
10166,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,,A,,CHEMBL622400,,BAO_0000218,
10167,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,,A,,CHEMBL628428,,BAO_0000218,
10168,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,N,,A,,CHEMBL628590,,BAO_0000218,
10169,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,,A,,CHEMBL628591,,BAO_0000218,
10170,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,N,,A,,CHEMBL628592,,BAO_0000218,
10171,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,,A,,CHEMBL628593,,BAO_0000218,
10172,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,N,,A,,CHEMBL875333,,BAO_0000218,
10173,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,,A,,CHEMBL628594,,BAO_0000218,
10174,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,4969,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,N,,A,,CHEMBL628595,,BAO_0000218,
10175,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6737,Stability in rat plasma was determined,,N,,A,,CHEMBL628596,,BAO_0000218,
10176,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,6737,Stability in rat plasma was determined; ND= no data,,N,,A,,CHEMBL628597,,BAO_0000218,
10177,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5089,Tested for plasma half life period in rat (0-8 hr),,N,,A,,CHEMBL628598,,BAO_0000218,
10178,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,5089,Tested for plasma half life period in rat (0-8 hr); Not determined,,N,,A,,CHEMBL628599,,BAO_0000218,
10179,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,N,,A,,CHEMBL628600,,BAO_0000218,
10180,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,N,,A,,CHEMBL628601,,BAO_0000218,
10181,Rattus norvegicus,50597,,,1,,,Intermediate,4950,Tested for the half life in rat,,N,,A,,CHEMBL628602,,BAO_0000218,
10182,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,N,,A,,CHEMBL628603,,BAO_0000218,
10183,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,N,,A,,CHEMBL628604,,BAO_0000218,
10184,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,N,,A,,CHEMBL628605,,BAO_0000218,
10185,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,N,,A,,CHEMBL628606,,BAO_0000218,
10186,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,2412,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,N,,A,,CHEMBL628607,,BAO_0000218,
10187,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The biological half life the compound was measured at the dose of 100 umol/kg,,N,,A,,CHEMBL628608,,BAO_0000218,
10188,Rattus norvegicus,50597,,,1,,,Intermediate,15022,The biological half life the compound was measured at the dose of 30 umol/kg,,N,,A,,CHEMBL628609,,BAO_0000218,
10189,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,406,The compound was evaluated for plasma half life period in rat,,N,,A,,CHEMBL628610,,BAO_0000218,
10190,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL873819,,BAO_0000218,
10191,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL628611,,BAO_0000218,
10192,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5247,The pharmacokinetic parameter half-life period in vivo in rats,,N,,A,,CHEMBL628612,,BAO_0000218,
10193,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,"The pharmacokinetic property, Half-life was determined",,N,,A,,CHEMBL628613,,BAO_0000218,
10194,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,"The pharmacokinetic property, Half-life in rat in vivo",,N,,A,,CHEMBL628614,,BAO_0000218,
10195,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,N,,A,,CHEMBL628615,,BAO_0000218,
10196,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5041,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,N,,A,,CHEMBL628616,,BAO_0000218,
10197,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,3918,The plasma half life period in rats,,N,,A,,CHEMBL627924,,BAO_0000218,
10198,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,2906,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,N,,A,,CHEMBL627925,,BAO_0000218,
10199,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6467,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,N,,A,,CHEMBL627926,,BAO_0000218,
10200,Rattus norvegicus,50597,,,1,,,Intermediate,5510,t1/2 (apparent elimination)of the compound was determined,,N,,A,,CHEMBL627927,,BAO_0000218,
10201,Rattus norvegicus,50597,,,1,,,Intermediate,3788,t1/2 value in rat,,N,,A,,CHEMBL627928,,BAO_0000218,
10202,Rattus norvegicus,50597,,,1,,,Intermediate,17796,Half life in rat,,N,,A,,CHEMBL627539,,BAO_0000218,
10203,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12873,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,N,,A,,CHEMBL876790,,BAO_0000218,
10204,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5983,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,N,,A,,CHEMBL858186,,BAO_0000218,
10205,Rattus norvegicus,50597,,,1,,,Intermediate,15765,Half-life period in fasted rats,,N,,A,,CHEMBL627540,,BAO_0000218,
10206,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,N,,A,,CHEMBL627541,,BAO_0000218,
10207,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,N,,A,,CHEMBL627715,,BAO_0000218,
10208,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,N,,A,,CHEMBL627716,,BAO_0000218,
10209,Rattus norvegicus,50597,,,1,,,Intermediate,17655,Maximum time required to achieve Cmax was determined in rat,,N,,A,,CHEMBL627717,,BAO_0000218,
10210,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,A,,CHEMBL627718,,BAO_0000218,
10211,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,A,,CHEMBL627719,,BAO_0000218,
10212,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,N,,A,,CHEMBL627720,,BAO_0000218,
10213,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,N,,A,,CHEMBL627721,,BAO_0000218,
10214,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,N,,A,,CHEMBL627722,,BAO_0000218,
10215,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL627723,,BAO_0000218,
10216,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL626058,,BAO_0000218,
10217,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL626059,,BAO_0000218,
10218,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL626060,,BAO_0000218,
10219,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,A,,CHEMBL626061,,BAO_0000218,
10220,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4723,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL876791,,BAO_0000218,
10221,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4723,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,A,,CHEMBL626062,,BAO_0000218,
10222,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4756,Tmax at the dose of 2 mg/Kg administered perorally in rats,,N,,A,,CHEMBL626063,,BAO_0000218,
10223,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4756,Tmax at the dose of 5 mg/Kg administered perorally in rats,,N,,A,,CHEMBL626064,,BAO_0000218,
10224,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,N,,A,,CHEMBL626065,,BAO_0000218,
10225,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17720,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,N,,A,,CHEMBL626066,,BAO_0000218,
10226,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1466,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,N,,A,,CHEMBL626067,,BAO_0000218,
10227,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,N,,F,,CHEMBL626068,,BAO_0000218,
10228,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,N,,F,,CHEMBL626069,,BAO_0000218,
10229,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of 3-methoxyacetaminophen glucuronide,,N,,F,,CHEMBL626070,,BAO_0000218,
10230,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of N-methoxyacetaminophen glucuronide,,N,,F,,CHEMBL626071,,BAO_0000218,
10231,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of N-methoxyacetaminophen sulfate,,N,,F,,CHEMBL626072,,BAO_0000218,
10232,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of acetaminophen,,N,,F,,CHEMBL626073,,BAO_0000218,
10233,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7768,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,N,,A,,CHEMBL626741,,BAO_0000218,
10234,Rattus norvegicus,50597,,,1,,,Intermediate,17655,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,N,,A,,CHEMBL626742,,BAO_0000218,
10235,Rattus norvegicus,50597,,,1,,,Intermediate,17735,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,N,,A,,CHEMBL626743,,BAO_0000218,
10236,Rattus norvegicus,50597,,,1,,,Intermediate,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,N,,A,,CHEMBL876792,,BAO_0000218,
10237,Rattus norvegicus,50597,,,1,,,Intermediate,17735,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,,A,,CHEMBL626744,,BAO_0000218,
10238,Rattus norvegicus,50597,,,1,,,Intermediate,7116,Compound was tested for antidiuretic activity in rats,,N,,A,,CHEMBL626745,,BAO_0000218,
10239,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,4878,AUC in rat after 3mg/kg oral dose,,N,,A,,CHEMBL626746,,BAO_0000218,
10240,Rattus norvegicus,50597,,,1,,,Intermediate,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,N,,A,,CHEMBL626747,,BAO_0000218,
10241,Rattus norvegicus,50597,,,1,,,Intermediate,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,N,,A,,CHEMBL626748,,BAO_0000218,
10242,Rattus norvegicus,50597,,,1,,,Intermediate,16367,Bioavailability administered orally at a dose of 10 mg/kg to rats,,N,,A,,CHEMBL626749,,BAO_0000218,
10243,Rattus norvegicus,50597,,,1,,,Intermediate,16366,Oral Bioavailability was determined,,N,,A,,CHEMBL626750,,BAO_0000218,
10244,Rattus norvegicus,50597,,,1,,,Intermediate,4426,Oral bioavailability in rat,,N,,A,,CHEMBL626751,,BAO_0000218,
10245,Rattus norvegicus,50597,,,1,,,Intermediate,4426,Oral bioavailability in rat; Not performed.,,N,,A,,CHEMBL626913,,BAO_0000218,
10246,Rattus norvegicus,50597,,,1,,,Intermediate,5041,Bioavailability,,N,,A,,CHEMBL626914,,BAO_0000218,
10247,Rattus norvegicus,50597,,,1,,,Intermediate,5041,Bioavailability was determined; ND denotes no data,,N,,A,,CHEMBL626915,,BAO_0000218,
10248,Rattus norvegicus,50597,,,1,,,Intermediate,1500,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,N,,A,,CHEMBL626916,,BAO_0000218,
10249,Rattus norvegicus,50597,,,1,,,Intermediate,1500,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,N,,A,,CHEMBL626917,,BAO_0000218,
10250,Rattus norvegicus,50597,,,1,,,Intermediate,17409,Binding towards rat plasma protein at 10 uM,,N,,A,,CHEMBL626918,,BAO_0000218,
10251,Rattus norvegicus,50597,,,1,,,Intermediate,17409,Binding towards rat plasma protein at 100 uM,,N,,A,,CHEMBL626919,,BAO_0000218,
10252,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2959,Bioavailability in rat (dose 20 mg/kg p.o.),,N,,A,,CHEMBL626920,,BAO_0000218,
10253,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,N,,A,,CHEMBL621976,,BAO_0000218,
10254,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6567,Bioavailability in rat after 5 mg/kg oral gavage,,N,,A,,CHEMBL877599,,BAO_0000218,
10255,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6571,Bioavailability in rat,,N,,A,,CHEMBL621977,,BAO_0000218,
10256,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6715,Bioavailability in rat (dose 1 mg/kg i.v.),,N,,A,,CHEMBL621978,,BAO_0000218,
10257,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6715,Bioavailability in rat (dose 3 mg/kg p.o.),,N,,A,,CHEMBL621979,,BAO_0000218,
10258,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2932,Oral bioavailability in rat,,N,,A,,CHEMBL621980,,BAO_0000218,
10259,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4171,Bioavailability of the compound in rats after administration of 30 mg/kg,,N,,A,,CHEMBL621981,,BAO_0000218,
10260,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17509,Bioavailability after administration of 10 mg/kg in rats,,N,,A,,CHEMBL621982,,BAO_0000218,
10261,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17509,Bioavailability after administration of 2 mg/kg in rats,,N,,A,,CHEMBL882953,,BAO_0000218,
10262,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4527,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,N,,A,,CHEMBL621983,,BAO_0000218,
10263,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4026,Bioavailability in dogs was determined; high,,N,,A,,CHEMBL621984,,BAO_0000218,
10264,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6659,Bioavailability in monkey after intravenous administration at 1 mpk,,N,,A,,CHEMBL621985,,BAO_0000218,
10265,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6659,Bioavailability in monkey after peroral administration at 10 mpk,,N,,A,,CHEMBL621986,,BAO_0000218,
10266,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6659,Bioavailability in rat after intravenous administration at 1 mpk,,N,,A,,CHEMBL621987,,BAO_0000218,
10267,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6659,Bioavailability in rat after intravenous administration at 2 mpk,,N,,F,,CHEMBL877600,,BAO_0000218,
10268,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6659,Bioavailability in rat after peroral administration at 30 mpk,,N,,A,,CHEMBL621988,,BAO_0000218,
10269,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6659,Bioavailability in rat after peroral administration at at 100 mpk,,N,,F,,CHEMBL621989,,BAO_0000218,
10270,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6597,Bioavailability in rats was evaluated,,N,,A,,CHEMBL621990,,BAO_0000218,
10271,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1202,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,N,,A,,CHEMBL621991,,BAO_0000218,
10272,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1202,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,N,,A,,CHEMBL621992,,BAO_0000218,
10273,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,N,,A,,CHEMBL621993,,BAO_0000218,
10274,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,N,,A,,CHEMBL621994,,BAO_0000218,
10275,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5207,Bioavailability in rat,,N,,A,,CHEMBL621995,,BAO_0000218,
10276,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5970,Bioavailability in rat,,N,,A,,CHEMBL621996,,BAO_0000218,
10277,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17538,Oral bioavailability in rat (dose 10 mg/kg),,N,,A,,CHEMBL621997,,BAO_0000218,
10278,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17538,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,N,,A,,CHEMBL621998,,BAO_0000218,
10279,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1466,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,N,,A,,CHEMBL621999,,BAO_0000218,
10280,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2879,Oral bioavailability in rat,,N,,A,,CHEMBL622000,,BAO_0000218,
10281,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2879,Bioavailability was measured in rat after oral administration; 2-4,,N,,A,,CHEMBL622001,,BAO_0000218,
10282,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2879,Bioavailability was measured in rat after oral administration; 3-7,,N,,A,,CHEMBL622002,,BAO_0000218,
10283,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3777,Bioavailability in rat (intraduodenal administration),,N,,A,,CHEMBL622003,,BAO_0000218,
10284,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3777,Bioavailability in rat (intraduodenal administration),,N,,A,,CHEMBL877601,,BAO_0000218,
10285,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3777,Oral bioavailability in rat,,N,,A,,CHEMBL624871,,BAO_0000218,
10286,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3777,Oral bioavailability in rat,,N,,A,,CHEMBL622004,,BAO_0000218,
10287,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5423,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,N,,A,,CHEMBL882954,,BAO_0000218,
10288,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,N,,A,,CHEMBL622005,,BAO_0000218,
10289,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,N,,A,,CHEMBL622006,,BAO_0000218,
10290,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4239,Bioavailability was measured in rat,,N,,A,,CHEMBL622007,,BAO_0000218,
10291,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5438,Bioavailability was reported,,N,,A,,CHEMBL622008,,BAO_0000218,
10292,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,,A,,CHEMBL622009,,BAO_0000218,
10293,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,,A,,CHEMBL622010,,BAO_0000218,
10294,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4199,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,,A,,CHEMBL622011,,BAO_0000218,
10295,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4199,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,N,,A,,CHEMBL622012,,BAO_0000218,
10296,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4199,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,N,,A,,CHEMBL622013,,BAO_0000218,
10297,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4890,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,N,,A,,CHEMBL622014,,BAO_0000218,
10298,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2792,Bioavailability was determined at 3 mg/kg po dose in rats,,N,,A,,CHEMBL624749,,BAO_0000218,
10299,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5529,Oral bioavailability in rat (dose 2 mg/kg),,N,,A,,CHEMBL624750,,BAO_0000218,
10300,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,N,,A,,CHEMBL624751,,BAO_0000218,
10301,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,N,,A,,CHEMBL624752,,BAO_0000218,
10302,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6685,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,,A,,CHEMBL624753,,BAO_0000218,
10303,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6005,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,N,,A,,CHEMBL624754,,BAO_0000218,
10304,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,N,,A,,CHEMBL624755,,BAO_0000218,
10305,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,N,,A,,CHEMBL624756,,BAO_0000218,
10306,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6103,Bioavailability in rat,,N,,A,,CHEMBL624757,,BAO_0000218,
10307,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,N,,A,,CHEMBL624758,,BAO_0000218,
10308,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,N,,A,,CHEMBL622270,,BAO_0000218,
10309,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5353,Bioavailability in rat (Sprague-Dawley),,N,,A,,CHEMBL622271,,BAO_0000218,
10310,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4727,Bioavailability in rat at the dose of 2 mg/kg,,N,,A,,CHEMBL622272,,BAO_0000218,
10311,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Oral bioavailability in rat,,N,,A,,CHEMBL622273,,BAO_0000218,
10312,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),,N,,A,,CHEMBL622274,,BAO_0000218,
10313,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,Bioavailability value of compound in rats was determined after peroral administration,,N,,A,,CHEMBL622275,,BAO_0000218,
10314,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3634,Oral bioavailability in rat (dose 20 mg/kg),,N,,A,,CHEMBL622276,,BAO_0000218,
10315,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3341,Oral bioavailability in rat,,N,,A,,CHEMBL622277,,BAO_0000218,
10316,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2690,Oral bioavailability in rat (dose 5 mg/kg),,N,,A,,CHEMBL622278,,BAO_0000218,
10317,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3184,Oral bioavailability in rat,,N,,A,,CHEMBL622279,,BAO_0000218,
10318,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,740,Oral bioavailability in rat,,N,,A,,CHEMBL622280,,BAO_0000218,
10319,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1806,Compound was evaluated for oral bioavailability in rats; 15-27 %,,N,,A,,CHEMBL624083,,BAO_0000218,
10320,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,N,,A,,CHEMBL624084,,BAO_0000218,
10321,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3634,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,N,,A,,CHEMBL624085,,BAO_0000218,
10322,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,64,Compound was tested for bioavailability in rats,,N,,A,,CHEMBL624086,,BAO_0000218,
10323,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4839,Bioavailability in rat,,N,,A,,CHEMBL624087,,BAO_0000218,
10324,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1094,Oral bioavailability in rat,,N,,A,,CHEMBL624088,,BAO_0000218,
10325,Macaca mulatta,22224,,,1,In vivo,,Intermediate,5005,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,U,,A,,CHEMBL624089,,BAO_0000218,
10326,Rattus norvegicus,22224,,,1,In vivo,,Intermediate,5005,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,U,,A,,CHEMBL624090,,BAO_0000218,
10327,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4687,Evaluated for the bioavailability in rat (in vivo),,N,,A,,CHEMBL624091,,BAO_0000218,
10328,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17804,F value of compound in rats was determined after peroral administration,,N,,A,,CHEMBL624092,,BAO_0000218,
10329,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624093,,BAO_0000218,
10330,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624094,,BAO_0000218,
10331,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624095,,BAO_0000218,
10332,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,A,,CHEMBL624096,,BAO_0000218,
10333,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1088,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,N,,A,,CHEMBL624097,,BAO_0000218,
10334,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1742,Maximum fall in carotid flow in rat,,N,,A,,CHEMBL624098,,BAO_0000218,
10335,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4689,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,N,,A,,CHEMBL874392,,BAO_0000218,
10336,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2463,Oral bioavailability in rat (dose 5 mg/kg),,N,,A,,CHEMBL624099,,BAO_0000218,
10337,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,N,,A,,CHEMBL624100,,BAO_0000218,
10338,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,N,,A,,CHEMBL624101,,BAO_0000218,
10339,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6874,Oral bioavailability in rat (male Wistar),,N,,A,,CHEMBL624102,,BAO_0000218,
10340,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5633,Oral bioavailability after administration (30 mg/kg) in rat; good,,N,,A,,CHEMBL624103,,BAO_0000218,
10341,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5496,Oral bioavailability at the dose of 2 mg/kg in rat,,N,,A,,CHEMBL624104,,BAO_0000218,
10342,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2358,Oral bioavailability determined in rats,,N,,A,,CHEMBL624105,,BAO_0000218,
10343,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16456,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,N,,A,,CHEMBL624106,,BAO_0000218,
10344,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5302,Oral bioavailability in rat (dose single 10 mg/kg),,N,,A,,CHEMBL624107,,BAO_0000218,
10345,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5302,Oral bioavailability in rat (dose single 10 mg/kg),,N,,A,,CHEMBL623943,,BAO_0000218,
10346,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5302,Oral bioavailability in rat (dose 5 mg/kg,,N,,A,,CHEMBL623944,,BAO_0000218,
10347,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,N,,A,,CHEMBL623945,,BAO_0000218,
10348,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,N,,A,,CHEMBL623946,,BAO_0000218,
10349,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,N,,A,,CHEMBL623947,,BAO_0000218,
10350,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,N,,A,,CHEMBL623948,,BAO_0000218,
10351,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,N,,A,,CHEMBL623949,,BAO_0000218,
10352,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,N,,A,,CHEMBL623950,,BAO_0000218,
10353,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,N,,A,,CHEMBL874398,,BAO_0000218,
10354,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,N,,A,,CHEMBL623951,,BAO_0000218,
10355,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,N,,A,,CHEMBL623952,,BAO_0000218,
10356,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,N,,A,,CHEMBL623953,,BAO_0000218,
10357,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,N,,A,,CHEMBL623954,,BAO_0000218,
10358,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,N,,A,,CHEMBL623955,,BAO_0000218,
10359,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,N,,A,,CHEMBL623956,,BAO_0000218,
10360,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,N,,A,,CHEMBL627807,,BAO_0000218,
10361,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,N,,A,,CHEMBL627808,,BAO_0000218,
10362,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,N,,A,,CHEMBL627809,,BAO_0000218,
10363,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,N,,A,,CHEMBL627810,,BAO_0000218,
10364,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,N,,A,,CHEMBL627811,,BAO_0000218,
10365,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,N,,A,,CHEMBL627812,,BAO_0000218,
10366,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,N,,A,,CHEMBL627813,,BAO_0000218,
10367,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,N,,A,,CHEMBL627814,,BAO_0000218,
10368,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,N,,A,,CHEMBL875336,,BAO_0000218,
10369,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,N,,A,,CHEMBL627815,,BAO_0000218,
10370,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,N,,A,,CHEMBL627816,,BAO_0000218,
10371,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,N,,A,,CHEMBL627817,,BAO_0000218,
10372,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,N,,A,,CHEMBL627818,,BAO_0000218,
10373,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,N,,A,,CHEMBL627819,,BAO_0000218,
10374,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,N,,A,,CHEMBL627820,,BAO_0000218,
10375,Rattus norvegicus,50597,,,1,,,Intermediate,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,N,,A,,CHEMBL627821,,BAO_0000218,
10376,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,,A,,CHEMBL628464,,BAO_0000218,
10377,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,,A,,CHEMBL626239,,BAO_0000218,
10378,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,N,,A,,CHEMBL626240,,BAO_0000218,
10379,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,,A,,CHEMBL626241,,BAO_0000218,
10380,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,N,,A,,CHEMBL626242,,BAO_0000218,
10381,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,N,,A,,CHEMBL626243,,BAO_0000218,
10382,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,,A,,CHEMBL626244,,BAO_0000218,
10383,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,N,,A,,CHEMBL626907,,BAO_0000218,
10384,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,,A,,CHEMBL626908,,BAO_0000218,
10385,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,,A,,CHEMBL626909,,BAO_0000218,
10386,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,,A,,CHEMBL626910,,BAO_0000218,
10387,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of acetaminophen cysteine conjugate,,N,,F,,CHEMBL875342,,BAO_0000218,
10388,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of acetaminophen glucuronide,,N,,F,,CHEMBL626911,,BAO_0000218,
10389,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of acetaminophen sulfate,,N,,F,,CHEMBL626912,,BAO_0000218,
10390,Rattus norvegicus,50597,,,1,,,Intermediate,7449,Percent total excretion of acetaminophen-mercapturic acid,,N,,F,,CHEMBL627065,,BAO_0000218,
10391,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,3172,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,N,,A,,CHEMBL627066,,BAO_0000218,
10392,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16456,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,N,,A,,CHEMBL627067,,BAO_0000218,
10393,ratrat,22224,2385.0,,1,In vivo,,Autocuration,10839,Biodistribution of compound in rat muscle after 5 min of administration,,U,,A,,CHEMBL627068,,BAO_0000218,
10394,ratrat,22224,2385.0,,1,In vivo,,Autocuration,10839,Biodistribution of compound in rat muscle after 5 min of administration.,,U,,A,,CHEMBL627069,,BAO_0000218,
10395,Ovis aries,22224,,,1,In vivo,,Autocuration,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL627070,,BAO_0000218,
10396,Ovis aries,22224,,,1,In vivo,,Autocuration,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL627071,,BAO_0000218,
10397,Ovis aries,22224,,,1,In vivo,,Autocuration,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL627072,,BAO_0000218,
10398,Ovis aries,22224,,,1,In vivo,,Autocuration,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL627073,,BAO_0000218,
10399,Ovis aries,22224,,,1,In vivo,,Autocuration,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL625387,,BAO_0000218,
10400,Ovis aries,22224,,,1,In vivo,,Autocuration,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL625388,,BAO_0000218,
10401,Ovis aries,22224,1969.0,,1,In vivo,,Autocuration,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL625389,,BAO_0000218,
10402,Ovis aries,22224,1969.0,,1,In vivo,,Autocuration,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,U,,A,,CHEMBL875343,,BAO_0000218,
10403,Serpentes,50497,,,1,,,Intermediate,1735,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,N,,A,,CHEMBL876795,,BAO_0000218,
10404,Serpentes,50497,,,1,,,Intermediate,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,N,,A,,CHEMBL626552,,BAO_0000218,
10405,Serpentes,50497,,,1,,,Intermediate,1336,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,N,,A,,CHEMBL626553,,BAO_0000218,
10406,Homo sapiens,22224,1969.0,,1,,,Autocuration,12403,The human biological plasma half life of the compound,,U,,A,,CHEMBL626554,,BAO_0000366,
10407,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,,A,,CHEMBL626555,,BAO_0000218,
10408,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,N,,A,,CHEMBL626556,,BAO_0000218,
10409,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,N,,A,,CHEMBL626557,,BAO_0000218,
10410,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,N,,A,,CHEMBL626558,,BAO_0000218,
10411,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,,A,,CHEMBL626559,,BAO_0000218,
10412,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,,A,,CHEMBL626560,,BAO_0000218,
10413,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,,A,,CHEMBL876803,,BAO_0000218,
10414,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,N,,A,,CHEMBL627964,,BAO_0000218,
10415,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,N,,A,,CHEMBL627965,,BAO_0000218,
10416,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,N,,A,,CHEMBL627966,,BAO_0000218,
10417,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,,A,,CHEMBL627967,,BAO_0000218,
10418,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,,A,,CHEMBL627968,,BAO_0000218,
10419,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,,A,,CHEMBL627969,,BAO_0000218,
10420,Rattus norvegicus,50597,,,1,,,Intermediate,8004,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,,A,,CHEMBL627970,,BAO_0000218,
10421,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,N,,A,,CHEMBL627971,,BAO_0000218,
10422,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,N,,A,,CHEMBL627972,,BAO_0000218,
10423,Homo sapiens,180,,,1,,,Expert,15917,Dissociation constant against binding to human cyclophilin A,,D,,B,,CHEMBL856029,,BAO_0000357,
10424,Bos taurus,11591,,,1,,,Expert,12396,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,H,,B,,CHEMBL627973,,BAO_0000019,
10425,,22224,,,1,,,Autocuration,7065,-Log C was determined by performing the electroshock minimum test,,U,,A,,CHEMBL627974,,BAO_0000019,
10426,,22224,,,1,,,Autocuration,7065,-Log C was determined by performing the foot shock test,,U,,A,,CHEMBL627975,,BAO_0000019,
10427,,22224,,,1,,,Autocuration,7065,-Log C was determined by performing the incl screen test,,U,,A,,CHEMBL627976,,BAO_0000019,
10428,,22224,,,1,,,Autocuration,7065,-Log C was determined by performing the maximum electroshock test,,U,,A,,CHEMBL627977,,BAO_0000019,
10429,,22224,,,1,,,Autocuration,7065,-Log C was determined by performing the pentylenetetrazole test,,U,,A,,CHEMBL627978,,BAO_0000019,
10430,,22224,,,1,,,Autocuration,12415,Tested for experimental arotinoid inhibitory dose,,U,,A,,CHEMBL627979,,BAO_0000019,
10431,,22224,,,1,,,Autocuration,10256,Negative log transformed activity,,U,,A,,CHEMBL876804,,BAO_0000019,
10432,,22224,,,1,,,Autocuration,7991,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,U,,A,,CHEMBL627980,,BAO_0000019,
10433,Cavia porcellus,50512,,,1,,,Intermediate,14342,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,N,,A,,CHEMBL627981,,BAO_0000218,
10434,Cavia porcellus,50512,,,1,,,Intermediate,14342,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,N,,A,,CHEMBL627982,,BAO_0000218,
10435,Cavia porcellus,50512,,,1,,,Intermediate,14342,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,N,,A,,CHEMBL627983,,BAO_0000218,
10436,Cavia porcellus,50512,2116.0,,1,,,Intermediate,14342,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,N,,A,,CHEMBL627984,,BAO_0000218,
10437,,22229,,,1,,,Autocuration,6047,Solubility in water was determined; values expressed as -log,,U,,P,,CHEMBL627985,,BAO_0000100,
10438,,22224,,,1,,,Autocuration,17269,Ratio of Kcat to that of Km was determined,,U,,A,,CHEMBL627986,,BAO_0000019,
10439,,22224,,,1,,,Autocuration,10026,Observed first order rate constant,,U,,A,,CHEMBL627987,,BAO_0000019,
10440,,22224,,,1,,,Autocuration,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,U,,A,,CHEMBL627988,,BAO_0000019,
10441,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,N,,A,,CHEMBL627989,,BAO_0000218,
10442,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,N,,A,,CHEMBL627990,,BAO_0000218,
10443,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4029,Oral Bioavailability after administration of 10 mg/kg in male rat,,N,,A,,CHEMBL876805,,BAO_0000218,
10444,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17735,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,N,,A,,CHEMBL627991,,BAO_0000218,
10445,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4576,Oral bioavailability in rat,,N,,A,,CHEMBL627992,,BAO_0000218,
10446,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17582,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,N,,A,,CHEMBL627993,,BAO_0000218,
10447,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17651,Oral bioavailability at 1 mg/kg was determined in rat,,N,,A,,CHEMBL622817,,BAO_0000218,
10448,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17651,Oral bioavailability at 10 mg/kg was determined in rat,,N,,A,,CHEMBL622818,,BAO_0000218,
10449,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17670,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,N,,A,,CHEMBL622819,,BAO_0000218,
10450,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5045,Oral bioavailability in rat,,N,,A,,CHEMBL872267,,BAO_0000218,
10451,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1696,Oral bioavailability in rat,,N,,A,,CHEMBL622820,,BAO_0000218,
10452,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17764,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,N,,A,,CHEMBL622821,,BAO_0000218,
10453,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6448,Oral bioavailability in rat,,N,,A,,CHEMBL622822,,BAO_0000218,
10454,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6596,Oral bioavailability in rat,,N,,A,,CHEMBL622823,,BAO_0000218,
10455,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17547,Oral bioavailability in rat,,N,,A,,CHEMBL622824,,BAO_0000218,
10456,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17771,Oral bioavailability in rat at a dose of 3 mg/kg,,N,,A,,CHEMBL622825,,BAO_0000218,
10457,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6495,Oral bioavailability in rat after oral administration at 10 mg/kg,,N,,A,,CHEMBL622901,,BAO_0000218,
10458,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4558,Oral bioavailability in rat,,N,,A,,CHEMBL622902,,BAO_0000218,
10459,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17596,Oral bioavailability in rat,,N,,A,,CHEMBL621844,,BAO_0000218,
10460,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6827,Oral bioavailability in Dawley rats,,N,,A,,CHEMBL621845,,BAO_0000218,
10461,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4026,Oral bioavailability,,N,,A,,CHEMBL621846,,BAO_0000218,
10462,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,10,Oral bioavailability in rat (dose 30 mg/kg),,N,,A,,CHEMBL621847,,BAO_0000218,
10463,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,N,,A,,CHEMBL877609,,BAO_0000218,
10464,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Bioavailability in rat (dose 3 mg/kg i.v.),,N,,A,,CHEMBL621848,,BAO_0000218,
10465,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,N,,A,,CHEMBL621849,,BAO_0000218,
10466,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),,N,,A,,CHEMBL622030,,BAO_0000218,
10467,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4796,Percent oral bioavailability determined in rats,,N,,A,,CHEMBL622031,,BAO_0000218,
10468,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4883,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,N,,A,,CHEMBL622032,,BAO_0000218,
10469,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2137,The compound was evaluated for bioavailability in rats; 32-51,,N,,A,,CHEMBL622033,,BAO_0000218,
10470,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2959,Bioavailability in rat (dose 20 mg/kg p.o.),,N,,A,,CHEMBL622034,,BAO_0000218,
10471,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1361,Oral bioavailability in rat,,N,,A,,CHEMBL622035,,BAO_0000218,
10472,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4727,Bioavailability percent in rat at the dose of 2 mg/kg,,N,,A,,CHEMBL882966,,BAO_0000218,
10473,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16423,Bioavailability was evaluated after 20 uM/kg of peroral administration,,N,,A,,CHEMBL622036,,BAO_0000218,
10474,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5206,Oral bioavailability in rat,,N,,A,,CHEMBL622037,,BAO_0000218,
10475,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6448,Oral bioavailability in rat,,N,,A,,CHEMBL622038,,BAO_0000218,
10476,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17723,Bioavailability in rats,,N,,A,,CHEMBL622039,,BAO_0000218,
10477,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,N,,A,,CHEMBL622040,,BAO_0000218,
10478,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622041,,BAO_0000218,
10479,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622042,,BAO_0000218,
10480,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622043,,BAO_0000218,
10481,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622044,,BAO_0000218,
10482,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622045,,BAO_0000218,
10483,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622046,,BAO_0000218,
10484,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622047,,BAO_0000218,
10485,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL877610,,BAO_0000218,
10486,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622048,,BAO_0000218,
10487,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622049,,BAO_0000218,
10488,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622050,,BAO_0000218,
10489,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622051,,BAO_0000218,
10490,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622052,,BAO_0000218,
10491,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622053,,BAO_0000218,
10492,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622054,,BAO_0000218,
10493,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622055,,BAO_0000218,
10494,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5237,Oral bioavailability in rats was determined; High,,N,,A,,CHEMBL622056,,BAO_0000218,
10495,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5503,Oral bioavailability in the rat was determined,,N,,A,,CHEMBL622057,,BAO_0000218,
10496,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15765,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,N,,A,,CHEMBL628008,,BAO_0000218,
10497,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15660,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,N,,A,,CHEMBL622058,,BAO_0000218,
10498,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL622059,,BAO_0000218,
10499,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL622060,,BAO_0000218,
10500,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL622061,,BAO_0000218,
10501,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5978,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,N,,A,,CHEMBL622062,,BAO_0000218,
10502,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5656,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,N,,A,,CHEMBL622063,,BAO_0000218,
10503,Rattus norvegicus,50597,,,1,In vivo,,Expert,3598,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,A,,CHEMBL877611,,BAO_0000218,
10504,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4216,Oral bioavailability of compound in Sprague Dawley rats,,N,,A,,CHEMBL622064,,BAO_0000218,
10505,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17839,Oral bioavailability of compound in rat,,N,,A,,CHEMBL622065,,BAO_0000218,
10506,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6570,Oral bioavailability in rat (dose 2 mg/kg),,N,,A,,CHEMBL622066,,BAO_0000218,
10507,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5334,Oral bioavailability of compound in rat was determined,,N,,A,,CHEMBL622067,,BAO_0000218,
10508,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6886,Oral bioavailability of compound in rats,,N,,A,,CHEMBL622068,,BAO_0000218,
10509,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5210,Oral bioavailability of compound was determined in rats,,N,,A,,CHEMBL622069,,BAO_0000218,
10510,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4170,Oral bioavailability at a dose of 30 mg/kg in rats,,N,,A,,CHEMBL624796,,BAO_0000218,
10511,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6028,Oral bioavailability in rat (dose 10 mg/kg),,N,,A,,CHEMBL624797,,BAO_0000218,
10512,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6028,Oral bioavailability in rat (dose 10 mg/kg),,N,,A,,CHEMBL623053,,BAO_0000218,
10513,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6078,Oral bioavailability evaluated in rat,,N,,A,,CHEMBL623054,,BAO_0000218,
10514,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6168,Oral bioavailability in fasted rat,,N,,A,,CHEMBL623055,,BAO_0000218,
10515,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6168,Oral bioavailability in fed rat,,N,,A,,CHEMBL623056,,BAO_0000218,
10516,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5160,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,N,,A,,CHEMBL623057,,BAO_0000218,
10517,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6057,Oral bioavailability in rat,,N,,A,,CHEMBL623058,,BAO_0000218,
10518,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Oral bioavailability in rat (dose 10 mg/kg p.o.),,N,,A,,CHEMBL623059,,BAO_0000218,
10519,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6535,Oral bioavailability in rat after administration of 10 mg/kg po,,N,,A,,CHEMBL623060,,BAO_0000218,
10520,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4194,Oral bioavailability in rat,,N,,A,,CHEMBL623061,,BAO_0000218,
10521,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6230,Oral bioavailability in rat,,N,,A,,CHEMBL623062,,BAO_0000218,
10522,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6619,Oral bioavailability in rat,,N,,A,,CHEMBL623063,,BAO_0000218,
10523,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17607,Oral bioavailability in rat,,N,,A,,CHEMBL623064,,BAO_0000218,
10524,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4942,Oral bioavailability in ratrs,,N,,A,,CHEMBL623065,,BAO_0000218,
10525,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4942,Oral bioavailability in rat,,N,,A,,CHEMBL623066,,BAO_0000218,
10526,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6646,Oral bioavailability in rat,,N,,A,,CHEMBL623067,,BAO_0000218,
10527,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5237,Oral bioavailability in rats was determined; High,,N,,A,,CHEMBL623068,,BAO_0000218,
10528,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6646,Oral bioavailability in rat,,N,,A,,CHEMBL623069,,BAO_0000218,
10529,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4449,Oral bioavailability in rat,,N,,A,,CHEMBL623070,,BAO_0000218,
10530,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6057,Oral bioavailability was calculated in rat,,N,,A,,CHEMBL623071,,BAO_0000218,
10531,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2552,Oral bioavailability,,N,,A,,CHEMBL623072,,BAO_0000218,
10532,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5496,Oral bioavailability,,N,,A,,CHEMBL623073,,BAO_0000218,
10533,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6484,Oral bioavailability,,N,,A,,CHEMBL623074,,BAO_0000218,
10534,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6485,Oral bioavailability,,N,,A,,CHEMBL623075,,BAO_0000218,
10535,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6616,Oral bioavailability after i.v. administration,,N,,A,,CHEMBL623076,,BAO_0000218,
10536,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4969,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,,A,,CHEMBL623077,,BAO_0000218,
10537,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5862,Oral bioavailability in rat (Sprague-Dawley),,N,,A,,CHEMBL623078,,BAO_0000218,
10538,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4514,Oral bioavailability in Sprague-Dawley rats,,N,,A,,CHEMBL623079,,BAO_0000218,
10539,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,,A,,CHEMBL623080,,BAO_0000218,
10540,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,,A,,CHEMBL623081,,BAO_0000218,
10541,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5546,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,N,,A,,CHEMBL623082,,BAO_0000218,
10542,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6168,Oral bioavailability in fasted rat,,N,,A,,CHEMBL874400,,BAO_0000218,
10543,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6168,Oral bioavailability in fed rat,,N,,A,,CHEMBL623083,,BAO_0000218,
10544,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3624,Oral bioavailability in rat,,N,,A,,CHEMBL623084,,BAO_0000218,
10545,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5213,Oral bioavailability in rat,,N,,A,,CHEMBL623085,,BAO_0000218,
10546,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5496,Oral bioavailability in rat,,N,,A,,CHEMBL623086,,BAO_0000218,
10547,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5553,Oral bioavailability in rat,,N,,A,,CHEMBL623087,,BAO_0000218,
10548,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5833,Oral bioavailability in rat,,N,,A,,CHEMBL623088,,BAO_0000218,
10549,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5836,Oral bioavailability in rat,,N,,A,,CHEMBL623089,,BAO_0000218,
10550,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5865,Oral bioavailability in rat,,N,,A,,CHEMBL623090,,BAO_0000218,
10551,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5960,Oral bioavailability in rat,,N,,A,,CHEMBL623091,,BAO_0000218,
10552,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6249,Oral bioavailability in rat,,N,,A,,CHEMBL623092,,BAO_0000218,
10553,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6448,Oral bioavailability in rat,,N,,A,,CHEMBL623093,,BAO_0000218,
10554,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6453,Oral bioavailability in rat,,N,,A,,CHEMBL874401,,BAO_0000218,
10555,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6640,Oral bioavailability in rat,,N,,A,,CHEMBL623094,,BAO_0000218,
10556,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17607,Oral bioavailability in rat,,N,,A,,CHEMBL623095,,BAO_0000218,
10557,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Oral bioavailability in rat after peroral administration at 10 mg/kg,,N,,A,,CHEMBL623096,,BAO_0000218,
10558,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5939,Oral bioavailability in rat after peroral administration at 5 mg/kg,,N,,A,,CHEMBL624913,,BAO_0000218,
10559,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6281,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,N,,A,,CHEMBL624914,,BAO_0000218,
10560,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5874,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,N,,A,,CHEMBL624915,,BAO_0000218,
10561,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5213,Oral bioavailability in rat; Not measured,,N,,A,,CHEMBL624916,,BAO_0000218,
10562,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4964,Oral bioavailability in rat,,N,,A,,CHEMBL624917,,BAO_0000218,
10563,Rattus norvegicus,50597,,,1,,,Intermediate,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,N,,A,,CHEMBL625157,,BAO_0000218,
10564,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,6251,In vitro metabolic potential in rat liver microsomes,,N,,A,,CHEMBL625158,,BAO_0000218,
10565,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1568,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,N,,A,,CHEMBL625159,,BAO_0000218,
10566,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3032,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,N,,A,,CHEMBL625160,,BAO_0000218,
10567,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3748,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,N,,A,,CHEMBL625161,,BAO_0000218,
10568,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,401,Oral bioavailability in rat,,N,,A,,CHEMBL625162,,BAO_0000218,
10569,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6512,Oral bioavailability in rat,,N,,A,,CHEMBL625163,,BAO_0000218,
10570,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17617,Oral bioavailability in rats at 10 mg/kg,,N,,A,,CHEMBL625164,,BAO_0000218,
10571,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,N,,A,,CHEMBL625165,,BAO_0000218,
10572,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6742,Oral bioavailability in rat,,N,,A,,CHEMBL625166,,BAO_0000218,
10573,Rattus norvegicus,50597,,,1,,,Intermediate,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,N,,A,,CHEMBL625167,,BAO_0000218,
10574,Rattus norvegicus,50597,,,1,,,Intermediate,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,N,,A,,CHEMBL625168,,BAO_0000218,
10575,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3185,Plasma clearance of the compound,,N,,A,,CHEMBL625169,,BAO_0000218,
10576,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17596,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,N,,A,,CHEMBL626264,,BAO_0000218,
10577,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2713,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,N,,A,,CHEMBL626265,,BAO_0000218,
10578,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12500,The compound was tested for plasma clearance in rat,,N,,A,,CHEMBL626266,,BAO_0000218,
10579,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12500,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,N,,A,,CHEMBL626267,,BAO_0000218,
10580,Rattus norvegicus,50597,,,1,,,Intermediate,2713,Plasma concentration upon oral administration of 1 mg/Kg in rats,,N,,A,,CHEMBL626268,,BAO_0000218,
10581,Rattus norvegicus,50597,,,1,,,Intermediate,1446,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,N,,A,,CHEMBL626269,,BAO_0000218,
10582,Rattus norvegicus,50597,,,1,,,Intermediate,6227,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,N,,A,,CHEMBL626270,,BAO_0000218,
10583,Rattus norvegicus,50597,,,1,,,Intermediate,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,N,,A,,CHEMBL626271,,BAO_0000218,
10584,Rattus norvegicus,50597,,,1,,,Intermediate,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,N,,A,,CHEMBL626272,,BAO_0000218,
10585,Rattus norvegicus,50597,,,1,,,Intermediate,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,,A,,CHEMBL626273,,BAO_0000218,
10586,Rattus norvegicus,50597,,,1,,,Intermediate,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,,A,,CHEMBL875346,,BAO_0000218,
10587,Rattus norvegicus,50597,,,1,,,Intermediate,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,N,,A,,CHEMBL626274,,BAO_0000218,
10588,Rattus norvegicus,50597,,,1,,,Intermediate,4514,Compound was tested for protein binding in rat plasma,,N,,A,,CHEMBL626275,,BAO_0000218,
10589,Rattus norvegicus,50597,,,1,,,Intermediate,2713,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,N,,A,,CHEMBL624646,,BAO_0000218,
10590,Rattus norvegicus,50597,,,1,,,Intermediate,2713,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,N,,A,,CHEMBL624647,,BAO_0000218,
10591,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,5340,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,N,,A,,CHEMBL624648,,BAO_0000218,
10592,Rattus norvegicus,50597,,,1,,,Intermediate,12058,Area under curve ratio was determined (po/iv) in rat,,N,,A,,CHEMBL624649,,BAO_0000218,
10593,Rattus norvegicus,50597,,,1,,,Intermediate,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,N,,A,,CHEMBL624650,,BAO_0000218,
10594,Rattus norvegicus,50597,,,1,,,Intermediate,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,N,,A,,CHEMBL624651,,BAO_0000218,
10595,Rattus norvegicus,50597,,,1,,,Intermediate,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,N,,A,,CHEMBL624652,,BAO_0000218,
10596,Rattus norvegicus,50597,,,1,,,Intermediate,6495,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,N,,A,,CHEMBL624653,,BAO_0000218,
10597,Rattus norvegicus,50597,,,1,,,Intermediate,6078,Ratio of AUCbrain to AUCplasma,,N,,A,,CHEMBL624654,,BAO_0000218,
10598,Rattus norvegicus,50597,,,1,,,Intermediate,5656,Ratio of brain to plasma,,N,,A,,CHEMBL624655,,BAO_0000218,
10599,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,N,,A,,CHEMBL624656,,BAO_0000218,
10600,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,,A,,CHEMBL624657,,BAO_0000218,
10601,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,,A,,CHEMBL624658,,BAO_0000218,
10602,Rattus norvegicus,50597,,,1,,,Intermediate,10130,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,N,,A,,CHEMBL624659,,BAO_0000218,
10603,Rattus norvegicus,50597,,,1,,,Intermediate,10130,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,N,,A,,CHEMBL624660,,BAO_0000218,
10604,Rattus norvegicus,50597,,,1,,,Intermediate,10130,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,N,,A,,CHEMBL624661,,BAO_0000218,
10605,Rattus norvegicus,50597,,,1,,,Intermediate,5213,Steady state brain :blood ratio was determined,,N,,A,,CHEMBL624662,,BAO_0000218,
10606,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL625199,,BAO_0000218,
10607,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,,A,,CHEMBL625200,,BAO_0000218,
10608,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,,A,,CHEMBL625201,,BAO_0000218,
10609,Rattus norvegicus,50597,,,1,,,Intermediate,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,,A,,CHEMBL625202,,BAO_0000218,
10610,Rattus norvegicus,50597,,,1,,,Intermediate,2083,Percentage recovery after 3h incubation with rat hapatocytes was determined,,N,,A,,CHEMBL625203,,BAO_0000218,
10611,Rattus norvegicus,50597,,,1,,,Intermediate,2082,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,N,,A,,CHEMBL625204,,BAO_0000218,
10612,Rattus norvegicus,50597,,,1,,,Intermediate,2082,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,N,,A,,CHEMBL625205,,BAO_0000218,
10613,Rattus norvegicus,50597,,,1,,,Intermediate,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,N,,A,,CHEMBL625206,,BAO_0000218,
10614,,22224,,,1,,,Autocuration,14583,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,U,,A,,CHEMBL625207,,BAO_0000019,
10615,,22224,,,1,,,Autocuration,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,U,,A,,CHEMBL625208,,BAO_0000019,
10616,Homo sapiens,50587,,,1,,,Intermediate,4608,In vivo absorption in Caco-2 cell line monolayers was determined,,N,Caco-2,A,,CHEMBL625209,495.0,BAO_0000218,
10617,,22229,,,1,,,Autocuration,13668,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625210,,BAO_0000100,
10618,Rattus norvegicus,50597,,,1,,,Intermediate,5669,Area under curve was determine after peroral administration at 10 mpk in Rat,,N,,A,,CHEMBL625211,,BAO_0000218,
10619,Macaca mulatta,50797,,,1,,,Intermediate,5669,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,N,,A,,CHEMBL625212,,BAO_0000218,
10620,Rattus norvegicus,50597,,,1,,,Intermediate,5669,Area under curve was determine after peroral administration at 160 mpk in Rat,,N,,A,,CHEMBL625213,,BAO_0000218,
10621,Rattus norvegicus,50597,,,1,,,Intermediate,5669,Area under curve was determine after peroral administration at 20 mpk in Rat,,N,,A,,CHEMBL625214,,BAO_0000218,
10622,Rattus norvegicus,50597,,,1,,,Intermediate,5669,Area under curve was determine after peroral administration at 50 mpk in Rat,,N,,A,,CHEMBL874542,,BAO_0000218,
10623,,22229,,,1,,,Autocuration,6472,Calculated partition coefficient (clogP) (AlogP),,U,,P,,CHEMBL625215,,BAO_0000100,
10624,,22224,,,1,,,Autocuration,15106,Activated partial thromboplastin time measured,,U,,A,,CHEMBL625216,,BAO_0000019,
10625,,22224,,,1,,,Autocuration,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,U,,P,,CHEMBL625217,,BAO_0000100,
10626,,22224,,,1,,,Autocuration,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,U,,P,,CHEMBL625218,,BAO_0000100,
10627,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,13941,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,N,,A,,CHEMBL622864,,BAO_0000218,
10628,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,13941,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,N,,A,,CHEMBL622865,,BAO_0000218,
10629,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,13941,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,N,,A,,CHEMBL622866,,BAO_0000218,
10630,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,13941,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,N,,A,,CHEMBL622867,,BAO_0000218,
10631,Cavia porcellus,50512,1969.0,,1,,,Intermediate,15240,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,N,,A,,CHEMBL876808,,BAO_0000218,
10632,,22224,955.0,,1,,,Autocuration,10655,AUC in brain,,U,,A,,CHEMBL627725,,BAO_0000019,
10633,,22224,1977.0,,1,,,Autocuration,10655,AUC in serum,,U,,A,,CHEMBL627726,,BAO_0000019,
10634,,22224,1969.0,,1,,,Autocuration,6504,AUC was determined,,U,,A,,CHEMBL627727,,BAO_0000019,
10635,,22224,1969.0,,1,,,Autocuration,10615,AUC of the compound.,,U,,A,,CHEMBL627728,,BAO_0000019,
10636,,22224,1969.0,,1,,,Autocuration,10353,AUC value (0-4 hr),,U,,A,,CHEMBL627729,,BAO_0000019,
10637,,22224,1969.0,,1,,,Autocuration,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,U,,A,,CHEMBL627730,,BAO_0000019,
10638,,22224,1969.0,,1,,,Autocuration,14907,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,U,,A,,CHEMBL627731,,BAO_0000019,
10639,,22224,1969.0,,1,,,Autocuration,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,U,,A,,CHEMBL627732,,BAO_0000019,
10640,,22224,1969.0,,1,,,Autocuration,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,U,,A,,CHEMBL627733,,BAO_0000019,
10641,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,16359,AUC(area under curve) was determined after intravenous administration in rats,,N,,A,,CHEMBL627734,,BAO_0000218,
10642,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,16359,AUC(area under curve) was determined after oral administration in rats,,N,,A,,CHEMBL627735,,BAO_0000218,
10643,Cavia porcellus,50512,1969.0,,1,,,Intermediate,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,N,,A,,CHEMBL627736,,BAO_0000218,
10644,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,N,,A,,CHEMBL876809,,BAO_0000218,
10645,,22224,,,1,,,Autocuration,15469,Area Under Curve after oral dosing of 100 uM/Kg,,U,,A,,CHEMBL627737,,BAO_0000019,
10646,,22224,,,1,,,Autocuration,15469,Area Under Curve after oral dosing of 30 uM/Kg,,U,,A,,CHEMBL627738,,BAO_0000019,
10647,,22224,,,1,,,Autocuration,13520,Area Under Curve was measured by ploting the graph between concentration verses time,,U,,A,,CHEMBL627739,,BAO_0000019,
10648,Canis lupus familiaris,50588,,,1,,,Intermediate,17025,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,N,,A,,CHEMBL626143,,BAO_0000218,
10649,Simiiformes,22224,,,1,,,Autocuration,17025,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,U,,A,,CHEMBL626144,,BAO_0000218,
10650,Oryctolagus cuniculus,50592,,,1,,,Intermediate,17025,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,N,,A,,CHEMBL626145,,BAO_0000218,
10651,Rattus norvegicus,50597,,,1,,,Intermediate,17025,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,N,,A,,CHEMBL626146,,BAO_0000218,
10652,Rattus norvegicus,50597,178.0,,1,,,Intermediate,12032,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,N,,A,,CHEMBL626147,,BAO_0000218,
10653,,22224,,,1,,,Autocuration,10291,Area under curve (AUC) was determined,,U,,A,,CHEMBL626148,,BAO_0000019,
10654,,22224,,,1,,,Autocuration,5767,Area under curve (AUC) following ip administration at 1 mg/kg,,U,,A,,CHEMBL626149,,BAO_0000218,
10655,,22224,,,1,,,Autocuration,1434,Area under curve (AUC) was determined; ND is Not determined,,U,,A,,CHEMBL626150,,BAO_0000019,
10656,Canis lupus familiaris,50588,,,1,,,Intermediate,14925,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,N,,A,,CHEMBL626151,,BAO_0000218,
10657,Canis lupus familiaris,50588,,,1,,,Intermediate,14925,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,N,,A,,CHEMBL626152,,BAO_0000218,
10658,Canis lupus familiaris,50588,,,1,,,Intermediate,14925,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,N,,A,,CHEMBL626153,,BAO_0000218,
10659,,22224,,,1,,,Autocuration,1434,Area under curve (AUR) was determined,,U,,A,,CHEMBL626154,,BAO_0000019,
10660,,22224,,,1,,,Autocuration,11883,Area under curve at 1 uM/dg administered intravenously,,U,,A,,CHEMBL626155,,BAO_0000019,
10661,,22224,,,1,,,Autocuration,11883,Area under curve at 10 uM/dg administered perorally,,U,,A,,CHEMBL626156,,BAO_0000019,
10662,,22224,,,1,,,Autocuration,11883,Area under curve at 2 uM/dg administered intravenously,,U,,A,,CHEMBL626157,,BAO_0000019,
10663,,22224,,,1,,,Autocuration,11883,Area under curve at 20 uM/dg administered perorally,,U,,A,,CHEMBL626158,,BAO_0000019,
10664,Canis lupus familiaris,50588,,,1,,,Intermediate,15233,Area under curve at a peroral dose of 3 mg/kg in dog,,N,,A,,CHEMBL626159,,BAO_0000218,
10665,Rattus norvegicus,50597,,,1,,,Intermediate,15233,Area under curve at a peroral dose of 3 mg/kg in rat,,N,,A,,CHEMBL626160,,BAO_0000218,
10666,Canis lupus familiaris,50588,,,1,,,Intermediate,15233,Area under curve at an iv dose of 1 mg/kg in dog,,N,,A,,CHEMBL626161,,BAO_0000218,
10667,Rattus norvegicus,50597,,,1,,,Intermediate,15233,Area under curve at an iv dose of 1 mg/kg in rat,,N,,A,,CHEMBL626162,,BAO_0000218,
10668,,22224,,,1,,,Autocuration,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,U,,A,,CHEMBL626163,,BAO_0000019,
10669,,22224,,,1,,,Autocuration,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,U,,A,,CHEMBL626164,,BAO_0000019,
10670,Mus musculus,50594,,,1,,,Intermediate,11355,Area under curve measured as conc vs time after intravenous administration to mice.,,N,,A,,CHEMBL626165,,BAO_0000218,
10671,Mus musculus,50594,,,1,,,Intermediate,11355,Area under curve measured as conc vs time after peroral administration to mice.,,N,,A,,CHEMBL626166,,BAO_0000218,
10672,Canis lupus familiaris,50588,,,1,,,Intermediate,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,,A,,CHEMBL626167,,BAO_0000218,
10673,Canis lupus familiaris,50588,,,1,,,Intermediate,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,N,,A,,CHEMBL626168,,BAO_0000218,
10674,Canis lupus familiaris,50588,,,1,,,Intermediate,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,N,,A,,CHEMBL877463,,BAO_0000218,
10675,Canis lupus familiaris,50588,,,1,,,Intermediate,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,N,,A,,CHEMBL626169,,BAO_0000218,
10676,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL626170,,BAO_0000218,
10677,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL626171,,BAO_0000218,
10678,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL626172,,BAO_0000218,
10679,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL626173,,BAO_0000218,
10680,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,N,,A,,CHEMBL626174,,BAO_0000218,
10681,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL626175,,BAO_0000218,
10682,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL626176,,BAO_0000218,
10683,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL626177,,BAO_0000218,
10684,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622499,,BAO_0000218,
10685,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,N,,A,,CHEMBL622500,,BAO_0000218,
10686,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622501,,BAO_0000218,
10687,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL622502,,BAO_0000218,
10688,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL622503,,BAO_0000218,
10689,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL877614,,BAO_0000218,
10690,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL624839,,BAO_0000218,
10691,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL624840,,BAO_0000218,
10692,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL624841,,BAO_0000218,
10693,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL624842,,BAO_0000218,
10694,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL624843,,BAO_0000218,
10695,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,N,,A,,CHEMBL624844,,BAO_0000218,
10696,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,N,,A,,CHEMBL624845,,BAO_0000218,
10697,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,17738,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,N,,A,,CHEMBL621904,,BAO_0000218,
10698,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,N,,A,,CHEMBL621905,,BAO_0000218,
10699,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,N,,A,,CHEMBL874382,,BAO_0000218,
10700,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,N,,A,,CHEMBL621906,,BAO_0000218,
10701,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,N,,A,,CHEMBL621907,,BAO_0000218,
10702,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,N,,A,,CHEMBL622096,,BAO_0000218,
10703,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,N,,A,,CHEMBL622097,,BAO_0000218,
10704,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,N,,A,,CHEMBL622098,,BAO_0000218,
10705,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,N,,A,,CHEMBL622099,,BAO_0000218,
10706,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,N,,A,,CHEMBL622100,,BAO_0000218,
10707,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,N,,A,,CHEMBL622101,,BAO_0000218,
10708,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,N,,A,,CHEMBL622102,,BAO_0000218,
10709,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,N,,A,,CHEMBL622103,,BAO_0000218,
10710,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,N,,A,,CHEMBL622104,,BAO_0000218,
10711,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,N,,A,,CHEMBL622105,,BAO_0000218,
10712,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,N,,A,,CHEMBL622106,,BAO_0000218,
10713,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,N,,A,,CHEMBL622107,,BAO_0000218,
10714,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,N,,A,,CHEMBL622108,,BAO_0000218,
10715,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,N,,A,,CHEMBL622109,,BAO_0000218,
10716,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,N,,A,,CHEMBL622110,,BAO_0000218,
10717,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,N,,A,,CHEMBL622111,,BAO_0000218,
10718,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,N,,A,,CHEMBL874383,,BAO_0000218,
10719,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,N,,A,,CHEMBL622112,,BAO_0000218,
10720,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,N,,A,,CHEMBL622113,,BAO_0000218,
10721,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,N,,A,,CHEMBL622114,,BAO_0000218,
10722,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,N,,A,,CHEMBL622115,,BAO_0000218,
10723,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,N,,A,,CHEMBL622116,,BAO_0000218,
10724,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6193,Oral bioavailability in rat,,N,,A,,CHEMBL622117,,BAO_0000218,
10725,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6803,Oral bioavailability in rat,,N,,A,,CHEMBL622118,,BAO_0000218,
10726,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6647,Oral bioavailability in rats at 6 mg/kg,,N,,A,,CHEMBL622119,,BAO_0000218,
10727,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6647,Oral bioavailability in rat (dose 6 mg/kg),,N,,A,,CHEMBL622120,,BAO_0000218,
10728,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6647,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,N,,A,,CHEMBL622121,,BAO_0000218,
10729,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6640,Oral bioavailability in rat,,N,,A,,CHEMBL622122,,BAO_0000218,
10730,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Oral bioavailability in rat,,N,,A,,CHEMBL622123,,BAO_0000218,
10731,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6641,Oral bioavailability in rat,,N,,A,,CHEMBL622124,,BAO_0000218,
10732,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6642,Bioavailability in rat,,N,,A,,CHEMBL622125,,BAO_0000218,
10733,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5472,Oral bioavailability,,N,,A,,CHEMBL622126,,BAO_0000218,
10734,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6141,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,,A,,CHEMBL620455,,BAO_0000218,
10735,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4390,Oral bioavailability in rat,,N,,A,,CHEMBL620456,,BAO_0000218,
10736,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5472,Oral bioavailability in rat,,N,,A,,CHEMBL620457,,BAO_0000218,
10737,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5472,Oral bioavailability was evaluated; Not tested,,N,,A,,CHEMBL620458,,BAO_0000218,
10738,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5438,Oral bioavailability,,N,,A,,CHEMBL620459,,BAO_0000218,
10739,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4883,Oral bioavailability in rat by oral dosing,,N,,A,,CHEMBL620460,,BAO_0000218,
10740,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1908,Oral bioavailability in rat (dose 10 mg/kg p.o.),,N,,A,,CHEMBL620461,,BAO_0000218,
10741,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability in rat (Sprague-Dawley),,N,,A,,CHEMBL620462,,BAO_0000218,
10742,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,,A,,CHEMBL620463,,BAO_0000218,
10743,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,N,,A,,CHEMBL620464,,BAO_0000218,
10744,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,N,,A,,CHEMBL620465,,BAO_0000218,
10745,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,N,,A,,CHEMBL620466,,BAO_0000218,
10746,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,N,,A,,CHEMBL620467,,BAO_0000218,
10747,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,N,,A,,CHEMBL620468,,BAO_0000218,
10748,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,N,,A,,CHEMBL620469,,BAO_0000218,
10749,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,N,,A,,CHEMBL620470,,BAO_0000218,
10750,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3169,Oral bioavailability in rat,,N,,A,,CHEMBL620471,,BAO_0000218,
10751,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6305,Oral bioavailability in rat,,N,,A,,CHEMBL620472,,BAO_0000218,
10752,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4762,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,N,,A,,CHEMBL620473,,BAO_0000218,
10753,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17847,Oral bioavailability in rat,,N,,A,,CHEMBL620474,,BAO_0000218,
10754,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6211,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,N,,A,,CHEMBL620475,,BAO_0000218,
10755,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6011,Oral bioavailability in rat,,N,,A,,CHEMBL620476,,BAO_0000218,
10756,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6317,Oral bioavailability in rat,,N,,A,,CHEMBL620477,,BAO_0000218,
10757,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,N,,A,,CHEMBL620478,,BAO_0000218,
10758,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,N,,A,,CHEMBL618768,,BAO_0000218,
10759,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,N,,A,,CHEMBL618769,,BAO_0000218,
10760,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6644,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,N,,A,,CHEMBL618770,,BAO_0000218,
10761,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6113,Oral bioavailability (dose 20 mg/kg p.o.),,N,,A,,CHEMBL618771,,BAO_0000218,
10762,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5937,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,N,,A,,CHEMBL618772,,BAO_0000218,
10763,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5711,Oral bioavailability in rat at 10 mg/kg of the compound,,N,,A,,CHEMBL618773,,BAO_0000218,
10764,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,N,,A,,CHEMBL875842,,BAO_0000218,
10765,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Bioavailability in rat (dose 3 mg/kg i.v.),,N,,A,,CHEMBL618774,,BAO_0000218,
10766,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,N,,A,,CHEMBL618775,,BAO_0000218,
10767,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),,N,,A,,CHEMBL618776,,BAO_0000218,
10768,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4722,Percent bioavailability (F) in rats after iv administration,,N,,A,,CHEMBL618777,,BAO_0000218,
10769,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4722,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,N,,A,,CHEMBL618778,,BAO_0000218,
10770,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4353,Bioavailability in rat (dose 5 uM/kg p.o.),,N,,A,,CHEMBL618779,,BAO_0000218,
10771,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15662,Oral bioavailability,,N,,A,,CHEMBL618780,,BAO_0000218,
10772,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4756,Bioavailability in rat (dose 2 mg/kg p.o.),,N,,A,,CHEMBL618781,,BAO_0000218,
10773,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,4756,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,N,,A,,CHEMBL618782,,BAO_0000218,
10774,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3436,Oral bioavailability in rat (dose 20 mg/kg),,N,,A,,CHEMBL618783,,BAO_0000218,
10775,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17800,Oral bioavailability in rat,,N,,A,,CHEMBL618784,,BAO_0000218,
10776,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15762,Percent oral bioavailability evaluated in rat,,N,,A,,CHEMBL618785,,BAO_0000218,
10777,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5089,Oral bioavailability in rat,,N,,A,,CHEMBL618786,,BAO_0000218,
10778,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5089,Percent oral bioavailability in rat; Not determined,,N,,A,,CHEMBL618787,,BAO_0000218,
10779,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3185,Oral bioavailability in rat,,N,,A,,CHEMBL618788,,BAO_0000218,
10780,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5145,Bioavailability in rat,,N,,A,,CHEMBL618789,,BAO_0000218,
10781,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,N,,A,,CHEMBL618790,,BAO_0000218,
10782,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,N,,A,,CHEMBL618791,,BAO_0000218,
10783,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5983,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,N,,A,,CHEMBL875843,,BAO_0000218,
10784,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5739,Oral bioavailability in rat (dose 20 mg/kg p.o.),,N,,A,,CHEMBL618792,,BAO_0000218,
10785,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,3579,Cmax at a dose of 30 mg/kg in rat,,N,,A,,CHEMBL623395,,BAO_0000218,
10786,Simiiformes,22224,,,1,In vivo,,Autocuration,17788,Cmax in monkeys at a dose of 1 mg/kg,,U,,A,,CHEMBL623396,,BAO_0000218,
10787,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14956,Cmax in rat,,N,,A,,CHEMBL623397,,BAO_0000218,
10788,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17788,Cmax in rats at a dose of 1 mg/kg,,N,,A,,CHEMBL623398,,BAO_0000218,
10789,Mus musculus,50594,,,1,In vivo,,Intermediate,9750,Cmax was measured in mice after an oral dose of 50 mg/kg.,,N,,A,,CHEMBL623399,,BAO_0000218,
10790,,22224,,,1,In vivo,,Autocuration,12767,"Cmax value at a dose of 12.7 uM/kg, po",,U,,A,,CHEMBL623400,,BAO_0000218,
10791,,22224,,,1,In vivo,,Autocuration,12767,"Cmax value at a dose of 6.3 uM/kg, iv",,U,,A,,CHEMBL623401,,BAO_0000218,
10792,,22224,,,1,In vivo,,Autocuration,12767,"Cmax value at a dose of 7.1 uM/kg, iv",,U,,A,,CHEMBL623402,,BAO_0000218,
10793,,22224,,,1,In vivo,,Autocuration,12703,Cmax value of compound was determined after 1 hr,,U,,A,,CHEMBL623403,,BAO_0000218,
10794,,22224,,,1,In vivo,,Autocuration,15778,Cmax value of the compound,,U,,A,,CHEMBL623404,,BAO_0000218,
10795,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12818,Cmax value administered intraintestinal in rats.,,N,,A,,CHEMBL625997,,BAO_0000218,
10796,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14964,Cmax value administered perorally was determined in rat; Not determined,,N,,A,,CHEMBL625998,,BAO_0000218,
10797,,22224,,,1,In vivo,,Autocuration,15808,Cmax value at the dose of 2.3 mg/kg,,U,,A,,CHEMBL625999,,BAO_0000218,
10798,,22224,,,1,In vivo,,Autocuration,15808,Cmax value at the dose of 5 mg/kg,,U,,A,,CHEMBL626000,,BAO_0000218,
10799,,22224,,,1,In vivo,,Autocuration,15778,Cmax value in the period of 8 hr after dosing. ,,U,,A,,CHEMBL626001,,BAO_0000218,
10800,,22224,,,1,In vivo,,Autocuration,3715,Cmax value at a oral dose of 20 mg/kg; Not tested,,U,,A,,CHEMBL626002,,BAO_0000218,
10801,,22224,,,1,In vivo,,Autocuration,3715,Cmax value at a oral dose of 20 mg/kg,,U,,A,,CHEMBL626003,,BAO_0000218,
10802,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,N,,A,,CHEMBL626004,,BAO_0000218,
10803,Cavia porcellus,50512,,,1,In vivo,,Intermediate,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,N,,A,,CHEMBL626005,,BAO_0000218,
10804,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,N,,A,,CHEMBL626006,,BAO_0000218,
10805,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14810,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,N,,A,,CHEMBL626007,,BAO_0000218,
10806,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,N,,A,,CHEMBL626008,,BAO_0000218,
10807,Canis lupus familiaris,50588,2107.0,,1,In vivo,,Intermediate,12555,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,N,,A,,CHEMBL626009,,BAO_0000218,
10808,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,10754,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,N,,A,,CHEMBL626010,,BAO_0000218,
10809,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,N,,A,,CHEMBL626011,,BAO_0000218,
10810,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,N,,A,,CHEMBL626012,,BAO_0000218,
10811,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,N,,A,,CHEMBL626013,,BAO_0000218,
10812,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,N,,A,,CHEMBL626014,,BAO_0000218,
10813,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,N,,A,,CHEMBL877496,,BAO_0000218,
10814,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14600,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,N,,F,,CHEMBL626015,,BAO_0000218,
10815,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14600,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,N,,F,,CHEMBL626016,,BAO_0000218,
10816,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14600,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,N,,F,,CHEMBL626017,,BAO_0000218,
10817,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,13543,Bioavailability as maximal plasma concentration in dogs,,N,,A,,CHEMBL626018,,BAO_0000218,
10818,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,13543,Bioavailability as maximal plasma concentration in dogs,,N,,A,,CHEMBL626692,,BAO_0000218,
10819,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13543,Bioavailability as maximal plasma concentration in rats,,N,,A,,CHEMBL626693,,BAO_0000218,
10820,Rattus norvegicus,22224,1969.0,,1,In vivo,,Autocuration,13543,Bioavailability as maximal plasma concentration in rats,,U,,A,,CHEMBL626694,,BAO_0000218,
10821,Canis lupus familiaris,50588,178.0,,1,In vivo,,Intermediate,14600,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,,A,,CHEMBL626695,,BAO_0000218,
10822,Canis lupus familiaris,50588,178.0,,1,In vivo,,Intermediate,14600,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,,A,,CHEMBL626696,,BAO_0000218,
10823,Canis lupus familiaris,50588,178.0,,1,In vivo,,Intermediate,14600,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,,A,,CHEMBL626697,,BAO_0000218,
10824,Canis lupus familiaris,50588,178.0,,1,In vivo,,Intermediate,14600,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,N,,A,,CHEMBL626859,,BAO_0000218,
10825,Canis lupus familiaris,50588,178.0,,1,In vivo,,Intermediate,14600,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,,A,,CHEMBL626860,,BAO_0000218,
10826,Canis lupus familiaris,50588,178.0,,1,In vivo,,Intermediate,14600,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,N,,A,,CHEMBL626861,,BAO_0000218,
10827,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14681,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,,A,,CHEMBL626296,,BAO_0000218,
10828,,22224,,,1,In vivo,,Autocuration,15905,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,U,,A,,CHEMBL626297,,BAO_0000218,
10829,,22224,1969.0,,1,In vivo,,Autocuration,15905,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,U,,A,,CHEMBL626298,,BAO_0000218,
10830,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13304,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,N,,A,,CHEMBL626299,,BAO_0000218,
10831,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,N,,A,,CHEMBL626300,,BAO_0000218,
10832,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,N,,A,,CHEMBL626301,,BAO_0000218,
10833,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,N,,A,,CHEMBL626962,,BAO_0000218,
10834,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,N,,A,,CHEMBL626963,,BAO_0000218,
10835,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,N,,A,,CHEMBL626964,,BAO_0000218,
10836,Macaca fascicularis,100710,1969.0,,1,In vivo,,Intermediate,14839,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,N,,A,,CHEMBL626965,,BAO_0000218,
10837,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,,A,,CHEMBL626966,,BAO_0000218,
10838,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,,A,,CHEMBL626967,,BAO_0000218,
10839,Macaca fascicularis,100710,1969.0,,1,In vivo,,Intermediate,14839,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,N,,A,,CHEMBL626968,,BAO_0000218,
10840,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,N,,A,,CHEMBL626969,,BAO_0000218,
10841,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,N,,A,,CHEMBL627126,,BAO_0000218,
10842,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,N,,A,,CHEMBL631276,,BAO_0000218,
10843,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,N,,A,,CHEMBL631277,,BAO_0000218,
10844,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,N,,A,,CHEMBL631278,,BAO_0000218,
10845,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,N,,A,,CHEMBL874457,,BAO_0000218,
10846,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,N,,A,,CHEMBL631279,,BAO_0000218,
10847,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,N,,A,,CHEMBL631280,,BAO_0000218,
10848,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,N,,A,,CHEMBL631281,,BAO_0000218,
10849,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,N,,A,,CHEMBL631968,,BAO_0000218,
10850,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,N,,A,,CHEMBL631969,,BAO_0000218,
10851,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,N,,A,,CHEMBL631970,,BAO_0000218,
10852,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,N,,A,,CHEMBL631971,,BAO_0000218,
10853,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,N,,A,,CHEMBL631972,,BAO_0000218,
10854,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,N,,A,,CHEMBL630435,,BAO_0000218,
10855,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,N,,A,,CHEMBL630436,,BAO_0000218,
10856,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,N,,A,,CHEMBL630437,,BAO_0000218,
10857,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,N,,A,,CHEMBL630438,,BAO_0000218,
10858,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,N,,A,,CHEMBL630439,,BAO_0000218,
10859,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,N,,A,,CHEMBL630440,,BAO_0000218,
10860,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,N,,A,,CHEMBL630441,,BAO_0000218,
10861,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,N,,A,,CHEMBL630442,,BAO_0000218,
10862,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,N,,A,,CHEMBL625234,,BAO_0000218,
10863,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,N,,A,,CHEMBL625235,,BAO_0000218,
10864,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,N,,A,,CHEMBL625236,,BAO_0000218,
10865,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,N,,A,,CHEMBL625237,,BAO_0000218,
10866,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,N,,A,,CHEMBL626125,,BAO_0000218,
10867,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,N,,A,,CHEMBL626126,,BAO_0000218,
10868,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,N,,A,,CHEMBL626127,,BAO_0000218,
10869,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,N,,A,,CHEMBL626128,,BAO_0000218,
10870,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,N,,A,,CHEMBL626129,,BAO_0000218,
10871,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,N,,A,,CHEMBL626130,,BAO_0000218,
10872,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,N,,A,,CHEMBL626131,,BAO_0000218,
10873,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,N,,A,,CHEMBL626132,,BAO_0000218,
10874,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,N,,A,,CHEMBL626752,,BAO_0000218,
10875,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,N,,A,,CHEMBL626753,,BAO_0000218,
10876,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,N,,A,,CHEMBL626754,,BAO_0000218,
10877,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,N,,A,,CHEMBL626755,,BAO_0000218,
10878,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,N,,A,,CHEMBL626756,,BAO_0000218,
10879,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,N,,A,,CHEMBL626757,,BAO_0000218,
10880,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,N,,A,,CHEMBL626758,,BAO_0000218,
10881,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,N,,A,,CHEMBL626759,,BAO_0000218,
10882,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,N,,A,,CHEMBL626760,,BAO_0000218,
10883,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL626394,,BAO_0000218,
10884,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,N,,A,,CHEMBL626395,,BAO_0000218,
10885,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL626396,,BAO_0000218,
10886,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL626397,,BAO_0000218,
10887,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,,A,,CHEMBL626398,,BAO_0000218,
10888,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL626399,,BAO_0000218,
10889,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,N,,A,,CHEMBL874653,,BAO_0000218,
10890,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL626400,,BAO_0000218,
10891,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL626401,,BAO_0000218,
10892,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL626402,,BAO_0000218,
10893,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL626403,,BAO_0000218,
10894,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL626404,,BAO_0000218,
10895,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,N,,A,,CHEMBL626405,,BAO_0000218,
10896,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL625529,,BAO_0000218,
10897,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL625530,,BAO_0000218,
10898,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL625531,,BAO_0000218,
10899,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL625532,,BAO_0000218,
10900,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL625533,,BAO_0000218,
10901,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,N,,A,,CHEMBL875474,,BAO_0000218,
10902,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL625534,,BAO_0000218,
10903,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL625535,,BAO_0000218,
10904,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL625536,,BAO_0000218,
10905,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL625537,,BAO_0000218,
10906,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL625538,,BAO_0000218,
10907,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,N,,A,,CHEMBL625539,,BAO_0000218,
10908,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL625540,,BAO_0000218,
10909,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL625541,,BAO_0000218,
10910,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL625542,,BAO_0000218,
10911,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL625543,,BAO_0000218,
10912,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL625544,,BAO_0000218,
10913,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,N,,A,,CHEMBL625545,,BAO_0000218,
10914,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL625546,,BAO_0000218,
10915,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,N,,A,,CHEMBL625547,,BAO_0000218,
10916,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL625548,,BAO_0000218,
10917,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL625549,,BAO_0000218,
10918,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL625550,,BAO_0000218,
10919,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL625551,,BAO_0000218,
10920,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL875475,,BAO_0000218,
10921,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL625552,,BAO_0000218,
10922,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL625553,,BAO_0000218,
10923,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL625554,,BAO_0000218,
10924,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,,A,,CHEMBL625555,,BAO_0000218,
10925,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL625556,,BAO_0000218,
10926,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,N,,A,,CHEMBL624986,,BAO_0000218,
10927,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL624987,,BAO_0000218,
10928,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL624988,,BAO_0000218,
10929,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,N,,A,,CHEMBL624989,,BAO_0000218,
10930,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,N,,A,,CHEMBL624990,,BAO_0000218,
10931,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,N,,A,,CHEMBL874391,,BAO_0000218,
10932,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,N,,A,,CHEMBL624991,,BAO_0000218,
10933,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,N,,A,,CHEMBL624992,,BAO_0000218,
10934,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,N,,A,,CHEMBL624993,,BAO_0000218,
10935,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,N,,A,,CHEMBL624994,,BAO_0000218,
10936,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,N,,A,,CHEMBL624995,,BAO_0000218,
10937,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,N,,A,,CHEMBL624996,,BAO_0000218,
10938,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,N,,A,,CHEMBL624997,,BAO_0000218,
10939,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,N,,A,,CHEMBL624998,,BAO_0000218,
10940,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,N,,A,,CHEMBL624999,,BAO_0000218,
10941,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,N,,A,,CHEMBL882955,,BAO_0000218,
10942,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,N,,A,,CHEMBL625000,,BAO_0000218,
10943,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,N,,A,,CHEMBL625001,,BAO_0000218,
10944,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,N,,A,,CHEMBL625089,,BAO_0000218,
10945,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,N,,A,,CHEMBL625090,,BAO_0000218,
10946,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,N,,A,,CHEMBL625091,,BAO_0000218,
10947,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,N,,A,,CHEMBL625092,,BAO_0000218,
10948,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,N,,A,,CHEMBL625093,,BAO_0000218,
10949,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,N,,A,,CHEMBL625094,,BAO_0000218,
10950,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,N,,A,,CHEMBL625095,,BAO_0000218,
10951,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,2249,Compound was evaluated for its bioavailability in the dogs,,N,,A,,CHEMBL625096,,BAO_0000218,
10952,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2249,Compound was evaluated for its bioavailability in the rats,,N,,A,,CHEMBL625097,,BAO_0000218,
10953,,22224,,,1,In vivo,,Autocuration,17515,Compound was evaluated for oral bioavailability,,U,,A,,CHEMBL882956,,BAO_0000218,
10954,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14541,Compound was evaluated for percentage of Oral bioavailability in rats,,N,,A,,CHEMBL625098,,BAO_0000218,
10955,Cavia porcellus,22224,,,1,In vivo,,Autocuration,12797,Bioavailability in guinea pig,,U,,A,,CHEMBL625099,,BAO_0000218,
10956,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12797,Compound was evaluated for the oral bioavailability in rat,,N,,A,,CHEMBL625100,,BAO_0000218,
10957,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,12797,Compound was evaluated for the oral bioavailability in dog,,N,,A,,CHEMBL625101,,BAO_0000218,
10958,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12797,Compound was evaluated for the oral bioavailability in rat,,N,,A,,CHEMBL874396,,BAO_0000218,
10959,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,11727,Bioavailability in dog (dosed i.v.),,U,,F,,CHEMBL625102,,BAO_0000218,
10960,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13249,Compound was tested for in vivo bioavailability in dog,,N,,A,,CHEMBL625103,,BAO_0000218,
10961,Cricetinae,100712,,,1,In vivo,,Intermediate,13249,Compound was tested for in vivo bioavailability in hamsters,,N,,A,,CHEMBL625104,,BAO_0000218,
10962,Simiiformes,22224,,,1,In vivo,,Autocuration,13249,Compound was tested for in vivo bioavailability in monkey,,U,,A,,CHEMBL625105,,BAO_0000218,
10963,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13249,Compound was tested for in vivo bioavailability in rat,,N,,A,,CHEMBL625106,,BAO_0000218,
10964,Mus musculus,22224,,,1,In vivo,,Autocuration,9552,Oral bioavailability in mouse,,U,,A,,CHEMBL625107,,BAO_0000218,
10965,Mus musculus,50594,,,1,In vivo,,Intermediate,9552,Compound was tested for percent of oral bioavailability in mice; 56-74,,N,,A,,CHEMBL625108,,BAO_0000218,
10966,Mus musculus,22224,,,1,In vivo,,Autocuration,14839,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,U,,A,,CHEMBL625109,,BAO_0000218,
10967,Macaca fascicularis,22224,,,1,In vivo,,Autocuration,14839,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,U,,A,,CHEMBL625110,,BAO_0000218,
10968,Macaca fascicularis,22224,,,1,In vivo,,Autocuration,14839,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,U,,A,,CHEMBL625111,,BAO_0000218,
10969,Mus musculus,50594,,,1,In vivo,,Intermediate,14839,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,N,,A,,CHEMBL625112,,BAO_0000218,
10970,Mus musculus,50594,,,1,In vivo,,Intermediate,14839,Oral bioavailability in nude mice,,N,,A,,CHEMBL875334,,BAO_0000218,
10971,Primates,22224,,,1,In vivo,,Autocuration,11219,Bioavailability in monkey (i.d. dosing),,U,,A,,CHEMBL628617,,BAO_0000218,
10972,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,9552,Bioavailability in rat,,U,,A,,CHEMBL628618,,BAO_0000218,
10973,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,U,,A,,CHEMBL628619,,BAO_0000218,
10974,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,U,,A,,CHEMBL628620,,BAO_0000218,
10975,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,,A,,CHEMBL628621,,BAO_0000218,
10976,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,,A,,CHEMBL628622,,BAO_0000218,
10977,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,N,,A,,CHEMBL628623,,BAO_0000218,
10978,Macaca fascicularis,100710,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,N,,A,,CHEMBL628624,,BAO_0000218,
10979,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,,A,,CHEMBL628625,,BAO_0000218,
10980,Macaca fascicularis,100710,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,N,,A,,CHEMBL628626,,BAO_0000218,
10981,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,,A,,CHEMBL627041,,BAO_0000218,
10982,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,,A,,CHEMBL627042,,BAO_0000218,
10983,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,N,,A,,CHEMBL627043,,BAO_0000218,
10984,,22224,1969.0,,1,In vivo,,Autocuration,13932,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,U,,A,,CHEMBL627044,,BAO_0000218,
10985,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,11637,Cmax in mouse plasma,,N,,A,,CHEMBL627045,,BAO_0000218,
10986,,22224,1969.0,,1,In vivo,,Autocuration,11637,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,U,,A,,CHEMBL627046,,BAO_0000218,
10987,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13960,Maximal plasma concentration in rat,,N,,A,,CHEMBL627047,,BAO_0000218,
10988,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15905,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,N,,A,,CHEMBL627048,,BAO_0000218,
10989,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,N,,A,,CHEMBL627049,,BAO_0000218,
10990,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,N,,A,,CHEMBL627050,,BAO_0000218,
10991,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,N,,A,,CHEMBL627051,,BAO_0000218,
10992,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,N,,A,,CHEMBL627052,,BAO_0000218,
10993,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,N,,A,,CHEMBL627053,,BAO_0000218,
10994,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,N,,A,,CHEMBL627054,,BAO_0000218,
10995,Mus musculus,50594,,,1,In vivo,,Intermediate,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL627055,,BAO_0000218,
10996,Mus musculus,50594,,,1,In vivo,,Intermediate,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL627056,,BAO_0000218,
10997,Mus musculus,50594,,,1,In vivo,,Intermediate,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,,A,,CHEMBL627057,,BAO_0000218,
10998,Mus musculus,50594,,,1,In vivo,,Intermediate,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL627058,,BAO_0000218,
10999,Mus musculus,50594,,,1,In vivo,,Intermediate,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,N,,A,,CHEMBL626211,,BAO_0000218,
11000,,22224,,,1,In vivo,,Autocuration,10291,Maximum Concentration of the compound.,,U,,A,,CHEMBL626212,,BAO_0000218,
11001,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14599,Maximum Concentration was measured after iv administration into Beagle dog,,N,,A,,CHEMBL626213,,BAO_0000218,
11002,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14599,Maximum Concentration was measured after iv administration into Beagle dog.,,N,,A,,CHEMBL626214,,BAO_0000218,
11003,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14599,Maximum Concentration was measured after po administration into Beagle dog,,N,,A,,CHEMBL626215,,BAO_0000218,
11004,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14599,Maximum Concentration was measured after po administration into Beagle dog.,,N,,A,,CHEMBL626216,,BAO_0000218,
11005,,22224,178.0,,1,In vivo,,Autocuration,12767,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,U,,A,,CHEMBL626217,,BAO_0000218,
11006,,22224,178.0,,1,In vivo,,Autocuration,12767,Maximum blood level reached after an iv dose of 12.2 uM/kg,,U,,A,,CHEMBL626218,,BAO_0000218,
11007,,22224,178.0,,1,In vivo,,Autocuration,12767,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,U,,A,,CHEMBL626219,,BAO_0000218,
11008,,22224,178.0,,1,In vivo,,Autocuration,12767,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,U,,A,,CHEMBL626220,,BAO_0000218,
11009,,22224,178.0,,1,In vivo,,Autocuration,12767,Maximum blood level reached after an oral dose of 5.0 mg/kg,,U,,A,,CHEMBL626221,,BAO_0000218,
11010,,22224,178.0,,1,In vivo,,Autocuration,12767,Maximum blood level reached at dose of 10.6 uM/kg orally,,U,,A,,CHEMBL626222,,BAO_0000218,
11011,Cavia porcellus,50512,,,1,In vivo,,Intermediate,14706,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,N,,A,,CHEMBL626223,,BAO_0000218,
11012,Cavia porcellus,50512,,,1,In vivo,,Intermediate,14706,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,N,,A,,CHEMBL626224,,BAO_0000218,
11013,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,N,,A,,CHEMBL626225,,BAO_0000218,
11014,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,N,,A,,CHEMBL626226,,BAO_0000218,
11015,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,N,,A,,CHEMBL626227,,BAO_0000218,
11016,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,N,,A,,CHEMBL626228,,BAO_0000218,
11017,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,,A,,CHEMBL626229,,BAO_0000218,
11018,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,N,,A,,CHEMBL626921,,BAO_0000218,
11019,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,N,,A,,CHEMBL876793,,BAO_0000218,
11020,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,N,,A,,CHEMBL625309,,BAO_0000218,
11021,Bacillus subtilis,50278,,,1,In vivo,,Intermediate,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,,A,,CHEMBL625310,,BAO_0000218,
11022,Simiiformes,22224,,,1,In vivo,,Autocuration,11871,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,U,,A,,CHEMBL625311,,BAO_0000218,
11023,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,11871,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,N,,A,,CHEMBL625312,,BAO_0000218,
11024,,22224,,,1,In vivo,,Autocuration,3437,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,U,,A,,CHEMBL625313,,BAO_0000218,
11025,Mus musculus,50594,,,1,In vivo,,Intermediate,12038,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,N,,A,,CHEMBL625314,,BAO_0000218,
11026,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12038,Maximum concentration in male rats after iv administration of 20 mg/kg,,N,,A,,CHEMBL625315,,BAO_0000218,
11027,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,N,,A,,CHEMBL625316,,BAO_0000218,
11028,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,N,,A,,CHEMBL625317,,BAO_0000218,
11029,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,N,,A,,CHEMBL625318,,BAO_0000218,
11030,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,N,,A,,CHEMBL625319,,BAO_0000218,
11031,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,N,,A,,CHEMBL625320,,BAO_0000218,
11032,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,N,,A,,CHEMBL625321,,BAO_0000218,
11033,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,N,,A,,CHEMBL625322,,BAO_0000218,
11034,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,N,,A,,CHEMBL876801,,BAO_0000218,
11035,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,N,,A,,CHEMBL625323,,BAO_0000218,
11036,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,N,,A,,CHEMBL625324,,BAO_0000218,
11037,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,N,,A,,CHEMBL625325,,BAO_0000218,
11038,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,N,,A,,CHEMBL625326,,BAO_0000218,
11039,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,N,,A,,CHEMBL625327,,BAO_0000218,
11040,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,N,,A,,CHEMBL625328,,BAO_0000218,
11041,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,N,,A,,CHEMBL625329,,BAO_0000218,
11042,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,N,,A,,CHEMBL625330,,BAO_0000218,
11043,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,N,,A,,CHEMBL627774,,BAO_0000218,
11044,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,N,,A,,CHEMBL627775,,BAO_0000218,
11045,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,N,,A,,CHEMBL627949,,BAO_0000218,
11046,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,N,,A,,CHEMBL627950,,BAO_0000218,
11047,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,N,,A,,CHEMBL627951,,BAO_0000218,
11048,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,N,,A,,CHEMBL627952,,BAO_0000218,
11049,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,N,,A,,CHEMBL627953,,BAO_0000218,
11050,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,N,,A,,CHEMBL627954,,BAO_0000218,
11051,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,N,,A,,CHEMBL627955,,BAO_0000218,
11052,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,N,,A,,CHEMBL627956,,BAO_0000218,
11053,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,N,,A,,CHEMBL876802,,BAO_0000218,
11054,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,N,,A,,CHEMBL627957,,BAO_0000218,
11055,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,N,,A,,CHEMBL627958,,BAO_0000218,
11056,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,N,,A,,CHEMBL627959,,BAO_0000218,
11057,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,N,,A,,CHEMBL627960,,BAO_0000218,
11058,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,N,,A,,CHEMBL627961,,BAO_0000218,
11059,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,N,,A,,CHEMBL627962,,BAO_0000218,
11060,Rattus norvegicus,50597,,,1,,,Intermediate,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,,A,,CHEMBL627963,,BAO_0000218,
11061,Rattus norvegicus,50597,,,1,,,Intermediate,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624759,,BAO_0000218,
11062,Rattus norvegicus,50597,,,1,,,Intermediate,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624760,,BAO_0000218,
11063,Rattus norvegicus,50597,,,1,,,Intermediate,9796,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624761,,BAO_0000218,
11064,Rattus norvegicus,50597,,,1,,,Intermediate,9796,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL877607,,BAO_0000218,
11065,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,,A,,CHEMBL624762,,BAO_0000218,
11066,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624763,,BAO_0000218,
11067,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624764,,BAO_0000218,
11068,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624765,,BAO_0000218,
11069,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL624766,,BAO_0000218,
11070,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL624767,,BAO_0000218,
11071,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,N,,A,,CHEMBL624768,,BAO_0000218,
11072,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL624769,,BAO_0000218,
11073,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL624770,,BAO_0000218,
11074,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,,A,,CHEMBL624771,,BAO_0000218,
11075,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL624772,,BAO_0000218,
11076,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,N,,A,,CHEMBL624773,,BAO_0000218,
11077,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL624774,,BAO_0000218,
11078,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL624775,,BAO_0000218,
11079,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL624776,,BAO_0000218,
11080,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL624777,,BAO_0000218,
11081,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL624778,,BAO_0000218,
11082,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,N,,A,,CHEMBL624779,,BAO_0000218,
11083,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL624780,,BAO_0000218,
11084,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL624781,,BAO_0000218,
11085,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL877608,,BAO_0000218,
11086,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL624782,,BAO_0000218,
11087,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL624783,,BAO_0000218,
11088,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,N,,A,,CHEMBL624784,,BAO_0000218,
11089,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL624785,,BAO_0000218,
11090,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL624786,,BAO_0000218,
11091,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL624787,,BAO_0000218,
11092,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL628676,,BAO_0000218,
11093,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,N,,A,,CHEMBL621842,,BAO_0000218,
11094,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL621843,,BAO_0000218,
11095,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL623873,,BAO_0000218,
11096,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL623874,,BAO_0000218,
11097,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL623875,,BAO_0000218,
11098,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL623876,,BAO_0000218,
11099,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,N,,A,,CHEMBL623877,,BAO_0000218,
11100,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL623878,,BAO_0000218,
11101,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,N,,A,,CHEMBL623879,,BAO_0000218,
11102,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL623880,,BAO_0000218,
11103,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL623881,,BAO_0000218,
11104,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL623957,,BAO_0000218,
11105,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL623958,,BAO_0000218,
11106,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL623959,,BAO_0000218,
11107,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL623960,,BAO_0000218,
11108,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL623961,,BAO_0000218,
11109,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL623962,,BAO_0000218,
11110,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,,A,,CHEMBL624676,,BAO_0000218,
11111,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL624677,,BAO_0000218,
11112,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,N,,A,,CHEMBL624678,,BAO_0000218,
11113,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL624679,,BAO_0000218,
11114,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL624680,,BAO_0000218,
11115,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,U,,A,,CHEMBL624849,,BAO_0000218,
11116,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,U,,A,,CHEMBL624850,,BAO_0000218,
11117,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,U,,A,,CHEMBL874399,,BAO_0000218,
11118,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,U,,A,,CHEMBL624851,,BAO_0000218,
11119,,22224,,,1,In vivo,,Autocuration,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,U,,A,,CHEMBL624852,,BAO_0000218,
11120,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,13359,Oral bioavailability in rat (dose 10 mg/kg),,U,,A,,CHEMBL624853,,BAO_0000218,
11121,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,16618,Oral bioavailability in rat (Sprague-Dawley),,U,,A,,CHEMBL624854,,BAO_0000218,
11122,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,13960,Oral bioavailability in rat,,U,,A,,CHEMBL624855,,BAO_0000218,
11123,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,13917,Oral bioavailability in rats was determined in vivo,,U,,A,,CHEMBL624856,,BAO_0000218,
11124,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,14266,Oral bioavailability in dog,,U,,A,,CHEMBL882957,,BAO_0000218,
11125,Simiiformes,22224,,,1,In vivo,,Autocuration,12359,Oral bioavailability of compound in monkey,,U,,A,,CHEMBL624857,,BAO_0000218,
11126,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12359,Oral bioavailability of compound in rat,,N,,A,,CHEMBL622202,,BAO_0000218,
11127,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12359,Bioavailability in rat of PMEA prodrug,,U,,A,,CHEMBL622203,,BAO_0000218,
11128,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12359,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,N,,A,,CHEMBL625522,,BAO_0000218,
11129,Macaca mulatta,22224,,,1,In vivo,,Autocuration,10791,Serum conc at 3 hours following 25 mg/kg dose,,U,,A,,CHEMBL622868,,BAO_0000218,
11130,Macaca mulatta,22224,1088.0,,1,In vivo,,Autocuration,10791,Urine conc 0-5 hours following 25 mg/kg dose,,U,,A,,CHEMBL622869,,BAO_0000218,
11131,Macaca mulatta,22224,1088.0,,1,In vivo,,Autocuration,10791,Urine conc 0-24 hours following 25 mg/kg dose,,U,,A,,CHEMBL622870,,BAO_0000218,
11132,Chlorocebus aethiops,22224,,,1,In vivo,,Autocuration,138,Oral bioavailability in African green monkeys; 20-25,,U,,A,,CHEMBL622871,,BAO_0000218,
11133,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14521,Oral bioavailability in cynomolgus monkey.,,N,,A,,CHEMBL620560,,BAO_0000218,
11134,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,13953,Oral bioavailability in dog,,U,,A,,CHEMBL620561,,BAO_0000218,
11135,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,12836,Oral bioavailability in dog at 10 mg/kg oral dose,,N,,A,,CHEMBL620562,,BAO_0000218,
11136,Cricetinae,100712,,,1,In vivo,,Intermediate,12836,Oral bioavailability in hamster at 10 mg/kg oral dose,,N,,A,,CHEMBL620563,,BAO_0000218,
11137,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12836,Oral bioavailability in rat at 10 mg/kg oral dose,,N,,A,,CHEMBL620564,,BAO_0000218,
11138,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,14521,Oral bioavailability in rat,,U,,A,,CHEMBL872265,,BAO_0000218,
11139,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,13953,Oral bioavailability in rat,,U,,A,,CHEMBL620565,,BAO_0000218,
11140,Eutheria,22224,,,1,In vivo,,Autocuration,6799,Oral bioavailability,,U,,A,,CHEMBL620566,,BAO_0000218,
11141,,22224,,,1,In vivo,,Autocuration,11311,Oral bioavailability was determined; range 49-102%,,U,,A,,CHEMBL620567,,BAO_0000218,
11142,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,4013,Oral bioavailability was determined in dogs,,N,,A,,CHEMBL620568,,BAO_0000218,
11143,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,4013,Oral bioavailability in rat,,U,,A,,CHEMBL620569,,BAO_0000218,
11144,Eutheria,22224,,,1,In vivo,,Autocuration,17591,Oral bioavailability,,U,,A,,CHEMBL620570,,BAO_0000218,
11145,,22224,,,1,In vivo,,Autocuration,17591,Oral bioavailability was determined; Not orally available,,U,,A,,CHEMBL620571,,BAO_0000218,
11146,Mus musculus,50594,,,1,In vivo,,Intermediate,15011,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,N,,A,,CHEMBL620572,,BAO_0000218,
11147,Mus musculus,22224,,,1,In vivo,,Autocuration,15011,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,U,,A,,CHEMBL620573,,BAO_0000218,
11148,Mus musculus,22224,,,1,In vivo,,Autocuration,15011,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,U,,A,,CHEMBL620574,,BAO_0000218,
11149,Macaca mulatta,22224,,,1,In vivo,,Autocuration,9552,Oral bioavailability in Rhesus monkey,,U,,A,,CHEMBL620575,,BAO_0000218,
11150,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,9552,Oral bioavailability in dog (female mongrel),,U,,A,,CHEMBL620576,,BAO_0000218,
11151,,22224,,,1,In vivo,,Autocuration,3639,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,U,,A,,CHEMBL875846,,BAO_0000218,
11152,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,13397,Oral bioavailability in dog,,U,,A,,CHEMBL620577,,BAO_0000218,
11153,,22224,,,1,In vivo,,Autocuration,3031,Percentage Bioavailability was evaluated.,,U,,A,,CHEMBL620578,,BAO_0000218,
11154,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12818,Bioavailability in rat administered i.d.,,U,,A,,CHEMBL620579,,BAO_0000218,
11155,Eutheria,22224,,,1,In vivo,,Autocuration,4847,Bioavailability,,U,,A,,CHEMBL621248,,BAO_0000218,
11156,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,12421,Bioavailability in dog (male Beagle) i.v. administration,,U,,A,,CHEMBL625390,,BAO_0000218,
11157,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,11966,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,U,,A,,CHEMBL625391,,BAO_0000218,
11158,Primates,22224,,,1,In vivo,,Autocuration,11218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,U,,A,,CHEMBL872266,,BAO_0000218,
11159,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,13129,Oral bioavailability in rat (Sprague-Dawley) (male),,U,,A,,CHEMBL625392,,BAO_0000218,
11160,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12350,The oral bioavailability was measured on rats after oral administration,,N,,A,,CHEMBL625393,,BAO_0000218,
11161,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,2231,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,N,,A,,CHEMBL625394,,BAO_0000218,
11162,Macaca mulatta,50797,,,1,In vivo,,Intermediate,2231,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,N,,A,,CHEMBL625395,,BAO_0000218,
11163,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12187,Bioavailability in rat (dose 10 mg/kg i.d.),,U,,A,,CHEMBL625396,,BAO_0000218,
11164,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,12421,Bioavailability in dog (male Beagle) i.v. administration,,U,,A,,CHEMBL625397,,BAO_0000218,
11165,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625398,,BAO_0000218,
11166,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625399,,BAO_0000218,
11167,Mus musculus,50594,2037.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL626074,,BAO_0000218,
11168,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL626075,,BAO_0000218,
11169,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2231,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,N,,A,,CHEMBL626076,,BAO_0000218,
11170,Macaca mulatta,50797,1969.0,,1,In vivo,,Intermediate,2231,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,N,,A,,CHEMBL626077,,BAO_0000218,
11171,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,N,,A,,CHEMBL626078,,BAO_0000218,
11172,,22224,178.0,,1,In vivo,,Autocuration,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,U,,A,,CHEMBL625846,,BAO_0000218,
11173,,22224,178.0,,1,In vivo,,Autocuration,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,U,,A,,CHEMBL625847,,BAO_0000218,
11174,Rattus norvegicus,50597,,,1,In vivo,,Expert,15633,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,N,,A,,CHEMBL625848,,BAO_0000218,
11175,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14258,Maximum concentration of compound in plasma administered orally to rats,,N,,A,,CHEMBL625849,,BAO_0000218,
11176,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,N,,A,,CHEMBL626023,,BAO_0000218,
11177,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,N,,A,,CHEMBL626024,,BAO_0000218,
11178,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,N,,A,,CHEMBL626025,,BAO_0000218,
11179,,22224,,,1,In vivo,,Autocuration,5566,Maximum concentration after 10 mg/kg by oral administration,,U,,A,,CHEMBL626026,,BAO_0000218,
11180,,22224,,,1,In vivo,,Autocuration,16935,Maximum concentration at a dose of 1.5 mg/kg,,U,,A,,CHEMBL626027,,BAO_0000218,
11181,,22224,,,1,In vivo,,Autocuration,16935,Maximum concentration at a dose of 2.0 mg/kg,,U,,A,,CHEMBL626028,,BAO_0000218,
11182,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,Maximum concentration in dog plasma,,N,,A,,CHEMBL626029,,BAO_0000218,
11183,,22224,1969.0,,1,In vivo,,Autocuration,12536,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,U,,A,,CHEMBL626030,,BAO_0000218,
11184,,22224,1969.0,,1,In vivo,,Autocuration,12536,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,U,,A,,CHEMBL626031,,BAO_0000218,
11185,,22224,1969.0,,1,In vivo,,Autocuration,12536,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,U,,A,,CHEMBL626032,,BAO_0000218,
11186,,22224,1969.0,,1,In vivo,,Autocuration,12536,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,U,,A,,CHEMBL626033,,BAO_0000218,
11187,,22224,1969.0,,1,In vivo,,Autocuration,12536,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,U,,A,,CHEMBL626034,,BAO_0000218,
11188,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,9994,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,N,,A,,CHEMBL626035,,BAO_0000218,
11189,,22224,1969.0,,1,In vivo,,Autocuration,1434,Maximum concentration in plasma at Tmax,,U,,A,,CHEMBL626036,,BAO_0000218,
11190,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Expert,12836,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,N,,A,,CHEMBL626037,,BAO_0000218,
11191,Cricetinae,100712,1969.0,,1,In vivo,,Intermediate,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,N,,A,,CHEMBL626038,,BAO_0000218,
11192,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,N,,A,,CHEMBL626039,,BAO_0000218,
11193,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12545,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,N,,A,,CHEMBL626040,,BAO_0000218,
11194,Oryctolagus cuniculus,50592,1969.0,,1,In vivo,,Intermediate,13856,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,N,,A,,CHEMBL626041,,BAO_0000218,
11195,,22224,,,1,In vivo,,Autocuration,3550,Maximum concentration was calculated,,U,,A,,CHEMBL626042,,BAO_0000218,
11196,,22224,,,1,In vivo,,Autocuration,2632,Maximum concentration was calculated.,,U,,A,,CHEMBL626043,,BAO_0000218,
11197,,22224,,,1,In vivo,,Autocuration,5566,Maximum concentration at a peroral dose of 10 mg/kg,,U,,A,,CHEMBL626044,,BAO_0000218,
11198,,22224,,,1,In vivo,,Autocuration,11883,Maximum concentration of the drug at 10 uM/dg administered perorally,,U,,A,,CHEMBL626045,,BAO_0000218,
11199,,22224,,,1,In vivo,,Autocuration,11883,Maximum concentration of the drug at 2 uM/dg administered intravenously,,U,,A,,CHEMBL626046,,BAO_0000218,
11200,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14122,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,N,,A,,CHEMBL626047,,BAO_0000218,
11201,Cricetinae,100712,1969.0,,1,In vivo,,Intermediate,14122,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,N,,A,,CHEMBL626048,,BAO_0000218,
11202,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14122,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,N,,A,,CHEMBL626049,,BAO_0000218,
11203,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,N,,A,,CHEMBL626050,,BAO_0000218,
11204,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,N,,A,,CHEMBL874541,,BAO_0000218,
11205,Cricetinae,100712,1969.0,,1,In vivo,,Intermediate,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,N,,A,,CHEMBL622826,,BAO_0000218,
11206,Cricetinae,100712,1969.0,,1,In vivo,,Intermediate,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,N,,A,,CHEMBL622827,,BAO_0000218,
11207,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,N,,A,,CHEMBL622828,,BAO_0000218,
11208,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14080,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,N,,A,,CHEMBL622829,,BAO_0000218,
11209,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,11911,Maximum concentration reached following intravenous administration in male rat,,N,,A,,CHEMBL876806,,BAO_0000218,
11210,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,N,,A,,CHEMBL622830,,BAO_0000218,
11211,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,N,,A,,CHEMBL622831,,BAO_0000218,
11212,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14346,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,N,,A,,CHEMBL626794,,BAO_0000218,
11213,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14346,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL626795,,BAO_0000218,
11214,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14346,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL626796,,BAO_0000218,
11215,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14346,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL626797,,BAO_0000218,
11216,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14127,Maximum drug concentration is determined after oral dosing in rats.,,N,,A,,CHEMBL626798,,BAO_0000218,
11217,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14339,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,N,,A,,CHEMBL626799,,BAO_0000218,
11218,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14339,Maximum observed concentration in oral (5 mg/kg) fed dogs,,N,,A,,CHEMBL626800,,BAO_0000218,
11219,,22224,1969.0,,1,In vivo,,Autocuration,13494,Maximum plasma concentration,,U,,A,,CHEMBL626801,,BAO_0000218,
11220,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14925,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,N,,A,,CHEMBL876816,,BAO_0000218,
11221,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14474,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,N,,A,,CHEMBL626802,,BAO_0000218,
11222,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14474,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,N,,A,,CHEMBL626803,,BAO_0000218,
11223,,22224,1969.0,,1,In vivo,,Autocuration,13917,Maximum plasma concentration following oral administration of 30 umol/kg,,U,,A,,CHEMBL626804,,BAO_0000218,
11224,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,N,,A,,CHEMBL626805,,BAO_0000218,
11225,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,,A,,CHEMBL626309,,BAO_0000218,
11226,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626310,,BAO_0000218,
11227,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626311,,BAO_0000218,
11228,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626312,,BAO_0000218,
11229,Rattus norvegicus,50597,995.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626313,,BAO_0000218,
11230,Rattus norvegicus,50597,995.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,,A,,CHEMBL626314,,BAO_0000218,
11231,Rattus norvegicus,50597,995.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626315,,BAO_0000218,
11232,Rattus norvegicus,50597,995.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626316,,BAO_0000218,
11233,Rattus norvegicus,50597,995.0,,1,,,Intermediate,9796,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,A,,CHEMBL626317,,BAO_0000218,
11234,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,A,,CHEMBL626318,,BAO_0000218,
11235,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,A,,CHEMBL626319,,BAO_0000218,
11236,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,A,,CHEMBL626320,,BAO_0000218,
11237,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,A,,CHEMBL875053,,BAO_0000218,
11238,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,A,,CHEMBL626321,,BAO_0000218,
11239,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,A,,CHEMBL626322,,BAO_0000218,
11240,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,A,,CHEMBL626323,,BAO_0000218,
11241,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,A,,CHEMBL626324,,BAO_0000218,
11242,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,A,,CHEMBL626325,,BAO_0000218,
11243,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,A,,CHEMBL626326,,BAO_0000218,
11244,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,A,,CHEMBL626327,,BAO_0000218,
11245,Rattus norvegicus,50597,,,1,,,Intermediate,8363,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,A,,CHEMBL626328,,BAO_0000218,
11246,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626329,,BAO_0000218,
11247,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626330,,BAO_0000218,
11248,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626331,,BAO_0000218,
11249,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626332,,BAO_0000218,
11250,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626333,,BAO_0000218,
11251,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626334,,BAO_0000218,
11252,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL626335,,BAO_0000218,
11253,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8684,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624798,,BAO_0000218,
11254,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624799,,BAO_0000218,
11255,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624800,,BAO_0000218,
11256,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624801,,BAO_0000218,
11257,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624802,,BAO_0000218,
11258,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624803,,BAO_0000218,
11259,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624804,,BAO_0000218,
11260,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624805,,BAO_0000218,
11261,Rattus norvegicus,50597,955.0,,1,,,Intermediate,8684,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,N,,A,,CHEMBL624806,,BAO_0000218,
11262,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624807,,BAO_0000218,
11263,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624808,,BAO_0000218,
11264,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624809,,BAO_0000218,
11265,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624810,,BAO_0000218,
11266,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL877618,,BAO_0000218,
11267,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624811,,BAO_0000218,
11268,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624812,,BAO_0000218,
11269,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624813,,BAO_0000218,
11270,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624814,,BAO_0000218,
11271,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624815,,BAO_0000218,
11272,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624816,,BAO_0000218,
11273,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624817,,BAO_0000218,
11274,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL624818,,BAO_0000218,
11275,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,N,,A,,CHEMBL624819,,BAO_0000218,
11276,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL624820,,BAO_0000218,
11277,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL624821,,BAO_0000218,
11278,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,,A,,CHEMBL624822,,BAO_0000218,
11279,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL624823,,BAO_0000218,
11280,Escherichia coli,50212,,,1,,,Intermediate,15599,Observed diffusion coefficient in organic solvent for Escherichia coli,,N,,A,,CHEMBL624824,,BAO_0000218,
11281,Rattus norvegicus,50597,178.0,,1,,,Intermediate,9614,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL624825,,BAO_0000218,
11282,Rattus norvegicus,50597,178.0,,1,,,Intermediate,9614,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624826,,BAO_0000218,
11283,Rattus norvegicus,50597,2081.0,,1,,,Intermediate,9614,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL876817,,BAO_0000218,
11284,Rattus norvegicus,50597,2081.0,,1,,,Intermediate,9614,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624827,,BAO_0000218,
11285,Rattus norvegicus,50597,,,1,,,Intermediate,9614,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL624828,,BAO_0000218,
11286,Rattus norvegicus,50597,,,1,,,Intermediate,9614,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624829,,BAO_0000218,
11287,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9614,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL624830,,BAO_0000218,
11288,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9614,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624831,,BAO_0000218,
11289,Rattus norvegicus,50597,2081.0,,1,,,Intermediate,9614,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL624832,,BAO_0000218,
11290,Rattus norvegicus,50597,2081.0,,1,,,Intermediate,9614,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624833,,BAO_0000218,
11291,Rattus norvegicus,50597,,,1,,,Intermediate,9614,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624834,,BAO_0000218,
11292,Rattus norvegicus,50597,,,1,,,Intermediate,9614,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL624835,,BAO_0000218,
11293,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,9614,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,A,,CHEMBL624836,,BAO_0000218,
11294,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,9614,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,A,,CHEMBL624837,,BAO_0000218,
11295,Rattus norvegicus,50597,178.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL624838,,BAO_0000218,
11296,Rattus norvegicus,50597,178.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,N,,A,,CHEMBL622188,,BAO_0000218,
11297,Rattus norvegicus,50597,948.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL622189,,BAO_0000218,
11298,Rattus norvegicus,50597,948.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,N,,A,,CHEMBL622190,,BAO_0000218,
11299,Rattus norvegicus,50597,948.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,N,,A,,CHEMBL625170,,BAO_0000218,
11300,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL625171,,BAO_0000218,
11301,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL625172,,BAO_0000218,
11302,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,N,,A,,CHEMBL625173,,BAO_0000218,
11303,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL625174,,BAO_0000218,
11304,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,N,,A,,CHEMBL625175,,BAO_0000218,
11305,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,N,,A,,CHEMBL625176,,BAO_0000218,
11306,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL625177,,BAO_0000218,
11307,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,N,,A,,CHEMBL625178,,BAO_0000218,
11308,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,N,,A,,CHEMBL625179,,BAO_0000218,
11309,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,,A,,CHEMBL625180,,BAO_0000218,
11310,,22224,,,1,,,Autocuration,10677,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,U,,A,,CHEMBL625181,,BAO_0000218,
11311,Mus musculus,50594,1088.0,,1,,,Intermediate,9750,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,N,,A,,CHEMBL625182,,BAO_0000218,
11312,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL625183,,BAO_0000218,
11313,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,A,,CHEMBL875848,,BAO_0000218,
11314,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL622260,,BAO_0000218,
11315,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,A,,CHEMBL622261,,BAO_0000218,
11316,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL622262,,BAO_0000218,
11317,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,,A,,CHEMBL622263,,BAO_0000218,
11318,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL622418,,BAO_0000218,
11319,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,,A,,CHEMBL622419,,BAO_0000218,
11320,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623388,,BAO_0000218,
11321,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623389,,BAO_0000218,
11322,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623390,,BAO_0000218,
11323,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623391,,BAO_0000218,
11324,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623392,,BAO_0000218,
11325,Mus musculus,50594,2037.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623393,,BAO_0000218,
11326,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL623394,,BAO_0000218,
11327,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL618885,,BAO_0000218,
11328,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL618886,,BAO_0000218,
11329,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL618887,,BAO_0000218,
11330,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619535,,BAO_0000218,
11331,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619536,,BAO_0000218,
11332,Mus musculus,50594,2037.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619537,,BAO_0000218,
11333,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619705,,BAO_0000218,
11334,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619706,,BAO_0000218,
11335,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619707,,BAO_0000218,
11336,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL619708,,BAO_0000218,
11337,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625219,,BAO_0000218,
11338,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625220,,BAO_0000218,
11339,Mus musculus,50594,2037.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625221,,BAO_0000218,
11340,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625222,,BAO_0000218,
11341,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625223,,BAO_0000218,
11342,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625224,,BAO_0000218,
11343,Mus musculus,50594,,,1,In vivo,,Intermediate,13256,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,N,,A,,CHEMBL625225,,BAO_0000218,
11344,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat blood after 24 hours of iv administration,,N,,A,,CHEMBL625226,,BAO_0000218,
11345,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,N,,A,,CHEMBL625227,,BAO_0000218,
11346,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat blood after 30 minutes of iv administration,,N,,A,,CHEMBL625228,,BAO_0000218,
11347,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL875354,,BAO_0000218,
11348,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat blood after 5 minutes of iv administration,,N,,A,,CHEMBL625229,,BAO_0000218,
11349,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL625230,,BAO_0000218,
11350,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat heart after 24 hours of iv administration,,N,,A,,CHEMBL625231,,BAO_0000218,
11351,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,N,,A,,CHEMBL625900,,BAO_0000218,
11352,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat heart after 30 minutes of iv administration,,N,,A,,CHEMBL625901,,BAO_0000218,
11353,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL625902,,BAO_0000218,
11354,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat heart after 5 minutes of iv administration,,N,,A,,CHEMBL625903,,BAO_0000218,
11355,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL625904,,BAO_0000218,
11356,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 24 hours of iv administration,,N,,A,,CHEMBL625905,,BAO_0000218,
11357,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,N,,A,,CHEMBL627861,,BAO_0000218,
11358,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 30 minutes of iv administration,,N,,A,,CHEMBL627862,,BAO_0000218,
11359,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL627863,,BAO_0000218,
11360,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 30 minutes of iv administration,,N,,A,,CHEMBL627769,,BAO_0000218,
11361,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,13249,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,,A,,CHEMBL627770,,BAO_0000218,
11362,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,13622,Cmax in cynomolgus monkey (PO dose),,N,,A,,CHEMBL627771,,BAO_0000218,
11363,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13622,Cmax in rat (PO dose),,N,,A,,CHEMBL627772,,BAO_0000218,
11364,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13622,Cmax in rat (PO dose),,N,,A,,CHEMBL627773,,BAO_0000218,
11365,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13494,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,N,,A,,CHEMBL621922,,BAO_0000218,
11366,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12170,Cmax in rat plasma after oral dose (10 mg/kg),,N,,A,,CHEMBL621923,,BAO_0000218,
11367,,22224,1969.0,,1,In vivo,,Autocuration,12170,Cmax in plasma after oral dose (10 mg/kg),,U,,A,,CHEMBL621924,,BAO_0000218,
11368,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,17025,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,N,,A,,CHEMBL621925,,BAO_0000218,
11369,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,17025,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,U,,A,,CHEMBL621926,,BAO_0000218,
11370,Oryctolagus cuniculus,50592,1969.0,,1,In vivo,,Intermediate,17025,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,N,,A,,CHEMBL621927,,BAO_0000218,
11371,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17025,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,N,,A,,CHEMBL621928,,BAO_0000218,
11372,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14187,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,N,,A,,CHEMBL621929,,BAO_0000218,
11373,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14816,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,N,,A,,CHEMBL621930,,BAO_0000218,
11374,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17820,Maximum plasma concentration after oral dosing in rat,,N,,A,,CHEMBL621931,,BAO_0000218,
11375,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621932,,BAO_0000218,
11376,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621933,,BAO_0000218,
11377,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14691,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,N,,A,,CHEMBL621934,,BAO_0000218,
11378,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14691,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,N,,A,,CHEMBL621935,,BAO_0000218,
11379,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13375,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,N,,A,,CHEMBL621936,,BAO_0000218,
11380,,22224,1969.0,,1,In vivo,,Autocuration,6236,Maximum plasma concentration was determined,,U,,A,,CHEMBL621937,,BAO_0000218,
11381,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621938,,BAO_0000218,
11382,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621939,,BAO_0000218,
11383,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621940,,BAO_0000218,
11384,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621941,,BAO_0000218,
11385,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL621942,,BAO_0000218,
11386,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL626178,,BAO_0000218,
11387,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL626179,,BAO_0000218,
11388,,22224,1969.0,,1,In vivo,,Autocuration,14380,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL626180,,BAO_0000218,
11389,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13622,Plasma Cmax in rat (PO dose),,N,,A,,CHEMBL626181,,BAO_0000218,
11390,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15372,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,N,,A,,CHEMBL626182,,BAO_0000218,
11391,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15372,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,N,,A,,CHEMBL626183,,BAO_0000218,
11392,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15372,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,N,,A,,CHEMBL626184,,BAO_0000218,
11393,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15372,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,N,,A,,CHEMBL626185,,BAO_0000218,
11394,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14925,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,N,,A,,CHEMBL626186,,BAO_0000218,
11395,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14925,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,N,,A,,CHEMBL877589,,BAO_0000218,
11396,,22224,,,1,In vivo,,Autocuration,11883,Maximum concentration of the drug at 1 uM/dg administered intravenously,,U,,A,,CHEMBL626187,,BAO_0000218,
11397,,22224,,,1,In vivo,,Autocuration,11883,Maximum concentration of the drug at 20 uM/dg administered perorally,,U,,A,,CHEMBL626188,,BAO_0000218,
11398,,22224,,,1,In vivo,,Autocuration,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,U,,A,,CHEMBL626189,,BAO_0000218,
11399,,22224,178.0,,1,In vivo,,Autocuration,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,A,,CHEMBL626855,,BAO_0000218,
11400,,22224,178.0,,1,In vivo,,Autocuration,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,,A,,CHEMBL623781,,BAO_0000218,
11401,,22224,178.0,,1,In vivo,,Autocuration,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,A,,CHEMBL623782,,BAO_0000218,
11402,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16360,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,N,,A,,CHEMBL623783,,BAO_0000218,
11403,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,3673,Cmax in dog plasma after 1mg/kg oral dose,,N,,A,,CHEMBL623784,,BAO_0000218,
11404,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14431,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,N,,A,,CHEMBL623785,,BAO_0000218,
11405,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14431,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,N,,A,,CHEMBL623786,,BAO_0000218,
11406,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14964,Oral maximum concentration in rat,,N,,A,,CHEMBL623787,,BAO_0000218,
11407,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14964,Oral maximum concentration in rat,,N,,A,,CHEMBL623788,,BAO_0000218,
11408,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,14209,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,N,,A,,CHEMBL623789,,BAO_0000218,
11409,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,11355,Peak concentration in blood after intravenous administration to mice,,N,,A,,CHEMBL623790,,BAO_0000218,
11410,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,11355,Peak concentration in blood after peroral administration to mice,,N,,A,,CHEMBL623791,,BAO_0000218,
11411,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,11966,Peak concentration in rat plasma was determined,,N,,A,,CHEMBL623792,,BAO_0000218,
11412,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,U,,A,,CHEMBL623793,,BAO_0000218,
11413,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,N,,A,,CHEMBL623794,,BAO_0000218,
11414,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,N,,A,,CHEMBL623795,,BAO_0000218,
11415,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623796,,BAO_0000218,
11416,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623797,,BAO_0000218,
11417,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623798,,BAO_0000218,
11418,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623799,,BAO_0000218,
11419,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624490,,BAO_0000218,
11420,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624491,,BAO_0000218,
11421,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624492,,BAO_0000218,
11422,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624493,,BAO_0000218,
11423,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL877595,,BAO_0000218,
11424,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624494,,BAO_0000218,
11425,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624495,,BAO_0000218,
11426,Rattus norvegicus,50597,160.0,,1,,,Intermediate,8684,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624681,,BAO_0000218,
11427,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624682,,BAO_0000218,
11428,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624683,,BAO_0000218,
11429,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624684,,BAO_0000218,
11430,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624685,,BAO_0000218,
11431,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624686,,BAO_0000218,
11432,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624687,,BAO_0000218,
11433,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624688,,BAO_0000218,
11434,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL627161,,BAO_0000218,
11435,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL622127,,BAO_0000218,
11436,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL622128,,BAO_0000218,
11437,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL874384,,BAO_0000218,
11438,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624898,,BAO_0000218,
11439,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624899,,BAO_0000218,
11440,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624900,,BAO_0000218,
11441,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624901,,BAO_0000218,
11442,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624902,,BAO_0000218,
11443,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624903,,BAO_0000218,
11444,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624904,,BAO_0000218,
11445,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624905,,BAO_0000218,
11446,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624906,,BAO_0000218,
11447,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624907,,BAO_0000218,
11448,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624908,,BAO_0000218,
11449,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624909,,BAO_0000218,
11450,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624910,,BAO_0000218,
11451,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624911,,BAO_0000218,
11452,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL874388,,BAO_0000218,
11453,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL624912,,BAO_0000218,
11454,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL622930,,BAO_0000218,
11455,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623121,,BAO_0000218,
11456,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623122,,BAO_0000218,
11457,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623123,,BAO_0000218,
11458,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,8684,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623124,,BAO_0000218,
11459,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623125,,BAO_0000218,
11460,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623126,,BAO_0000218,
11461,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623127,,BAO_0000218,
11462,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623128,,BAO_0000218,
11463,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623129,,BAO_0000218,
11464,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623130,,BAO_0000218,
11465,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623131,,BAO_0000218,
11466,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL623132,,BAO_0000218,
11467,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623133,,BAO_0000218,
11468,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623134,,BAO_0000218,
11469,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL874389,,BAO_0000218,
11470,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,A,,CHEMBL623135,,BAO_0000218,
11471,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623136,,BAO_0000218,
11472,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,A,,CHEMBL623137,,BAO_0000218,
11473,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623138,,BAO_0000218,
11474,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,,A,,CHEMBL623139,,BAO_0000218,
11475,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623140,,BAO_0000218,
11476,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,,A,,CHEMBL623141,,BAO_0000218,
11477,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623142,,BAO_0000218,
11478,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL623143,,BAO_0000218,
11479,Mus musculus,50594,1088.0,,1,,,Intermediate,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,N,,A,,CHEMBL623144,,BAO_0000218,
11480,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,N,,A,,CHEMBL623405,,BAO_0000218,
11481,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624074,,BAO_0000218,
11482,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,A,,CHEMBL624075,,BAO_0000218,
11483,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624076,,BAO_0000218,
11484,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,A,,CHEMBL624077,,BAO_0000218,
11485,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624078,,BAO_0000218,
11486,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,,A,,CHEMBL624079,,BAO_0000218,
11487,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624261,,BAO_0000218,
11488,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,,A,,CHEMBL624262,,BAO_0000218,
11489,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624263,,BAO_0000218,
11490,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624264,,BAO_0000218,
11491,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624265,,BAO_0000218,
11492,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,A,,CHEMBL624266,,BAO_0000218,
11493,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624267,,BAO_0000218,
11494,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,A,,CHEMBL624268,,BAO_0000218,
11495,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL875227,,BAO_0000218,
11496,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,,A,,CHEMBL624269,,BAO_0000218,
11497,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624270,,BAO_0000218,
11498,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,,A,,CHEMBL624271,,BAO_0000218,
11499,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624272,,BAO_0000218,
11500,Rattus norvegicus,50597,,,1,,,Intermediate,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,A,,CHEMBL624273,,BAO_0000218,
11501,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12064,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,N,,A,,CHEMBL624274,,BAO_0000218,
11502,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12064,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,N,,A,,CHEMBL624275,,BAO_0000218,
11503,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12064,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,N,,A,,CHEMBL624276,,BAO_0000218,
11504,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12038,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,N,,A,,CHEMBL624277,,BAO_0000218,
11505,,22224,,,1,,,Autocuration,14314,% dose converted to 2-amino-5-chlorophenyl sulfate,,U,,A,,CHEMBL624278,,BAO_0000019,
11506,,22224,,,1,,,Autocuration,14314,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,U,,A,,CHEMBL624279,,BAO_0000019,
11507,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,,A,,CHEMBL624280,,BAO_0000218,
11508,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,,A,,CHEMBL624281,,BAO_0000218,
11509,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,,A,,CHEMBL622933,,BAO_0000218,
11510,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,,A,,CHEMBL622934,,BAO_0000218,
11511,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL622935,,BAO_0000218,
11512,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 5 minutes of iv administration,,N,,A,,CHEMBL622936,,BAO_0000218,
11513,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL875228,,BAO_0000218,
11514,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat lung after 24 hours of iv administration,,N,,A,,CHEMBL622937,,BAO_0000218,
11515,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,N,,A,,CHEMBL622938,,BAO_0000218,
11516,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat lung after 30 minutes of iv administration,,N,,A,,CHEMBL619736,,BAO_0000218,
11517,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL625117,,BAO_0000218,
11518,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat lung after 5 minutes of iv administration,,N,,A,,CHEMBL625118,,BAO_0000218,
11519,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,8829,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,N,,A,,CHEMBL625119,,BAO_0000218,
11520,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14972,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,N,,A,,CHEMBL625120,,BAO_0000218,
11521,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14972,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,N,,A,,CHEMBL625121,,BAO_0000218,
11522,Rattus norvegicus,50597,10000006.0,,1,In vivo,,Intermediate,14972,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,N,,A,,CHEMBL625122,,BAO_0000218,
11523,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL622204,,BAO_0000218,
11524,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL877503,,BAO_0000218,
11525,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL627127,,BAO_0000218,
11526,,22224,10000000.0,,1,In vivo,,Autocuration,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,U,,A,,CHEMBL627128,,BAO_0000218,
11527,,22224,10000000.0,,1,In vivo,,Autocuration,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,U,,A,,CHEMBL627129,,BAO_0000218,
11528,,22224,10000000.0,,1,In vivo,,Autocuration,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,U,,A,,CHEMBL627130,,BAO_0000218,
11529,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL627131,,BAO_0000218,
11530,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL627132,,BAO_0000218,
11531,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL627133,,BAO_0000218,
11532,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL627134,,BAO_0000218,
11533,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL627135,,BAO_0000218,
11534,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL627136,,BAO_0000218,
11535,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL628435,,BAO_0000218,
11536,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL628436,,BAO_0000218,
11537,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL628437,,BAO_0000218,
11538,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL628438,,BAO_0000218,
11539,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL628439,,BAO_0000218,
11540,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL628440,,BAO_0000218,
11541,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL628441,,BAO_0000218,
11542,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL628442,,BAO_0000218,
11543,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL628443,,BAO_0000218,
11544,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL628444,,BAO_0000218,
11545,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL628445,,BAO_0000218,
11546,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL877504,,BAO_0000218,
11547,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL628446,,BAO_0000218,
11548,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL626874,,BAO_0000218,
11549,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL626875,,BAO_0000218,
11550,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL626876,,BAO_0000218,
11551,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL626877,,BAO_0000218,
11552,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL626878,,BAO_0000218,
11553,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL626879,,BAO_0000218,
11554,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,U,,A,,CHEMBL626880,,BAO_0000218,
11555,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,N,,A,,CHEMBL626881,,BAO_0000218,
11556,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,N,,A,,CHEMBL626882,,BAO_0000218,
11557,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14470,Peak plasma concentration was measured in dogs,,N,,A,,CHEMBL626883,,BAO_0000218,
11558,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14393,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,A,,CHEMBL626884,,BAO_0000218,
11559,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,N,,A,,CHEMBL626885,,BAO_0000218,
11560,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,N,,A,,CHEMBL626886,,BAO_0000218,
11561,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,N,,A,,CHEMBL626887,,BAO_0000218,
11562,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14393,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,A,,CHEMBL626888,,BAO_0000218,
11563,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,N,,A,,CHEMBL626889,,BAO_0000218,
11564,Simiiformes,22224,,,1,In vivo,,Autocuration,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,U,,A,,CHEMBL626761,,BAO_0000218,
11565,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,N,,A,,CHEMBL626762,,BAO_0000218,
11566,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,N,,A,,CHEMBL626763,,BAO_0000218,
11567,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,N,,A,,CHEMBL626764,,BAO_0000218,
11568,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,N,,A,,CHEMBL626765,,BAO_0000218,
11569,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,N,,A,,CHEMBL626766,,BAO_0000218,
11570,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,N,,A,,CHEMBL626767,,BAO_0000218,
11571,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,N,,A,,CHEMBL626768,,BAO_0000218,
11572,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,N,,A,,CHEMBL626769,,BAO_0000218,
11573,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,N,,A,,CHEMBL874463,,BAO_0000218,
11574,Simiiformes,22224,,,1,In vivo,,Autocuration,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,U,,A,,CHEMBL626770,,BAO_0000218,
11575,Simiiformes,22224,,,1,In vivo,,Autocuration,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,U,,A,,CHEMBL626771,,BAO_0000218,
11576,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,N,,A,,CHEMBL626772,,BAO_0000218,
11577,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,,A,,CHEMBL626773,,BAO_0000218,
11578,Mus musculus,50594,,,1,In vivo,,Intermediate,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,N,,A,,CHEMBL626774,,BAO_0000218,
11579,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,,A,,CHEMBL626775,,BAO_0000218,
11580,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,,A,,CHEMBL626776,,BAO_0000218,
11581,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14443,Maximum concentration (Cmax) in rat when administered orally,,N,,A,,CHEMBL626777,,BAO_0000218,
11582,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,13465,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,U,,A,,CHEMBL626778,,BAO_0000218,
11583,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,U,,A,,CHEMBL626779,,BAO_0000218,
11584,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,U,,A,,CHEMBL626780,,BAO_0000218,
11585,,22224,1969.0,,1,In vivo,,Autocuration,15618,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,U,,A,,CHEMBL626781,,BAO_0000218,
11586,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14554,Pharmacokinetic profile Cmax was evaluated in rats,,N,,A,,CHEMBL632164,,BAO_0000218,
11587,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,N,,A,,CHEMBL632165,,BAO_0000218,
11588,Mus musculus,50594,,,1,In vivo,,Intermediate,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,N,,A,,CHEMBL632166,,BAO_0000218,
11589,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,N,,A,,CHEMBL632167,,BAO_0000218,
11590,Mus musculus,50594,,,1,In vivo,,Intermediate,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,N,,A,,CHEMBL632168,,BAO_0000218,
11591,Rattus norvegicus,22224,1969.0,,1,In vivo,,Autocuration,2021,Cmax in rat plasma,,U,,A,,CHEMBL632169,,BAO_0000218,
11592,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,5932,Cmax in dog plasma after 30mg/kg oral dose,,N,,A,,CHEMBL632170,,BAO_0000218,
11593,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5932,Cmax in rat plasma after 30mg/kg oral dose,,N,,A,,CHEMBL632171,,BAO_0000218,
11594,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,17320,Plasma level in rats at 30 mg/kg,,N,,A,,CHEMBL632172,,BAO_0000218,
11595,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,15831,Tested for maximum plasma concentration in mice,,N,,A,,CHEMBL632173,,BAO_0000218,
11596,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL632174,,BAO_0000218,
11597,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14941,The Cmax values in female wistar rats.,,N,,A,,CHEMBL632175,,BAO_0000218,
11598,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,15343,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,N,,A,,CHEMBL632176,,BAO_0000218,
11599,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15343,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,N,,A,,CHEMBL632177,,BAO_0000218,
11600,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14856,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,N,,A,,CHEMBL632178,,BAO_0000218,
11601,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13129,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,N,,A,,CHEMBL632179,,BAO_0000218,
11602,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,N,,A,,CHEMBL632180,,BAO_0000218,
11603,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,N,,A,,CHEMBL632181,,BAO_0000218,
11604,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,N,,A,,CHEMBL632182,,BAO_0000218,
11605,Mus musculus,22224,178.0,,1,In vivo,,Autocuration,15478,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,U,,A,,CHEMBL632183,,BAO_0000218,
11606,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,15341,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,N,,A,,CHEMBL632184,,BAO_0000218,
11607,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,N,,A,,CHEMBL874470,,BAO_0000218,
11608,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631302,,BAO_0000218,
11609,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631303,,BAO_0000218,
11610,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631304,,BAO_0000218,
11611,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631305,,BAO_0000218,
11612,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631306,,BAO_0000218,
11613,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631307,,BAO_0000218,
11614,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL631308,,BAO_0000218,
11615,Rattus norvegicus,50597,,,1,,,Intermediate,8684,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625557,,BAO_0000218,
11616,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625558,,BAO_0000218,
11617,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625559,,BAO_0000218,
11618,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625560,,BAO_0000218,
11619,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625561,,BAO_0000218,
11620,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625562,,BAO_0000218,
11621,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL875320,,BAO_0000218,
11622,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625563,,BAO_0000218,
11623,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,8684,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625564,,BAO_0000218,
11624,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625565,,BAO_0000218,
11625,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625566,,BAO_0000218,
11626,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625567,,BAO_0000218,
11627,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL625568,,BAO_0000218,
11628,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL628217,,BAO_0000218,
11629,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,N,,A,,CHEMBL628218,,BAO_0000218,
11630,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL628219,,BAO_0000218,
11631,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8684,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,N,,A,,CHEMBL628220,,BAO_0000218,
11632,,22224,,,1,,,Autocuration,8926,Distribution in the blood after 120 min of intravenous administration,,U,,A,,CHEMBL628221,,BAO_0000019,
11633,,22224,,,1,,,Autocuration,8926,Distribution in the blood after 15 min of intravenous administration,,U,,A,,CHEMBL628222,,BAO_0000019,
11634,,22224,,,1,,,Autocuration,8926,Distribution in the blood after 30 min of intravenous administration,,U,,A,,CHEMBL628223,,BAO_0000019,
11635,,22224,,,1,,,Autocuration,8926,Distribution in the blood after 5 min of intravenous administration,,U,,A,,CHEMBL628224,,BAO_0000019,
11636,,22224,,,1,,,Autocuration,8926,Distribution in the blood after 60 min of intravenous administration,,U,,A,,CHEMBL628225,,BAO_0000019,
11637,,22224,,,1,,,Autocuration,8926,Distribution in the blood after 90 min of intravenous administration,,U,,A,,CHEMBL628226,,BAO_0000019,
11638,,22224,,,1,,,Autocuration,8926,Distribution in the bone after 120 min of intravenous administration,,U,,A,,CHEMBL628227,,BAO_0000019,
11639,,22224,,,1,,,Autocuration,8926,Distribution in the bone after 15 min of intravenous administration,,U,,A,,CHEMBL875481,,BAO_0000019,
11640,,22224,,,1,,,Autocuration,8926,Distribution in the bone after 30 min of intravenous administration,,U,,A,,CHEMBL628228,,BAO_0000019,
11641,,22224,,,1,,,Autocuration,8926,Distribution in the bone after 5 min of intravenous administration,,U,,A,,CHEMBL628229,,BAO_0000019,
11642,,22224,,,1,,,Autocuration,8926,Distribution in the bone after 60 min of intravenous administration,,U,,A,,CHEMBL628230,,BAO_0000019,
11643,,22224,,,1,,,Autocuration,8926,Distribution in the bone after 90 min of intravenous administration,,U,,A,,CHEMBL628231,,BAO_0000019,
11644,,22224,,,1,,,Autocuration,8926,Distribution in the heart after 120 min of intravenous administration,,U,,A,,CHEMBL628232,,BAO_0000019,
11645,,22224,,,1,,,Autocuration,8926,Distribution in the heart after 15 min of intravenous administration,,U,,A,,CHEMBL628233,,BAO_0000019,
11646,,22224,,,1,,,Autocuration,8926,Distribution in the heart after 30 min of intravenous administration,,U,,A,,CHEMBL628234,,BAO_0000019,
11647,,22224,,,1,,,Autocuration,8926,Distribution in the heart after 5 min of intravenous administration,,U,,A,,CHEMBL628235,,BAO_0000019,
11648,,22224,,,1,,,Autocuration,8926,Distribution in the heart after 60 min of intravenous administration,,U,,A,,CHEMBL628236,,BAO_0000019,
11649,,22224,,,1,,,Autocuration,8926,Distribution in the heart after 90 min of intravenous administration,,U,,A,,CHEMBL628237,,BAO_0000019,
11650,,22224,,,1,,,Autocuration,8926,Distribution in the kidneys after 120 min of intravenous administration,,U,,A,,CHEMBL628238,,BAO_0000019,
11651,,22224,,,1,,,Autocuration,8926,Distribution in the kidneys after 15 min of intravenous administration,,U,,A,,CHEMBL628239,,BAO_0000019,
11652,,22224,,,1,,,Autocuration,8926,Distribution in the kidneys after 30 min of intravenous administration,,U,,A,,CHEMBL628240,,BAO_0000019,
11653,,22224,,,1,,,Autocuration,8926,Distribution in the kidneys after 5 min of intravenous administration,,U,,A,,CHEMBL628241,,BAO_0000019,
11654,,22224,,,1,,,Autocuration,8926,Distribution in the kidneys after 60 min of intravenous administration,,U,,A,,CHEMBL628242,,BAO_0000019,
11655,,22224,,,1,,,Autocuration,8926,Distribution in the kidneys after 90 min of intravenous administration,,U,,A,,CHEMBL875482,,BAO_0000019,
11656,,22224,,,1,,,Autocuration,8926,Distribution in the liver after 120 min of intravenous administration,,U,,A,,CHEMBL628243,,BAO_0000019,
11657,,22224,,,1,,,Autocuration,8926,Distribution in the liver after 15 min of intravenous administration,,U,,A,,CHEMBL628244,,BAO_0000019,
11658,,22224,,,1,,,Autocuration,8926,Distribution in the liver after 30 min of intravenous administration,,U,,A,,CHEMBL628245,,BAO_0000019,
11659,,22224,,,1,,,Autocuration,8926,Distribution in the liver after 5 min of intravenous administration,,U,,A,,CHEMBL628246,,BAO_0000019,
11660,,22224,,,1,,,Autocuration,8926,Distribution in the liver after 60 min of intravenous administration,,U,,A,,CHEMBL628247,,BAO_0000019,
11661,,22224,,,1,,,Autocuration,8926,Distribution in the liver after 90 min of intravenous administration,,U,,A,,CHEMBL628248,,BAO_0000019,
11662,,22224,,,1,,,Autocuration,8926,Distribution in the lung after 120 min of intravenous administration,,U,,A,,CHEMBL628249,,BAO_0000019,
11663,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,N,,A,,CHEMBL625452,,BAO_0000218,
11664,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,N,,A,,CHEMBL625453,,BAO_0000218,
11665,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,N,,A,,CHEMBL625454,,BAO_0000218,
11666,Mus musculus,50594,,,1,,,Intermediate,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,N,,A,,CHEMBL623844,,BAO_0000218,
11667,Rattus norvegicus,50597,,,1,,,Intermediate,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,,A,,CHEMBL623845,,BAO_0000218,
11668,Rattus norvegicus,50597,,,1,,,Intermediate,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,,A,,CHEMBL623846,,BAO_0000218,
11669,,22224,,,1,,,Autocuration,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,U,,A,,CHEMBL623847,,BAO_0000218,
11670,Macaca fascicularis,100710,,,1,,,Intermediate,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,A,,CHEMBL623848,,BAO_0000218,
11671,Macaca fascicularis,100710,,,1,,,Intermediate,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,,A,,CHEMBL623849,,BAO_0000218,
11672,Macaca fascicularis,100710,,,1,,,Intermediate,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,A,,CHEMBL623850,,BAO_0000218,
11673,Macaca fascicularis,100710,,,1,,,Intermediate,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,,A,,CHEMBL623851,,BAO_0000218,
11674,Simiiformes,22224,,,1,,,Autocuration,12187,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,A,,CHEMBL623852,,BAO_0000218,
11675,Mustela putorius furo,50506,,,1,,,Intermediate,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,,A,,CHEMBL624551,,BAO_0000218,
11676,Mustela putorius furo,50506,,,1,,,Intermediate,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,,A,,CHEMBL624552,,BAO_0000218,
11677,Simiiformes,22224,,,1,,,Autocuration,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,A,,CHEMBL624553,,BAO_0000218,
11678,Simiiformes,22224,,,1,,,Autocuration,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,U,,A,,CHEMBL624554,,BAO_0000218,
11679,Rattus norvegicus,50597,,,1,,,Intermediate,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,,A,,CHEMBL624555,,BAO_0000218,
11680,Rattus norvegicus,50597,,,1,,,Intermediate,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,,A,,CHEMBL624741,,BAO_0000218,
11681,Canis lupus familiaris,50588,,,1,,,Intermediate,14122,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,N,,A,,CHEMBL624742,,BAO_0000218,
11682,Cricetinae,100712,,,1,,,Intermediate,14122,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,N,,A,,CHEMBL624743,,BAO_0000218,
11683,Rattus norvegicus,50597,,,1,,,Intermediate,14122,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,N,,A,,CHEMBL877606,,BAO_0000218,
11684,,22224,,,1,,,Autocuration,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,U,,A,,CHEMBL624744,,BAO_0000218,
11685,,22224,178.0,,1,,,Autocuration,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,A,,CHEMBL624745,,BAO_0000218,
11686,,22224,178.0,,1,,,Autocuration,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,,A,,CHEMBL624746,,BAO_0000218,
11687,,22224,178.0,,1,,,Autocuration,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,,A,,CHEMBL624747,,BAO_0000218,
11688,,22224,,,1,,,Autocuration,16360,Oral absorption expressed as Area under curve was determined,,U,,A,,CHEMBL624748,,BAO_0000019,
11689,Canis lupus familiaris,50588,,,1,,,Intermediate,3673,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,N,,A,,CHEMBL622504,,BAO_0000218,
11690,Canis lupus familiaris,50588,,,1,,,Intermediate,14122,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,N,,A,,CHEMBL622505,,BAO_0000218,
11691,Cricetinae,100712,,,1,,,Intermediate,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,,A,,CHEMBL622506,,BAO_0000218,
11692,Cricetinae,100712,,,1,,,Intermediate,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,,A,,CHEMBL622507,,BAO_0000218,
11693,Rattus norvegicus,50597,,,1,,,Intermediate,14122,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,N,,A,,CHEMBL622508,,BAO_0000218,
11694,,22224,,,1,,,Autocuration,13889,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,U,,A,,CHEMBL622509,,BAO_0000019,
11695,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,A,,CHEMBL622510,,BAO_0000218,
11696,Rattus norvegicus,50597,,,1,,,Intermediate,17279,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,N,,A,,CHEMBL622511,,BAO_0000218,
11697,Macaca fascicularis,100710,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,,A,,CHEMBL622512,,BAO_0000218,
11698,Macaca fascicularis,100710,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,,A,,CHEMBL622513,,BAO_0000218,
11699,Macaca fascicularis,100710,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,N,,A,,CHEMBL622514,,BAO_0000218,
11700,Canis lupus familiaris,50588,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,,A,,CHEMBL622515,,BAO_0000218,
11701,Canis lupus familiaris,50588,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,N,,A,,CHEMBL622516,,BAO_0000218,
11702,Rattus norvegicus,50597,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,,A,,CHEMBL622517,,BAO_0000218,
11703,Rattus norvegicus,50597,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,N,,A,,CHEMBL622518,,BAO_0000218,
11704,Rattus norvegicus,50597,,,1,,,Intermediate,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,N,,A,,CHEMBL622519,,BAO_0000218,
11705,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL622520,,BAO_0000218,
11706,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL622521,,BAO_0000218,
11707,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL625113,,BAO_0000218,
11708,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL625114,,BAO_0000218,
11709,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL874397,,BAO_0000218,
11710,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL625115,,BAO_0000218,
11711,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL625116,,BAO_0000218,
11712,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL623932,,BAO_0000218,
11713,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL623933,,BAO_0000218,
11714,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL623934,,BAO_0000218,
11715,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL623935,,BAO_0000218,
11716,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,N,,A,,CHEMBL623936,,BAO_0000218,
11717,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,N,,A,,CHEMBL623937,,BAO_0000218,
11718,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,N,,A,,CHEMBL623938,,BAO_0000218,
11719,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL623939,,BAO_0000218,
11720,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,,A,,CHEMBL623940,,BAO_0000218,
11721,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,A,,CHEMBL623941,,BAO_0000218,
11722,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL627216,,BAO_0000218,
11723,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL623942,,BAO_0000218,
11724,Mus musculus,50594,955.0,,1,,,Intermediate,15383,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL618793,,BAO_0000218,
11725,Mus musculus,50594,955.0,,1,,,Intermediate,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618794,,BAO_0000218,
11726,Mus musculus,50594,955.0,,1,,,Intermediate,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL618795,,BAO_0000218,
11727,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618796,,BAO_0000218,
11728,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL618797,,BAO_0000218,
11729,Mus musculus,50594,2113.0,,1,,,Intermediate,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,,A,,CHEMBL618798,,BAO_0000218,
11730,Mus musculus,50594,2113.0,,1,,,Intermediate,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL618799,,BAO_0000218,
11731,Mus musculus,50594,2113.0,,1,,,Intermediate,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,,A,,CHEMBL618800,,BAO_0000218,
11732,Mus musculus,50594,2113.0,,1,,,Intermediate,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,A,,CHEMBL618801,,BAO_0000218,
11733,Mus musculus,50594,2113.0,,1,,,Intermediate,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618802,,BAO_0000218,
11734,Mus musculus,50594,2113.0,,1,,,Intermediate,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL618803,,BAO_0000218,
11735,Mus musculus,50594,2107.0,,1,,,Intermediate,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,,A,,CHEMBL618804,,BAO_0000218,
11736,Mus musculus,50594,2107.0,,1,,,Intermediate,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL618805,,BAO_0000218,
11737,Mus musculus,50594,2107.0,,1,,,Intermediate,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,,A,,CHEMBL618806,,BAO_0000218,
11738,Mus musculus,50594,2107.0,,1,,,Intermediate,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,A,,CHEMBL618807,,BAO_0000218,
11739,Mus musculus,50594,2107.0,,1,,,Intermediate,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618808,,BAO_0000218,
11740,Mus musculus,50594,2107.0,,1,,,Intermediate,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL618809,,BAO_0000218,
11741,Mus musculus,50594,2385.0,,1,,,Intermediate,15383,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL618810,,BAO_0000218,
11742,Mus musculus,50594,2385.0,,1,,,Intermediate,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,,A,,CHEMBL618811,,BAO_0000218,
11743,Mus musculus,50594,2385.0,,1,,,Intermediate,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,A,,CHEMBL875844,,BAO_0000218,
11744,Mus musculus,50594,2385.0,,1,,,Intermediate,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618812,,BAO_0000218,
11745,Mus musculus,50594,2385.0,,1,,,Intermediate,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL618813,,BAO_0000218,
11746,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL618814,,BAO_0000218,
11747,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618815,,BAO_0000218,
11748,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL618816,,BAO_0000218,
11749,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL618817,,BAO_0000218,
11750,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL620544,,BAO_0000218,
11751,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,N,,A,,CHEMBL626230,,BAO_0000218,
11752,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,N,,A,,CHEMBL626231,,BAO_0000218,
11753,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,N,,A,,CHEMBL626232,,BAO_0000218,
11754,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,N,,A,,CHEMBL626233,,BAO_0000218,
11755,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,N,,A,,CHEMBL626234,,BAO_0000218,
11756,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,N,,A,,CHEMBL875341,,BAO_0000218,
11757,Homo sapiens,50587,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (100 mg/kg) administered orally in human,,N,,A,,CHEMBL626235,,BAO_0000218,
11758,Callithrix,22224,1969.0,,1,In vivo,,Autocuration,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,U,,A,,CHEMBL626236,,BAO_0000218,
11759,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,U,,A,,CHEMBL626237,,BAO_0000218,
11760,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,N,,A,,CHEMBL626238,,BAO_0000218,
11761,Homo sapiens,50587,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (200 mg/kg) administered orally in human,,N,,A,,CHEMBL622412,,BAO_0000218,
11762,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,N,,A,,CHEMBL623114,,BAO_0000218,
11763,Callithrix,22224,1969.0,,1,In vivo,,Autocuration,14215,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,U,,A,,CHEMBL623115,,BAO_0000218,
11764,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,14215,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,U,,A,,CHEMBL623116,,BAO_0000218,
11765,Canis lupus familiaris,22224,1969.0,,1,In vivo,,Autocuration,14215,The maximum plasma concentration (30 mg/kg) administered orally in dog,,U,,A,,CHEMBL623117,,BAO_0000218,
11766,Homo sapiens,50587,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (400 mg/kg) administered orally in human,,N,,A,,CHEMBL623118,,BAO_0000218,
11767,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,N,,A,,CHEMBL623119,,BAO_0000218,
11768,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (50 mg/kg) administered orally in rat,,N,,A,,CHEMBL623120,,BAO_0000218,
11769,Homo sapiens,50587,1969.0,,1,In vivo,,Intermediate,14215,The maximum plasma concentration (800 mg/kg) administered orally in human,,N,,A,,CHEMBL623286,,BAO_0000218,
11770,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14067,The maximum plasma concentration was measured on rats,,N,,A,,CHEMBL623287,,BAO_0000218,
11771,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12350,The maximum plasma concentration was measured on rats after oral administration,,N,,A,,CHEMBL623288,,BAO_0000218,
11772,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14813,Plasma drug Cmax in rat (PO dose),,N,,A,,CHEMBL623289,,BAO_0000218,
11773,,22224,,,1,In vivo,,Autocuration,12536,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,U,,A,,CHEMBL623290,,BAO_0000218,
11774,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14169,maximum Plasma concentration in Dog was determined after Peroral administration,,N,,A,,CHEMBL623291,,BAO_0000218,
11775,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14169,maximum Plasma concentration in Rats was determined after Peroral administration,,N,,A,,CHEMBL623292,,BAO_0000218,
11776,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,,A,,CHEMBL623293,,BAO_0000218,
11777,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,,A,,CHEMBL623294,,BAO_0000218,
11778,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,,A,,CHEMBL623295,,BAO_0000218,
11779,Mus musculus,50594,,,1,In vivo,,Intermediate,14387,maximum concentration was measured when administered through oral route in mice,,N,,A,,CHEMBL623296,,BAO_0000218,
11780,Mus musculus,50594,,,1,,,Intermediate,15115,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,N,,A,,CHEMBL875349,,BAO_0000218,
11781,Simiiformes,22224,,,1,,,Autocuration,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,U,,A,,CHEMBL623297,,BAO_0000019,
11782,Simiiformes,22224,,,1,,,Autocuration,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,U,,A,,CHEMBL623298,,BAO_0000019,
11783,Simiiformes,22224,,,1,,,Autocuration,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,U,,A,,CHEMBL623299,,BAO_0000019,
11784,Rattus norvegicus,50597,,,1,,,Intermediate,16359,Pharmacokinetic parameter was evaluated in rats,,N,,A,,CHEMBL623300,,BAO_0000218,
11785,Mus musculus,50594,,,1,,,Intermediate,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,,A,,CHEMBL623301,,BAO_0000218,
11786,Mus musculus,50594,,,1,,,Intermediate,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,N,,A,,CHEMBL623302,,BAO_0000218,
11787,Mus musculus,50594,,,1,,,Intermediate,12829,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,,A,,CHEMBL623303,,BAO_0000218,
11788,Mus musculus,50594,,,1,,,Intermediate,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,N,,A,,CHEMBL623304,,BAO_0000218,
11789,Mus musculus,50594,,,1,,,Intermediate,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,N,,A,,CHEMBL623305,,BAO_0000218,
11790,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,N,,A,,CHEMBL623306,,BAO_0000218,
11791,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,N,,A,,CHEMBL623307,,BAO_0000218,
11792,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,N,,A,,CHEMBL623308,,BAO_0000218,
11793,Mus musculus,50594,1969.0,,1,,,Intermediate,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,N,,A,,CHEMBL623309,,BAO_0000218,
11794,Mus musculus,50594,,,1,,,Intermediate,13509,Plasma Concentration after 120 min of oral administration to mice,,N,,A,,CHEMBL623310,,BAO_0000218,
11795,Mus musculus,50594,,,1,,,Intermediate,13509,Plasma Concentration after 30 min of oral administration to mice,,N,,A,,CHEMBL623311,,BAO_0000218,
11796,Macaca fascicularis,100710,,,1,,,Intermediate,13509,Plasma Concentration after 60 min of oral administration to mice,,N,,A,,CHEMBL623312,,BAO_0000218,
11797,Mus musculus,50594,,,1,,,Intermediate,13509,Plasma Concentration after 60 min of oral administration to mice; Not determined,,N,,A,,CHEMBL875350,,BAO_0000218,
11798,Mus musculus,50594,,,1,,,Intermediate,13509,Plasma Concentration after 90 min of oral administration to mice,,N,,A,,CHEMBL628635,,BAO_0000218,
11799,Rattus norvegicus,50597,,,1,,,Intermediate,12064,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,N,,A,,CHEMBL628636,,BAO_0000218,
11800,Rattus norvegicus,50597,,,1,,,Intermediate,12064,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,N,,A,,CHEMBL628637,,BAO_0000218,
11801,Rattus norvegicus,50597,,,1,,,Intermediate,12064,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,N,,A,,CHEMBL628058,,BAO_0000218,
11802,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,N,,A,,CHEMBL628059,,BAO_0000218,
11803,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,N,,A,,CHEMBL628060,,BAO_0000218,
11804,,22224,,,1,,,Autocuration,8926,Distribution in the lung after 15 min of intravenous administration,,U,,A,,CHEMBL628061,,BAO_0000019,
11805,,22224,,,1,,,Autocuration,8926,Distribution in the lung after 30 min of intravenous administration,,U,,A,,CHEMBL628062,,BAO_0000019,
11806,,22224,,,1,,,Autocuration,8926,Distribution in the lung after 5 min of intravenous administration,,U,,A,,CHEMBL628063,,BAO_0000019,
11807,,22224,,,1,,,Autocuration,8926,Distribution in the lung after 60 min of intravenous administration,,U,,A,,CHEMBL628064,,BAO_0000019,
11808,,22224,,,1,,,Autocuration,8926,Distribution in the lung after 90 min of intravenous administration,,U,,A,,CHEMBL628065,,BAO_0000019,
11809,,22224,2385.0,,1,,,Autocuration,8926,Distribution in the muscle after 120 min of intravenous administration,,U,,A,,CHEMBL628066,,BAO_0000019,
11810,,22224,2385.0,,1,,,Autocuration,8926,Distribution in the muscle after 15 min of intravenous administration,,U,,A,,CHEMBL628067,,BAO_0000019,
11811,Mus musculus,50594,2385.0,,1,,,Intermediate,8926,Distribution in the muscle after 30 min of intravenous administration,,N,,A,,CHEMBL874646,,BAO_0000218,
11812,,22224,2385.0,,1,,,Autocuration,8926,Distribution in the muscle after 5 min of intravenous administration,,U,,A,,CHEMBL628068,,BAO_0000019,
11813,,22224,2385.0,,1,,,Autocuration,8926,Distribution in the muscle after 60 min of intravenous administration,,U,,A,,CHEMBL628069,,BAO_0000019,
11814,,22224,2385.0,,1,,,Autocuration,8926,Distribution in the muscle after 90 min of intravenous administration,,U,,A,,CHEMBL628070,,BAO_0000019,
11815,,22224,2106.0,,1,,,Autocuration,8926,Distribution in the spleen after 120 min of intravenous administration,,U,,A,,CHEMBL628071,,BAO_0000019,
11816,,22224,2106.0,,1,,,Autocuration,8926,Distribution in the spleen after 15 min of intravenous administration,,U,,A,,CHEMBL628072,,BAO_0000019,
11817,,22224,2106.0,,1,,,Autocuration,8926,Distribution in the spleen after 30 min of intravenous administration,,U,,A,,CHEMBL628073,,BAO_0000019,
11818,,22224,2106.0,,1,,,Autocuration,8926,Distribution in the spleen after 5 min of intravenous administration,,U,,A,,CHEMBL628074,,BAO_0000019,
11819,,22224,2106.0,,1,,,Autocuration,8926,Distribution in the spleen after 60 min of intravenous administration,,U,,A,,CHEMBL628075,,BAO_0000019,
11820,,22224,2106.0,,1,,,Autocuration,8926,Distribution in the spleen after 90 min of intravenous administration,,U,,A,,CHEMBL628076,,BAO_0000019,
11821,Rattus norvegicus,50597,1235.0,,1,,,Intermediate,7570,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,,A,,CHEMBL628077,,BAO_0000218,
11822,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7570,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,N,,A,,CHEMBL628078,,BAO_0000218,
11823,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7570,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,N,,A,,CHEMBL628079,,BAO_0000218,
11824,Rattus norvegicus,50597,992.0,,1,,,Intermediate,7570,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,N,,A,,CHEMBL628080,,BAO_0000218,
11825,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7570,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,N,,A,,CHEMBL628081,,BAO_0000218,
11826,Rattus norvegicus,50597,1235.0,,1,,,Intermediate,7570,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,,A,,CHEMBL628082,,BAO_0000218,
11827,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7570,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,N,,A,,CHEMBL874647,,BAO_0000218,
11828,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7570,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,N,,A,,CHEMBL626406,,BAO_0000218,
11829,Rattus norvegicus,50597,992.0,,1,,,Intermediate,7570,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,N,,A,,CHEMBL626407,,BAO_0000218,
11830,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,7570,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,N,,A,,CHEMBL626408,,BAO_0000218,
11831,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,N,,A,,CHEMBL626409,,BAO_0000218,
11832,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,N,,A,,CHEMBL626410,,BAO_0000218,
11833,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,N,,A,,CHEMBL626411,,BAO_0000218,
11834,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,N,,A,,CHEMBL626412,,BAO_0000218,
11835,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,N,,A,,CHEMBL626413,,BAO_0000218,
11836,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,N,,A,,CHEMBL626414,,BAO_0000218,
11837,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,N,,A,,CHEMBL626415,,BAO_0000218,
11838,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,N,,A,,CHEMBL626416,,BAO_0000218,
11839,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,N,,A,,CHEMBL627062,,BAO_0000218,
11840,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,N,,A,,CHEMBL627063,,BAO_0000218,
11841,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,N,,A,,CHEMBL627064,,BAO_0000218,
11842,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,N,,A,,CHEMBL627227,,BAO_0000218,
11843,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,N,,A,,CHEMBL627228,,BAO_0000218,
11844,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,N,,A,,CHEMBL627229,,BAO_0000218,
11845,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,N,,A,,CHEMBL625792,,BAO_0000218,
11846,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,N,,A,,CHEMBL625793,,BAO_0000218,
11847,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,N,,A,,CHEMBL625794,,BAO_0000218,
11848,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,N,,A,,CHEMBL625795,,BAO_0000218,
11849,Mus musculus,50594,,,1,,,Intermediate,13792,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,N,,A,,CHEMBL625796,,BAO_0000218,
11850,Canis lupus familiaris,50588,,,1,,,Intermediate,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,,A,,CHEMBL625797,,BAO_0000218,
11851,Canis lupus familiaris,50588,,,1,,,Intermediate,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,,A,,CHEMBL625798,,BAO_0000218,
11852,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,A,,CHEMBL875613,,BAO_0000218,
11853,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,A,,CHEMBL625799,,BAO_0000218,
11854,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,U,,A,,CHEMBL625800,,BAO_0000218,
11855,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL625801,,BAO_0000218,
11856,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL625802,,BAO_0000218,
11857,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL625803,,BAO_0000218,
11858,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,U,,A,,CHEMBL625804,,BAO_0000019,
11859,,22224,,,1,,,Autocuration,14380,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,U,,A,,CHEMBL622530,,BAO_0000218,
11860,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,N,,A,,CHEMBL622531,,BAO_0000218,
11861,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,,A,,CHEMBL622532,,BAO_0000218,
11862,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,,A,,CHEMBL623176,,BAO_0000218,
11863,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,,A,,CHEMBL623177,,BAO_0000218,
11864,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,,A,,CHEMBL623178,,BAO_0000218,
11865,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,N,,A,,CHEMBL623179,,BAO_0000218,
11866,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,,A,,CHEMBL623180,,BAO_0000218,
11867,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,,A,,CHEMBL623181,,BAO_0000218,
11868,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,,A,,CHEMBL624131,,BAO_0000218,
11869,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,N,,A,,CHEMBL624132,,BAO_0000218,
11870,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,,A,,CHEMBL624133,,BAO_0000218,
11871,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,N,,A,,CHEMBL624846,,BAO_0000218,
11872,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,,A,,CHEMBL624847,,BAO_0000218,
11873,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,,A,,CHEMBL624848,,BAO_0000218,
11874,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,,A,,CHEMBL625012,,BAO_0000218,
11875,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,,A,,CHEMBL625013,,BAO_0000218,
11876,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,N,,A,,CHEMBL625014,,BAO_0000218,
11877,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,N,,A,,CHEMBL625015,,BAO_0000218,
11878,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,,A,,CHEMBL625016,,BAO_0000218,
11879,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,N,,A,,CHEMBL625017,,BAO_0000218,
11880,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,,A,,CHEMBL625018,,BAO_0000218,
11881,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,N,,A,,CHEMBL625019,,BAO_0000218,
11882,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,N,,A,,CHEMBL625020,,BAO_0000218,
11883,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,N,,A,,CHEMBL625021,,BAO_0000218,
11884,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,A,,CHEMBL625022,,BAO_0000218,
11885,Mus musculus,50594,,,1,,,Intermediate,14731,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,N,,A,,CHEMBL625023,,BAO_0000218,
11886,Macaca fascicularis,100710,,,1,,,Intermediate,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,N,,A,,CHEMBL625024,,BAO_0000218,
11887,Macaca fascicularis,100710,,,1,,,Intermediate,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,,A,,CHEMBL627626,,BAO_0000218,
11888,,22224,955.0,,1,,,Autocuration,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,,A,,CHEMBL627627,,BAO_0000218,
11889,,22224,1977.0,,1,,,Autocuration,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,U,,A,,CHEMBL627628,,BAO_0000218,
11890,,22224,955.0,,1,,,Autocuration,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,,A,,CHEMBL627629,,BAO_0000218,
11891,,22224,1977.0,,1,,,Autocuration,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,U,,A,,CHEMBL627630,,BAO_0000218,
11892,,22224,,,1,,,Autocuration,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,U,,A,,CHEMBL627631,,BAO_0000019,
11893,,22224,,,1,,,Autocuration,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,U,,A,,CHEMBL629515,,BAO_0000218,
11894,Mus musculus,50594,2106.0,,1,,,Intermediate,15383,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL629516,,BAO_0000218,
11895,Mus musculus,50594,2106.0,,1,,,Intermediate,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL629517,,BAO_0000218,
11896,Mus musculus,50594,2106.0,,1,,,Intermediate,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL629518,,BAO_0000218,
11897,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,A,,CHEMBL877499,,BAO_0000218,
11898,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,A,,CHEMBL629519,,BAO_0000218,
11899,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,A,,CHEMBL629520,,BAO_0000218,
11900,Mus musculus,50594,,,1,,,Intermediate,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,A,,CHEMBL629521,,BAO_0000218,
11901,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,N,,A,,CHEMBL629522,,BAO_0000218,
11902,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,N,,A,,CHEMBL629523,,BAO_0000218,
11903,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,N,,A,,CHEMBL629524,,BAO_0000218,
11904,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,N,,A,,CHEMBL629525,,BAO_0000218,
11905,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,N,,A,,CHEMBL629526,,BAO_0000218,
11906,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,N,,A,,CHEMBL629527,,BAO_0000218,
11907,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,N,,A,,CHEMBL629528,,BAO_0000218,
11908,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,N,,A,,CHEMBL629529,,BAO_0000218,
11909,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,N,,A,,CHEMBL629530,,BAO_0000218,
11910,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,N,,A,,CHEMBL629531,,BAO_0000218,
11911,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,N,,A,,CHEMBL628656,,BAO_0000218,
11912,Mus musculus,50594,,,1,,,Intermediate,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,N,,A,,CHEMBL628657,,BAO_0000218,
11913,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL628658,,BAO_0000218,
11914,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL628659,,BAO_0000218,
11915,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL877500,,BAO_0000218,
11916,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL628660,,BAO_0000218,
11917,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL628661,,BAO_0000218,
11918,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL628662,,BAO_0000218,
11919,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL628663,,BAO_0000218,
11920,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL628664,,BAO_0000218,
11921,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL628665,,BAO_0000218,
11922,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL628666,,BAO_0000218,
11923,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL628667,,BAO_0000218,
11924,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL628668,,BAO_0000218,
11925,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL628669,,BAO_0000218,
11926,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL628670,,BAO_0000218,
11927,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13751,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL628671,,BAO_0000218,
11928,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,13751,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL628672,,BAO_0000218,
11929,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,13751,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL630300,,BAO_0000218,
11930,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,13751,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL629787,,BAO_0000218,
11931,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,13751,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL629788,,BAO_0000218,
11932,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL629789,,BAO_0000218,
11933,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL629790,,BAO_0000218,
11934,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL629791,,BAO_0000218,
11935,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL629792,,BAO_0000218,
11936,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL629793,,BAO_0000218,
11937,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL629794,,BAO_0000218,
11938,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,N,,A,,CHEMBL874459,,BAO_0000218,
11939,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,N,,A,,CHEMBL629795,,BAO_0000218,
11940,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,N,,A,,CHEMBL629796,,BAO_0000218,
11941,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,N,,A,,CHEMBL629797,,BAO_0000218,
11942,Rattus norvegicus,50597,,,1,,,Intermediate,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,N,,A,,CHEMBL629798,,BAO_0000218,
11943,Rattus norvegicus,50597,2369.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629799,,BAO_0000218,
11944,Rattus norvegicus,50597,2369.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629800,,BAO_0000218,
11945,Rattus norvegicus,50597,2369.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629801,,BAO_0000218,
11946,Rattus norvegicus,50597,2369.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,N,,A,,CHEMBL629802,,BAO_0000218,
11947,Rattus norvegicus,50597,2369.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629803,,BAO_0000218,
11948,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629804,,BAO_0000218,
11949,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629805,,BAO_0000218,
11950,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629806,,BAO_0000218,
11951,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629807,,BAO_0000218,
11952,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629808,,BAO_0000218,
11953,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629809,,BAO_0000218,
11954,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629810,,BAO_0000218,
11955,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629811,,BAO_0000218,
11956,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629812,,BAO_0000218,
11957,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629813,,BAO_0000218,
11958,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL874460,,BAO_0000218,
11959,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629814,,BAO_0000218,
11960,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629815,,BAO_0000218,
11961,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,10911,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629816,,BAO_0000218,
11962,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,10911,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL629817,,BAO_0000218,
11963,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626643,,BAO_0000218,
11964,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626644,,BAO_0000218,
11965,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626806,,BAO_0000218,
11966,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626807,,BAO_0000218,
11967,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627261,,BAO_0000218,
11968,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627262,,BAO_0000218,
11969,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627263,,BAO_0000218,
11970,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627264,,BAO_0000218,
11971,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627265,,BAO_0000218,
11972,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627266,,BAO_0000218,
11973,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627267,,BAO_0000218,
11974,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627268,,BAO_0000218,
11975,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627269,,BAO_0000218,
11976,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627270,,BAO_0000218,
11977,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,N,,A,,CHEMBL627271,,BAO_0000218,
11978,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,N,,A,,CHEMBL627946,,BAO_0000218,
11979,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,N,,A,,CHEMBL875472,,BAO_0000218,
11980,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,N,,A,,CHEMBL627947,,BAO_0000218,
11981,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,N,,A,,CHEMBL627948,,BAO_0000218,
11982,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,N,,A,,CHEMBL628113,,BAO_0000218,
11983,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,N,,A,,CHEMBL628114,,BAO_0000218,
11984,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,N,,A,,CHEMBL628115,,BAO_0000218,
11985,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,N,,A,,CHEMBL628116,,BAO_0000218,
11986,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,N,,A,,CHEMBL628117,,BAO_0000218,
11987,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,N,,A,,CHEMBL628118,,BAO_0000218,
11988,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,N,,A,,CHEMBL628119,,BAO_0000218,
11989,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,N,,A,,CHEMBL628120,,BAO_0000218,
11990,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,N,,A,,CHEMBL628121,,BAO_0000218,
11991,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,N,,A,,CHEMBL628122,,BAO_0000218,
11992,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,N,,A,,CHEMBL627297,,BAO_0000218,
11993,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,N,,A,,CHEMBL627298,,BAO_0000218,
11994,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,N,,A,,CHEMBL627299,,BAO_0000218,
11995,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,N,,A,,CHEMBL627300,,BAO_0000218,
11996,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,N,,A,,CHEMBL627301,,BAO_0000218,
11997,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,N,,A,,CHEMBL627302,,BAO_0000218,
11998,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,N,,A,,CHEMBL627303,,BAO_0000218,
11999,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,N,,A,,CHEMBL627304,,BAO_0000218,
12000,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,N,,A,,CHEMBL627305,,BAO_0000218,
12001,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,,A,,CHEMBL627306,,BAO_0000218,
12002,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,N,,A,,CHEMBL623982,,BAO_0000218,
12003,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,N,,A,,CHEMBL623983,,BAO_0000218,
12004,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,N,,A,,CHEMBL623984,,BAO_0000218,
12005,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,N,,A,,CHEMBL623985,,BAO_0000218,
12006,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,N,,A,,CHEMBL623986,,BAO_0000218,
12007,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,N,,A,,CHEMBL623987,,BAO_0000218,
12008,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,N,,A,,CHEMBL623988,,BAO_0000218,
12009,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,N,,A,,CHEMBL623989,,BAO_0000218,
12010,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,N,,A,,CHEMBL622215,,BAO_0000218,
12011,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,N,,A,,CHEMBL622216,,BAO_0000218,
12012,Rattus norvegicus,50597,,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,N,,A,,CHEMBL877481,,BAO_0000218,
12013,,22224,,,1,,,Autocuration,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,U,,A,,CHEMBL622217,,BAO_0000218,
12014,Mus musculus,50594,,,1,,,Intermediate,13701,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,,A,,CHEMBL622218,,BAO_0000218,
12015,Rattus norvegicus,50597,,,1,,,Intermediate,14554,Pharmacokinetic profile AUC was evaluated in rats,,N,,A,,CHEMBL622219,,BAO_0000218,
12016,,22224,,,1,,,Autocuration,6241,Pharmacokinetic property (Area under curve),,U,,A,,CHEMBL622220,,BAO_0000019,
12017,Canis lupus familiaris,50588,,,1,,,Intermediate,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,N,,A,,CHEMBL622221,,BAO_0000218,
12018,Mus musculus,50594,,,1,,,Intermediate,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,N,,A,,CHEMBL622222,,BAO_0000218,
12019,Canis lupus familiaris,50588,,,1,,,Intermediate,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,N,,A,,CHEMBL622223,,BAO_0000218,
12020,Mus musculus,50594,,,1,,,Intermediate,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,N,,A,,CHEMBL622224,,BAO_0000218,
12021,,22224,,,1,,,Autocuration,13118,Plasma concentration (AUC) was determined,,U,,A,,CHEMBL622225,,BAO_0000019,
12022,,22224,,,1,,,Autocuration,13118,Plasma concentration (AUC) was determined; Not detectable,,U,,A,,CHEMBL622226,,BAO_0000019,
12023,Cavia porcellus,50512,,,1,,,Intermediate,9562,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,N,,A,,CHEMBL624154,,BAO_0000218,
12024,Rattus norvegicus,50597,,,1,,,Intermediate,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,N,,A,,CHEMBL624155,,BAO_0000218,
12025,Rattus norvegicus,50597,,,1,,,Intermediate,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,,A,,CHEMBL624156,,BAO_0000218,
12026,Rattus norvegicus,50597,,,1,,,Intermediate,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,N,,A,,CHEMBL624157,,BAO_0000218,
12027,Rattus norvegicus,50597,,,1,,,Intermediate,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,N,,A,,CHEMBL624158,,BAO_0000218,
12028,Rattus norvegicus,50597,,,1,,,Intermediate,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,N,,A,,CHEMBL624159,,BAO_0000218,
12029,Rattus norvegicus,50597,,,1,,,Intermediate,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,N,,A,,CHEMBL624160,,BAO_0000218,
12030,Rattus norvegicus,50597,,,1,,,Intermediate,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,N,,A,,CHEMBL624161,,BAO_0000218,
12031,Rattus norvegicus,50597,,,1,,,Intermediate,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,N,,A,,CHEMBL624162,,BAO_0000218,
12032,Canis lupus familiaris,50588,,,1,,,Intermediate,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,N,,A,,CHEMBL624163,,BAO_0000218,
12033,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL624164,,BAO_0000218,
12034,Rattus norvegicus,50597,,,1,,,Intermediate,14941,The AUC(0-infinity) values in female wistar rats.,,N,,A,,CHEMBL624165,,BAO_0000218,
12035,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL624166,,BAO_0000218,
12036,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,N,,A,,CHEMBL624167,,BAO_0000218,
12037,Rattus norvegicus,50597,,,1,,,Intermediate,14941,The AUC(0-t)values in female wistar rats.,,N,,A,,CHEMBL624168,,BAO_0000218,
12038,Rattus norvegicus,50597,,,1,,,Intermediate,14067,The Area under the concentration time curve of compound was measured on rats,,N,,A,,CHEMBL624169,,BAO_0000218,
12039,Homo sapiens,50587,,,1,,,Intermediate,14215,The area under curve (100 mg/kg) administered orally in humans,,N,,A,,CHEMBL624170,,BAO_0000218,
12040,Callithrix,22224,,,1,,,Autocuration,14215,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,U,,A,,CHEMBL624171,,BAO_0000218,
12041,Simiiformes,22224,,,1,,,Autocuration,14215,The area under curve (12.5 mg/kg) administered intravenously in monkey,,U,,A,,CHEMBL624172,,BAO_0000218,
12042,Canis lupus familiaris,50588,,,1,,,Intermediate,14215,The area under curve (15 mg/kg) administered intravenously in dog,,N,,A,,CHEMBL624173,,BAO_0000218,
12043,Homo sapiens,50587,,,1,,,Intermediate,14215,The area under curve (200 mg/kg) administered orally in humans,,N,,A,,CHEMBL877488,,BAO_0000218,
12044,Rattus norvegicus,50597,,,1,,,Intermediate,14215,The area under curve (25 mg/kg) administered intravenously in rat,,N,,A,,CHEMBL624174,,BAO_0000218,
12045,Callithrix,22224,,,1,,,Autocuration,14215,The area under curve (25 mg/kg) administered orally in marmoset,,U,,A,,CHEMBL624175,,BAO_0000218,
12046,Simiiformes,22224,,,1,,,Autocuration,14215,The area under curve (25 mg/kg) administered orally in monkey,,U,,A,,CHEMBL624176,,BAO_0000218,
12047,Canis lupus familiaris,50588,,,1,,,Intermediate,14215,The area under curve (30 mg/kg) administered orally in dog,,N,,A,,CHEMBL624177,,BAO_0000218,
12048,Homo sapiens,50587,,,1,,,Intermediate,14215,The area under curve (400 mg/kg) administered orally in humans,,N,,A,,CHEMBL624178,,BAO_0000218,
12049,Rattus norvegicus,50597,,,1,,,Intermediate,14215,The area under curve (50 mg/kg) administered orally in fasted rat,,N,,A,,CHEMBL624179,,BAO_0000218,
12050,Rattus norvegicus,50597,,,1,,,Intermediate,14215,The area under curve (50 mg/kg) administered orally in rat,,N,,A,,CHEMBL627689,,BAO_0000218,
12051,Homo sapiens,50587,,,1,,,Intermediate,14215,The area under curve (800 mg/kg) administered orally in humans,,N,,A,,CHEMBL627690,,BAO_0000218,
12052,,22224,,,1,,,Autocuration,11324,The compound was evaluated for area under the curve,,U,,A,,CHEMBL627691,,BAO_0000019,
12053,Callithrix,22224,,,1,,,Autocuration,11324,The compound was evaluated for area under the curve in marmosets,,U,,A,,CHEMBL627692,,BAO_0000019,
12054,Callithrix,22224,,,1,,,Autocuration,11324,The compound was evaluated for area under the curve in marmosets,,U,,A,,CHEMBL627693,,BAO_0000019,
12055,Rattus norvegicus,50597,,,1,,,Intermediate,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,A,,CHEMBL627694,,BAO_0000218,
12056,Rattus norvegicus,50597,,,1,,,Intermediate,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,A,,CHEMBL627695,,BAO_0000218,
12057,,22224,,,1,,,Autocuration,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,U,,A,,CHEMBL627696,,BAO_0000218,
12058,Rattus norvegicus,50597,,,1,,,Intermediate,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,A,,CHEMBL627697,,BAO_0000218,
12059,Rattus norvegicus,50597,,,1,,,Intermediate,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,A,,CHEMBL627698,,BAO_0000218,
12060,Rattus norvegicus,50597,,,1,,,Intermediate,13875,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,A,,CHEMBL627699,,BAO_0000218,
12061,Rattus norvegicus,50597,,,1,,,Intermediate,13807,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,N,,A,,CHEMBL627700,,BAO_0000218,
12062,Rattus norvegicus,50597,,,1,,,Intermediate,14127,Total drug exposure is determined after oral dosing in rats.,,N,,A,,CHEMBL627701,,BAO_0000218,
12063,,22224,,,1,,,Autocuration,15116,Total drug exposure (5 mg/kg) when administered intravenously,,U,,A,,CHEMBL627702,,BAO_0000218,
12064,,22224,,,1,,,Autocuration,15116,Total drug exposure (5 mg/kg) when administered orally,,U,,A,,CHEMBL627703,,BAO_0000218,
12065,Simiiformes,22224,,,1,,,Autocuration,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,,A,,CHEMBL626873,,BAO_0000218,
12066,Rattus norvegicus,50597,,,1,,,Intermediate,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,,A,,CHEMBL629583,,BAO_0000218,
12067,Canis lupus familiaris,50588,,,1,,,Intermediate,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,,A,,CHEMBL629584,,BAO_0000218,
12068,Canis lupus familiaris,50588,,,1,,,Intermediate,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,,A,,CHEMBL629585,,BAO_0000218,
12069,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL629586,,BAO_0000218,
12070,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL629587,,BAO_0000218,
12071,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL629588,,BAO_0000218,
12072,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL629589,,BAO_0000218,
12073,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL629590,,BAO_0000218,
12074,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL629591,,BAO_0000218,
12075,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL629592,,BAO_0000218,
12076,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL629593,,BAO_0000218,
12077,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL629594,,BAO_0000218,
12078,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL629595,,BAO_0000218,
12079,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL630290,,BAO_0000218,
12080,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL627137,,BAO_0000218,
12081,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL627138,,BAO_0000218,
12082,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL627139,,BAO_0000218,
12083,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL627140,,BAO_0000218,
12084,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13751,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL627141,,BAO_0000218,
12085,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL627142,,BAO_0000218,
12086,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL627143,,BAO_0000218,
12087,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL874449,,BAO_0000218,
12088,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL627144,,BAO_0000218,
12089,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL627145,,BAO_0000218,
12090,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL627146,,BAO_0000218,
12091,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13751,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL627147,,BAO_0000218,
12092,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL627148,,BAO_0000218,
12093,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL627149,,BAO_0000218,
12094,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL632160,,BAO_0000218,
12095,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL632161,,BAO_0000218,
12096,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL632162,,BAO_0000218,
12097,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL632163,,BAO_0000218,
12098,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL874469,,BAO_0000218,
12099,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13751,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL627182,,BAO_0000218,
12100,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,N,,A,,CHEMBL627183,,BAO_0000218,
12101,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL627184,,BAO_0000218,
12102,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL627185,,BAO_0000218,
12103,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL627186,,BAO_0000218,
12104,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL627187,,BAO_0000218,
12105,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL627188,,BAO_0000218,
12106,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13751,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL627189,,BAO_0000218,
12107,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13751,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL627190,,BAO_0000218,
12108,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,N,,A,,CHEMBL627191,,BAO_0000218,
12109,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,N,,A,,CHEMBL627192,,BAO_0000218,
12110,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,N,,A,,CHEMBL627193,,BAO_0000218,
12111,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL874590,,BAO_0000218,
12112,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627194,,BAO_0000218,
12113,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627195,,BAO_0000218,
12114,Rattus norvegicus,50597,992.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627196,,BAO_0000218,
12115,Rattus norvegicus,50597,992.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627197,,BAO_0000218,
12116,Rattus norvegicus,50597,992.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627198,,BAO_0000218,
12117,Rattus norvegicus,50597,992.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,N,,A,,CHEMBL627199,,BAO_0000218,
12118,Rattus norvegicus,50597,992.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627200,,BAO_0000218,
12119,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627201,,BAO_0000218,
12120,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627202,,BAO_0000218,
12121,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627203,,BAO_0000218,
12122,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627204,,BAO_0000218,
12123,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627205,,BAO_0000218,
12124,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627206,,BAO_0000218,
12125,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627207,,BAO_0000218,
12126,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627208,,BAO_0000218,
12127,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627209,,BAO_0000218,
12128,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627210,,BAO_0000218,
12129,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627211,,BAO_0000218,
12130,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627212,,BAO_0000218,
12131,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL627213,,BAO_0000218,
12132,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626599,,BAO_0000218,
12133,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626600,,BAO_0000218,
12134,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,10911,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,N,,A,,CHEMBL626601,,BAO_0000218,
12135,,22224,,,1,,,Autocuration,8081,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,U,,A,,CHEMBL627484,,BAO_0000019,
12136,Macaca fascicularis,100710,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,N,,A,,CHEMBL627485,,BAO_0000218,
12137,Macaca fascicularis,100710,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,N,,A,,CHEMBL628147,,BAO_0000218,
12138,Macaca fascicularis,100710,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,N,,A,,CHEMBL628148,,BAO_0000218,
12139,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,N,,A,,CHEMBL628149,,BAO_0000218,
12140,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,N,,A,,CHEMBL628150,,BAO_0000218,
12141,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,N,,A,,CHEMBL628318,,BAO_0000218,
12142,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,N,,A,,CHEMBL628319,,BAO_0000218,
12143,Canis lupus familiaris,50588,,,1,,,Intermediate,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,,A,,CHEMBL875609,,BAO_0000218,
12144,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,U,,A,,CHEMBL628320,,BAO_0000019,
12145,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,U,,A,,CHEMBL628321,,BAO_0000019,
12146,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,U,,A,,CHEMBL628322,,BAO_0000019,
12147,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,U,,A,,CHEMBL628323,,BAO_0000019,
12148,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,U,,A,,CHEMBL628324,,BAO_0000019,
12149,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,U,,A,,CHEMBL628325,,BAO_0000019,
12150,,22224,,,1,,,Autocuration,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,U,,A,,CHEMBL628326,,BAO_0000019,
12151,Canis lupus familiaris,50588,1236.0,,1,,,Intermediate,9614,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,N,,A,,CHEMBL628327,,BAO_0000218,
12152,Canis lupus familiaris,50588,1236.0,,1,,,Intermediate,9614,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,N,,A,,CHEMBL628328,,BAO_0000218,
12153,Canis lupus familiaris,50588,178.0,,1,,,Intermediate,9614,"Concentration of compound in blood of dog 1, after administering intravenously",,N,,A,,CHEMBL628329,,BAO_0000218,
12154,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,N,,A,,CHEMBL628330,,BAO_0000218,
12155,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,N,,A,,CHEMBL628331,,BAO_0000218,
12156,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,N,,A,,CHEMBL628332,,BAO_0000218,
12157,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,N,,A,,CHEMBL628333,,BAO_0000218,
12158,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,N,,A,,CHEMBL628334,,BAO_0000218,
12159,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,N,,A,,CHEMBL628335,,BAO_0000218,
12160,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,N,,A,,CHEMBL628336,,BAO_0000218,
12161,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,,A,,CHEMBL628337,,BAO_0000218,
12162,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,N,,A,,CHEMBL628338,,BAO_0000218,
12163,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,N,,A,,CHEMBL875610,,BAO_0000218,
12164,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,N,,A,,CHEMBL628339,,BAO_0000218,
12165,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,N,,A,,CHEMBL628340,,BAO_0000218,
12166,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,N,,A,,CHEMBL628341,,BAO_0000218,
12167,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,N,,A,,CHEMBL622214,,BAO_0000218,
12168,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,N,,A,,CHEMBL623167,,BAO_0000218,
12169,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,N,,A,,CHEMBL623168,,BAO_0000218,
12170,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,N,,A,,CHEMBL623169,,BAO_0000218,
12171,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,N,,A,,CHEMBL623170,,BAO_0000218,
12172,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,N,,A,,CHEMBL627224,,BAO_0000218,
12173,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,N,,A,,CHEMBL875634,,BAO_0000218,
12174,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,N,,A,,CHEMBL627225,,BAO_0000218,
12175,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,N,,A,,CHEMBL627226,,BAO_0000218,
12176,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,N,,A,,CHEMBL626083,,BAO_0000218,
12177,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,N,,A,,CHEMBL626084,,BAO_0000218,
12178,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,N,,A,,CHEMBL626085,,BAO_0000218,
12179,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,N,,A,,CHEMBL626086,,BAO_0000218,
12180,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,N,,A,,CHEMBL626087,,BAO_0000218,
12181,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,N,,A,,CHEMBL626088,,BAO_0000218,
12182,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,N,,A,,CHEMBL626089,,BAO_0000218,
12183,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,N,,A,,CHEMBL626090,,BAO_0000218,
12184,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,N,,A,,CHEMBL626091,,BAO_0000218,
12185,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,N,,A,,CHEMBL626092,,BAO_0000218,
12186,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,N,,A,,CHEMBL626093,,BAO_0000218,
12187,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,N,,A,,CHEMBL626094,,BAO_0000218,
12188,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,N,,A,,CHEMBL626095,,BAO_0000218,
12189,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,N,,A,,CHEMBL626096,,BAO_0000218,
12190,Simiiformes,22224,,,1,,,Autocuration,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,,A,,CHEMBL626097,,BAO_0000218,
12191,Rattus norvegicus,50597,,,1,,,Intermediate,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,,A,,CHEMBL626098,,BAO_0000218,
12192,,22224,1969.0,,1,,,Autocuration,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,U,,A,,CHEMBL626099,,BAO_0000218,
12193,,22224,1969.0,,1,,,Autocuration,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,U,,A,,CHEMBL626100,,BAO_0000218,
12194,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,17237,AUC 0-inf in dog,,N,,A,,CHEMBL626101,,BAO_0000218,
12195,Cavia porcellus,50512,1969.0,,1,,,Intermediate,17237,AUC 0-inf in guinea pig,,N,,A,,CHEMBL626102,,BAO_0000218,
12196,Canis lupus familiaris,50588,1969.0,,1,,,Intermediate,17237,AUC 0-t in dog,,N,,A,,CHEMBL626103,,BAO_0000218,
12197,Cavia porcellus,50512,1969.0,,1,,,Intermediate,17237,AUC 0-t in guinea pig,,N,,A,,CHEMBL628391,,BAO_0000218,
12198,Rattus norvegicus,50597,,,1,,,Intermediate,15194,The compound was tested for brain to plasma partition in rat,,N,,A,,CHEMBL628392,,BAO_0000218,
12199,Rattus norvegicus,50597,,,1,,,Intermediate,15194,The compound was tested for brain to plasma partition in rat.,,N,,A,,CHEMBL628393,,BAO_0000218,
12200,,22224,178.0,,1,,,Autocuration,8787,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,U,,A,,CHEMBL628394,,BAO_0000019,
12201,Canis lupus familiaris,50588,,,1,,,Intermediate,17025,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL628395,,BAO_0000218,
12202,Simiiformes,22224,,,1,,,Autocuration,17025,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,,A,,CHEMBL628396,,BAO_0000218,
12203,Oryctolagus cuniculus,50592,,,1,,,Intermediate,17025,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL628397,,BAO_0000218,
12204,Rattus norvegicus,50597,,,1,,,Intermediate,17025,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL628398,,BAO_0000218,
12205,Macaca mulatta,50797,,,1,,,Intermediate,4236,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,,A,,CHEMBL628399,,BAO_0000218,
12206,Canis lupus familiaris,50588,,,1,,,Intermediate,15343,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,N,,A,,CHEMBL628400,,BAO_0000218,
12207,Rattus norvegicus,50597,,,1,,,Intermediate,15343,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,N,,A,,CHEMBL874907,,BAO_0000218,
12208,,22224,,,1,,,Autocuration,17720,Area under curve of the compound was determined,,U,,A,,CHEMBL628401,,BAO_0000019,
12209,Simiiformes,22224,1969.0,,1,,,Autocuration,17788,AUC in monkeys at a dose of 1 mg/kg,,U,,A,,CHEMBL628402,,BAO_0000218,
12210,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,17788,AUC in rats at a dose of 1 mg/kg,,N,,A,,CHEMBL628403,,BAO_0000218,
12211,,22224,,,1,,,Autocuration,8778,Compound was evaluated for the overall absorbance loss at pH of 2,,U,,A,,CHEMBL628404,,BAO_0000019,
12212,,22224,,,1,,,Autocuration,8778,Compound was evaluated for the overall absorbance loss at pH of 4,,U,,A,,CHEMBL628405,,BAO_0000019,
12213,,22224,,,1,,,Autocuration,8778,Compound was evaluated for the overall absorbance loss at pH of 7,,U,,A,,CHEMBL628406,,BAO_0000019,
12214,Rattus norvegicus,50597,,,1,,,Intermediate,2249,Compound was evaluated for its absorption in the rats,,N,,A,,CHEMBL628407,,BAO_0000218,
12215,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,,A,,CHEMBL628408,,BAO_0000218,
12216,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,N,,A,,CHEMBL629171,,BAO_0000218,
12217,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,,A,,CHEMBL629172,,BAO_0000218,
12218,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,N,,A,,CHEMBL629173,,BAO_0000218,
12219,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum,,N,,A,,CHEMBL629174,,BAO_0000218,
12220,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 10-17,,N,,A,,CHEMBL629175,,BAO_0000218,
12221,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 10-18,,N,,A,,CHEMBL629176,,BAO_0000218,
12222,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 10-19,,N,,A,,CHEMBL629177,,BAO_0000218,
12223,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 12-15,,N,,A,,CHEMBL629178,,BAO_0000218,
12224,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 13-19,,N,,A,,CHEMBL631869,,BAO_0000218,
12225,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 14-17,,N,,A,,CHEMBL631870,,BAO_0000218,
12226,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 15-18,,N,,A,,CHEMBL631871,,BAO_0000218,
12227,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 2-5,,N,,A,,CHEMBL631872,,BAO_0000218,
12228,,22224,2116.0,,1,,,Autocuration,15286,In vitro percent permeability into rat ileum; Range is 23-42,,U,,A,,CHEMBL875775,,BAO_0000221,
12229,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 28-36,,N,,A,,CHEMBL631873,,BAO_0000218,
12230,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 29-35,,N,,A,,CHEMBL631874,,BAO_0000218,
12231,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 46-66,,N,,A,,CHEMBL631875,,BAO_0000218,
12232,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 50-68,,N,,A,,CHEMBL631876,,BAO_0000218,
12233,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; Range is 78-81,,N,,A,,CHEMBL631877,,BAO_0000218,
12234,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,N,,A,,CHEMBL631878,,BAO_0000218,
12235,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; nd indicates not detected,,N,,A,,CHEMBL631879,,BAO_0000218,
12236,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; nt indicates not detected,,N,,A,,CHEMBL631880,,BAO_0000218,
12237,Rattus norvegicus,50597,,,1,,,Intermediate,15286,In vitro percent permeability into rat ileum; nt indicates not tested,,N,,A,,CHEMBL631881,,BAO_0000218,
12238,Rattus norvegicus,50597,,,1,,,Intermediate,13770,Compound was tested for oral absorption in bile-duct cannulated rats,,N,,A,,CHEMBL631882,,BAO_0000218,
12239,Rattus norvegicus,50597,,,1,,,Intermediate,13770,Compound was tested for oral absorption in bile-duct cannulated rats.,,N,,A,,CHEMBL630749,,BAO_0000218,
12240,Homo sapiens,50587,,,1,,,Intermediate,5202,Oral absorption using Caco-2 cell monolayers.,,N,,A,,CHEMBL630750,,BAO_0000218,
12241,Homo sapiens,50587,,,1,,,Intermediate,14920,Percent of the drug absorbed after administration to humans was determined,,N,,A,,CHEMBL630253,,BAO_0000218,
12242,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,,A,,CHEMBL630254,,BAO_0000218,
12243,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,,A,,CHEMBL630255,,BAO_0000218,
12244,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,,A,,CHEMBL630256,,BAO_0000218,
12245,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,N,,A,,CHEMBL875781,,BAO_0000218,
12246,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,N,,A,,CHEMBL630257,,BAO_0000218,
12247,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13751,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,N,,A,,CHEMBL630258,,BAO_0000218,
12248,Rattus norvegicus,50597,,,1,,,Intermediate,15807,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,N,,A,,CHEMBL630259,,BAO_0000218,
12249,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,N,,A,,CHEMBL630260,,BAO_0000218,
12250,Rattus norvegicus,50597,2435.0,,1,,,Intermediate,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,N,,A,,CHEMBL630261,,BAO_0000218,
12251,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,N,,A,,CHEMBL630262,,BAO_0000218,
12252,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,N,,A,,CHEMBL630263,,BAO_0000218,
12253,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,N,,A,,CHEMBL630264,,BAO_0000218,
12254,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,N,,A,,CHEMBL630265,,BAO_0000218,
12255,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,N,,A,,CHEMBL630266,,BAO_0000218,
12256,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,N,,A,,CHEMBL630267,,BAO_0000218,
12257,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,N,,A,,CHEMBL630268,,BAO_0000218,
12258,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,N,,A,,CHEMBL630269,,BAO_0000218,
12259,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,N,,A,,CHEMBL630270,,BAO_0000218,
12260,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,N,,A,,CHEMBL630141,,BAO_0000218,
12261,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,N,,A,,CHEMBL630142,,BAO_0000218,
12262,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,N,,A,,CHEMBL630143,,BAO_0000218,
12263,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,N,,A,,CHEMBL630144,,BAO_0000218,
12264,Rattus norvegicus,50597,2367.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,N,,A,,CHEMBL630145,,BAO_0000218,
12265,Rattus norvegicus,50597,2367.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,N,,A,,CHEMBL630146,,BAO_0000218,
12266,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,N,,A,,CHEMBL630147,,BAO_0000218,
12267,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,N,,A,,CHEMBL630148,,BAO_0000218,
12268,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,N,,A,,CHEMBL630149,,BAO_0000218,
12269,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,N,,A,,CHEMBL630150,,BAO_0000218,
12270,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,N,,A,,CHEMBL630151,,BAO_0000218,
12271,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,N,,A,,CHEMBL632031,,BAO_0000218,
12272,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,N,,A,,CHEMBL632032,,BAO_0000218,
12273,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,N,,A,,CHEMBL632033,,BAO_0000218,
12274,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,N,,A,,CHEMBL632034,,BAO_0000218,
12275,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,N,,A,,CHEMBL632035,,BAO_0000218,
12276,Rattus norvegicus,50597,,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,N,,A,,CHEMBL632036,,BAO_0000218,
12277,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,N,,A,,CHEMBL632037,,BAO_0000218,
12278,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,,A,,CHEMBL632038,,BAO_0000218,
12279,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,,A,,CHEMBL632039,,BAO_0000218,
12280,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,,A,,CHEMBL632040,,BAO_0000218,
12281,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,,A,,CHEMBL632041,,BAO_0000218,
12282,Canis lupus familiaris,50588,178.0,,1,,,Intermediate,9614,"Concentration of compound in blood of dog 2, after administering intravenously",,N,,A,,CHEMBL632042,,BAO_0000218,
12283,Canis lupus familiaris,50588,,,1,,,Intermediate,9614,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,N,,A,,CHEMBL632043,,BAO_0000218,
12284,Canis lupus familiaris,50588,,,1,,,Intermediate,9614,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,N,,A,,CHEMBL632044,,BAO_0000218,
12285,Canis lupus familiaris,50588,2107.0,,1,,,Intermediate,9614,"Concentration of compound in liver of dog 1, after administering intravenously",,N,,A,,CHEMBL632045,,BAO_0000218,
12286,Canis lupus familiaris,50588,2107.0,,1,,,Intermediate,9614,"Concentration of compound in liver of dog 2, after administering intravenously",,N,,A,,CHEMBL632046,,BAO_0000218,
12287,Canis lupus familiaris,50588,2048.0,,1,,,Intermediate,9614,"Concentration of compound in lung of dog 1, after administering intravenously",,N,,A,,CHEMBL632047,,BAO_0000218,
12288,Canis lupus familiaris,50588,2048.0,,1,,,Intermediate,9614,"Concentration of compound in lung of dog 2, after administering intravenously",,N,,A,,CHEMBL632048,,BAO_0000218,
12289,Canis lupus familiaris,50588,2385.0,,1,,,Intermediate,9614,"Concentration of compound in muscle of dog 1, after administering intravenously",,N,,A,,CHEMBL632049,,BAO_0000218,
12290,Canis lupus familiaris,50588,2385.0,,1,,,Intermediate,9614,"Concentration of compound in muscle of dog 2, after administering intravenously",,N,,A,,CHEMBL876418,,BAO_0000218,
12291,Canis lupus familiaris,50588,2106.0,,1,,,Intermediate,9614,"Concentration of compound in spleen of dog 1,after administering intravenously",,N,,A,,CHEMBL632050,,BAO_0000218,
12292,Canis lupus familiaris,50588,2106.0,,1,,,Intermediate,9614,"Concentration of compound in spleen of dog 2, after administering intravenously",,N,,A,,CHEMBL632051,,BAO_0000218,
12293,,22224,,,1,,,Autocuration,10353,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,U,,F,,CHEMBL632052,,BAO_0000218,
12294,,22224,,,1,,,Autocuration,10353,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,U,,F,,CHEMBL632053,,BAO_0000218,
12295,,22224,,,1,,,Autocuration,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,,A,,CHEMBL632054,,BAO_0000218,
12296,,22224,,,1,,,Autocuration,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,,F,,CHEMBL632055,,BAO_0000218,
12297,,22224,,,1,,,Autocuration,10353,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,U,,F,,CHEMBL631181,,BAO_0000218,
12298,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,U,,A,,CHEMBL631182,,BAO_0000218,
12299,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,A,,CHEMBL631183,,BAO_0000218,
12300,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL631184,,BAO_0000218,
12301,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL629774,,BAO_0000218,
12302,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,A,,CHEMBL629775,,BAO_0000218,
12303,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL876549,,BAO_0000218,
12304,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL628172,,BAO_0000218,
12305,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,A,,CHEMBL628173,,BAO_0000218,
12306,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,U,,A,,CHEMBL628174,,BAO_0000218,
12307,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,U,,A,,CHEMBL628175,,BAO_0000218,
12308,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL628176,,BAO_0000218,
12309,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL628177,,BAO_0000218,
12310,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL628178,,BAO_0000218,
12311,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,A,,CHEMBL628179,,BAO_0000218,
12312,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,,A,,CHEMBL628180,,BAO_0000218,
12313,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,U,,A,,CHEMBL628181,,BAO_0000218,
12314,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL628182,,BAO_0000218,
12315,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,A,,CHEMBL628183,,BAO_0000218,
12316,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,U,,A,,CHEMBL628184,,BAO_0000218,
12317,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL628185,,BAO_0000218,
12318,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL875617,,BAO_0000218,
12319,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,,A,,CHEMBL628186,,BAO_0000218,
12320,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL628187,,BAO_0000218,
12321,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL628188,,BAO_0000218,
12322,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,,A,,CHEMBL628189,,BAO_0000218,
12323,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,U,,A,,CHEMBL628190,,BAO_0000218,
12324,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL628191,,BAO_0000218,
12325,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,U,,A,,CHEMBL626513,,BAO_0000218,
12326,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,N,,A,,CHEMBL626514,,BAO_0000218,
12327,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,N,,A,,CHEMBL626515,,BAO_0000218,
12328,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,N,,A,,CHEMBL626516,,BAO_0000218,
12329,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,N,,A,,CHEMBL626517,,BAO_0000218,
12330,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,N,,A,,CHEMBL626518,,BAO_0000218,
12331,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,N,,A,,CHEMBL626519,,BAO_0000218,
12332,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,N,,A,,CHEMBL626520,,BAO_0000218,
12333,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,N,,A,,CHEMBL626521,,BAO_0000218,
12334,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,N,,A,,CHEMBL626522,,BAO_0000218,
12335,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,N,,A,,CHEMBL626523,,BAO_0000218,
12336,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,N,,A,,CHEMBL626524,,BAO_0000218,
12337,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,N,,A,,CHEMBL626688,,BAO_0000218,
12338,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,N,,A,,CHEMBL626689,,BAO_0000218,
12339,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,N,,A,,CHEMBL626690,,BAO_0000218,
12340,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,N,,A,,CHEMBL626691,,BAO_0000218,
12341,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,N,,A,,CHEMBL627319,,BAO_0000218,
12342,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,N,,A,,CHEMBL624052,,BAO_0000218,
12343,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,N,,A,,CHEMBL624053,,BAO_0000218,
12344,Rattus norvegicus,50597,,,1,,,Intermediate,8085,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL624054,,BAO_0000218,
12345,Rattus norvegicus,50597,,,1,,,Intermediate,8085,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL624055,,BAO_0000218,
12346,Rattus norvegicus,50597,,,1,,,Intermediate,8085,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL624056,,BAO_0000218,
12347,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL624057,,BAO_0000218,
12348,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL622281,,BAO_0000218,
12349,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL622282,,BAO_0000218,
12350,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL622283,,BAO_0000218,
12351,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL622284,,BAO_0000218,
12352,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL622285,,BAO_0000218,
12353,Rattus norvegicus,50597,995.0,,1,,,Intermediate,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,A,,CHEMBL622286,,BAO_0000218,
12354,,22224,,,1,,,Autocuration,7657,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,U,,P,,CHEMBL622287,,BAO_0000100,
12355,Mus musculus,50594,,,1,,,Intermediate,8935,Partition coefficient (logD7.4),,N,,A,,CHEMBL622288,,BAO_0000218,
12356,Mus musculus,50594,,,1,,,Intermediate,13792,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,,A,,CHEMBL622289,,BAO_0000218,
12357,Mus musculus,50594,955.0,,1,,,Intermediate,13792,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,,A,,CHEMBL622290,,BAO_0000218,
12358,Mus musculus,50594,,,1,,,Intermediate,13792,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,,A,,CHEMBL622291,,BAO_0000218,
12359,Mus musculus,50594,955.0,,1,,,Intermediate,13792,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,,A,,CHEMBL622292,,BAO_0000218,
12360,Mus musculus,50594,,,1,,,Intermediate,13792,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,,A,,CHEMBL622293,,BAO_0000218,
12361,Mus musculus,50594,955.0,,1,,,Intermediate,13792,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,,A,,CHEMBL622294,,BAO_0000218,
12362,Mus musculus,50594,,,1,,,Intermediate,13792,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,,A,,CHEMBL622295,,BAO_0000218,
12363,Rattus norvegicus,50597,955.0,,1,,,Intermediate,13792,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,,A,,CHEMBL622296,,BAO_0000218,
12364,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,N,,A,,CHEMBL874409,,BAO_0000218,
12365,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,,A,,CHEMBL622297,,BAO_0000218,
12366,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,,A,,CHEMBL622298,,BAO_0000218,
12367,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,,A,,CHEMBL622299,,BAO_0000218,
12368,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,,A,,CHEMBL622300,,BAO_0000218,
12369,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,,A,,CHEMBL622301,,BAO_0000218,
12370,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,,A,,CHEMBL622302,,BAO_0000218,
12371,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,,A,,CHEMBL622303,,BAO_0000218,
12372,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,,A,,CHEMBL622304,,BAO_0000218,
12373,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,N,,A,,CHEMBL622305,,BAO_0000218,
12374,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,,A,,CHEMBL622306,,BAO_0000218,
12375,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,N,,A,,CHEMBL626864,,BAO_0000218,
12376,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,,A,,CHEMBL626865,,BAO_0000218,
12377,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,N,,A,,CHEMBL626866,,BAO_0000218,
12378,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,,A,,CHEMBL626867,,BAO_0000218,
12379,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,,A,,CHEMBL626868,,BAO_0000218,
12380,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,N,,A,,CHEMBL626869,,BAO_0000218,
12381,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,,A,,CHEMBL626870,,BAO_0000218,
12382,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,N,,A,,CHEMBL626871,,BAO_0000218,
12383,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,,A,,CHEMBL626872,,BAO_0000218,
12384,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,,A,,CHEMBL632185,,BAO_0000218,
12385,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,N,,A,,CHEMBL632186,,BAO_0000218,
12386,,22224,,,1,,,Autocuration,12904,Amount of acetic acid produced by the compound,,U,,A,,CHEMBL629310,,BAO_0000019,
12387,,22224,,,1,,,Autocuration,12904,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,U,,A,,CHEMBL629311,,BAO_0000019,
12388,Rattus norvegicus,50597,,,1,,,Intermediate,9663,Log of (Cbrain/Cblood) in rats,,N,,A,,CHEMBL629312,,BAO_0000218,
12389,,22224,,,1,,,Autocuration,7652,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,,A,,CHEMBL629313,,BAO_0000221,
12390,,22224,,,1,,,Autocuration,7652,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,A,,CHEMBL629314,,BAO_0000221,
12391,,22224,,,1,,,Autocuration,7652,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,,A,,CHEMBL629315,,BAO_0000221,
12392,,22224,,,1,,,Autocuration,7652,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,U,,B,,CHEMBL629316,,BAO_0000219,
12393,,22224,,,1,,,Autocuration,7652,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,A,,CHEMBL629317,,BAO_0000221,
12394,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,,A,,CHEMBL629318,,BAO_0000019,
12395,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,U,,A,,CHEMBL877497,,BAO_0000019,
12396,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,U,,A,,CHEMBL629319,,BAO_0000019,
12397,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,A,,CHEMBL629320,,BAO_0000019,
12398,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,U,,A,,CHEMBL629496,,BAO_0000019,
12399,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,U,,A,,CHEMBL629497,,BAO_0000019,
12400,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,U,,A,,CHEMBL629498,,BAO_0000019,
12401,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,U,,A,,CHEMBL629499,,BAO_0000019,
12402,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,,A,,CHEMBL629500,,BAO_0000019,
12403,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,U,,A,,CHEMBL629501,,BAO_0000019,
12404,,22224,,,1,,,Autocuration,7652,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,U,,A,,CHEMBL629502,,BAO_0000019,
12405,,22224,,,1,In vivo,,Autocuration,8267,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,U,,F,,CHEMBL629503,,BAO_0000218,
12406,Canis lupus familiaris,50588,,,1,,,Intermediate,8267,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,N,,A,,CHEMBL629504,,BAO_0000218,
12407,,22224,,,1,,,Autocuration,14479,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,U,,A,,CHEMBL629505,,BAO_0000019,
12408,,22224,,,1,,,Autocuration,17515,Compound was evaluated for total body clearance,,U,,A,,CHEMBL629506,,BAO_0000019,
12409,,22224,,,1,,,Autocuration,17515,Compound was evaluated for volume of distribution at steady state,,U,,A,,CHEMBL629507,,BAO_0000019,
12410,,22224,,,1,,,Autocuration,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,U,,A,,CHEMBL877498,,BAO_0000019,
12411,,22224,,,1,,,Autocuration,14849,Percentage of the diamine which is monoprotonated at pH 7.4,,U,,A,,CHEMBL629508,,BAO_0000019,
12412,,22224,,,1,,,Autocuration,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,U,,A,,CHEMBL629509,,BAO_0000019,
12413,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,,A,,CHEMBL629510,,BAO_0000218,
12414,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,,A,,CHEMBL629511,,BAO_0000218,
12415,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,,A,,CHEMBL629512,,BAO_0000218,
12416,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,,A,,CHEMBL629513,,BAO_0000218,
12417,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,,A,,CHEMBL629514,,BAO_0000218,
12418,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,,A,,CHEMBL628447,,BAO_0000218,
12419,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,,A,,CHEMBL628448,,BAO_0000218,
12420,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,,A,,CHEMBL628449,,BAO_0000218,
12421,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,,A,,CHEMBL631119,,BAO_0000218,
12422,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,,A,,CHEMBL631120,,BAO_0000218,
12423,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,,A,,CHEMBL631121,,BAO_0000218,
12424,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,N,,A,,CHEMBL874458,,BAO_0000218,
12425,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,,A,,CHEMBL631122,,BAO_0000218,
12426,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,,A,,CHEMBL631123,,BAO_0000218,
12427,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,,A,,CHEMBL631124,,BAO_0000218,
12428,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,,A,,CHEMBL631125,,BAO_0000218,
12429,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,,A,,CHEMBL631290,,BAO_0000218,
12430,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,,A,,CHEMBL631291,,BAO_0000218,
12431,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,,A,,CHEMBL631292,,BAO_0000218,
12432,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,,A,,CHEMBL631293,,BAO_0000218,
12433,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,,A,,CHEMBL631294,,BAO_0000218,
12434,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,,A,,CHEMBL631295,,BAO_0000218,
12435,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,,A,,CHEMBL631296,,BAO_0000218,
12436,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,,A,,CHEMBL631297,,BAO_0000218,
12437,,22224,,,1,,,Autocuration,10263,Maximum biodistribution (Bmax) was determined.,,U,,A,,CHEMBL631298,,BAO_0000218,
12438,Mus musculus,50594,,,1,,,Intermediate,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,N,,A,,CHEMBL631299,,BAO_0000218,
12439,Mus musculus,50594,,,1,,,Intermediate,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,N,,A,,CHEMBL631300,,BAO_0000218,
12440,Mus musculus,50594,,,1,,,Intermediate,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,N,,A,,CHEMBL631301,,BAO_0000218,
12441,Mus musculus,50594,,,1,,,Intermediate,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,N,,A,,CHEMBL630291,,BAO_0000218,
12442,,22224,,,1,,,Autocuration,14793,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,A,,CHEMBL630292,,BAO_0000218,
12443,,22224,,,1,,,Autocuration,14793,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,U,,A,,CHEMBL630293,,BAO_0000218,
12444,,22224,,,1,,,Autocuration,14793,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,U,,A,,CHEMBL630294,,BAO_0000218,
12445,,22224,,,1,,,Autocuration,14793,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,U,,A,,CHEMBL630295,,BAO_0000218,
12446,,22224,,,1,,,Autocuration,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,U,,A,,CHEMBL630296,,BAO_0000218,
12447,,22224,,,1,,,Autocuration,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,U,,A,,CHEMBL626782,,BAO_0000218,
12448,,22224,,,1,,,Autocuration,14793,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,U,,A,,CHEMBL626783,,BAO_0000218,
12449,,22224,,,1,,,Autocuration,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,A,,CHEMBL626784,,BAO_0000218,
12450,,22224,,,1,,,Autocuration,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,U,,A,,CHEMBL626785,,BAO_0000218,
12451,,22224,,,1,,,Autocuration,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,U,,A,,CHEMBL626786,,BAO_0000218,
12452,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL626787,,BAO_0000218,
12453,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,,A,,CHEMBL626788,,BAO_0000218,
12454,,22224,,,1,,,Autocuration,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL625927,,BAO_0000218,
12455,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL625928,,BAO_0000218,
12456,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,,A,,CHEMBL625929,,BAO_0000218,
12457,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,,A,,CHEMBL625930,,BAO_0000218,
12458,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,N,,A,,CHEMBL625931,,BAO_0000218,
12459,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,N,,A,,CHEMBL627230,,BAO_0000218,
12460,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627231,,BAO_0000218,
12461,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,,A,,CHEMBL627232,,BAO_0000218,
12462,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,,A,,CHEMBL627233,,BAO_0000218,
12463,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL875470,,BAO_0000218,
12464,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627234,,BAO_0000218,
12465,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627235,,BAO_0000218,
12466,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627236,,BAO_0000218,
12467,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627237,,BAO_0000218,
12468,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627238,,BAO_0000218,
12469,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627239,,BAO_0000218,
12470,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627240,,BAO_0000218,
12471,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627241,,BAO_0000218,
12472,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627242,,BAO_0000218,
12473,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,N,,A,,CHEMBL627243,,BAO_0000218,
12474,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,,A,,CHEMBL627244,,BAO_0000218,
12475,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627245,,BAO_0000218,
12476,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627246,,BAO_0000218,
12477,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627247,,BAO_0000218,
12478,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627248,,BAO_0000218,
12479,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627249,,BAO_0000218,
12480,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL625569,,BAO_0000218,
12481,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL625570,,BAO_0000218,
12482,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL625571,,BAO_0000218,
12483,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,,A,,CHEMBL625572,,BAO_0000218,
12484,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,,A,,CHEMBL625573,,BAO_0000218,
12485,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,N,,A,,CHEMBL625574,,BAO_0000218,
12486,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,,A,,CHEMBL626245,,BAO_0000218,
12487,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL626246,,BAO_0000218,
12488,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL626247,,BAO_0000218,
12489,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,A,,CHEMBL626248,,BAO_0000218,
12490,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,,A,,CHEMBL626249,,BAO_0000218,
12491,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL626420,,BAO_0000218,
12492,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,A,,CHEMBL626421,,BAO_0000218,
12493,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,A,,CHEMBL626422,,BAO_0000218,
12494,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL626423,,BAO_0000218,
12495,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL626424,,BAO_0000218,
12496,Canis lupus familiaris,50588,,,1,,,Intermediate,12023,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,N,,A,,CHEMBL626425,,BAO_0000218,
12497,Rattus norvegicus,50597,,,1,,,Intermediate,12023,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,N,,A,,CHEMBL875476,,BAO_0000218,
12498,Macaca fascicularis,100710,,,1,,,Intermediate,12023,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,N,,A,,CHEMBL626426,,BAO_0000218,
12499,,22224,,,1,,,Autocuration,10580,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,,P,,CHEMBL626427,,BAO_0000100,
12500,,22224,,,1,,,Autocuration,10580,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,,P,,CHEMBL626428,,BAO_0000100,
12501,,22224,,,1,,,Autocuration,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,U,,A,,CHEMBL626429,,BAO_0000019,
12502,,22224,1088.0,,1,,,Autocuration,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,U,,A,,CHEMBL625025,,BAO_0000019,
12503,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL625026,,BAO_0000218,
12504,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL625027,,BAO_0000218,
12505,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL874410,,BAO_0000218,
12506,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL625028,,BAO_0000218,
12507,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL625029,,BAO_0000218,
12508,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL625030,,BAO_0000218,
12509,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL625031,,BAO_0000218,
12510,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL625032,,BAO_0000218,
12511,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL625033,,BAO_0000218,
12512,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL625034,,BAO_0000218,
12513,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624872,,BAO_0000218,
12514,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL624873,,BAO_0000218,
12515,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624874,,BAO_0000218,
12516,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL624875,,BAO_0000218,
12517,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL624876,,BAO_0000218,
12518,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624877,,BAO_0000218,
12519,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624878,,BAO_0000218,
12520,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624879,,BAO_0000218,
12521,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624880,,BAO_0000218,
12522,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,N,,A,,CHEMBL624881,,BAO_0000218,
12523,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,N,,A,,CHEMBL624882,,BAO_0000218,
12524,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624883,,BAO_0000218,
12525,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624884,,BAO_0000218,
12526,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624885,,BAO_0000218,
12527,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL624886,,BAO_0000218,
12528,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL624887,,BAO_0000218,
12529,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624888,,BAO_0000218,
12530,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624889,,BAO_0000218,
12531,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624890,,BAO_0000218,
12532,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL621964,,BAO_0000218,
12533,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL621965,,BAO_0000218,
12534,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL621966,,BAO_0000218,
12535,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL621967,,BAO_0000218,
12536,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL622164,,BAO_0000218,
12537,,22224,,,1,,,Autocuration,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,U,,A,,CHEMBL623097,,BAO_0000019,
12538,,22224,,,1,,,Autocuration,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,U,,A,,CHEMBL623098,,BAO_0000019,
12539,,22224,,,1,,,Autocuration,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,U,,A,,CHEMBL623099,,BAO_0000019,
12540,,22224,,,1,,,Autocuration,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,U,,A,,CHEMBL623100,,BAO_0000019,
12541,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,N,,A,,CHEMBL628673,,BAO_0000218,
12542,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,N,,A,,CHEMBL628674,,BAO_0000218,
12543,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,N,,A,,CHEMBL628675,,BAO_0000218,
12544,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,N,,A,,CHEMBL627644,,BAO_0000218,
12545,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,N,,A,,CHEMBL627645,,BAO_0000218,
12546,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,N,,A,,CHEMBL627646,,BAO_0000218,
12547,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,N,,A,,CHEMBL627647,,BAO_0000218,
12548,Rattus norvegicus,50597,,,1,,,Intermediate,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,N,,A,,CHEMBL627648,,BAO_0000218,
12549,Rattus norvegicus,50597,,,1,,,Intermediate,12902,Free level in rat plasma,,N,,A,,CHEMBL627649,,BAO_0000218,
12550,,22224,,,1,,,Autocuration,6614,Level reaching in blood plasma of rat or human was determined,,U,,A,,CHEMBL628313,,BAO_0000019,
12551,Rattus norvegicus,50597,,,1,,,Intermediate,9663,Log (Cbrain/Cblood) in rats,,N,,A,,CHEMBL628314,,BAO_0000218,
12552,,22224,,,1,,,Autocuration,17658,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,U,,A,,CHEMBL628315,,BAO_0000019,
12553,,22224,,,1,,,Autocuration,17658,Mean percentage of compound transport through membrane; expressed as membrane transport,,U,,A,,CHEMBL628316,,BAO_0000019,
12554,,22224,,,1,,,Autocuration,14314,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,U,,A,,CHEMBL628317,,BAO_0000218,
12555,,22224,,,1,,,Autocuration,7385,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,U,,A,,CHEMBL628473,,BAO_0000019,
12556,,22224,,,1,,,Autocuration,7385,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,U,,A,,CHEMBL628474,,BAO_0000019,
12557,,22224,,,1,,,Autocuration,7385,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,U,,A,,CHEMBL628475,,BAO_0000019,
12558,,22224,,,1,,,Autocuration,1329,Net water uptake by a carrier mediated transport (%cm) mechanism,,U,,A,,CHEMBL628476,,BAO_0000019,
12559,Simiiformes,22224,,,1,,,Autocuration,12187,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,A,,CHEMBL628477,,BAO_0000218,
12560,Mustela putorius furo,50506,,,1,,,Intermediate,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,,A,,CHEMBL628478,,BAO_0000218,
12561,Mustela putorius furo,50506,,,1,,,Intermediate,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,,A,,CHEMBL628479,,BAO_0000218,
12562,Simiiformes,22224,,,1,,,Autocuration,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,A,,CHEMBL628480,,BAO_0000218,
12563,Simiiformes,22224,,,1,,,Autocuration,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,U,,A,,CHEMBL628481,,BAO_0000218,
12564,Rattus norvegicus,50597,,,1,,,Intermediate,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,,A,,CHEMBL628482,,BAO_0000218,
12565,Rattus norvegicus,50597,,,1,,,Intermediate,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,,A,,CHEMBL628483,,BAO_0000218,
12566,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,,A,,CHEMBL628484,,BAO_0000218,
12567,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,,A,,CHEMBL628485,,BAO_0000218,
12568,Macaca fascicularis,100710,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,N,,A,,CHEMBL628486,,BAO_0000218,
12569,Homo sapiens,50587,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,N,,A,,CHEMBL628487,,BAO_0000218,
12570,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,,A,,CHEMBL628488,,BAO_0000218,
12571,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,,A,,CHEMBL628489,,BAO_0000218,
12572,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,9278,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,,A,,CHEMBL628490,,BAO_0000218,
12573,Macaca fascicularis,100710,,,1,,,Intermediate,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,A,,CHEMBL628491,,BAO_0000218,
12574,Macaca fascicularis,100710,,,1,,,Intermediate,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,A,,CHEMBL877507,,BAO_0000218,
12575,,22224,,,1,,,Autocuration,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,U,,A,,CHEMBL628492,,BAO_0000218,
12576,Simiiformes,22224,,,1,,,Autocuration,12041,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,U,,A,,CHEMBL628493,,BAO_0000019,
12577,Simiiformes,22224,,,1,,,Autocuration,12041,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,U,,A,,CHEMBL628494,,BAO_0000019,
12578,Simiiformes,22224,,,1,,,Autocuration,12041,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,U,,A,,CHEMBL628495,,BAO_0000019,
12579,Homo sapiens,50587,,,1,,,Intermediate,6737,Permeability in Caco-2 assay at 10E-6,,N,,A,,CHEMBL628496,,BAO_0000218,
12580,,22224,955.0,,1,,,Autocuration,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,,A,,CHEMBL628497,,BAO_0000218,
12581,,22224,955.0,,1,,,Autocuration,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,,A,,CHEMBL628498,,BAO_0000218,
12582,,22224,,,1,,,Autocuration,5676,Plasma protein binding was determined,,U,,A,,CHEMBL628499,,BAO_0000019,
12583,,22224,,,1,,,Autocuration,14793,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,U,,A,,CHEMBL627656,,BAO_0000218,
12584,,22224,,,1,,,Autocuration,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,A,,CHEMBL627657,,BAO_0000218,
12585,,22224,,,1,,,Autocuration,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,U,,A,,CHEMBL626808,,BAO_0000218,
12586,,22224,,,1,,,Autocuration,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,U,,A,,CHEMBL626809,,BAO_0000218,
12587,,22224,,,1,,,Autocuration,14793,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,U,,A,,CHEMBL626810,,BAO_0000218,
12588,,22224,,,1,,,Autocuration,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,A,,CHEMBL626811,,BAO_0000218,
12589,,22224,,,1,,,Autocuration,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,U,,A,,CHEMBL874465,,BAO_0000218,
12590,,22224,,,1,,,Autocuration,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,U,,A,,CHEMBL626812,,BAO_0000218,
12591,,22224,,,1,,,Autocuration,14793,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,U,,A,,CHEMBL626813,,BAO_0000218,
12592,,22224,,,1,,,Autocuration,14793,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,U,,A,,CHEMBL626814,,BAO_0000218,
12593,,22224,,,1,,,Autocuration,14000,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,U,,A,,CHEMBL626815,,BAO_0000019,
12594,,22224,,,1,,,Autocuration,5948,Partition coefficient (logP),,U,,A,,CHEMBL628566,,BAO_0000019,
12595,,22229,,,1,,,Autocuration,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,P,,CHEMBL628567,,BAO_0000100,
12596,,22229,,,1,,,Autocuration,10778,Calculated partition coefficient (clogP),,U,,P,,CHEMBL628568,,BAO_0000100,
12597,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,17237,C max in dog,,N,,A,,CHEMBL628569,,BAO_0000218,
12598,Cavia porcellus,50512,,,1,In vivo,,Intermediate,17237,C max in guinea pig,,N,,A,,CHEMBL628570,,BAO_0000218,
12599,,22224,,,1,In vivo,,Autocuration,2809,C max value was evaluated,,U,,A,,CHEMBL628571,,BAO_0000218,
12600,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 0.1 mg//kg,,U,,A,,CHEMBL628572,,BAO_0000218,
12601,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 0.3 mg/kg,,U,,A,,CHEMBL628573,,BAO_0000218,
12602,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 1 mg/kg,,U,,A,,CHEMBL628574,,BAO_0000218,
12603,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 10 mg/kg,,U,,A,,CHEMBL628575,,BAO_0000218,
12604,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 23.4 mg/kg,,U,,A,,CHEMBL628576,,BAO_0000218,
12605,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 3 mg/kg,,U,,A,,CHEMBL628577,,BAO_0000218,
12606,,22224,,,1,In vivo,,Autocuration,11954,Cmax value after oral dose of 3.87 mg/kg,,U,,A,,CHEMBL628578,,BAO_0000218,
12607,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,12768,Cmax value in female Beagle dogs,,N,,A,,CHEMBL874466,,BAO_0000218,
12608,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12768,Cmax value in male rats,,N,,A,,CHEMBL628579,,BAO_0000218,
12609,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,12780,Cmax value in rat plasma when administered 20 mg/kg perorally,,N,,A,,CHEMBL628580,,BAO_0000218,
12610,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,,A,,CHEMBL628581,,BAO_0000218,
12611,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,,A,,CHEMBL628582,,BAO_0000218,
12612,Canis lupus familiaris,50588,,,1,,,Intermediate,17025,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL628583,,BAO_0000218,
12613,Simiiformes,22224,,,1,,,Autocuration,17025,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,U,,A,,CHEMBL625782,,BAO_0000218,
12614,Oryctolagus cuniculus,50592,,,1,,,Intermediate,17025,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL625783,,BAO_0000218,
12615,Rattus norvegicus,50597,,,1,,,Intermediate,17025,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL625784,,BAO_0000218,
12616,Macaca mulatta,50797,1969.0,,1,,,Intermediate,4236,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,,A,,CHEMBL625785,,BAO_0000218,
12617,Rattus norvegicus,50597,,,1,,,Intermediate,15791,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,N,,A,,CHEMBL625786,,BAO_0000218,
12618,,22224,,,1,,,Autocuration,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,U,,A,,CHEMBL874467,,BAO_0000019,
12619,Canis lupus familiaris,50588,,,1,,,Intermediate,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,,A,,CHEMBL625787,,BAO_0000218,
12620,Human immunodeficiency virus,50677,,,1,,,Intermediate,15778,cytotoxicity against HIV protease enzyme.,,N,,A,,CHEMBL625964,,BAO_0000218,
12621,Mus musculus,50594,,,1,,,Intermediate,12745,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,N,,A,,CHEMBL625965,,BAO_0000218,
12622,Mus musculus,50594,,,1,,,Intermediate,12745,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,N,,A,,CHEMBL625966,,BAO_0000218,
12623,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,13941,The plasma clearance in dog.,,N,,A,,CHEMBL625967,,BAO_0000218,
12624,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,13941,The plasma clearance in rat.,,N,,A,,CHEMBL625968,,BAO_0000218,
12625,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,16449,Clearance from plasma in male Sprague-Dawley rats,,N,,A,,CHEMBL625969,,BAO_0000218,
12626,Macaca fascicularis,100710,1969.0,,1,In vivo,,Intermediate,16449,Clearance from plasma in male cynomolgus monkeys,,N,,A,,CHEMBL625970,,BAO_0000218,
12627,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,N,,A,,CHEMBL625971,,BAO_0000218,
12628,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,Clearance of compound in dog plasma,,N,,A,,CHEMBL625972,,BAO_0000218,
12629,Homo sapiens,50587,1969.0,,1,In vivo,,Intermediate,14224,Clearance of compound in human plasma,,N,,A,,CHEMBL625973,,BAO_0000218,
12630,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14317,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,N,,A,,CHEMBL625974,,BAO_0000218,
12631,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14317,Clearance of compound when administered intravenously as an individual dose to a single dog.,,N,,A,,CHEMBL625975,,BAO_0000218,
12632,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14224,"Clearance (10 mg/kg, intravenously) in dog plasma",,N,,A,,CHEMBL625976,,BAO_0000218,
12633,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,17237,Clearance value in dog,,N,,A,,CHEMBL625977,,BAO_0000218,
12634,Cavia porcellus,50512,,,1,In vivo,,Intermediate,17237,Clearance value in guinea pig,,N,,A,,CHEMBL625978,,BAO_0000218,
12635,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14187,Clearance values in rats after iv administration.,,N,,A,,CHEMBL874468,,BAO_0000218,
12636,,22224,1969.0,,1,In vivo,,Autocuration,4806,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,U,,A,,CHEMBL625421,,BAO_0000218,
12637,Oryctolagus cuniculus,50592,,,1,In vivo,,Intermediate,15025,In vivo clearance (5 mg/kg) was determined in rabbits,,N,,A,,CHEMBL625422,,BAO_0000218,
12638,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13197,Plasma Clearance rate was determined for the compound in rats,,N,,A,,CHEMBL625423,,BAO_0000218,
12639,Saimiri,22224,,,1,In vivo,,Autocuration,13197,Plasma Clearance rate was determined for the compound in squirrel monkeys,,U,,A,,CHEMBL625424,,BAO_0000218,
12640,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13960,Plasma clearance in rat,,N,,A,,CHEMBL625425,,BAO_0000218,
12641,,22224,,,1,In vivo,,Autocuration,17820,Plasma clearance of the compound,,U,,A,,CHEMBL625426,,BAO_0000218,
12642,Cavia porcellus,50512,,,1,In vivo,,Intermediate,14706,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,N,,A,,CHEMBL625427,,BAO_0000218,
12643,Cavia porcellus,50512,,,1,In vivo,,Intermediate,14706,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,N,,A,,CHEMBL625428,,BAO_0000218,
12644,,22224,,,1,In vivo,,Autocuration,6504,Plasma clearance was determined,,U,,A,,CHEMBL625429,,BAO_0000218,
12645,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14925,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,N,,A,,CHEMBL625430,,BAO_0000218,
12646,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13197,Plasma clearance rate was determined for the compound in rats,,N,,A,,CHEMBL625431,,BAO_0000218,
12647,Saimiri,22224,,,1,In vivo,,Autocuration,13197,Plasma clearance rate was determined for the compound in squirrel monkeys,,U,,A,,CHEMBL627307,,BAO_0000218,
12648,,22224,,,1,In vivo,,Autocuration,3437,Slow clearance (CL) was determined,,U,,A,,CHEMBL627308,,BAO_0000218,
12649,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL627309,,BAO_0000218,
12650,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,,A,,CHEMBL627310,,BAO_0000218,
12651,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,,A,,CHEMBL627311,,BAO_0000218,
12652,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL627312,,BAO_0000218,
12653,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,,A,,CHEMBL627313,,BAO_0000218,
12654,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,A,,CHEMBL627314,,BAO_0000218,
12655,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL627315,,BAO_0000218,
12656,,22224,,,1,,,Autocuration,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL627316,,BAO_0000218,
12657,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,A,,CHEMBL627317,,BAO_0000218,
12658,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,A,,CHEMBL627318,,BAO_0000218,
12659,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,,A,,CHEMBL627999,,BAO_0000218,
12660,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,A,,CHEMBL628000,,BAO_0000218,
12661,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,A,,CHEMBL628001,,BAO_0000218,
12662,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL628002,,BAO_0000218,
12663,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,A,,CHEMBL625610,,BAO_0000218,
12664,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL625611,,BAO_0000218,
12665,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,,A,,CHEMBL625612,,BAO_0000218,
12666,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,,A,,CHEMBL625613,,BAO_0000218,
12667,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,A,,CHEMBL875479,,BAO_0000218,
12668,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,A,,CHEMBL625614,,BAO_0000218,
12669,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,A,,CHEMBL625615,,BAO_0000218,
12670,,22224,,,1,,,Autocuration,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,,A,,CHEMBL626302,,BAO_0000218,
12671,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL626303,,BAO_0000218,
12672,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,,A,,CHEMBL627420,,BAO_0000218,
12673,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,N,,A,,CHEMBL627421,,BAO_0000218,
12674,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,N,,A,,CHEMBL625695,,BAO_0000218,
12675,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,N,,A,,CHEMBL625696,,BAO_0000218,
12676,Mus musculus,50594,955.0,,1,,,Intermediate,10009,Distribution of compound in mice brain was measured after 1 hr,,N,,A,,CHEMBL875606,,BAO_0000218,
12677,Mus musculus,50594,955.0,,1,,,Intermediate,10009,Distribution of compound in mice brain was measured after 24 hr r,,N,,A,,CHEMBL625697,,BAO_0000218,
12678,Mus musculus,50594,955.0,,1,,,Intermediate,10009,Distribution of compound in mice brain was measured after 2 hr,,N,,A,,CHEMBL625698,,BAO_0000218,
12679,Mus musculus,50594,955.0,,1,,,Intermediate,10009,Distribution of compound in mice brain was measured after 3 hr,,N,,A,,CHEMBL625699,,BAO_0000218,
12680,Mus musculus,50594,955.0,,1,,,Intermediate,10009,Distribution of compound in mice brain was measured after 6 hr,,N,,A,,CHEMBL625700,,BAO_0000218,
12681,Mus musculus,50594,,,1,,,Intermediate,10009,Distribution of compound in mice liver was measured after 1 hr,,N,,A,,CHEMBL625701,,BAO_0000218,
12682,Mus musculus,50594,,,1,,,Intermediate,10009,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,N,,A,,CHEMBL625702,,BAO_0000218,
12683,Mus musculus,50594,,,1,,,Intermediate,10009,Distribution of compound in mice liver was measured after 2 hr,,N,,A,,CHEMBL625703,,BAO_0000218,
12684,Mus musculus,50594,,,1,,,Intermediate,10009,Distribution of compound in mice liver was measured after 3 hr,,N,,A,,CHEMBL625704,,BAO_0000218,
12685,Mus musculus,50594,,,1,,,Intermediate,10009,Distribution of compound in mice liver was measured after 6 hr,,N,,A,,CHEMBL625705,,BAO_0000218,
12686,Canis lupus familiaris,50588,1236.0,,1,,,Intermediate,8170,Distribution in dog adrenal medulla 30 min after administration.,,N,,A,,CHEMBL625706,,BAO_0000218,
12687,Canis lupus familiaris,50588,1236.0,,1,,,Intermediate,8170,Distribution in dog adrenal medulla 72 hours after administration.,,N,,A,,CHEMBL625707,,BAO_0000218,
12688,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog Ovary 24 hours after administration.,,N,,A,,CHEMBL625708,,BAO_0000218,
12689,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog Ovary 72 hours after administration.,,N,,A,,CHEMBL625709,,BAO_0000218,
12690,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog adipose 24 hours after administration.,,N,,A,,CHEMBL624180,,BAO_0000218,
12691,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog adipose 72 hours after administration.,,N,,A,,CHEMBL624181,,BAO_0000218,
12692,Canis lupus familiaris,50588,1235.0,,1,,,Intermediate,8170,Distribution in female dog adrenal cortex 72 hours after administration.,,N,,A,,CHEMBL624182,,BAO_0000218,
12693,Canis lupus familiaris,50588,1235.0,,1,,,Intermediate,8170,Distribution in female dog adrenal cortex 72 hours after administration.,,N,,A,,CHEMBL624183,,BAO_0000218,
12694,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL624184,,BAO_0000218,
12695,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL877489,,BAO_0000218,
12696,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624185,,BAO_0000218,
12697,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624186,,BAO_0000218,
12698,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624187,,BAO_0000218,
12699,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624188,,BAO_0000218,
12700,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624189,,BAO_0000218,
12701,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624190,,BAO_0000218,
12702,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624191,,BAO_0000218,
12703,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624192,,BAO_0000218,
12704,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL624193,,BAO_0000218,
12705,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL624194,,BAO_0000218,
12706,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624891,,BAO_0000218,
12707,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL624892,,BAO_0000218,
12708,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL624893,,BAO_0000218,
12709,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL627632,,BAO_0000218,
12710,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL627633,,BAO_0000218,
12711,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL627634,,BAO_0000218,
12712,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL627635,,BAO_0000218,
12713,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL627636,,BAO_0000218,
12714,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL626816,,BAO_0000218,
12715,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL626817,,BAO_0000218,
12716,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL626818,,BAO_0000218,
12717,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626819,,BAO_0000218,
12718,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL626820,,BAO_0000218,
12719,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626821,,BAO_0000218,
12720,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626822,,BAO_0000218,
12721,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626823,,BAO_0000218,
12722,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL626824,,BAO_0000218,
12723,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626825,,BAO_0000218,
12724,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,A,,CHEMBL626826,,BAO_0000218,
12725,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,A,,CHEMBL626827,,BAO_0000218,
12726,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL626828,,BAO_0000218,
12727,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626829,,BAO_0000218,
12728,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL626830,,BAO_0000218,
12729,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL627150,,BAO_0000218,
12730,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL627151,,BAO_0000218,
12731,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,A,,CHEMBL627152,,BAO_0000218,
12732,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,A,,CHEMBL627153,,BAO_0000218,
12733,,22224,,,1,,,Autocuration,12904,Rate of acetate production by the compound was determined,,U,,A,,CHEMBL627154,,BAO_0000019,
12734,,22224,,,1,,,Autocuration,12904,Rate of acetate production by the compound was determined; Not determined,,U,,A,,CHEMBL627155,,BAO_0000019,
12735,,22224,,,1,,,Autocuration,3730,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,U,,A,,CHEMBL627156,,BAO_0000019,
12736,,22224,,,1,,,Autocuration,3627,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,U,,A,,CHEMBL627157,,BAO_0000019,
12737,Oryctolagus cuniculus,50592,,,1,,,Intermediate,13799,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,,A,,CHEMBL627158,,BAO_0000218,
12738,Oryctolagus cuniculus,50592,1969.0,,1,,,Intermediate,13799,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,,A,,CHEMBL627159,,BAO_0000218,
12739,Mus musculus,50594,,,1,,,Intermediate,13799,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,,A,,CHEMBL627160,,BAO_0000218,
12740,Rattus norvegicus,50597,,,1,,,Intermediate,13799,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,,A,,CHEMBL628540,,BAO_0000218,
12741,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,13799,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,,A,,CHEMBL628541,,BAO_0000218,
12742,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,13799,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,,A,,CHEMBL628542,,BAO_0000218,
12743,,22229,,,1,,,Autocuration,6629,Solubility after at a pH 1.2,,U,,P,,CHEMBL628543,,BAO_0000100,
12744,,22229,,,1,,,Autocuration,6629,Solubility after at pH 1.2,,U,,P,,CHEMBL628544,,BAO_0000100,
12745,,22229,,,1,,,Autocuration,6629,Solubility after injection of water,,U,,P,,CHEMBL628545,,BAO_0000100,
12746,,22224,,,1,,,Autocuration,14000,Statistical significance of IC 50 values; Expressed as R value,,U,,A,,CHEMBL628546,,BAO_0000019,
12747,,22224,,,1,,,Autocuration,8267,Systemic availability with respect to methyldopa was determined,,U,,A,,CHEMBL874455,,BAO_0000019,
12748,Rattus norvegicus,50597,,,1,,,Intermediate,13799,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,N,,A,,CHEMBL628547,,BAO_0000218,
12749,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,13799,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,N,,A,,CHEMBL628548,,BAO_0000218,
12750,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,N,,A,,CHEMBL628549,,BAO_0000218,
12751,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,N,,A,,CHEMBL628550,,BAO_0000218,
12752,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,N,,A,,CHEMBL628551,,BAO_0000218,
12753,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,N,,A,,CHEMBL628552,,BAO_0000218,
12754,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,N,,A,,CHEMBL628553,,BAO_0000218,
12755,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,N,,A,,CHEMBL628554,,BAO_0000218,
12756,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,N,,A,,CHEMBL628555,,BAO_0000218,
12757,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,N,,A,,CHEMBL628556,,BAO_0000218,
12758,Oryctolagus cuniculus,50592,2113.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,N,,A,,CHEMBL628557,,BAO_0000218,
12759,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,N,,A,,CHEMBL628558,,BAO_0000218,
12760,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,N,,A,,CHEMBL628559,,BAO_0000218,
12761,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,N,,A,,CHEMBL628560,,BAO_0000218,
12762,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,N,,A,,CHEMBL874456,,BAO_0000218,
12763,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,N,,A,,CHEMBL628561,,BAO_0000218,
12764,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,N,,A,,CHEMBL628562,,BAO_0000218,
12765,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,N,,A,,CHEMBL628563,,BAO_0000218,
12766,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,N,,A,,CHEMBL628564,,BAO_0000218,
12767,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,N,,A,,CHEMBL628565,,BAO_0000218,
12768,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,N,,A,,CHEMBL631248,,BAO_0000218,
12769,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,N,,A,,CHEMBL631249,,BAO_0000218,
12770,Oryctolagus cuniculus,50592,2113.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,N,,A,,CHEMBL627214,,BAO_0000218,
12771,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,N,,A,,CHEMBL874591,,BAO_0000218,
12772,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,N,,A,,CHEMBL627215,,BAO_0000218,
12773,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,N,,A,,CHEMBL625471,,BAO_0000218,
12774,Oryctolagus cuniculus,50592,,,1,,,Intermediate,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,N,,A,,CHEMBL625472,,BAO_0000218,
12775,Oryctolagus cuniculus,50592,,,1,,,Intermediate,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,N,,A,,CHEMBL625473,,BAO_0000218,
12776,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,N,,A,,CHEMBL625474,,BAO_0000218,
12777,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,15341,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,N,,A,,CHEMBL625475,,BAO_0000218,
12778,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,N,,A,,CHEMBL625476,,BAO_0000218,
12779,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,N,,A,,CHEMBL625477,,BAO_0000218,
12780,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15341,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,N,,A,,CHEMBL625478,,BAO_0000218,
12781,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,12801,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,N,,A,,CHEMBL625479,,BAO_0000218,
12782,Rattus norvegicus,50597,,,1,In vitro,,Intermediate,12801,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,N,,A,,CHEMBL625480,,BAO_0000218,
12783,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14856,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,N,,A,,CHEMBL625481,,BAO_0000218,
12784,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,N,,A,,CHEMBL625482,,BAO_0000218,
12785,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,N,,A,,CHEMBL625483,,BAO_0000218,
12786,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,N,,A,,CHEMBL625484,,BAO_0000218,
12787,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14062,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,N,,A,,CHEMBL625485,,BAO_0000218,
12788,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,N,,A,,CHEMBL625486,,BAO_0000218,
12789,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL625487,,BAO_0000218,
12790,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL625488,,BAO_0000218,
12791,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL625489,,BAO_0000218,
12792,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL625490,,BAO_0000218,
12793,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,N,,A,,CHEMBL625491,,BAO_0000218,
12794,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14346,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,N,,A,,CHEMBL625492,,BAO_0000218,
12795,Homo sapiens,50587,1969.0,,1,In vivo,,Intermediate,15711,plasma clearance in human,,N,,A,,CHEMBL625493,,BAO_0000218,
12796,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,N,,A,,CHEMBL625494,,BAO_0000218,
12797,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,N,,A,,CHEMBL625495,,BAO_0000218,
12798,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14886,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,N,,A,,CHEMBL625496,,BAO_0000218,
12799,,22229,,,1,,,Autocuration,4115,1-Octanol/water partition coefficient measured at 7.4,,U,,P,,CHEMBL625497,,BAO_0000100,
12800,,22229,,,1,,,Autocuration,13733,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625498,,BAO_0000100,
12801,,22224,,,1,,,Autocuration,12102,Partition coefficient (logP),,U,,A,,CHEMBL625499,,BAO_0000019,
12802,,22229,,,1,,,Autocuration,12676,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625500,,BAO_0000100,
12803,,22229,,,1,,,Autocuration,13733,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625501,,BAO_0000100,
12804,,22229,,,1,,,Autocuration,13740,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625502,,BAO_0000100,
12805,,22229,,,1,,,Autocuration,12766,Calculated partition coefficient (clogP) (relative to BAY K 8644),,U,,P,,CHEMBL625503,,BAO_0000100,
12806,,22229,,,1,,,Autocuration,2764,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625504,,BAO_0000100,
12807,,22229,,,1,,,Autocuration,12355,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625505,,BAO_0000100,
12808,,22229,,,1,,,Autocuration,11314,Calculated partition coefficient of the compound,,U,,P,,CHEMBL625506,,BAO_0000100,
12809,,22224,,,1,,,Autocuration,12706,Partition coefficient (logP),,U,,A,,CHEMBL625507,,BAO_0000019,
12810,,22229,,,1,,,Autocuration,12645,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625508,,BAO_0000100,
12811,,22229,,,1,,,Autocuration,13668,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625509,,BAO_0000100,
12812,,22229,,,1,,,Autocuration,12819,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625510,,BAO_0000100,
12813,,22229,,,1,,,Autocuration,13668,Calculated partition coefficient (clogP),,U,,P,,CHEMBL883125,,BAO_0000100,
12814,,22229,,,1,,,Autocuration,13017,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625511,,BAO_0000100,
12815,,22224,,,1,,,Autocuration,2448,Partition coefficient of the compound,,U,,A,,CHEMBL874650,,BAO_0000019,
12816,,22224,,,1,,,Autocuration,11526,Partition coefficient of the compound,,U,,A,,CHEMBL625512,,BAO_0000019,
12817,,22224,,,1,,,Autocuration,12426,Partition coefficient of compound was determined,,U,,A,,CHEMBL625513,,BAO_0000019,
12818,,22224,,,1,,,Autocuration,2448,Partition coefficient was determined,,U,,A,,CHEMBL625514,,BAO_0000019,
12819,,22229,,,1,,,Autocuration,12001,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625515,,BAO_0000100,
12820,,22229,,,1,,,Autocuration,12426,partition coefficient of compound was determined,,U,,P,,CHEMBL625516,,BAO_0000100,
12821,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13204,The total body administered intravenously in dog,,N,,A,,CHEMBL625517,,BAO_0000218,
12822,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13204,The total body administered intravenously in rats,,N,,A,,CHEMBL625518,,BAO_0000218,
12823,Mus musculus,50594,,,1,,,Intermediate,13889,Time taken for the administration to female NIH mice weighing 25-30 g.,,N,,A,,CHEMBL625519,,BAO_0000218,
12824,,22224,,,1,,,Autocuration,13889,Time taken for the administration,,U,,A,,CHEMBL625520,,BAO_0000019,
12825,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,17025,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL874651,,BAO_0000218,
12826,Simiiformes,22224,,,1,In vivo,,Autocuration,17025,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,,A,,CHEMBL625521,,BAO_0000218,
12827,Oryctolagus cuniculus,50592,,,1,In vivo,,Intermediate,17025,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL623171,,BAO_0000218,
12828,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,17025,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,N,,A,,CHEMBL623853,,BAO_0000218,
12829,,22224,,,1,,,Autocuration,15067,Plasma clearance for the compound was determined.,,U,,A,,CHEMBL623854,,BAO_0000019,
12830,,22224,,,1,,,Autocuration,3091,CLog P value of the compound,,U,,P,,CHEMBL874405,,BAO_0000100,
12831,,22229,,,1,,,Autocuration,15592,Calculated partition coefficient (clogP),,U,,P,,CHEMBL623855,,BAO_0000100,
12832,,22229,,,1,,,Autocuration,14738,Calculated partition coefficient (clogP),,U,,P,,CHEMBL623856,,BAO_0000100,
12833,,22224,,,1,,,Autocuration,14738,ClogP value of the compound; nd ='no data',,U,,P,,CHEMBL623857,,BAO_0000100,
12834,,22224,,,1,,,Autocuration,14738,ClogP value of the compound; nd ='not determined',,U,,P,,CHEMBL623858,,BAO_0000100,
12835,,22224,,,1,,,Autocuration,6076,CLog P was determined,,U,,P,,CHEMBL623859,,BAO_0000100,
12836,,22229,,,1,,,Autocuration,17840,Calculated partition coefficient (clogP),,U,,P,,CHEMBL839829,,BAO_0000100,
12837,,22224,,,1,,,Autocuration,13589,CLogP was calculated,,U,,A,,CHEMBL623860,,BAO_0000019,
12838,,22224,,,1,,,Autocuration,17655,CLogP value was determined,,U,,A,,CHEMBL623861,,BAO_0000019,
12839,,22224,,,1,,,Autocuration,5867,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,U,,A,,CHEMBL623862,,BAO_0000019,
12840,,22229,,,1,,,Autocuration,5867,Calculated partition coefficient (clogP),,U,,P,,CHEMBL874406,,BAO_0000100,
12841,,22229,,,1,,,Autocuration,10783,Calculated partition coefficient (clogP),,U,,P,,CHEMBL623863,,BAO_0000100,
12842,,22229,,,1,,,Autocuration,14849,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624021,,BAO_0000100,
12843,Canis lupus familiaris,50588,1236.0,,1,,,Intermediate,8170,Distribution in female dog adrenal medulla 24 hours after administration.,,N,,A,,CHEMBL624022,,BAO_0000218,
12844,Canis lupus familiaris,50588,1236.0,,1,,,Intermediate,8170,Distribution in female dog adrenal medulla 72 hours after administration.,,N,,A,,CHEMBL624023,,BAO_0000218,
12845,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog bile 24 hours after administration.,,N,,A,,CHEMBL624024,,BAO_0000218,
12846,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog bile 72 hr after administration.,,N,,A,,CHEMBL624025,,BAO_0000218,
12847,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog blood 24 hours after administration.,,N,,A,,CHEMBL624026,,BAO_0000218,
12848,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog blood 72 hours after administration.,,N,,A,,CHEMBL624027,,BAO_0000218,
12849,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog heart 24 hours after administration.,,N,,A,,CHEMBL624028,,BAO_0000218,
12850,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog heart 72 hours after administration.,,N,,A,,CHEMBL624029,,BAO_0000218,
12851,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog kidney 24 hours after administration.,,N,,A,,CHEMBL624030,,BAO_0000218,
12852,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog kidney 72 hours after administration.,,N,,A,,CHEMBL624031,,BAO_0000218,
12853,Canis lupus familiaris,50588,160.0,,1,,,Intermediate,8170,Distribution in female dog large intestine 24 hours after administration.,,N,,A,,CHEMBL624032,,BAO_0000218,
12854,Canis lupus familiaris,50588,160.0,,1,,,Intermediate,8170,Distribution in female dog large intestine 72 hours after administration.,,N,,A,,CHEMBL874407,,BAO_0000218,
12855,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog liver 24 hours after administration.,,N,,A,,CHEMBL624033,,BAO_0000218,
12856,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog liver 72 hours after administration.,,N,,A,,CHEMBL624034,,BAO_0000218,
12857,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog lung 24 hours after administration.,,N,,A,,CHEMBL624035,,BAO_0000218,
12858,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog lung 72 hours after administration.,,N,,A,,CHEMBL624036,,BAO_0000218,
12859,Canis lupus familiaris,50588,2385.0,,1,,,Intermediate,8170,Distribution in female dog muscle 24 hours after administration.,,N,,A,,CHEMBL624037,,BAO_0000218,
12860,Canis lupus familiaris,50588,2385.0,,1,,,Intermediate,8170,Distribution in female dog muscle 72 hours after administration.,,N,,A,,CHEMBL624038,,BAO_0000218,
12861,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog pancreas 24 hours after administration.,,N,,A,,CHEMBL624039,,BAO_0000218,
12862,Canis lupus familiaris,50588,,,1,,,Intermediate,8170,Distribution in female dog pancreas 72 hours after administration.,,N,,A,,CHEMBL624040,,BAO_0000218,
12863,Canis lupus familiaris,50588,160.0,,1,,,Intermediate,8170,Distribution in female dog small intestine 24 hours after administration.,,N,,A,,CHEMBL624041,,BAO_0000218,
12864,Canis lupus familiaris,50588,160.0,,1,,,Intermediate,8170,Distribution in female dog small intestine 72 hours after administration.,,N,,A,,CHEMBL624042,,BAO_0000218,
12865,Canis lupus familiaris,50588,2106.0,,1,,,Intermediate,8170,Distribution in female dog spleen 24 hours after administration.,,N,,A,,CHEMBL624043,,BAO_0000218,
12866,Canis lupus familiaris,50588,2106.0,,1,,,Intermediate,8170,Distribution in female dog spleen 72 hours after administration.,,N,,A,,CHEMBL624044,,BAO_0000218,
12867,Canis lupus familiaris,50588,945.0,,1,,,Intermediate,8170,Distribution in female dog stomach 24 hours after administration.,,N,,A,,CHEMBL624045,,BAO_0000218,
12868,Canis lupus familiaris,50588,945.0,,1,,,Intermediate,8170,Distribution in female dog stomach 72 hours after administration.,,N,,A,,CHEMBL624046,,BAO_0000218,
12869,Canis lupus familiaris,50588,2046.0,,1,,,Intermediate,8170,Distribution in female dog thyroid 24 hours after administration.,,N,,A,,CHEMBL624047,,BAO_0000218,
12870,Canis lupus familiaris,50588,2046.0,,1,,,Intermediate,8170,Distribution in female dog thyroid 72 hours after administration.,,N,,A,,CHEMBL624048,,BAO_0000218,
12871,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8170,Distribution in female dog urine 24 hours after administration.,,N,,A,,CHEMBL874408,,BAO_0000218,
12872,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8170,Distribution in female dog urine 72 hr after administration.,,N,,A,,CHEMBL624049,,BAO_0000218,
12873,,22224,1969.0,,1,,,Autocuration,14283,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,U,,A,,CHEMBL624050,,BAO_0000218,
12874,,22224,,,1,,,Autocuration,5623,Plasma concentration at 7 hr after intravenous dosing,,U,,A,,CHEMBL624051,,BAO_0000019,
12875,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,N,,A,,CHEMBL623278,,BAO_0000218,
12876,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,N,,A,,CHEMBL623279,,BAO_0000218,
12877,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,N,,A,,CHEMBL623280,,BAO_0000218,
12878,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,N,,A,,CHEMBL623963,,BAO_0000218,
12879,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,N,,A,,CHEMBL623964,,BAO_0000218,
12880,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,N,,A,,CHEMBL623965,,BAO_0000218,
12881,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,N,,A,,CHEMBL623966,,BAO_0000218,
12882,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,N,,A,,CHEMBL874415,,BAO_0000218,
12883,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,N,,A,,CHEMBL623967,,BAO_0000218,
12884,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,N,,A,,CHEMBL623968,,BAO_0000218,
12885,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,N,,A,,CHEMBL623969,,BAO_0000218,
12886,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,N,,A,,CHEMBL628409,,BAO_0000218,
12887,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,N,,A,,CHEMBL628410,,BAO_0000218,
12888,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,N,,A,,CHEMBL628411,,BAO_0000218,
12889,Rattus norvegicus,50597,,,1,,,Intermediate,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,N,,A,,CHEMBL628412,,BAO_0000218,
12890,,22224,,,1,,,Autocuration,12553,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,U,,A,,CHEMBL628413,,BAO_0000019,
12891,,22224,1969.0,,1,,,Autocuration,14548,The concentration in plasmat; Not determined,,U,,A,,CHEMBL628414,,BAO_0000019,
12892,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in blood,,N,,A,,CHEMBL628415,,BAO_0000218,
12893,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,N,,A,,CHEMBL628416,,BAO_0000218,
12894,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in heart,,N,,A,,CHEMBL628417,,BAO_0000218,
12895,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in liver,,N,,A,,CHEMBL874908,,BAO_0000218,
12896,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in plasma,,N,,A,,CHEMBL628418,,BAO_0000218,
12897,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,N,,A,,CHEMBL628419,,BAO_0000218,
12898,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,N,,A,,CHEMBL628420,,BAO_0000218,
12899,,22224,,,1,,,Autocuration,1629,Water solubility at 37 degree C.,,U,,A,,CHEMBL628421,,BAO_0000019,
12900,,22229,,,1,,,Autocuration,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,,P,,CHEMBL626726,,BAO_0000100,
12901,,22229,,,1,,,Autocuration,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,P,,CHEMBL626727,,BAO_0000100,
12902,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626728,,BAO_0000218,
12903,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626729,,BAO_0000218,
12904,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626730,,BAO_0000218,
12905,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626731,,BAO_0000218,
12906,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626732,,BAO_0000218,
12907,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626733,,BAO_0000218,
12908,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626734,,BAO_0000218,
12909,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626735,,BAO_0000218,
12910,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL874909,,BAO_0000218,
12911,Rattus norvegicus,50597,948.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626736,,BAO_0000218,
12912,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL626737,,BAO_0000218,
12913,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630999,,BAO_0000218,
12914,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631000,,BAO_0000218,
12915,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631001,,BAO_0000218,
12916,Rattus norvegicus,50597,2113.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631002,,BAO_0000218,
12917,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631003,,BAO_0000218,
12918,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631004,,BAO_0000218,
12919,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631005,,BAO_0000218,
12920,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631006,,BAO_0000218,
12921,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631007,,BAO_0000218,
12922,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631008,,BAO_0000218,
12923,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631009,,BAO_0000218,
12924,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631010,,BAO_0000218,
12925,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631011,,BAO_0000218,
12926,Rattus norvegicus,50597,2048.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL631012,,BAO_0000218,
12927,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630271,,BAO_0000218,
12928,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630272,,BAO_0000218,
12929,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630273,,BAO_0000218,
12930,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630274,,BAO_0000218,
12931,Rattus norvegicus,50597,2046.0,,1,,,Intermediate,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630275,,BAO_0000218,
12932,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL875782,,BAO_0000218,
12933,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630276,,BAO_0000218,
12934,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630277,,BAO_0000218,
12935,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630278,,BAO_0000218,
12936,Rattus norvegicus,50597,,,1,,,Intermediate,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,N,,A,,CHEMBL630279,,BAO_0000218,
12937,,22224,,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,U,,A,,CHEMBL630280,,BAO_0000019,
12938,,22224,,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,,A,,CHEMBL630281,,BAO_0000019,
12939,Oryctolagus cuniculus,50592,,,1,,,Intermediate,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,N,,A,,CHEMBL630282,,BAO_0000218,
12940,Oryctolagus cuniculus,50592,,,1,,,Intermediate,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,N,,A,,CHEMBL630283,,BAO_0000218,
12941,,22224,,,1,,,Autocuration,5797,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,U,,A,,CHEMBL630284,,BAO_0000019,
12942,,22224,,,1,,,Autocuration,7849,Alkylating activity was determined,,U,,A,,CHEMBL630285,,BAO_0000019,
12943,,22224,,,1,,,Autocuration,14220,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Microsomes,U,,A,,CHEMBL630286,,BAO_0000251,
12944,Oryctolagus cuniculus,50592,,,1,,,Intermediate,8650,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,N,,A,,CHEMBL630069,,BAO_0000218,
12945,Oryctolagus cuniculus,50592,,,1,,,Intermediate,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,N,,A,,CHEMBL630070,,BAO_0000218,
12946,Oryctolagus cuniculus,50592,,,1,,,Intermediate,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,N,,A,,CHEMBL630071,,BAO_0000218,
12947,Oryctolagus cuniculus,50592,,,1,,,Intermediate,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,N,,A,,CHEMBL630072,,BAO_0000218,
12948,Oryctolagus cuniculus,50592,,,1,,,Intermediate,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,N,,A,,CHEMBL875110,,BAO_0000218,
12949,Rattus norvegicus,50597,,,1,,,Intermediate,7116,Compound was tested for antidiuretic activity in rats,,N,,A,,CHEMBL630073,,BAO_0000218,
12950,,22224,,,1,,,Autocuration,14131,Compound was tested for inactivation kinetic values,,U,,A,,CHEMBL630074,,BAO_0000019,
12951,,22224,,,1,In vivo,,Autocuration,7415,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,U,,A,,CHEMBL630075,,BAO_0000218,
12952,,22224,,,1,,,Autocuration,13178,Dissociation rate calculated from the first-order equation using the t1/2 value,,U,,A,,CHEMBL630076,,BAO_0000019,
12953,,22229,,,1,,,Autocuration,8815,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,U,,P,,CHEMBL630077,,BAO_0000100,
12954,,22229,,,1,,,Autocuration,1450,Aqueous solubility was measured,,U,,P,,CHEMBL630078,,BAO_0000100,
12955,,22229,,,1,,,Autocuration,1450,Aqueous solubility was measured at a pH 4,,U,,P,,CHEMBL630079,,BAO_0000100,
12956,,22229,,,1,,,Autocuration,1450,Aqueous solubility (pH 7),,U,,P,,CHEMBL630080,,BAO_0000100,
12957,,22229,,,1,,,Autocuration,1450,Aqueous solubility was measured at a pH 9,,U,,P,,CHEMBL630081,,BAO_0000100,
12958,,22224,,,1,,,Autocuration,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,U,,A,,CHEMBL630082,,BAO_0000019,
12959,,22224,,,1,,,Autocuration,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,,A,,CHEMBL630083,,BAO_0000019,
12960,,22224,,,1,,,Autocuration,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,,A,,CHEMBL630084,,BAO_0000019,
12961,,22229,,,1,,,Autocuration,15032,Aqueous solubility of the compound,,U,,P,,CHEMBL629198,,BAO_0000100,
12962,,22229,,,1,,,Autocuration,9964,Aqueous solubility at 37 degree Celsius at pH 7.38,,U,,P,,CHEMBL629199,,BAO_0000100,
12963,,22229,,,1,,,Autocuration,14962,Aqueous solubility in pH 7.4 phosphate buffer,,U,,P,,CHEMBL629200,,BAO_0000100,
12964,Canis lupus familiaris,50588,,,1,,,Intermediate,12487,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,N,,A,,CHEMBL629201,,BAO_0000218,
12965,Canis lupus familiaris,50588,,,1,,,Intermediate,12487,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,N,,A,,CHEMBL629202,,BAO_0000218,
12966,Homo sapiens,50587,,,1,,,Intermediate,10026,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,N,,A,,CHEMBL875111,,BAO_0000218,
12967,Homo sapiens,50587,,,1,,,Intermediate,10026,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,N,,A,,CHEMBL629203,,BAO_0000218,
12968,Homo sapiens,50587,,,1,,,Intermediate,10026,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,N,,A,,CHEMBL629204,,BAO_0000218,
12969,Homo sapiens,50587,,,1,,,Intermediate,10026,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,N,,A,,CHEMBL629205,,BAO_0000218,
12970,Homo sapiens,50587,,,1,,,Intermediate,10026,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,N,,A,,CHEMBL629206,,BAO_0000218,
12971,,22224,,,1,,,Autocuration,10026,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,U,,A,,CHEMBL631185,,BAO_0000019,
12972,Rattus norvegicus,50597,,,1,,,Intermediate,7415,Compound was evaluated for the average bile flow rat in rats,,N,,A,,CHEMBL631186,,BAO_0000218,
12973,Oryctolagus cuniculus,50592,,,1,,,Intermediate,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,,A,,CHEMBL631187,,BAO_0000218,
12974,Oryctolagus cuniculus,50592,,,1,,,Intermediate,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,,A,,CHEMBL631188,,BAO_0000218,
12975,,22224,,,1,,,Autocuration,10184,Average half life period was determined,,U,,A,,CHEMBL876419,,BAO_0000019,
12976,,22224,,,1,,,Autocuration,10184,Average half life period was determined,,U,,A,,CHEMBL631189,,BAO_0000019,
12977,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,,A,,CHEMBL631190,,BAO_0000218,
12978,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,,A,,CHEMBL631191,,BAO_0000218,
12979,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,N,,A,,CHEMBL631192,,BAO_0000218,
12980,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,N,,A,,CHEMBL632400,,BAO_0000218,
12981,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,,A,,CHEMBL630564,,BAO_0000218,
12982,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,,A,,CHEMBL630565,,BAO_0000218,
12983,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,N,,A,,CHEMBL630566,,BAO_0000218,
12984,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,N,,A,,CHEMBL631229,,BAO_0000218,
12985,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,N,,A,,CHEMBL631230,,BAO_0000218,
12986,,22229,,,1,,,Autocuration,6030,Calculated partition coefficient (clogP),,U,,P,,CHEMBL876428,,BAO_0000100,
12987,,22229,,,1,,,Autocuration,6147,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631231,,BAO_0000100,
12988,,22229,,,1,,,Autocuration,14556,Calculated partition coefficient (clogP) (MacLogP),,U,,P,,CHEMBL631232,,BAO_0000100,
12989,,22224,,,1,,,Autocuration,768,Hydrophilicity was determined,,U,,A,,CHEMBL631233,,BAO_0000019,
12990,,22229,,,1,,,Autocuration,14452,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631234,,BAO_0000100,
12991,,22224,,,1,,,Autocuration,5237,Increased absorption was determined,,U,,A,,CHEMBL883126,,BAO_0000019,
12992,,22224,,,1,,,Autocuration,14378,Lipophilicity value was evaluated,,U,,P,,CHEMBL631235,,BAO_0000100,
12993,,22224,,,1,,,Autocuration,14418,Log P value of the compound.,,U,,P,,CHEMBL631236,,BAO_0000100,
12994,,22224,,,1,,,Autocuration,5249,Partition coefficient of compound was determined,,U,,A,,CHEMBL631237,,BAO_0000019,
12995,,22229,,,1,,,Autocuration,14621,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631238,,BAO_0000100,
12996,,22229,,,1,,,Autocuration,12542,Calculated partition coefficient (clogP),,U,,P,,CHEMBL876429,,BAO_0000100,
12997,,22224,,,1,,,Autocuration,12542,Partition coefficient was measured by medchem software; Not calculated,,U,,A,,CHEMBL631414,,BAO_0000019,
12998,,22224,,,1,,,Autocuration,12542,Partition coefficient was measured by octanol-water using standard shake-flask method,,U,,P,,CHEMBL631415,,BAO_0000100,
12999,,22229,,,1,,,Autocuration,15462,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631416,,BAO_0000100,
13000,,22224,,,1,,,Autocuration,14884,Partition coefficient (logP),,U,,A,,CHEMBL631417,,BAO_0000019,
13001,,22229,,,1,,,Autocuration,16526,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631418,,BAO_0000100,
13002,,22229,,,1,,,Autocuration,13693,The Octanol/Water partition coefficient CLogP,,U,,P,,CHEMBL631419,,BAO_0000100,
13003,,22224,,,1,,,Autocuration,13693,The pharmacokinetic parameter C Log p was reported,,U,,A,,CHEMBL631420,,BAO_0000019,
13004,,22229,,,1,,,Autocuration,13779,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631421,,BAO_0000100,
13005,,22229,,,1,,,Autocuration,14772,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631422,,BAO_0000100,
13006,,22229,,,1,,,Autocuration,14393,Calculated partition coefficient (clogP),,U,,P,,CHEMBL631423,,BAO_0000100,
13007,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14793,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,,A,,CHEMBL876430,,BAO_0000218,
13008,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14793,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,N,,A,,CHEMBL631424,,BAO_0000218,
13009,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,13744,Compound was administered intravenously in dog to evaluate plasma clearance values,,N,,A,,CHEMBL631425,,BAO_0000218,
13010,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,13744,Compound was administered intravenously in monkey to evaluate plasma clearance values,,U,,A,,CHEMBL631426,,BAO_0000218,
13011,Mus musculus,50594,1969.0,,1,In vivo,,Intermediate,13744,Compound was administered intravenously in mouse to evaluate plasma clearance values,,N,,A,,CHEMBL631427,,BAO_0000218,
13012,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,13207,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,N,,A,,CHEMBL631428,,BAO_0000218,
13013,Macaca mulatta,50797,2107.0,,1,In vitro,,Intermediate,5669,Intrinsic clearance in Rhesus liver microsome,Microsomes,N,,A,,CHEMBL631429,,BAO_0000218,
13014,Canis lupus familiaris,50588,2107.0,,1,In vitro,,Intermediate,5669,Intrinsic clearance in dog liver microsome,Microsomes,N,,A,,CHEMBL631430,,BAO_0000218,
13015,Rattus norvegicus,50597,2107.0,,1,In vitro,,Intermediate,5669,Intrinsic clearance in rat liver microsome,Microsomes,N,,A,,CHEMBL631431,,BAO_0000218,
13016,Macaca mulatta,50797,1969.0,,1,In vivo,,Intermediate,4853,Low plasma clearance was calculated in rhesus monkey,,N,,A,,CHEMBL631432,,BAO_0000218,
13017,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,N,,A,,CHEMBL631433,,BAO_0000218,
13018,,22224,,,1,In vivo,,Autocuration,11954,Plasma clearance after intravenous dose of 0.3 mg/kg,,U,,A,,CHEMBL631434,,BAO_0000218,
13019,,22224,,,1,In vivo,,Autocuration,11954,Plasma clearance after intravenous dose of 1 mg/kg,,U,,A,,CHEMBL631435,,BAO_0000218,
13020,,22224,,,1,In vivo,,Autocuration,11954,Plasma clearance after intravenous dose of 3 mg/kg,,U,,A,,CHEMBL631436,,BAO_0000218,
13021,,22224,,,1,In vivo,,Autocuration,11954,Plasma clearance after intravenous dose of 3.87 mg/kg,,U,,A,,CHEMBL631437,,BAO_0000218,
13022,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5669,Plasma clearance after peroral administration at 10 mpk in Rat,,N,,A,,CHEMBL631438,,BAO_0000218,
13023,Macaca mulatta,50797,,,1,In vivo,,Intermediate,5669,Plasma clearance after peroral administration at 10 mpk in Rhesus,,N,,A,,CHEMBL876431,,BAO_0000218,
13024,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,5669,Plasma clearance after peroral administration at 10 mpk in dog,,N,,A,,CHEMBL631439,,BAO_0000218,
13025,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13662,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,N,,A,,CHEMBL631440,,BAO_0000218,
13026,,22224,,,1,,,Autocuration,8272,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,U,,A,,CHEMBL631441,,BAO_0000019,
13027,,22224,,,1,,,Autocuration,13410,Critical Micellar concentration was determined,,U,,A,,CHEMBL631442,,BAO_0000019,
13028,,22224,,,1,,,Autocuration,13410,Critical Micellar concentration of the compound. was determined,,U,,A,,CHEMBL626525,,BAO_0000019,
13029,,22224,,,1,,,Autocuration,12628,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,U,,A,,CHEMBL627168,,BAO_0000019,
13030,,22224,,,1,,,Autocuration,9675,Critical micellar concentration was measured in water by the dye solubilization method,,U,,A,,CHEMBL875618,,BAO_0000019,
13031,,22224,,,1,,,Autocuration,12628,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,U,,B,,CHEMBL626612,,BAO_0000019,
13032,,22224,,,1,,,Autocuration,12766,CMR value (relative to BAY K 8644),,U,,A,,CHEMBL626613,,BAO_0000019,
13033,,22224,,,1,,,Autocuration,7849,Carbamoylating activity was determined,,U,,A,,CHEMBL626614,,BAO_0000019,
13034,Simiiformes,22224,,,1,,,Autocuration,12187,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,U,,A,,CHEMBL626615,,BAO_0000218,
13035,,22224,,,1,,,Autocuration,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,U,,A,,CHEMBL626616,,BAO_0000019,
13036,,22224,,,1,,,Autocuration,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,U,,A,,CHEMBL626617,,BAO_0000019,
13037,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,14180,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,N,,A,,CHEMBL626618,,BAO_0000218,
13038,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14180,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,N,,A,,CHEMBL626619,,BAO_0000218,
13039,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14474,"Clearance rate at 0.46 mg/kg, iv, in dogs",,N,,A,,CHEMBL626620,,BAO_0000218,
13040,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14474,"Clearance rate at 5.5 mg/kg, iv, in rat",,N,,A,,CHEMBL626621,,BAO_0000218,
13041,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,,A,,CHEMBL626622,,BAO_0000218,
13042,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,,A,,CHEMBL626623,,BAO_0000218,
13043,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,14548,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,,A,,CHEMBL626624,,BAO_0000218,
13044,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14548,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,,A,,CHEMBL626625,,BAO_0000218,
13045,Rattus norvegicus,50597,2107.0,,1,Ex vivo,,Intermediate,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,N,,A,,CHEMBL626626,,BAO_0000218,
13046,,22224,,,1,In vivo,,Autocuration,6874,Tested for the total clearance of the compound,,U,,A,,CHEMBL626627,,BAO_0000218,
13047,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,15343,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,N,,A,,CHEMBL626628,,BAO_0000218,
13048,,22224,,,1,In vivo,,Autocuration,6236,Total body clearance was determined,,U,,A,,CHEMBL626629,,BAO_0000218,
13049,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,,A,,CHEMBL626630,,BAO_0000218,
13050,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,,A,,CHEMBL626631,,BAO_0000218,
13051,,22229,,,1,,,Autocuration,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,,P,,CHEMBL626632,,BAO_0000100,
13052,,22229,,,1,,,Autocuration,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,P,,CHEMBL626633,,BAO_0000100,
13053,,22229,,,1,,,Autocuration,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,U,,P,,CHEMBL626634,,BAO_0000100,
13054,,22229,,,1,,,Autocuration,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,,P,,CHEMBL626635,,BAO_0000100,
13055,,22229,,,1,,,Autocuration,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,P,,CHEMBL626636,,BAO_0000100,
13056,,22229,,,1,,,Autocuration,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,,P,,CHEMBL626637,,BAO_0000100,
13057,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,N,,A,,CHEMBL626638,,BAO_0000218,
13058,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,N,,A,,CHEMBL626639,,BAO_0000218,
13059,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,N,,A,,CHEMBL626640,,BAO_0000218,
13060,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,N,,A,,CHEMBL626641,,BAO_0000218,
13061,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,N,,A,,CHEMBL627272,,BAO_0000218,
13062,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,N,,A,,CHEMBL627273,,BAO_0000218,
13063,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,N,,A,,CHEMBL627441,,BAO_0000218,
13064,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,N,,A,,CHEMBL628355,,BAO_0000218,
13065,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,N,,A,,CHEMBL628356,,BAO_0000218,
13066,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,N,,A,,CHEMBL628357,,BAO_0000218,
13067,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,N,,A,,CHEMBL628358,,BAO_0000218,
13068,Pneumocystis carinii,50339,,,1,,,Intermediate,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,N,,A,,CHEMBL622307,,BAO_0000218,
13069,,22224,,,1,,,Autocuration,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,U,,A,,CHEMBL622527,,BAO_0000019,
13070,,22224,,,1,,,Autocuration,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,U,,A,,CHEMBL622528,,BAO_0000019,
13071,,22224,,,1,,,Autocuration,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,U,,A,,CHEMBL622529,,BAO_0000019,
13072,,22224,,,1,,,Autocuration,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,U,,A,,CHEMBL622992,,BAO_0000019,
13073,,22224,,,1,,,Autocuration,13118,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,U,,A,,CHEMBL622993,,BAO_0000019,
13074,,22224,,,1,,,Autocuration,13118,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,U,,A,,CHEMBL622994,,BAO_0000019,
13075,Rattus norvegicus,50597,,,1,,,Intermediate,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,N,,A,,CHEMBL622995,,BAO_0000218,
13076,Rattus norvegicus,50597,,,1,,,Intermediate,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,N,,A,,CHEMBL622996,,BAO_0000218,
13077,Rattus norvegicus,50597,,,1,,,Intermediate,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,N,,A,,CHEMBL622997,,BAO_0000218,
13078,Rattus norvegicus,50597,,,1,,,Intermediate,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,N,,A,,CHEMBL622998,,BAO_0000218,
13079,,22224,,,1,,,Autocuration,5767,Cp max following ip administration at 1 mg/kg,,U,,A,,CHEMBL622999,,BAO_0000218,
13080,,22224,1969.0,,1,In vivo,,Autocuration,3302,Maximum concentration in plasma was reported at 0.5 hour,,U,,A,,CHEMBL623000,,BAO_0000218,
13081,,22224,1969.0,,1,In vivo,,Autocuration,3302,Maximum concentration in plasma was reported at 2 hour,,U,,A,,CHEMBL623001,,BAO_0000218,
13082,Mus musculus,50594,,,1,,,Intermediate,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,N,,A,,CHEMBL623002,,BAO_0000218,
13083,,22229,,,1,,,Autocuration,11778,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,U,,P,,CHEMBL623003,,BAO_0000100,
13084,,22224,,,1,,,Autocuration,4321,Steady state concentration was evaluated,,U,,A,,CHEMBL623004,,BAO_0000019,
13085,,22224,,,1,,,Autocuration,14884,Partition coefficient (logP),,U,,A,,CHEMBL623005,,BAO_0000019,
13086,,22224,,,1,,,Autocuration,15234,Partition coefficient (logD7.4),,U,,A,,CHEMBL623006,,BAO_0000019,
13087,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14198,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,N,,A,,CHEMBL623007,,BAO_0000218,
13088,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,N,,A,,CHEMBL623008,,BAO_0000218,
13089,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,N,,A,,CHEMBL876654,,BAO_0000218,
13090,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,N,,A,,CHEMBL623009,,BAO_0000218,
13091,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,N,,A,,CHEMBL623010,,BAO_0000218,
13092,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,N,,A,,CHEMBL623011,,BAO_0000218,
13093,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,N,,A,,CHEMBL623012,,BAO_0000218,
13094,,22224,,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,U,,A,,CHEMBL623013,,BAO_0000019,
13095,,22224,,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,,A,,CHEMBL623014,,BAO_0000019,
13096,,22224,1088.0,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,U,,A,,CHEMBL623015,,BAO_0000019,
13097,,22224,1088.0,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,U,,A,,CHEMBL623016,,BAO_0000019,
13098,,22224,1088.0,,1,,,Autocuration,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,U,,A,,CHEMBL624858,,BAO_0000019,
13099,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,N,,A,,CHEMBL624859,,BAO_0000218,
13100,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,,A,,CHEMBL624860,,BAO_0000218,
13101,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,,A,,CHEMBL624861,,BAO_0000218,
13102,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,N,,A,,CHEMBL624862,,BAO_0000218,
13103,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,N,,A,,CHEMBL624863,,BAO_0000218,
13104,Rattus norvegicus,50597,,,1,,,Intermediate,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,,A,,CHEMBL876655,,BAO_0000218,
13105,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,,A,,CHEMBL624864,,BAO_0000218,
13106,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,,A,,CHEMBL624865,,BAO_0000218,
13107,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,,A,,CHEMBL624866,,BAO_0000218,
13108,Canis lupus familiaris,50588,,,1,,,Expert,6996,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,N,,F,,CHEMBL624867,,BAO_0000218,
13109,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,,A,,CHEMBL624868,,BAO_0000218,
13110,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,N,,A,,CHEMBL628450,,BAO_0000218,
13111,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,,A,,CHEMBL628451,,BAO_0000218,
13112,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,,A,,CHEMBL628452,,BAO_0000218,
13113,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,,A,,CHEMBL628453,,BAO_0000218,
13114,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,N,,A,,CHEMBL628454,,BAO_0000218,
13115,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,,A,,CHEMBL628455,,BAO_0000218,
13116,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,,A,,CHEMBL628456,,BAO_0000218,
13117,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,,A,,CHEMBL628457,,BAO_0000218,
13118,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,N,,A,,CHEMBL877505,,BAO_0000218,
13119,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,N,,A,,CHEMBL628458,,BAO_0000218,
13120,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,,A,,CHEMBL628459,,BAO_0000218,
13121,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,,A,,CHEMBL628460,,BAO_0000218,
13122,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,,A,,CHEMBL628461,,BAO_0000218,
13123,,22224,,,1,,,Autocuration,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,U,,B,,CHEMBL628462,,BAO_0000218,
13124,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,,A,,CHEMBL628463,,BAO_0000218,
13125,Rattus norvegicus,50597,,,1,,,Expert,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,N,,F,,CHEMBL625666,,BAO_0000218,
13126,,22224,,,1,,,Autocuration,6996,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,U,,B,,CHEMBL625667,,BAO_0000218,
13127,Rattus norvegicus,50597,,,1,,,Expert,6996,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,,A,,CHEMBL625668,,BAO_0000218,
13128,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,,A,,CHEMBL625669,,BAO_0000218,
13129,,22224,,,1,,,Autocuration,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,U,,A,,CHEMBL625670,,BAO_0000019,
13130,Rattus norvegicus,50597,,,1,,,Intermediate,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,N,,A,,CHEMBL625671,,BAO_0000218,
13131,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,N,,A,,CHEMBL625672,,BAO_0000218,
13132,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,N,,A,,CHEMBL625673,,BAO_0000218,
13133,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,N,,A,,CHEMBL625674,,BAO_0000218,
13134,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,N,,A,,CHEMBL625675,,BAO_0000218,
13135,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,,A,,CHEMBL627637,,BAO_0000218,
13136,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,N,,A,,CHEMBL627638,,BAO_0000218,
13137,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,N,,A,,CHEMBL627639,,BAO_0000218,
13138,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,N,,A,,CHEMBL627640,,BAO_0000218,
13139,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,N,,A,,CHEMBL627641,,BAO_0000218,
13140,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,,A,,CHEMBL627642,,BAO_0000218,
13141,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,,A,,CHEMBL877506,,BAO_0000218,
13142,Mus musculus,50594,,,1,,,Intermediate,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,,A,,CHEMBL627275,,BAO_0000218,
13143,Mustela putorius furo,50506,,,1,,,Intermediate,11219,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,N,,A,,CHEMBL627643,,BAO_0000218,
13144,Mustela putorius furo,50506,,,1,,,Intermediate,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,,A,,CHEMBL631246,,BAO_0000218,
13145,Mustela putorius furo,50506,,,1,,,Intermediate,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,,A,,CHEMBL631247,,BAO_0000218,
13146,Mustela putorius furo,50506,,,1,,,Intermediate,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,,A,,CHEMBL629532,,BAO_0000218,
13147,Mustela putorius furo,50506,,,1,,,Intermediate,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,N,,A,,CHEMBL629533,,BAO_0000218,
13148,Mustela putorius furo,50506,,,1,,,Intermediate,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,,A,,CHEMBL629534,,BAO_0000218,
13149,Mustela putorius furo,50506,,,1,,,Intermediate,11219,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,N,,A,,CHEMBL629535,,BAO_0000218,
13150,,22224,,,1,,,Autocuration,14837,Pharmacokinetic parameter :drug bound to plasma was reported,,U,,A,,CHEMBL625932,,BAO_0000019,
13151,,22224,,,1,,,Autocuration,14837,compound was evaluated for drug bound in plasma,,U,,A,,CHEMBL625933,,BAO_0000019,
13152,Rattus norvegicus,50597,,,1,,,Intermediate,15343,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,N,,A,,CHEMBL625934,,BAO_0000218,
13153,Eutheria,22224,,,1,,,Autocuration,13761,Bioavailability,,U,,A,,CHEMBL625935,,BAO_0000218,
13154,Rattus norvegicus,50597,,,1,,,Intermediate,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,N,,A,,CHEMBL625936,,BAO_0000218,
13155,Rattus norvegicus,50597,,,1,,,Intermediate,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,N,,A,,CHEMBL625937,,BAO_0000218,
13156,Canis lupus familiaris,50588,,,1,,,Intermediate,13249,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,,A,,CHEMBL625938,,BAO_0000218,
13157,Rattus norvegicus,50597,1970.0,,1,,,Intermediate,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,N,,A,,CHEMBL625939,,BAO_0000218,
13158,Rattus norvegicus,50597,1970.0,,1,,,Intermediate,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,N,,A,,CHEMBL625940,,BAO_0000218,
13159,Rattus norvegicus,50597,1970.0,,1,,,Intermediate,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,N,,A,,CHEMBL874464,,BAO_0000218,
13160,Rattus norvegicus,50597,1970.0,,1,,,Intermediate,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,N,,A,,CHEMBL625941,,BAO_0000218,
13161,Rattus norvegicus,50597,1970.0,,1,,,Intermediate,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,N,,A,,CHEMBL625942,,BAO_0000218,
13162,Rattus norvegicus,50597,1970.0,,1,,,Intermediate,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,N,,A,,CHEMBL625943,,BAO_0000218,
13163,Homo sapiens,50587,1977.0,,1,,,Intermediate,15549,In vitro protein binding in human serum at 5 ug/ml,,N,,A,,CHEMBL625944,,BAO_0000218,
13164,,22224,,,1,,,Autocuration,10929,Serum protein binding ability was measured,,U,,A,,CHEMBL625945,,BAO_0000019,
13165,,22224,,,1,,,Autocuration,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,U,,A,,CHEMBL625946,,BAO_0000019,
13166,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,12860,Oral bioavailability in dog,,U,,A,,CHEMBL625947,,BAO_0000218,
13167,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,N,,A,,CHEMBL625948,,BAO_0000218,
13168,,22224,,,1,In vivo,,Autocuration,15173,Absolute oral bioavailability at an iv dose of 14 mg/kg,,U,,A,,CHEMBL625949,,BAO_0000218,
13169,,22224,,,1,In vivo,,Autocuration,15173,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,U,,A,,CHEMBL625950,,BAO_0000218,
13170,Eutheria,22224,,,1,In vivo,,Autocuration,15173,Oral bioavailability (dose 15 mg/kg i.v.),,U,,A,,CHEMBL625951,,BAO_0000218,
13171,,22224,,,1,In vivo,,Autocuration,15173,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,U,,A,,CHEMBL625952,,BAO_0000218,
13172,,22224,,,1,In vivo,,Autocuration,15173,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,U,,A,,CHEMBL625953,,BAO_0000218,
13173,,22224,,,1,In vivo,,Autocuration,15173,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,U,,A,,CHEMBL625954,,BAO_0000218,
13174,,22224,,,1,In vivo,,Autocuration,15173,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,U,,A,,CHEMBL882959,,BAO_0000218,
13175,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,11767,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,N,,A,,CHEMBL625955,,BAO_0000218,
13176,Mustela putorius furo,22224,,,1,In vivo,,Autocuration,11219,Bioavailability in ferret,,U,,A,,CHEMBL625956,,BAO_0000218,
13177,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,12186,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,N,,A,,CHEMBL625957,,BAO_0000218,
13178,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,,A,,CHEMBL625958,,BAO_0000218,
13179,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,,A,,CHEMBL625959,,BAO_0000218,
13180,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,,A,,CHEMBL626642,,BAO_0000218,
13181,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,,A,,CHEMBL631330,,BAO_0000218,
13182,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,,A,,CHEMBL631331,,BAO_0000218,
13183,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,,A,,CHEMBL631332,,BAO_0000218,
13184,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,,A,,CHEMBL631333,,BAO_0000218,
13185,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,,A,,CHEMBL632018,,BAO_0000218,
13186,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,,A,,CHEMBL632019,,BAO_0000218,
13187,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,,A,,CHEMBL632020,,BAO_0000218,
13188,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,,A,,CHEMBL632021,,BAO_0000218,
13189,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,,A,,CHEMBL632022,,BAO_0000218,
13190,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,,A,,CHEMBL632023,,BAO_0000218,
13191,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,,A,,CHEMBL632024,,BAO_0000218,
13192,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,,A,,CHEMBL874472,,BAO_0000218,
13193,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,,A,,CHEMBL632025,,BAO_0000218,
13194,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,,A,,CHEMBL632026,,BAO_0000218,
13195,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,,A,,CHEMBL632027,,BAO_0000218,
13196,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,,A,,CHEMBL632028,,BAO_0000218,
13197,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,,A,,CHEMBL626430,,BAO_0000218,
13198,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,,A,,CHEMBL626431,,BAO_0000218,
13199,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,,A,,CHEMBL626432,,BAO_0000218,
13200,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,,A,,CHEMBL626433,,BAO_0000218,
13201,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,,A,,CHEMBL626434,,BAO_0000218,
13202,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,,A,,CHEMBL627280,,BAO_0000218,
13203,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,,A,,CHEMBL627281,,BAO_0000218,
13204,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,,A,,CHEMBL627282,,BAO_0000218,
13205,,22224,,,1,,,Autocuration,7199,Total body clearance was measured at given dose,,U,,A,,CHEMBL627283,,BAO_0000019,
13206,,22224,,,1,,,Autocuration,7199,Total body clearance was measured at given dose.,,U,,A,,CHEMBL627284,,BAO_0000218,
13207,Rattus norvegicus,50597,,,1,,,Intermediate,7095,Metabolic clearance from the body in rat,,N,,A,,CHEMBL627285,,BAO_0000218,
13208,,22224,,,1,In vivo,,Autocuration,7095,Renal clearance from the body,,U,,A,,CHEMBL627286,,BAO_0000218,
13209,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,7095,Renal clearance from the body in rat,,N,,A,,CHEMBL875477,,BAO_0000218,
13210,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,N,,A,,CHEMBL627287,,BAO_0000218,
13211,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,N,,A,,CHEMBL627288,,BAO_0000218,
13212,Rattus norvegicus,50597,,,1,,,Intermediate,7095,Total clearance from the body in rat,,N,,A,,CHEMBL627289,,BAO_0000218,
13213,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14223,Clearance into cortex from rat plasma or PBS,,N,,A,,CHEMBL627290,,BAO_0000218,
13214,,22224,,,1,In vivo,,Autocuration,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,U,,A,,CHEMBL627291,,BAO_0000218,
13215,,22224,,,1,In vivo,,Autocuration,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,U,,A,,CHEMBL627292,,BAO_0000218,
13216,,22224,,,1,In vivo,,Autocuration,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,U,,A,,CHEMBL627293,,BAO_0000218,
13217,,22224,,,1,In vivo,,Autocuration,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,U,,A,,CHEMBL627294,,BAO_0000218,
13218,,22224,,,1,In vivo,,Autocuration,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,U,,A,,CHEMBL875478,,BAO_0000218,
13219,,22224,,,1,In vivo,,Autocuration,13979,Clearance was determined,,U,,A,,CHEMBL627295,,BAO_0000218,
13220,Mus musculus,50594,,,1,In vivo,,Intermediate,14315,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,N,,A,,CHEMBL627296,,BAO_0000218,
13221,Oryctolagus cuniculus,50592,,,1,In vivo,,Intermediate,14315,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,N,,A,,CHEMBL626119,,BAO_0000218,
13222,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14315,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,N,,A,,CHEMBL626120,,BAO_0000218,
13223,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12174,Clearance in rat after iv dose (100 ug/kg),,N,,A,,CHEMBL626121,,BAO_0000218,
13224,Cavia porcellus,22224,,,1,In vivo,,Autocuration,12797,Clearance in guinea pig,,U,,A,,CHEMBL626122,,BAO_0000218,
13225,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12797,Compound was evaluated for clearance in rat,,N,,A,,CHEMBL626123,,BAO_0000218,
13226,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,12797,Compound was evaluated for the clearance in dog,,N,,A,,CHEMBL623456,,BAO_0000218,
13227,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12797,Compound was evaluated for the clearance in rat,,N,,A,,CHEMBL623457,,BAO_0000218,
13228,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,11500,Compound was tested in vivo for clearance after iv administration in the rat,,N,,A,,CHEMBL623458,,BAO_0000218,
13229,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an iv dose of 14 mg/kg,,U,,A,,CHEMBL623459,,BAO_0000218,
13230,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an iv dose of 15.2 mg/kg,,U,,A,,CHEMBL875484,,BAO_0000218,
13231,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an iv dose of 15 mg/kg,,U,,A,,CHEMBL623460,,BAO_0000218,
13232,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an peroral dose of 30 mg/kg.,,U,,A,,CHEMBL623461,,BAO_0000218,
13233,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an peroral dose of 30.2 mg/kg.,,U,,A,,CHEMBL623462,,BAO_0000218,
13234,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an peroral dose of 30.3 mg/kg.,,U,,A,,CHEMBL627386,,BAO_0000218,
13235,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,N,,A,,CHEMBL627387,,BAO_0000218,
13236,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,N,,A,,CHEMBL627388,,BAO_0000218,
13237,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,N,,A,,CHEMBL627389,,BAO_0000218,
13238,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,N,,A,,CHEMBL627390,,BAO_0000218,
13239,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,N,,A,,CHEMBL627391,,BAO_0000218,
13240,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,N,,A,,CHEMBL627392,,BAO_0000218,
13241,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,N,,A,,CHEMBL627393,,BAO_0000218,
13242,Rattus norvegicus,50597,3126.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,N,,A,,CHEMBL627394,,BAO_0000218,
13243,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,N,,A,,CHEMBL627395,,BAO_0000218,
13244,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,N,,A,,CHEMBL875485,,BAO_0000218,
13245,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,N,,A,,CHEMBL627396,,BAO_0000218,
13246,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,N,,A,,CHEMBL627397,,BAO_0000218,
13247,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,N,,A,,CHEMBL627398,,BAO_0000218,
13248,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,N,,A,,CHEMBL627399,,BAO_0000218,
13249,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,N,,A,,CHEMBL627400,,BAO_0000218,
13250,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,N,,A,,CHEMBL627401,,BAO_0000218,
13251,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,N,,A,,CHEMBL627402,,BAO_0000218,
13252,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,N,,A,,CHEMBL627403,,BAO_0000218,
13253,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,N,,A,,CHEMBL627404,,BAO_0000218,
13254,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,N,,A,,CHEMBL623101,,BAO_0000218,
13255,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,N,,A,,CHEMBL877480,,BAO_0000218,
13256,Rattus norvegicus,50597,3126.0,,1,In vivo,,Intermediate,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,N,,A,,CHEMBL623102,,BAO_0000218,
13257,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,N,,A,,CHEMBL623103,,BAO_0000218,
13258,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,N,,A,,CHEMBL623104,,BAO_0000218,
13259,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,N,,A,,CHEMBL623105,,BAO_0000218,
13260,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,N,,A,,CHEMBL623106,,BAO_0000218,
13261,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,N,,A,,CHEMBL623107,,BAO_0000218,
13262,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,N,,A,,CHEMBL623108,,BAO_0000218,
13263,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,N,,A,,CHEMBL623109,,BAO_0000218,
13264,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,N,,A,,CHEMBL623110,,BAO_0000218,
13265,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,N,,A,,CHEMBL623111,,BAO_0000218,
13266,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,N,,A,,CHEMBL625060,,BAO_0000218,
13267,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,N,,A,,CHEMBL625061,,BAO_0000218,
13268,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,N,,A,,CHEMBL625062,,BAO_0000218,
13269,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,N,,A,,CHEMBL625063,,BAO_0000218,
13270,Rattus norvegicus,50597,3126.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,N,,A,,CHEMBL625064,,BAO_0000218,
13271,Rattus norvegicus,50597,10000001.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,N,,A,,CHEMBL625065,,BAO_0000218,
13272,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,N,,A,,CHEMBL625066,,BAO_0000218,
13273,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,N,,A,,CHEMBL625067,,BAO_0000218,
13274,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,N,,A,,CHEMBL625068,,BAO_0000218,
13275,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,N,,A,,CHEMBL622159,,BAO_0000218,
13276,Rattus norvegicus,50597,160.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,N,,A,,CHEMBL622160,,BAO_0000218,
13277,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,N,,A,,CHEMBL622161,,BAO_0000218,
13278,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,N,,A,,CHEMBL622162,,BAO_0000218,
13279,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,N,,A,,CHEMBL622163,,BAO_0000218,
13280,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,N,,A,,CHEMBL622313,,BAO_0000218,
13281,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,N,,A,,CHEMBL622314,,BAO_0000218,
13282,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,N,,A,,CHEMBL622315,,BAO_0000218,
13283,Rattus norvegicus,50597,3126.0,,1,In vivo,,Intermediate,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,N,,A,,CHEMBL622316,,BAO_0000218,
13284,Escherichia coli,50212,,,1,,,Intermediate,15599,Normal diffusion coefficient in water for Escherichia coli,,N,,A,,CHEMBL877486,,BAO_0000218,
13285,,22224,,,1,,,Autocuration,8204,Average max percent decrease in RVR (renal vascular resistance) was determined,,U,,A,,CHEMBL622317,,BAO_0000019,
13286,,22224,,,1,,,Autocuration,8204,Average max percent decrease in RVR (renal vascular resistance) was determined.,,U,,A,,CHEMBL622318,,BAO_0000019,
13287,,22224,,,1,,,Autocuration,6154,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,U,,A,,CHEMBL622319,,BAO_0000019,
13288,,22224,,,1,,,Autocuration,6154,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,U,,A,,CHEMBL622320,,BAO_0000019,
13289,,22224,,,1,,,Autocuration,6154,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,U,,A,,CHEMBL622321,,BAO_0000019,
13290,,22224,,,1,,,Autocuration,6154,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,U,,A,,CHEMBL622322,,BAO_0000019,
13291,,22224,,,1,,,Autocuration,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,U,,A,,CHEMBL622323,,BAO_0000019,
13292,Rattus norvegicus,50597,,,1,,,Intermediate,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,N,,A,,CHEMBL622324,,BAO_0000218,
13293,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,,A,,CHEMBL622325,,BAO_0000218,
13294,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,,A,,CHEMBL622326,,BAO_0000218,
13295,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,N,,A,,CHEMBL877487,,BAO_0000218,
13296,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,,A,,CHEMBL622327,,BAO_0000218,
13297,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,N,,A,,CHEMBL622328,,BAO_0000218,
13298,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,,A,,CHEMBL622329,,BAO_0000218,
13299,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,,A,,CHEMBL622330,,BAO_0000218,
13300,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,,A,,CHEMBL622331,,BAO_0000218,
13301,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,,A,,CHEMBL622332,,BAO_0000218,
13302,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,N,,A,,CHEMBL622333,,BAO_0000218,
13303,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,,A,,CHEMBL627658,,BAO_0000218,
13304,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,,A,,CHEMBL630428,,BAO_0000218,
13305,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,,A,,CHEMBL630429,,BAO_0000218,
13306,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,U,,A,,CHEMBL630430,,BAO_0000218,
13307,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,U,,A,,CHEMBL630431,,BAO_0000218,
13308,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,,A,,CHEMBL630432,,BAO_0000218,
13309,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,,A,,CHEMBL630433,,BAO_0000218,
13310,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,,A,,CHEMBL630434,,BAO_0000218,
13311,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,,A,,CHEMBL629372,,BAO_0000218,
13312,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,N,,A,,CHEMBL629553,,BAO_0000218,
13313,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,,A,,CHEMBL629554,,BAO_0000218,
13314,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,,A,,CHEMBL874447,,BAO_0000218,
13315,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,,A,,CHEMBL629555,,BAO_0000218,
13316,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,,A,,CHEMBL629556,,BAO_0000218,
13317,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,N,,A,,CHEMBL629557,,BAO_0000218,
13318,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,,A,,CHEMBL629558,,BAO_0000218,
13319,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,,A,,CHEMBL629559,,BAO_0000218,
13320,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,,A,,CHEMBL629560,,BAO_0000218,
13321,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,,A,,CHEMBL629561,,BAO_0000218,
13322,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,,A,,CHEMBL629562,,BAO_0000218,
13323,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,,A,,CHEMBL629563,,BAO_0000218,
13324,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,,A,,CHEMBL629564,,BAO_0000218,
13325,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,,A,,CHEMBL629565,,BAO_0000218,
13326,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,,A,,CHEMBL629566,,BAO_0000218,
13327,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,,A,,CHEMBL629567,,BAO_0000218,
13328,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,,A,,CHEMBL629568,,BAO_0000218,
13329,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,N,,A,,CHEMBL629569,,BAO_0000218,
13330,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,,A,,CHEMBL629570,,BAO_0000218,
13331,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,,A,,CHEMBL629571,,BAO_0000218,
13332,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,U,,A,,CHEMBL629572,,BAO_0000218,
13333,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,U,,A,,CHEMBL629573,,BAO_0000218,
13334,Eutheria,22224,,,1,In vivo,,Autocuration,4985,Bioavailability (dose 20 mg/kg),,U,,A,,CHEMBL629574,,BAO_0000218,
13335,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,15145,Bioavailability in dog,,U,,A,,CHEMBL629575,,BAO_0000218,
13336,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,14080,Bioavailability in rat (Sprague-Dawley) (male),,U,,A,,CHEMBL874448,,BAO_0000218,
13337,Primates,22224,,,1,In vivo,,Autocuration,11219,Bioavailability in monkey (dose 10 mg/kg i.d.),,U,,A,,CHEMBL629576,,BAO_0000218,
13338,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,15145,Bioavailability in rat,,U,,A,,CHEMBL629577,,BAO_0000218,
13339,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,15145,Bioavailability in rat,,U,,A,,CHEMBL629578,,BAO_0000218,
13340,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,1202,Bioavailability in dog (dose 3.0 mg/kg p.o.),,U,,A,,CHEMBL629579,,BAO_0000218,
13341,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,1202,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,U,,A,,CHEMBL882958,,BAO_0000218,
13342,Pan troglodytes,50505,,,1,In vivo,,Intermediate,1202,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,N,,A,,CHEMBL629580,,BAO_0000218,
13343,Eutheria,22224,,,1,In vivo,,Autocuration,4026,Bioavailability,,U,,A,,CHEMBL629581,,BAO_0000218,
13344,Saimiri,22224,,,1,In vivo,,Autocuration,1492,Bioavailability in squirrel monkey,,U,,A,,CHEMBL629582,,BAO_0000218,
13345,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,12793,Bioavailability was evaluated in dog,,N,,A,,CHEMBL628522,,BAO_0000218,
13346,Cricetinae,100712,,,1,In vivo,,Intermediate,12793,Bioavailability was evaluated in hamster,,N,,A,,CHEMBL625432,,BAO_0000218,
13347,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12793,Bioavailability in rat,,U,,A,,CHEMBL625433,,BAO_0000218,
13348,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14793,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,N,,A,,CHEMBL625434,,BAO_0000218,
13349,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,14793,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,N,,A,,CHEMBL625435,,BAO_0000218,
13350,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,14793,Bioavailability in rat (dose 10 mg/kg p.o.),,U,,A,,CHEMBL625436,,BAO_0000218,
13351,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,14731,Bioavailability was measured in cynomolgus monkeys.,,N,,A,,CHEMBL874588,,BAO_0000218,
13352,Mus musculus,50594,,,1,In vivo,,Intermediate,14731,Bioavailability was measured in nude mice.,,N,,A,,CHEMBL625437,,BAO_0000218,
13353,Mustela putorius furo,22224,,,1,In vivo,,Autocuration,12187,Bioavailability in ferret (dose 10 mg/kg i.d.),,U,,A,,CHEMBL625438,,BAO_0000218,
13354,Simiiformes,22224,,,1,In vivo,,Autocuration,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,U,,A,,CHEMBL625439,,BAO_0000218,
13355,Simiiformes,22224,,,1,In vivo,,Autocuration,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,U,,A,,CHEMBL625440,,BAO_0000218,
13356,Simiiformes,22224,,,1,In vivo,,Autocuration,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,U,,A,,CHEMBL625441,,BAO_0000218,
13357,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,12187,Bioavailability in rat (dose 10 mg/kg i.d.),,U,,A,,CHEMBL625442,,BAO_0000218,
13358,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,,A,,CHEMBL625443,,BAO_0000218,
13359,,22224,,,1,In vivo,,Autocuration,17431,Bioavailability was determined; extremely poor,,U,,A,,CHEMBL625444,,BAO_0000218,
13360,Mus musculus,50594,,,1,In vivo,,Intermediate,13318,% bioavailability in mice after oral administration of prodrug,,N,,A,,CHEMBL625445,,BAO_0000218,
13361,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,N,,A,,CHEMBL625446,,BAO_0000218,
13362,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,N,,A,,CHEMBL882960,,BAO_0000218,
13363,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,N,,A,,CHEMBL625447,,BAO_0000218,
13364,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,N,,A,,CHEMBL625448,,BAO_0000218,
13365,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,N,,A,,CHEMBL625449,,BAO_0000218,
13366,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,N,,A,,CHEMBL874589,,BAO_0000218,
13367,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,N,,A,,CHEMBL625450,,BAO_0000218,
13368,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,N,,A,,CHEMBL625451,,BAO_0000218,
13369,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,N,,A,,CHEMBL626584,,BAO_0000218,
13370,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,N,,A,,CHEMBL626585,,BAO_0000218,
13371,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,N,,A,,CHEMBL626586,,BAO_0000218,
13372,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,N,,A,,CHEMBL626587,,BAO_0000218,
13373,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,N,,A,,CHEMBL626588,,BAO_0000218,
13374,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,N,,A,,CHEMBL626589,,BAO_0000218,
13375,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,N,,A,,CHEMBL626590,,BAO_0000218,
13376,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,N,,A,,CHEMBL626591,,BAO_0000218,
13377,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,N,,A,,CHEMBL627181,,BAO_0000218,
13378,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,N,,A,,CHEMBL628083,,BAO_0000218,
13379,,22224,,,1,In vivo,,Autocuration,15173,IV clearance determined at an peroral dose of 15 mg/kg.,,U,,A,,CHEMBL628084,,BAO_0000218,
13380,Hymenolepis nana,50064,,,1,In vivo,,Expert,7732,Mouse oral clearance was measured against Hymenolepiasis nana.,,N,,F,,CHEMBL628085,,BAO_0000218,
13381,Heligmosomoides polygyrus,50545,,,1,In vivo,,Expert,7732,Mouse oral clearance was measured against Nematospiroides dubius,,N,,F,,CHEMBL628086,,BAO_0000218,
13382,,22224,,,1,In vivo,,Autocuration,7732,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,U,,F,,CHEMBL628087,,BAO_0000218,
13383,Mus musculus,50594,,,1,In vivo,,Intermediate,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,,N,,A,,CHEMBL628088,,BAO_0000218,
13384,,22224,,,1,In vivo,,Autocuration,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,,U,,B,,CHEMBL628089,,BAO_0000218,
13385,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL628090,,BAO_0000218,
13386,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL628091,,BAO_0000218,
13387,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL628092,,BAO_0000218,
13388,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL628093,,BAO_0000218,
13389,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL875607,,BAO_0000218,
13390,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL625710,,BAO_0000218,
13391,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL625711,,BAO_0000218,
13392,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL625712,,BAO_0000218,
13393,,22224,,,1,In vivo,,Autocuration,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,U,,A,,CHEMBL625713,,BAO_0000218,
13394,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,13376,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,N,,A,,CHEMBL625714,,BAO_0000218,
13395,Macaca mulatta,50797,,,1,In vivo,,Intermediate,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,N,,A,,CHEMBL625715,,BAO_0000218,
13396,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,N,,A,,CHEMBL625716,,BAO_0000218,
13397,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13477,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,N,,A,,CHEMBL625717,,BAO_0000218,
13398,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13313,Plasma clearance was determined for the compound in rats,,N,,A,,CHEMBL625718,,BAO_0000218,
13399,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,N,,A,,CHEMBL625719,,BAO_0000218,
13400,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,N,,A,,CHEMBL625720,,BAO_0000218,
13401,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,N,,A,,CHEMBL625721,,BAO_0000218,
13402,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,N,,A,,CHEMBL625722,,BAO_0000218,
13403,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13129,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,N,,A,,CHEMBL625723,,BAO_0000218,
13404,Heligmosomoides polygyrus,50545,,,1,In vivo,,Intermediate,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,N,,A,,CHEMBL625724,,BAO_0000218,
13405,Heligmosomoides polygyrus,50545,,,1,In vivo,,Intermediate,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,N,,A,,CHEMBL625725,,BAO_0000218,
13406,Heligmosomoides polygyrus,50545,,,1,In vivo,,Intermediate,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,N,,A,,CHEMBL625726,,BAO_0000218,
13407,Heligmosomoides polygyrus,50545,,,1,In vivo,,Intermediate,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,N,,A,,CHEMBL875608,,BAO_0000218,
13408,Heligmosomoides polygyrus,50545,,,1,In vivo,,Intermediate,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,N,,A,,CHEMBL625727,,BAO_0000218,
13409,Rattus norvegicus,22224,1088.0,,1,In vivo,,Autocuration,9278,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,U,,A,,CHEMBL625728,,BAO_0000218,
13410,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,9278,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,U,,A,,CHEMBL625729,,BAO_0000218,
13411,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,9278,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,U,,A,,CHEMBL625730,,BAO_0000218,
13412,Rattus norvegicus,22224,1088.0,,1,In vivo,,Autocuration,9278,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,U,,A,,CHEMBL625731,,BAO_0000218,
13413,Rattus norvegicus,22224,1088.0,,1,In vivo,,Autocuration,9278,Urinary clearance was determined in rat at 25 mg/kg os dosage,,U,,A,,CHEMBL626417,,BAO_0000218,
13414,Homo sapiens,50587,1088.0,,1,In vivo,,Intermediate,9278,Urinary clearance was determined at 100 mg/kg oral dosage in human,,N,,A,,CHEMBL626418,,BAO_0000218,
13415,Canis lupus familiaris,50588,1088.0,,1,In vivo,,Intermediate,9278,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,N,,A,,CHEMBL626419,,BAO_0000218,
13416,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,N,,A,,CHEMBL626592,,BAO_0000218,
13417,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,N,,A,,CHEMBL626593,,BAO_0000218,
13418,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,N,,A,,CHEMBL626594,,BAO_0000218,
13419,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,10499,Clearance rate in dogs,,N,,A,,CHEMBL625035,,BAO_0000218,
13420,,22224,,,1,In vitro,,Autocuration,6051,Compound was measured for intrinsic clearance,,U,,A,,CHEMBL625036,,BAO_0000019,
13421,,22229,,,1,,,Autocuration,17508,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625037,,BAO_0000100,
13422,,22229,,,1,,,Autocuration,6228,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625038,,BAO_0000100,
13423,,22229,,,1,,,Autocuration,6231,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625039,,BAO_0000100,
13424,,22229,,,1,,,Autocuration,17740,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625040,,BAO_0000100,
13425,,22229,,,1,,,Autocuration,6495,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625041,,BAO_0000100,
13426,,22229,,,1,,,Autocuration,2171,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625042,,BAO_0000100,
13427,,22224,,,1,,,Autocuration,3255,Partition coefficient of the compound,,U,,A,,CHEMBL874411,,BAO_0000019,
13428,,22224,,,1,,,Autocuration,6821,Permeability,,U,,A,,CHEMBL625043,,BAO_0000019,
13429,,22229,,,1,,,Autocuration,2685,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625044,,BAO_0000100,
13430,,22224,,,1,,,Autocuration,17584,Partition coefficient (logD),,U,,A,,CHEMBL625045,,BAO_0000019,
13431,,22229,,,1,,,Autocuration,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,P,,CHEMBL625046,,BAO_0000100,
13432,,22229,,,1,,,Autocuration,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,P,,CHEMBL625047,,BAO_0000100,
13433,,22229,,,1,,,Autocuration,16479,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625048,,BAO_0000100,
13434,,22229,,,1,,,Autocuration,11997,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625049,,BAO_0000100,
13435,,22229,,,1,,,Autocuration,2988,Calculated logarithm of partition coefficient (P) was determined,,U,,P,,CHEMBL625050,,BAO_0000100,
13436,,22229,,,1,,,Autocuration,931,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625051,,BAO_0000100,
13437,,22229,,,1,,,Autocuration,4381,Calculated partition coefficient (clogP),,U,,P,,CHEMBL874412,,BAO_0000100,
13438,,22229,,,1,,,Autocuration,4397,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625052,,BAO_0000100,
13439,,22229,,,1,,,Autocuration,5889,Calculated partition coefficient (clogP),,U,,P,,CHEMBL625053,,BAO_0000100,
13440,,22224,,,1,,,Autocuration,6154,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,U,,A,,CHEMBL623250,,BAO_0000019,
13441,,22224,,,1,,,Autocuration,6154,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,U,,A,,CHEMBL623251,,BAO_0000019,
13442,,22224,,,1,,,Autocuration,6154,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,U,,A,,CHEMBL623252,,BAO_0000019,
13443,,22224,,,1,,,Autocuration,6154,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,U,,A,,CHEMBL623253,,BAO_0000019,
13444,,22224,,,1,,,Autocuration,6154,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,U,,A,,CHEMBL623254,,BAO_0000019,
13445,,22224,,,1,,,Autocuration,6154,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,U,,A,,CHEMBL623255,,BAO_0000019,
13446,,22224,,,1,,,Autocuration,6887,Percent degradation of compound at a pH of 1 over a 18 hr period,,U,,A,,CHEMBL626831,,BAO_0000019,
13447,,22224,,,1,,,Autocuration,6887,Percent degradation of compound at pH of 1 over an 18 hr period,,U,,A,,CHEMBL877494,,BAO_0000019,
13448,,22224,,,1,,,Autocuration,14116,Delta Logarithm of Partition Coefficient value was determined.,,U,,A,,CHEMBL626832,,BAO_0000019,
13449,,22224,,,1,,,Autocuration,11137,Delta logPoct-cyc,,U,,A,,CHEMBL626833,,BAO_0000019,
13450,,22224,,,1,,,Autocuration,7230,Lipophilicity estimated on reversed phase TLC,,U,,P,,CHEMBL626834,,BAO_0000100,
13451,,22224,,,1,,,Autocuration,15741,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,U,,A,,CHEMBL626835,,BAO_0000019,
13452,,22224,,,1,,,Autocuration,9663,Delta logPoct-cyc,,U,,A,,CHEMBL626836,,BAO_0000019,
13453,,22229,,,1,,,Autocuration,9663,Change in logarithm of partition coefficient of the compound,,U,,P,,CHEMBL626837,,BAO_0000100,
13454,,22224,,,1,,,Autocuration,13807,Delta logD (pH 6.5),,U,,A,,CHEMBL626838,,BAO_0000019,
13455,,22224,,,1,,,Autocuration,13807,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,U,,P,,CHEMBL626839,,BAO_0000100,
13456,,22224,,,1,,,Autocuration,17425,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,U,,A,,CHEMBL626840,,BAO_0000019,
13457,,22224,,,1,,,Autocuration,12143,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,U,,A,,CHEMBL626841,,BAO_0000019,
13458,,22224,,,1,,,Autocuration,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,U,,A,,CHEMBL626842,,BAO_0000219,
13459,,22224,,,1,,,Autocuration,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,U,,A,,CHEMBL626843,,BAO_0000219,
13460,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,N,,A,,CHEMBL626844,,BAO_0000218,
13461,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Amount of deuterium retained was reported after normal workup in rats,,N,,A,,CHEMBL877495,,BAO_0000218,
13462,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,N,,A,,CHEMBL626845,,BAO_0000218,
13463,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,N,,A,,CHEMBL626846,,BAO_0000218,
13464,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,,A,,CHEMBL626847,,BAO_0000218,
13465,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,,A,,CHEMBL628677,,BAO_0000218,
13466,Rattus norvegicus,50597,,,1,,,Intermediate,8649,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,N,,A,,CHEMBL628678,,BAO_0000218,
13467,,22224,,,1,,,Autocuration,9659,Compound was subjected to electrochemical oxidation,,U,,A,,CHEMBL628679,,BAO_0000019,
13468,,22224,,,1,,,Autocuration,9659,Compound was subjected to photochemical oxidation,,U,,A,,CHEMBL628680,,BAO_0000019,
13469,,22224,,,1,,,Autocuration,9659,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,U,,A,,CHEMBL628681,,BAO_0000019,
13470,,22224,,,1,,,Autocuration,9659,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,U,,A,,CHEMBL628682,,BAO_0000019,
13471,,22224,,,1,,,Autocuration,9659,Oxidation of compound by methemoglobin in presence of hydroperoxide,,U,,A,,CHEMBL628683,,BAO_0000019,
13472,Rattus norvegicus,50597,,,1,,,Intermediate,9607,Percent diffusion through fuzzy rat skin after 48 h of incubation,,N,,A,,CHEMBL628684,,BAO_0000218,
13473,,22229,,,1,,,Autocuration,7057,Dissociation constant (pKa),,U,,P,,CHEMBL877501,,BAO_0000100,
13474,,22224,,,1,,,Autocuration,7057,Dissociation constant value of the compound; ND means not determined.,,U,,P,,CHEMBL628685,,BAO_0000100,
13475,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7911,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,N,,A,,CHEMBL628686,,BAO_0000218,
13476,Rattus norvegicus,50597,178.0,,1,,,Intermediate,7911,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,,A,,CHEMBL628687,,BAO_0000218,
13477,Rattus norvegicus,50597,,,1,,,Intermediate,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,N,,A,,CHEMBL628688,,BAO_0000218,
13478,Rattus norvegicus,50597,,,1,,,Intermediate,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,,A,,CHEMBL628689,,BAO_0000218,
13479,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7911,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,N,,A,,CHEMBL628690,,BAO_0000218,
13480,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,7911,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,,A,,CHEMBL629363,,BAO_0000218,
13481,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,N,,A,,CHEMBL629364,,BAO_0000218,
13482,Rattus norvegicus,50597,2106.0,,1,,,Intermediate,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,,A,,CHEMBL629365,,BAO_0000218,
13483,Rattus norvegicus,50597,,,1,,,Intermediate,7911,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,N,,A,,CHEMBL629366,,BAO_0000218,
13484,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,7911,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,N,,A,,CHEMBL629367,,BAO_0000218,
13485,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,7911,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,,A,,CHEMBL629368,,BAO_0000218,
13486,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,7911,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,,A,,CHEMBL877502,,BAO_0000218,
13487,Mus musculus,50594,2037.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,N,,A,,CHEMBL629369,,BAO_0000218,
13488,Mus musculus,50594,955.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,N,,A,,CHEMBL629370,,BAO_0000218,
13489,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,U,,A,,CHEMBL629371,,BAO_0000218,
13490,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,,A,,CHEMBL626276,,BAO_0000218,
13491,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,,A,,CHEMBL626277,,BAO_0000218,
13492,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,,A,,CHEMBL631250,,BAO_0000218,
13493,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,,A,,CHEMBL631251,,BAO_0000218,
13494,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,,A,,CHEMBL631252,,BAO_0000218,
13495,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,N,,A,,CHEMBL631253,,BAO_0000218,
13496,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,,A,,CHEMBL631254,,BAO_0000218,
13497,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,,A,,CHEMBL631255,,BAO_0000218,
13498,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,,A,,CHEMBL631256,,BAO_0000218,
13499,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,,A,,CHEMBL631257,,BAO_0000218,
13500,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,N,,A,,CHEMBL628009,,BAO_0000218,
13501,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,,A,,CHEMBL628010,,BAO_0000218,
13502,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,,A,,CHEMBL628011,,BAO_0000218,
13503,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,N,,A,,CHEMBL628012,,BAO_0000218,
13504,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,,A,,CHEMBL628013,,BAO_0000218,
13505,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,,A,,CHEMBL628014,,BAO_0000218,
13506,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,N,,A,,CHEMBL628015,,BAO_0000218,
13507,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,,A,,CHEMBL628016,,BAO_0000218,
13508,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,N,,A,,CHEMBL874461,,BAO_0000218,
13509,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,,A,,CHEMBL628017,,BAO_0000218,
13510,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,,A,,CHEMBL628018,,BAO_0000218,
13511,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,,A,,CHEMBL628019,,BAO_0000218,
13512,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,,A,,CHEMBL628020,,BAO_0000218,
13513,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,,A,,CHEMBL628021,,BAO_0000218,
13514,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,,A,,CHEMBL628022,,BAO_0000218,
13515,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,,A,,CHEMBL628023,,BAO_0000218,
13516,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,,A,,CHEMBL628024,,BAO_0000218,
13517,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,,A,,CHEMBL628025,,BAO_0000218,
13518,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,,A,,CHEMBL628026,,BAO_0000218,
13519,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,,A,,CHEMBL628027,,BAO_0000218,
13520,Simiiformes,22224,1088.0,,1,,,Autocuration,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,,A,,CHEMBL628028,,BAO_0000218,
13521,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,,A,,CHEMBL628029,,BAO_0000218,
13522,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,N,,A,,CHEMBL628030,,BAO_0000218,
13523,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,,A,,CHEMBL628031,,BAO_0000218,
13524,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,N,,A,,CHEMBL628032,,BAO_0000218,
13525,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,,A,,CHEMBL628033,,BAO_0000218,
13526,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,N,,A,,CHEMBL628034,,BAO_0000218,
13527,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,,A,,CHEMBL628035,,BAO_0000218,
13528,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,N,,A,,CHEMBL628036,,BAO_0000218,
13529,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,,A,,CHEMBL874462,,BAO_0000218,
13530,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,N,,A,,CHEMBL628037,,BAO_0000218,
13531,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,N,,A,,CHEMBL628123,,BAO_0000218,
13532,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,N,,A,,CHEMBL628124,,BAO_0000218,
13533,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,N,,A,,CHEMBL628125,,BAO_0000218,
13534,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,N,,A,,CHEMBL628126,,BAO_0000218,
13535,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,N,,A,,CHEMBL628127,,BAO_0000218,
13536,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,N,,A,,CHEMBL628128,,BAO_0000218,
13537,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,N,,A,,CHEMBL628129,,BAO_0000218,
13538,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,N,,A,,CHEMBL628130,,BAO_0000218,
13539,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,N,,A,,CHEMBL628131,,BAO_0000218,
13540,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,N,,A,,CHEMBL628132,,BAO_0000218,
13541,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,N,,A,,CHEMBL628133,,BAO_0000218,
13542,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,N,,A,,CHEMBL628134,,BAO_0000218,
13543,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,N,,A,,CHEMBL628135,,BAO_0000218,
13544,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,N,,A,,CHEMBL628136,,BAO_0000218,
13545,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,N,,A,,CHEMBL628137,,BAO_0000218,
13546,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,N,,A,,CHEMBL628138,,BAO_0000218,
13547,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,N,,A,,CHEMBL628139,,BAO_0000218,
13548,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,N,,A,,CHEMBL628140,,BAO_0000218,
13549,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,N,,A,,CHEMBL628141,,BAO_0000218,
13550,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,N,,A,,CHEMBL628142,,BAO_0000218,
13551,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,N,,A,,CHEMBL628143,,BAO_0000218,
13552,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,N,,A,,CHEMBL628144,,BAO_0000218,
13553,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,N,,A,,CHEMBL628145,,BAO_0000218,
13554,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,N,,A,,CHEMBL628146,,BAO_0000218,
13555,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,N,,A,,CHEMBL625355,,BAO_0000218,
13556,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,N,,A,,CHEMBL625356,,BAO_0000218,
13557,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,N,,A,,CHEMBL625357,,BAO_0000218,
13558,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,N,,A,,CHEMBL625527,,BAO_0000218,
13559,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,N,,A,,CHEMBL875473,,BAO_0000218,
13560,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,N,,A,,CHEMBL625528,,BAO_0000218,
13561,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,N,,A,,CHEMBL626304,,BAO_0000218,
13562,Canis lupus familiaris,50588,1637.0,,1,In vivo,,Intermediate,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,N,,A,,CHEMBL624138,,BAO_0000218,
13563,,22229,,,1,,,Autocuration,6448,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624139,,BAO_0000100,
13564,,22229,,,1,,,Autocuration,17221,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624140,,BAO_0000100,
13565,,22229,,,1,,,Autocuration,6545,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624141,,BAO_0000100,
13566,,22229,,,1,,,Autocuration,577,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624142,,BAO_0000100,
13567,,22229,,,1,,,Autocuration,6285,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624143,,BAO_0000100,
13568,,22229,,,1,,,Autocuration,6500,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624144,,BAO_0000100,
13569,,22229,,,1,,,Autocuration,6716,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624145,,BAO_0000100,
13570,,22229,,,1,,,Autocuration,13658,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624146,,BAO_0000100,
13571,,22229,,,1,,,Autocuration,6549,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624147,,BAO_0000100,
13572,,22229,,,1,,,Autocuration,14685,Calculated partition coefficient (clogP) (MacLogP),,U,,P,,CHEMBL883123,,BAO_0000100,
13573,,22224,,,1,,,Autocuration,6893,Partition coefficient (logP),,U,,A,,CHEMBL624148,,BAO_0000019,
13574,,22224,,,1,,,Autocuration,3687,Kinetic parameter was determined,,U,,A,,CHEMBL874416,,BAO_0000019,
13575,,22229,,,1,,,Autocuration,4207,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624149,,BAO_0000100,
13576,,22229,,,1,,,Autocuration,4626,Calculated partition coefficient (clogP),,U,,P,,CHEMBL624150,,BAO_0000100,
13577,,22224,,,1,,,Autocuration,1021,Lipophilicity was determined,,U,,P,,CHEMBL624151,,BAO_0000100,
13578,,22224,,,1,,,Autocuration,3777,Lipophilicity was determined,,U,,P,,CHEMBL624152,,BAO_0000100,
13579,,22224,,,1,,,Autocuration,17533,Lipophilicity was determined,,U,,P,,CHEMBL622139,,BAO_0000100,
13580,,22229,,,1,,,Autocuration,6524,Calculated partition coefficient (clogP),,U,,P,,CHEMBL622140,,BAO_0000100,
13581,,22224,,,1,,,Autocuration,17533,Lipophilicity was determined,,U,,P,,CHEMBL622141,,BAO_0000100,
13582,,22224,,,1,,,Autocuration,6480,Lipophilicity in octanol-water,,U,,P,,CHEMBL622142,,BAO_0000100,
13583,,22229,,,1,,,Autocuration,17606,Calculated partition coefficient (clogP),,U,,P,,CHEMBL622143,,BAO_0000100,
13584,,22229,,,1,,,Autocuration,6863,Octanol-water partition coefficient was determined,,U,,P,,CHEMBL622144,,BAO_0000100,
13585,,22224,,,1,,,Autocuration,1356,Partition coefficient (logP),,U,,A,,CHEMBL877473,,BAO_0000019,
13586,,22229,,,1,,,Autocuration,3326,Calculated partition coefficient (clogP),,U,,P,,CHEMBL622145,,BAO_0000100,
13587,,22224,,,1,,,Autocuration,1356,Partition coefficient was determined; ND means not determined,,U,,A,,CHEMBL622146,,BAO_0000019,
13588,,22229,,,1,,,Autocuration,12984,Calculated partition coefficient (clogP),,U,,P,,CHEMBL622147,,BAO_0000100,
13589,,22224,,,1,,,Autocuration,17363,Partition coefficient of the compound,,U,,A,,CHEMBL622148,,BAO_0000019,
13590,,22224,,,1,,,Autocuration,6827,Permeability was determined,,U,,A,,CHEMBL883124,,BAO_0000019,
13591,,22229,,,1,,,Autocuration,261,The compound was evaluated for the partition coefficient,,U,,P,,CHEMBL622149,,BAO_0000100,
13592,,22224,,,1,,,Autocuration,2685,Partition coefficient (logP),,U,,A,,CHEMBL622150,,BAO_0000019,
13593,,22224,,,1,,,Autocuration,414,The lipophilicity was reported,,U,,P,,CHEMBL622151,,BAO_0000100,
13594,,22229,,,1,,,Autocuration,15769,logarithm of the octanol-water partition coefficient for the compound,,U,,P,,CHEMBL622152,,BAO_0000100,
13595,,22224,,,1,,,Autocuration,17248,Clogp value was determined,,U,,A,,CHEMBL622153,,BAO_0000019,
13596,,22224,,,1,In vivo,,Autocuration,16935,Clp at a dose of 1.5 mg/kg,,U,,A,,CHEMBL877474,,BAO_0000218,
13597,,22224,,,1,In vivo,,Autocuration,16935,Clp at a dose of 2.0 mg/kg,,U,,A,,CHEMBL622154,,BAO_0000218,
13598,,22224,1969.0,,1,In vivo,,Autocuration,14832,"Clp, plasma clearance at a dose of 10 mg/kg",,U,,A,,CHEMBL622155,,BAO_0000218,
13599,,22224,1969.0,,1,In vivo,,Autocuration,14832,"Clp, plasma clearance at a dose of 50 mg/kg",,U,,A,,CHEMBL622156,,BAO_0000218,
13600,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2399,Compound was tested for plasma clearance in rat,,N,,A,,CHEMBL622157,,BAO_0000218,
13601,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,2399,Compound was tested for plasma clearance in rat; Not determined,,N,,A,,CHEMBL622158,,BAO_0000218,
13602,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,6227,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,N,,A,,CHEMBL622807,,BAO_0000218,
13603,Macaca mulatta,50797,,,1,In vivo,,Intermediate,6227,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,N,,A,,CHEMBL622808,,BAO_0000218,
13604,,22224,,,1,In vivo,,Autocuration,5623,Plasma clearance by iv administration at a dose 0.003 ug/mL,,U,,A,,CHEMBL622809,,BAO_0000218,
13605,,22224,,,1,In vivo,,Autocuration,4854,Plasma clearance determined,,U,,A,,CHEMBL622810,,BAO_0000218,
13606,Cricetinae,100712,,,1,In vivo,,Intermediate,4493,Plasma clearance after iv administration at 3 mg/kg in hamster,,N,,A,,CHEMBL876653,,BAO_0000218,
13607,Cricetinae,100712,,,1,In vivo,,Intermediate,4493,Plasma clearance after iv administration at 4 mg/kg in hamster,,N,,A,,CHEMBL622811,,BAO_0000218,
13608,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14956,Rate of clearance in rat was determined,,N,,A,,CHEMBL622986,,BAO_0000218,
13609,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15372,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,N,,A,,CHEMBL622987,,BAO_0000218,
13610,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15372,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,N,,A,,CHEMBL622988,,BAO_0000218,
13611,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15372,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,,A,,CHEMBL622989,,BAO_0000218,
13612,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15372,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,,A,,CHEMBL622990,,BAO_0000218,
13613,Simiiformes,22224,1969.0,,1,In vivo,,Autocuration,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,,A,,CHEMBL622991,,BAO_0000218,
13614,Rattus norvegicus,50597,1969.0,,1,In vivo,,Intermediate,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,,A,,CHEMBL622227,,BAO_0000218,
13615,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,,A,,CHEMBL622228,,BAO_0000218,
13616,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14964,Clpl value in rat,,N,,A,,CHEMBL622229,,BAO_0000218,
13617,Cavia porcellus,50512,,,1,In vivo,,Intermediate,15240,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,N,,A,,CHEMBL622230,,BAO_0000218,
13618,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16449,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,N,,A,,CHEMBL622231,,BAO_0000218,
13619,Macaca fascicularis,100710,,,1,In vivo,,Intermediate,16449,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,N,,A,,CHEMBL622232,,BAO_0000218,
13620,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,U,,A,,CHEMBL622233,,BAO_0000218,
13621,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,U,,A,,CHEMBL622234,,BAO_0000218,
13622,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,U,,A,,CHEMBL622235,,BAO_0000218,
13623,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,U,,A,,CHEMBL622236,,BAO_0000218,
13624,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,U,,A,,CHEMBL622237,,BAO_0000218,
13625,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,U,,A,,CHEMBL877482,,BAO_0000218,
13626,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,U,,A,,CHEMBL622238,,BAO_0000218,
13627,,22224,,,1,In vivo,,Autocuration,12902,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,U,,A,,CHEMBL622239,,BAO_0000218,
13628,,22224,178.0,,1,In vivo,,Autocuration,11149,Cmax was calculated as maximum concentration reached in the blood,,U,,A,,CHEMBL622240,,BAO_0000218,
13629,,22224,178.0,,1,In vivo,,Autocuration,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,U,,A,,CHEMBL622241,,BAO_0000218,
13630,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5669,Cmax was determine after peroral administration at 10 mpk in Rat,,N,,A,,CHEMBL631013,,BAO_0000218,
13631,Macaca mulatta,50797,,,1,In vivo,,Intermediate,5669,Cmax was determine after peroral administration at 10 mpk in Rhesus,,N,,A,,CHEMBL631014,,BAO_0000218,
13632,Canis lupus familiaris,50588,,,1,In vivo,,Intermediate,5669,Cmax was determine after peroral administration at 10 mpk in dog,,N,,A,,CHEMBL631015,,BAO_0000218,
13633,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5669,Cmax was determine after peroral administration at 160 mpk in Rat,,N,,A,,CHEMBL631016,,BAO_0000218,
13634,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5669,Cmax was determine after peroral administration at 20 mpk in Rat,,N,,A,,CHEMBL631017,,BAO_0000218,
13635,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,5669,Cmax was determine after peroral administration at 50 mpk in Rat,,N,,A,,CHEMBL631018,,BAO_0000218,
13636,,22224,,,1,In vivo,,Autocuration,4236,Cmax was determined,,U,,A,,CHEMBL631019,,BAO_0000218,
13637,Mus musculus,50594,955.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,N,,A,,CHEMBL875761,,BAO_0000218,
13638,Mus musculus,50594,955.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,N,,A,,CHEMBL631020,,BAO_0000218,
13639,Mus musculus,50594,955.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,N,,A,,CHEMBL631669,,BAO_0000218,
13640,Mus musculus,50594,955.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,N,,A,,CHEMBL631670,,BAO_0000218,
13641,Mus musculus,50594,2435.0,,1,,,Intermediate,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,N,,A,,CHEMBL631671,,BAO_0000218,
13642,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,N,,A,,CHEMBL631672,,BAO_0000218,
13643,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,N,,A,,CHEMBL631673,,BAO_0000218,
13644,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,N,,A,,CHEMBL631856,,BAO_0000218,
13645,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,N,,A,,CHEMBL631857,,BAO_0000218,
13646,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,N,,A,,CHEMBL631858,,BAO_0000218,
13647,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,N,,A,,CHEMBL631859,,BAO_0000218,
13648,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,N,,A,,CHEMBL631860,,BAO_0000218,
13649,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,N,,A,,CHEMBL631861,,BAO_0000218,
13650,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,N,,A,,CHEMBL631862,,BAO_0000218,
13651,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,N,,A,,CHEMBL631863,,BAO_0000218,
13652,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,N,,A,,CHEMBL631864,,BAO_0000218,
13653,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,N,,A,,CHEMBL631865,,BAO_0000218,
13654,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,N,,A,,CHEMBL631866,,BAO_0000218,
13655,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,N,,A,,CHEMBL629360,,BAO_0000218,
13656,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,N,,A,,CHEMBL629361,,BAO_0000218,
13657,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,N,,A,,CHEMBL629362,,BAO_0000218,
13658,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,N,,A,,CHEMBL630740,,BAO_0000218,
13659,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,N,,A,,CHEMBL630741,,BAO_0000218,
13660,Rattus norvegicus,50597,178.0,,1,,,Intermediate,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,N,,A,,CHEMBL630742,,BAO_0000218,
13661,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,N,,A,,CHEMBL630743,,BAO_0000218,
13662,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,N,,A,,CHEMBL630744,,BAO_0000218,
13663,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,N,,A,,CHEMBL630745,,BAO_0000218,
13664,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,N,,A,,CHEMBL630746,,BAO_0000218,
13665,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,N,,A,,CHEMBL630747,,BAO_0000218,
13666,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,N,,A,,CHEMBL630748,,BAO_0000218,
13667,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,N,,A,,CHEMBL632056,,BAO_0000218,
13668,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,N,,A,,CHEMBL632057,,BAO_0000218,
13669,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,N,,A,,CHEMBL632058,,BAO_0000218,
13670,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,N,,A,,CHEMBL632059,,BAO_0000218,
13671,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,N,,A,,CHEMBL632060,,BAO_0000218,
13672,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,N,,A,,CHEMBL632061,,BAO_0000218,
13673,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,N,,A,,CHEMBL629207,,BAO_0000218,
13674,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,N,,A,,CHEMBL629208,,BAO_0000218,
13675,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,N,,A,,CHEMBL629209,,BAO_0000218,
13676,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,N,,A,,CHEMBL629210,,BAO_0000218,
13677,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,N,,A,,CHEMBL629211,,BAO_0000218,
13678,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,N,,A,,CHEMBL629212,,BAO_0000218,
13679,Rattus norvegicus,50597,,,1,,,Intermediate,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,N,,A,,CHEMBL629213,,BAO_0000218,
13680,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,,A,,CHEMBL629214,,BAO_0000218,
13681,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,N,,A,,CHEMBL629215,,BAO_0000218,
13682,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,N,,A,,CHEMBL635154,,BAO_0000218,
13683,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL629216,,BAO_0000218,
13684,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,N,,A,,CHEMBL629217,,BAO_0000218,
13685,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL629218,,BAO_0000218,
13686,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL629219,,BAO_0000218,
13687,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL629220,,BAO_0000218,
13688,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL629221,,BAO_0000218,
13689,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL631127,,BAO_0000218,
13690,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,N,,A,,CHEMBL631128,,BAO_0000218,
13691,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL631129,,BAO_0000218,
13692,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL631130,,BAO_0000218,
13693,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL631131,,BAO_0000218,
13694,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL631132,,BAO_0000218,
13695,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL631133,,BAO_0000218,
13696,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,N,,A,,CHEMBL631134,,BAO_0000218,
13697,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL875120,,BAO_0000218,
13698,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL631135,,BAO_0000218,
13699,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL631136,,BAO_0000218,
13700,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL631137,,BAO_0000218,
13701,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL631138,,BAO_0000218,
13702,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,N,,A,,CHEMBL631139,,BAO_0000218,
13703,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL631140,,BAO_0000218,
13704,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,A,,CHEMBL631141,,BAO_0000218,
13705,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,,A,,CHEMBL631142,,BAO_0000218,
13706,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,,A,,CHEMBL631143,,BAO_0000218,
13707,Rattus norvegicus,50597,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,A,,CHEMBL631144,,BAO_0000218,
13708,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,N,,A,,CHEMBL631145,,BAO_0000218,
13709,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL631146,,BAO_0000218,
13710,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,N,,A,,CHEMBL631147,,BAO_0000218,
13711,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL631148,,BAO_0000218,
13712,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL631149,,BAO_0000218,
13713,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL631150,,BAO_0000218,
13714,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL631151,,BAO_0000218,
13715,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL631152,,BAO_0000218,
13716,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL631443,,BAO_0000218,
13717,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL631444,,BAO_0000218,
13718,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL631445,,BAO_0000218,
13719,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,,A,,CHEMBL631446,,BAO_0000218,
13720,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,N,,A,,CHEMBL631447,,BAO_0000218,
13721,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,,A,,CHEMBL631448,,BAO_0000218,
13722,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,N,,A,,CHEMBL631449,,BAO_0000218,
13723,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,,A,,CHEMBL631450,,BAO_0000218,
13724,Canis lupus familiaris,50588,,,1,,,Intermediate,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,,A,,CHEMBL629724,,BAO_0000218,
13725,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL629725,,BAO_0000218,
13726,Mus musculus,50594,14.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL629726,,BAO_0000218,
13727,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL629727,,BAO_0000218,
13728,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630404,,BAO_0000218,
13729,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630405,,BAO_0000218,
13730,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630406,,BAO_0000218,
13731,Mus musculus,50594,945.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630407,,BAO_0000218,
13732,Mus musculus,50594,945.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630573,,BAO_0000218,
13733,Mus musculus,50594,945.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630574,,BAO_0000218,
13734,Mus musculus,50594,945.0,,1,In vivo,,Intermediate,9716,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630575,,BAO_0000218,
13735,Mus musculus,50594,,,1,In vivo,,Intermediate,9716,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630576,,BAO_0000218,
13736,Mus musculus,50594,,,1,In vivo,,Intermediate,9716,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630577,,BAO_0000218,
13737,Mus musculus,50594,,,1,In vivo,,Intermediate,9716,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630578,,BAO_0000218,
13738,Mus musculus,50594,,,1,In vivo,,Intermediate,9716,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,N,,A,,CHEMBL630579,,BAO_0000218,
13739,Mus musculus,50594,2113.0,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,N,,A,,CHEMBL630580,,BAO_0000218,
13740,Mus musculus,50594,2113.0,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,N,,A,,CHEMBL630581,,BAO_0000218,
13741,Mus musculus,50594,2113.0,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,N,,A,,CHEMBL630582,,BAO_0000218,
13742,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,N,,A,,CHEMBL630583,,BAO_0000218,
13743,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,N,,A,,CHEMBL630584,,BAO_0000218,
13744,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,N,,A,,CHEMBL630585,,BAO_0000218,
13745,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,N,,A,,CHEMBL630586,,BAO_0000218,
13746,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,N,,A,,CHEMBL630587,,BAO_0000218,
13747,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,N,,A,,CHEMBL630588,,BAO_0000218,
13748,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,N,,A,,CHEMBL630589,,BAO_0000218,
13749,Mus musculus,50594,,,1,,,Intermediate,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,N,,A,,CHEMBL630590,,BAO_0000218,
13750,,22224,1988.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in feces at 24 h,,U,,A,,CHEMBL630591,,BAO_0000019,
13751,,22224,1988.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,U,,A,,CHEMBL630592,,BAO_0000019,
13752,,22224,,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,U,,A,,CHEMBL630593,,BAO_0000019,
13753,,22224,,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,U,,A,,CHEMBL630594,,BAO_0000019,
13754,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,U,,A,,CHEMBL630595,,BAO_0000019,
13755,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,U,,A,,CHEMBL630596,,BAO_0000019,
13756,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine after 0-24 h,,U,,A,,CHEMBL630597,,BAO_0000019,
13757,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,U,,A,,CHEMBL630598,,BAO_0000019,
13758,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine after 0-4 h,,U,,A,,CHEMBL630599,,BAO_0000019,
13759,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,U,,A,,CHEMBL630600,,BAO_0000019,
13760,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine after 4-24 h,,U,,A,,CHEMBL630601,,BAO_0000019,
13761,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,U,,A,,CHEMBL630602,,BAO_0000019,
13762,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,U,,A,,CHEMBL630603,,BAO_0000019,
13763,,22224,1088.0,,1,,,Autocuration,12192,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,U,,A,,CHEMBL630604,,BAO_0000019,
13764,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL624869,,BAO_0000218,
13765,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL624870,,BAO_0000218,
13766,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL623189,,BAO_0000218,
13767,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623190,,BAO_0000218,
13768,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623191,,BAO_0000218,
13769,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623192,,BAO_0000218,
13770,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623193,,BAO_0000218,
13771,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL623194,,BAO_0000218,
13772,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623195,,BAO_0000218,
13773,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623196,,BAO_0000218,
13774,Rattus norvegicus,50597,,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,N,,A,,CHEMBL623197,,BAO_0000218,
13775,Rattus norvegicus,50597,,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623198,,BAO_0000218,
13776,Rattus norvegicus,50597,,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,,A,,CHEMBL623199,,BAO_0000218,
13777,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623200,,BAO_0000218,
13778,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623201,,BAO_0000218,
13779,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623202,,BAO_0000218,
13780,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623203,,BAO_0000218,
13781,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623204,,BAO_0000218,
13782,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,N,,A,,CHEMBL623205,,BAO_0000218,
13783,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623206,,BAO_0000218,
13784,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,N,,A,,CHEMBL623207,,BAO_0000218,
13785,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,N,,A,,CHEMBL623208,,BAO_0000218,
13786,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623209,,BAO_0000218,
13787,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,,A,,CHEMBL623210,,BAO_0000218,
13788,Rattus norvegicus,50597,,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623211,,BAO_0000218,
13789,Rattus norvegicus,50597,995.0,,1,,,Intermediate,11836,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,,A,,CHEMBL623212,,BAO_0000218,
13790,,22224,,,1,,,Autocuration,12640,Tested in vitro for intrinsic activity relative to quinpirole,,U,,A,,CHEMBL623213,,BAO_0000019,
13791,,22224,,,1,,,Autocuration,14218,"Relative ion enhancement, determined in pulsed ultrafiltration",,U,,A,,CHEMBL623214,,BAO_0000019,
13792,,22224,,,1,,,Autocuration,11296,% ionization at the pH 7.4 at 37 degree Centigrade,,U,,A,,CHEMBL623215,,BAO_0000019,
13793,,22224,,,1,,,Autocuration,10929,Percentage ionization was measured,,U,,A,,CHEMBL623216,,BAO_0000019,
13794,Bos taurus,50591,,,1,,,Intermediate,13841,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,N,,A,,CHEMBL623217,,BAO_0000218,
13795,,22224,,,1,,,Autocuration,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,U,,A,,CHEMBL623218,,BAO_0000019,
13796,,22224,,,1,,,Autocuration,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,U,,A,,CHEMBL623913,,BAO_0000019,
13797,,22224,,,1,,,Autocuration,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,U,,A,,CHEMBL623914,,BAO_0000019,
13798,,22229,,,1,,,Autocuration,8826,Compound was evaluated for the partition coefficient in octanol/water,,U,,P,,CHEMBL623915,,BAO_0000100,
13799,,22229,,,1,,,Autocuration,8826,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,U,,P,,CHEMBL624080,,BAO_0000100,
13800,,22224,,,1,,,Autocuration,9884,Equilibrium constant measured by the pulse radiolysis at pH 7,,U,,A,,CHEMBL624081,,BAO_0000019,
13801,Homo sapiens,50587,,,1,,,Intermediate,9827,In vitro hydrolytic rate constant determined in human blood,,N,,A,,CHEMBL624082,,BAO_0000218,
13802,Homo sapiens,50587,,,1,,,Intermediate,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,N,,A,,CHEMBL625054,,BAO_0000218,
13803,,22224,,,1,,,Autocuration,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,U,,A,,CHEMBL877485,,BAO_0000019,
13804,Mus musculus,50594,,,1,,,Intermediate,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,N,,A,,CHEMBL625055,,BAO_0000218,
13805,Mus musculus,50594,,,1,,,Intermediate,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,N,,A,,CHEMBL625056,,BAO_0000218,
13806,Homo sapiens,50587,,,1,,,Intermediate,10009,In vitro oxidation of compound in presence of human plasma,,N,,A,,CHEMBL625057,,BAO_0000218,
13807,,22224,,,1,,,Autocuration,10009,In vitro oxidation of compound in presence of hydrogen peroxide,,U,,A,,CHEMBL625058,,BAO_0000019,
13808,Mus musculus,50594,,,1,,,Intermediate,10009,In vitro oxidation of compound in presence of mouse brain homogenate,,N,,A,,CHEMBL625059,,BAO_0000218,
13809,Mus musculus,50594,,,1,,,Intermediate,10009,In vitro oxidation of compound in presence of mouse liver homogenate,,N,,A,,CHEMBL629536,,BAO_0000218,
13810,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,,A,,CHEMBL629537,,BAO_0000218,
13811,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,,A,,CHEMBL629538,,BAO_0000218,
13812,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,,A,,CHEMBL629539,,BAO_0000218,
13813,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,,A,,CHEMBL874445,,BAO_0000218,
13814,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,,A,,CHEMBL629540,,BAO_0000218,
13815,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,,A,,CHEMBL629541,,BAO_0000218,
13816,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,,A,,CHEMBL629542,,BAO_0000218,
13817,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,,A,,CHEMBL630243,,BAO_0000218,
13818,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,,A,,CHEMBL630244,,BAO_0000218,
13819,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,,A,,CHEMBL630245,,BAO_0000218,
13820,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,,A,,CHEMBL630246,,BAO_0000218,
13821,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,,A,,CHEMBL630247,,BAO_0000218,
13822,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,,A,,CHEMBL630248,,BAO_0000218,
13823,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat blood at 240 minutes after dose administration.,,N,,A,,CHEMBL630249,,BAO_0000218,
13824,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat blood at 30 minutes after dose administration.,,N,,A,,CHEMBL630250,,BAO_0000218,
13825,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat blood at 360 minutes after dose administration.,,N,,A,,CHEMBL630251,,BAO_0000218,
13826,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat blood at 3 hr after dose administration.,,N,,A,,CHEMBL630252,,BAO_0000218,
13827,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat blood at 60 minutes after dose administration.,,N,,A,,CHEMBL630408,,BAO_0000218,
13828,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,N,,A,,CHEMBL630409,,BAO_0000218,
13829,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,N,,A,,CHEMBL874446,,BAO_0000218,
13830,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,N,,A,,CHEMBL630410,,BAO_0000218,
13831,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,N,,A,,CHEMBL630411,,BAO_0000218,
13832,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,N,,A,,CHEMBL630412,,BAO_0000218,
13833,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,N,,A,,CHEMBL630413,,BAO_0000218,
13834,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 3 hr after dose administration.,,N,,A,,CHEMBL630414,,BAO_0000218,
13835,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,N,,A,,CHEMBL630415,,BAO_0000218,
13836,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 120 minutes after dose administration.,,N,,A,,CHEMBL630416,,BAO_0000218,
13837,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 1440 minutes after dose administration.,,N,,A,,CHEMBL630417,,BAO_0000218,
13838,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 15 minutes after dose administration.,,N,,A,,CHEMBL630418,,BAO_0000218,
13839,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 240 minutes after dose administration.,,N,,A,,CHEMBL630419,,BAO_0000218,
13840,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 30 minutes after dose administration.,,N,,A,,CHEMBL630420,,BAO_0000218,
13841,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 360 minutes after dose administration.,,N,,A,,CHEMBL630421,,BAO_0000218,
13842,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 3 hr after dose administration.,,N,,A,,CHEMBL630422,,BAO_0000218,
13843,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat cortex at 60 minutes after dose administration.,,N,,A,,CHEMBL630423,,BAO_0000218,
13844,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 120 minutes after dose administration.,,N,,A,,CHEMBL630424,,BAO_0000218,
13845,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 15 minutes after dose administration.,,N,,A,,CHEMBL630425,,BAO_0000218,
13846,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 240 minutes after dose administration.,,N,,A,,CHEMBL629462,,BAO_0000218,
13847,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 30 minutes after dose administration.,,N,,A,,CHEMBL630426,,BAO_0000218,
13848,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 360 minutes after dose administration.,,N,,A,,CHEMBL630427,,BAO_0000218,
13849,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 3 hr after dose administration.,,N,,A,,CHEMBL625877,,BAO_0000218,
13850,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat heart at 60 minutes after dose administration.,,N,,A,,CHEMBL625878,,BAO_0000218,
13851,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,N,,A,,CHEMBL625879,,BAO_0000218,
13852,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,N,,A,,CHEMBL625880,,BAO_0000218,
13853,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,N,,A,,CHEMBL625881,,BAO_0000218,
13854,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,N,,A,,CHEMBL625882,,BAO_0000218,
13855,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,N,,A,,CHEMBL625883,,BAO_0000218,
13856,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 120 minutes after dose administration.,,N,,A,,CHEMBL625884,,BAO_0000218,
13857,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 1440 minutes after dose administration.,,N,,A,,CHEMBL625885,,BAO_0000218,
13858,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 15 minutes after dose administration.,,N,,A,,CHEMBL628649,,BAO_0000218,
13859,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 240 minutes after dose administration.,,N,,A,,CHEMBL628650,,BAO_0000218,
13860,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 30 minutes after dose administration.,,N,,A,,CHEMBL628651,,BAO_0000218,
13861,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 360 minutes after dose administration.,,N,,A,,CHEMBL628652,,BAO_0000218,
13862,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat kidney at 60 minutes after dose administration.,,N,,A,,CHEMBL628653,,BAO_0000218,
13863,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 120 minutes after dose administration.,,N,,A,,CHEMBL628654,,BAO_0000218,
13864,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 1440 minutes after dose administration.,,N,,A,,CHEMBL628655,,BAO_0000218,
13865,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 15 minutes after dose administration.,,N,,A,,CHEMBL625238,,BAO_0000218,
13866,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 240 minutes after dose administration.,,N,,A,,CHEMBL625239,,BAO_0000218,
13867,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 30 minutes after dose administration.,,N,,A,,CHEMBL625240,,BAO_0000218,
13868,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 360 minutes after dose administration.,,N,,A,,CHEMBL625241,,BAO_0000218,
13869,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat liver at 60 minutes after dose administration.,,N,,A,,CHEMBL625242,,BAO_0000218,
13870,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 120 minutes after dose administration.,,N,,A,,CHEMBL874587,,BAO_0000218,
13871,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 1440 minutes after dose administration.,,N,,A,,CHEMBL625405,,BAO_0000218,
13872,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 15 minutes after dose administration.,,N,,A,,CHEMBL625406,,BAO_0000218,
13873,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 240 minutes after dose administration.,,N,,A,,CHEMBL625407,,BAO_0000218,
13874,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 30 minutes after dose administration.,,N,,A,,CHEMBL625408,,BAO_0000218,
13875,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 360 minutes after dose administration.,,N,,A,,CHEMBL625409,,BAO_0000218,
13876,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,N,,A,,CHEMBL625410,,BAO_0000218,
13877,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,N,,A,,CHEMBL625411,,BAO_0000218,
13878,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,N,,A,,CHEMBL625412,,BAO_0000218,
13879,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,N,,A,,CHEMBL625413,,BAO_0000218,
13880,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,N,,A,,CHEMBL625414,,BAO_0000218,
13881,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,,A,,CHEMBL625415,,BAO_0000218,
13882,Rattus norvegicus,50597,1515.0,,1,,,Intermediate,12361,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,,A,,CHEMBL625416,,BAO_0000218,
13883,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12712,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,N,,A,,CHEMBL625417,,BAO_0000218,
13884,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,N,,A,,CHEMBL625418,,BAO_0000218,
13885,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,N,,A,,CHEMBL625419,,BAO_0000218,
13886,Rattus norvegicus,50597,,,1,,,Intermediate,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,N,,A,,CHEMBL625420,,BAO_0000218,
13887,Rattus norvegicus,50597,,,1,,,Intermediate,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,N,,A,,CHEMBL626996,,BAO_0000218,
13888,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,N,,A,,CHEMBL626997,,BAO_0000218,
13889,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,N,,A,,CHEMBL626998,,BAO_0000218,
13890,Rattus norvegicus,50597,,,1,,,Intermediate,7415,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,N,,A,,CHEMBL626999,,BAO_0000218,
13891,Mus musculus,50594,,,1,,,Intermediate,8050,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,N,,A,,CHEMBL627000,,BAO_0000218,
13892,Mus musculus,50594,,,1,,,Intermediate,8050,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,N,,A,,CHEMBL627001,,BAO_0000218,
13893,Mus musculus,50594,,,1,,,Intermediate,8050,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,N,,A,,CHEMBL627002,,BAO_0000218,
13894,Mus musculus,50594,,,1,,,Intermediate,8050,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,N,,A,,CHEMBL627003,,BAO_0000218,
13895,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,N,,A,,CHEMBL627004,,BAO_0000218,
13896,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,N,,A,,CHEMBL627005,,BAO_0000218,
13897,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,N,,A,,CHEMBL874594,,BAO_0000218,
13898,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,N,,A,,CHEMBL627006,,BAO_0000218,
13899,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,N,,A,,CHEMBL627007,,BAO_0000218,
13900,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,N,,A,,CHEMBL627884,,BAO_0000218,
13901,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,N,,A,,CHEMBL627885,,BAO_0000218,
13902,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,N,,A,,CHEMBL627886,,BAO_0000218,
13903,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,N,,A,,CHEMBL627887,,BAO_0000218,
13904,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,N,,A,,CHEMBL627888,,BAO_0000218,
13905,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,N,,A,,CHEMBL628057,,BAO_0000218,
13906,Mus musculus,50594,1088.0,,1,,,Intermediate,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,N,,A,,CHEMBL627405,,BAO_0000218,
13907,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,,A,,CHEMBL627406,,BAO_0000218,
13908,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,,A,,CHEMBL627407,,BAO_0000218,
13909,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,,A,,CHEMBL627408,,BAO_0000218,
13910,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,,A,,CHEMBL627409,,BAO_0000218,
13911,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,,A,,CHEMBL875486,,BAO_0000218,
13912,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL627410,,BAO_0000218,
13913,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,,A,,CHEMBL627411,,BAO_0000218,
13914,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,,A,,CHEMBL627412,,BAO_0000218,
13915,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,,A,,CHEMBL627413,,BAO_0000218,
13916,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,,A,,CHEMBL627414,,BAO_0000218,
13917,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,,A,,CHEMBL627415,,BAO_0000218,
13918,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,,A,,CHEMBL627416,,BAO_0000218,
13919,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,,A,,CHEMBL627417,,BAO_0000218,
13920,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,,A,,CHEMBL627418,,BAO_0000218,
13921,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL627419,,BAO_0000218,
13922,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,,A,,CHEMBL627320,,BAO_0000218,
13923,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,,A,,CHEMBL627321,,BAO_0000218,
13924,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627322,,BAO_0000218,
13925,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627323,,BAO_0000218,
13926,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL627491,,BAO_0000218,
13927,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627492,,BAO_0000218,
13928,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627493,,BAO_0000218,
13929,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627494,,BAO_0000218,
13930,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627495,,BAO_0000218,
13931,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL627496,,BAO_0000218,
13932,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627497,,BAO_0000218,
13933,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627498,,BAO_0000218,
13934,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627499,,BAO_0000218,
13935,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL627500,,BAO_0000218,
13936,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL627501,,BAO_0000218,
13937,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625616,,BAO_0000218,
13938,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625617,,BAO_0000218,
13939,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625618,,BAO_0000218,
13940,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625619,,BAO_0000218,
13941,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL625620,,BAO_0000218,
13942,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625621,,BAO_0000218,
13943,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625622,,BAO_0000218,
13944,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625788,,BAO_0000218,
13945,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625789,,BAO_0000218,
13946,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL625790,,BAO_0000218,
13947,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL625791,,BAO_0000218,
13948,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL622334,,BAO_0000218,
13949,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL622335,,BAO_0000218,
13950,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL622336,,BAO_0000218,
13951,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL622337,,BAO_0000218,
13952,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,12017,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL622338,,BAO_0000218,
13953,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,12017,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL622339,,BAO_0000218,
13954,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL624153,,BAO_0000218,
13955,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL628430,,BAO_0000218,
13956,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL628431,,BAO_0000218,
13957,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL628432,,BAO_0000218,
13958,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL628433,,BAO_0000218,
13959,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,,A,,CHEMBL628434,,BAO_0000218,
13960,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,,A,,CHEMBL626789,,BAO_0000218,
13961,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,N,,A,,CHEMBL626790,,BAO_0000218,
13962,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,,A,,CHEMBL626791,,BAO_0000218,
13963,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,,A,,CHEMBL626792,,BAO_0000218,
13964,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,,A,,CHEMBL626793,,BAO_0000218,
13965,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,,A,,CHEMBL627436,,BAO_0000218,
13966,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,,A,,CHEMBL627437,,BAO_0000218,
13967,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,,A,,CHEMBL627438,,BAO_0000218,
13968,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,,A,,CHEMBL627439,,BAO_0000218,
13969,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,,A,,CHEMBL627440,,BAO_0000218,
13970,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,,A,,CHEMBL627602,,BAO_0000218,
13971,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,,A,,CHEMBL627603,,BAO_0000218,
13972,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,,A,,CHEMBL627604,,BAO_0000218,
13973,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,,A,,CHEMBL627605,,BAO_0000218,
13974,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,,A,,CHEMBL627606,,BAO_0000218,
13975,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,,A,,CHEMBL627607,,BAO_0000218,
13976,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,,A,,CHEMBL627608,,BAO_0000218,
13977,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,,A,,CHEMBL627609,,BAO_0000218,
13978,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,,A,,CHEMBL627610,,BAO_0000218,
13979,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,,A,,CHEMBL627611,,BAO_0000218,
13980,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,,A,,CHEMBL627612,,BAO_0000218,
13981,,22229,,,1,,,Autocuration,8362,Octanol:water partition coefficient is evaluated,,U,,P,,CHEMBL627613,,BAO_0000100,
13982,,22224,,,1,,,Autocuration,8257,Partition coefficient in 1-octanol/water system,,U,,P,,CHEMBL627614,,BAO_0000100,
13983,,22224,,,1,,,Autocuration,8257,Partition coefficient in 1-octanol/water system measured using radio active compounds,,U,,P,,CHEMBL627615,,BAO_0000100,
13984,,22224,,,1,,,Autocuration,9468,Partition coefficient in octanol/water system was determined,,U,,P,,CHEMBL627616,,BAO_0000100,
13985,,22224,,,1,,,Autocuration,9468,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,U,,P,,CHEMBL627617,,BAO_0000100,
13986,,22224,,,1,,,Autocuration,10568,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,U,,A,,CHEMBL627618,,BAO_0000019,
13987,,22224,,,1,,,Autocuration,10568,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,U,,A,,CHEMBL627619,,BAO_0000019,
13988,,22224,,,1,,,Autocuration,15359,Pseudo-first-order rate constant of the compound,,U,,A,,CHEMBL627620,,BAO_0000019,
13989,,22224,,,1,,,Autocuration,15359,Pseudo-first-order rate constant with 1-min time point,,U,,A,,CHEMBL627621,,BAO_0000019,
13990,,22224,,,1,,,Autocuration,15359,Pseudo-first-order rate constant without 1-min time point,,U,,A,,CHEMBL627622,,BAO_0000019,
13991,,22224,,,1,,,Autocuration,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,U,,A,,CHEMBL627623,,BAO_0000019,
13992,,22224,,,1,,,Autocuration,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,U,,A,,CHEMBL627624,,BAO_0000019,
13993,,22224,,,1,,,Autocuration,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,U,,A,,CHEMBL627625,,BAO_0000019,
13994,,22224,,,1,,,Autocuration,15704,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,U,,A,,CHEMBL628523,,BAO_0000019,
13995,,22224,,,1,,,Autocuration,15287,The alkaline hydrolysis second order rate constant(K OH) of the compound,,U,,A,,CHEMBL628524,,BAO_0000019,
13996,,22224,,,1,,,Autocuration,7516,The efflux rate constant of the compound,,U,,A,,CHEMBL628525,,BAO_0000019,
13997,,22224,,,1,,,Autocuration,12973,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,A,,CHEMBL625732,,BAO_0000019,
13998,,22224,,,1,,,Autocuration,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,A,,CHEMBL625733,,BAO_0000019,
13999,,22224,,,1,,,Autocuration,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,F,,CHEMBL625734,,BAO_0000019,
14000,,22224,,,1,,,Autocuration,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,U,,A,,CHEMBL625913,,BAO_0000019,
14001,,22224,,,1,,,Autocuration,8696,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,U,,A,,CHEMBL625914,,BAO_0000019,
14002,,22224,,,1,,,Autocuration,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,U,,A,,CHEMBL625915,,BAO_0000019,
14003,,22224,,,1,,,Autocuration,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,U,,A,,CHEMBL625916,,BAO_0000019,
14004,,22224,,,1,,,Autocuration,10503,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,U,,A,,CHEMBL625917,,BAO_0000019,
14005,,22224,,,1,,,Autocuration,8354,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625918,,BAO_0000019,
14006,,22224,,,1,,,Autocuration,8354,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625919,,BAO_0000019,
14007,,22224,,,1,,,Autocuration,8354,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625920,,BAO_0000019,
14008,,22224,,,1,,,Autocuration,8354,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL874453,,BAO_0000019,
14009,,22224,,,1,,,Autocuration,8354,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625921,,BAO_0000019,
14010,,22224,,,1,,,Autocuration,10503,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,U,,A,,CHEMBL625922,,BAO_0000019,
14011,,22224,,,1,,,Autocuration,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625923,,BAO_0000019,
14012,,22224,,,1,,,Autocuration,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625924,,BAO_0000019,
14013,,22224,,,1,,,Autocuration,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625925,,BAO_0000019,
14014,,22224,,,1,,,Autocuration,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL625926,,BAO_0000019,
14015,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat lung at 60 minutes after dose administration.,,N,,A,,CHEMBL627704,,BAO_0000218,
14016,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,N,,A,,CHEMBL627705,,BAO_0000218,
14017,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,N,,A,,CHEMBL627706,,BAO_0000218,
14018,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,N,,A,,CHEMBL627707,,BAO_0000218,
14019,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,N,,A,,CHEMBL627708,,BAO_0000218,
14020,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,N,,A,,CHEMBL628361,,BAO_0000218,
14021,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,13100,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,N,,A,,CHEMBL628362,,BAO_0000218,
14022,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 120 minutes after dose administration.,,N,,A,,CHEMBL628363,,BAO_0000218,
14023,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 1440 minutes after dose administration.,,N,,A,,CHEMBL628364,,BAO_0000218,
14024,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 15 minutes after dose administration.,,N,,A,,CHEMBL628365,,BAO_0000218,
14025,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 240 minutes after dose administration.,,N,,A,,CHEMBL874454,,BAO_0000218,
14026,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 30 minutes after dose administration.,,N,,A,,CHEMBL628531,,BAO_0000218,
14027,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 360 minutes after dose administration.,,N,,A,,CHEMBL628532,,BAO_0000218,
14028,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 3 hr after dose administration.,,N,,A,,CHEMBL628533,,BAO_0000218,
14029,Rattus norvegicus,50597,2435.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat striatum at 60 minutes after dose administration.,,N,,A,,CHEMBL628534,,BAO_0000218,
14030,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 120 minutes after dose administration.,,N,,A,,CHEMBL628535,,BAO_0000218,
14031,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,N,,A,,CHEMBL628536,,BAO_0000218,
14032,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 15 minutes after dose administration.,,N,,A,,CHEMBL628537,,BAO_0000218,
14033,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 240 minutes after dose administration.,,N,,A,,CHEMBL628538,,BAO_0000218,
14034,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 30 minutes after dose administration.,,N,,A,,CHEMBL628539,,BAO_0000218,
14035,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 360 minutes after dose administration.,,N,,A,,CHEMBL630297,,BAO_0000218,
14036,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,13100,Biodistribution in rat thyroid at 60 minutes after dose administration.,,N,,A,,CHEMBL630298,,BAO_0000218,
14037,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,N,,A,,CHEMBL630299,,BAO_0000218,
14038,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,N,,A,,CHEMBL628094,,BAO_0000218,
14039,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,N,,A,,CHEMBL628095,,BAO_0000218,
14040,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,N,,A,,CHEMBL874648,,BAO_0000218,
14041,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,N,,A,,CHEMBL628096,,BAO_0000218,
14042,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,N,,A,,CHEMBL628097,,BAO_0000218,
14043,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13100,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,N,,A,,CHEMBL628098,,BAO_0000218,
14044,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,U,,A,,CHEMBL628099,,BAO_0000019,
14045,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,,A,,CHEMBL628100,,BAO_0000019,
14046,,22224,,,1,,,Autocuration,13331,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,U,,A,,CHEMBL628101,,BAO_0000019,
14047,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,U,,A,,CHEMBL628102,,BAO_0000019,
14048,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,U,,A,,CHEMBL628103,,BAO_0000019,
14049,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,,A,,CHEMBL628104,,BAO_0000019,
14050,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,U,,A,,CHEMBL628105,,BAO_0000019,
14051,,22224,,,1,,,Autocuration,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,U,,A,,CHEMBL628106,,BAO_0000019,
14052,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,N,,A,,CHEMBL628107,,BAO_0000218,
14053,,22224,1088.0,,1,,,Autocuration,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,U,,F,,CHEMBL628108,,BAO_0000218,
14054,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,N,,A,,CHEMBL628109,,BAO_0000218,
14055,,22224,1088.0,,1,,,Autocuration,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,U,,F,,CHEMBL625299,,BAO_0000218,
14056,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,10086,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,N,,A,,CHEMBL625300,,BAO_0000218,
14057,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,10086,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,N,,A,,CHEMBL625301,,BAO_0000218,
14058,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,10086,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,N,,A,,CHEMBL625302,,BAO_0000218,
14059,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,10086,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,N,,A,,CHEMBL874649,,BAO_0000218,
14060,Rattus norvegicus,50597,,,1,,,Intermediate,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,N,,A,,CHEMBL625303,,BAO_0000218,
14061,Rattus norvegicus,50597,,,1,,,Intermediate,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,N,,A,,CHEMBL625463,,BAO_0000218,
14062,Homo sapiens,50587,2107.0,,1,,,Intermediate,14527,In vitro metabolism in human liver microsomes,,N,,A,,CHEMBL625464,,BAO_0000218,
14063,Homo sapiens,50587,,,1,,,Intermediate,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,N,,A,,CHEMBL625465,,BAO_0000218,
14064,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,,A,,CHEMBL625466,,BAO_0000218,
14065,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,,A,,CHEMBL625467,,BAO_0000218,
14066,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,,A,,CHEMBL625468,,BAO_0000218,
14067,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,N,,A,,CHEMBL625469,,BAO_0000218,
14068,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,,A,,CHEMBL625470,,BAO_0000218,
14069,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,,A,,CHEMBL632418,,BAO_0000218,
14070,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,,A,,CHEMBL627250,,BAO_0000218,
14071,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,N,,A,,CHEMBL627251,,BAO_0000218,
14072,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,N,,A,,CHEMBL627252,,BAO_0000218,
14073,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,,A,,CHEMBL627253,,BAO_0000218,
14074,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,N,,A,,CHEMBL627254,,BAO_0000218,
14075,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,,A,,CHEMBL875471,,BAO_0000218,
14076,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,N,,A,,CHEMBL627255,,BAO_0000218,
14077,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,,A,,CHEMBL627256,,BAO_0000218,
14078,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,N,,A,,CHEMBL627257,,BAO_0000218,
14079,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,,A,,CHEMBL627258,,BAO_0000218,
14080,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,N,,A,,CHEMBL627259,,BAO_0000218,
14081,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,,A,,CHEMBL627260,,BAO_0000218,
14082,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,N,,A,,CHEMBL623256,,BAO_0000218,
14083,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,,A,,CHEMBL874413,,BAO_0000218,
14084,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,N,,A,,CHEMBL623257,,BAO_0000218,
14085,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,,A,,CHEMBL623258,,BAO_0000218,
14086,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,N,,A,,CHEMBL623259,,BAO_0000218,
14087,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,N,,A,,CHEMBL623260,,BAO_0000218,
14088,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,,A,,CHEMBL623261,,BAO_0000218,
14089,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,N,,A,,CHEMBL623262,,BAO_0000218,
14090,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,N,,A,,CHEMBL623263,,BAO_0000218,
14091,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,,A,,CHEMBL623264,,BAO_0000218,
14092,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,,A,,CHEMBL623265,,BAO_0000218,
14093,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,,A,,CHEMBL623266,,BAO_0000218,
14094,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,N,,A,,CHEMBL623267,,BAO_0000218,
14095,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,N,,A,,CHEMBL623268,,BAO_0000218,
14096,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,,A,,CHEMBL623269,,BAO_0000218,
14097,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,,A,,CHEMBL623270,,BAO_0000218,
14098,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,,A,,CHEMBL623271,,BAO_0000218,
14099,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,N,,A,,CHEMBL623272,,BAO_0000218,
14100,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,,A,,CHEMBL623273,,BAO_0000218,
14101,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,N,,A,,CHEMBL623274,,BAO_0000218,
14102,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,,A,,CHEMBL874414,,BAO_0000218,
14103,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,N,,A,,CHEMBL623275,,BAO_0000218,
14104,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,,A,,CHEMBL629150,,BAO_0000218,
14105,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL623276,,BAO_0000218,
14106,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,,A,,CHEMBL623277,,BAO_0000218,
14107,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,N,,A,,CHEMBL623112,,BAO_0000218,
14108,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,N,,A,,CHEMBL623113,,BAO_0000218,
14109,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,,A,,CHEMBL623800,,BAO_0000218,
14110,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,,A,,CHEMBL623801,,BAO_0000218,
14111,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,N,,A,,CHEMBL623802,,BAO_0000218,
14112,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,12017,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623803,,BAO_0000218,
14113,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,12017,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623970,,BAO_0000218,
14114,Rattus norvegicus,50597,995.0,,1,In vivo,,Intermediate,12017,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL623971,,BAO_0000218,
14115,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,N,,A,,CHEMBL623972,,BAO_0000218,
14116,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,N,,A,,CHEMBL623973,,BAO_0000218,
14117,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,N,,A,,CHEMBL623974,,BAO_0000218,
14118,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,N,,A,,CHEMBL623975,,BAO_0000218,
14119,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,N,,A,,CHEMBL623976,,BAO_0000218,
14120,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,N,,A,,CHEMBL623977,,BAO_0000218,
14121,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,N,,A,,CHEMBL623978,,BAO_0000218,
14122,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,N,,A,,CHEMBL623979,,BAO_0000218,
14123,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,N,,A,,CHEMBL623980,,BAO_0000218,
14124,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,N,,A,,CHEMBL623981,,BAO_0000218,
14125,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,N,,A,,CHEMBL626278,,BAO_0000218,
14126,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,N,,A,,CHEMBL626279,,BAO_0000218,
14127,Mus musculus,50594,,,1,In vivo,,Intermediate,14045,Biodistribution in mice bladder plus excreted urine was determined,,N,,A,,CHEMBL626280,,BAO_0000218,
14128,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse blood, 10 minutes post injection",,N,,A,,CHEMBL626281,,BAO_0000218,
14129,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse blood, 30 minutes post injection",,N,,A,,CHEMBL626282,,BAO_0000218,
14130,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse blood, 5 minutes post injection",,N,,A,,CHEMBL626283,,BAO_0000218,
14131,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse blood, 60 minutes post injection",,N,,A,,CHEMBL626284,,BAO_0000218,
14132,Mus musculus,50594,955.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse brain, 10 minutes post injection",,N,,A,,CHEMBL626285,,BAO_0000218,
14133,Mus musculus,50594,955.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse brain, 30 minutes post injection",,N,,A,,CHEMBL626286,,BAO_0000218,
14134,Mus musculus,50594,955.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse brain, 5 minutes post injection",,N,,A,,CHEMBL626287,,BAO_0000218,
14135,Mus musculus,50594,955.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse brain, 60 minutes post injection",,N,,A,,CHEMBL626288,,BAO_0000218,
14136,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse heart, 10 minutes post injection",,N,,A,,CHEMBL626289,,BAO_0000218,
14137,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse heart, 30 minutes post injection",,N,,A,,CHEMBL626290,,BAO_0000218,
14138,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse heart, 5 minutes post injection",,N,,A,,CHEMBL626291,,BAO_0000218,
14139,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse heart, 60 minutes post injection",,N,,A,,CHEMBL839888,,BAO_0000218,
14140,Mus musculus,50594,160.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,N,,A,,CHEMBL626292,,BAO_0000218,
14141,Mus musculus,50594,160.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,N,,A,,CHEMBL626293,,BAO_0000218,
14142,Mus musculus,50594,160.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,N,,A,,CHEMBL626294,,BAO_0000218,
14143,Mus musculus,50594,160.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,N,,A,,CHEMBL626295,,BAO_0000218,
14144,Mus musculus,50594,2107.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse liver, 10 minutes post injection",,N,,A,,CHEMBL627659,,BAO_0000218,
14145,Mus musculus,50594,2107.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,N,,A,,CHEMBL627660,,BAO_0000218,
14146,Mus musculus,50594,2107.0,,1,,,Intermediate,14045,"Percentage biodistribution in mouse liver, 5 minutes post injection",,N,,A,,CHEMBL627661,,BAO_0000218,
14147,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,14045,Biodistribution in mice liver at 60 minutes of post injection,,N,,A,,CHEMBL627662,,BAO_0000218,
14148,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,14045,Biodistribution in mice lungs at 10 min of post injection,,N,,A,,CHEMBL627663,,BAO_0000218,
14149,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mouse lung, 30 minutes post injection",,N,,A,,CHEMBL627664,,BAO_0000218,
14150,Mus musculus,50594,,,1,,,Intermediate,14045,"Percentage biodistribution in mousee lung, 5 minutes post injection",,N,,A,,CHEMBL627665,,BAO_0000218,
14151,Mus musculus,50594,2048.0,,1,In vivo,,Intermediate,14045,Biodistribution in mice lungs at 60 min of post injection,,N,,A,,CHEMBL627666,,BAO_0000218,
14152,Mus musculus,50594,2106.0,,1,,,Intermediate,14045,Percentage biodistribution in mouse spleen,,N,,A,,CHEMBL627667,,BAO_0000218,
14153,Mus musculus,50594,945.0,,1,,,Intermediate,14045,Percentage biodistribution in mouse stomach,,N,,A,,CHEMBL627668,,BAO_0000218,
14154,Mus musculus,50594,1088.0,,1,,,Intermediate,11745,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,N,,A,,CHEMBL627669,,BAO_0000218,
14155,,22224,1255.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,U,,A,,CHEMBL627670,,BAO_0000218,
14156,,22224,178.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,U,,A,,CHEMBL627671,,BAO_0000218,
14157,,22224,1474.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,U,,A,,CHEMBL627672,,BAO_0000218,
14158,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,U,,A,,CHEMBL627673,,BAO_0000218,
14159,,22224,2113.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,U,,A,,CHEMBL627674,,BAO_0000218,
14160,,22224,2107.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,U,,A,,CHEMBL627675,,BAO_0000218,
14161,,22224,2048.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,U,,A,,CHEMBL627676,,BAO_0000218,
14162,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,U,,A,,CHEMBL627677,,BAO_0000218,
14163,,22224,,,1,,,Autocuration,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL627678,,BAO_0000019,
14164,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,7095,Affinity for protein binding expressed as association constant in fresh rat serum,,N,,A,,CHEMBL627679,,BAO_0000218,
14165,,22224,,,1,,,Autocuration,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,,A,,CHEMBL627680,,BAO_0000019,
14166,,22224,,,1,,,Autocuration,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,,A,,CHEMBL627681,,BAO_0000019,
14167,,22224,,,1,,,Autocuration,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,,A,,CHEMBL627682,,BAO_0000019,
14168,,22224,,,1,,,Autocuration,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,,A,,CHEMBL627683,,BAO_0000019,
14169,,22224,,,1,,,Autocuration,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,U,,A,,CHEMBL627684,,BAO_0000019,
14170,,22224,,,1,,,Autocuration,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,,A,,CHEMBL874441,,BAO_0000019,
14171,,22224,,,1,,,Autocuration,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,U,,A,,CHEMBL627685,,BAO_0000019,
14172,,22224,,,1,,,Autocuration,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,,A,,CHEMBL627686,,BAO_0000019,
14173,,22224,,,1,,,Autocuration,8057,Apparent rate constant Koff for inactivation of dTMP synthase.,,U,,A,,CHEMBL627687,,BAO_0000019,
14174,,22224,,,1,,,Autocuration,15778,The irreversible inhibitor activity by second order rate equation.,,U,,A,,CHEMBL627688,,BAO_0000019,
14175,Rattus norvegicus,50597,,,1,,,Intermediate,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,N,,A,,CHEMBL628038,,BAO_0000218,
14176,Rattus norvegicus,50597,,,1,,,Intermediate,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,N,,A,,CHEMBL628039,,BAO_0000218,
14177,Rattus norvegicus,50597,,,1,,,Intermediate,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,N,,A,,CHEMBL628040,,BAO_0000218,
14178,,22224,,,1,,,Autocuration,13588,Dissociation rate calculated from the first-order equation using t1/2 value,,U,,A,,CHEMBL628041,,BAO_0000019,
14179,,22224,,,1,,,Autocuration,15039,The compound was tested for Binding constant against DNA,,U,,A,,CHEMBL630226,,BAO_0000019,
14180,,22224,,,1,,,Autocuration,9500,First order rate constant for cyclization of the compound,,U,,A,,CHEMBL628042,,BAO_0000019,
14181,,22224,,,1,,,Autocuration,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,,A,,CHEMBL625232,,BAO_0000019,
14182,,22224,,,1,,,Autocuration,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,,A,,CHEMBL625233,,BAO_0000019,
14183,,22224,,,1,,,Autocuration,568,Hydrolysis rate constant was determined,,U,,A,,CHEMBL625979,,BAO_0000019,
14184,,22224,,,1,,,Autocuration,10026,Observed first order rate constant,,U,,A,,CHEMBL625980,,BAO_0000019,
14185,,22224,,,1,,,Autocuration,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,A,,CHEMBL625981,,BAO_0000019,
14186,,22224,,,1,,,Autocuration,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,A,,CHEMBL625982,,BAO_0000019,
14187,,22224,,,1,,,Autocuration,9680,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,U,,A,,CHEMBL625983,,BAO_0000019,
14188,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625984,,BAO_0000019,
14189,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625985,,BAO_0000019,
14190,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625986,,BAO_0000019,
14191,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625987,,BAO_0000019,
14192,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625988,,BAO_0000019,
14193,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625989,,BAO_0000019,
14194,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625990,,BAO_0000019,
14195,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625991,,BAO_0000019,
14196,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625992,,BAO_0000019,
14197,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL625993,,BAO_0000019,
14198,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL631973,,BAO_0000019,
14199,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632143,,BAO_0000019,
14200,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632144,,BAO_0000019,
14201,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632145,,BAO_0000019,
14202,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632146,,BAO_0000019,
14203,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632147,,BAO_0000019,
14204,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632148,,BAO_0000019,
14205,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632149,,BAO_0000019,
14206,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632150,,BAO_0000019,
14207,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL632151,,BAO_0000019,
14208,Homo sapiens,50587,,,1,,,Intermediate,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,N,,A,,CHEMBL632152,,BAO_0000218,
14209,Homo sapiens,50587,,,1,,,Intermediate,4509,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,,A,,CHEMBL632153,,BAO_0000218,
14210,Homo sapiens,50587,,,1,,,Intermediate,4509,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,,A,,CHEMBL632154,,BAO_0000218,
14211,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL632155,,BAO_0000218,
14212,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,N,,A,,CHEMBL632156,,BAO_0000218,
14213,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL632157,,BAO_0000218,
14214,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL632158,,BAO_0000218,
14215,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,N,,A,,CHEMBL632159,,BAO_0000218,
14216,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL626305,,BAO_0000218,
14217,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,N,,A,,CHEMBL626306,,BAO_0000218,
14218,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL626307,,BAO_0000218,
14219,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL626308,,BAO_0000218,
14220,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL626479,,BAO_0000218,
14221,Human herpesvirus 1,50602,,,1,,,Intermediate,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,N,,A,,CHEMBL626480,,BAO_0000218,
14222,,22229,,,1,,,Autocuration,6021,Calculated partition coefficient (clogP) (MlogP),,U,,P,,CHEMBL626481,,BAO_0000100,
14223,,22224,,,1,,,Autocuration,9348,Equipotent potent ratio relative to carbachol (nicotinic activity),,U,,A,,CHEMBL626482,,BAO_0000019,
14224,Canis lupus familiaris,50588,,,1,,,Intermediate,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,N,,A,,CHEMBL626483,,BAO_0000218,
14225,Canis lupus familiaris,50588,,,1,,,Intermediate,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,N,,A,,CHEMBL626484,,BAO_0000218,
14226,,22229,,,1,,,Autocuration,15592,Solubility at pH 7.4 in micro g/mL;NA denotes available,,U,,P,,CHEMBL626485,,BAO_0000100,
14227,,22229,,,1,,,Autocuration,15592,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,U,,P,,CHEMBL626486,,BAO_0000100,
14228,,22229,,,1,,,Autocuration,15592,Solubility at pH 7.4 in ug/mL;NA denotes not available,,U,,P,,CHEMBL626487,,BAO_0000100,
14229,Canis lupus familiaris,50588,1969.0,,1,In vivo,,Intermediate,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,N,,A,,CHEMBL626488,,BAO_0000218,
14230,Rattus norvegicus,50597,1977.0,,1,,,Intermediate,7095,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,N,,A,,CHEMBL626489,,BAO_0000218,
14231,,22224,,,1,,,Autocuration,16618,Area under the MAP curve measured over 5 min; ND means Not determined,,U,,A,,CHEMBL626490,,BAO_0000019,
14232,,22224,,,1,,,Autocuration,16835,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,U,,P,,CHEMBL626491,,BAO_0000100,
14233,,22229,,,1,,,Autocuration,15284,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,U,,P,,CHEMBL626492,,BAO_0000100,
14234,,22224,,,1,,,Autocuration,15750,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,U,,A,,CHEMBL626493,,BAO_0000019,
14235,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16618,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,N,,A,,CHEMBL626494,,BAO_0000218,
14236,,22224,,,1,In vivo,,Autocuration,16618,Half life after oral tested,,U,,A,,CHEMBL626495,,BAO_0000218,
14237,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15812,Half life was determined in plasma of rat; NT indicates not tested,,N,,A,,CHEMBL626496,,BAO_0000218,
14238,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,16618,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,N,,A,,CHEMBL626497,,BAO_0000218,
14239,,22224,,,1,In vivo,,Autocuration,16618,Oral bioavailability after oral tested,,U,,A,,CHEMBL626498,,BAO_0000218,
14240,Rattus norvegicus,50597,,,1,,,Intermediate,13098,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,N,,A,,CHEMBL626499,,BAO_0000218,
14241,Rattus norvegicus,50597,,,1,,,Intermediate,13098,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,N,,A,,CHEMBL626500,,BAO_0000218,
14242,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15812,half life was determined in plasma of rat; NT indicates not tested,,N,,A,,CHEMBL626501,,BAO_0000218,
14243,Rattus norvegicus,50597,1969.0,,1,,,Intermediate,15812,half life was determined in plasma of rat; NT means not tested,,N,,A,,CHEMBL626502,,BAO_0000218,
14244,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,N,,A,,CHEMBL626503,,BAO_0000218,
14245,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,N,,A,,CHEMBL626504,,BAO_0000218,
14246,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,N,,A,,CHEMBL626505,,BAO_0000218,
14247,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,N,,A,,CHEMBL626506,,BAO_0000218,
14248,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,N,,A,,CHEMBL626507,,BAO_0000218,
14249,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,N,,A,,CHEMBL626508,,BAO_0000218,
14250,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,N,,A,,CHEMBL626509,,BAO_0000218,
14251,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,N,,A,,CHEMBL875480,,BAO_0000218,
14252,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,N,,A,,CHEMBL626510,,BAO_0000218,
14253,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,N,,A,,CHEMBL626511,,BAO_0000218,
14254,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,N,,A,,CHEMBL626512,,BAO_0000218,
14255,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,N,,A,,CHEMBL628208,,BAO_0000218,
14256,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,N,,A,,CHEMBL628209,,BAO_0000218,
14257,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,N,,A,,CHEMBL628210,,BAO_0000218,
14258,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,N,,A,,CHEMBL628211,,BAO_0000218,
14259,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,N,,A,,CHEMBL628212,,BAO_0000218,
14260,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,N,,A,,CHEMBL628213,,BAO_0000218,
14261,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,,A,,CHEMBL628214,,BAO_0000218,
14262,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,,A,,CHEMBL628215,,BAO_0000218,
14263,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,,A,,CHEMBL628216,,BAO_0000218,
14264,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,,A,,CHEMBL626595,,BAO_0000218,
14265,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,,A,,CHEMBL626596,,BAO_0000218,
14266,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,,A,,CHEMBL626597,,BAO_0000218,
14267,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,,A,,CHEMBL626598,,BAO_0000218,
14268,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,,A,,CHEMBL622242,,BAO_0000218,
14269,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,,A,,CHEMBL622243,,BAO_0000218,
14270,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,,A,,CHEMBL622244,,BAO_0000218,
14271,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,,A,,CHEMBL622245,,BAO_0000218,
14272,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,,A,,CHEMBL622246,,BAO_0000218,
14273,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,,A,,CHEMBL622247,,BAO_0000218,
14274,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,,A,,CHEMBL622248,,BAO_0000218,
14275,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,,A,,CHEMBL877483,,BAO_0000218,
14276,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,,A,,CHEMBL622249,,BAO_0000218,
14277,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,,A,,CHEMBL622250,,BAO_0000218,
14278,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,,A,,CHEMBL622251,,BAO_0000218,
14279,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,,A,,CHEMBL622252,,BAO_0000218,
14280,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,,A,,CHEMBL622253,,BAO_0000218,
14281,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,,A,,CHEMBL622254,,BAO_0000218,
14282,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL622255,,BAO_0000218,
14283,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,,A,,CHEMBL622256,,BAO_0000218,
14284,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,,A,,CHEMBL622257,,BAO_0000218,
14285,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,,A,,CHEMBL622258,,BAO_0000218,
14286,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,,A,,CHEMBL622259,,BAO_0000218,
14287,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,,A,,CHEMBL622927,,BAO_0000218,
14288,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,,A,,CHEMBL622928,,BAO_0000218,
14289,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,,A,,CHEMBL622929,,BAO_0000218,
14290,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,,A,,CHEMBL623182,,BAO_0000218,
14291,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,,A,,CHEMBL623183,,BAO_0000218,
14292,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,,A,,CHEMBL623184,,BAO_0000218,
14293,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,,A,,CHEMBL623185,,BAO_0000218,
14294,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,,A,,CHEMBL877484,,BAO_0000218,
14295,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,,A,,CHEMBL627274,,BAO_0000218,
14296,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,,A,,CHEMBL623186,,BAO_0000218,
14297,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,,A,,CHEMBL623187,,BAO_0000218,
14298,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,,A,,CHEMBL623188,,BAO_0000218,
14299,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,,A,,CHEMBL628055,,BAO_0000218,
14300,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,,A,,CHEMBL628056,,BAO_0000218,
14301,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,,A,,CHEMBL628200,,BAO_0000218,
14302,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,,A,,CHEMBL628201,,BAO_0000218,
14303,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,,A,,CHEMBL628202,,BAO_0000218,
14304,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,,A,,CHEMBL628203,,BAO_0000218,
14305,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,,A,,CHEMBL628204,,BAO_0000218,
14306,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,,A,,CHEMBL628205,,BAO_0000218,
14307,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,,A,,CHEMBL628206,,BAO_0000218,
14308,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,U,,A,,CHEMBL628207,,BAO_0000218,
14309,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,U,,A,,CHEMBL627220,,BAO_0000218,
14310,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,U,,A,,CHEMBL627221,,BAO_0000218,
14311,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,U,,A,,CHEMBL627222,,BAO_0000218,
14312,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,U,,A,,CHEMBL627223,,BAO_0000218,
14313,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,U,,A,,CHEMBL632062,,BAO_0000218,
14314,,22224,2106.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,U,,A,,CHEMBL632063,,BAO_0000218,
14315,,22224,1255.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,U,,A,,CHEMBL632064,,BAO_0000218,
14316,,22224,178.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,U,,A,,CHEMBL632065,,BAO_0000218,
14317,,22224,1474.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,U,,A,,CHEMBL632066,,BAO_0000218,
14318,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,U,,A,,CHEMBL632067,,BAO_0000218,
14319,,22224,2113.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,U,,A,,CHEMBL629188,,BAO_0000218,
14320,,22224,2107.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,U,,A,,CHEMBL629189,,BAO_0000218,
14321,,22224,2048.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,U,,A,,CHEMBL629190,,BAO_0000218,
14322,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,U,,A,,CHEMBL629191,,BAO_0000218,
14323,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,U,,A,,CHEMBL629192,,BAO_0000218,
14324,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,U,,A,,CHEMBL629193,,BAO_0000218,
14325,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,U,,A,,CHEMBL629194,,BAO_0000218,
14326,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,U,,A,,CHEMBL629195,,BAO_0000218,
14327,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,U,,A,,CHEMBL629373,,BAO_0000218,
14328,,22224,2106.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,U,,A,,CHEMBL629374,,BAO_0000218,
14329,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,U,,A,,CHEMBL629375,,BAO_0000218,
14330,,22224,1255.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,U,,A,,CHEMBL629376,,BAO_0000218,
14331,,22224,178.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,U,,A,,CHEMBL629377,,BAO_0000218,
14332,,22224,1474.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,U,,A,,CHEMBL629378,,BAO_0000218,
14333,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,U,,A,,CHEMBL629379,,BAO_0000218,
14334,,22224,2113.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,U,,A,,CHEMBL629151,,BAO_0000218,
14335,,22224,2107.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,U,,A,,CHEMBL629152,,BAO_0000218,
14336,,22224,2048.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,U,,A,,CHEMBL629153,,BAO_0000218,
14337,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,U,,A,,CHEMBL629154,,BAO_0000218,
14338,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,U,,A,,CHEMBL629155,,BAO_0000218,
14339,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,U,,A,,CHEMBL629156,,BAO_0000218,
14340,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,U,,A,,CHEMBL629157,,BAO_0000218,
14341,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,U,,A,,CHEMBL629158,,BAO_0000218,
14342,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,U,,A,,CHEMBL629159,,BAO_0000218,
14343,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,U,,A,,CHEMBL629160,,BAO_0000218,
14344,,22224,2106.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,U,,A,,CHEMBL629161,,BAO_0000218,
14345,,22224,1255.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,U,,A,,CHEMBL629162,,BAO_0000218,
14346,,22224,178.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,U,,A,,CHEMBL629163,,BAO_0000218,
14347,,22224,1474.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,U,,A,,CHEMBL629164,,BAO_0000218,
14348,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,U,,A,,CHEMBL629165,,BAO_0000218,
14349,,22224,2107.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,U,,A,,CHEMBL629166,,BAO_0000218,
14350,,22224,2048.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,U,,A,,CHEMBL629167,,BAO_0000218,
14351,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,U,,A,,CHEMBL629168,,BAO_0000218,
14352,,22224,,,1,,,Autocuration,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,U,,A,,CHEMBL629169,,BAO_0000019,
14353,,22224,,,1,,,Autocuration,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,U,,A,,CHEMBL629170,,BAO_0000019,
14354,,22224,,,1,,,Autocuration,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,U,,A,,CHEMBL631153,,BAO_0000019,
14355,,22224,,,1,,,Autocuration,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,U,,A,,CHEMBL875121,,BAO_0000019,
14356,,22224,,,1,,,Autocuration,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,U,,A,,CHEMBL631154,,BAO_0000019,
14357,,22224,,,1,,,Autocuration,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,U,,A,,CHEMBL631155,,BAO_0000019,
14358,,22224,,,1,,,Autocuration,568,Hydrolysis rate constant was determined,,U,,A,,CHEMBL631156,,BAO_0000019,
14359,,22224,,,1,,,Autocuration,9680,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,U,,A,,CHEMBL631157,,BAO_0000019,
14360,,22224,,,1,,,Autocuration,9680,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,,A,,CHEMBL631158,,BAO_0000019,
14361,,22224,,,1,,,Autocuration,9680,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,,A,,CHEMBL631159,,BAO_0000019,
14362,,22224,,,1,,,Autocuration,10026,Observed second order rate constant,,U,,A,,CHEMBL631160,,BAO_0000019,
14363,,22224,,,1,,,Autocuration,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,A,,CHEMBL631161,,BAO_0000019,
14364,,22224,,,1,,,Autocuration,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,,A,,CHEMBL631162,,BAO_0000019,
14365,,22224,,,1,,,Autocuration,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,,A,,CHEMBL630313,,BAO_0000019,
14366,,22224,,,1,,,Autocuration,9680,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,,A,,CHEMBL630314,,BAO_0000019,
14367,,22224,,,1,,,Autocuration,9680,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,,A,,CHEMBL630315,,BAO_0000019,
14368,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630316,,BAO_0000019,
14369,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630986,,BAO_0000019,
14370,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630987,,BAO_0000019,
14371,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630988,,BAO_0000019,
14372,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630989,,BAO_0000019,
14373,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630990,,BAO_0000019,
14374,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630991,,BAO_0000019,
14375,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630992,,BAO_0000019,
14376,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630993,,BAO_0000019,
14377,,22224,,,1,,,Autocuration,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,A,,CHEMBL630994,,BAO_0000019,
14378,Rattus norvegicus,50597,,,1,,,Intermediate,10014,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,N,,A,,CHEMBL630995,,BAO_0000218,
14379,,22224,,,1,,,Autocuration,9962,Association constant for compound at 31 degree C was determined,,U,,A,,CHEMBL629252,,BAO_0000019,
14380,,22224,,,1,,,Autocuration,12029,Calculated antagonist equilibrium dissociation constant of the compound,,U,,A,,CHEMBL629253,,BAO_0000019,
14381,,22224,,,1,,,Autocuration,12029,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,U,,A,,CHEMBL629944,,BAO_0000019,
14382,Cavia porcellus,50512,3126.0,,1,,,Intermediate,10583,Dissociation constants vs LTE4 on guinea pig trachea,,N,,A,,CHEMBL629945,,BAO_0000218,
14383,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,U,,A,,CHEMBL629946,,BAO_0000019,
14384,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,U,,A,,CHEMBL629947,,BAO_0000019,
14385,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,U,,A,,CHEMBL629948,,BAO_0000019,
14386,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,U,,A,,CHEMBL856024,,BAO_0000019,
14387,,22224,,,1,,,Autocuration,7493,Affinity constant KD value was derived from TMP,,U,,A,,CHEMBL629949,,BAO_0000019,
14388,,22224,,,1,,,Autocuration,8371,Apparent dissociation (binding) rate constant was evaluated,,U,,A,,CHEMBL629950,,BAO_0000019,
14389,,22224,,,1,,,Autocuration,13114,Dissociation constant (KD) of the compound,,U,,P,,CHEMBL630127,,BAO_0000100,
14390,,22224,,,1,,,Autocuration,15515,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,U,,P,,CHEMBL630128,,BAO_0000100,
14391,,22224,,,1,,,Autocuration,522,Dissociation constant from ESR titration experiments,,U,,P,,CHEMBL630129,,BAO_0000100,
14392,,22224,,,1,,,Autocuration,13888,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,U,,,,CHEMBL630130,,BAO_0000019,
14393,,22224,,,1,,,Autocuration,2616,Dissociation constant was evaluated.,,U,,P,,CHEMBL875234,,BAO_0000100,
14394,,22224,,,1,,,Autocuration,3798,Dissociation constant was reported,,U,,P,,CHEMBL630131,,BAO_0000100,
14395,Rattus norvegicus,50597,,,1,,,Intermediate,8731,Dissociation constant was determined in rat pituitary cells.,,N,,A,,CHEMBL630132,,BAO_0000218,
14396,,22224,,,1,,,Autocuration,11892,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,U,,A,,CHEMBL630133,,BAO_0000019,
14397,,22224,,,1,,,Autocuration,11892,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,U,,A,,CHEMBL630134,,BAO_0000019,
14398,,22224,,,1,,,Autocuration,2582,Equilibrium dissociation constant of the compound,,U,,A,,CHEMBL630135,,BAO_0000019,
14399,,22224,,,1,,,Autocuration,11892,Equilibrium dissociation constant was determined,,U,,A,,CHEMBL630136,,BAO_0000019,
14400,,22224,,,1,,,Autocuration,13396,Kinetic constant KD was evaluated,,U,,A,,CHEMBL630137,,BAO_0000019,
14401,,22224,,,1,,,Autocuration,603,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,U,,A,,CHEMBL630138,,BAO_0000019,
14402,,22224,,,1,,,Autocuration,15673,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,U,,A,,CHEMBL630139,,BAO_0000019,
14403,,22224,,,1,,,Autocuration,10368,Rate constant for hydrolysis in aqueous acetone.,,U,,A,,CHEMBL630140,,BAO_0000019,
14404,,22224,,,1,,,Autocuration,14228,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,U,,A,,CHEMBL875235,,BAO_0000019,
14405,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,N,,A,,CHEMBL876439,,BAO_0000218,
14406,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,N,,A,,CHEMBL630605,,BAO_0000218,
14407,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,N,,A,,CHEMBL630606,,BAO_0000218,
14408,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,N,,A,,CHEMBL630607,,BAO_0000218,
14409,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,N,,A,,CHEMBL630608,,BAO_0000218,
14410,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,N,,A,,CHEMBL630609,,BAO_0000218,
14411,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,N,,A,,CHEMBL630610,,BAO_0000218,
14412,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,N,,A,,CHEMBL630611,,BAO_0000218,
14413,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,N,,A,,CHEMBL629552,,BAO_0000218,
14414,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,,A,,CHEMBL629733,,BAO_0000218,
14415,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,,A,,CHEMBL629734,,BAO_0000218,
14416,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,,A,,CHEMBL629735,,BAO_0000218,
14417,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,,A,,CHEMBL629736,,BAO_0000218,
14418,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,,A,,CHEMBL629737,,BAO_0000218,
14419,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,,A,,CHEMBL629738,,BAO_0000218,
14420,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,,A,,CHEMBL629739,,BAO_0000218,
14421,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,,A,,CHEMBL629740,,BAO_0000218,
14422,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,,A,,CHEMBL629741,,BAO_0000218,
14423,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,,A,,CHEMBL629742,,BAO_0000218,
14424,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,,A,,CHEMBL629743,,BAO_0000218,
14425,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,,A,,CHEMBL629744,,BAO_0000218,
14426,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,,A,,CHEMBL629745,,BAO_0000218,
14427,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,,A,,CHEMBL629746,,BAO_0000218,
14428,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,,A,,CHEMBL629747,,BAO_0000218,
14429,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,,A,,CHEMBL629748,,BAO_0000218,
14430,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,,A,,CHEMBL629749,,BAO_0000218,
14431,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,,A,,CHEMBL629750,,BAO_0000218,
14432,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,,A,,CHEMBL629751,,BAO_0000218,
14433,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,,A,,CHEMBL629752,,BAO_0000218,
14434,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,,A,,CHEMBL629753,,BAO_0000218,
14435,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,,A,,CHEMBL629754,,BAO_0000218,
14436,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,,A,,CHEMBL629755,,BAO_0000218,
14437,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,,A,,CHEMBL629756,,BAO_0000218,
14438,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,,A,,CHEMBL629757,,BAO_0000218,
14439,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,,A,,CHEMBL629758,,BAO_0000218,
14440,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,,A,,CHEMBL629759,,BAO_0000218,
14441,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,,A,,CHEMBL629760,,BAO_0000218,
14442,Rattus norvegicus,50597,,,1,,,Intermediate,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,,A,,CHEMBL876443,,BAO_0000218,
14443,Canis lupus familiaris,50588,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,,A,,CHEMBL629761,,BAO_0000218,
14444,Canis lupus familiaris,50588,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,N,,A,,CHEMBL629762,,BAO_0000218,
14445,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,A,,CHEMBL629763,,BAO_0000218,
14446,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,,A,,CHEMBL629764,,BAO_0000218,
14447,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,,A,,CHEMBL629765,,BAO_0000218,
14448,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,N,,A,,CHEMBL629766,,BAO_0000218,
14449,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,A,,CHEMBL629767,,BAO_0000218,
14450,Canis lupus familiaris,50588,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,N,,A,,CHEMBL629768,,BAO_0000218,
14451,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,N,,A,,CHEMBL629769,,BAO_0000218,
14452,Canis lupus familiaris,50588,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,,A,,CHEMBL629770,,BAO_0000218,
14453,Canis lupus familiaris,50588,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,N,,A,,CHEMBL629771,,BAO_0000218,
14454,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,A,,CHEMBL629772,,BAO_0000218,
14455,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,A,,CHEMBL629773,,BAO_0000218,
14456,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,,A,,CHEMBL625455,,BAO_0000218,
14457,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,N,,A,,CHEMBL625456,,BAO_0000218,
14458,Mus musculus,50594,,,1,,,Intermediate,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,N,,A,,CHEMBL625457,,BAO_0000218,
14459,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,,A,,CHEMBL625458,,BAO_0000218,
14460,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,,A,,CHEMBL625459,,BAO_0000218,
14461,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,,A,,CHEMBL875483,,BAO_0000218,
14462,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,,A,,CHEMBL634779,,BAO_0000218,
14463,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,,A,,CHEMBL625460,,BAO_0000218,
14464,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,,A,,CHEMBL626117,,BAO_0000218,
14465,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,,A,,CHEMBL626118,,BAO_0000218,
14466,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,,A,,CHEMBL628342,,BAO_0000218,
14467,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,,A,,CHEMBL628343,,BAO_0000218,
14468,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,,A,,CHEMBL628344,,BAO_0000218,
14469,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,,A,,CHEMBL628345,,BAO_0000218,
14470,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,,A,,CHEMBL628346,,BAO_0000218,
14471,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,,A,,CHEMBL628347,,BAO_0000218,
14472,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,,A,,CHEMBL628348,,BAO_0000218,
14473,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,,A,,CHEMBL628349,,BAO_0000218,
14474,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,,A,,CHEMBL875611,,BAO_0000218,
14475,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,,A,,CHEMBL628350,,BAO_0000218,
14476,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,,A,,CHEMBL628351,,BAO_0000218,
14477,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,,A,,CHEMBL628352,,BAO_0000218,
14478,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,,A,,CHEMBL628353,,BAO_0000218,
14479,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,,A,,CHEMBL628354,,BAO_0000218,
14480,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,,A,,CHEMBL626667,,BAO_0000218,
14481,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL626668,,BAO_0000218,
14482,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,,A,,CHEMBL626669,,BAO_0000218,
14483,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,,A,,CHEMBL626670,,BAO_0000218,
14484,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,,A,,CHEMBL626671,,BAO_0000218,
14485,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,,A,,CHEMBL626672,,BAO_0000218,
14486,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,N,,A,,CHEMBL626673,,BAO_0000218,
14487,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,,A,,CHEMBL626674,,BAO_0000218,
14488,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,,A,,CHEMBL626675,,BAO_0000218,
14489,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,N,,A,,CHEMBL626676,,BAO_0000218,
14490,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,N,,A,,CHEMBL626677,,BAO_0000218,
14491,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,,A,,CHEMBL626678,,BAO_0000218,
14492,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,,A,,CHEMBL626679,,BAO_0000218,
14493,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,,A,,CHEMBL875612,,BAO_0000218,
14494,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,,A,,CHEMBL626680,,BAO_0000218,
14495,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,,A,,CHEMBL626681,,BAO_0000218,
14496,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,,A,,CHEMBL626682,,BAO_0000218,
14497,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,,A,,CHEMBL626683,,BAO_0000218,
14498,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,,A,,CHEMBL626684,,BAO_0000218,
14499,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,,A,,CHEMBL626685,,BAO_0000218,
14500,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,,A,,CHEMBL626686,,BAO_0000218,
14501,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,,A,,CHEMBL626687,,BAO_0000218,
14502,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,,A,,CHEMBL624978,,BAO_0000218,
14503,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,,A,,CHEMBL624979,,BAO_0000218,
14504,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,,A,,CHEMBL624980,,BAO_0000218,
14505,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,,A,,CHEMBL624981,,BAO_0000218,
14506,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,,A,,CHEMBL624982,,BAO_0000218,
14507,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,U,,A,,CHEMBL627564,,BAO_0000218,
14508,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,U,,A,,CHEMBL627565,,BAO_0000218,
14509,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,U,,A,,CHEMBL627566,,BAO_0000218,
14510,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,U,,A,,CHEMBL627567,,BAO_0000218,
14511,,22224,2106.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,U,,A,,CHEMBL627568,,BAO_0000218,
14512,,22224,2113.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,U,,A,,CHEMBL627569,,BAO_0000218,
14513,,22224,1255.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,U,,A,,CHEMBL627570,,BAO_0000218,
14514,,22224,178.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,U,,A,,CHEMBL627571,,BAO_0000218,
14515,,22224,1474.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,U,,A,,CHEMBL627572,,BAO_0000218,
14516,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,U,,A,,CHEMBL627573,,BAO_0000218,
14517,,22224,2113.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,U,,A,,CHEMBL627574,,BAO_0000218,
14518,,22224,2107.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,U,,A,,CHEMBL627575,,BAO_0000218,
14519,,22224,2048.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,U,,A,,CHEMBL627576,,BAO_0000218,
14520,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,U,,A,,CHEMBL627577,,BAO_0000218,
14521,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,U,,A,,CHEMBL627578,,BAO_0000218,
14522,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,U,,A,,CHEMBL627579,,BAO_0000218,
14523,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,U,,A,,CHEMBL627580,,BAO_0000218,
14524,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,U,,A,,CHEMBL627581,,BAO_0000218,
14525,,22224,,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,U,,A,,CHEMBL627582,,BAO_0000218,
14526,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,U,,A,,CHEMBL627583,,BAO_0000218,
14527,,22224,2106.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,U,,A,,CHEMBL627584,,BAO_0000218,
14528,,22224,2367.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,U,,A,,CHEMBL627585,,BAO_0000218,
14529,,22224,2385.0,,1,In vivo,,Autocuration,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,U,,A,,CHEMBL627586,,BAO_0000218,
14530,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,N,,A,,CHEMBL627587,,BAO_0000218,
14531,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL627588,,BAO_0000218,
14532,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,N,,A,,CHEMBL628250,,BAO_0000218,
14533,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628251,,BAO_0000218,
14534,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,N,,A,,CHEMBL628252,,BAO_0000218,
14535,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628253,,BAO_0000218,
14536,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,N,,A,,CHEMBL628254,,BAO_0000218,
14537,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL877493,,BAO_0000218,
14538,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628255,,BAO_0000218,
14539,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628256,,BAO_0000218,
14540,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628257,,BAO_0000218,
14541,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628258,,BAO_0000218,
14542,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628259,,BAO_0000218,
14543,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL628429,,BAO_0000218,
14544,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,N,,A,,CHEMBL626862,,BAO_0000218,
14545,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,N,,A,,CHEMBL626863,,BAO_0000218,
14546,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,N,,A,,CHEMBL625886,,BAO_0000218,
14547,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,N,,A,,CHEMBL625887,,BAO_0000218,
14548,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,N,,A,,CHEMBL625888,,BAO_0000218,
14549,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,N,,A,,CHEMBL625889,,BAO_0000218,
14550,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,N,,A,,CHEMBL625890,,BAO_0000218,
14551,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,N,,A,,CHEMBL625891,,BAO_0000218,
14552,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,N,,A,,CHEMBL625892,,BAO_0000218,
14553,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,N,,A,,CHEMBL625893,,BAO_0000218,
14554,Rattus norvegicus,50597,2037.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,N,,A,,CHEMBL625894,,BAO_0000218,
14555,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,15413,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,N,,A,,CHEMBL625895,,BAO_0000218,
14556,,22224,,,1,,,Autocuration,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,A,,CHEMBL625896,,BAO_0000019,
14557,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,U,,A,,CHEMBL625897,,BAO_0000019,
14558,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,,A,,CHEMBL625898,,BAO_0000019,
14559,,22224,,,1,,,Autocuration,568,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,,A,,CHEMBL625899,,BAO_0000019,
14560,,22224,,,1,,,Autocuration,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,A,,CHEMBL626124,,BAO_0000019,
14561,Escherichia coli,50212,,,1,,,Intermediate,7624,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,N,,A,,CHEMBL628500,,BAO_0000218,
14562,Rattus norvegicus,50597,,,1,,,Intermediate,7624,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,N,,A,,CHEMBL857856,,BAO_0000218,
14563,Rattus norvegicus,50597,,,1,,,Intermediate,7624,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,N,,A,,CHEMBL628501,,BAO_0000218,
14564,,22224,,,1,,,Autocuration,4643,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,U,,A,,CHEMBL628502,,BAO_0000019,
14565,,22224,,,1,,,Autocuration,11532,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,U,,A,,CHEMBL628503,,BAO_0000019,
14566,,22224,,,1,,,Autocuration,11018,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,U,,A,,CHEMBL628504,,BAO_0000019,
14567,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,,A,,CHEMBL628505,,BAO_0000019,
14568,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,U,,A,,CHEMBL874452,,BAO_0000019,
14569,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,U,,A,,CHEMBL628506,,BAO_0000019,
14570,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,,A,,CHEMBL628507,,BAO_0000019,
14571,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,U,,A,,CHEMBL628508,,BAO_0000019,
14572,,22224,,,1,,,Autocuration,8949,Michaelis constant (KM) was evaluated,,U,,A,,CHEMBL628509,,BAO_0000019,
14573,,22224,,,1,,,Autocuration,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,A,,CHEMBL628510,,BAO_0000019,
14574,,22224,,,1,,,Autocuration,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,U,,B,,CHEMBL628511,,BAO_0000019,
14575,,22224,,,1,,,Autocuration,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,U,,B,,CHEMBL628512,,BAO_0000019,
14576,,22224,,,1,,,Autocuration,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,U,,B,,CHEMBL628513,,BAO_0000019,
14577,,22224,,,1,,,Autocuration,7625,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,U,,B,,CHEMBL628514,,BAO_0000019,
14578,,22224,,,1,,,Autocuration,12908,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,U,,A,,CHEMBL628515,,BAO_0000019,
14579,,22224,,,1,,,Autocuration,10368,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,U,,A,,CHEMBL628516,,BAO_0000019,
14580,,22224,,,1,,,Autocuration,13108,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,,A,,CHEMBL628517,,BAO_0000019,
14581,,22224,,,1,,,Autocuration,13108,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,,A,,CHEMBL628518,,BAO_0000019,
14582,,22224,,,1,,,Autocuration,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,U,,A,,CHEMBL628519,,BAO_0000019,
14583,,22224,,,1,,,Autocuration,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,U,,A,,CHEMBL628520,,BAO_0000019,
14584,,22224,,,1,,,Autocuration,10933,Binding constant was determined,,U,,A,,CHEMBL628521,,BAO_0000019,
14585,,22224,,,1,,,Autocuration,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,U,,A,,CHEMBL630443,,BAO_0000019,
14586,,22224,,,1,,,Autocuration,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,U,,A,,CHEMBL630444,,BAO_0000019,
14587,,22224,,,1,,,Autocuration,2276,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,U,,A,,CHEMBL857732,,BAO_0000019,
14588,,22224,,,1,,,Autocuration,14915,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,U,,P,,CHEMBL630445,,BAO_0000100,
14589,,22224,,,1,,,Autocuration,8847,Catalytic rate constant of the compound,,U,,A,,CHEMBL630446,,BAO_0000019,
14590,,22224,,,1,,,Autocuration,15357,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,U,,B,,CHEMBL630447,,BAO_0000019,
14591,,22224,,,1,,,Autocuration,2869,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,U,,A,,CHEMBL630448,,BAO_0000019,
14592,,22224,,,1,,,Autocuration,3484,Catalytic rate constant against phospholipase A2 was determined,,U,,A,,CHEMBL630449,,BAO_0000019,
14593,,22224,,,1,,,Autocuration,1373,"Compound was evaluated for catalytic constant, Kcat",,U,,A,,CHEMBL630450,,BAO_0000019,
14594,,22224,,,1,,,Autocuration,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,U,,A,,CHEMBL630451,,BAO_0000019,
14595,,22224,,,1,,,Autocuration,14131,Kcat calculated from 0.693/T1/2,,U,,A,,CHEMBL630452,,BAO_0000019,
14596,,22224,,,1,,,Autocuration,17269,Kcat was determined,,U,,A,,CHEMBL630453,,BAO_0000019,
14597,,22224,,,1,,,Autocuration,3485,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,U,,A,,CHEMBL630454,,BAO_0000019,
14598,,22224,,,1,,,Autocuration,3485,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,U,,A,,CHEMBL630455,,BAO_0000019,
14599,,22224,,,1,,,Autocuration,3485,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,U,,A,,CHEMBL631487,,BAO_0000019,
14600,,22224,,,1,,,Autocuration,5962,Kcat value was determined,,U,,A,,CHEMBL631488,,BAO_0000019,
14601,,22224,,,1,,,Autocuration,3133,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,U,,A,,CHEMBL876440,,BAO_0000019,
14602,,22224,,,1,,,Autocuration,3133,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,U,,A,,CHEMBL631489,,BAO_0000019,
14603,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,,A,,CHEMBL857742,,BAO_0000019,
14604,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,,A,,CHEMBL631490,,BAO_0000019,
14605,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,U,,A,,CHEMBL631491,,BAO_0000019,
14606,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,,A,,CHEMBL631492,,BAO_0000019,
14607,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,,A,,CHEMBL631493,,BAO_0000019,
14608,,22224,,,1,,,Autocuration,4892,Kinetic parameter for rate of conversion to PABA was determined,,U,,A,,CHEMBL631494,,BAO_0000019,
14609,,22224,,,1,,,Autocuration,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,,A,,CHEMBL631495,,BAO_0000019,
14610,Rattus norvegicus,50597,1988.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,,A,,CHEMBL631496,,BAO_0000218,
14611,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,,A,,CHEMBL631497,,BAO_0000218,
14612,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,,A,,CHEMBL631498,,BAO_0000218,
14613,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,,A,,CHEMBL629776,,BAO_0000218,
14614,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,,A,,CHEMBL629777,,BAO_0000218,
14615,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,,A,,CHEMBL629778,,BAO_0000218,
14616,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,N,,A,,CHEMBL630456,,BAO_0000218,
14617,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,N,,A,,CHEMBL630457,,BAO_0000218,
14618,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,N,,A,,CHEMBL630458,,BAO_0000218,
14619,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,N,,A,,CHEMBL630459,,BAO_0000218,
14620,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,N,,A,,CHEMBL630460,,BAO_0000218,
14621,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,N,,A,,CHEMBL876550,,BAO_0000218,
14622,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,N,,A,,CHEMBL630461,,BAO_0000218,
14623,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,N,,A,,CHEMBL630462,,BAO_0000218,
14624,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,N,,A,,CHEMBL630463,,BAO_0000218,
14625,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,N,,A,,CHEMBL630464,,BAO_0000218,
14626,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,N,,A,,CHEMBL630465,,BAO_0000218,
14627,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,N,,A,,CHEMBL630466,,BAO_0000218,
14628,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,N,,A,,CHEMBL630467,,BAO_0000218,
14629,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,N,,A,,CHEMBL630633,,BAO_0000218,
14630,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,N,,A,,CHEMBL630634,,BAO_0000218,
14631,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,N,,A,,CHEMBL630635,,BAO_0000218,
14632,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,N,,A,,CHEMBL630636,,BAO_0000218,
14633,Rattus norvegicus,50597,,,1,,,Intermediate,11488,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,N,,A,,CHEMBL630637,,BAO_0000218,
14634,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,,A,,CHEMBL630638,,BAO_0000218,
14635,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,,A,,CHEMBL630639,,BAO_0000218,
14636,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,,A,,CHEMBL630640,,BAO_0000218,
14637,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,,A,,CHEMBL876551,,BAO_0000218,
14638,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,N,,A,,CHEMBL630641,,BAO_0000218,
14639,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,,A,,CHEMBL630642,,BAO_0000218,
14640,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,,A,,CHEMBL630643,,BAO_0000218,
14641,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,,A,,CHEMBL630644,,BAO_0000218,
14642,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,,A,,CHEMBL630645,,BAO_0000218,
14643,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,,A,,CHEMBL625599,,BAO_0000218,
14644,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,,A,,CHEMBL625600,,BAO_0000218,
14645,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,,A,,CHEMBL625601,,BAO_0000218,
14646,Oryctolagus cuniculus,50592,1988.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,,A,,CHEMBL625602,,BAO_0000218,
14647,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,N,,A,,CHEMBL627470,,BAO_0000218,
14648,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,,A,,CHEMBL627471,,BAO_0000218,
14649,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,,A,,CHEMBL627472,,BAO_0000218,
14650,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,,A,,CHEMBL627473,,BAO_0000218,
14651,Oryctolagus cuniculus,50592,1088.0,,1,,,Intermediate,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,,A,,CHEMBL627474,,BAO_0000218,
14652,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL627475,,BAO_0000218,
14653,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL627476,,BAO_0000218,
14654,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,,A,,CHEMBL627477,,BAO_0000218,
14655,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,,A,,CHEMBL627478,,BAO_0000218,
14656,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,,A,,CHEMBL627479,,BAO_0000218,
14657,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,,A,,CHEMBL627480,,BAO_0000218,
14658,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,,A,,CHEMBL627481,,BAO_0000218,
14659,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL627482,,BAO_0000218,
14660,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,,A,,CHEMBL627483,,BAO_0000218,
14661,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,,A,,CHEMBL875636,,BAO_0000218,
14662,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,,A,,CHEMBL625764,,BAO_0000218,
14663,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,,A,,CHEMBL625765,,BAO_0000218,
14664,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,,A,,CHEMBL625766,,BAO_0000218,
14665,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,,A,,CHEMBL625767,,BAO_0000218,
14666,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,,A,,CHEMBL625768,,BAO_0000218,
14667,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL625769,,BAO_0000218,
14668,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,,A,,CHEMBL625770,,BAO_0000218,
14669,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,,A,,CHEMBL625771,,BAO_0000218,
14670,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,N,,A,,CHEMBL625772,,BAO_0000218,
14671,Canis lupus familiaris,50588,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,,A,,CHEMBL625773,,BAO_0000218,
14672,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,,A,,CHEMBL625774,,BAO_0000218,
14673,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,,A,,CHEMBL625775,,BAO_0000218,
14674,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,,A,,CHEMBL625776,,BAO_0000218,
14675,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,,A,,CHEMBL625777,,BAO_0000218,
14676,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,,A,,CHEMBL625778,,BAO_0000218,
14677,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,,A,,CHEMBL625779,,BAO_0000218,
14678,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,,A,,CHEMBL625780,,BAO_0000218,
14679,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,,A,,CHEMBL625781,,BAO_0000218,
14680,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,,A,,CHEMBL875637,,BAO_0000218,
14681,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,,A,,CHEMBL626473,,BAO_0000218,
14682,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,,A,,CHEMBL626474,,BAO_0000218,
14683,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,,A,,CHEMBL626475,,BAO_0000218,
14684,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,,A,,CHEMBL626476,,BAO_0000218,
14685,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,,A,,CHEMBL634397,,BAO_0000218,
14686,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,,A,,CHEMBL626477,,BAO_0000218,
14687,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,,A,,CHEMBL631069,,BAO_0000218,
14688,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,,A,,CHEMBL631070,,BAO_0000218,
14689,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,,A,,CHEMBL631071,,BAO_0000218,
14690,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,,A,,CHEMBL631072,,BAO_0000218,
14691,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,,A,,CHEMBL631073,,BAO_0000218,
14692,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,,A,,CHEMBL631074,,BAO_0000218,
14693,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,,A,,CHEMBL631075,,BAO_0000218,
14694,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,,A,,CHEMBL631725,,BAO_0000218,
14695,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,,A,,CHEMBL631726,,BAO_0000218,
14696,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,,A,,CHEMBL631727,,BAO_0000218,
14697,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,,A,,CHEMBL631728,,BAO_0000218,
14698,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,,A,,CHEMBL631729,,BAO_0000218,
14699,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,,A,,CHEMBL631730,,BAO_0000218,
14700,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,,A,,CHEMBL631731,,BAO_0000218,
14701,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,,A,,CHEMBL631910,,BAO_0000218,
14702,Rattus norvegicus,50597,10000000.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,N,,A,,CHEMBL631911,,BAO_0000218,
14703,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,N,,A,,CHEMBL631912,,BAO_0000218,
14704,Rattus norvegicus,50597,1898.0,,1,In vivo,,Intermediate,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,N,,A,,CHEMBL631913,,BAO_0000218,
14705,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631914,,BAO_0000218,
14706,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631915,,BAO_0000218,
14707,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL875778,,BAO_0000218,
14708,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631916,,BAO_0000218,
14709,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631917,,BAO_0000218,
14710,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631918,,BAO_0000218,
14711,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631919,,BAO_0000218,
14712,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL631920,,BAO_0000218,
14713,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631921,,BAO_0000218,
14714,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631922,,BAO_0000218,
14715,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,12017,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL631923,,BAO_0000218,
14716,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631924,,BAO_0000218,
14717,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630234,,BAO_0000218,
14718,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630235,,BAO_0000218,
14719,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630236,,BAO_0000218,
14720,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630237,,BAO_0000218,
14721,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630238,,BAO_0000218,
14722,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630239,,BAO_0000218,
14723,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630303,,BAO_0000218,
14724,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630304,,BAO_0000218,
14725,Rattus norvegicus,50597,,,1,In vivo,,Intermediate,12017,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630305,,BAO_0000218,
14726,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630306,,BAO_0000218,
14727,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630307,,BAO_0000218,
14728,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630308,,BAO_0000218,
14729,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630309,,BAO_0000218,
14730,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL629309,,BAO_0000218,
14731,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL629993,,BAO_0000218,
14732,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL629994,,BAO_0000218,
14733,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL629995,,BAO_0000218,
14734,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631993,,BAO_0000218,
14735,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631994,,BAO_0000218,
14736,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631995,,BAO_0000218,
14737,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL631996,,BAO_0000218,
14738,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631997,,BAO_0000218,
14739,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631998,,BAO_0000218,
14740,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631999,,BAO_0000218,
14741,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL632000,,BAO_0000218,
14742,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL632001,,BAO_0000218,
14743,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL874424,,BAO_0000218,
14744,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL632002,,BAO_0000218,
14745,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL632003,,BAO_0000218,
14746,,22224,,,1,,,Autocuration,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,,A,,CHEMBL632004,,BAO_0000019,
14747,,22224,,,1,,,Autocuration,2742,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,U,,A,,CHEMBL632005,,BAO_0000019,
14748,,22224,,,1,,,Autocuration,2742,Compound was tested for amidase rate in the presence of N62C screen enzyme,,U,,A,,CHEMBL632006,,BAO_0000019,
14749,,22224,,,1,,,Autocuration,2742,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,U,,A,,CHEMBL632007,,BAO_0000019,
14750,,22224,,,1,,,Autocuration,2742,Compound was tested for amidase rate in the presence of S166C screen enzyme,,U,,A,,CHEMBL632008,,BAO_0000019,
14751,,22224,,,1,,,Autocuration,2742,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,U,,A,,CHEMBL632009,,BAO_0000019,
14752,,22224,,,1,,,Autocuration,2742,Compound was tested for esterase rate in the presence of N62C screen enzyme,,U,,A,,CHEMBL632010,,BAO_0000019,
14753,,22224,,,1,,,Autocuration,2742,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,U,,A,,CHEMBL857750,,BAO_0000019,
14754,,22224,,,1,,,Autocuration,2742,Compound was tested for esterase rate in the presence of S166C screen enzyme,,U,,A,,CHEMBL632011,,BAO_0000019,
14755,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,A,,CHEMBL632012,,BAO_0000019,
14756,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,A,,CHEMBL632013,,BAO_0000019,
14757,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,U,,A,,CHEMBL632014,,BAO_0000019,
14758,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,A,,CHEMBL629622,,BAO_0000019,
14759,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,A,,CHEMBL629623,,BAO_0000019,
14760,,22224,,,1,,,Autocuration,2276,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,U,,A,,CHEMBL629624,,BAO_0000019,
14761,,22224,,,1,,,Autocuration,17269,Ratio of Kcat to that of Km was determined,,U,,A,,CHEMBL629625,,BAO_0000019,
14762,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,,A,,CHEMBL629626,,BAO_0000019,
14763,,22224,,,1,,,Autocuration,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,,A,,CHEMBL629627,,BAO_0000019,
14764,,22224,,,1,,,Autocuration,15917,"Compound was evaluated for constant, Kd",,U,,A,,CHEMBL629628,,BAO_0000019,
14765,,22224,,,1,,,Autocuration,10933,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,U,,A,,CHEMBL629629,,BAO_0000019,
14766,,22224,,,1,,,Autocuration,10933,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,U,,A,,CHEMBL629630,,BAO_0000019,
14767,,22224,,,1,,,Autocuration,14293,Dissociation Constant of compound determined,,U,,A,,CHEMBL856030,,BAO_0000019,
14768,,22224,,,1,,,Autocuration,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,U,,B,,CHEMBL629631,,BAO_0000019,
14769,,22224,,,1,,,Autocuration,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,U,,B,,CHEMBL629632,,BAO_0000019,
14770,,22224,,,1,,,Autocuration,4318,Dissociation constant of compound with Fructose was determined,,U,,P,,CHEMBL629633,,BAO_0000100,
14771,,22224,,,1,,,Autocuration,4318,Dissociation constant of compound with Fructose was determined; Not determined,,U,,P,,CHEMBL629634,,BAO_0000100,
14772,,22224,,,1,,,Autocuration,4318,Dissociation constant of compound with Lactulose was determined,,U,,P,,CHEMBL629635,,BAO_0000100,
14773,,22224,,,1,,,Autocuration,4318,Dissociation constant of compound with Lactulose was determined; Not determined,,U,,P,,CHEMBL629636,,BAO_0000100,
14774,,22224,,,1,,,Autocuration,14959,Dissociation constant of the Compound,,U,,P,,CHEMBL629637,,BAO_0000100,
14775,,22224,,,1,,,Autocuration,5913,Dissociation constant by non-linear regression analysis,,U,,P,,CHEMBL629638,,BAO_0000100,
14776,,22224,,,1,,,Autocuration,14218,Dissociation constant was determined,,U,,P,,CHEMBL629639,,BAO_0000100,
14777,,22224,,,1,,,Autocuration,10689,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,U,,P,,CHEMBL629640,,BAO_0000100,
14778,,22224,,,1,,,Autocuration,13925,Dissociation constant was determined,,U,,P,,CHEMBL629641,,BAO_0000100,
14779,,22224,,,1,,,Autocuration,16359,Dissociation constant was determined,,U,,P,,CHEMBL631344,,BAO_0000100,
14780,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,10944,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,N,,A,,CHEMBL631345,,BAO_0000218,
14781,,22224,,,1,,,Autocuration,11080,The dissociation constant determined by fluorescence displacement assay,,U,,A,,CHEMBL631346,,BAO_0000019,
14782,,22224,,,1,,,Autocuration,17805,kd value surface plasmon resonance (SPR) method,,U,,A,,CHEMBL631524,,BAO_0000019,
14783,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,10944,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,N,,A,,CHEMBL631525,,BAO_0000218,
14784,,22224,,,1,,,Autocuration,16645,First dissociation constant of the binding of compound to V30M TTR,,U,,F,,CHEMBL631526,,BAO_0000019,
14785,,22224,,,1,,,Autocuration,16645,Second dissociation constant of the binding of compound to V30M TTR,,U,,F,,CHEMBL631527,,BAO_0000019,
14786,,22224,,,1,,,Autocuration,7793,"Compound was evaluated for equilibrium constant, Ke",,U,,A,,CHEMBL631528,,BAO_0000019,
14787,,22224,1898.0,,1,,,Autocuration,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,U,,A,,CHEMBL631529,,BAO_0000019,
14788,,22224,1898.0,,1,,,Autocuration,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,U,,A,,CHEMBL631530,,BAO_0000019,
14789,,22224,,,1,,,Autocuration,9680,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,U,,A,,CHEMBL631531,,BAO_0000019,
14790,,22224,,,1,,,Autocuration,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,U,,A,,CHEMBL631532,,BAO_0000019,
14791,,22224,,,1,,,Autocuration,9680,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,U,,A,,CHEMBL631533,,BAO_0000019,
14792,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,A,,CHEMBL876552,,BAO_0000218,
14793,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,,A,,CHEMBL631534,,BAO_0000218,
14794,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,A,,CHEMBL631535,,BAO_0000218,
14795,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,A,,CHEMBL631536,,BAO_0000218,
14796,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,N,,A,,CHEMBL631537,,BAO_0000218,
14797,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,,A,,CHEMBL631538,,BAO_0000218,
14798,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,N,,A,,CHEMBL631539,,BAO_0000218,
14799,Mus musculus,50594,,,1,,,Intermediate,13758,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,A,,CHEMBL631540,,BAO_0000218,
14800,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,A,,CHEMBL625637,,BAO_0000218,
14801,Rattus norvegicus,50597,,,1,,,Intermediate,14393,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,A,,CHEMBL625638,,BAO_0000218,
14802,Rattus norvegicus,50597,,,1,,,Intermediate,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,,A,,CHEMBL625639,,BAO_0000218,
14803,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625640,,BAO_0000218,
14804,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625641,,BAO_0000218,
14805,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625642,,BAO_0000218,
14806,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625643,,BAO_0000218,
14807,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625644,,BAO_0000218,
14808,Rattus norvegicus,50597,2113.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625645,,BAO_0000218,
14809,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625646,,BAO_0000218,
14810,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625647,,BAO_0000218,
14811,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625648,,BAO_0000218,
14812,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625649,,BAO_0000218,
14813,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625650,,BAO_0000218,
14814,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625651,,BAO_0000218,
14815,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625652,,BAO_0000218,
14816,Rattus norvegicus,50597,14.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625653,,BAO_0000218,
14817,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625654,,BAO_0000218,
14818,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,13925,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,N,,A,,CHEMBL625655,,BAO_0000218,
14819,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat blood after 15 minutes of administration,,N,,A,,CHEMBL625656,,BAO_0000218,
14820,Rattus norvegicus,50597,178.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat blood after 2 minutes of administration,,N,,A,,CHEMBL625657,,BAO_0000218,
14821,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat brain after 15 minutes of administration,,N,,A,,CHEMBL625658,,BAO_0000218,
14822,Rattus norvegicus,50597,955.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat brain after 2 minutes of administration,,N,,A,,CHEMBL625659,,BAO_0000218,
14823,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat heart after 15 minutes of administration,,N,,A,,CHEMBL625660,,BAO_0000218,
14824,Rattus norvegicus,50597,948.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat heart after 2 minutes of administration,,N,,A,,CHEMBL625661,,BAO_0000218,
14825,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat liver after 15 minutes of administration,,N,,A,,CHEMBL625662,,BAO_0000218,
14826,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat liver after 2 minutes of administration,,N,,A,,CHEMBL625663,,BAO_0000218,
14827,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat lung after 15 minutes of administration,,N,,A,,CHEMBL875621,,BAO_0000218,
14828,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat lung after 2 minutes of administration,,N,,A,,CHEMBL628382,,BAO_0000218,
14829,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat muscle after 15 minutes of administration,,N,,A,,CHEMBL628383,,BAO_0000218,
14830,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,9712,Biodistribution of Compound in rat muscle after 2 minutes of administration,,N,,A,,CHEMBL628384,,BAO_0000218,
14831,Rattus norvegicus,50597,,,1,,,Intermediate,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,N,,A,,CHEMBL628385,,BAO_0000218,
14832,Rattus norvegicus,50597,,,1,,,Intermediate,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,N,,A,,CHEMBL875753,,BAO_0000218,
14833,Rattus norvegicus,50597,,,1,,,Intermediate,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,N,,A,,CHEMBL628386,,BAO_0000218,
14834,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat blood 2 minutes after intravenous injection,,N,,A,,CHEMBL628387,,BAO_0000218,
14835,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat blood 2 hr after intravenous injection,,N,,A,,CHEMBL628388,,BAO_0000218,
14836,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat blood 30 minutes after intravenous injection,,N,,A,,CHEMBL628389,,BAO_0000218,
14837,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat blood 30 min after intravenous injection,,N,,A,,CHEMBL632756,,BAO_0000218,
14838,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat brain 2 minutes after intravenous injection,,N,,A,,CHEMBL628390,,BAO_0000218,
14839,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat brain 2 hr after intravenous injection,,N,,A,,CHEMBL631811,,BAO_0000218,
14840,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat brain 30 minutes after intravenous injection,,N,,A,,CHEMBL631812,,BAO_0000218,
14841,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat heart 2 minutes after intravenous injection,,N,,A,,CHEMBL631813,,BAO_0000218,
14842,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat heart 2 hr after intravenous injection,,N,,A,,CHEMBL631814,,BAO_0000218,
14843,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat heart 30 minutes after intravenous injection,,N,,A,,CHEMBL631815,,BAO_0000218,
14844,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat kidney 2 minutes after intravenous injection,,N,,A,,CHEMBL631816,,BAO_0000218,
14845,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat kidney 2 hr after intravenous injection,,N,,A,,CHEMBL875758,,BAO_0000218,
14846,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat kidney 30 minutes after intravenous injection,,N,,A,,CHEMBL631817,,BAO_0000218,
14847,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,6941,Organ distribution in rat liver 2 minutes after intravenous injection,,N,,A,,CHEMBL631818,,BAO_0000218,
14848,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,6941,Organ distribution in rat liver 2 hr after intravenous injection,,N,,A,,CHEMBL631819,,BAO_0000218,
14849,Rattus norvegicus,50597,2107.0,,1,,,Intermediate,6941,Organ distribution in rat liver 30 minutes after intravenous injection,,N,,A,,CHEMBL631820,,BAO_0000218,
14850,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat lung 2 minutes after intravenous injection,,N,,A,,CHEMBL631821,,BAO_0000218,
14851,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat lung 2 hr after intravenous injection,,N,,A,,CHEMBL631822,,BAO_0000218,
14852,Rattus norvegicus,50597,,,1,,,Intermediate,6941,Organ distribution in rat lung 30 minutes after intravenous injection,,N,,A,,CHEMBL631823,,BAO_0000218,
14853,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,6941,Organ distribution in rat muscle 2 minutes after intravenous injection,,N,,A,,CHEMBL631824,,BAO_0000218,
14854,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,6941,Organ distribution in rat muscle 2 hr after intravenous injection,,N,,A,,CHEMBL631825,,BAO_0000218,
14855,Rattus norvegicus,50597,2385.0,,1,,,Intermediate,6941,Organ distribution in rat muscle 30 minutes after intravenous injection,,N,,A,,CHEMBL631826,,BAO_0000218,
14856,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,N,,A,,CHEMBL631827,,BAO_0000218,
14857,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,N,,A,,CHEMBL631828,,BAO_0000218,
14858,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,N,,A,,CHEMBL631829,,BAO_0000218,
14859,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,,A,,CHEMBL875759,,BAO_0000218,
14860,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,N,,A,,CHEMBL631830,,BAO_0000218,
14861,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,,A,,CHEMBL631831,,BAO_0000218,
14862,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,,A,,CHEMBL631832,,BAO_0000218,
14863,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,,A,,CHEMBL631833,,BAO_0000218,
14864,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,,A,,CHEMBL631834,,BAO_0000218,
14865,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,,A,,CHEMBL631835,,BAO_0000218,
14866,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,,A,,CHEMBL631836,,BAO_0000218,
14867,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,,A,,CHEMBL631837,,BAO_0000218,
14868,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,,A,,CHEMBL631838,,BAO_0000218,
14869,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,,A,,CHEMBL631839,,BAO_0000218,
14870,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,,A,,CHEMBL631840,,BAO_0000218,
14871,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,,A,,CHEMBL631841,,BAO_0000218,
14872,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,,A,,CHEMBL631842,,BAO_0000218,
14873,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,,A,,CHEMBL631843,,BAO_0000218,
14874,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,,A,,CHEMBL631844,,BAO_0000218,
14875,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,,A,,CHEMBL631845,,BAO_0000218,
14876,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,,A,,CHEMBL631846,,BAO_0000218,
14877,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,,A,,CHEMBL875760,,BAO_0000218,
14878,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,,A,,CHEMBL632199,,BAO_0000218,
14879,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,,A,,CHEMBL631847,,BAO_0000218,
14880,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,,A,,CHEMBL631848,,BAO_0000218,
14881,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,,A,,CHEMBL628707,,BAO_0000218,
14882,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,,A,,CHEMBL628708,,BAO_0000218,
14883,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,,A,,CHEMBL628709,,BAO_0000218,
14884,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,,A,,CHEMBL628710,,BAO_0000218,
14885,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,,A,,CHEMBL628711,,BAO_0000218,
14886,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,,A,,CHEMBL628712,,BAO_0000218,
14887,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,,A,,CHEMBL628713,,BAO_0000218,
14888,Rattus norvegicus,50597,1088.0,,1,,,Intermediate,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,,A,,CHEMBL628714,,BAO_0000218,
14889,Rattus norvegicus,50597,,,1,,,Intermediate,7415,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,N,,A,,CHEMBL628715,,BAO_0000218,
14890,,22224,,,1,,,Autocuration,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,U,,A,,CHEMBL629179,,BAO_0000019,
14891,,22224,,,1,,,Autocuration,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,U,,A,,CHEMBL629180,,BAO_0000019,
14892,,22224,,,1,,,Autocuration,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,U,,A,,CHEMBL875108,,BAO_0000019,
14893,,22224,1235.0,,1,,,Autocuration,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629181,,BAO_0000019,
14894,,22224,1235.0,,1,,,Autocuration,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629182,,BAO_0000019,
14895,,22224,,,1,,,Autocuration,7570,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,U,,A,,CHEMBL629183,,BAO_0000019,
14896,,22224,,,1,,,Autocuration,7570,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629184,,BAO_0000019,
14897,,22224,1235.0,,1,,,Autocuration,7570,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,,A,,CHEMBL629185,,BAO_0000019,
14898,,22224,1235.0,,1,,,Autocuration,7570,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629186,,BAO_0000019,
14899,,22224,,,1,,,Autocuration,7570,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,U,,A,,CHEMBL629187,,BAO_0000019,
14900,,22224,,,1,,,Autocuration,7570,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,,A,,CHEMBL629887,,BAO_0000019,
14901,,22224,,,1,,,Autocuration,7570,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,U,,A,,CHEMBL629888,,BAO_0000019,
14902,,22224,,,1,,,Autocuration,7570,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629889,,BAO_0000019,
14903,,22224,1235.0,,1,,,Autocuration,7570,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,U,,A,,CHEMBL629890,,BAO_0000019,
14904,,22224,,,1,,,Autocuration,7570,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629891,,BAO_0000019,
14905,,22224,,,1,,,Autocuration,7570,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,U,,A,,CHEMBL629892,,BAO_0000019,
14906,,22224,1235.0,,1,,,Autocuration,7570,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,,A,,CHEMBL629893,,BAO_0000019,
14907,,22224,,,1,,,Autocuration,7570,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,U,,A,,CHEMBL629894,,BAO_0000019,
14908,,22224,,,1,,,Autocuration,7570,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,,A,,CHEMBL629895,,BAO_0000019,
14909,Canis lupus familiaris,22224,,,1,In vivo,,Autocuration,14122,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,U,,A,,CHEMBL875109,,BAO_0000218,
14910,Macaca fascicularis,22224,,,1,In vivo,,Autocuration,16449,Absolute bioavailability in male cynomolgus monkeys,,U,,A,,CHEMBL629896,,BAO_0000218,
14911,Rattus norvegicus,22224,,,1,In vivo,,Autocuration,16449,Absolute bioavailability in maleSprague-Dawley rats,,U,,A,,CHEMBL629897,,BAO_0000218,
14912,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL629898,,BAO_0000218,
14913,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630057,,BAO_0000218,
14914,Rattus norvegicus,50597,2107.0,,1,In vivo,,Intermediate,12017,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630058,,BAO_0000218,
14915,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630059,,BAO_0000218,
14916,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630060,,BAO_0000218,
14917,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630061,,BAO_0000218,
14918,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630062,,BAO_0000218,
14919,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630063,,BAO_0000218,
14920,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630064,,BAO_0000218,
14921,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630065,,BAO_0000218,
14922,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630066,,BAO_0000218,
14923,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630067,,BAO_0000218,
14924,Rattus norvegicus,50597,2048.0,,1,In vivo,,Intermediate,12017,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630068,,BAO_0000218,
14925,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631113,,BAO_0000218,
14926,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631114,,BAO_0000218,
14927,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL631115,,BAO_0000218,
14928,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL631116,,BAO_0000218,
14929,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630528,,BAO_0000218,
14930,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630529,,BAO_0000218,
14931,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630530,,BAO_0000218,
14932,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630531,,BAO_0000218,
14933,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630532,,BAO_0000218,
14934,Rattus norvegicus,50597,2385.0,,1,In vivo,,Intermediate,12017,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630533,,BAO_0000218,
14935,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice blood after 120 hr,,N,,A,,CHEMBL630534,,BAO_0000218,
14936,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice blood after 24 hr,,N,,A,,CHEMBL630535,,BAO_0000218,
14937,Mus musculus,50594,178.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice blood after 4 hr,,N,,A,,CHEMBL630536,,BAO_0000218,
14938,Mus musculus,50594,10000001.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice bone after 120 hr,,N,,A,,CHEMBL630537,,BAO_0000218,
14939,Mus musculus,50594,10000001.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice bone after 24 hr,,N,,A,,CHEMBL630538,,BAO_0000218,
14940,Mus musculus,50594,10000001.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice bone after 4 hr,,N,,A,,CHEMBL630539,,BAO_0000218,
14941,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice heart after 120 hr,,N,,A,,CHEMBL630540,,BAO_0000218,
14942,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice heart after 24 hr,,N,,A,,CHEMBL630541,,BAO_0000218,
14943,Mus musculus,50594,948.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice heart after 4 hr,,N,,A,,CHEMBL630542,,BAO_0000218,
14944,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice kidney after 120 hr,,N,,A,,CHEMBL630543,,BAO_0000218,
14945,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice kidney after 24 hr,,N,,A,,CHEMBL630544,,BAO_0000218,
14946,Mus musculus,50594,2113.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice kidney after 4 hr,,N,,A,,CHEMBL630545,,BAO_0000218,
14947,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice liver after 120 hr,,N,,A,,CHEMBL630546,,BAO_0000218,
14948,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice liver after 24 hr,,N,,A,,CHEMBL630547,,BAO_0000218,
14949,Mus musculus,50594,2107.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice liver after 4 hr,,N,,A,,CHEMBL630548,,BAO_0000218,
14950,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice spleen after 120 hr,,N,,A,,CHEMBL630549,,BAO_0000218,
14951,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice spleen after 24 hr,,N,,A,,CHEMBL630550,,BAO_0000218,
14952,Mus musculus,50594,2106.0,,1,In vivo,,Intermediate,15045,Biodistribution in normal mice spleen after 4 hr,,N,,A,,CHEMBL876426,,BAO_0000218,
14953,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630551,,BAO_0000218,
14954,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630552,,BAO_0000218,
14955,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630553,,BAO_0000218,
14956,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630554,,BAO_0000218,
14957,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630555,,BAO_0000218,
14958,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630556,,BAO_0000218,
14959,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630557,,BAO_0000218,
14960,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,N,,A,,CHEMBL630558,,BAO_0000218,
14961,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630559,,BAO_0000218,
14962,Rattus norvegicus,50597,2106.0,,1,In vivo,,Intermediate,12017,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL630560,,BAO_0000218,
14963,Rattus norvegicus,50597,2046.0,,1,In vivo,,Intermediate,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,N,,A,,CHEMBL876427,,BAO_0000218,
14964,Rattus norvegicus,50597,,,1,,,Intermediate,14941,The Kel values in female wistar rats.,,N,,A,,CHEMBL630561,,BAO_0000218,
14965,,22224,,,1,,,Autocuration,4646,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,U,,A,,CHEMBL630562,,BAO_0000019,
14966,,22224,,,1,,,Autocuration,8847,Hydrolysis rate constant of the compound,,U,,A,,CHEMBL630563,,BAO_0000019,
14967,,22229,,,1,,,Autocuration,11778,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,U,,P,,CHEMBL629673,,BAO_0000100,
14968,,22224,,,1,,,Autocuration,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,U,,A,,CHEMBL629674,,BAO_0000019,
14969,,22224,,,1,,,Autocuration,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,U,,A,,CHEMBL629675,,BAO_0000019,
14970,,22224,,,1,,,Autocuration,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,U,,A,,CHEMBL629676,,BAO_0000019,
14971,,22224,,,1,,,Autocuration,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,U,,A,,CHEMBL629677,,BAO_0000019,
14972,,22224,,,1,,,Autocuration,8371,Apparent inactivation rate constant was evaluated,,U,,A,,CHEMBL629678,,BAO_0000019,
14973,,22224,,,1,,,Autocuration,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,U,,A,,CHEMBL629679,,BAO_0000019,
14974,,22224,,,1,,,Autocuration,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,U,,A,,CHEMBL629680,,BAO_0000019,
14975,,22224,,,1,,,Autocuration,4643,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,U,,A,,CHEMBL629681,,BAO_0000019,
14976,,22224,,,1,,,Autocuration,3519,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,U,,A,,CHEMBL629682,,BAO_0000019,
14977,,22224,,,1,,,Autocuration,10600,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,U,,A,,CHEMBL629683,,BAO_0000019,
14978,,22224,,,1,,,Autocuration,8501,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,U,,F,,CHEMBL629684,,BAO_0000019,
14979,,22224,,,1,,,Autocuration,8505,Dissociation constant was determined,,U,,P,,CHEMBL629685,,BAO_0000100,
14980,,22224,,,1,,,Autocuration,9778,Dissociation constant was determined,,U,,P,,CHEMBL629686,,BAO_0000100,
14981,,22224,,,1,,,Autocuration,9778,Dissociation constant at pH 7.4,,U,,P,,CHEMBL872932,,BAO_0000100,
14982,,22224,,,1,,,Autocuration,9778,Dissociation constant in presence of 1 mM dithiothreitol,,U,,P,,CHEMBL629687,,BAO_0000100,
14983,,22224,,,1,,,Autocuration,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,,A,,CHEMBL872931,,BAO_0000019,
14984,,22224,,,1,,,Autocuration,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,,A,,CHEMBL628151,,BAO_0000019,
14985,,22224,,,1,,,Autocuration,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,,A,,CHEMBL628152,,BAO_0000019,
14986,,22224,,,1,,,Autocuration,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,,A,,CHEMBL628153,,BAO_0000019,
14987,,22224,,,1,,,Autocuration,11482,Kinetic constant for aromatization of androstenedione,,U,,A,,CHEMBL628154,,BAO_0000019,
14988,,22224,,,1,,,Autocuration,11482,Kinetic constant for aromatization of testosterone,,U,,A,,CHEMBL628155,,BAO_0000019,
14989,,22224,,,1,,,Autocuration,2303,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,U,,A,,CHEMBL628156,,BAO_0000019,
14990,,22224,,,1,,,Autocuration,11964,Local inhibition constant was determined,,U,,A,,CHEMBL628157,,BAO_0000019,
14991,Saccharomyces cerevisiae,50347,,,1,,,Intermediate,3140,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,N,,A,,CHEMBL857533,,BAO_0000218,
14992,,22224,,,1,,,Autocuration,10650,Dissociation constant value of the compound,,U,,P,,CHEMBL628158,,BAO_0000100,
14993,,22224,964.0,,1,,,Autocuration,4667,In vitro permeability through cornea without epithelium,,U,,A,,CHEMBL628159,,BAO_0000019,
14994,,22224,964.0,,1,,,Autocuration,4667,In vitro permeability through intact cornea,,U,,A,,CHEMBL875616,,BAO_0000019,
14995,Oryctolagus cuniculus,50592,964.0,,1,,,Intermediate,9199,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,N,,A,,CHEMBL628160,,BAO_0000218,
14996,,22224,,,1,,,Autocuration,11966,Rate of enzyme inactivation for the compound was determined,,U,,A,,CHEMBL628161,,BAO_0000019,
14997,,22224,964.0,,1,,,Autocuration,4667,In vitro permeability through cornea without epithelium,,U,,A,,CHEMBL628162,,BAO_0000019,
14998,,22224,964.0,,1,,,Autocuration,4667,In vitro permeability through intact cornea,,U,,A,,CHEMBL628163,,BAO_0000019,
14999,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628164,,BAO_0000019,
15000,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628165,,BAO_0000019,
15001,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628166,,BAO_0000019,
15002,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628167,,BAO_0000019,
15003,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628168,,BAO_0000019,
15004,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628169,,BAO_0000019,
15005,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628170,,BAO_0000019,
15006,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628171,,BAO_0000019,
15007,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL627434,,BAO_0000019,
15008,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL627435,,BAO_0000019,
15009,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628110,,BAO_0000019,
15010,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628111,,BAO_0000019,
15011,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628112,,BAO_0000019,
15012,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628260,,BAO_0000019,
15013,,22224,,,1,,,Autocuration,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,A,,CHEMBL628261,,BAO_0000019,
15014,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,N,,A,,CHEMBL628262,,BAO_0000218,
15015,Homo sapiens,50587,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,N,,A,,CHEMBL628263,,BAO_0000218,
15016,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,N,,A,,CHEMBL628264,,BAO_0000218,
15017,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,N,,A,,CHEMBL628265,,BAO_0000218,
15018,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,N,,A,,CHEMBL628266,,BAO_0000218,
15019,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,N,,A,,CHEMBL628267,,BAO_0000218,
15020,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,N,,A,,CHEMBL628268,,BAO_0000218,
15021,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,N,,A,,CHEMBL628269,,BAO_0000218,
15022,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,N,,A,,CHEMBL628270,,BAO_0000218,
15023,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,N,,A,,CHEMBL628271,,BAO_0000218,
15024,Mus musculus,50594,,,1,In vivo,,Intermediate,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,N,,A,,CHEMBL628272,,BAO_0000218,
1,,12052,,,1,,,Autocuration,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,,H,,B,,CHEMBL615117,,BAO_0000019,
2,,22226,,,1,,,Autocuration,684,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,,U,,F,,CHEMBL615118,,BAO_0000219,
3,,22226,,,1,,,Autocuration,15453,,,U,,B,,CHEMBL615119,,BAO_0000019,
4,Bos taurus,104729,,,1,,,Autocuration,17841,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,,H,,B,,CHEMBL615120,,BAO_0000249,
5,Homo sapiens,80001,,,1,,,Intermediate,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),,N,143B,F,,CHEMBL615121,163.0,BAO_0000219,
6,Homo sapiens,80001,,,1,,,Intermediate,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),,N,143B,F,,CHEMBL615122,163.0,BAO_0000219,
7,Mus musculus,80001,,,1,,,Intermediate,13799,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,,N,143B,F,,CHEMBL615123,163.0,BAO_0000219,
8,Homo sapiens,80001,,,1,,,Expert,17774,In vitro cell cytotoxicity was determined against 143B cell line,,N,143B,F,,CHEMBL615124,163.0,BAO_0000219,
9,Homo sapiens,80001,,,1,,,Intermediate,3801,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,,N,143B,F,,CHEMBL615125,163.0,BAO_0000219,
10,Homo sapiens,80001,,,1,,,Intermediate,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,N,143B,F,,CHEMBL615126,163.0,BAO_0000219,
11,Homo sapiens,80001,,,1,,,Intermediate,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,,N,143B,F,,CHEMBL615127,163.0,BAO_0000219,
12,Homo sapiens,80001,,,1,,,Expert,17774,In vitro cell cytotoxicity was determined against 143B-LTK cell line,,N,143B,F,,CHEMBL615128,163.0,BAO_0000219,
13,Staphylococcus aureus,50185,,,1,,,Intermediate,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,,F,,CHEMBL857900,,BAO_0000218,
14,Staphylococcus aureus,50185,,,1,,,Intermediate,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,,F,,CHEMBL615129,,BAO_0000218,
15,Staphylococcus aureus,50185,,,1,,,Intermediate,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,,F,,CHEMBL615130,,BAO_0000218,
16,Staphylococcus aureus,50185,,,1,,,Intermediate,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",,N,,F,,CHEMBL615131,,BAO_0000218,
17,Rattus norvegicus,100122,,,1,,,Expert,11347,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,,D,,A,,CHEMBL884521,,BAO_0000357,
18,,12054,,,1,,,Autocuration,16474,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),,H,,B,,CHEMBL615132,,BAO_0000357,
19,,12054,,,1,,,Autocuration,10091,Inhibition of partially purified 15-lipoxygenase from human leukocytes,,H,,B,,CHEMBL615133,,BAO_0000019,
20,,12054,,,1,,,Autocuration,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,H,,B,,CHEMBL615134,,BAO_0000357,
21,,12054,,,1,,,Autocuration,16474,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),,H,,B,,CHEMBL615135,,BAO_0000357,
22,,12054,,,1,,,Autocuration,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,H,,B,,CHEMBL615136,,BAO_0000357,
23,,12054,,,1,,,Autocuration,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,H,,B,,CHEMBL615137,,BAO_0000357,
24,,12054,,,1,,,Autocuration,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,H,,B,,CHEMBL615138,,BAO_0000357,
25,,22226,,,1,,,Autocuration,14352,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",,U,,B,,CHEMBL836324,,BAO_0000219,
26,Oryctolagus cuniculus,12054,,,1,,,Autocuration,5646,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,,H,,B,,CHEMBL615139,,BAO_0000357,
27,Oryctolagus cuniculus,12054,,,1,,,Autocuration,5646,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),,H,,B,,CHEMBL615140,,BAO_0000357,
28,,12426,,,1,,,Autocuration,10997,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,,H,,B,,CHEMBL615141,,BAO_0000219,
29,soya bean,12054,,,1,,,Autocuration,6309,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,,H,,B,,CHEMBL615142,,BAO_0000357,
30,Glycine max,12054,,,1,,,Autocuration,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated,,H,,B,,CHEMBL615143,,BAO_0000357,
31,Glycine max,12054,,,1,,,Autocuration,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,,H,,B,,CHEMBL615144,,BAO_0000357,
32,Glycine max,12054,,,1,,,Autocuration,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,,H,,B,,CHEMBL872867,,BAO_0000357,
33,Glycine max,12054,,,1,,,Autocuration,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,,H,,B,,CHEMBL615145,,BAO_0000357,
34,Glycine max,12054,,,1,,,Autocuration,13622,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,,H,,B,,CHEMBL615146,,BAO_0000357,
35,Glycine max,12054,,,1,,,Autocuration,13622,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,,H,,B,,CHEMBL615147,,BAO_0000357,
36,Rattus norvegicus,22226,,,1,,,Autocuration,11347,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,,U,,A,,CHEMBL615148,,BAO_0000019,
37,Escherichia coli,22226,,,1,,,Autocuration,5926,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,,U,,B,,CHEMBL615149,,BAO_0000019,
38,,22226,,,1,,,Autocuration,4567,Dissociation constant with dimeric 16S rRNA RNA construct B,,U,,B,,CHEMBL615150,,BAO_0000019,
39,,22222,,,1,,,Intermediate,3782,Dissociation constant towards 16S rRNA construct A,,M,,B,,CHEMBL615151,,BAO_0000225,
40,,22222,,,1,,,Intermediate,3782,Dissociation constant towards 16S rRNA construct B,,M,,B,,CHEMBL615152,,BAO_0000225,
41,Escherichia coli,100263,,,1,,,Expert,4466,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,,M,,B,,CHEMBL615153,,BAO_0000225,
42,Escherichia coli,100263,,,1,,,Expert,6592,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,,M,,B,,CHEMBL615154,,BAO_0000225,
43,,13053,,,1,,,Autocuration,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,H,,B,,CHEMBL615155,,BAO_0000019,
44,,13053,,,1,,,Autocuration,898,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,H,,B,,CHEMBL615156,,BAO_0000019,
45,Homo sapiens,20001,,,1,,,Autocuration,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,H,,B,,CHEMBL615157,,BAO_0000019,
46,Homo sapiens,20001,,,1,,,Autocuration,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,,H,,B,,CHEMBL615158,,BAO_0000019,
47,Rattus norvegicus,12971,,,1,,,Expert,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,D,,B,,CHEMBL615159,,BAO_0000019,
48,Rattus norvegicus,12971,,,1,,,Expert,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",,D,,B,,CHEMBL615172,,BAO_0000019,
49,Rattus norvegicus,12971,,,1,,,Expert,10691,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,D,,B,,CHEMBL615173,,BAO_0000019,
50,Rattus norvegicus,12971,,,1,,,Expert,10691,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",,D,,B,,CHEMBL615174,,BAO_0000019,
51,,13053,,,1,,,Autocuration,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,H,,B,,CHEMBL884518,,BAO_0000019,
52,,11512,,,1,,,Autocuration,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),,H,,B,,CHEMBL615175,,BAO_0000357,
53,,11512,,,1,,,Autocuration,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,,H,,B,,CHEMBL615176,,BAO_0000357,
54,,11512,,,1,,,Autocuration,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,,H,,B,,CHEMBL615177,,BAO_0000357,
55,Rattus norvegicus,104740,,,1,,,Autocuration,15103,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,Membranes,D,,B,,CHEMBL615178,,BAO_0000249,
56,Homo sapiens,80002,,,1,,,Intermediate,5116,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,,N,1A9,F,,CHEMBL615179,506.0,BAO_0000219,
57,Rattus norvegicus,104835,,,1,,,Autocuration,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,,D,Oocytes,F,,CHEMBL615180,,BAO_0000219,
58,Rattus norvegicus,104821,,,1,,,Autocuration,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,,D,Oocytes,F,,CHEMBL615181,,BAO_0000219,
59,Rattus norvegicus,104848,,,1,,,Autocuration,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,,D,Oocytes,F,,CHEMBL615182,,BAO_0000219,
60,Homo sapiens,80002,,,1,,,Expert,4787,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,,N,1A9,F,,CHEMBL615183,506.0,BAO_0000219,
61,Homo sapiens,80002,,,1,,,Intermediate,4787,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,,N,1A9,F,,CHEMBL615184,506.0,BAO_0000219,
62,Homo sapiens,80002,,,1,,,Intermediate,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line,,N,1A9,F,,CHEMBL615185,506.0,BAO_0000219,
63,Homo sapiens,80002,,,1,,,Intermediate,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,,N,1A9,F,,CHEMBL615186,506.0,BAO_0000219,
64,Homo sapiens,80002,,,1,,,Intermediate,6726,Effective dose of compound against replication of 1A9 cell line was evaluated,,N,1A9,F,,CHEMBL615187,506.0,BAO_0000219,
65,Homo sapiens,80002,,,1,,,Expert,3455,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,,N,1A9,F,,CHEMBL885343,506.0,BAO_0000219,
66,Homo sapiens,80002,,,1,,,Intermediate,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),,N,1A9,F,,CHEMBL615188,506.0,BAO_0000219,
67,Homo sapiens,80002,,,1,,,Intermediate,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,,N,1A9,F,,CHEMBL615189,506.0,BAO_0000219,
68,Homo sapiens,80002,,,1,,,Intermediate,5726,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,,N,1A9,F,,CHEMBL615190,506.0,BAO_0000219,
69,Homo sapiens,80002,,,1,,,Intermediate,3395,Inhibitory activity against Taxol resistant 1A9 cell lines,,N,1A9,F,,CHEMBL615191,506.0,BAO_0000219,
70,Homo sapiens,80002,,,1,,,Expert,3415,Cytotoxicity against human ovarian cancer (1A9) cell lines.,,N,1A9,F,,CHEMBL615192,506.0,BAO_0000219,
71,Homo sapiens,80002,,,1,,,Expert,3415,Percentage inhibition of human ovarian cancer (1A9) cell lines.,,N,1A9,F,,CHEMBL827083,506.0,BAO_0000219,
72,Homo sapiens,80002,,,1,,,Expert,17099,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,,N,1A9,F,,CHEMBL615193,506.0,BAO_0000219,
73,Homo sapiens,80002,,,1,,,Intermediate,17099,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,,N,1A9,F,,CHEMBL615194,506.0,BAO_0000219,
74,Homo sapiens,80002,,,1,,,Intermediate,17099,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,,N,1A9,F,,CHEMBL615195,506.0,BAO_0000219,
75,Homo sapiens,80002,,,1,,,Intermediate,17099,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,,N,1A9,F,,CHEMBL615196,506.0,BAO_0000219,
76,Homo sapiens,81072,,,1,,,Intermediate,17721,Inhibitory concentration against Jurkat cells,,N,Jurkat,F,,CHEMBL615197,503.0,BAO_0000219,
77,,22226,,,1,,,Intermediate,1229,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,,U,,F,,CHEMBL615198,,BAO_0000019,
78,Rattus norvegicus,100121,,,1,,,Expert,11347,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,,D,,A,,CHEMBL615199,,BAO_0000357,
79,,11231,,,1,,,Expert,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,H,,B,,CHEMBL615200,,BAO_0000357,
80,,11231,,,1,,,Expert,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,H,,B,,CHEMBL615201,,BAO_0000357,
81,,11231,,,1,,,Expert,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",,H,,B,,CHEMBL615202,,BAO_0000357,
82,Candida albicans,11231,,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",Microsomes,H,,B,,CHEMBL615203,,BAO_0000251,
83,Candida albicans,11231,,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",Microsomes,H,,B,,CHEMBL615204,,BAO_0000251,
84,Saccharomyces cerevisiae,11231,,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",Microsomes,H,,B,,CHEMBL615205,,BAO_0000251,
85,Saccharomyces cerevisiae,11231,,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",Microsomes,H,,B,,CHEMBL615206,,BAO_0000251,
86,Sus scrofa,12083,2107.0,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",Microsomes,H,,B,,CHEMBL615207,,BAO_0000251,
87,Rattus norvegicus,11231,,,1,,,Autocuration,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",,H,,B,,CHEMBL827084,,BAO_0000019,
88,Rattus norvegicus,11231,,,1,,,Autocuration,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",,H,,B,,CHEMBL615208,,BAO_0000019,
89,Rattus norvegicus,11231,,,1,,,Autocuration,791,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",,H,,B,,CHEMBL615209,,BAO_0000019,
90,Rattus norvegicus,12083,2107.0,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",Microsomes,D,,B,,CHEMBL615210,,BAO_0000251,
91,Rattus norvegicus,12083,2107.0,,1,,,Autocuration,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Microsomes,D,,B,,CHEMBL615211,,BAO_0000251,
92,Rattus norvegicus,12083,2107.0,,1,,,Autocuration,153,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Microsomes,D,,B,,CHEMBL615212,,BAO_0000251,
93,,11377,,,1,,,Expert,8269,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),,H,,B,,CHEMBL615213,,BAO_0000357,
94,,11377,,,1,,,Expert,8269,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,,H,,B,,CHEMBL615273,,BAO_0000357,
95,Homo sapiens,81020,,,1,,,Expert,17653,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,N,HepG2,F,,CHEMBL615274,726.0,BAO_0000219,
96,Homo sapiens,81020,,,1,,,Intermediate,14277,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,,N,HepG2,F,,CHEMBL615275,726.0,BAO_0000219,
97,Homo sapiens,81020,,,1,,,Intermediate,1717,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,,N,HepG2,F,,CHEMBL615276,726.0,BAO_0000219,
98,Homo sapiens,81020,,,1,,,Intermediate,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,,N,HepG2,F,,CHEMBL615277,726.0,BAO_0000219,
99,Homo sapiens,81020,,,1,,,Intermediate,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,,N,HepG2,F,,CHEMBL615326,726.0,BAO_0000219,
100,Hepatitis B virus,50606,,,1,,,Expert,17653,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,,N,,F,,CHEMBL883130,,BAO_0000218,
101,Homo sapiens,81020,,,1,,,Intermediate,13105,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,,N,HepG2,F,,CHEMBL884519,726.0,BAO_0000219,
102,Homo sapiens,81020,,,1,,,Intermediate,1717,Concentration required to inhibit 50% of 2.2.15 cell line,,N,HepG2,F,,CHEMBL615327,726.0,BAO_0000219,
103,Homo sapiens,81020,,,1,,,Intermediate,13105,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,,N,HepG2,A,,CHEMBL615328,726.0,BAO_0000219,
104,Homo sapiens,50587,,,1,,,Intermediate,13600,Cytotoxic activity of compound against uninfected 2.2.15 cells.,,N,2.2.15,F,,CHEMBL615329,,BAO_0000218,
105,Homo sapiens,50587,,,1,,,Intermediate,13467,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,,N,2.2.15,F,,CHEMBL615330,,BAO_0000218,
106,Hepatitis B virus,50606,,,1,,,Expert,17477,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",,N,2.2.15,F,,CHEMBL615331,,BAO_0000218,
107,Homo sapiens,50587,,,1,,,Intermediate,1593,In vitro anti-HBV activity in 2.2.15 cells,,N,2.2.15,F,,CHEMBL615332,,BAO_0000218,
108,Homo sapiens,50587,,,1,,,Intermediate,1593,In vitro anti-HBV activity in 2.2.15 cells; Not determined,,N,2.2.15,F,,CHEMBL615333,,BAO_0000218,
109,Homo sapiens,50587,,,1,,,Intermediate,15089,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,,N,2.2.15,F,,CHEMBL615334,,BAO_0000218,
110,Homo sapiens,50587,,,1,,,Intermediate,15089,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,,N,2.2.15,F,,CHEMBL615335,,BAO_0000218,
111,Homo sapiens,50587,,,1,,,Intermediate,1593,Cytotoxicity in 2.2.15 cells,,N,2.2.15,F,,CHEMBL615336,,BAO_0000218,
112,Homo sapiens,50587,,,1,,,Intermediate,1593,Cytotoxicity in 2.2.15 cells; Not determined,,N,2.2.15,F,,CHEMBL615337,,BAO_0000218,
113,Homo sapiens,50587,,,1,,,Intermediate,13600,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,,N,2.2.15,F,,CHEMBL615338,,BAO_0000218,
114,Homo sapiens,50587,,,1,,,Intermediate,13467,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,,N,2.2.15,F,,CHEMBL615339,,BAO_0000218,
115,Homo sapiens,50587,,,1,,,Intermediate,13467,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,,N,2.2.15,F,,CHEMBL615340,,BAO_0000218,
116,Homo sapiens,81020,,,1,,,Intermediate,14764,Antiviral activity against HBV was determined in 2.215 cell line,,N,HepG2,F,,CHEMBL615341,726.0,BAO_0000219,
117,Homo sapiens,22226,,,1,,,Autocuration,6531,Inhibition of 20-HETE synthesis in human renal microsomes,Microsomes,U,,B,,CHEMBL615342,,BAO_0000251,
118,,22226,,,1,,,Autocuration,17322,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,,U,,B,,CHEMBL615343,,BAO_0000019,
119,Homo sapiens,80612,,,1,,,Intermediate,17072,Inhibitory concentration against 2008 (ovarian) cells,,N,2008,F,,CHEMBL615344,388.0,BAO_0000219,
120,Homo sapiens,80612,,,1,,,Intermediate,16936,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,,N,2008,F,,CHEMBL615345,388.0,BAO_0000219,
121,Homo sapiens,80612,,,1,,,Intermediate,16936,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),,N,2008,F,,CHEMBL615346,388.0,BAO_0000219,
122,Homo sapiens,80612,,,1,,,Intermediate,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,,N,2008,F,,CHEMBL615347,388.0,BAO_0000219,
123,Homo sapiens,80612,,,1,,,Intermediate,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,,N,2008,F,,CHEMBL615348,388.0,BAO_0000219,
124,Homo sapiens,80613,,,1,,,Intermediate,10797,In vitro inhibition of 2008/R ovarian cancer cell line,,N,2008/R,F,,CHEMBL827085,561.0,BAO_0000219,
125,Homo sapiens,80613,,,1,,,Intermediate,10797,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,,N,2008/R,F,,CHEMBL615349,561.0,BAO_0000219,
126,Homo sapiens,80614,,,1,,,Intermediate,10797,In vitro inhibition of 2008/S ovarian cancer cell line,,N,2008/S,F,,CHEMBL615350,389.0,BAO_0000219,
127,Homo sapiens,80614,,,1,,,Intermediate,10797,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,,N,2008/S,F,,CHEMBL615351,389.0,BAO_0000219,
128,Homo sapiens,100256,,,1,,,Expert,4823,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,,S,,B,,CHEMBL615352,,BAO_0000220,
129,Homo sapiens,100256,,,1,,,Intermediate,12912,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,,S,,B,,CHEMBL615353,,BAO_0000220,
130,,100256,,,1,,,Expert,2957,Inhibition of chymotrypsin-like activity of 20S proteasome,,S,,B,,CHEMBL615354,,BAO_0000220,
131,,100256,,,1,,,Expert,2957,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,,S,,B,,CHEMBL615355,,BAO_0000220,
132,,100256,,,1,,,Intermediate,3260,Inhibitory activity against 20S proteosome,,S,,B,,CHEMBL615356,,BAO_0000220,
133,Homo sapiens,22226,,,1,,,Autocuration,3451,Compound was tested for inhibitory activity against tryptase,,U,,B,,CHEMBL615357,,BAO_0000019,
134,Homo sapiens,81020,,,1,,,Intermediate,13885,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,,N,HepG2,F,,CHEMBL615358,726.0,BAO_0000219,
135,Homo sapiens,81020,,,1,,,Intermediate,13885,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,,N,HepG2,F,,CHEMBL827086,726.0,BAO_0000219,
136,,22226,,,1,,,Autocuration,3676,Compound was tested for the inhibition of Alpha-glucosidase,,U,,B,,CHEMBL615359,,BAO_0000019,
137,,235,,,1,,,Autocuration,6043,Inhibitory concentration against human neutrophil elastase (HNE),,H,,B,,CHEMBL615360,,BAO_0000357,
138,Rattus norvegicus,22226,948.0,,1,,,Autocuration,11140,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,,U,,F,,CHEMBL615361,,BAO_0000218,
139,,19640,,,1,,,Autocuration,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,H,,F,,CHEMBL615362,,BAO_0000019,
140,,19640,,,1,,,Expert,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,H,,F,,CHEMBL615363,,BAO_0000019,
141,,19640,,,1,,,Autocuration,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,H,,B,,CHEMBL615364,,BAO_0000357,
142,,19640,,,1,,,Expert,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,H,,F,,CHEMBL615365,,BAO_0000019,
143,Mus musculus,80360,,,1,,,Intermediate,11365,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,,N,P338,F,,CHEMBL615366,524.0,BAO_0000219,
144,Mus musculus,80360,,,1,,,Intermediate,11365,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,,N,P338,F,,CHEMBL615367,524.0,BAO_0000219,
145,Homo sapiens,80384,,,1,,,Intermediate,11803,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,,N,PBL,F,,CHEMBL615368,554.0,BAO_0000219,
146,Ovis aries,22226,,,1,,,Autocuration,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,,U,,F,,CHEMBL615369,,BAO_0000019,
147,Ovis aries,22226,,,1,,,Autocuration,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,,U,,F,,CHEMBL615370,,BAO_0000019,
148,,191,,,1,,,Autocuration,12278,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),,H,,B,,CHEMBL615673,,BAO_0000357,
149,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,,U,,F,,CHEMBL615674,,BAO_0000019,
150,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,,U,,F,,CHEMBL615675,,BAO_0000019,
151,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,,U,CCRF-CEM,F,,CHEMBL615676,635.0,BAO_0000219,
152,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,,U,CCRF-CEM,F,,CHEMBL615677,635.0,BAO_0000219,
153,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,,U,CCRF-CEM,F,,CHEMBL615678,635.0,BAO_0000219,
154,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,,U,CCRF-CEM,F,,CHEMBL615679,635.0,BAO_0000219,
155,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,,U,,F,,CHEMBL615680,,BAO_0000019,
156,Homo sapiens,22226,,,1,,,Autocuration,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,,U,,F,,CHEMBL615681,,BAO_0000019,
157,,104290,,,1,,,Autocuration,16992,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,,H,,B,,CHEMBL857972,,BAO_0000249,
158,Streptococcus pyogenes,50264,,,1,,,Intermediate,10543,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,,N,,F,,CHEMBL857899,,BAO_0000218,
159,Human herpesvirus 3,50527,,,1,,,Intermediate,17833,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),,N,,F,,CHEMBL615371,,BAO_0000218,
160,vericilla zoster virus,50527,,,1,,,Expert,17290,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,,N,HEL,F,,CHEMBL615372,468.0,BAO_0000218,
161,vericilla zoster virus,50527,,,1,,,Intermediate,17290,Antiviral activity against 07/1 strain of VZV; ND: No data,,N,,F,,CHEMBL615373,,BAO_0000218,
162,vericilla zoster virus,50527,,,1,,,Intermediate,17290,Antiviral activity against 07/1 strain of VZV; ND=No data,,N,,F,,CHEMBL615374,,BAO_0000218,
163,escherichia cloac,50145,,,1,,,Intermediate,10932,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",,N,,F,,CHEMBL615375,,BAO_0000218,
164,,22226,,,1,,,Autocuration,9707,Ratio of Ki at A2 to Ki at A1 receptors,,U,,B,,CHEMBL615376,,BAO_0000019,
165,Candida albicans,11143,,,1,,,Expert,2346,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",,H,,B,,CHEMBL615377,,BAO_0000249,
166,Candida glabrata CBS 138,18077,,,1,,,Expert,2205,"Inhibition of 1,3-beta-glucan synthase",,H,,B,,CHEMBL615378,,BAO_0000357,
167,Homo sapiens,80609,,,1,,,Intermediate,11900,Inhibition of growth of 1-87 human tumor cell line,,N,1-87 tumor cell line,F,,CHEMBL615379,832.0,BAO_0000219,
168,Rattus norvegicus,12166,,,1,,,Expert,14864,Inhibition of 1-lipoxygenase (LOX)in RBL cells,,D,,B,,CHEMBL615380,,BAO_0000219,
169,Glycine max,100171,,,1,,,Autocuration,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO),,D,,B,,CHEMBL615381,,BAO_0000357,
170,Glycine max,100171,,,1,,,Autocuration,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,,D,,B,,CHEMBL615382,,BAO_0000357,
171,Glycine max,100171,,,1,,,Autocuration,16474,% inhibition against soybean 1-lipoxygenase (SLO),,D,,B,,CHEMBL615383,,BAO_0000357,
172,Glycine max,100171,,,1,,,Autocuration,16474,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,,D,,B,,CHEMBL615384,,BAO_0000357,
173,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,,D,,B,,CHEMBL615385,,BAO_0000357,
174,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,,D,,B,,CHEMBL615386,,BAO_0000357,
175,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,,D,,B,,CHEMBL615387,,BAO_0000357,
176,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,,D,,B,,CHEMBL615388,,BAO_0000357,
177,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,,D,,B,,CHEMBL615214,,BAO_0000357,
178,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,,D,,B,,CHEMBL827087,,BAO_0000357,
179,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,,D,,B,,CHEMBL615215,,BAO_0000357,
180,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,,D,,B,,CHEMBL615216,,BAO_0000357,
181,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,,D,,B,,CHEMBL615217,,BAO_0000357,
182,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,,D,,B,,CHEMBL615218,,BAO_0000357,
183,Glycine max,100171,,,1,,,Autocuration,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,,D,,B,,CHEMBL615219,,BAO_0000357,
184,Mus musculus,22226,,,1,,,Autocuration,10413,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,,U,,B,,CHEMBL615220,,BAO_0000019,
185,Mus musculus,80049,,,1,,,Intermediate,16929,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),,N,C3H 10T1/2,F,,CHEMBL615221,294.0,BAO_0000219,
186,,22226,,,1,,,Intermediate,1229,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,,U,,F,,CHEMBL615222,,BAO_0000019,
187,,11489,,,1,,,Autocuration,16587,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,H,,B,,CHEMBL615223,,BAO_0000357,
188,,11862,,,1,,,Autocuration,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,H,,B,,CHEMBL615224,,BAO_0000357,
189,,11862,,,1,,,Autocuration,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,,H,,B,,CHEMBL615225,,BAO_0000357,
190,,11489,,,1,,,Autocuration,16587,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,,H,,B,,CHEMBL615226,,BAO_0000357,
191,,11862,,,1,,,Autocuration,16587,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,,H,,B,,CHEMBL615227,,BAO_0000357,
192,Bos taurus,12347,,,1,,,Expert,8058,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,,D,,F,,CHEMBL615228,,BAO_0000019,
193,Rattus norvegicus,100120,,,1,,,Expert,9065,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,,D,,B,,CHEMBL615229,,BAO_0000357,
194,Rattus norvegicus,100120,2369.0,,1,,,Expert,8865,Inhibition of 11 beta-hydroxylase from rat adrenal gland,,D,,B,,CHEMBL615230,,BAO_0000357,
195,Rattus norvegicus,100120,,,1,,,Expert,9066,Inhibition of rat adrenal 11-beta-hydroxylase,,D,,B,,CHEMBL615231,,BAO_0000357,
196,Rattus norvegicus,100120,,,1,,,Expert,8394,Inhibition of rat adrenal 11-beta-hydroxylase,,D,,B,,CHEMBL884520,,BAO_0000357,
197,Rattus norvegicus,100120,,,1,,,Expert,8394,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,,D,,B,,CHEMBL615232,,BAO_0000357,
198,,10328,,,1,,,Autocuration,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,,H,,B,,CHEMBL615233,,BAO_0000019,
199,,11490,,,1,,,Autocuration,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,H,,B,,CHEMBL827088,,BAO_0000357,
200,,11490,,,1,,,Autocuration,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,H,,B,,CHEMBL615234,,BAO_0000357,
201,,11134,,,1,,,Autocuration,9295,Compound was tested for the percent of inhibition against 12-LO at 10 uM,,H,,F,,CHEMBL615235,,BAO_0000019,
202,,12052,,,1,,,Autocuration,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,H,,B,,CHEMBL615236,,BAO_0000019,
203,,11134,,,1,,,Autocuration,13622,Compound was tested in vitro for inhibition of 12-LO human platelet,,H,,B,,CHEMBL615237,,BAO_0000019,
204,,11134,,,1,,,Autocuration,12079,Inhibitory concentration against human platelet 12-lipoxygenase,,H,,F,,CHEMBL615238,,BAO_0000019,
205,,11134,,,1,,,Autocuration,13622,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,,H,,B,,CHEMBL615239,,BAO_0000019,
206,Homo sapiens,11134,,,1,,,Autocuration,12079,Inhibitory concentration against human platelet 12-lipoxygenase,,D,,F,,CHEMBL615240,,BAO_0000019,
207,,11835,,,1,,,Expert,13500,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,,H,,B,,CHEMBL615241,,BAO_0000019,
208,,11601,,,1,,,Expert,13723,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,,H,,B,,CHEMBL615242,,BAO_0000357,
209,,11134,,,1,,,Autocuration,16474,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),,H,,B,,CHEMBL615243,,BAO_0000019,
210,,11134,,,1,,,Autocuration,1630,Inhibitory activity against human platelet 12-lipoxygenase,,H,,B,,CHEMBL615244,,BAO_0000019,
211,,11134,,,1,,,Autocuration,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,,H,,B,,CHEMBL615245,,BAO_0000019,
212,,11134,,,1,,,Autocuration,16474,% inhibition against human platelet 12-lipoxygenase (12-HLO),,H,,B,,CHEMBL615246,,BAO_0000019,
213,,11134,,,1,,,Autocuration,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,,H,,B,,CHEMBL615247,,BAO_0000019,
214,,11134,,,1,,,Autocuration,16474,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,,H,,B,,CHEMBL615248,,BAO_0000019,
215,,11601,,,1,,,Autocuration,10091,Inhibitory activity towards porcine 12-lipoxygenase,,H,,B,,CHEMBL615249,,BAO_0000357,
216,,11601,,,1,,,Autocuration,11966,Tested for inhibition against porcine 12-LO,,H,,B,,CHEMBL615250,,BAO_0000357,
217,,12052,,,1,,,Autocuration,951,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,,H,,B,,CHEMBL615251,,BAO_0000019,
218,,12052,,,1,,,Autocuration,10997,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,,H,,B,,CHEMBL615252,,BAO_0000019,
219,,12052,,,1,,,Expert,10193,In vitro inhibition of rat platelet 12-lipoxygenase,,H,,B,,CHEMBL828340,,BAO_0000019,
220,,12052,,,1,,,Autocuration,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,H,,B,,CHEMBL615253,,BAO_0000019,
221,,12052,,,1,,,Autocuration,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,,H,,B,,CHEMBL615254,,BAO_0000019,
222,,12052,,,1,,,Autocuration,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,,H,,B,,CHEMBL615255,,BAO_0000019,
223,,12052,,,1,,,Autocuration,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,H,,B,,CHEMBL615256,,BAO_0000019,
224,,12052,,,1,,,Autocuration,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase,,H,,B,,CHEMBL615257,,BAO_0000019,
225,,12052,,,1,,,Autocuration,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,,H,,B,,CHEMBL615258,,BAO_0000019,
226,Homo sapiens,80007,,,1,,,Intermediate,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,,N,41M,F,,CHEMBL615259,621.0,BAO_0000219,
227,Homo sapiens,80007,,,1,,,Expert,12989,In vitro antitumor activity against 41M cell line.,,N,41M,F,,CHEMBL615260,621.0,BAO_0000219,
228,Homo sapiens,80007,,,1,,,Intermediate,16745,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,,N,41M,F,,CHEMBL615261,621.0,BAO_0000219,
229,Homo sapiens,80007,,,1,,,Intermediate,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,,N,41M,F,,CHEMBL615262,621.0,BAO_0000219,
230,Homo sapiens,80007,,,1,,,Expert,12989,In vitro antitumor activity against 41McisR cell line.,,N,41M,F,,CHEMBL615263,621.0,BAO_0000219,
231,Homo sapiens,80007,,,1,,,Expert,12989,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,,N,41M,F,,CHEMBL838393,621.0,BAO_0000219,
232,Homo sapiens,80007,,,1,,,Intermediate,16745,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,,N,41M,F,,CHEMBL615264,621.0,BAO_0000219,
233,Homo sapiens,84,,,1,,,Expert,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),,D,,B,,CHEMBL615265,,BAO_0000357,
234,Homo sapiens,68,,,1,,,Expert,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,D,,B,,CHEMBL615266,,BAO_0000357,
235,,68,,,1,,,Expert,6226,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,H,,B,,CHEMBL615267,,BAO_0000357,
236,,10201,,,1,,,Expert,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,,H,,B,,CHEMBL615268,,BAO_0000357,
237,,10201,,,1,,,Expert,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,,H,,B,,CHEMBL615269,,BAO_0000357,
238,,10201,,,1,,,Expert,17855,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,,H,,B,,CHEMBL615270,,BAO_0000357,
239,,12220,,,1,,,Autocuration,10413,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,H,,B,,CHEMBL615271,,BAO_0000357,
240,Escherichia coli,11303,,,1,,,Autocuration,10413,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,H,,B,,CHEMBL615272,,BAO_0000357,
241,Escherichia coli,11303,,,1,,,Autocuration,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",,H,,B,,CHEMBL615103,,BAO_0000357,
242,Escherichia coli,11303,,,1,,,Autocuration,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",,H,,B,,CHEMBL615104,,BAO_0000357,
243,,12220,,,1,,,Autocuration,10413,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,H,,B,,CHEMBL615105,,BAO_0000357,
244,,12220,,,1,,,Autocuration,10413,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",,H,,B,,CHEMBL872866,,BAO_0000357,
245,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,H,,B,,CHEMBL615106,,BAO_0000357,
246,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",,H,,B,,CHEMBL615107,,BAO_0000019,
247,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",,H,,B,,CHEMBL615108,,BAO_0000357,
248,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",,H,,B,,CHEMBL615109,,BAO_0000357,
249,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,H,,B,,CHEMBL615110,,BAO_0000357,
250,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,H,,B,,CHEMBL840105,,BAO_0000019,
251,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",,H,,B,,CHEMBL615111,,BAO_0000019,
252,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",,H,,B,,CHEMBL615112,,BAO_0000019,
253,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",,H,,B,,CHEMBL615113,,BAO_0000019,
254,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",,H,,B,,CHEMBL615114,,BAO_0000019,
255,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",,H,,B,,CHEMBL615115,,BAO_0000357,
256,Sus scrofa,11303,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",,H,,B,,CHEMBL615116,,BAO_0000019,
257,,11303,,,1,,,Autocuration,7323,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",,H,,B,,CHEMBL615698,,BAO_0000357,
258,Sus scrofa,22226,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",,U,,B,,CHEMBL615699,,BAO_0000019,
259,Sus scrofa,22226,,,1,,,Autocuration,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",,U,,B,,CHEMBL615700,,BAO_0000019,
260,Saccharomyces cerevisiae,100249,,,1,,,Expert,13750,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,,H,,B,,CHEMBL615701,,BAO_0000357,
261,Rattus norvegicus,22226,,,1,,,Autocuration,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,U,,B,,CHEMBL615702,,BAO_0000019,
262,Rattus norvegicus,22226,,,1,,,Autocuration,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,,U,,B,,CHEMBL615703,,BAO_0000019,
263,Rattus norvegicus,22226,,,1,,,Autocuration,7662,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",,U,,B,,CHEMBL615704,,BAO_0000019,
264,,104698,,,1,,,Autocuration,12211,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,H,,F,,CHEMBL615705,,BAO_0000019,
265,,104698,,,1,,,Autocuration,12211,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,H,,F,,CHEMBL615706,,BAO_0000019,
266,Cavia porcellus,20033,2116.0,,1,,,Intermediate,12211,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,,D,,F,,CHEMBL615707,,BAO_0000221,
267,,10623,,,1,,,Expert,12211,Stimulatory activity of intragastric pressure was tested in the rat,,H,,F,,CHEMBL615708,,BAO_0000019,
268,,121,,,1,,,Autocuration,15453,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,,H,,B,,CHEMBL615709,,BAO_0000357,
269,Rattus norvegicus,22226,,,1,,,Autocuration,11884,Dose to reduce neuronal firing against 5-HT cells in rats (iv),,U,,F,,CHEMBL615710,,BAO_0000218,
270,,12688,,,1,,,Autocuration,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,H,,F,,CHEMBL615711,,BAO_0000019,
271,Homo sapiens,121,,,1,,,Expert,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,,D,,B,,CHEMBL615712,,BAO_0000357,
272,Homo sapiens,121,,,1,,,Expert,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,,D,,B,,CHEMBL836325,,BAO_0000357,
273,,12198,,,1,,,Autocuration,11863,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,,H,,F,,CHEMBL615713,,BAO_0000019,
274,,12198,,,1,,,Autocuration,11863,Inhibition constant of high-affinity 5-HT uptake,,H,,B,,CHEMBL615714,,BAO_0000357,
275,,12198,,,1,,,Autocuration,11863,Michaelis-Menten constant was reported for high affinity transport of 5-HT,,H,,F,,CHEMBL615715,,BAO_0000019,
276,,12198,,,1,,,Autocuration,11863,Maximum rate was determined for high affinity transport of 5-HT,,H,,F,,CHEMBL615716,,BAO_0000019,
277,,104714,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-HT uptake,,H,,F,,CHEMBL615717,,BAO_0000019,
278,,10577,,,1,,,Expert,15796,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,,H,,B,,CHEMBL881818,,BAO_0000019,
279,Bos taurus,105,,,1,,,Expert,15796,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,,H,,B,,CHEMBL884540,,BAO_0000357,
280,Rattus norvegicus,104744,,,1,,,Autocuration,12801,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,D,,B,,CHEMBL615718,,BAO_0000224,
281,,104744,,,1,,,Autocuration,12801,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,,H,,B,,CHEMBL615719,,BAO_0000224,
282,,104744,,,1,,,Autocuration,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,Membranes,H,,B,,CHEMBL615720,,BAO_0000249,
283,,104744,,,1,,,Autocuration,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,Membranes,H,,B,,CHEMBL615721,,BAO_0000249,
284,,104744,,,1,,,Autocuration,11963,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,,B,,CHEMBL615722,,BAO_0000019,
285,,51,,,1,,,Autocuration,11701,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,,H,,F,,CHEMBL615723,,BAO_0000019,
286,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL615724,,BAO_0000221,
287,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615725,,BAO_0000221,
288,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL615726,,BAO_0000221,
289,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),,H,,F,,CHEMBL615727,,BAO_0000218,
290,Cavia porcellus,105570,,,1,,,Intermediate,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,,D,,F,,CHEMBL615728,,BAO_0000019,
291,,279,,,1,,,Autocuration,15779,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,CHO,B,,CHEMBL857971,449.0,BAO_0000219,
292,,107,,,1,,,Autocuration,15363,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL615729,,BAO_0000357,
293,Rattus norvegicus,12687,,,1,,,Expert,15363,Efficacy against 5-hydroxytryptamine 2A receptor,,D,,F,,CHEMBL615730,,BAO_0000019,
294,,12687,,,1,,,Expert,15329,Intrinsic activity towards 5-HT2A receptor of rat tail artery,,H,,F,,CHEMBL615731,,BAO_0000019,
295,,12687,,,1,,,Expert,15329,Relative potency towards 5-HT2A receptor of rat tail artery,,H,,F,,CHEMBL615732,,BAO_0000019,
296,,12687,,,1,,,Expert,15329,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,,H,,F,,CHEMBL615733,,BAO_0000019,
297,,12687,,,1,,,Expert,15329,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,,H,,F,,CHEMBL615734,,BAO_0000019,
298,,12687,,,1,,,Autocuration,15329,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,,H,,F,,CHEMBL615735,,BAO_0000019,
299,,12687,,,1,,,Expert,15329,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,H,,F,,CHEMBL615736,,BAO_0000019,
300,Cavia porcellus,20033,2116.0,,1,,,Intermediate,273,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,D,,F,,CHEMBL615737,,BAO_0000221,
301,Cavia porcellus,20033,2116.0,,1,,,Intermediate,273,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),,D,,F,,CHEMBL615738,,BAO_0000221,
302,Cavia porcellus,20033,2116.0,,1,,,Intermediate,273,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,,D,,F,,CHEMBL615739,,BAO_0000221,
303,,10623,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,,H,,B,,CHEMBL615278,,BAO_0000357,
304,Rattus norvegicus,10623,,,1,,,Expert,1317,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,D,,F,,CHEMBL615279,,BAO_0000019,
305,,168,,,1,,,Expert,12409,Binding affinity against 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL615280,,BAO_0000357,
306,Gallus gallus,22226,,,1,,,Autocuration,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,,U,,B,,CHEMBL615281,,BAO_0000019,
307,Homo sapiens,22226,,,1,,,Autocuration,11126,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,,U,,F,,CHEMBL615282,,BAO_0000019,
308,Homo sapiens,22226,,,1,,,Autocuration,11126,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,,U,,F,,CHEMBL615283,,BAO_0000019,
309,Homo sapiens,80156,,,1,,,Autocuration,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,,N,HL-60,B,,CHEMBL615284,649.0,BAO_0000219,
310,Homo sapiens,22226,,,1,,,Autocuration,11126,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,,U,,B,,CHEMBL615285,,BAO_0000019,
311,Homo sapiens,22226,,,1,,,Autocuration,11126,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,,U,,B,,CHEMBL615286,,BAO_0000019,
312,Homo sapiens,104703,,,1,,,Autocuration,17807,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,,D,Oocytes,B,,CHEMBL615287,,BAO_0000219,
313,,100256,,,1,,,Intermediate,16575,Chymotryptic inhibitory activity against 26S proteasome,,S,,F,,CHEMBL615288,,BAO_0000220,
314,,100256,,,1,,,Intermediate,15407,Inhibitory activity against 26S proteasome degradation of IkB,,S,,B,,CHEMBL615289,,BAO_0000220,
315,Homo sapiens,81034,,,1,,,Intermediate,10797,In vitro inhibition of 2780/DOX ovarian cancer cell line,,N,A2780,F,,CHEMBL615290,478.0,BAO_0000219,
316,Homo sapiens,81034,,,1,,,Intermediate,10797,In vitro inhibition of 2780/S ovarian cancer cell line,,N,A2780,F,,CHEMBL884522,478.0,BAO_0000219,
317,Homo sapiens,22226,,,1,,,Autocuration,3469,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,,U,,F,,CHEMBL615291,,BAO_0000019,
318,,22222,,,1,,,Intermediate,16037,Association constant for binding to AATT 28-mer AATT hairpin,,M,,B,,CHEMBL615292,,BAO_0000225,
319,,22222,,,1,,,Intermediate,16037,Kinetically Defined Association Constant for 28-mer AATT hairpin.,,M,,B,,CHEMBL615293,,BAO_0000225,
320,,22222,,,1,,,Intermediate,16037,Reaction Rate Parameter for 28-mer AATT hairpin,,M,,B,,CHEMBL615294,,BAO_0000225,
321,,22222,,,1,,,Intermediate,16037,Reaction Rate Parameter for 28-mer AATT hairpin,,M,,B,,CHEMBL615295,,BAO_0000225,
322,Homo sapiens,22226,,,1,,,Autocuration,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),,U,,F,,CHEMBL825021,,BAO_0000019,
323,Homo sapiens,22226,,,1,,,Autocuration,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),,U,,F,,CHEMBL615296,,BAO_0000019,
324,Homo sapiens,22226,,,1,,,Autocuration,16524,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,,U,,F,,CHEMBL615297,,BAO_0000019,
325,Cricetulus griseus,22226,,,1,,,Autocuration,16758,Cytotoxicity against cell line 2SC/20 determined by MTT test,,U,,F,,CHEMBL615298,,BAO_0000019,
326,Cricetulus griseus,22226,,,1,,,Autocuration,16758,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,,U,,F,,CHEMBL615299,,BAO_0000019,
327,Cricetulus griseus,22226,,,1,,,Autocuration,16758,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,,U,,F,,CHEMBL615300,,BAO_0000019,
328,,241,,,1,,,Autocuration,14360,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,,H,,B,,CHEMBL615301,,BAO_0000357,
329,Homo sapiens,241,,,1,,,Expert,14360,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,,D,,B,,CHEMBL615302,,BAO_0000357,
330,Rattus norvegicus,22226,,,1,,,Autocuration,9964,Selectivity ratio of ID50 in liver and heart,,U,,B,,CHEMBL615303,,BAO_0000019,
331,,12132,,,1,,,Autocuration,9964,"Selectivity, ratio of relative ID50 in liver and heart",,H,,B,,CHEMBL615304,,BAO_0000019,
332,,12132,,,1,,,Autocuration,9964,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,,H,,B,,CHEMBL615305,,BAO_0000019,
333,,12132,,,1,,,Autocuration,9964,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,,B,,CHEMBL615306,,BAO_0000218,
334,,12132,,,1,,,Autocuration,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,,B,,CHEMBL615307,,BAO_0000218,
335,,12132,,,1,In vivo,,Autocuration,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,,B,,CHEMBL615308,,BAO_0000218,
336,,12132,,,1,In vivo,,Autocuration,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,,F,,CHEMBL615309,,BAO_0000218,
337,,22226,,,1,,,Autocuration,9964,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",,U,,B,,CHEMBL615310,,BAO_0000019,
338,,12132,,,1,,,Autocuration,9964,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,,H,,B,,CHEMBL615311,,BAO_0000019,
339,Homo sapiens,22226,,,1,,,Autocuration,9964,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",,U,,B,,CHEMBL615312,,BAO_0000019,
340,,12132,,,1,,,Autocuration,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,H,,B,,CHEMBL615313,,BAO_0000019,
341,,12132,,,1,,,Autocuration,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,H,,F,,CHEMBL615314,,BAO_0000019,
342,,12132,,,1,,,Autocuration,9964,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",,H,,B,,CHEMBL615315,,BAO_0000019,
343,Rattus norvegicus,22226,,,1,,,Autocuration,9964,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",,U,,B,,CHEMBL615316,,BAO_0000218,
344,,12132,,,1,In vivo,,Autocuration,9964,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,,H,,B,,CHEMBL615317,,BAO_0000218,
345,,12132,,,1,,,Autocuration,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,H,,B,,CHEMBL615318,,BAO_0000218,
346,Rattus norvegicus,22226,,,1,,,Autocuration,9964,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",,U,,B,,CHEMBL615319,,BAO_0000218,
347,,12132,,,1,,,Autocuration,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,H,,B,,CHEMBL615320,,BAO_0000019,
348,,12132,,,1,,,Autocuration,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,H,,F,,CHEMBL615321,,BAO_0000019,
349,Rattus norvegicus,22226,,,1,,,Autocuration,3796,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",,U,,B,,CHEMBL615322,,BAO_0000019,
350,Escherichia coli,19690,,,1,,,Autocuration,4251,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,H,,B,,CHEMBL615323,,BAO_0000357,
351,Escherichia coli,19690,,,1,,,Autocuration,4251,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,,H,,B,,CHEMBL615407,,BAO_0000357,
352,Escherichia coli,19690,,,1,,,Autocuration,4251,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,H,,B,,CHEMBL857267,,BAO_0000357,
353,Escherichia coli,19690,,,1,,,Autocuration,4251,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,,H,,B,,CHEMBL615408,,BAO_0000357,
354,,19690,,,1,,,Autocuration,166,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,,H,,B,,CHEMBL615409,,BAO_0000357,
355,,19690,,,1,,,Autocuration,17861,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,,H,,B,,CHEMBL615410,,BAO_0000357,
356,,19690,,,1,,,Autocuration,166,Inhibition constant against 3-dehydroquinate synthase,,H,,B,,CHEMBL615411,,BAO_0000357,
357,,19690,,,1,,,Autocuration,166,Association rate constant against 3-dehydroquinate synthase,,H,,B,,CHEMBL615412,,BAO_0000357,
358,,19690,,,1,,,Autocuration,166,Rate constant against 3-dehydroquinate synthase,,H,,B,,CHEMBL615413,,BAO_0000357,
359,,22226,,,1,,,Autocuration,3548,Inhibitory activity against fuc-TVII,,U,,B,,CHEMBL615414,,BAO_0000019,
360,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,,B,,CHEMBL615415,,BAO_0000251,
361,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,,B,,CHEMBL615416,,BAO_0000251,
362,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,,B,,CHEMBL615417,,BAO_0000251,
363,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,,B,,CHEMBL615418,,BAO_0000251,
364,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Microsomes,D,,B,,CHEMBL615419,,BAO_0000251,
365,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,Microsomes,D,,B,,CHEMBL615420,,BAO_0000251,
366,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,Microsomes,D,,B,,CHEMBL615421,,BAO_0000251,
367,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,Microsomes,D,,B,,CHEMBL615422,,BAO_0000251,
368,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,Microsomes,D,,B,,CHEMBL615423,,BAO_0000251,
369,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,Microsomes,D,,B,,CHEMBL872868,,BAO_0000251,
370,Rattus norvegicus,12236,2107.0,,1,,,Autocuration,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,Microsomes,D,,B,,CHEMBL615424,,BAO_0000251,
371,,104832,,,1,,,Autocuration,3003,Inhibitory activity against 3-phosphoglycerate kinase.,,H,,B,,CHEMBL825022,,BAO_0000224,
372,,104832,,,1,,,Autocuration,3003,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,,H,,B,,CHEMBL615425,,BAO_0000224,
373,,104832,,,1,,,Autocuration,3003,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",,H,,B,,CHEMBL615426,,BAO_0000224,
374,Homo sapiens,10612,,,1,,,Expert,17185,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,,D,,B,,CHEMBL615427,,BAO_0000357,
375,Homo sapiens,80616,,,1,,,Intermediate,6072,Cytotoxicity on 3677 melanoma cells,,N,3677 melanoma cell line,F,,CHEMBL615428,844.0,BAO_0000219,
376,Homo sapiens,80616,,,1,,,Intermediate,6072,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,,N,3677 melanoma cell line,F,,CHEMBL615429,844.0,BAO_0000219,
377,Mus musculus,80617,,,1,,,Intermediate,5018,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,,N,MC-38,F,,CHEMBL615430,700.0,BAO_0000219,
378,Homo sapiens,22226,,,1,,,Intermediate,2852,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,,U,,F,,CHEMBL615431,,BAO_0000019,
379,,22226,,,1,,,Autocuration,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,,U,B16,F,,CHEMBL615432,798.0,BAO_0000218,
380,,22226,,,1,,,Autocuration,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,,U,B16,F,,CHEMBL615433,798.0,BAO_0000218,
381,Human rhinovirus 14,12464,,,1,,,Expert,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,,D,,F,,CHEMBL615434,,BAO_0000019,
382,Human rhinovirus sp.,50085,,,1,,,Intermediate,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,,N,,F,,CHEMBL615435,,BAO_0000218,
383,human rhinovirus type 14,50679,,,1,,,Intermediate,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,,N,,F,,CHEMBL615436,,BAO_0000218,
384,human rhinovirus type 14,50679,,,1,,,Intermediate,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,,N,,F,,CHEMBL615437,,BAO_0000218,
385,Human rhinovirus 14,12464,,,1,,,Expert,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,D,,F,,CHEMBL615438,,BAO_0000019,
386,Human rhinovirus 14,12464,,,1,,,Expert,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,D,,F,,CHEMBL615439,,BAO_0000019,
387,Human rhinovirus 14,12464,,,1,,,Expert,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,,D,,F,,CHEMBL615440,,BAO_0000019,
388,Human rhinovirus 14,12464,,,1,,,Expert,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,,D,,F,,CHEMBL615441,,BAO_0000019,
389,Enterovirus,50665,,,1,,,Intermediate,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,,N,,F,,CHEMBL615641,,BAO_0000218,
390,Enterovirus,50665,,,1,,,Intermediate,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,,N,,F,,CHEMBL872065,,BAO_0000218,
391,Enterovirus,50665,,,1,,,Intermediate,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,,N,,F,,CHEMBL825023,,BAO_0000218,
392,Enterovirus,50665,,,1,,,Intermediate,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,,N,,F,,CHEMBL615642,,BAO_0000218,
393,Human rhinovirus B,12464,,,1,,,Expert,13748,Inhibition of human rhinovirus 3C protease,,H,,B,,CHEMBL615643,,BAO_0000357,
394,Homo sapiens,22226,,,1,,,Autocuration,17699,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,,U,,B,,CHEMBL615644,,BAO_0000019,
395,Mus musculus,80619,,,1,,,Intermediate,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),,N,3EM 37,F,,CHEMBL615645,833.0,BAO_0000218,
396,Mus musculus,80619,,,1,,,Intermediate,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),,N,3EM 37,F,,CHEMBL615646,833.0,BAO_0000218,
397,Mus musculus,80619,,,1,,,Intermediate,7145,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),,N,3EM 37,F,,CHEMBL615647,833.0,BAO_0000218,
398,Mus musculus,80619,,,1,,,Intermediate,7145,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),,N,3EM 37,F,,CHEMBL615648,833.0,BAO_0000218,
399,Mus musculus,80619,,,1,,,Intermediate,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,,N,3EM 37,F,,CHEMBL615649,833.0,BAO_0000218,
400,Mus musculus,80619,,,1,,,Intermediate,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,,N,3EM 37,F,,CHEMBL615650,833.0,BAO_0000218,
401,Mus musculus,80620,,,1,,,Intermediate,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,N,3LL cell line,F,,CHEMBL615651,847.0,BAO_0000218,
402,Mus musculus,80620,,,1,,,Intermediate,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,,N,3LL cell line,F,,CHEMBL615652,847.0,BAO_0000218,
403,Mus musculus,80620,,,1,,,Expert,5325,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,,N,3LL cell line,F,,CHEMBL615653,847.0,BAO_0000218,
404,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,,N,3LL cell line,F,,CHEMBL615654,847.0,BAO_0000219,
405,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,,N,3LL cell line,F,,CHEMBL615655,847.0,BAO_0000219,
406,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,,N,3LL cell line,F,,CHEMBL825024,847.0,BAO_0000219,
407,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,,N,3LL cell line,F,,CHEMBL615656,847.0,BAO_0000219,
408,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,,N,3LL cell line,F,,CHEMBL615657,847.0,BAO_0000219,
409,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,,N,3LL cell line,F,,CHEMBL615658,847.0,BAO_0000219,
410,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,,N,3LL cell line,F,,CHEMBL615659,847.0,BAO_0000219,
411,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,,N,3LL cell line,F,,CHEMBL615660,847.0,BAO_0000219,
412,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,,N,3LL cell line,F,,CHEMBL615661,847.0,BAO_0000219,
413,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,,N,3LL cell line,F,,CHEMBL615662,847.0,BAO_0000219,
414,Mus musculus,80620,,,1,,,Intermediate,16169,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,,N,3LL cell line,F,,CHEMBL615663,847.0,BAO_0000219,
415,Mus musculus,80620,,,1,,,Intermediate,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,,N,3LL cell line,F,,CHEMBL615664,847.0,BAO_0000219,
416,Mus musculus,80620,,,1,,,Intermediate,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,,N,3LL cell line,F,,CHEMBL615665,847.0,BAO_0000219,
417,Mus musculus,80620,,,1,,,Intermediate,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,,N,3LL cell line,F,,CHEMBL615666,847.0,BAO_0000219,
418,Mus musculus,80620,,,1,,,Intermediate,16169,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,,N,3LL cell line,F,,CHEMBL615667,847.0,BAO_0000219,
419,Mus musculus,80620,,,1,,,Intermediate,16169,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,,N,3LL cell line,F,,CHEMBL615668,847.0,BAO_0000219,
420,Mus musculus,80620,,,1,,,Intermediate,16169,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,,N,3LL cell line,F,,CHEMBL615669,847.0,BAO_0000219,
421,Mus musculus,80620,,,1,,,Intermediate,16169,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,,N,3LL cell line,F,,CHEMBL615670,847.0,BAO_0000219,
422,Mus musculus,80620,,,1,,,Intermediate,16169,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,,N,3LL cell line,F,,CHEMBL836739,847.0,BAO_0000219,
423,Mus musculus,80620,,,1,,,Intermediate,16169,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,,N,3LL cell line,F,,CHEMBL615671,847.0,BAO_0000219,
424,Mus musculus,80620,,,1,,,Intermediate,16169,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,,N,3LL cell line,F,,CHEMBL615672,847.0,BAO_0000219,
425,Mus musculus,80620,,,1,,,Intermediate,16169,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,,N,3LL cell line,F,,CHEMBL615791,847.0,BAO_0000219,
426,Mus musculus,80620,,,1,,,Intermediate,16169,spermine levels in 3LL cells after the treatment of 1 uM of Compound,,N,3LL cell line,F,,CHEMBL615792,847.0,BAO_0000219,
427,Mus musculus,80620,,,1,,,Intermediate,16169,spermine levels in 3LL cells after the treatment of 10 uM of Compound,,N,3LL cell line,F,,CHEMBL615793,847.0,BAO_0000219,
428,Mus musculus,80620,,,1,,,Intermediate,16169,spermine levels in 3LL cells after the treatment of 250 uM of Compound,,N,3LL cell line,F,,CHEMBL615794,847.0,BAO_0000219,
429,Mus musculus,80620,,,1,,,Intermediate,16169,spermine levels in 3LL cells after the treatment of 50 uM of Compound,,N,3LL cell line,F,,CHEMBL615795,847.0,BAO_0000219,
430,Homo sapiens,80621,,,1,,,Intermediate,15547,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,,N,3LLD122,F,,CHEMBL615590,971.0,BAO_0000219,
431,,22226,,,1,,,Autocuration,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,,U,,F,,CHEMBL615591,,BAO_0000218,
432,,22226,,,1,,,Autocuration,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,,U,,F,,CHEMBL615592,,BAO_0000218,
433,,22226,,,1,,,Autocuration,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,,U,,F,,CHEMBL615593,,BAO_0000218,
434,,22226,,,1,,,Autocuration,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,,U,,F,,CHEMBL615594,,BAO_0000218,
435,Mus musculus,80951,,,1,,,Intermediate,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,,N,NIH3T3,F,,CHEMBL615595,723.0,BAO_0000219,
436,Mus musculus,80951,,,1,,,Intermediate,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,,N,NIH3T3,F,,CHEMBL615596,723.0,BAO_0000219,
437,,11169,,,1,,,Expert,12695,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,,H,NIH3T3,F,,CHEMBL615597,723.0,BAO_0000219,
438,Mus musculus,80951,,,1,,,Intermediate,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,,N,NIH3T3,F,,CHEMBL615598,723.0,BAO_0000219,
439,Mus musculus,80951,,,1,,,Intermediate,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,,N,NIH3T3,F,,CHEMBL615599,723.0,BAO_0000219,
440,Mus musculus,80951,,,1,,,Expert,17642,Effective dose against murine 3T3 fibroblasts cells,,N,NIH3T3,F,,CHEMBL615600,723.0,BAO_0000219,
441,Mus musculus,80951,,,1,,,Expert,17642,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,,N,NIH3T3,F,,CHEMBL615601,723.0,BAO_0000219,
442,Mus musculus,80951,,,1,,,Expert,12340,Cytotoxic effect on 3T3 cells,,N,NIH3T3,F,,CHEMBL615602,723.0,BAO_0000219,
443,Mus musculus,80951,,,1,,,Expert,12340,Cytotoxic effect on 3T3 cells,,N,NIH3T3,F,,CHEMBL615603,723.0,BAO_0000219,
444,Mus musculus,80951,,,1,,,Intermediate,12716,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,,N,NIH3T3,F,,CHEMBL615604,723.0,BAO_0000219,
445,Mus musculus,80951,,,1,,,Intermediate,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,N,NIH3T3,F,,CHEMBL615605,723.0,BAO_0000219,
446,Mus musculus,80951,,,1,,,Intermediate,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,,N,NIH3T3,F,,CHEMBL615606,723.0,BAO_0000219,
447,Mus musculus,80951,,,1,,,Expert,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,,N,NIH3T3,F,,CHEMBL884526,723.0,BAO_0000219,
448,Mus musculus,80951,,,1,,,Expert,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,,N,NIH3T3,F,,CHEMBL615607,723.0,BAO_0000219,
449,Mus musculus,80951,,,1,,,Intermediate,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,,N,NIH3T3,F,,CHEMBL615608,723.0,BAO_0000219,
450,Mus musculus,80951,,,1,,,Expert,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,,N,NIH3T3,F,,CHEMBL615609,723.0,BAO_0000219,
451,Mus musculus,80951,,,1,,,Expert,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,,N,NIH3T3,F,,CHEMBL615682,723.0,BAO_0000219,
452,Mus musculus,80951,,,1,,,Intermediate,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,,N,NIH3T3,F,,CHEMBL615683,723.0,BAO_0000219,
453,Mus musculus,80951,,,1,,,Expert,17780,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,,N,NIH3T3,F,,CHEMBL615684,723.0,BAO_0000218,
454,Mus musculus,104860,,,1,,,Autocuration,12751,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,,D,,F,,CHEMBL615685,,BAO_0000219,
455,Mus musculus,80951,,,1,,,Expert,12380,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,,N,NIH3T3,F,,CHEMBL615686,723.0,BAO_0000219,
456,Mus musculus,80951,,,1,,,Intermediate,14892,Inhibitory activity against 3T3 cell line,,N,NIH3T3,F,,CHEMBL615687,723.0,BAO_0000219,
457,Mus musculus,80951,,,1,,,Intermediate,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,,N,NIH3T3,F,,CHEMBL884523,723.0,BAO_0000219,
458,,11169,,,1,,,Expert,12695,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,,H,,F,,CHEMBL615688,,BAO_0000019,
459,Mus musculus,80951,,,1,,,Intermediate,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,,N,NIH3T3,F,,CHEMBL615689,723.0,BAO_0000219,
460,Mus musculus,80951,,,1,,,Intermediate,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,,N,NIH3T3,F,,CHEMBL615690,723.0,BAO_0000219,
461,,11169,,,1,,,Expert,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,,H,,F,,CHEMBL615691,,BAO_0000019,
462,,11169,,,1,,,Expert,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,,H,,F,,CHEMBL615692,,BAO_0000019,
463,Mus musculus,80951,,,1,,,Intermediate,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,,N,NIH3T3,F,,CHEMBL615693,723.0,BAO_0000219,
464,Mus musculus,80951,,,1,,,Expert,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,,N,NIH3T3,F,,CHEMBL615324,723.0,BAO_0000219,
465,Homo sapiens,9,,,1,,,Expert,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,,D,NIH3T3,F,,CHEMBL615325,723.0,BAO_0000219,
466,Homo sapiens,9,,,1,,,Expert,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),,D,NIH3T3,F,,CHEMBL615490,723.0,BAO_0000219,
467,Homo sapiens,188,,,1,,,Expert,4959,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,,D,NIH3T3,F,,CHEMBL615491,723.0,BAO_0000219,
468,Homo sapiens,188,,,1,,,Expert,4959,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),,D,NIH3T3,F,,CHEMBL615492,723.0,BAO_0000219,
469,Mus musculus,80951,,,1,,,Intermediate,12082,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,,N,NIH3T3,F,,CHEMBL615493,723.0,BAO_0000219,
470,Mus musculus,80951,,,1,,,Intermediate,12082,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,,N,NIH3T3,F,,CHEMBL615494,723.0,BAO_0000219,
471,Mus musculus,80951,,,1,,,Intermediate,12082,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,,N,NIH3T3,F,,CHEMBL615495,723.0,BAO_0000219,
472,Mus musculus,80951,,,1,,,Intermediate,12082,Inhibitory concentration was calculated on 3T3 cells by using growth assay,,N,NIH3T3,F,,CHEMBL615496,723.0,BAO_0000219,
473,Mus musculus,80951,,,1,,,Intermediate,2643,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,,N,NIH3T3,F,,CHEMBL615497,723.0,BAO_0000219,
474,Mus musculus,80951,,,1,,,Expert,11926,Inhibition of Swiss 3T3 mouse fibroblast proliferation,,N,NIH3T3,F,,CHEMBL615498,723.0,BAO_0000219,
475,Mus musculus,80951,,,1,,,Intermediate,15204,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,,N,NIH3T3,A,,CHEMBL615499,723.0,BAO_0000219,
476,Mus musculus,80951,,,1,,,Expert,15992,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,,N,NIH3T3,F,,CHEMBL835522,723.0,BAO_0000219,
477,Mus musculus,80951,,,1,,,Intermediate,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,,N,NIH3T3,F,,CHEMBL615500,723.0,BAO_0000219,
478,Mus musculus,80951,,,1,,,Intermediate,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,NIH3T3,F,,CHEMBL615501,723.0,BAO_0000219,
479,Mus musculus,80951,,,1,,,Intermediate,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,NIH3T3,F,,CHEMBL615502,723.0,BAO_0000219,
480,Mus musculus,80951,,,1,,,Intermediate,16279,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,NIH3T3,F,,CHEMBL615503,723.0,BAO_0000219,
481,Mus musculus,80951,,,1,,,Intermediate,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,NIH3T3,F,,CHEMBL615504,723.0,BAO_0000219,
482,Mus musculus,80951,,,1,,,Intermediate,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),,N,NIH3T3,F,,CHEMBL615505,723.0,BAO_0000219,
483,Mus musculus,80951,,,1,,,Expert,12831,Inhibition of swiss 3T3 mouse fibroblast proliferation,,N,NIH3T3,F,,CHEMBL615506,723.0,BAO_0000219,
484,Mus musculus,80951,,,1,,,Intermediate,13497,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,,N,NIH3T3,F,,CHEMBL615507,723.0,BAO_0000219,
485,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,N,3T3-L1,F,,CHEMBL615508,620.0,BAO_0000218,
486,Mus musculus,80006,,,1,,,Intermediate,13618,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,,N,3T3-L1,F,,CHEMBL615509,620.0,BAO_0000219,
487,Mus musculus,80006,,,1,,,Intermediate,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,,N,3T3-L1,F,,CHEMBL615510,620.0,BAO_0000219,
488,Mus musculus,80006,,,1,,,Intermediate,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,,N,3T3-L1,F,,CHEMBL615511,620.0,BAO_0000219,
489,Mus musculus,80006,,,1,,,Intermediate,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,,N,3T3-L1,F,,CHEMBL615512,620.0,BAO_0000219,
490,Mus musculus,80006,,,1,,,Intermediate,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",,N,3T3-L1,F,,CHEMBL615513,620.0,BAO_0000218,
491,Mus musculus,80006,,,1,,,Intermediate,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",,N,3T3-L1,F,,CHEMBL615514,620.0,BAO_0000218,
492,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,,N,3T3-L1,F,,CHEMBL615515,620.0,BAO_0000219,
493,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,N,3T3-L1,F,,CHEMBL615516,620.0,BAO_0000219,
494,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,N,3T3-L1,F,,CHEMBL615517,620.0,BAO_0000219,
495,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,N,3T3-L1,F,,CHEMBL615518,620.0,BAO_0000219,
496,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,N,3T3-L1,F,,CHEMBL615519,620.0,BAO_0000219,
497,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,,N,3T3-L1,F,,CHEMBL615520,620.0,BAO_0000218,
498,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,,N,3T3-L1,F,,CHEMBL615521,620.0,BAO_0000218,
499,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,N,3T3-L1,F,,CHEMBL615522,620.0,BAO_0000218,
500,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,N,3T3-L1,F,,CHEMBL615523,620.0,BAO_0000218,
501,,80006,,,1,,,Expert,13715,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,N,3T3-L1,F,,CHEMBL615524,620.0,BAO_0000218,
502,,80006,,,1,,,Expert,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,N,3T3-L1,F,,CHEMBL615525,620.0,BAO_0000218,
503,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,N,3T3-L1,F,,CHEMBL615526,620.0,BAO_0000218,
504,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,N,3T3-L1,F,,CHEMBL615527,620.0,BAO_0000218,
505,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,,N,3T3-L1,F,,CHEMBL615528,620.0,BAO_0000218,
506,,80006,,,1,,,Expert,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,N,3T3-L1,F,,CHEMBL615529,620.0,BAO_0000218,
507,,80006,,,1,,,Expert,13715,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,N,3T3-L1,F,,CHEMBL615530,620.0,BAO_0000218,
508,,80006,,,1,,,Expert,13715,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,N,3T3-L1,F,,CHEMBL615531,620.0,BAO_0000218,
509,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,N,3T3-L1,F,,CHEMBL615532,620.0,BAO_0000219,
510,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,N,3T3-L1,F,,CHEMBL615533,620.0,BAO_0000219,
511,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,N,3T3-L1,F,,CHEMBL615534,620.0,BAO_0000219,
512,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,N,3T3-L1,F,,CHEMBL615535,620.0,BAO_0000218,
513,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,N,3T3-L1,F,,CHEMBL615536,620.0,BAO_0000218,
514,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,N,3T3-L1,F,,CHEMBL615537,620.0,BAO_0000218,
515,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,N,3T3-L1,F,,CHEMBL615538,620.0,BAO_0000218,
516,,80006,,,1,,,Intermediate,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,N,3T3-L1,F,,CHEMBL836166,620.0,BAO_0000218,
517,,11214,,,1,,,Expert,6411,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,,H,3T3-L1,F,,CHEMBL615539,620.0,BAO_0000219,
518,Mus musculus,80006,,,1,,,Intermediate,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,,N,3T3-L1,F,,CHEMBL615540,620.0,BAO_0000219,
519,,11214,,,1,,,Expert,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,,H,3T3-L1,F,,CHEMBL615541,620.0,BAO_0000219,
520,Mus musculus,80006,,,1,,,Expert,3966,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,,N,3T3-L1,F,,CHEMBL615542,620.0,BAO_0000219,
521,Mus musculus,80006,,,1,,,Intermediate,3966,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,,N,3T3-L1,F,,CHEMBL615543,620.0,BAO_0000219,
522,Mus musculus,80006,,,1,,,Expert,15556,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,,N,3T3-L1,F,,CHEMBL615544,620.0,BAO_0000219,
523,Mus musculus,80006,,,1,,,Expert,5845,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,N,3T3-L1,F,,CHEMBL615545,620.0,BAO_0000219,
524,Mus musculus,80006,,,1,,,Expert,14422,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,,N,3T3-L1,F,,CHEMBL615546,620.0,BAO_0000219,
525,Mus musculus,80006,,,1,,,Expert,5845,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,,N,3T3-L1,F,,CHEMBL615547,620.0,BAO_0000219,
526,Mus musculus,80006,,,1,,,Expert,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,,N,3T3-L1,F,,CHEMBL615548,620.0,BAO_0000219,
527,Mus musculus,80006,,,1,,,Expert,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,,N,3T3-L1,F,,CHEMBL615549,620.0,BAO_0000219,
528,Mus musculus,80006,,,1,,,Expert,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,,N,3T3-L1,F,,CHEMBL615550,620.0,BAO_0000219,
529,Rattus norvegicus,80622,,,1,,,Intermediate,6349,Inhibitory activity against rat fibroblast (3Y1) cell line,,N,3Y1 cell line,F,,CHEMBL615551,1118.0,BAO_0000219,
530,Rattus norvegicus,80622,,,1,,,Expert,15899,Mean concentration causing inhibition of cell growth in 3Y1 cells.,,N,3Y1 cell line,F,,CHEMBL615552,1118.0,BAO_0000219,
531,Rattus norvegicus,80622,,,1,,,Expert,15899,Cytotoxicity in 3Y1 cells.,,N,3Y1 cell line,F,,CHEMBL615553,1118.0,BAO_0000219,
532,Rattus norvegicus,80622,,,1,,,Expert,15899,Cytostatic effect in 3Y1 cells.,,N,3Y1 cell line,F,,CHEMBL615554,1118.0,BAO_0000219,
533,Rattus norvegicus,80622,,,1,,,Intermediate,15899,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",,N,3Y1 cell line,F,,CHEMBL615555,1118.0,BAO_0000219,
534,Rattus norvegicus,80622,,,1,,,Expert,17038,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,,N,3Y1 cell line,F,,CHEMBL615556,1118.0,BAO_0000219,
535,,22226,,,1,,,Autocuration,12421,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,,U,,B,,CHEMBL615557,,BAO_0000019,
536,,22226,,,1,,,Autocuration,12947,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,U,,B,,CHEMBL615558,,BAO_0000019,
537,,22226,,,1,,,Autocuration,12947,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,U,,B,,CHEMBL872066,,BAO_0000019,
538,Sus scrofa,11607,,,1,,,Expert,4896,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,,D,,B,,CHEMBL615559,,BAO_0000019,
539,,11607,,,1,,,Autocuration,6148,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,,H,,B,,CHEMBL615560,,BAO_0000019,
540,,11607,,,1,,,Autocuration,16432,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,,H,,B,,CHEMBL615561,,BAO_0000019,
541,,11607,,,1,,,Expert,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,,H,,B,,CHEMBL857062,,BAO_0000019,
542,,11607,,,1,,,Expert,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),,H,,B,,CHEMBL615562,,BAO_0000019,
543,,11607,,,1,,,Autocuration,3723,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,,H,,B,,CHEMBL615563,,BAO_0000019,
544,,11607,,,1,,,Autocuration,3518,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),,H,,B,,CHEMBL615564,,BAO_0000357,
545,,11607,,,1,,,Autocuration,4164,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,H,,B,,CHEMBL615565,,BAO_0000019,
546,,11607,,,1,,,Autocuration,3518,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,,H,,B,,CHEMBL615566,,BAO_0000019,
547,Sus scrofa,11607,,,1,,,Expert,4164,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,,D,,B,,CHEMBL615567,,BAO_0000019,
548,,11607,,,1,,,Autocuration,3518,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,,H,,B,,CHEMBL615568,,BAO_0000019,
549,,11607,,,1,,,Autocuration,3518,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),,H,,B,,CHEMBL615569,,BAO_0000357,
550,,11607,,,1,,,Autocuration,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,,H,,B,,CHEMBL615570,,BAO_0000019,
551,,11607,,,1,,,Autocuration,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),,H,,B,,CHEMBL615571,,BAO_0000019,
552,,104733,,,1,,,Autocuration,6455,Binding affinity against melatonin (MT1) receptor (pC1),,H,,B,,CHEMBL615572,,BAO_0000224,
553,,22226,,,1,,,Autocuration,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,,U,,B,,CHEMBL615573,,BAO_0000019,
554,,22226,,,1,,,Autocuration,13020,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,,U,,B,,CHEMBL615574,,BAO_0000019,
555,,22226,,,1,,,Autocuration,13021,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,,U,,B,,CHEMBL615575,,BAO_0000019,
556,,10619,,,1,,,Autocuration,14532,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,,H,,B,,CHEMBL615576,,BAO_0000357,
557,,10619,,,1,,,Autocuration,14118,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL615577,,BAO_0000357,
558,,51,10000000.0,,1,,,Autocuration,11884,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,,H,,B,,CHEMBL615578,,BAO_0000221,
559,,51,,,1,,,Expert,13969,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615579,,BAO_0000357,
560,,51,,,1,,,Expert,13392,Binding affinity for 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615580,,BAO_0000357,
561,,51,,,1,,,Expert,14430,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,,H,,B,,CHEMBL615581,,BAO_0000019,
562,,51,10000000.0,,1,,,Autocuration,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,,B,,CHEMBL615582,,BAO_0000221,
563,,51,10000000.0,,1,,,Autocuration,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,,B,,CHEMBL615583,,BAO_0000221,
564,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615584,,BAO_0000221,
565,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL833691,,BAO_0000221,
566,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615585,,BAO_0000221,
567,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615586,,BAO_0000221,
568,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL884524,,BAO_0000221,
569,,51,10000000.0,,1,,,Autocuration,12249,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,,B,,CHEMBL615587,,BAO_0000221,
570,,51,10000000.0,,1,,,Autocuration,11799,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,H,,B,,CHEMBL615588,,BAO_0000221,
571,Rattus norvegicus,10576,,,1,,,Expert,14331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,Membranes,D,,B,,CHEMBL615589,,BAO_0000249,
572,Bos taurus,51,10000000.0,,1,,,Expert,11884,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,,H,,B,,CHEMBL615442,,BAO_0000221,
573,,51,10000000.0,,1,,,Autocuration,14331,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,,H,,B,,CHEMBL615443,,BAO_0000221,
574,,51,10000000.0,,1,,,Autocuration,11701,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,,H,,B,,CHEMBL615444,,BAO_0000221,
575,,51,10000000.0,,1,,,Expert,11701,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,,H,,B,,CHEMBL615445,,BAO_0000221,
576,,51,10000000.0,,1,,,Autocuration,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,,H,,B,,CHEMBL615446,,BAO_0000221,
577,,51,,,1,,,Autocuration,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,,H,CHO,B,,CHEMBL615447,449.0,BAO_0000219,
578,,51,10000000.0,,1,,,Expert,12248,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,,B,,CHEMBL615448,,BAO_0000221,
579,,51,10000000.0,,1,,,Expert,12249,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,H,,B,,CHEMBL615449,,BAO_0000221,
580,,51,,,1,,,Autocuration,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,CHO,B,,CHEMBL615450,449.0,BAO_0000219,
581,,51,10000000.0,,1,,,Expert,11799,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,H,,B,,CHEMBL615451,,BAO_0000221,
582,,51,,,1,,,Autocuration,634,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,H,,B,,CHEMBL615452,,BAO_0000357,
583,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615453,,BAO_0000221,
584,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL615454,,BAO_0000221,
585,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615455,,BAO_0000221,
586,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL615456,,BAO_0000221,
587,,51,10000000.0,,1,,,Autocuration,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,H,,B,,CHEMBL615457,,BAO_0000221,
588,,51,10000000.0,,1,,,Expert,12210,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,,H,,B,,CHEMBL615458,,BAO_0000218,
589,,51,10000000.0,,1,,,Expert,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL615459,,BAO_0000221,
590,Homo sapiens,51,,,1,,,Expert,2331,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",,D,CHO,B,,CHEMBL615460,449.0,BAO_0000219,
591,Cavia porcellus,51,,,1,,,Autocuration,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,,H,,F,,CHEMBL615461,,BAO_0000019,
592,Cavia porcellus,51,,,1,,,Autocuration,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,,H,,F,,CHEMBL615462,,BAO_0000019,
593,Cavia porcellus,51,10000000.0,,1,,,Autocuration,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,,H,,F,,CHEMBL615463,,BAO_0000221,
594,Cavia porcellus,51,2116.0,,1,,,Autocuration,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,H,,B,,CHEMBL615464,,BAO_0000221,
595,Cavia porcellus,51,2116.0,,1,,,Autocuration,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,H,,B,,CHEMBL615465,,BAO_0000221,
596,Cavia porcellus,51,2116.0,,1,,,Autocuration,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,,H,,B,,CHEMBL615466,,BAO_0000221,
597,Cavia porcellus,51,2116.0,,1,,,Autocuration,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,H,,B,,CHEMBL615467,,BAO_0000221,
598,Cavia porcellus,51,2116.0,,1,,,Autocuration,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,,H,,B,,CHEMBL615468,,BAO_0000221,
599,Cavia porcellus,51,2116.0,,1,,,Autocuration,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,,H,,B,,CHEMBL615469,,BAO_0000221,
600,Cavia porcellus,51,,,1,,,Autocuration,11574,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615470,,BAO_0000357,
601,Cavia porcellus,51,,,1,,,Autocuration,13114,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615471,,BAO_0000357,
602,Cavia porcellus,51,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615472,,BAO_0000357,
603,Cavia porcellus,106,10000000.0,,1,,,Autocuration,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,H,,B,,CHEMBL883242,,BAO_0000221,
604,Cavia porcellus,106,10000000.0,,1,,,Autocuration,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,,H,,F,,CHEMBL615473,,BAO_0000221,
605,Cricetulus griseus,11863,,,1,,,Autocuration,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,H,CHO,B,,CHEMBL615474,449.0,BAO_0000218,
606,,51,,,1,,,Autocuration,17785,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615475,,BAO_0000357,
607,,51,,,1,,,Autocuration,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,,H,HeLa,F,,CHEMBL615476,308.0,BAO_0000219,
608,,51,,,1,,,Autocuration,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,,H,HeLa,F,,CHEMBL615477,308.0,BAO_0000219,
609,,51,,,1,,,Autocuration,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL615478,,BAO_0000019,
610,,51,,,1,,,Autocuration,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,H,CHO,F,,CHEMBL615160,449.0,BAO_0000219,
611,,51,,,1,,,Expert,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,H,CHO,F,,CHEMBL615161,449.0,BAO_0000219,
612,,51,,,1,,,Autocuration,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,,H,CHO,F,,CHEMBL615162,449.0,BAO_0000219,
613,,51,,,1,,,Autocuration,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,,H,CHO,F,,CHEMBL615163,449.0,BAO_0000219,
614,,51,,,1,,,Expert,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,CHO,B,,CHEMBL615164,449.0,BAO_0000219,
615,,51,,,1,,,Expert,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,CHO,B,,CHEMBL615165,449.0,BAO_0000219,
616,,51,,,1,,,Autocuration,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,,H,CHO,B,,CHEMBL615166,449.0,BAO_0000219,
617,,51,,,1,,,Autocuration,14256,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,,H,,F,,CHEMBL615167,,BAO_0000219,
618,Homo sapiens,51,,,1,,,Expert,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,D,HeLa,B,,CHEMBL615168,308.0,BAO_0000219,
619,Homo sapiens,51,,,1,,,Expert,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,,D,HeLa,B,,CHEMBL615169,308.0,BAO_0000219,
620,Homo sapiens,51,,,1,,,Expert,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,,D,CHO,B,,CHEMBL615170,449.0,BAO_0000219,
621,Homo sapiens,51,,,1,,,Expert,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,,D,CHO,B,,CHEMBL615171,449.0,BAO_0000219,
622,,51,,,1,,,Autocuration,15180,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL615694,,BAO_0000019,
623,,51,,,1,,,Autocuration,15180,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL615695,,BAO_0000019,
624,,51,,,1,,,Autocuration,16026,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL615696,,BAO_0000019,
625,,51,,,1,,,Autocuration,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,H,CHO,F,,CHEMBL615697,449.0,BAO_0000219,
626,Homo sapiens,51,,,1,,,Expert,2759,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),,D,CHO,F,,CHEMBL859410,449.0,BAO_0000219,
627,,51,,,1,,,Autocuration,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,H,CHO,F,,CHEMBL615841,449.0,BAO_0000219,
628,Homo sapiens,51,,,1,,,Expert,2759,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),,D,CHO,F,,CHEMBL615842,449.0,BAO_0000219,
629,,51,,,1,,,Autocuration,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,H,CHO,F,,CHEMBL835003,449.0,BAO_0000219,
630,,51,,,1,,,Autocuration,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,H,CHO,F,,CHEMBL615843,449.0,BAO_0000219,
631,Homo sapiens,51,,,1,,,Expert,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),,D,CHO,F,,CHEMBL615979,449.0,BAO_0000219,
632,,51,,,1,,,Autocuration,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,H,CHO,F,,CHEMBL615980,449.0,BAO_0000219,
633,Homo sapiens,51,,,1,,,Expert,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),,D,CHO,F,,CHEMBL615981,449.0,BAO_0000219,
634,Homo sapiens,51,,,1,,,Expert,3445,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,,D,,F,,CHEMBL615982,,BAO_0000019,
635,Homo sapiens,51,,,1,,,Expert,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,D,,F,,CHEMBL615983,,BAO_0000019,
636,Homo sapiens,51,,,1,,,Expert,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",,D,,F,,CHEMBL615984,,BAO_0000019,
637,Homo sapiens,51,,,1,,,Expert,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",,D,,F,,CHEMBL615985,,BAO_0000019,
638,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,H,CHO,F,,CHEMBL615986,449.0,BAO_0000219,
639,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,H,CHO,F,,CHEMBL615987,449.0,BAO_0000219,
640,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,H,CHO,F,,CHEMBL615988,449.0,BAO_0000219,
641,,51,,,1,,,Expert,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,H,CHO,F,,CHEMBL615989,449.0,BAO_0000219,
642,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,H,CHO,F,,CHEMBL615990,449.0,BAO_0000219,
643,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,,H,CHO,F,,CHEMBL615991,449.0,BAO_0000219,
644,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,H,CHO,F,,CHEMBL615992,449.0,BAO_0000219,
645,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,,H,CHO,F,,CHEMBL615993,449.0,BAO_0000219,
646,,51,,,1,,,Expert,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,H,CHO,F,,CHEMBL615994,449.0,BAO_0000219,
647,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,,H,CHO,F,,CHEMBL615995,449.0,BAO_0000219,
648,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,H,CHO,F,,CHEMBL615996,449.0,BAO_0000219,
649,,51,,,1,,,Autocuration,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,,H,CHO,F,,CHEMBL615997,449.0,BAO_0000219,
650,,51,,,1,,,Autocuration,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,,F,,CHEMBL615998,,BAO_0000019,
651,,51,,,1,,,Autocuration,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,,F,,CHEMBL615999,,BAO_0000019,
652,,51,,,1,,,Autocuration,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,H,,F,,CHEMBL616000,,BAO_0000019,
653,,51,,,1,,,Autocuration,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,HEK293,F,,CHEMBL616001,722.0,BAO_0000219,
654,Homo sapiens,51,,,1,,,Expert,6876,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",,D,,F,,CHEMBL616002,,BAO_0000019,
655,,51,,,1,,,Expert,6876,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",,H,,F,,CHEMBL616003,,BAO_0000019,
656,Homo sapiens,51,,,1,,,Expert,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,,D,,F,,CHEMBL616004,,BAO_0000019,
657,Homo sapiens,51,,,1,,,Expert,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,,D,,F,,CHEMBL616005,,BAO_0000019,
658,,51,,,1,,,Autocuration,5548,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,H,,F,,CHEMBL616006,,BAO_0000019,
659,,51,,,1,,,Expert,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",,H,,F,,CHEMBL616007,,BAO_0000019,
660,,51,,,1,,,Autocuration,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,H,,F,,CHEMBL616008,,BAO_0000019,
661,,51,,,1,,,Autocuration,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,H,,F,,CHEMBL616009,,BAO_0000019,
662,,51,,,1,,,Expert,5929,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",,H,,F,,CHEMBL616010,,BAO_0000019,
663,Homo sapiens,51,,,1,,,Expert,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",,D,,F,,CHEMBL616011,,BAO_0000019,
664,Homo sapiens,51,,,1,,,Expert,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",,D,,F,,CHEMBL615740,,BAO_0000019,
665,,51,,,1,,,Autocuration,16245,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL615741,,BAO_0000019,
666,,51,,,1,,,Expert,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,H,,F,,CHEMBL615742,,BAO_0000019,
667,,51,,,1,,,Autocuration,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",,H,,F,,CHEMBL615743,,BAO_0000019,
668,,51,,,1,,,Autocuration,14509,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,,H,CHO,F,,CHEMBL615744,449.0,BAO_0000219,
669,,51,,,1,,,Expert,14509,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,,H,CHO,F,,CHEMBL615745,449.0,BAO_0000219,
670,,51,,,1,,,Autocuration,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,H,,B,,CHEMBL615746,,BAO_0000357,
671,,51,,,1,,,Autocuration,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,H,,B,,CHEMBL615747,,BAO_0000357,
672,,51,,,1,,,Autocuration,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,,F,,CHEMBL615748,,BAO_0000019,
673,,51,,,1,,,Autocuration,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",,H,,F,,CHEMBL615749,,BAO_0000019,
674,,51,,,1,,,Autocuration,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,H,,F,,CHEMBL615750,,BAO_0000019,
675,Homo sapiens,51,,,1,,,Expert,6563,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,,D,,F,,CHEMBL616259,,BAO_0000019,
676,,51,,,1,,,Autocuration,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,,F,,CHEMBL616260,,BAO_0000019,
677,Homo sapiens,51,,,1,,,Expert,5272,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,,D,,F,,CHEMBL616261,,BAO_0000019,
678,Homo sapiens,51,,,1,,,Expert,5272,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,D,,F,,CHEMBL616262,,BAO_0000019,
679,Homo sapiens,51,,,1,,,Expert,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,D,,F,,CHEMBL616263,,BAO_0000019,
680,Homo sapiens,51,,,1,,,Expert,5272,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,,D,,F,,CHEMBL616264,,BAO_0000019,
681,Homo sapiens,51,,,1,,,Expert,5272,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,,D,,F,,CHEMBL616265,,BAO_0000019,
682,Homo sapiens,51,,,1,,,Expert,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",,D,,F,,CHEMBL616266,,BAO_0000019,
683,Homo sapiens,51,,,1,,,Expert,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",,D,,F,,CHEMBL616267,,BAO_0000019,
684,Homo sapiens,51,,,1,,,Expert,5272,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,,D,,F,,CHEMBL616268,,BAO_0000019,
685,Homo sapiens,51,,,1,,,Expert,16146,Inhibition of human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616269,,BAO_0000357,
686,,51,,,1,,,Autocuration,17624,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,CHO,B,,CHEMBL884528,449.0,BAO_0000219,
687,,105,,,1,,,Expert,13706,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,,D,HEK293,B,,CHEMBL616270,722.0,BAO_0000219,
688,,51,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616271,449.0,BAO_0000219,
689,,51,,,1,,,Autocuration,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,H,CHO,F,,CHEMBL616272,449.0,BAO_0000219,
690,,51,,,1,,,Expert,6861,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,,H,,B,,CHEMBL616273,,BAO_0000357,
691,Homo sapiens,51,,,1,,,Expert,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616274,,BAO_0000357,
692,,51,,,1,,,Autocuration,17624,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,,H,CHO,B,,CHEMBL616275,449.0,BAO_0000219,
693,,51,,,1,,,Autocuration,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,CHO,B,,CHEMBL616276,449.0,BAO_0000219,
694,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,U,,F,,CHEMBL616277,,BAO_0000218,
695,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,,U,,F,,CHEMBL616278,,BAO_0000218,
696,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,,U,,F,,CHEMBL616279,,BAO_0000218,
697,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,U,,F,,CHEMBL616280,,BAO_0000218,
698,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,,U,,F,,CHEMBL616281,,BAO_0000218,
699,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,,U,,F,,CHEMBL616282,,BAO_0000218,
700,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,,U,,F,,CHEMBL616283,,BAO_0000218,
701,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,,U,,F,,CHEMBL616284,,BAO_0000218,
702,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,,U,,F,,CHEMBL616285,,BAO_0000218,
703,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,,U,,F,,CHEMBL616286,,BAO_0000218,
704,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,,U,,F,,CHEMBL616287,,BAO_0000218,
705,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,,U,,F,,CHEMBL616288,,BAO_0000218,
706,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,,U,,F,,CHEMBL616289,,BAO_0000218,
707,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,,U,,F,,CHEMBL615610,,BAO_0000218,
708,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,,U,,F,,CHEMBL615611,,BAO_0000218,
709,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,,U,,F,,CHEMBL615612,,BAO_0000218,
710,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,,U,,F,,CHEMBL615613,,BAO_0000218,
711,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,,U,,F,,CHEMBL615614,,BAO_0000218,
712,Rattus norvegicus,22226,,,1,In vivo,,Autocuration,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,,U,,F,,CHEMBL615615,,BAO_0000218,
713,,105093,,,1,,,Autocuration,11440,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,,H,,B,,CHEMBL615616,,BAO_0000019,
714,,11923,1898.0,,1,,,Autocuration,6238,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,,H,,B,,CHEMBL615617,,BAO_0000249,
715,,10577,,,1,,,Autocuration,10046,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,,H,,B,,CHEMBL615618,,BAO_0000019,
716,,10577,,,1,,,Autocuration,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,,H,,B,,CHEMBL615619,,BAO_0000019,
717,,10577,,,1,,,Expert,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,,H,,B,,CHEMBL615620,,BAO_0000019,
718,,55,,,1,,,Autocuration,167,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",,H,,B,,CHEMBL615621,,BAO_0000357,
719,,55,,,1,,,Autocuration,167,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",,H,,B,,CHEMBL615622,,BAO_0000357,
720,,12166,,,1,,,Autocuration,11520,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),,H,,F,,CHEMBL615623,,BAO_0000019,
721,,12166,,,1,,,Autocuration,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,H,,F,,CHEMBL615624,,BAO_0000019,
722,,12166,,,1,,,Autocuration,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,H,,F,,CHEMBL615625,,BAO_0000019,
723,,12166,,,1,,,Autocuration,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,H,,F,,CHEMBL767045,,BAO_0000019,
724,Cavia porcellus,55,,,1,,,Autocuration,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,,H,,F,,CHEMBL615626,,BAO_0000019,
725,Cavia porcellus,55,,,1,,,Autocuration,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,,H,,F,,CHEMBL615627,,BAO_0000019,
726,Cavia porcellus,55,,,1,,,Autocuration,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,,H,,B,,CHEMBL615628,,BAO_0000019,
727,Cavia porcellus,55,,,1,,,Autocuration,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,,H,,B,,CHEMBL615629,,BAO_0000357,
728,Homo sapiens,55,,,1,,,Expert,12281,Inhibitory concentration against 5-lipoxygenase from human whole blood,,D,,B,,CHEMBL615630,,BAO_0000357,
729,,55,,,1,,,Autocuration,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],,H,,B,,CHEMBL615631,,BAO_0000219,
730,,17087,,,1,,,Autocuration,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,H,,F,,CHEMBL615632,,BAO_0000218,
731,,17087,,,1,,,Autocuration,12281,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,,H,,B,,CHEMBL615633,,BAO_0000357,
732,,17087,,,1,,,Autocuration,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,H,,F,,CHEMBL615634,,BAO_0000218,
733,Sus scrofa,55,,,1,,,Expert,11089,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,,H,,B,,CHEMBL615635,,BAO_0000019,
734,,12166,,,1,,,Expert,11006,In vitro inhibition of rat 5-Lipoxygenase,,H,,B,,CHEMBL615636,,BAO_0000357,
735,Rattus norvegicus,12166,,,1,,,Expert,11481,Inhibitory activity against 5-Lipoxygenase,,D,,B,,CHEMBL615637,,BAO_0000357,
736,,12166,,,1,,,Expert,10864,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,,H,RBL-1,B,,CHEMBL615638,702.0,BAO_0000219,
737,,12166,,,1,,,Autocuration,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),,H,RBL-1,B,,CHEMBL615639,702.0,BAO_0000219,
738,,12166,,,1,,,Autocuration,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,,H,RBL-1,B,,CHEMBL615640,702.0,BAO_0000219,
739,,12166,,,1,,,Autocuration,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,,H,,B,,CHEMBL615796,,BAO_0000019,
740,,12166,,,1,,,Autocuration,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],,H,,B,,CHEMBL615845,,BAO_0000219,
741,,12166,,,1,,,Autocuration,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,H,,B,,CHEMBL615846,,BAO_0000357,
742,,12166,,,1,,,Autocuration,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,,H,RBL-1,B,,CHEMBL615847,702.0,BAO_0000219,
743,,12166,,,1,,,Autocuration,11311,The compound was tested for inhibition of isolated 5-Lipoxygenase,,H,,B,,CHEMBL615848,,BAO_0000357,
744,Rattus norvegicus,22226,,,1,,,Autocuration,11481,Ratio of IC50 against 5-LO and COX,,U,,B,,CHEMBL615849,,BAO_0000019,
745,,12166,,,1,,,Autocuration,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,H,,B,,CHEMBL615850,,BAO_0000357,
746,,12166,,,1,,,Autocuration,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,,H,,B,,CHEMBL615851,,BAO_0000357,
747,,12166,,,1,,,Autocuration,11311,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,,H,,B,,CHEMBL615852,,BAO_0000219,
748,,12166,,,1,,,Autocuration,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,,H,,F,,CHEMBL615853,,BAO_0000019,
749,,120,2367.0,,1,,,Autocuration,4288,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,,H,,B,,CHEMBL884527,,BAO_0000357,
750,Columba livia,22226,,,1,,,Autocuration,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,,U,,B,,CHEMBL872871,,BAO_0000019,
751,Columba livia,22226,,,1,,,Autocuration,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,,U,,B,,CHEMBL615854,,BAO_0000019,
752,Columba livia,22226,,,1,,,Autocuration,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,,U,,B,,CHEMBL767046,,BAO_0000019,
753,,10732,,,1,,,Autocuration,11249,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,,H,,B,,CHEMBL615855,,BAO_0000357,
754,Rattus norvegicus,12198,,,1,,,Expert,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,,D,,F,,CHEMBL615856,,BAO_0000019,
755,Rattus norvegicus,12198,,,1,,,Expert,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,D,,F,,CHEMBL615857,,BAO_0000019,
756,Rattus norvegicus,12198,,,1,,,Expert,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),,D,,F,,CHEMBL615858,,BAO_0000019,
757,,10576,10000000.0,,1,,,Expert,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,H,,B,,CHEMBL615859,,BAO_0000221,
758,,51,,,1,,,Autocuration,16293,Binding affinity towards human 5-hydroxytryptamine 1 receptor,,H,,B,,CHEMBL615860,,BAO_0000357,
759,Oryctolagus cuniculus,22226,,,1,,,Autocuration,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,U,,B,,CHEMBL615861,,BAO_0000019,
760,Oryctolagus cuniculus,22226,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,U,,B,,CHEMBL615862,,BAO_0000019,
761,Oryctolagus cuniculus,22226,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,,U,,B,,CHEMBL615863,,BAO_0000019,
762,Oryctolagus cuniculus,22226,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,U,,B,,CHEMBL615864,,BAO_0000019,
763,,104744,10000000.0,,1,,,Autocuration,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,H,,B,,CHEMBL615865,,BAO_0000221,
764,,104744,10000000.0,,1,,,Autocuration,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,H,,B,,CHEMBL615866,,BAO_0000221,
765,,104744,10000000.0,,1,,,Autocuration,10085,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,H,,B,,CHEMBL615867,,BAO_0000221,
766,,104744,,,1,,,Autocuration,9841,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,Membranes,H,,B,,CHEMBL615868,,BAO_0000249,
767,Rattus norvegicus,104744,,,1,,,Autocuration,8822,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,,D,,B,,CHEMBL615869,,BAO_0000249,
768,Rattus norvegicus,104744,,,1,,,Autocuration,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,,D,,B,,CHEMBL615870,,BAO_0000019,
769,Rattus norvegicus,104744,,,1,,,Autocuration,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,,D,,B,,CHEMBL615871,,BAO_0000019,
770,,104744,,,1,,,Autocuration,8868,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,,H,,B,,CHEMBL615872,,BAO_0000224,
771,,104744,10000000.0,,1,,,Autocuration,9036,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,,H,,B,,CHEMBL833492,,BAO_0000221,
772,,104744,10000000.0,,1,,,Autocuration,11374,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,,H,,B,,CHEMBL615873,,BAO_0000221,
773,,104744,,,1,,,Autocuration,10881,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,,H,,B,,CHEMBL615479,,BAO_0000224,
774,,104744,,,1,,,Autocuration,8822,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,,H,,B,,CHEMBL615480,,BAO_0000019,
775,Rattus norvegicus,104744,,,1,,,Autocuration,9806,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,,D,,B,,CHEMBL615481,,BAO_0000249,
776,,104744,,,1,,,Autocuration,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,,B,,CHEMBL872869,,BAO_0000019,
777,,104744,,,1,,,Autocuration,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,,B,,CHEMBL615482,,BAO_0000019,
778,,104744,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,H,,B,,CHEMBL615483,,BAO_0000221,
779,,104744,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,H,,B,,CHEMBL615484,,BAO_0000221,
780,,104744,,,1,,,Autocuration,8569,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,,H,,B,,CHEMBL615485,,BAO_0000019,
781,Rattus norvegicus,104744,,,1,,,Autocuration,10062,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,,D,,B,,CHEMBL615486,,BAO_0000224,
782,,104744,,,1,,,Autocuration,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,,H,,B,,CHEMBL615487,,BAO_0000224,
783,,104744,,,1,,,Autocuration,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,H,,B,,CHEMBL615488,,BAO_0000224,
784,,104744,,,1,,,Autocuration,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,H,,B,,CHEMBL615489,,BAO_0000224,
785,,104744,,,1,,,Autocuration,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,H,,B,,CHEMBL615389,,BAO_0000224,
786,,104744,,,1,,,Autocuration,15463,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,H,,B,,CHEMBL615390,,BAO_0000019,
787,,104744,,,1,,,Autocuration,15463,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,H,,B,,CHEMBL615391,,BAO_0000019,
788,,104744,,,1,,,Autocuration,9098,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,,H,,B,,CHEMBL615392,,BAO_0000224,
789,Rattus norvegicus,22226,,,1,,,Autocuration,3070,Affinity for 5-hydroxytryptamine 1 receptor,,U,,B,,CHEMBL615393,,BAO_0000019,
790,,104744,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,,H,,B,,CHEMBL615394,,BAO_0000221,
791,,104744,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,H,,B,,CHEMBL615395,,BAO_0000221,
792,,104744,,,1,,,Autocuration,6398,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,,H,,B,,CHEMBL615396,,BAO_0000224,
793,,104744,955.0,,1,,,Autocuration,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,,H,,B,,CHEMBL615397,,BAO_0000221,
794,,104744,,,1,,,Autocuration,11963,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,H,,B,,CHEMBL615398,,BAO_0000019,
795,Rattus norvegicus,22226,,,1,,,Autocuration,8908,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,,U,,B,,CHEMBL615399,,BAO_0000019,
796,,104744,,,1,,,Autocuration,9098,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,,H,,B,,CHEMBL615400,,BAO_0000019,
797,Rattus norvegicus,104744,,,1,,,Autocuration,8841,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,,D,,B,,CHEMBL615401,,BAO_0000019,
798,Rattus norvegicus,22226,,,1,,,Autocuration,8814,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,,U,,B,,CHEMBL615402,,BAO_0000019,
799,,104744,,,1,,,Autocuration,11752,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,,H,,B,,CHEMBL615403,,BAO_0000019,
800,,104744,955.0,,1,,,Autocuration,11642,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,,H,,B,,CHEMBL615404,,BAO_0000221,
801,,104744,,,1,,,Autocuration,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,,H,,B,,CHEMBL615781,,BAO_0000019,
802,,104744,955.0,,1,,,Autocuration,9231,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,,H,,B,,CHEMBL615782,,BAO_0000220,
803,,104744,955.0,,1,,,Autocuration,11351,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,,H,,B,,CHEMBL615783,,BAO_0000221,
804,,22226,,,1,,,Autocuration,4639,Compound was tested for binding affinity against 5-HT1 receptor,,U,,B,,CHEMBL873481,,BAO_0000019,
805,,22226,,,1,,,Autocuration,1205,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,,U,,B,,CHEMBL615784,,BAO_0000019,
806,,10576,,,1,,,Expert,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,H,,B,,CHEMBL615785,,BAO_0000357,
807,,10576,,,1,,,Autocuration,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL615786,,BAO_0000249,
808,,10576,,,1,In vivo,,Autocuration,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,H,,F,,CHEMBL615787,,BAO_0000218,
809,,10576,,,1,In vivo,,Autocuration,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,H,,F,,CHEMBL615788,,BAO_0000218,
810,,10576,,,1,,,Autocuration,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL767044,,BAO_0000019,
811,,10576,,,1,In vivo,,Autocuration,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,H,,F,,CHEMBL615789,,BAO_0000218,
812,,10576,,,1,In vivo,,Autocuration,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,H,,F,,CHEMBL615790,,BAO_0000218,
813,,10576,,,1,,,Autocuration,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,,H,,F,,CHEMBL615813,,BAO_0000019,
814,,10576,,,1,,,Autocuration,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,,H,,F,,CHEMBL615814,,BAO_0000219,
815,,51,,,1,,,Expert,15535,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,,H,,F,,CHEMBL615815,,BAO_0000219,
816,,10576,,,1,,,Autocuration,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,,H,,F,,CHEMBL615816,,BAO_0000219,
817,,10576,,,1,,,Expert,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,,H,,B,,CHEMBL615817,,BAO_0000249,
818,,10576,10000000.0,,1,,,Autocuration,10085,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,,H,,B,,CHEMBL615818,,BAO_0000221,
819,,10576,10000000.0,,1,,,Autocuration,10085,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,,H,,B,,CHEMBL615819,,BAO_0000221,
820,,10576,,,1,,,Expert,17331,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,Membranes,H,,B,,CHEMBL615820,,BAO_0000249,
821,Rattus norvegicus,10576,10000000.0,,1,,,Expert,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,,D,,B,,CHEMBL615821,,BAO_0000221,
822,Rattus norvegicus,10576,10000000.0,,1,,,Expert,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,D,,B,,CHEMBL615822,,BAO_0000221,
823,,10576,10000000.0,,1,,,Expert,10845,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615823,,BAO_0000221,
824,Rattus norvegicus,10576,10000000.0,,1,,,Expert,10845,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,,D,,B,,CHEMBL615824,,BAO_0000221,
825,Rattus norvegicus,10576,10000000.0,,1,,,Expert,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,,D,,B,,CHEMBL615825,,BAO_0000221,
826,,10576,,,1,,,Expert,13730,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615826,,BAO_0000357,
827,,10576,,,1,,,Expert,13508,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615827,,BAO_0000249,
828,,10576,10000000.0,,1,,,Expert,13508,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615828,,BAO_0000249,
829,,10576,10000000.0,,1,,,Expert,12073,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL615829,,BAO_0000221,
830,,10576,10000000.0,,1,,,Autocuration,4671,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615830,,BAO_0000221,
831,,10576,10000000.0,,1,,,Expert,13631,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,,H,,B,,CHEMBL615831,,BAO_0000221,
832,,10576,,,1,,,Autocuration,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615832,,BAO_0000357,
833,,10576,,,1,,,Autocuration,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,,H,,B,,CHEMBL615833,,BAO_0000019,
834,,10576,10000000.0,,1,,,Autocuration,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,,H,,B,,CHEMBL615834,,BAO_0000221,
835,,10576,,,1,,,Intermediate,12352,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,,H,,B,,CHEMBL615835,,BAO_0000249,
836,,10576,10000000.0,,1,,,Autocuration,14732,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,,H,,B,,CHEMBL615836,,BAO_0000249,
837,Rattus norvegicus,10576,,,1,,,Expert,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,,D,,B,,CHEMBL615837,,BAO_0000019,
838,Rattus norvegicus,10576,,,1,,,Expert,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,,D,,B,,CHEMBL615838,,BAO_0000019,
839,,10576,,,1,,,Expert,13657,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",,H,,B,,CHEMBL615839,,BAO_0000249,
840,,10576,,,1,,,Autocuration,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,,H,,B,,CHEMBL884525,,BAO_0000019,
841,,10576,,,1,,,Autocuration,2014,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,H,,B,,CHEMBL615840,,BAO_0000249,
842,,10576,10000000.0,,1,,,Expert,3086,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL615405,,BAO_0000221,
843,,10576,,,1,,,Expert,15854,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,H,,B,,CHEMBL615406,,BAO_0000019,
844,,10576,10000000.0,,1,,,Expert,10922,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,H,,B,,CHEMBL615900,,BAO_0000221,
845,,10576,10000000.0,,1,,,Expert,13346,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,,H,,B,,CHEMBL615901,,BAO_0000221,
846,,10576,,,1,,,Expert,15311,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,,H,,B,,CHEMBL615902,,BAO_0000357,
847,,10576,10000000.0,,1,,,Autocuration,10922,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,H,,B,,CHEMBL615903,,BAO_0000221,
848,,10576,,,1,,,Autocuration,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,,H,,B,,CHEMBL615904,,BAO_0000357,
849,,10576,,,1,,,Expert,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,H,,B,,CHEMBL615905,,BAO_0000357,
850,,10576,,,1,,,Autocuration,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,H,,B,,CHEMBL615906,,BAO_0000019,
851,,10576,,,1,,,Autocuration,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,H,,F,,CHEMBL615907,,BAO_0000019,
852,,10576,,,1,,,Expert,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,H,,B,,CHEMBL615908,,BAO_0000019,
853,,10576,10000000.0,,1,,,Autocuration,15789,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,H,,B,,CHEMBL615909,,BAO_0000221,
854,,10576,,,1,,,Autocuration,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,H,,B,,CHEMBL615910,,BAO_0000019,
855,,10576,,,1,,,Autocuration,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",,H,,B,,CHEMBL615911,,BAO_0000019,
856,,10576,,,1,,,Autocuration,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",,H,,B,,CHEMBL615912,,BAO_0000019,
857,,10576,,,1,,,Expert,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615913,,BAO_0000019,
858,,10576,,,1,,,Expert,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,H,,B,,CHEMBL615914,,BAO_0000357,
859,,10576,10000000.0,,1,,,Autocuration,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,H,,B,,CHEMBL615915,,BAO_0000221,
860,,10576,,,1,,,Autocuration,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,,H,,B,,CHEMBL615916,,BAO_0000357,
861,,10576,,,1,,,Expert,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,,H,,B,,CHEMBL615917,,BAO_0000357,
862,,10576,,,1,,,Expert,13830,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615918,,BAO_0000357,
863,,10576,10000000.0,,1,,,Expert,14286,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,,H,,B,,CHEMBL615919,,BAO_0000249,
864,Rattus norvegicus,10576,10000000.0,,1,,,Expert,14356,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,D,,B,,CHEMBL615920,,BAO_0000221,
865,,10576,,,1,,,Autocuration,15306,Inhibition concentration against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615921,,BAO_0000357,
866,,10576,,,1,,,Expert,15306,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),,H,,B,,CHEMBL615922,,BAO_0000357,
867,Rattus norvegicus,10576,,,1,,,Expert,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,D,,F,,CHEMBL881290,,BAO_0000249,
868,,10576,10000000.0,,1,,,Autocuration,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",,H,,B,,CHEMBL615923,,BAO_0000221,
869,,10576,10000000.0,,1,,,Autocuration,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,F,,CHEMBL615924,,BAO_0000221,
870,,10576,10000000.0,,1,,,Autocuration,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,F,,CHEMBL615925,,BAO_0000221,
871,Rattus norvegicus,10576,,,1,,,Expert,14178,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL615926,,BAO_0000357,
872,Rattus norvegicus,10576,,,1,,,Expert,10639,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL615927,,BAO_0000019,
873,,10576,10000000.0,,1,,,Autocuration,12306,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,,B,,CHEMBL615928,,BAO_0000221,
874,Rattus norvegicus,10576,,,1,,,Expert,1348,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,,D,,B,,CHEMBL615929,,BAO_0000357,
875,,10576,10000000.0,,1,,,Autocuration,13605,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,,H,,B,,CHEMBL615930,,BAO_0000221,
876,,51,,,1,,,Autocuration,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,H,CHO,B,,CHEMBL615931,449.0,BAO_0000219,
877,,51,,,1,,,Autocuration,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,H,CHO,F,,CHEMBL615932,449.0,BAO_0000219,
878,,51,,,1,,,Autocuration,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,H,CHO,F,,CHEMBL615933,449.0,BAO_0000219,
879,,51,,,1,,,Autocuration,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615934,,BAO_0000357,
880,,51,,,1,,,Autocuration,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,,H,,B,,CHEMBL615935,,BAO_0000357,
881,,51,,,1,,,Autocuration,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,H,,F,,CHEMBL615936,,BAO_0000019,
882,,51,,,1,,,Autocuration,4751,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,,H,CHO,B,,CHEMBL615937,449.0,BAO_0000219,
883,,51,,,1,,,Autocuration,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615938,,BAO_0000357,
884,,51,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),,H,,B,,CHEMBL615797,,BAO_0000357,
885,,51,,,1,,,Autocuration,5640,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615798,,BAO_0000357,
886,,51,,,1,,,Autocuration,6563,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,,H,,B,,CHEMBL872870,,BAO_0000357,
887,,51,,,1,,,Autocuration,5548,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,,H,,B,,CHEMBL615799,,BAO_0000357,
888,,51,,,1,,,Autocuration,6347,Percent binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615800,,BAO_0000357,
889,,51,,,1,,,Autocuration,17296,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,HEK293,F,,CHEMBL615801,722.0,BAO_0000219,
890,,51,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,,H,,B,,CHEMBL615802,,BAO_0000019,
891,,51,,,1,,,Autocuration,15740,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,,H,,B,,CHEMBL615803,,BAO_0000357,
892,,51,,,1,,,Expert,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,H,,F,,CHEMBL835002,,BAO_0000019,
893,,51,,,1,,,Autocuration,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",,H,,F,,CHEMBL615804,,BAO_0000019,
894,,51,,,1,,,Expert,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,,H,HeLa,B,,CHEMBL615805,308.0,BAO_0000219,
895,,51,,,1,,,Autocuration,4751,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,,H,CHO,B,,CHEMBL615806,449.0,BAO_0000219,
896,Homo sapiens,51,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,,D,,B,,CHEMBL615807,,BAO_0000357,
897,,51,,,1,,,Autocuration,4707,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,,H,,B,,CHEMBL615808,,BAO_0000357,
898,Homo sapiens,51,,,1,,,Expert,13910,Binding affinity against 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL615809,,BAO_0000357,
899,,51,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,,H,HeLa,B,,CHEMBL615810,308.0,BAO_0000219,
900,,51,,,1,,,Autocuration,16633,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615811,,BAO_0000357,
901,,51,,,1,,,Autocuration,11898,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,,H,CHO,B,,CHEMBL615812,449.0,BAO_0000219,
902,,51,,,1,,,Autocuration,11898,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,CHO,B,,CHEMBL615751,449.0,BAO_0000219,
903,,51,,,1,,,Autocuration,14331,Binding affinity against human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615752,,BAO_0000357,
904,,51,,,1,,,Expert,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,,H,CHO,B,,CHEMBL615753,449.0,BAO_0000219,
905,,51,,,1,,,Autocuration,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,,H,CHO,B,,CHEMBL615754,449.0,BAO_0000219,
906,,51,,,1,,,Autocuration,3307,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615755,,BAO_0000357,
907,Homo sapiens,51,,,1,,,Expert,6563,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,D,CHO,B,,CHEMBL615756,449.0,BAO_0000219,
908,,51,,,1,,,Autocuration,14165,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615757,,BAO_0000019,
909,,51,,,1,,,Autocuration,5732,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL615758,,BAO_0000357,
910,,51,,,1,,,Expert,13366,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,H,,B,,CHEMBL615759,,BAO_0000357,
911,,51,,,1,,,Autocuration,17626,Binding affinity towards human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615760,,BAO_0000357,
912,,51,,,1,,,Expert,6588,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,,H,HeLa,B,,CHEMBL615761,308.0,BAO_0000219,
913,,51,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,,H,,B,,CHEMBL872104,,BAO_0000357,
914,,51,,,1,,,Autocuration,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615762,,BAO_0000357,
915,,51,,,1,,,Autocuration,15463,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615763,,BAO_0000357,
916,,51,,,1,,,Autocuration,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL615764,,BAO_0000357,
917,,51,,,1,,,Autocuration,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),,H,Cell line,B,,CHEMBL615765,1167.0,BAO_0000219,
918,,51,,,1,,,Autocuration,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),,H,,B,,CHEMBL615766,,BAO_0000019,
919,,51,,,1,,,Autocuration,5548,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615767,,BAO_0000357,
920,,51,,,1,,,Expert,5548,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615768,,BAO_0000357,
921,,51,,,1,,,Autocuration,5548,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615769,,BAO_0000357,
922,,51,,,1,,,Expert,6876,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,,H,,B,,CHEMBL615770,,BAO_0000357,
923,,51,,,1,,,Autocuration,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615771,,BAO_0000357,
924,,51,,,1,,,Expert,17785,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,,H,,B,,CHEMBL615772,,BAO_0000357,
925,,51,,,1,,,Autocuration,6013,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615773,,BAO_0000357,
926,,51,,,1,,,Expert,5929,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615774,,BAO_0000357,
927,,51,,,1,,,Autocuration,16633,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615775,,BAO_0000357,
928,,51,,,1,,,Autocuration,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL615776,,BAO_0000357,
929,,51,,,1,,,Expert,16026,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615777,,BAO_0000357,
930,,51,,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,,H,,B,,CHEMBL615778,,BAO_0000219,
931,Homo sapiens,51,,,1,,,Expert,15874,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,D,,B,,CHEMBL615779,,BAO_0000357,
932,,51,,,1,,,Autocuration,15874,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,H,,B,,CHEMBL615780,,BAO_0000357,
933,,51,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616298,,BAO_0000357,
934,,51,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616299,,BAO_0000357,
935,,51,,,1,,,Autocuration,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL616300,485.0,BAO_0000219,
936,,51,,,1,,,Expert,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,,H,CHO-K1,F,,CHEMBL616301,485.0,BAO_0000219,
937,,51,,,1,,,Autocuration,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616302,,BAO_0000019,
938,,51,,,1,,,Autocuration,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),,H,,B,,CHEMBL616117,,BAO_0000019,
939,,51,,,1,,,Autocuration,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),,H,,B,,CHEMBL616118,,BAO_0000019,
940,,51,,,1,,,Autocuration,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,,H,,B,,CHEMBL616119,,BAO_0000019,
941,Homo sapiens,51,,,1,,,Expert,3445,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,,D,HeLa,B,,CHEMBL616120,308.0,BAO_0000219,
942,,51,,,1,,,Autocuration,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616121,,BAO_0000357,
943,,51,,,1,,,Autocuration,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,,H,,B,,CHEMBL616122,,BAO_0000357,
944,,51,,,1,,,Autocuration,17626,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616123,,BAO_0000357,
945,Homo sapiens,51,,,1,,,Expert,4234,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616124,,BAO_0000357,
946,,51,,,1,,,Expert,5640,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,H,,B,,CHEMBL616125,,BAO_0000357,
947,Rattus norvegicus,51,,,1,,,Expert,5272,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,,H,,B,,CHEMBL616126,,BAO_0000357,
948,,51,,,1,,,Autocuration,4622,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,,H,CHO,B,,CHEMBL616127,449.0,BAO_0000219,
949,,51,,,1,,,Expert,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616128,,BAO_0000019,
950,,51,,,1,,,Autocuration,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,H,,B,,CHEMBL616129,,BAO_0000357,
951,,51,,,1,,,Expert,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616130,,BAO_0000357,
952,,51,,,1,,,Autocuration,15267,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,,H,,B,,CHEMBL616131,,BAO_0000357,
953,,51,,,1,,,Autocuration,17158,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,,H,HeLa,B,,CHEMBL616132,308.0,BAO_0000219,
954,Homo sapiens,51,,,1,,,Expert,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,,D,HeLa,B,,CHEMBL616133,308.0,BAO_0000219,
955,,51,,,1,,,Autocuration,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616134,,BAO_0000357,
956,,51,,,1,,,Autocuration,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,,H,,B,,CHEMBL616135,,BAO_0000357,
957,Homo sapiens,51,,,1,,,Expert,2391,Affinity for 5-hydroxytryptamine 1A receptor subtype,,D,,B,,CHEMBL616136,,BAO_0000357,
958,,51,,,1,,,Autocuration,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,,H,,B,,CHEMBL616137,,BAO_0000019,
959,,51,,,1,,,Autocuration,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,,H,,B,,CHEMBL872105,,BAO_0000019,
960,,51,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,,H,,B,,CHEMBL616138,,BAO_0000357,
961,Homo sapiens,51,,,1,,,Expert,13051,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616139,,BAO_0000357,
962,,51,,,1,,,Autocuration,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",,H,,F,,CHEMBL616140,,BAO_0000019,
963,,51,,,1,,,Expert,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,,H,,B,,CHEMBL616141,,BAO_0000019,
964,,51,,,1,,,Autocuration,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616142,,BAO_0000357,
965,,51,,,1,,,Autocuration,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,,H,,B,,CHEMBL616143,,BAO_0000357,
966,,51,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,H,HeLa,B,,CHEMBL616144,308.0,BAO_0000219,
967,,51,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,,H,HeLa,B,,CHEMBL616145,308.0,BAO_0000219,
968,,51,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,H,HeLa,B,,CHEMBL616012,308.0,BAO_0000219,
969,,51,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,H,HeLa,B,,CHEMBL616013,308.0,BAO_0000219,
970,,51,,,1,,,Autocuration,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,H,,F,,CHEMBL616014,,BAO_0000019,
971,,51,,,1,,,Autocuration,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,H,,F,,CHEMBL616015,,BAO_0000019,
972,,51,,,1,,,Autocuration,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,H,,F,,CHEMBL616016,,BAO_0000019,
973,,51,,,1,In vivo,,Autocuration,16394,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,,H,,F,,CHEMBL616017,,BAO_0000218,
974,,51,,,1,,,Autocuration,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,,H,,B,,CHEMBL616018,,BAO_0000019,
975,,51,,,1,,,Autocuration,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,,H,,F,,CHEMBL616019,,BAO_0000019,
976,,51,,,1,,,Autocuration,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,,H,,F,,CHEMBL616020,,BAO_0000019,
977,,51,,,1,,,Autocuration,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL858018,,BAO_0000357,
978,,51,,,1,,,Autocuration,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,HEK293,F,,CHEMBL616021,722.0,BAO_0000219,
979,,51,,,1,,,Expert,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",,H,,F,,CHEMBL616022,,BAO_0000019,
980,,51,,,1,,,Autocuration,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",,H,,F,,CHEMBL616023,,BAO_0000019,
981,,51,,,1,,,Autocuration,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",,H,,F,,CHEMBL616024,,BAO_0000019,
982,,51,,,1,,,Autocuration,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",,H,,F,,CHEMBL616025,,BAO_0000019,
983,,51,,,1,,,Autocuration,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,H,CHO,F,,CHEMBL616026,449.0,BAO_0000219,
984,,51,,,1,,,Autocuration,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",,H,,F,,CHEMBL616027,,BAO_0000019,
985,Homo sapiens,51,,,1,,,Expert,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",,D,,F,,CHEMBL616028,,BAO_0000019,
986,Homo sapiens,51,,,1,,,Expert,3445,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,,D,,F,,CHEMBL616029,,BAO_0000019,
987,,51,,,1,,,Expert,4316,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,,H,CHO,B,,CHEMBL616030,449.0,BAO_0000219,
988,,51,,,1,,,Expert,4316,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,,H,,B,,CHEMBL616031,,BAO_0000019,
989,Homo sapiens,51,,,1,,,Expert,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,D,,F,,CHEMBL616032,,BAO_0000019,
990,Homo sapiens,51,,,1,,,Expert,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,,D,,F,,CHEMBL616033,,BAO_0000019,
991,,51,,,1,,,Autocuration,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,,F,,CHEMBL616034,,BAO_0000019,
992,,51,,,1,,,Autocuration,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,,F,,CHEMBL616035,,BAO_0000019,
993,,51,,,1,,,Autocuration,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL616036,,BAO_0000019,
994,,51,,,1,,,Autocuration,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,,F,,CHEMBL616037,,BAO_0000019,
995,,51,,,1,,,Autocuration,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,,F,,CHEMBL616038,,BAO_0000019,
996,,51,,,1,,,Autocuration,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,H,,F,,CHEMBL616039,,BAO_0000019,
997,,51,,,1,,,Autocuration,15042,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL616040,,BAO_0000019,
998,Homo sapiens,51,,,1,,,Expert,15180,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,D,HeLa,F,,CHEMBL616041,308.0,BAO_0000219,
999,Homo sapiens,51,,,1,,,Expert,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,D,HeLa,F,,CHEMBL616042,308.0,BAO_0000219,
1000,Homo sapiens,51,,,1,,,Expert,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,,D,HeLa,F,,CHEMBL616043,308.0,BAO_0000219,
1001,,51,,,1,,,Autocuration,16245,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL616044,,BAO_0000019,
1002,,51,,,1,,,Autocuration,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL616045,,BAO_0000019,
1003,,51,,,1,,,Autocuration,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,H,HEK293,F,,CHEMBL616046,722.0,BAO_0000219,
1004,,51,,,1,,,Autocuration,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,H,CHO,F,,CHEMBL616047,449.0,BAO_0000219,
1005,,51,,,1,,,Autocuration,2759,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,H,CHO,F,,CHEMBL616048,449.0,BAO_0000219,
1006,Homo sapiens,51,,,1,,,Expert,2759,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),,D,CHO,F,,CHEMBL616049,449.0,BAO_0000219,
1007,,51,,,1,,,Autocuration,2759,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,H,CHO,F,,CHEMBL616050,449.0,BAO_0000219,
1008,,51,,,1,,,Expert,15419,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,,H,,F,,CHEMBL616051,,BAO_0000219,
1009,,51,,,1,,,Autocuration,15419,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,,H,,F,,CHEMBL616212,,BAO_0000219,
1010,,51,,,1,,,Autocuration,16026,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL616213,,BAO_0000019,
1011,,51,,,1,In vitro,,Expert,1414,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,,H,,B,,CHEMBL616214,,BAO_0000219,
1012,,51,,,1,In vitro,,Expert,1414,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,,H,,B,,CHEMBL616215,,BAO_0000219,
1013,,51,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL616216,,BAO_0000357,
1014,,51,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,,B,,CHEMBL616217,,BAO_0000019,
1015,,51,,,1,,,Autocuration,5104,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616218,,BAO_0000357,
1016,,51,,,1,,,Autocuration,5105,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616219,,BAO_0000357,
1017,,51,,,1,,,Autocuration,16312,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616220,,BAO_0000357,
1018,Homo sapiens,51,,,1,,,Expert,15180,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL833493,,BAO_0000357,
1019,,51,,,1,,,Autocuration,5033,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616221,,BAO_0000357,
1020,Homo sapiens,51,,,1,,,Expert,16909,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,,D,CHO,B,,CHEMBL616222,449.0,BAO_0000219,
1021,,51,,,1,,,Autocuration,2590,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL616223,,BAO_0000019,
1022,,51,,,1,,,Autocuration,2590,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,,H,,F,,CHEMBL616224,,BAO_0000019,
1023,,51,,,1,,,Expert,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,,H,,B,,CHEMBL616225,,BAO_0000019,
1024,Homo sapiens,51,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,,D,HEK293,B,,CHEMBL616226,722.0,BAO_0000219,
1025,,51,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,,H,HEK293,B,,CHEMBL616227,722.0,BAO_0000219,
1026,,51,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,,H,HEK293,B,,CHEMBL616228,722.0,BAO_0000219,
1027,,51,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,H,HEK293,B,,CHEMBL616229,722.0,BAO_0000219,
1028,,51,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,,H,HEK293,B,,CHEMBL616230,722.0,BAO_0000219,
1029,,51,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,,H,HEK293,B,,CHEMBL616231,722.0,BAO_0000219,
1030,,51,,,1,,,Autocuration,6166,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616232,,BAO_0000357,
1031,,51,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,H,HEK293,B,,CHEMBL616233,722.0,BAO_0000219,
1032,,51,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,,H,HEK293,B,,CHEMBL857973,722.0,BAO_0000219,
1033,,51,,,1,,,Autocuration,15316,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,,H,,B,,CHEMBL616234,,BAO_0000219,
1034,,51,,,1,,,Autocuration,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616235,,BAO_0000357,
1035,,51,,,1,,,Expert,14727,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,H,HeLa,B,,CHEMBL616236,308.0,BAO_0000219,
1036,,51,,,1,,,Expert,14727,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,H,,B,,CHEMBL616237,,BAO_0000019,
1037,,51,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,,H,HEK293,B,,CHEMBL616238,722.0,BAO_0000219,
1038,,51,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,,H,HEK293,B,,CHEMBL616239,722.0,BAO_0000219,
1039,,51,,,1,,,Autocuration,16429,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,,H,,B,,CHEMBL616240,,BAO_0000219,
1040,Homo sapiens,51,,,1,,,Expert,15042,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,,D,HeLa,B,,CHEMBL616241,308.0,BAO_0000219,
1041,,51,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,,H,HEK293,B,,CHEMBL616242,722.0,BAO_0000219,
1042,,51,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",,H,HEK293,B,,CHEMBL616243,722.0,BAO_0000219,
1043,,51,,,1,,,Expert,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616244,,BAO_0000357,
1044,Homo sapiens,51,,,1,,,Autocuration,13051,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616245,,BAO_0000357,
1045,,106,,,1,,,Autocuration,5486,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,H,,B,,CHEMBL616246,,BAO_0000357,
1046,,105,,,1,,,Autocuration,5254,Binding affinity against 5-HT1D receptor,,H,,B,,CHEMBL616247,,BAO_0000357,
1047,,105,,,1,,,Autocuration,5254,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616248,,BAO_0000357,
1048,,107,,,1,,,Autocuration,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,H,,B,,CHEMBL616249,,BAO_0000357,
1049,Homo sapiens,10576,,,1,,,Autocuration,13506,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,H,,B,,CHEMBL616250,,BAO_0000357,
1050,,51,,,1,,,Autocuration,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616251,,BAO_0000357,
1051,,11863,,,1,In vivo,,Autocuration,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,,H,,F,,CHEMBL616252,,BAO_0000218,
1052,,11863,,,1,In vivo,,Autocuration,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,,H,,F,,CHEMBL616253,,BAO_0000218,
1053,,11863,,,1,In vivo,,Autocuration,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,,H,,F,,CHEMBL616254,,BAO_0000218,
1054,Mus musculus,11863,,,1,,,Expert,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,,D,,F,,CHEMBL616255,,BAO_0000218,
1055,Mus musculus,11863,,,1,,,Expert,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,,D,,F,,CHEMBL832872,,BAO_0000218,
1056,Mus musculus,11863,,,1,,,Expert,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,,D,,F,,CHEMBL616256,,BAO_0000218,
1057,Mus musculus,11863,,,1,,,Expert,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,,D,,F,,CHEMBL616257,,BAO_0000218,
1058,Mus musculus,11863,,,1,,,Expert,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,,D,,F,,CHEMBL616258,,BAO_0000218,
1059,Mus musculus,11863,,,1,,,Expert,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,,D,,F,,CHEMBL616384,,BAO_0000218,
1060,,11863,10000000.0,,1,,,Autocuration,10297,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,H,,B,,CHEMBL616385,,BAO_0000221,
1061,,11863,,,1,,,Expert,13704,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,,H,,B,,CHEMBL616386,,BAO_0000357,
1062,Mus musculus,11863,10000000.0,,1,,,Expert,10297,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,D,,B,,CHEMBL616387,,BAO_0000221,
1063,,11863,10000000.0,,1,,,Autocuration,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,H,,B,,CHEMBL616388,,BAO_0000221,
1064,Mus musculus,11863,10000000.0,,1,,,Expert,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,,D,,B,,CHEMBL616389,,BAO_0000221,
1065,,11863,10000000.0,,1,,,Autocuration,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,H,,B,,CHEMBL616390,,BAO_0000221,
1066,,11863,,,1,,,Autocuration,217,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,,H,,B,,CHEMBL616391,,BAO_0000357,
1067,Mus musculus,11863,10000000.0,,1,,,Expert,10297,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,D,,B,,CHEMBL616392,,BAO_0000221,
1068,Sus scrofa,51,,,1,,,Autocuration,4921,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616393,,BAO_0000357,
1069,Sus scrofa,51,,,1,,,Autocuration,4921,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,,H,,B,,CHEMBL616394,,BAO_0000357,
1070,Sus scrofa,51,,,1,,,Autocuration,4996,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,,H,,B,,CHEMBL616395,,BAO_0000019,
1071,Sus scrofa,51,,,1,,,Autocuration,12918,Compound was evaluated for the binding affinity at 5- HT1A receptor,,H,,B,,CHEMBL616396,,BAO_0000357,
1072,Sus scrofa,51,,,1,,,Autocuration,5333,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,H,,B,,CHEMBL872907,,BAO_0000019,
1073,Sus scrofa,51,,,1,,,Autocuration,4437,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,,H,,B,,CHEMBL616397,,BAO_0000019,
1074,Sus scrofa,51,,,1,,,Autocuration,1742,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,,H,,B,,CHEMBL616398,,BAO_0000019,
1075,Sus scrofa,51,,,1,,,Expert,16688,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616399,,BAO_0000357,
1076,Sus scrofa,51,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL857065,,BAO_0000357,
1077,Sus scrofa,51,,,1,,,Expert,12861,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,H,,B,,CHEMBL616400,,BAO_0000019,
1078,Sus scrofa,51,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,,H,,B,,CHEMBL616401,,BAO_0000019,
1079,,10624,,,1,,,Expert,12490,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,,H,,B,,CHEMBL616402,,BAO_0000019,
1080,Sus scrofa,51,,,1,,,Expert,11828,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616403,,BAO_0000019,
1081,Sus scrofa,51,10000000.0,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,,H,,B,,CHEMBL616404,,BAO_0000221,
1082,Sus scrofa,51,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,,H,,B,,CHEMBL616405,,BAO_0000249,
1083,Sus scrofa,51,,,1,,,Autocuration,12918,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,,H,,B,,CHEMBL616406,,BAO_0000019,
1084,Sus scrofa,51,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,,H,,F,,CHEMBL616407,,BAO_0000019,
1085,Oryctolagus cuniculus,51,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,,H,,B,,CHEMBL616408,,BAO_0000019,
1086,Rattus norvegicus,10576,,,1,,,Expert,15796,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,,D,,B,,CHEMBL616409,,BAO_0000249,
1087,Rattus norvegicus,10576,10000000.0,,1,,,Expert,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",,D,,B,,CHEMBL616410,,BAO_0000221,
1088,,10576,,,1,,,Autocuration,188,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,,H,,B,,CHEMBL616411,,BAO_0000357,
1089,Rattus norvegicus,10576,,,1,,,Expert,16616,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Membranes,D,,F,,CHEMBL616412,,BAO_0000249,
1090,Rattus norvegicus,10576,10000000.0,,1,,,Expert,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Membranes,D,,F,,CHEMBL616413,,BAO_0000249,
1091,,10576,10000000.0,,1,,,Autocuration,12306,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,,B,,CHEMBL616414,,BAO_0000221,
1092,Rattus norvegicus,10576,10000000.0,,1,,,Expert,17167,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,,D,,B,,CHEMBL616415,,BAO_0000221,
1093,,10576,,,1,,,Autocuration,14776,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,,H,,B,,CHEMBL616416,,BAO_0000019,
1094,,10576,,,1,,,Expert,12158,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616417,,BAO_0000357,
1095,,10576,,,1,,,Autocuration,13481,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,,H,,B,,CHEMBL616418,,BAO_0000357,
1096,,10576,,,1,In vitro,,Autocuration,13427,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,H,,B,,CHEMBL616419,,BAO_0000219,
1097,,10576,,,1,,,Autocuration,10210,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,,H,,B,,CHEMBL616420,,BAO_0000357,
1098,,10576,,,1,,,Autocuration,10205,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,Membranes,H,,B,,CHEMBL616421,,BAO_0000249,
1099,,10576,,,1,,,Autocuration,10205,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,Membranes,H,,B,,CHEMBL616422,,BAO_0000249,
1100,,10576,,,1,,,Expert,10205,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,Membranes,H,,B,,CHEMBL616423,,BAO_0000249,
1101,Rattus norvegicus,10576,,,1,,,Expert,12280,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,,D,,B,,CHEMBL616424,,BAO_0000357,
1102,,10576,,,1,,,Expert,17386,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616425,,BAO_0000357,
1103,,10576,,,1,,,Expert,13654,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,,H,,B,,CHEMBL616426,,BAO_0000357,
1104,,10576,10000000.0,,1,,,Autocuration,14423,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,,H,,B,,CHEMBL616427,,BAO_0000221,
1105,,10576,10000000.0,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,,H,,B,,CHEMBL616428,,BAO_0000221,
1106,,10576,10000000.0,,1,,,Autocuration,12073,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616290,,BAO_0000221,
1107,Rattus norvegicus,10576,,,1,,,Expert,4101,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616052,,BAO_0000357,
1108,,10576,,,1,,,Autocuration,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616053,,BAO_0000357,
1109,,10576,,,1,,,Autocuration,6238,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616054,,BAO_0000249,
1110,,10576,,,1,,,Autocuration,16273,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616055,,BAO_0000357,
1111,,10576,,,1,,,Autocuration,11139,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,,H,,B,,CHEMBL616056,,BAO_0000357,
1112,,10576,,,1,,,Expert,16796,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,H,,B,,CHEMBL616057,,BAO_0000019,
1113,Rattus norvegicus,10576,955.0,,1,,,Expert,9548,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,D,,B,,CHEMBL616058,,BAO_0000221,
1114,,10576,955.0,,1,,,Autocuration,10381,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,H,,B,,CHEMBL616059,,BAO_0000221,
1115,,10576,,,1,,,Autocuration,13408,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616060,,BAO_0000249,
1116,Rattus norvegicus,10576,10000000.0,,1,,,Expert,13825,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,,D,,B,,CHEMBL616061,,BAO_0000221,
1117,,10576,10000000.0,,1,,,Expert,11147,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,,H,,B,,CHEMBL616062,,BAO_0000221,
1118,,10576,,,1,,,Autocuration,10552,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616063,,BAO_0000249,
1119,,10576,2435.0,,1,,,Autocuration,10552,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,H,,B,,CHEMBL616064,,BAO_0000249,
1120,Rattus norvegicus,10576,,,1,,,Expert,17136,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,Membranes,D,,B,,CHEMBL616065,,BAO_0000249,
1121,Rattus norvegicus,10576,,,1,,,Expert,5778,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,Membranes,D,,B,,CHEMBL616066,,BAO_0000249,
1122,,10576,10000000.0,,1,,,Autocuration,13481,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616067,,BAO_0000221,
1123,,10576,10000000.0,,1,,,Autocuration,13481,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,,H,,B,,CHEMBL616068,,BAO_0000221,
1124,,10576,10000000.0,,1,,,Intermediate,13630,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616069,,BAO_0000221,
1125,,10576,,,1,,,Expert,16245,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,H,,B,,CHEMBL616070,,BAO_0000249,
1126,,10576,10000000.0,,1,,,Autocuration,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616071,,BAO_0000221,
1127,,10576,10000000.0,,1,,,Expert,14509,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616072,,BAO_0000221,
1128,,10576,10000000.0,,1,,,Autocuration,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,,H,,B,,CHEMBL616073,,BAO_0000221,
1129,,10576,10000000.0,,1,,,Autocuration,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,,H,,B,,CHEMBL616074,,BAO_0000221,
1130,,10576,,,1,,,Expert,14256,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,,H,,B,,CHEMBL616075,,BAO_0000019,
1131,,10576,,,1,,,Autocuration,11139,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616076,,BAO_0000357,
1132,Rattus norvegicus,10576,,,1,,,Expert,11047,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,,D,,B,,CHEMBL616077,,BAO_0000019,
1133,Rattus norvegicus,10576,,,1,,,Expert,11047,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,,D,,B,,CHEMBL616078,,BAO_0000019,
1134,Rattus norvegicus,10576,,,1,,,Expert,11047,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,,D,,B,,CHEMBL616079,,BAO_0000019,
1135,Rattus norvegicus,10576,,,1,,,Expert,2395,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,,D,CHO-K1,B,,CHEMBL616080,485.0,BAO_0000219,
1136,,10576,,,1,,,Autocuration,9699,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616081,,BAO_0000357,
1137,Rattus norvegicus,10576,10000000.0,,1,,,Expert,12028,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,,D,,B,,CHEMBL616082,,BAO_0000221,
1138,,10576,10000000.0,,1,,,Autocuration,12028,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,,H,,B,,CHEMBL616083,,BAO_0000221,
1139,,10576,,,1,,,Autocuration,5815,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,H,,B,,CHEMBL616084,,BAO_0000019,
1140,,10576,,,1,,,Expert,16616,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,,H,,B,,CHEMBL616085,,BAO_0000019,
1141,,10576,,,1,,,Autocuration,5815,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,,H,,B,,CHEMBL616086,,BAO_0000019,
1142,,10576,10000000.0,,1,,,Autocuration,2761,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",,H,,B,,CHEMBL616087,,BAO_0000221,
1143,,10576,,,1,,,Expert,13133,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,,H,,B,,CHEMBL616088,,BAO_0000357,
1144,,10576,,,1,,,Autocuration,10444,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,,H,,B,,CHEMBL616089,,BAO_0000019,
1145,Rattus norvegicus,10576,,,1,,,Expert,13278,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,,D,,B,,CHEMBL616090,,BAO_0000357,
1146,,10576,,,1,,,Autocuration,15874,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,H,,B,,CHEMBL616091,,BAO_0000357,
1147,,10576,2435.0,,1,,,Autocuration,10552,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",Membranes,H,,B,,CHEMBL616092,,BAO_0000249,
1148,,10576,,,1,,,Autocuration,11130,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),,H,,B,,CHEMBL616093,,BAO_0000357,
1149,,10576,,,1,In vivo,,Autocuration,11130,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),,H,,B,,CHEMBL616094,,BAO_0000218,
1150,,10576,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,,H,,B,,CHEMBL616095,,BAO_0000221,
1151,Rattus norvegicus,10576,,,1,,,Expert,13670,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616096,,BAO_0000357,
1152,,10576,,,1,,,Expert,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,,H,,B,,CHEMBL616097,,BAO_0000249,
1153,Rattus norvegicus,10576,,,1,,,Expert,3678,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,Membranes,D,,B,,CHEMBL616098,,BAO_0000249,
1154,,10576,10000000.0,,1,,,Autocuration,11332,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616099,,BAO_0000221,
1155,,10576,10000000.0,,1,,,Autocuration,11332,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616100,,BAO_0000221,
1156,,10576,,,1,,,Expert,1185,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616101,,BAO_0000357,
1157,,10576,,,1,,,Expert,2014,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,,H,,B,,CHEMBL616102,,BAO_0000249,
1158,,10576,,,1,,,Autocuration,1185,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616103,,BAO_0000357,
1159,,10576,,,1,,,Expert,14429,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,,H,,B,,CHEMBL616104,,BAO_0000019,
1160,,10576,,,1,,,Expert,16288,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",,H,,B,,CHEMBL616105,,BAO_0000019,
1161,Rattus norvegicus,10576,,,1,,,Expert,5432,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616106,,BAO_0000019,
1162,,10576,,,1,,,Autocuration,14429,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,,H,,B,,CHEMBL616107,,BAO_0000019,
1163,,10576,,,1,,,Expert,13672,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,,H,,B,,CHEMBL616108,,BAO_0000357,
1164,,10576,10000000.0,,1,,,Expert,11296,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,H,,B,,CHEMBL616109,,BAO_0000221,
1165,,10576,,,1,,,Autocuration,11296,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,,H,,B,,CHEMBL616110,,BAO_0000357,
1166,,10576,,,1,,,Expert,14749,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,,H,CHO,B,,CHEMBL616111,449.0,BAO_0000219,
1167,,10576,,,1,,,Expert,15086,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,,H,,B,,CHEMBL616112,,BAO_0000019,
1168,,10576,10000000.0,,1,,,Autocuration,13462,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,,H,,B,,CHEMBL616113,,BAO_0000221,
1169,,10576,,,1,,,Autocuration,15363,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616114,,BAO_0000019,
1170,,10576,,,1,,,Autocuration,15363,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616115,,BAO_0000019,
1171,,10576,,,1,,,Autocuration,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616116,,BAO_0000357,
1172,,10576,955.0,,1,,,Expert,12816,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615844,,BAO_0000221,
1173,,10576,10000000.0,,1,,,Expert,13542,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL615939,,BAO_0000221,
1174,,10576,,,1,,,Expert,13308,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,,H,,B,,CHEMBL615940,,BAO_0000019,
1175,,10576,10000000.0,,1,,,Expert,13541,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,,H,,B,,CHEMBL615941,,BAO_0000221,
1176,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,,H,,B,,CHEMBL615942,,BAO_0000221,
1177,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,H,,B,,CHEMBL615943,,BAO_0000221,
1178,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,,H,,B,,CHEMBL615944,,BAO_0000221,
1179,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,,H,,B,,CHEMBL615945,,BAO_0000221,
1180,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,,H,,B,,CHEMBL615946,,BAO_0000221,
1181,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,,H,,B,,CHEMBL615947,,BAO_0000221,
1182,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,,H,,B,,CHEMBL615948,,BAO_0000221,
1183,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,,H,,B,,CHEMBL615949,,BAO_0000221,
1184,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,,H,,B,,CHEMBL615950,,BAO_0000221,
1185,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,,H,,B,,CHEMBL615951,,BAO_0000221,
1186,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,,H,,B,,CHEMBL615952,,BAO_0000221,
1187,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,,H,,B,,CHEMBL615953,,BAO_0000221,
1188,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,,H,,B,,CHEMBL615954,,BAO_0000221,
1189,Rattus norvegicus,10576,10000000.0,,1,,,Expert,10058,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,D,,B,,CHEMBL615955,,BAO_0000221,
1190,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,,H,,B,,CHEMBL615956,,BAO_0000221,
1191,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,,H,,B,,CHEMBL615957,,BAO_0000221,
1192,,10576,,,1,,,Expert,12879,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,,H,,B,,CHEMBL615958,,BAO_0000019,
1193,,10576,,,1,,,Expert,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,,H,,B,,CHEMBL615959,,BAO_0000019,
1194,,10576,,,1,,,Autocuration,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),,H,,B,,CHEMBL615960,,BAO_0000019,
1195,,10576,,,1,,,Autocuration,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),,H,,B,,CHEMBL615961,,BAO_0000019,
1196,,10576,955.0,,1,,,Expert,9548,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,H,,B,,CHEMBL615962,,BAO_0000221,
1197,,10576,,,1,,,Expert,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,,H,,B,,CHEMBL615963,,BAO_0000019,
1198,,10576,,,1,,,Autocuration,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,,H,,B,,CHEMBL615964,,BAO_0000019,
1199,,10576,,,1,,,Autocuration,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,,H,,B,,CHEMBL615965,,BAO_0000019,
1200,,10576,,,1,,,Expert,13248,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,,H,CHO,B,,CHEMBL615966,449.0,BAO_0000219,
1201,,10576,,,1,,,Expert,3147,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,,H,,B,,CHEMBL615967,,BAO_0000249,
1202,,10576,,,1,,,Expert,13949,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,H,,B,,CHEMBL615968,,BAO_0000019,
1203,,10576,,,1,,,Autocuration,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,H,CHO,B,,CHEMBL615969,449.0,BAO_0000218,
1204,,10576,,,1,,,Autocuration,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),,H,,B,,CHEMBL615970,,BAO_0000218,
1205,Rattus norvegicus,10576,,,1,,,Expert,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,,D,,B,,CHEMBL615971,,BAO_0000357,
1206,,10576,,,1,,,Expert,15535,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,Membranes,H,,B,,CHEMBL615972,,BAO_0000249,
1207,,10576,,,1,,,Autocuration,15535,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,,H,,B,,CHEMBL615973,,BAO_0000249,
1208,,10576,,,1,,,Autocuration,15535,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,,H,,B,,CHEMBL615974,,BAO_0000249,
1209,Homo sapiens,51,,,1,,,Expert,16372,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,D,CHO,B,,CHEMBL615975,449.0,BAO_0000219,
1210,,10576,,,1,,,Expert,14608,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,,H,,B,,CHEMBL615976,,BAO_0000249,
1211,Rattus norvegicus,10576,10000000.0,,1,,,Expert,4795,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,,D,,B,,CHEMBL872106,,BAO_0000221,
1212,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL615977,,BAO_0000357,
1213,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,,H,,B,,CHEMBL615978,,BAO_0000357,
1214,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,,H,,B,,CHEMBL616166,,BAO_0000357,
1215,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,,H,,B,,CHEMBL616167,,BAO_0000357,
1216,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,,H,,B,,CHEMBL616168,,BAO_0000357,
1217,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,,H,,B,,CHEMBL616169,,BAO_0000357,
1218,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,,H,,B,,CHEMBL616170,,BAO_0000357,
1219,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,,H,,B,,CHEMBL616171,,BAO_0000357,
1220,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,,H,,B,,CHEMBL616172,,BAO_0000357,
1221,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,,H,,B,,CHEMBL616173,,BAO_0000357,
1222,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,,H,,B,,CHEMBL616174,,BAO_0000357,
1223,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,,H,,B,,CHEMBL616175,,BAO_0000357,
1224,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,,H,,B,,CHEMBL616176,,BAO_0000357,
1225,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,,H,,B,,CHEMBL616177,,BAO_0000357,
1226,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,,H,,B,,CHEMBL616178,,BAO_0000357,
1227,,10576,,,1,,,Autocuration,9742,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,,H,,B,,CHEMBL616179,,BAO_0000019,
1228,,10576,,,1,,,Autocuration,12073,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616180,,BAO_0000357,
1229,,10576,,,1,,,Autocuration,4101,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,,H,,B,,CHEMBL616181,,BAO_0000357,
1230,,10576,,,1,,,Autocuration,15360,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,,H,,B,,CHEMBL616182,,BAO_0000019,
1231,,10576,10000000.0,,1,,,Autocuration,11576,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616183,,BAO_0000221,
1232,,10576,,,1,,,Expert,5834,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,,H,,B,,CHEMBL615874,,BAO_0000019,
1233,Rattus norvegicus,10576,,,1,,,Expert,2395,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,,D,CHO-K1,B,,CHEMBL615875,485.0,BAO_0000219,
1234,,10576,,,1,,,Autocuration,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,,H,,B,,CHEMBL615876,,BAO_0000019,
1235,,10576,,,1,,,Autocuration,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,,H,,B,,CHEMBL615877,,BAO_0000019,
1236,,10576,,,1,,,Autocuration,3967,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),,H,,B,,CHEMBL615878,,BAO_0000357,
1237,,10576,,,1,,,Expert,12884,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,,H,,B,,CHEMBL615879,,BAO_0000357,
1238,,10576,,,1,,,Expert,2343,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,,H,,B,,CHEMBL615880,,BAO_0000357,
1239,,10576,,,1,,,Autocuration,11511,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,H,,B,,CHEMBL615881,,BAO_0000019,
1240,Rattus norvegicus,10576,,,1,,,Expert,11511,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,D,,B,,CHEMBL615882,,BAO_0000019,
1241,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,,H,,F,,CHEMBL615883,,BAO_0000218,
1242,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),,H,,F,,CHEMBL615884,,BAO_0000218,
1243,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),,H,,F,,CHEMBL615885,,BAO_0000218,
1244,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),,H,,F,,CHEMBL615886,,BAO_0000218,
1245,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),,H,,F,,CHEMBL615887,,BAO_0000218,
1246,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),,H,,F,,CHEMBL615888,,BAO_0000218,
1247,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),,H,,F,,CHEMBL615889,,BAO_0000218,
1248,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),,H,,F,,CHEMBL615890,,BAO_0000218,
1249,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),,H,,F,,CHEMBL615891,,BAO_0000218,
1250,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),,H,,F,,CHEMBL615892,,BAO_0000218,
1251,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),,H,,F,,CHEMBL615893,,BAO_0000218,
1252,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),,H,,F,,CHEMBL615894,,BAO_0000218,
1253,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),,H,,F,,CHEMBL615895,,BAO_0000218,
1254,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),,H,,F,,CHEMBL615896,,BAO_0000218,
1255,,10576,,,1,In vivo,,Autocuration,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,,H,,F,,CHEMBL615897,,BAO_0000218,
1256,Rattus norvegicus,10576,,,1,,,Expert,16616,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Membranes,D,,F,,CHEMBL615898,,BAO_0000249,
1257,,10576,,,1,,,Autocuration,16796,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,,H,,B,,CHEMBL615899,,BAO_0000019,
1258,,10576,,,1,,,Autocuration,16796,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,H,,B,,CHEMBL616291,,BAO_0000019,
1259,,10576,,,1,,,Autocuration,15629,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,,H,,B,,CHEMBL616292,,BAO_0000357,
1260,,10576,,,1,,,Autocuration,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,H,,F,,CHEMBL616293,,BAO_0000249,
1261,,10576,10000000.0,,1,,,Expert,12073,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616294,,BAO_0000221,
1262,,10576,10000000.0,,1,,,Autocuration,14286,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,,H,,B,,CHEMBL616295,,BAO_0000249,
1263,,10576,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,,H,,B,,CHEMBL616296,,BAO_0000221,
1264,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,H,,F,,CHEMBL616297,,BAO_0000019,
1265,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,,H,,F,,CHEMBL616605,,BAO_0000019,
1266,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,,H,,F,,CHEMBL616606,,BAO_0000019,
1267,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,H,,F,,CHEMBL616607,,BAO_0000019,
1268,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,H,,F,,CHEMBL616608,,BAO_0000019,
1269,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,,H,,F,,CHEMBL616609,,BAO_0000019,
1270,Rattus norvegicus,10576,,,1,,,Expert,13630,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,,D,,F,,CHEMBL616610,,BAO_0000019,
1271,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,H,,F,,CHEMBL616611,,BAO_0000019,
1272,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,,H,,F,,CHEMBL616612,,BAO_0000019,
1273,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,,H,,F,,CHEMBL616613,,BAO_0000019,
1274,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,,H,,F,,CHEMBL616614,,BAO_0000019,
1275,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,,H,,F,,CHEMBL616615,,BAO_0000019,
1276,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,H,,F,,CHEMBL616616,,BAO_0000019,
1277,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,,H,,F,,CHEMBL616617,,BAO_0000019,
1278,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,H,,F,,CHEMBL616618,,BAO_0000019,
1279,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,,H,,F,,CHEMBL616619,,BAO_0000019,
1280,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,,H,,F,,CHEMBL616620,,BAO_0000019,
1281,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,H,,F,,CHEMBL616621,,BAO_0000019,
1282,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,,H,,F,,CHEMBL616622,,BAO_0000019,
1283,,10576,,,1,,,Expert,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,,H,,F,,CHEMBL616146,,BAO_0000019,
1284,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,,H,,F,,CHEMBL832873,,BAO_0000019,
1285,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,,H,,F,,CHEMBL616147,,BAO_0000019,
1286,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,H,,F,,CHEMBL872872,,BAO_0000019,
1287,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,H,,F,,CHEMBL616148,,BAO_0000019,
1288,,10576,10000000.0,,1,,,Autocuration,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,,H,,B,,CHEMBL616149,,BAO_0000221,
1289,,10576,10000000.0,,1,,,Expert,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,,H,,B,,CHEMBL616150,,BAO_0000221,
1290,Rattus norvegicus,10576,,,1,,,Expert,14331,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,Membranes,D,,B,,CHEMBL616151,,BAO_0000249,
1291,,10576,10000000.0,,1,,,Expert,15260,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,,H,,B,,CHEMBL872873,,BAO_0000221,
1292,,10576,10000000.0,,1,,,Autocuration,15260,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,,H,,B,,CHEMBL616670,,BAO_0000221,
1293,,10576,10000000.0,,1,,,Autocuration,15260,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,,H,,B,,CHEMBL616671,,BAO_0000221,
1294,Rattus norvegicus,10576,,,1,,,Expert,16616,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",,D,,F,,CHEMBL884861,,BAO_0000249,
1295,,10576,,,1,,,Autocuration,15629,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,,H,,B,,CHEMBL616672,,BAO_0000357,
1296,,10576,,,1,,,Autocuration,15086,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,H,,B,,CHEMBL616673,,BAO_0000019,
1297,,10576,,,1,,,Expert,5717,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,H,,F,,CHEMBL616674,,BAO_0000019,
1298,,10576,,,1,,,Autocuration,12652,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,H,,B,,CHEMBL616675,,BAO_0000357,
1299,,10576,10000000.0,,1,,,Autocuration,14608,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,,H,,B,,CHEMBL616676,,BAO_0000221,
1300,,10576,10000000.0,,1,,,Autocuration,12306,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,,B,,CHEMBL616677,,BAO_0000221,
1301,,10576,10000000.0,,1,,,Autocuration,12306,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,,B,,CHEMBL616678,,BAO_0000221,
1302,Rattus norvegicus,10576,,,1,,,Expert,15247,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616679,,BAO_0000357,
1303,,10576,10000000.0,,1,,,Expert,17529,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,,H,,B,,CHEMBL616680,,BAO_0000221,
1304,,10576,10000000.0,,1,,,Autocuration,14826,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616681,,BAO_0000221,
1305,,10576,10000000.0,,1,,,Autocuration,14826,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616682,,BAO_0000221,
1306,,10576,10000000.0,,1,,,Autocuration,13241,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616683,,BAO_0000221,
1307,,10576,10000000.0,,1,,,Autocuration,14093,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616684,,BAO_0000221,
1308,,10576,10000000.0,,1,,,Autocuration,14093,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,,H,,B,,CHEMBL616685,,BAO_0000221,
1309,,10576,955.0,,1,,,Autocuration,14442,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,,H,,B,,CHEMBL616686,,BAO_0000221,
1310,,10576,,,1,,,Autocuration,9919,Affinity for 5-hydroxytryptamine 1A receptor site,,H,,B,,CHEMBL616687,,BAO_0000357,
1311,,10576,,,1,,,Autocuration,9919,Affinity for 5-hydroxytryptamine 1A receptor site,,H,,B,,CHEMBL616688,,BAO_0000357,
1312,,10576,10000000.0,,1,,,Autocuration,11440,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,,H,,B,,CHEMBL616689,,BAO_0000221,
1313,,10576,,,1,,,Autocuration,11257,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,,H,,B,,CHEMBL616690,,BAO_0000357,
1314,,10576,,,1,,,Expert,10330,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,H,,B,,CHEMBL616691,,BAO_0000357,
1315,Rattus norvegicus,10576,10000000.0,,1,,,Expert,17331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,,D,,B,,CHEMBL616692,,BAO_0000221,
1316,,10576,,,1,,,Expert,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,,H,,B,,CHEMBL616693,,BAO_0000249,
1317,Rattus norvegicus,10576,,,1,,,Expert,12058,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,D,,B,,CHEMBL616694,,BAO_0000019,
1318,,10576,10000000.0,,1,,,Autocuration,9699,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,,H,,B,,CHEMBL616695,,BAO_0000221,
1319,,10576,,,1,,,Autocuration,9547,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,,H,,B,,CHEMBL616696,,BAO_0000357,
1320,,10576,,,1,,,Autocuration,10330,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,,H,,B,,CHEMBL616697,,BAO_0000357,
1321,,10576,,,1,,,Autocuration,14331,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616698,,BAO_0000357,
1322,Rattus norvegicus,10576,,,1,,,Expert,14060,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616949,,BAO_0000019,
1323,,10576,10000000.0,,1,,,Autocuration,14744,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,,H,,B,,CHEMBL616950,,BAO_0000221,
1324,,10576,,,1,,,Autocuration,13506,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,H,,B,,CHEMBL832875,,BAO_0000357,
1325,,10576,955.0,,1,,,Expert,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,H,,B,,CHEMBL616951,,BAO_0000221,
1326,,10576,955.0,,1,,,Expert,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,H,,B,,CHEMBL616952,,BAO_0000221,
1327,,10576,,,1,,,Expert,10062,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,,H,,B,,CHEMBL616953,,BAO_0000357,
1328,,10576,,,1,,,Autocuration,12073,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,,H,,B,,CHEMBL616954,,BAO_0000357,
1329,,106,,,1,,,Autocuration,14875,GTPgammaS radioligand binding assay,,H,,B,,CHEMBL616955,,BAO_0000357,
1330,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,H,,B,,CHEMBL616956,,BAO_0000357,
1331,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,,H,,F,,CHEMBL616957,,BAO_0000019,
1332,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,,H,,F,,CHEMBL616958,,BAO_0000019,
1333,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616959,,BAO_0000357,
1334,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,H,,B,,CHEMBL616960,,BAO_0000357,
1335,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,,H,,F,,CHEMBL616961,,BAO_0000019,
1336,,106,,,1,,,Expert,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,,H,HeLa,B,,CHEMBL616962,308.0,BAO_0000219,
1337,,106,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,,H,HeLa,B,,CHEMBL616963,308.0,BAO_0000219,
1338,Homo sapiens,106,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,,D,,B,,CHEMBL616524,,BAO_0000357,
1339,,106,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,H,CHO,B,,CHEMBL616525,449.0,BAO_0000219,
1340,,106,,,1,,,Autocuration,14165,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,,H,,B,,CHEMBL872908,,BAO_0000019,
1341,,106,,,1,,,Autocuration,14165,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,,H,,B,,CHEMBL616526,,BAO_0000019,
1342,Homo sapiens,106,,,1,,,Expert,4234,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616527,,BAO_0000357,
1343,,106,,,1,,,Expert,6328,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,H,,B,,CHEMBL616528,,BAO_0000219,
1344,,106,,,1,,,Autocuration,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL616529,,BAO_0000357,
1345,,106,,,1,,,Autocuration,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,,H,,B,,CHEMBL616530,,BAO_0000357,
1346,,106,,,1,,,Expert,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616531,,BAO_0000357,
1347,,106,,,1,,,Autocuration,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616532,,BAO_0000357,
1348,,106,,,1,,,Autocuration,6013,Binding affinity towards 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616533,,BAO_0000357,
1349,,106,,,1,,,Expert,5843,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616534,,BAO_0000357,
1350,,106,,,1,,,Expert,14454,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,,H,,B,,CHEMBL616535,,BAO_0000357,
1351,,106,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,,H,,B,,CHEMBL616536,,BAO_0000357,
1352,,106,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616537,,BAO_0000357,
1353,,106,,,1,,,Expert,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,,H,CHO-K1,F,,CHEMBL616538,485.0,BAO_0000219,
1354,,106,,,1,,,Expert,14251,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,,H,,F,,CHEMBL616539,,BAO_0000019,
1355,,106,,,1,,,Expert,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616540,,BAO_0000019,
1356,,106,,,1,,,Autocuration,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,H,,B,,CHEMBL616429,,BAO_0000357,
1357,,106,,,1,,,Expert,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616430,,BAO_0000357,
1358,Homo sapiens,106,,,1,,,Expert,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,,D,,B,,CHEMBL616431,,BAO_0000219,
1359,Homo sapiens,106,,,1,,,Expert,3804,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616432,,BAO_0000357,
1360,Homo sapiens,106,,,1,,,Expert,2391,Affinity for 5-hydroxytryptamine 1B receptor subtype,,D,,B,,CHEMBL616433,,BAO_0000357,
1361,Homo sapiens,106,,,1,,,Expert,4175,Binding affinity for human 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616434,,BAO_0000357,
1362,,106,,,1,,,Autocuration,17296,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,,H,CHO,B,,CHEMBL616435,449.0,BAO_0000219,
1363,,106,,,1,,,Expert,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,,H,,B,,CHEMBL616436,,BAO_0000019,
1364,,106,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,H,HeLa,B,,CHEMBL616437,308.0,BAO_0000219,
1365,,106,,,1,,,Autocuration,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,,H,HeLa,B,,CHEMBL616438,308.0,BAO_0000219,
1366,,106,,,1,,,Autocuration,17211,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,H,HeLa,B,,CHEMBL616439,308.0,BAO_0000219,
1367,Homo sapiens,106,,,1,,,Expert,15926,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,,D,,B,,CHEMBL616440,,BAO_0000357,
1368,,106,,,1,,,Autocuration,16312,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,,H,CHO-K1,B,,CHEMBL616441,485.0,BAO_0000219,
1369,,106,,,1,,,Expert,5843,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,,H,,B,,CHEMBL616442,,BAO_0000357,
1370,,106,,,1,,,Autocuration,5843,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616443,,BAO_0000357,
1371,,106,,,1,,,Expert,16312,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,,H,CHO-K1,B,,CHEMBL616444,485.0,BAO_0000219,
1372,Homo sapiens,106,,,1,,,Expert,15926,Binding activity against human 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616445,,BAO_0000357,
1373,Homo sapiens,106,,,1,,,Expert,15926,Binding activity against human 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616446,,BAO_0000357,
1374,Homo sapiens,106,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,D,CHO,B,,CHEMBL616447,449.0,BAO_0000219,
1375,,106,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,,H,,B,,CHEMBL616448,,BAO_0000357,
1376,,106,,,1,,,Autocuration,17296,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,,H,CHO,B,,CHEMBL616449,449.0,BAO_0000219,
1377,,106,,,1,,,Autocuration,17296,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,,H,CHO,B,,CHEMBL616450,449.0,BAO_0000219,
1378,,106,,,1,,,Autocuration,17296,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,,H,CHO,B,,CHEMBL857974,449.0,BAO_0000219,
1379,,106,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,H,CHO,B,,CHEMBL616451,449.0,BAO_0000219,
1380,,106,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,H,CHO,B,,CHEMBL616452,449.0,BAO_0000219,
1381,,106,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,,H,CHO,B,,CHEMBL616453,449.0,BAO_0000219,
1382,,106,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,,H,CHO,B,,CHEMBL616454,449.0,BAO_0000219,
1383,Homo sapiens,106,,,1,,,Expert,14875,Binding affinity for human 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616455,,BAO_0000357,
1384,,106,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,H,CHO,B,,CHEMBL616456,449.0,BAO_0000219,
1385,,106,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,,H,,B,,CHEMBL616457,,BAO_0000357,
1386,,106,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,H,CHO,B,,CHEMBL616458,449.0,BAO_0000219,
1387,,106,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL616459,449.0,BAO_0000219,
1388,,106,,,1,,,Expert,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,,H,,F,,CHEMBL616460,,BAO_0000019,
1389,,106,,,1,,,Expert,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,,H,,F,,CHEMBL616461,,BAO_0000019,
1390,,106,,,1,,,Autocuration,14875,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",,H,CHO,F,,CHEMBL616462,449.0,BAO_0000219,
1391,,106,,,1,,,Autocuration,14875,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",,H,CHO,F,,CHEMBL616463,449.0,BAO_0000219,
1392,,105,,,1,,,Autocuration,15250,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",,H,,F,,CHEMBL616464,,BAO_0000019,
1393,,105,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,,H,CHO,B,,CHEMBL616465,449.0,BAO_0000219,
1394,,17105,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL832874,,BAO_0000357,
1395,Oryctolagus cuniculus,106,,,1,,,Autocuration,3025,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,,H,,F,,CHEMBL616184,,BAO_0000019,
1396,Oryctolagus cuniculus,106,,,1,,,Autocuration,14998,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,,H,,B,,CHEMBL616185,,BAO_0000019,
1397,Oryctolagus cuniculus,106,,,1,,,Intermediate,14998,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",,H,,B,,CHEMBL616186,,BAO_0000019,
1398,Oryctolagus cuniculus,106,,,1,,,Autocuration,14998,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,,H,,B,,CHEMBL616187,,BAO_0000019,
1399,,10577,,,1,,,Expert,13969,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,,H,,B,,CHEMBL616188,,BAO_0000357,
1400,,10577,,,1,,,Intermediate,13392,Binding affinity for 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL873475,,BAO_0000357,
1401,Rattus norvegicus,10577,2435.0,,1,,,Expert,3651,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,,D,,B,,CHEMBL616189,,BAO_0000019,
1402,,10577,,,1,,,Expert,10025,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,H,,B,,CHEMBL616190,,BAO_0000357,
1403,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,,H,,B,,CHEMBL616191,,BAO_0000357,
1404,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,,H,,B,,CHEMBL616192,,BAO_0000357,
1405,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,,H,,B,,CHEMBL616193,,BAO_0000357,
1406,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,,H,,B,,CHEMBL616194,,BAO_0000357,
1407,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,,H,,B,,CHEMBL616195,,BAO_0000357,
1408,,10576,,,1,,,Autocuration,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,,H,,B,,CHEMBL616196,,BAO_0000357,
1409,,10576,10000000.0,,1,,,Autocuration,4622,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,,H,,B,,CHEMBL616197,,BAO_0000249,
1410,,10576,,,1,,,Intermediate,14911,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616198,,BAO_0000019,
1411,,10576,10000000.0,,1,,,Autocuration,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,H,,B,,CHEMBL616199,,BAO_0000221,
1412,,10576,10000000.0,,1,,,Expert,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,,H,,B,,CHEMBL616200,,BAO_0000221,
1413,,10576,10000000.0,,1,,,Expert,14235,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616201,,BAO_0000221,
1414,,10576,10000000.0,,1,,,Expert,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,H,,B,,CHEMBL616202,,BAO_0000221,
1415,,10576,10000000.0,,1,,,Expert,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,H,,B,,CHEMBL616203,,BAO_0000221,
1416,,10576,10000000.0,,1,,,Expert,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,,H,,B,,CHEMBL616204,,BAO_0000221,
1417,,10576,10000000.0,,1,,,Expert,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,,H,,B,,CHEMBL616205,,BAO_0000221,
1418,,10576,10000000.0,,1,,,Expert,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,,H,,B,,CHEMBL616206,,BAO_0000221,
1419,,10576,,,1,,,Expert,16118,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,H,,B,,CHEMBL616207,,BAO_0000249,
1420,,10576,,,1,,,Autocuration,3268,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,,H,,B,,CHEMBL616208,,BAO_0000249,
1421,,10576,,,1,,,Autocuration,3268,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,,H,,B,,CHEMBL616209,,BAO_0000249,
1422,,10576,,,1,,,Expert,16117,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,,H,,B,,CHEMBL616210,,BAO_0000357,
1423,,10576,10000000.0,,1,,,Expert,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,,H,,B,,CHEMBL616211,,BAO_0000221,
1424,,10576,10000000.0,,1,,,Autocuration,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,,H,,B,,CHEMBL616504,,BAO_0000221,
1425,Rattus norvegicus,10576,10000000.0,,1,,,Expert,14356,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616505,,BAO_0000221,
1426,,10576,,,1,,,Autocuration,15740,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL616506,,BAO_0000019,
1427,,10576,10000000.0,,1,,,Autocuration,12306,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,H,,B,,CHEMBL872107,,BAO_0000221,
1428,Rattus norvegicus,10576,10000000.0,,1,,,Expert,13348,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,,D,,B,,CHEMBL616507,,BAO_0000221,
1429,,10576,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,,H,,B,,CHEMBL616303,,BAO_0000249,
1430,,10576,10000000.0,,1,,,Autocuration,15260,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,,H,,B,,CHEMBL616304,,BAO_0000221,
1431,,10576,10000000.0,,1,,,Expert,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,,H,,B,,CHEMBL616305,,BAO_0000221,
1432,,10576,10000000.0,,1,,,Intermediate,15260,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,,H,,F,,CHEMBL616306,,BAO_0000221,
1433,,10576,,,1,,,Autocuration,12851,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616307,,BAO_0000357,
1434,Rattus norvegicus,10576,10000000.0,,1,,,Expert,2148,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,,D,,B,,CHEMBL881829,,BAO_0000221,
1435,,10576,,,1,,,Expert,13134,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,,H,,B,,CHEMBL616308,,BAO_0000357,
1436,,10576,,,1,,,Autocuration,12462,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,,H,,B,,CHEMBL616309,,BAO_0000019,
1437,,10576,,,1,,,Expert,12462,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,,H,,B,,CHEMBL616310,,BAO_0000019,
1438,,10576,,,1,,,Autocuration,12462,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,,H,CHO,B,,CHEMBL616311,449.0,BAO_0000219,
1439,,10576,,,1,,,Expert,11933,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616312,,BAO_0000357,
1440,,10576,,,1,,,Autocuration,11933,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,,H,,B,,CHEMBL616313,,BAO_0000357,
1441,Rattus norvegicus,10576,10000000.0,,1,,,Expert,403,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616314,,BAO_0000221,
1442,,10576,10000000.0,,1,,,Autocuration,15538,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616315,,BAO_0000221,
1443,,10576,10000000.0,,1,,,Autocuration,15538,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,,H,,B,,CHEMBL616567,,BAO_0000221,
1444,,10576,10000000.0,,1,,,Autocuration,15538,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,,H,,B,,CHEMBL616568,,BAO_0000221,
1445,,10576,,,1,,,Intermediate,12464,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,,H,,B,,CHEMBL616569,,BAO_0000019,
1446,,10576,,,1,,,Expert,1455,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,,H,,B,,CHEMBL616570,,BAO_0000357,
1447,,10576,,,1,,,Autocuration,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,H,,B,,CHEMBL616571,,BAO_0000357,
1448,,10576,10000000.0,,1,,,Autocuration,12639,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,,H,,B,,CHEMBL616572,,BAO_0000221,
1449,,10576,,,1,,,Expert,13949,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,,H,,B,,CHEMBL616573,,BAO_0000249,
1450,Rattus norvegicus,10576,,,1,,,Expert,12463,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,,D,,B,,CHEMBL616574,,BAO_0000357,
1451,,10576,10000000.0,,1,,,Expert,14829,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,,H,,B,,CHEMBL616575,,BAO_0000221,
1452,,10576,10000000.0,,1,,,Autocuration,14829,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,,H,,B,,CHEMBL872108,,BAO_0000221,
1453,,10576,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616576,,BAO_0000357,
1454,,10576,,,1,,,Autocuration,403,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,,H,,B,,CHEMBL616577,,BAO_0000249,
1455,,10576,,,1,,,Autocuration,403,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,,H,,B,,CHEMBL616578,,BAO_0000249,
1456,,10576,,,1,,,Expert,3967,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,,H,,B,,CHEMBL616579,,BAO_0000357,
1457,Rattus norvegicus,10576,,,1,,,Expert,12771,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,,D,,B,,CHEMBL616580,,BAO_0000019,
1458,,10576,,,1,,,Autocuration,15086,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,H,,B,,CHEMBL616581,,BAO_0000019,
1459,,10576,10000000.0,,1,,,Autocuration,14909,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616582,,BAO_0000221,
1460,,10576,10000000.0,,1,,,Expert,14949,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,H,,B,,CHEMBL616583,,BAO_0000221,
1461,Rattus norvegicus,10576,10000000.0,,1,,,Expert,2309,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,,D,,B,,CHEMBL616584,,BAO_0000221,
1462,,10576,,,1,,,Expert,4170,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616585,,BAO_0000357,
1463,Rattus norvegicus,10576,10000000.0,,1,,,Expert,11642,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,,D,,B,,CHEMBL616586,,BAO_0000221,
1464,,10576,10000000.0,,1,,,Autocuration,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,,H,,B,,CHEMBL616587,,BAO_0000221,
1465,,10576,10000000.0,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,,H,,B,,CHEMBL616588,,BAO_0000221,
1466,,10576,10000000.0,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616589,,BAO_0000221,
1467,,10576,10000000.0,,1,,,Expert,12953,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616590,,BAO_0000221,
1468,,10576,,,1,,,Expert,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",,H,CHO,B,,CHEMBL616591,449.0,BAO_0000219,
1469,,10576,,,1,,,Expert,12536,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616592,,BAO_0000357,
1470,,10576,,,1,,,Autocuration,10058,The inhibition activity of 5-HT1A at 1 uM,,H,,B,,CHEMBL616593,,BAO_0000357,
1471,,10576,,,1,,,Expert,12902,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",,H,CHO-K1,B,,CHEMBL616594,485.0,BAO_0000219,
1472,,10576,,,1,,,Expert,14057,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,,H,,B,,CHEMBL616595,,BAO_0000249,
1473,,10576,,,1,,,Autocuration,11296,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,,H,,B,,CHEMBL616596,,BAO_0000357,
1474,,10576,10000000.0,,1,,,Autocuration,11296,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,H,,B,,CHEMBL616597,,BAO_0000221,
1475,,10576,10000000.0,,1,,,Expert,11296,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,H,,B,,CHEMBL616598,,BAO_0000221,
1476,Rattus norvegicus,10576,,,1,,,Expert,16616,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,Membranes,D,,F,,CHEMBL616599,,BAO_0000249,
1477,Rattus norvegicus,10576,10000000.0,,1,,,Expert,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Membranes,D,,F,,CHEMBL616600,,BAO_0000249,
1478,,10576,,,1,,,Autocuration,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,,H,,B,,CHEMBL616601,,BAO_0000019,
1479,,10576,,,1,,,Autocuration,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,,H,,B,,CHEMBL616602,,BAO_0000019,
1480,,10576,,,1,,,Autocuration,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,,H,,B,,CHEMBL616603,,BAO_0000019,
1481,,10576,,,1,,,Autocuration,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,,H,,B,,CHEMBL616604,,BAO_0000019,
1482,,10576,,,1,,,Autocuration,17136,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,,H,,B,,CHEMBL616316,,BAO_0000249,
1483,,10576,,,1,,,Autocuration,17136,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,,H,,B,,CHEMBL616317,,BAO_0000249,
1484,Rattus norvegicus,10576,,,1,,,Expert,16616,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,,D,,B,,CHEMBL616318,,BAO_0000019,
1485,,10576,10000000.0,,1,,,Autocuration,17331,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,,H,,B,,CHEMBL616319,,BAO_0000221,
1486,,10576,10000000.0,,1,,,Autocuration,17331,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,,H,,B,,CHEMBL616320,,BAO_0000221,
1487,Rattus norvegicus,10576,10000000.0,,1,,,Expert,17167,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,,D,,B,,CHEMBL616321,,BAO_0000221,
1488,,10576,,,1,,,Autocuration,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,H,,F,,CHEMBL616322,,BAO_0000019,
1489,,10576,,,1,,,Autocuration,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,,H,,F,,CHEMBL616323,,BAO_0000019,
1490,,10576,,,1,,,Autocuration,4671,Ratio of binding affinity to 5-HT 1A and D2 receptor,,H,,B,,CHEMBL616324,,BAO_0000357,
1491,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,H,,B,,CHEMBL616325,,BAO_0000221,
1492,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,H,,B,,CHEMBL616326,,BAO_0000221,
1493,,10576,10000000.0,,1,,,Autocuration,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,,H,,B,,CHEMBL616327,,BAO_0000221,
1494,,10576,,,1,,,Autocuration,12073,Percentage inhibition against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616328,,BAO_0000357,
1495,,10576,,,1,,,Autocuration,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,H,,B,,CHEMBL858110,,BAO_0000249,
1496,,10576,,,1,,,Autocuration,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,H,,F,,CHEMBL616329,,BAO_0000249,
1497,,10576,,,1,,,Autocuration,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,H,,B,,CHEMBL616330,,BAO_0000249,
1498,,10576,,,1,,,Autocuration,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,H,,F,,CHEMBL616331,,BAO_0000249,
1499,,10576,,,1,,,Autocuration,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,H,,F,,CHEMBL616332,,BAO_0000249,
1500,,10576,955.0,,1,,,Autocuration,9737,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,,B,,CHEMBL857063,,BAO_0000249,
1501,,10576,,,1,,,Autocuration,9737,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,,H,,B,,CHEMBL616333,,BAO_0000019,
1502,,10576,,,1,,,Expert,5717,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,,H,,F,,CHEMBL616334,,BAO_0000019,
1503,,10576,10000000.0,,1,,,Autocuration,12253,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,H,,B,,CHEMBL616335,,BAO_0000221,
1504,,10576,,,1,,,Autocuration,14025,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,,H,,B,,CHEMBL616336,,BAO_0000019,
1505,,10576,,,1,,,Expert,10425,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616337,,BAO_0000249,
1506,,10576,,,1,,,Autocuration,14998,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,,H,,B,,CHEMBL616338,,BAO_0000019,
1507,,10576,10000000.0,,1,,,Autocuration,13694,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,,H,,B,,CHEMBL616339,,BAO_0000221,
1508,,10576,10000000.0,,1,,,Autocuration,13694,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,,H,,B,,CHEMBL616340,,BAO_0000221,
1509,,10576,,,1,,,Autocuration,4342,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL616341,,BAO_0000357,
1510,Rattus norvegicus,10576,,,1,,,Expert,12936,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616342,,BAO_0000357,
1511,Rattus norvegicus,10576,,,1,,,Expert,13144,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,,D,,B,,CHEMBL616343,,BAO_0000019,
1512,,10576,,,1,,,Expert,13343,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,,H,,B,,CHEMBL616344,,BAO_0000019,
1513,,10576,,,1,,,Expert,12132,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616345,,BAO_0000357,
1514,,10576,,,1,,,Expert,15419,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,,H,,B,,CHEMBL616346,,BAO_0000019,
1515,,10576,10000000.0,,1,,,Autocuration,1479,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,H,,B,,CHEMBL616347,,BAO_0000221,
1516,,10576,,,1,,,Expert,14287,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,,H,,B,,CHEMBL616348,,BAO_0000019,
1517,,10576,,,1,,,Expert,13116,Binding affinity at 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616349,,BAO_0000357,
1518,Rattus norvegicus,10576,,,1,,,Expert,2759,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,Membranes,D,,B,,CHEMBL616152,,BAO_0000249,
1519,,10576,,,1,,,Autocuration,2759,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,H,,B,,CHEMBL616153,,BAO_0000249,
1520,,10576,,,1,,,Expert,14748,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",,H,,B,,CHEMBL616154,,BAO_0000019,
1521,,10576,,,1,,,Autocuration,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,H,,B,,CHEMBL616155,,BAO_0000019,
1522,Rattus norvegicus,10576,10000000.0,,1,,,Expert,12409,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,,D,,B,,CHEMBL616156,,BAO_0000221,
1523,Rattus norvegicus,10576,10000000.0,,1,,,Expert,12409,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,,D,,B,,CHEMBL616157,,BAO_0000221,
1524,,10576,10000000.0,,1,,,Autocuration,13267,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,,H,,B,,CHEMBL616158,,BAO_0000221,
1525,,10576,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,H,,B,,CHEMBL616159,,BAO_0000357,
1526,,10576,,,1,,,Expert,14256,pKi value against rat 5-hydroxytryptamine 1A receptor.,,H,,B,,CHEMBL616160,,BAO_0000357,
1527,,10576,,,1,,,Autocuration,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,,H,,B,,CHEMBL616161,,BAO_0000019,
1528,,10576,,,1,,,Autocuration,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,H,,F,,CHEMBL616162,,BAO_0000019,
1529,Rattus norvegicus,12687,,,1,,,Expert,13278,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,D,,B,,CHEMBL616163,,BAO_0000357,
1530,,10626,,,1,,,Expert,1970,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,Membranes,H,,B,,CHEMBL616164,,BAO_0000249,
1531,,10576,955.0,,1,,,Autocuration,10034,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,,H,,B,,CHEMBL616165,,BAO_0000221,
1532,Rattus norvegicus,51,,,1,,,Autocuration,13348,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,,H,,B,,CHEMBL616355,,BAO_0000019,
1533,,10576,,,1,,,Autocuration,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,H,,F,,CHEMBL616356,,BAO_0000019,
1534,,10576,955.0,,1,,,Autocuration,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,H,,B,,CHEMBL616357,,BAO_0000221,
1535,,10576,,,1,,,Autocuration,12058,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,H,,B,,CHEMBL616358,,BAO_0000019,
1536,,51,,,1,,,Autocuration,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616359,,BAO_0000357,
1537,,51,,,1,,,Expert,15453,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,,H,,B,,CHEMBL616360,,BAO_0000357,
1538,,51,,,1,,,Expert,4820,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616361,,BAO_0000357,
1539,,51,,,1,,,Autocuration,1089,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616362,,BAO_0000357,
1540,,51,,,1,,,Autocuration,386,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,Brain membranes,H,,B,,CHEMBL616363,,BAO_0000249,
1541,,51,,,1,,,Autocuration,6011,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,,H,,B,,CHEMBL616364,,BAO_0000357,
1542,,51,,,1,,,Autocuration,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616365,,BAO_0000357,
1543,,51,,,1,,,Expert,4402,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616366,,BAO_0000357,
1544,,51,,,1,,,Expert,17066,Binding affinity towards 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL872906,,BAO_0000357,
1545,,51,,,1,,,Autocuration,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,,H,,B,,CHEMBL616367,,BAO_0000357,
1546,,51,,,1,,,Autocuration,2474,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616368,,BAO_0000357,
1547,,51,,,1,,,Autocuration,4775,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL616369,,BAO_0000357,
1548,Homo sapiens,51,,,1,,,Expert,14294,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,,D,,B,,CHEMBL616370,,BAO_0000357,
1549,Homo sapiens,51,,,1,,,Expert,14294,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,,D,,B,,CHEMBL616371,,BAO_0000357,
1550,,51,,,1,,,Autocuration,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,CHO,B,,CHEMBL616372,449.0,BAO_0000219,
1551,,51,,,1,,,Expert,11376,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,,H,,B,,CHEMBL616373,,BAO_0000219,
1552,,51,,,1,In vivo,,Autocuration,2474,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616374,,BAO_0000218,
1553,,51,10000000.0,,1,,,Autocuration,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,H,,B,,CHEMBL616375,,BAO_0000221,
1554,,51,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL616376,,BAO_0000357,
1555,,51,,,1,,,Expert,1633,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,,H,,B,,CHEMBL857064,,BAO_0000357,
1556,,51,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL616377,,BAO_0000357,
1557,,51,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,H,,B,,CHEMBL616378,,BAO_0000357,
1558,,51,,,1,,,Autocuration,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616379,,BAO_0000357,
1559,,11863,,,1,,,Autocuration,16946,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616380,,BAO_0000357,
1560,,11863,,,1,,,Autocuration,13291,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,,H,,B,,CHEMBL616381,,BAO_0000357,
1561,,11863,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616382,,BAO_0000357,
1562,,11863,,,1,,,Autocuration,10812,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,,H,,B,,CHEMBL616383,,BAO_0000357,
1563,Mus musculus,11863,,,1,,,Expert,3032,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,,D,CHO,B,,CHEMBL616350,449.0,BAO_0000219,
1564,,11863,,,1,,,Autocuration,16655,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616351,,BAO_0000357,
1565,,11863,,,1,,,Autocuration,14532,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,,H,,B,,CHEMBL616352,,BAO_0000357,
1566,,11863,,,1,,,Autocuration,13944,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616353,,BAO_0000357,
1567,,11863,,,1,,,Autocuration,13033,Binding affinity against serotonergic 5-HT1a receptor,,H,,B,,CHEMBL616354,,BAO_0000357,
1568,,11863,,,1,,,Autocuration,10321,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616508,,BAO_0000357,
1569,Mus musculus,11863,,,1,,,Expert,2968,Binding affinity for 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616559,,BAO_0000357,
1570,,11863,,,1,,,Autocuration,13964,Binding affinity at 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616560,,BAO_0000357,
1571,,11863,,,1,,,Autocuration,15527,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",,H,,B,,CHEMBL616561,,BAO_0000357,
1572,,11863,,,1,,,Autocuration,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,CHO,B,,CHEMBL616562,449.0,BAO_0000219,
1573,,11863,,,1,,,Autocuration,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,H,CHO,B,,CHEMBL616563,449.0,BAO_0000219,
1574,,11863,,,1,,,Autocuration,15120,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616564,,BAO_0000357,
1575,,11863,,,1,,,Autocuration,13313,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,,H,,B,,CHEMBL616565,,BAO_0000357,
1576,,11863,,,1,,,Autocuration,2613,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616566,,BAO_0000218,
1577,,11863,,,1,,,Autocuration,16700,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,,H,,B,,CHEMBL616989,,BAO_0000357,
1578,,11863,,,1,,,Autocuration,2201,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL857975,,BAO_0000357,
1579,Mus musculus,11863,,,1,,,Expert,1274,Binding affinity against 5-hydroxytryptamine 1A receptor,,D,,B,,CHEMBL616990,,BAO_0000357,
1580,,11863,,,1,,,Autocuration,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,,H,,B,,CHEMBL616991,,BAO_0000357,
1581,,11863,,,1,,,Autocuration,12146,Tested against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616992,,BAO_0000357,
1582,,11863,,,1,,,Autocuration,14059,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL616993,,BAO_0000357,
1583,Oryctolagus cuniculus,106,,,1,,,Expert,14025,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,,H,,B,,CHEMBL616994,,BAO_0000019,
1584,Oryctolagus cuniculus,106,,,1,,,Autocuration,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,,H,,B,,CHEMBL616995,,BAO_0000019,
1585,Gorilla gorilla,105571,,,1,,,Intermediate,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,,D,HEK293,B,,CHEMBL616996,722.0,BAO_0000219,
1586,Cavia porcellus,106,,,1,In vivo,,Autocuration,3025,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,H,,F,,CHEMBL616997,,BAO_0000218,
1587,Cavia porcellus,106,,,1,In vivo,,Autocuration,3025,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,,H,,F,,CHEMBL616998,,BAO_0000218,
1588,Cavia porcellus,106,,,1,,,Autocuration,15329,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,,H,,F,,CHEMBL616999,,BAO_0000019,
1589,Cavia porcellus,106,,,1,,,Autocuration,15329,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,,H,,F,,CHEMBL617000,,BAO_0000019,
1590,Cavia porcellus,106,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,,H,,F,,CHEMBL617001,,BAO_0000019,
1591,Cavia porcellus,106,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,,H,,F,,CHEMBL858111,,BAO_0000019,
1592,,106,,,1,,,Autocuration,14165,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,,H,,F,,CHEMBL617002,,BAO_0000019,
1593,,106,,,1,,,Autocuration,14214,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),,H,,F,,CHEMBL617003,,BAO_0000019,
1594,,106,,,1,,,Autocuration,14214,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),,H,,F,,CHEMBL617004,,BAO_0000019,
1595,Homo sapiens,106,,,1,,,Expert,14214,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,,D,,F,,CHEMBL617005,,BAO_0000019,
1596,Homo sapiens,106,,,1,,,Expert,13729,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,,D,CHO-K1,F,,CHEMBL616623,485.0,BAO_0000219,
1597,,106,,,1,,,Autocuration,3025,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,,H,CHO,F,,CHEMBL616624,449.0,BAO_0000219,
1598,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL883243,,BAO_0000357,
1599,,106,,,1,,,Autocuration,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,,H,,F,,CHEMBL616625,,BAO_0000019,
1600,,106,,,1,,,Expert,14956,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",,H,CHO,F,,CHEMBL616626,449.0,BAO_0000219,
1601,,106,,,1,,,Autocuration,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,,H,CHO,F,,CHEMBL616627,449.0,BAO_0000219,
1602,,106,,,1,,,Autocuration,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,,H,CHO,F,,CHEMBL616628,449.0,BAO_0000219,
1603,,106,,,1,,,Autocuration,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,,H,CHO,F,,CHEMBL616629,449.0,BAO_0000219,
1604,,106,,,1,,,Autocuration,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,,H,CHO,F,,CHEMBL616630,449.0,BAO_0000219,
1605,,106,,,1,,,Expert,14956,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",,H,,F,,CHEMBL616631,,BAO_0000019,
1606,,106,,,1,,,Autocuration,14956,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",,H,,F,,CHEMBL616632,,BAO_0000019,
1607,Homo sapiens,106,,,1,,,Expert,14214,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616633,,BAO_0000357,
1608,,106,,,1,,,Expert,3463,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,,H,CHO,B,,CHEMBL616634,449.0,BAO_0000219,
1609,,106,,,1,,,Autocuration,15331,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,,H,,B,,CHEMBL616635,,BAO_0000357,
1610,Homo sapiens,106,,,1,,,Expert,16146,Binding affinity against 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL885358,,BAO_0000357,
1611,Homo sapiens,106,,,1,,,Expert,14159,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,D,CHO,B,,CHEMBL616636,449.0,BAO_0000219,
1612,,106,,,1,,,Expert,14158,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,,H,CHO,B,,CHEMBL616637,449.0,BAO_0000219,
1613,,106,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616638,,BAO_0000357,
1614,,106,,,1,,,Expert,15250,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616639,449.0,BAO_0000219,
1615,,106,,,1,,,Expert,15250,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,,H,CHO,B,,CHEMBL616640,449.0,BAO_0000219,
1616,,106,,,1,,,Expert,15331,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616641,449.0,BAO_0000219,
1617,,106,,,1,,,Expert,15332,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,,H,CHO,B,,CHEMBL616642,449.0,BAO_0000219,
1618,,106,,,1,,,Expert,14956,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,H,CHO,B,,CHEMBL616643,449.0,BAO_0000219,
1619,,106,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),,H,,B,,CHEMBL616644,,BAO_0000357,
1620,,106,,,1,,,Autocuration,14875,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,,H,,B,,CHEMBL616645,,BAO_0000357,
1621,Oryctolagus cuniculus,105,,,1,,,Autocuration,14454,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,H,,F,,CHEMBL616646,,BAO_0000019,
1622,Oryctolagus cuniculus,105,,,1,,,Expert,14454,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,H,,F,,CHEMBL616647,,BAO_0000019,
1623,,105,,,1,,,Autocuration,16288,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),,H,,B,,CHEMBL616509,,BAO_0000357,
1624,,105,,,1,,,Autocuration,16288,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),,H,,B,,CHEMBL616510,,BAO_0000357,
1625,,105,,,1,,,Autocuration,16312,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616511,,BAO_0000357,
1626,Bos taurus,105,,,1,,,Expert,1348,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,,H,,B,,CHEMBL616512,,BAO_0000357,
1627,Bos taurus,105,,,1,,,Autocuration,5834,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,,H,,B,,CHEMBL616513,,BAO_0000357,
1628,Bos taurus,105,2435.0,,1,,,Autocuration,13366,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,H,,B,,CHEMBL616514,,BAO_0000019,
1629,Bos taurus,105,,,1,,,Expert,1414,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,,H,,B,,CHEMBL616515,,BAO_0000357,
1630,Bos taurus,105,,,1,,,Autocuration,14998,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,,H,,B,,CHEMBL616516,,BAO_0000019,
1631,Bos taurus,105,,,1,,,Autocuration,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,H,,B,,CHEMBL616517,,BAO_0000357,
1632,Bos taurus,105,,,1,,,Autocuration,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,,H,,B,,CHEMBL616518,,BAO_0000357,
1633,Bos taurus,105,,,1,,,Autocuration,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,H,,B,,CHEMBL616519,,BAO_0000357,
1634,Bos taurus,105,,,1,,,Autocuration,10639,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,,H,,B,,CHEMBL616520,,BAO_0000357,
1635,Bos taurus,105,,,1,,,Autocuration,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,,H,,B,,CHEMBL616521,,BAO_0000357,
1636,Bos taurus,105,,,1,,,Autocuration,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,,H,,B,,CHEMBL616522,,BAO_0000357,
1637,Bos taurus,105,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,H,,B,,CHEMBL884531,,BAO_0000357,
1638,Bos taurus,105,,,1,,,Autocuration,11147,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL616523,,BAO_0000357,
1639,Bos taurus,105,2435.0,,1,,,Autocuration,13366,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,,H,,B,,CHEMBL616731,,BAO_0000019,
1640,Bos taurus,105,,,1,,,Autocuration,10444,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,,H,,B,,CHEMBL616732,,BAO_0000019,
1641,Bos taurus,105,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,,H,,B,,CHEMBL616733,,BAO_0000357,
1642,Bos taurus,105,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,,H,,B,,CHEMBL616734,,BAO_0000357,
1643,Bos taurus,105,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,,H,,B,,CHEMBL616735,,BAO_0000249,
1644,Bos taurus,105,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,,H,,B,,CHEMBL616736,,BAO_0000249,
1645,Bos taurus,105,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,,F,,CHEMBL616737,,BAO_0000019,
1646,Bos taurus,105,,,1,,,Autocuration,14025,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,,H,,B,,CHEMBL616738,,BAO_0000019,
1647,Bos taurus,105,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,,F,,CHEMBL616739,,BAO_0000019,
1648,Bos taurus,105,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,,F,,CHEMBL616740,,BAO_0000019,
1649,Bos taurus,105,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,,H,,F,,CHEMBL616741,,BAO_0000019,
1650,Gorilla gorilla,105,,,1,,,Autocuration,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,,H,HEK293,B,,CHEMBL616742,722.0,BAO_0000219,
1651,Cavia porcellus,105570,,,1,,,Intermediate,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,,D,,B,,CHEMBL616743,,BAO_0000019,
1652,Cavia porcellus,105570,,,1,,,Intermediate,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,,D,,B,,CHEMBL616744,,BAO_0000019,
1653,Cavia porcellus,105570,,,1,,,Intermediate,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,,D,,F,,CHEMBL616745,,BAO_0000019,
1654,Cavia porcellus,105570,,,1,,,Intermediate,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,,F,,CHEMBL616746,,BAO_0000019,
1655,Cavia porcellus,105570,,,1,,,Intermediate,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,,D,,F,,CHEMBL616747,,BAO_0000019,
1656,Cavia porcellus,105570,,,1,,,Intermediate,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,,D,,F,,CHEMBL616748,,BAO_0000019,
1657,Cavia porcellus,105570,,,1,,,Intermediate,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,,D,,F,,CHEMBL616648,,BAO_0000019,
1658,Cavia porcellus,105570,,,1,,,Intermediate,11574,Binding affinity against 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616649,,BAO_0000357,
1659,Cavia porcellus,105570,,,1,,,Intermediate,1558,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,,D,,B,,CHEMBL616650,,BAO_0000357,
1660,Cavia porcellus,105570,,,1,,,Intermediate,12409,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,,F,,CHEMBL616651,,BAO_0000218,
1661,Cavia porcellus,105570,,,1,,,Intermediate,12409,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,,F,,CHEMBL616652,,BAO_0000218,
1662,Cavia porcellus,105570,,,1,,,Intermediate,12409,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,,D,,F,,CHEMBL616653,,BAO_0000218,
1663,Cavia porcellus,105570,,,1,,,Intermediate,12409,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,,D,,F,,CHEMBL616654,,BAO_0000218,
1664,Cavia porcellus,105570,,,1,,,Intermediate,12253,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,,D,,B,,CHEMBL616655,,BAO_0000019,
1665,Cavia porcellus,105570,,,1,,,Intermediate,12936,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616656,,BAO_0000357,
1666,Cavia porcellus,105,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,,H,,B,,CHEMBL616657,,BAO_0000019,
1667,Cavia porcellus,105570,2435.0,,1,,,Intermediate,12409,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,,D,,B,,CHEMBL616658,,BAO_0000357,
1668,Cavia porcellus,105570,,,1,,,Intermediate,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,,D,,B,,CHEMBL616659,,BAO_0000357,
1669,,51,,,1,,,Autocuration,5254,Binding affinity against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616660,,BAO_0000357,
1670,,106,,,1,,,Autocuration,13051,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,,H,,B,,CHEMBL616661,,BAO_0000357,
1671,,105,,,1,,,Expert,3463,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL616662,,BAO_0000019,
1672,,105,,,1,,,Autocuration,15315,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL616663,,BAO_0000019,
1673,,105,,,1,,,Autocuration,6011,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL616664,,BAO_0000019,
1674,Homo sapiens,105,,,1,,,Expert,14159,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",,D,CHO,F,,CHEMBL881820,449.0,BAO_0000219,
1675,,105,,,1,,,Autocuration,14159,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",,H,CHO,F,,CHEMBL616665,449.0,BAO_0000219,
1676,,105,,,1,,,Expert,15250,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,H,CHO,B,,CHEMBL616666,449.0,BAO_0000219,
1677,,105,,,1,,,Autocuration,15250,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,,H,CHO,B,,CHEMBL616667,449.0,BAO_0000219,
1678,,105,,,1,,,Expert,15331,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,H,CHO,F,,CHEMBL616668,449.0,BAO_0000219,
1679,Homo sapiens,105,,,1,,,Expert,15332,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,D,CHO,F,,CHEMBL616669,449.0,BAO_0000219,
1680,,105,,,1,,,Expert,15332,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",,H,CHO,F,,CHEMBL617040,449.0,BAO_0000219,
1681,,105,,,1,,,Autocuration,3294,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",,H,CHO,F,,CHEMBL617041,449.0,BAO_0000219,
1682,,105,,,1,,,Expert,14158,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",,H,CHO,F,,CHEMBL617042,449.0,BAO_0000219,
1683,,105,,,1,,,Expert,14956,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",,H,CHO,F,,CHEMBL617043,449.0,BAO_0000219,
1684,,105,,,1,,,Autocuration,12469,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL617044,,BAO_0000019,
1685,,105,,,1,,,Expert,3463,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,H,CHO,F,,CHEMBL617045,449.0,BAO_0000219,
1686,Homo sapiens,105,,,1,,,Expert,15250,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",,D,CHO,F,,CHEMBL617046,449.0,BAO_0000219,
1687,Homo sapiens,105,,,1,,,Expert,15250,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",,D,CHO,F,,CHEMBL617047,449.0,BAO_0000219,
1688,,105,,,1,,,Expert,14956,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",,H,,F,,CHEMBL617048,,BAO_0000019,
1689,,105,,,1,,,Autocuration,14159,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",,H,,F,,CHEMBL616897,,BAO_0000019,
1690,Homo sapiens,105,,,1,,,Expert,14159,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",,D,,F,,CHEMBL616898,,BAO_0000019,
1691,Homo sapiens,105,,,1,,,Expert,14499,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,,D,CHO,F,,CHEMBL858201,449.0,BAO_0000219,
1692,,105,,,1,,,Autocuration,15315,Intrinsic activity for 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL616899,,BAO_0000019,
1693,,105,,,1,In vitro,,Autocuration,3294,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),,H,,B,,CHEMBL616900,,BAO_0000219,
1694,,105,,,1,,,Expert,3463,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,,H,CHO,B,,CHEMBL616901,449.0,BAO_0000219,
1695,,105,,,1,,,Autocuration,15331,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,,H,,B,,CHEMBL616902,,BAO_0000357,
1696,Homo sapiens,105,,,1,,,Expert,14159,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,D,CHO,B,,CHEMBL616903,449.0,BAO_0000219,
1697,,105,,,1,,,Expert,14158,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,,H,CHO,B,,CHEMBL616904,449.0,BAO_0000219,
1698,,105,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616905,,BAO_0000357,
1699,,105,,,1,,,Expert,15250,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,,H,CHO,B,,CHEMBL616906,449.0,BAO_0000219,
1700,,105,,,1,,,Expert,15250,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616907,449.0,BAO_0000219,
1701,,105,,,1,,,Expert,15331,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616908,449.0,BAO_0000219,
1702,Homo sapiens,105,,,1,,,Expert,15332,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,D,CHO,B,,CHEMBL616909,449.0,BAO_0000219,
1703,Homo sapiens,105,,,1,,,Expert,14499,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,D,CHO,B,,CHEMBL616910,449.0,BAO_0000219,
1704,,105,,,1,,,Expert,15332,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616911,449.0,BAO_0000219,
1705,,105,,,1,,,Expert,14956,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,H,CHO,B,,CHEMBL616912,449.0,BAO_0000219,
1706,,105,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),,H,,B,,CHEMBL616913,,BAO_0000357,
1707,Homo sapiens,105,,,1,,,Expert,6011,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,,D,CHO,B,,CHEMBL616914,449.0,BAO_0000219,
1708,,105,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,H,CHO,B,,CHEMBL616915,449.0,BAO_0000219,
1709,,105,,,1,,,Autocuration,14165,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,,H,,B,,CHEMBL616916,,BAO_0000019,
1710,Homo sapiens,105,,,1,,,Expert,4234,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616917,,BAO_0000357,
1711,,105,,,1,,,Autocuration,15527,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",,H,,B,,CHEMBL616918,,BAO_0000357,
1712,,105,,,1,,,Expert,6328,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,H,,B,,CHEMBL616919,,BAO_0000219,
1713,,105,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,,H,,B,,CHEMBL616920,,BAO_0000357,
1714,,105,,,1,,,Autocuration,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL872914,,BAO_0000357,
1715,,105,,,1,,,Autocuration,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,,H,,B,,CHEMBL616921,,BAO_0000357,
1716,,105,,,1,,,Expert,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616922,,BAO_0000357,
1717,,105,,,1,,,Autocuration,6013,Binding affinity towards 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616923,,BAO_0000357,
1718,,105,,,1,,,Expert,5843,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616924,,BAO_0000357,
1719,,105,,,1,,,Expert,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,,H,,B,,CHEMBL875909,,BAO_0000357,
1720,,105,,,1,,,Autocuration,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,,H,,B,,CHEMBL616925,,BAO_0000357,
1721,,105,,,1,,,Autocuration,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,,H,,B,,CHEMBL616926,,BAO_0000357,
1722,,105,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616927,,BAO_0000357,
1723,,105,,,1,,,Expert,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,,H,CHO-K1,F,,CHEMBL616928,485.0,BAO_0000219,
1724,Homo sapiens,105,,,1,In vitro,,Expert,6011,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),,D,,B,,CHEMBL616929,,BAO_0000219,
1725,Homo sapiens,105,,,1,,,Expert,4234,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616930,,BAO_0000357,
1726,,105,,,1,,,Expert,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616931,,BAO_0000019,
1727,,105,,,1,,,Autocuration,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,H,,B,,CHEMBL616932,,BAO_0000357,
1728,,105,,,1,,,Expert,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616933,,BAO_0000357,
1729,Homo sapiens,105,,,1,,,Expert,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,,D,,B,,CHEMBL616934,,BAO_0000219,
1730,Homo sapiens,105,,,1,,,Expert,3804,Binding affinity for human 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616935,,BAO_0000357,
1731,,105,,,1,,,Autocuration,16700,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,,H,,B,,CHEMBL616936,,BAO_0000357,
1732,Homo sapiens,105,,,1,,,Expert,2391,Affinity for 5-hydroxytryptamine 1D receptor subtype,,D,,B,,CHEMBL616937,,BAO_0000357,
1733,Homo sapiens,105,,,1,,,Expert,4175,Binding affinity for human 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616938,,BAO_0000357,
1734,,105,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616939,,BAO_0000019,
1735,,105,,,1,,,Expert,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,,H,,B,,CHEMBL616940,,BAO_0000019,
1736,Homo sapiens,105,,,1,,,Expert,15926,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,,D,,B,,CHEMBL616941,,BAO_0000357,
1737,,105,,,1,,,Autocuration,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,,H,CHO-K1,B,,CHEMBL616942,485.0,BAO_0000219,
1738,,105,,,1,,,Autocuration,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,,H,CHO-K1,B,,CHEMBL616943,485.0,BAO_0000219,
1739,,104802,,,1,,,Autocuration,14956,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,,H,CHO,B,,CHEMBL616944,449.0,BAO_0000219,
1740,,105,,,1,,,Autocuration,3294,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",,H,,F,,CHEMBL616945,,BAO_0000019,
1741,,105,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL616946,,BAO_0000357,
1742,,105,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,,B,,CHEMBL616947,,BAO_0000019,
1743,,105,,,1,,,Expert,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,,H,CHO-K1,B,,CHEMBL616948,485.0,BAO_0000219,
1744,,105,,,1,,,Autocuration,5104,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616851,,BAO_0000357,
1745,,105,,,1,,,Autocuration,5105,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616852,,BAO_0000357,
1746,,105,,,1,,,Autocuration,14499,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616853,,BAO_0000357,
1747,Homo sapiens,105,,,1,,,Expert,15926,Binding activity against human 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616854,,BAO_0000357,
1748,Homo sapiens,105,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,D,CHO,B,,CHEMBL616855,449.0,BAO_0000219,
1749,,105,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,,H,CHO,B,,CHEMBL616856,449.0,BAO_0000219,
1750,,105,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,CHO,B,,CHEMBL616857,449.0,BAO_0000219,
1751,,105,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616858,,BAO_0000357,
1752,,105,,,1,,,Autocuration,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,,H,CHO,B,,CHEMBL616859,449.0,BAO_0000219,
1753,,105,,,1,,,Autocuration,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,,H,CHO,B,,CHEMBL616860,449.0,BAO_0000219,
1754,,105,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,H,HEK293,B,,CHEMBL616861,722.0,BAO_0000219,
1755,,105,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,H,HEK293,B,,CHEMBL616541,722.0,BAO_0000219,
1756,,105,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,,H,HEK293,B,,CHEMBL616542,722.0,BAO_0000219,
1757,,105,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,,H,CHO,B,,CHEMBL616543,449.0,BAO_0000219,
1758,Homo sapiens,105,,,1,,,Expert,14875,Binding affinity for human 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL616544,,BAO_0000357,
1759,,105,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,,H,CHO,B,,CHEMBL616545,449.0,BAO_0000219,
1760,,105,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,,H,,B,,CHEMBL616546,,BAO_0000357,
1761,,105,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,,H,CHO,B,,CHEMBL616547,449.0,BAO_0000219,
1762,,105,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL616548,449.0,BAO_0000219,
1763,,105,,,1,,,Expert,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,,H,,F,,CHEMBL616549,,BAO_0000019,
1764,,105,,,1,,,Expert,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,,H,,F,,CHEMBL616550,,BAO_0000019,
1765,,108,,,1,,,Autocuration,5254,Binding affinity against 5-HT2C receptor,,H,,B,,CHEMBL857066,,BAO_0000357,
1766,,108,,,1,,,Autocuration,5254,Binding affinity against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616551,,BAO_0000357,
1767,,10577,,,1,,,Autocuration,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,H,,B,,CHEMBL616552,,BAO_0000357,
1768,,10577,,,1,,,Autocuration,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,H,,F,,CHEMBL832876,,BAO_0000019,
1769,,10577,,,1,,,Expert,12352,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",,H,,B,,CHEMBL616553,,BAO_0000019,
1770,,10577,,,1,,,Autocuration,9098,Binding affinity towards 5-HT1B was determined,,H,,B,,CHEMBL616554,,BAO_0000357,
1771,,10577,,,1,,,Expert,14430,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,,H,,B,,CHEMBL616555,,BAO_0000019,
1772,,10577,,,1,,,Expert,13657,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",,H,,B,,CHEMBL616556,,BAO_0000019,
1773,,10577,,,1,,,Autocuration,13657,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",,H,,B,,CHEMBL616557,,BAO_0000019,
1774,,10577,,,1,,,Expert,15854,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,H,,B,,CHEMBL616558,,BAO_0000019,
1775,Rattus norvegicus,10577,,,1,,,Expert,10639,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,,D,,B,,CHEMBL616749,,BAO_0000019,
1776,,10577,,,1,,,Autocuration,10025,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,H,,B,,CHEMBL616750,,BAO_0000357,
1777,,10577,,,1,,,Autocuration,10025,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",,H,,B,,CHEMBL616751,,BAO_0000357,
1778,,10577,,,1,,,Autocuration,14286,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,H,,B,,CHEMBL616752,,BAO_0000249,
1779,,10577,2435.0,,1,,,Autocuration,3651,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,,H,,B,,CHEMBL616753,,BAO_0000019,
1780,Rattus norvegicus,10577,,,1,,,Expert,14178,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616754,,BAO_0000357,
1781,,10577,,,1,,,Autocuration,10639,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,,H,,B,,CHEMBL616755,,BAO_0000019,
1782,,10577,2435.0,,1,,,Autocuration,13605,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,,H,,B,,CHEMBL616756,,BAO_0000019,
1783,,10577,2435.0,,1,,,Autocuration,5834,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,,H,,B,,CHEMBL616757,,BAO_0000019,
1784,,10577,2435.0,,1,,,Autocuration,10922,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,,H,,B,,CHEMBL616758,,BAO_0000357,
1785,,10577,,,1,,,Autocuration,14286,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,H,,B,,CHEMBL616759,,BAO_0000249,
1786,,10577,,,1,,,Autocuration,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,,H,,B,,CHEMBL616760,,BAO_0000357,
1787,,10577,2435.0,,1,,,Autocuration,14826,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,,H,,B,,CHEMBL616761,,BAO_0000019,
1788,,10577,2435.0,,1,,,Autocuration,9699,Binding affinity against 5-HT1B serotonin receptor in rat striatum,,H,,B,,CHEMBL616762,,BAO_0000019,
1789,,10577,,,1,,,Autocuration,14423,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,,H,,B,,CHEMBL616763,,BAO_0000019,
1790,,10577,,,1,,,Expert,10062,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,,H,,B,,CHEMBL872909,,BAO_0000357,
1791,,10577,,,1,,,Autocuration,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616764,,BAO_0000357,
1792,Rattus norvegicus,10577,,,1,,,Expert,12280,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616765,,BAO_0000357,
1793,,10577,2435.0,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,,H,,B,,CHEMBL616766,,BAO_0000357,
1794,,10577,2435.0,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,,H,,B,,CHEMBL616767,,BAO_0000357,
1795,,10577,,,1,,,Autocuration,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616768,,BAO_0000357,
1796,,10577,,,1,,,Autocuration,11147,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL616769,,BAO_0000357,
1797,,10577,,,1,,,Autocuration,9547,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,,H,,B,,CHEMBL616770,,BAO_0000019,
1798,,10577,,,1,,,Autocuration,10444,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,,H,,B,,CHEMBL616771,,BAO_0000019,
1799,,10577,2435.0,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,,H,,B,,CHEMBL616772,,BAO_0000019,
1800,,10577,,,1,,,Expert,9098,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,,H,,B,,CHEMBL616773,,BAO_0000019,
1801,,10577,,,1,,,Autocuration,9098,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,,H,,B,,CHEMBL616774,,BAO_0000019,
1802,,10577,,,1,,,Autocuration,9699,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616775,,BAO_0000357,
1803,,10577,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,,H,,B,,CHEMBL616776,,BAO_0000249,
1804,,10577,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,,H,,B,,CHEMBL616777,,BAO_0000357,
1805,,10577,,,1,,,Autocuration,16700,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,,H,,B,,CHEMBL616778,,BAO_0000357,
1806,Rattus norvegicus,10577,,,1,,,Expert,403,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,,D,,B,,CHEMBL616779,,BAO_0000249,
1807,Rattus norvegicus,10577,,,1,,,Expert,12771,Binding affinity towards 5-hydroxytryptamine 1B receptor,,D,,B,,CHEMBL616780,,BAO_0000357,
1808,,10577,,,1,,,Autocuration,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,,H,,B,,CHEMBL616781,,BAO_0000019,
1809,,10577,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,,H,,B,,CHEMBL616782,,BAO_0000357,
1810,,10577,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,,H,,B,,CHEMBL616783,,BAO_0000357,
1811,,10577,2435.0,,1,,,Expert,12953,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,,H,,B,,CHEMBL616784,,BAO_0000019,
1812,,10577,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,,H,,B,,CHEMBL616785,,BAO_0000357,
1813,,10577,955.0,,1,,,Autocuration,9737,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,,B,,CHEMBL857067,,BAO_0000249,
1814,,10577,,,1,,,Autocuration,9737,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,,H,,B,,CHEMBL616786,,BAO_0000019,
1815,,10577,955.0,,1,,,Autocuration,9737,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,,B,,CHEMBL616787,,BAO_0000249,
1816,,10577,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,,H,,B,,CHEMBL616788,,BAO_0000357,
1817,,10577,,,1,,,Autocuration,5033,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616789,,BAO_0000357,
1818,Rattus norvegicus,10577,,,1,,,Expert,9786,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,,D,,B,,CHEMBL616790,,BAO_0000019,
1819,,10577,,,1,,,Expert,13116,Binding affinity at 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616791,,BAO_0000357,
1820,,10577,,,1,,,Autocuration,16429,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,,H,,B,,CHEMBL616792,,BAO_0000019,
1821,Rattus norvegicus,10577,,,1,,,Expert,12409,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,,D,,B,,CHEMBL616793,,BAO_0000249,
1822,,10577,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL616794,,BAO_0000357,
1823,,10577,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL616795,,BAO_0000357,
1824,,104686,,,1,,,Autocuration,5486,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,,H,,B,,CHEMBL616796,,BAO_0000019,
1825,,106,,,1,,,Autocuration,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616797,,BAO_0000357,
1826,,106,,,1,,,Autocuration,386,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,Brain membranes,H,,B,,CHEMBL616798,,BAO_0000249,
1827,,106,,,1,,,Autocuration,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,,H,,B,,CHEMBL616799,,BAO_0000357,
1828,,106,,,1,,,Autocuration,6011,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,,H,,B,,CHEMBL616800,,BAO_0000357,
1829,,106,,,1,,,Autocuration,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616801,,BAO_0000357,
1830,,106,,,1,,,Autocuration,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,,H,,B,,CHEMBL616802,,BAO_0000357,
1831,,106,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,,H,,B,,CHEMBL616803,,BAO_0000357,
1832,,106,,,1,,,Expert,1633,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,,H,,B,,CHEMBL857068,,BAO_0000357,
1833,,106,,,1,,,Autocuration,1633,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,,H,,B,,CHEMBL616804,,BAO_0000357,
1834,,106,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,,H,,B,,CHEMBL616805,,BAO_0000357,
1835,,106,,,1,,,Autocuration,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616806,,BAO_0000357,
1836,,106,,,1,,,Autocuration,11574,Binding affinity against 5-hydroxytryptamine 1B receptor,,H,,B,,CHEMBL616807,,BAO_0000357,
1837,,106,,,1,,,Autocuration,10321,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,,H,,B,,CHEMBL616808,,BAO_0000357,
1838,,106,,,1,,,Autocuration,15527,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL616809,,BAO_0000357,
1839,,106,,,1,,,Autocuration,17200,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,,H,,B,,CHEMBL616810,,BAO_0000357,
1840,,104802,,,1,,,Autocuration,14423,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,,H,,B,,CHEMBL616811,,BAO_0000224,
1841,Bos taurus,108,,,1,,,Autocuration,5834,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,,H,,B,,CHEMBL616812,,BAO_0000357,
1842,Sus scrofa,108,,,1,,,Autocuration,11473,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,H,,B,,CHEMBL616813,,BAO_0000357,
1843,Sus scrofa,108,,,1,,,Autocuration,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,,H,,B,,CHEMBL616814,,BAO_0000357,
1844,Sus scrofa,108,,,1,,,Autocuration,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,H,,B,,CHEMBL616815,,BAO_0000357,
1845,Sus scrofa,108,,,1,,,Autocuration,10639,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,,H,,B,,CHEMBL616816,,BAO_0000357,
1846,Sus scrofa,108,,,1,,,Autocuration,14331,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,,H,,B,,CHEMBL616817,,BAO_0000357,
1847,Sus scrofa,108,,,1,,,Autocuration,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,,H,,B,,CHEMBL616818,,BAO_0000357,
1848,Sus scrofa,108,,,1,,,Expert,9098,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,,H,,B,,CHEMBL616819,,BAO_0000357,
1849,Sus scrofa,108,,,1,,,Expert,14331,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,,H,,B,,CHEMBL616820,,BAO_0000357,
1850,Sus scrofa,108,,,1,,,Expert,11828,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,,H,,B,,CHEMBL616821,,BAO_0000019,
1851,Sus scrofa,108,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,,H,,B,,CHEMBL616822,,BAO_0000357,
1852,Oryctolagus cuniculus,108,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,H,,B,,CHEMBL616823,,BAO_0000019,
1853,Rattus norvegicus,12689,,,1,,,Autocuration,188,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,,D,,B,,CHEMBL616824,,BAO_0000357,
1854,Rattus norvegicus,12689,,,1,,,Autocuration,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,D,,B,,CHEMBL616825,,BAO_0000357,
1855,Rattus norvegicus,12689,,,1,,,Autocuration,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,,D,,B,,CHEMBL616826,,BAO_0000357,
1856,Rattus norvegicus,12689,,,1,,,Expert,11624,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,,D,,B,,CHEMBL616827,,BAO_0000019,
1857,Rattus norvegicus,12689,,,1,,,Autocuration,11139,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,,D,,B,,CHEMBL616828,,BAO_0000357,
1858,Rattus norvegicus,12689,,,1,,,Autocuration,11147,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,,D,,B,,CHEMBL616829,,BAO_0000357,
1859,Rattus norvegicus,12689,,,1,,,Autocuration,10444,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,,D,,B,,CHEMBL616830,,BAO_0000019,
1860,Rattus norvegicus,12689,,,1,,,Expert,11624,Binding affinity against 5-hydroxytryptamine 1C receptor,,D,,B,,CHEMBL616831,,BAO_0000357,
1861,Rattus norvegicus,12689,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,,B,,CHEMBL616832,,BAO_0000019,
1862,Rattus norvegicus,12689,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,,B,,CHEMBL616833,,BAO_0000019,
1863,Rattus norvegicus,12689,,,1,,,Expert,11662,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,,B,,CHEMBL616834,,BAO_0000019,
1864,Rattus norvegicus,12689,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",,D,,B,,CHEMBL829595,,BAO_0000019,
1865,Rattus norvegicus,12689,,,1,,,Autocuration,9098,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,,D,,B,,CHEMBL616835,,BAO_0000357,
1866,Rattus norvegicus,12689,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,,D,,B,,CHEMBL872910,,BAO_0000249,
1867,,12689,,,1,,,Expert,11933,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,,H,,B,,CHEMBL616836,,BAO_0000357,
1868,Rattus norvegicus,12689,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,,D,,B,,CHEMBL616837,,BAO_0000357,
1869,Rattus norvegicus,12689,,,1,,,Autocuration,12253,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,,D,,B,,CHEMBL616466,,BAO_0000019,
1870,Rattus norvegicus,12689,,,1,,,Autocuration,12253,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,,D,HEK293,B,,CHEMBL616467,722.0,BAO_0000219,
1871,,108,,,1,,,Autocuration,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,H,,B,,CHEMBL616468,,BAO_0000357,
1872,,108,,,1,,,Autocuration,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,H,,B,,CHEMBL616469,,BAO_0000357,
1873,,108,,,1,,,Autocuration,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,H,,B,,CHEMBL616470,,BAO_0000357,
1874,,12689,,,1,,,Autocuration,11574,Binding affinity against 5-hydroxytryptamine 1C receptor,,H,,B,,CHEMBL616471,,BAO_0000357,
1875,,12689,,,1,,,Autocuration,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,H,,B,,CHEMBL616472,,BAO_0000357,
1876,,12689,,,1,,,Autocuration,13944,Binding affinity against 5-hydroxytryptamine 1C receptor,,H,,B,,CHEMBL616473,,BAO_0000357,
1877,,12689,,,1,,,Autocuration,13033,Binding affinity against serotonergic 5-HT1c receptor,,H,,B,,CHEMBL616474,,BAO_0000357,
1878,,12689,,,1,,,Autocuration,10321,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,,H,,B,,CHEMBL616475,,BAO_0000357,
1879,,12689,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,,H,,B,,CHEMBL616476,,BAO_0000357,
1880,Oryctolagus cuniculus,105,,,1,,,Autocuration,14454,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),,H,,B,,CHEMBL616477,,BAO_0000019,
1881,,104686,,,1,,,Autocuration,11574,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,,H,,B,,CHEMBL616478,,BAO_0000224,
1882,,104686,,,1,,,Autocuration,11574,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,,H,,B,,CHEMBL616479,,BAO_0000224,
1883,,104686,,,1,,,Autocuration,13631,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,,H,,B,,CHEMBL616480,,BAO_0000019,
1884,Rattus norvegicus,104686,,,1,,,Autocuration,9630,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,,D,,B,,CHEMBL616481,,BAO_0000019,
1885,Rattus norvegicus,104686,,,1,,,Autocuration,8822,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,,D,,B,,CHEMBL616482,,BAO_0000249,
1886,Rattus norvegicus,104686,955.0,,1,,,Autocuration,9064,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,,D,,B,,CHEMBL884713,,BAO_0000221,
1887,,104686,,,1,,,Autocuration,8868,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,,H,,B,,CHEMBL616483,,BAO_0000224,
1888,,104686,,,1,,,Autocuration,9064,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,,H,,B,,CHEMBL616484,,BAO_0000224,
1889,,104686,,,1,,,Autocuration,9806,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,,H,,B,,CHEMBL616485,,BAO_0000019,
1890,,104686,,,1,,,Autocuration,9098,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,H,,B,,CHEMBL616486,,BAO_0000224,
1891,,104686,,,1,,,Autocuration,8868,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,,H,,B,,CHEMBL616487,,BAO_0000224,
1892,,104686,,,1,,,Autocuration,12765,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,H,,B,,CHEMBL616488,,BAO_0000224,
1893,,104686,,,1,,,Autocuration,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL616489,,BAO_0000019,
1894,,104686,,,1,,,Autocuration,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL616490,,BAO_0000019,
1895,,104686,,,1,,,Autocuration,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,,H,,B,,CHEMBL616491,,BAO_0000019,
1896,,104686,,,1,,,Autocuration,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,,H,,B,,CHEMBL616492,,BAO_0000019,
1897,,104686,,,1,,,Autocuration,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL616493,,BAO_0000019,
1898,,104686,,,1,,,Autocuration,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,,H,,B,,CHEMBL616494,,BAO_0000019,
1899,,104686,,,1,,,Autocuration,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,,H,,B,,CHEMBL616495,,BAO_0000019,
1900,,104686,,,1,,,Autocuration,3086,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,,H,,B,,CHEMBL616496,,BAO_0000019,
1901,,104686,,,1,,,Autocuration,11049,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL616497,,BAO_0000019,
1902,,104686,,,1,,,Autocuration,11049,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL616498,,BAO_0000019,
1903,,104686,,,1,,,Autocuration,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,,H,,B,,CHEMBL616499,,BAO_0000019,
1904,,104686,,,1,,,Autocuration,10922,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,,H,,B,,CHEMBL616500,,BAO_0000019,
1905,Rattus norvegicus,104686,955.0,,1,,,Autocuration,9064,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,D,,B,,CHEMBL616501,,BAO_0000221,
1906,,104686,955.0,,1,,,Autocuration,10748,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,,H,,B,,CHEMBL616502,,BAO_0000221,
1907,,104686,,,1,,,Autocuration,11614,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,Membranes,H,,B,,CHEMBL884529,,BAO_0000249,
1908,,104686,,,1,,,Autocuration,11615,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,Membranes,H,,B,,CHEMBL616503,,BAO_0000249,
1909,,104686,,,1,,,Autocuration,11615,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL616964,,BAO_0000224,
1910,,104686,,,1,,,Autocuration,11614,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,Membranes,H,,B,,CHEMBL616965,,BAO_0000249,
1911,,104686,,,1,,,Autocuration,11702,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,,H,,B,,CHEMBL616966,,BAO_0000224,
1912,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,,H,,B,,CHEMBL616967,,BAO_0000224,
1913,Rattus norvegicus,104686,,,1,,,Autocuration,11702,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL616968,,BAO_0000224,
1914,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,,H,,B,,CHEMBL616969,,BAO_0000224,
1915,,104686,,,1,,,Autocuration,13346,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,,H,,B,,CHEMBL884530,,BAO_0000019,
1916,,104686,,,1,,,Autocuration,10025,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL616970,,BAO_0000224,
1917,,104686,,,1,,,Autocuration,10025,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,H,,B,,CHEMBL616971,,BAO_0000224,
1918,,104686,,,1,,,Autocuration,10025,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,H,,B,,CHEMBL616972,,BAO_0000224,
1919,,104686,,,1,,,Autocuration,9036,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,,H,,B,,CHEMBL616973,,BAO_0000224,
1920,,104686,,,1,,,Autocuration,9036,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,,H,,B,,CHEMBL616974,,BAO_0000224,
1921,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,,H,,B,,CHEMBL616975,,BAO_0000019,
1922,,104686,,,1,,,Autocuration,12304,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,,H,,B,,CHEMBL616976,,BAO_0000019,
1923,,104686,,,1,,,Autocuration,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL616977,,BAO_0000224,
1924,,104686,,,1,,,Autocuration,11825,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,H,,B,,CHEMBL616978,,BAO_0000224,
1925,,104686,,,1,,,Autocuration,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,,H,,B,,CHEMBL616979,,BAO_0000224,
1926,,104686,,,1,,,Autocuration,13830,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL616980,,BAO_0000224,
1927,,104686,,,1,,,Autocuration,9592,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,Membranes,H,,B,,CHEMBL616981,,BAO_0000249,
1928,,104686,,,1,,,Autocuration,9592,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,Membranes,H,,B,,CHEMBL616982,,BAO_0000249,
1929,,104686,,,1,,,Autocuration,10881,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,,H,,B,,CHEMBL616983,,BAO_0000224,
1930,,104686,,,1,,,Autocuration,13605,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,,H,,B,,CHEMBL616984,,BAO_0000019,
1931,Rattus norvegicus,104686,,,1,,,Autocuration,11624,Inhibitory activity against 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL616985,,BAO_0000224,
1932,,104686,,,1,,,Autocuration,4101,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,H,,B,,CHEMBL616986,,BAO_0000224,
1933,,104686,,,1,,,Autocuration,4101,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,H,,B,,CHEMBL616987,,BAO_0000224,
1934,,104686,,,1,,,Autocuration,15360,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,,H,,B,,CHEMBL616988,,BAO_0000019,
1935,,104686,,,1,,,Autocuration,11576,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,,H,,B,,CHEMBL617243,,BAO_0000019,
1936,,104686,,,1,,,Autocuration,5834,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,,H,,B,,CHEMBL617244,,BAO_0000019,
1937,Rattus norvegicus,104686,,,1,,,Autocuration,2395,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,D,CHO-K1,B,,CHEMBL617245,485.0,BAO_0000219,
1938,,104686,,,1,,,Autocuration,11965,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,Membranes,H,,B,,CHEMBL617246,,BAO_0000249,
1939,,104686,,,1,,,Autocuration,3967,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),,H,,B,,CHEMBL617546,,BAO_0000224,
1940,,104686,,,1,,,Autocuration,11130,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),Brain membranes,H,,B,,CHEMBL617547,,BAO_0000249,
1941,,104686,,,1,In vitro,,Autocuration,13427,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,H,,B,,CHEMBL617548,,BAO_0000219,
1942,,104686,,,1,,,Autocuration,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617549,,BAO_0000224,
1943,,104686,,,1,,,Autocuration,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,H,,B,,CHEMBL617550,,BAO_0000224,
1944,,104686,,,1,,,Autocuration,11825,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,H,,B,,CHEMBL617551,,BAO_0000224,
1945,,104686,,,1,,,Autocuration,12120,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,Membranes,H,,B,,CHEMBL617552,,BAO_0000249,
1946,,104686,,,1,,,Autocuration,12120,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,Membranes,H,,B,,CHEMBL617553,,BAO_0000249,
1947,,104686,1515.0,,1,,,Autocuration,11963,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,,H,,F,,CHEMBL617554,,BAO_0000019,
1948,,104686,,,1,,,Autocuration,9069,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617555,,BAO_0000019,
1949,,104686,,,1,,,Autocuration,8868,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,H,,B,,CHEMBL617556,,BAO_0000224,
1950,,10624,,,1,,,Autocuration,17200,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,H,,B,,CHEMBL617557,,BAO_0000357,
1951,,10624,,,1,,,Autocuration,17200,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,H,,B,,CHEMBL617558,,BAO_0000357,
1952,,17106,,,1,,,Expert,13969,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,,H,,B,,CHEMBL617559,,BAO_0000357,
1953,,17106,,,1,,,Expert,13392,Binding affinity for 5-hydroxytryptamine 1D receptor,,D,,B,,CHEMBL617560,,BAO_0000357,
1954,,17106,,,1,,,Autocuration,1742,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,H,,B,,CHEMBL617561,,BAO_0000249,
1955,,17106,,,1,,,Autocuration,1742,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,H,,B,,CHEMBL617562,,BAO_0000249,
1956,,17106,2435.0,,1,,,Autocuration,14331,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,,H,,B,,CHEMBL617563,,BAO_0000357,
1957,,17106,,,1,,,Autocuration,12861,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL617564,,BAO_0000019,
1958,,17106,,,1,,,Expert,12861,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,,H,,B,,CHEMBL617565,,BAO_0000019,
1959,,17106,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL856076,,BAO_0000357,
1960,,17106,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,H,,B,,CHEMBL617566,,BAO_0000019,
1961,,17106,,,1,,,Expert,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,,B,,CHEMBL875911,,BAO_0000019,
1962,,17106,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,H,,B,,CHEMBL617567,,BAO_0000019,
1963,,17106,,,1,,,Autocuration,675,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,H,,B,,CHEMBL617568,,BAO_0000249,
1964,,17106,,,1,,,Expert,12490,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,,H,,B,,CHEMBL617569,,BAO_0000019,
1965,,17106,,,1,,,Expert,11828,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,,H,,B,,CHEMBL617570,,BAO_0000249,
1966,,17106,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,,H,,B,,CHEMBL617571,,BAO_0000357,
1967,Sus scrofa,105,,,1,,,Autocuration,773,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,,H,,B,,CHEMBL617572,,BAO_0000357,
1968,Oryctolagus cuniculus,105,,,1,,,Expert,13047,The compound was tested for intrinsic activity against 5-HT1D receptor,,H,,B,,CHEMBL617573,,BAO_0000357,
1969,Oryctolagus cuniculus,105,,,1,,,Autocuration,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,,H,,B,,CHEMBL617574,,BAO_0000019,
1970,Oryctolagus cuniculus,105,,,1,,,Expert,13047,The compound was tested for binding affinity against 5-HT1D receptor,,H,,B,,CHEMBL617575,,BAO_0000357,
1971,,10578,,,1,,,Autocuration,188,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,,H,,B,,CHEMBL617576,,BAO_0000357,
1972,,10578,,,1,,,Autocuration,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,,H,,F,,CHEMBL617577,,BAO_0000019,
1973,,10578,,,1,,,Autocuration,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,,H,,F,,CHEMBL617578,,BAO_0000019,
1974,,10578,,,1,,,Autocuration,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL617579,,BAO_0000357,
1975,,10578,,,1,,,Expert,15854,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,H,,B,,CHEMBL617580,,BAO_0000019,
1976,,10578,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,,H,,B,,CHEMBL617581,,BAO_0000249,
1977,,10578,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,,H,,B,,CHEMBL617582,,BAO_0000357,
1978,,10578,,,1,,,Expert,3389,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,,H,,B,,CHEMBL617583,,BAO_0000019,
1979,,105,,,1,,,Autocuration,6011,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,,H,,B,,CHEMBL617584,,BAO_0000357,
1980,,105,,,1,,,Autocuration,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL617585,,BAO_0000357,
1981,,105,,,1,,,Autocuration,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,,H,,B,,CHEMBL875912,,BAO_0000357,
1982,,105,,,1,,,Autocuration,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL617586,,BAO_0000357,
1983,,105,,,1,,,Autocuration,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,,H,,B,,CHEMBL617587,,BAO_0000357,
1984,,105,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,,H,,B,,CHEMBL617588,,BAO_0000357,
1985,,105,,,1,,,Autocuration,4687,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL857980,,BAO_0000357,
1986,,105,,,1,,,Autocuration,12146,Tested against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL617589,,BAO_0000357,
1987,,105,,,1,,,Autocuration,10321,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,,H,,B,,CHEMBL617590,,BAO_0000357,
1988,,105,,,1,,,Autocuration,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL617591,722.0,BAO_0000219,
1989,Homo sapiens,105,,,1,,,Expert,1274,Binding affinity against 5-Hydroxytryptamine 1D receptor,,D,,B,,CHEMBL617592,,BAO_0000357,
1990,,105,,,1,,,Autocuration,15250,,,H,,B,,CHEMBL617593,,BAO_0000357,
1991,,106,,,1,,,Autocuration,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL617594,485.0,BAO_0000219,
1992,,105,,,1,,,Autocuration,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL617595,485.0,BAO_0000219,
1993,,105,,,1,,,Autocuration,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,,H,HEK293,B,,CHEMBL617596,722.0,BAO_0000219,
1994,,105,,,1,,,Autocuration,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,H,HEK293,B,,CHEMBL617597,722.0,BAO_0000219,
1995,,105,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,H,,B,,CHEMBL617598,,BAO_0000019,
1996,,105,,,1,,,Autocuration,13366,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,,H,,B,,CHEMBL872916,,BAO_0000357,
1997,,105,,,1,,,Expert,13366,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,,H,,B,,CHEMBL617599,,BAO_0000357,
1998,,105,,,1,,,Autocuration,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,,H,,B,,CHEMBL617091,,BAO_0000357,
1999,,105,,,1,,,Expert,12902,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",,H,CHO-K1,B,,CHEMBL617092,485.0,BAO_0000219,
2000,,105,,,1,,,Autocuration,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL617093,485.0,BAO_0000219,
2001,,105,,,1,,,Autocuration,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,,H,,F,,CHEMBL617094,,BAO_0000019,
2002,,105,,,1,,,Autocuration,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,H,,F,,CHEMBL617095,,BAO_0000019,
2003,,105,,,1,,,Autocuration,14251,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,H,,F,,CHEMBL617096,,BAO_0000019,
2004,,105,,,1,,,Autocuration,14251,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,H,,F,,CHEMBL617097,,BAO_0000019,
2005,,105,,,1,,,Autocuration,14251,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,H,,F,,CHEMBL617098,,BAO_0000019,
2006,,105,,,1,,,Autocuration,13313,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,,H,,B,,CHEMBL617301,,BAO_0000357,
2007,,105,,,1,,,Autocuration,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,,H,,B,,CHEMBL617302,,BAO_0000357,
2008,,105,,,1,,,Autocuration,13366,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617303,,BAO_0000357,
2009,,105,,,1,,,Expert,13051,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617304,,BAO_0000357,
2010,,105,,,1,,,Expert,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL617305,449.0,BAO_0000219,
2011,Homo sapiens,105,,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,,D,,B,,CHEMBL617306,,BAO_0000219,
2012,,17106,,,1,,,Autocuration,5619,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,,H,,B,,CHEMBL617307,,BAO_0000357,
2013,Oryctolagus cuniculus,105,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,,H,,B,,CHEMBL617308,,BAO_0000019,
2014,,105,,,1,,,Autocuration,16633,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617309,,BAO_0000357,
2015,,105,,,1,,,Autocuration,16633,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617310,,BAO_0000357,
2016,,105,,,1,,,Autocuration,16633,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617311,,BAO_0000357,
2017,,105,,,1,,,Autocuration,16633,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL617312,,BAO_0000357,
2018,,105,,,1,,,Autocuration,3269,Affinity against 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617313,,BAO_0000357,
2019,,105,,,1,,,Expert,12409,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,,H,,B,,CHEMBL617314,,BAO_0000357,
2020,,106,,,1,,,Autocuration,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,H,,F,,CHEMBL617315,,BAO_0000019,
2021,,106,,,1,,,Autocuration,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,,H,HEK293,B,,CHEMBL617316,722.0,BAO_0000219,
2022,,106,,,1,,,Autocuration,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,H,HEK293,B,,CHEMBL617317,722.0,BAO_0000219,
2023,,106,,,1,,,Autocuration,12903,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL617318,449.0,BAO_0000219,
2024,,106,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,H,,B,,CHEMBL617319,,BAO_0000019,
2025,,106,,,1,,,Expert,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,D,,B,,CHEMBL617320,,BAO_0000357,
2026,,106,,,1,,,Expert,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,D,,B,,CHEMBL617321,,BAO_0000357,
2027,,106,,,1,,,Expert,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,D,,B,,CHEMBL617322,,BAO_0000357,
2028,,106,,,1,,,Autocuration,13366,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616862,,BAO_0000357,
2029,,106,,,1,,,Autocuration,13366,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL616863,,BAO_0000357,
2030,,106,,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,,H,CHO,B,,CHEMBL616864,449.0,BAO_0000219,
2031,,106,,,1,,,Autocuration,13706,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL616865,485.0,BAO_0000219,
2032,,106,,,1,,,Autocuration,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL616866,485.0,BAO_0000219,
2033,,106,,,1,,,Autocuration,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,H,,F,,CHEMBL616867,,BAO_0000019,
2034,,106,,,1,,,Expert,12902,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",,H,CHO-K1,B,,CHEMBL616868,485.0,BAO_0000219,
2035,,105,,,1,,,Expert,13051,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,,H,,B,,CHEMBL616869,,BAO_0000357,
2036,,106,,,1,,,Expert,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL616870,449.0,BAO_0000219,
2037,,105,,,1,,,Autocuration,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,,H,CHO-K1,F,,CHEMBL616871,485.0,BAO_0000219,
2038,,105,,,1,,,Autocuration,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,,H,CHO-K1,F,,CHEMBL616872,485.0,BAO_0000219,
2039,,105,,,1,,,Autocuration,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,,H,CHO-K1,F,,CHEMBL616873,485.0,BAO_0000219,
2040,,105,,,1,,,Autocuration,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,,H,CHO-K1,F,,CHEMBL616838,485.0,BAO_0000219,
2041,,105,,,1,,,Autocuration,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,,H,,B,,CHEMBL616839,,BAO_0000357,
2042,Oryctolagus cuniculus,106,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,,H,,B,,CHEMBL616840,,BAO_0000019,
2043,,105,,,1,,,Autocuration,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,,H,,B,,CHEMBL616841,,BAO_0000357,
2044,,105,,,1,,,Autocuration,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,,H,,B,,CHEMBL616842,,BAO_0000357,
2045,,105,,,1,,,Expert,12409,Binding affinity against 5-hydroxytryptamine 1D receptor beta,,H,,B,,CHEMBL857976,,BAO_0000357,
2046,,10618,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616843,449.0,BAO_0000219,
2047,Homo sapiens,10618,,,1,,,Expert,1348,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,,D,,B,,CHEMBL616844,,BAO_0000357,
2048,,10618,,,1,,,Autocuration,1348,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,,H,,B,,CHEMBL616845,,BAO_0000357,
2049,Homo sapiens,10618,,,1,,,Expert,4234,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,,D,,B,,CHEMBL616846,,BAO_0000357,
2050,,10618,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,,H,,B,,CHEMBL616847,,BAO_0000357,
2051,,10618,,,1,,,Autocuration,10444,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,,H,,B,,CHEMBL616848,,BAO_0000019,
2052,,10618,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,,H,,B,,CHEMBL616849,,BAO_0000357,
2053,,10618,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,,H,,B,,CHEMBL872911,,BAO_0000357,
2054,,10618,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,,H,,B,,CHEMBL616850,,BAO_0000019,
2055,Homo sapiens,10618,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,,D,CHO,B,,CHEMBL616699,449.0,BAO_0000219,
2056,,10618,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,,H,,B,,CHEMBL616700,,BAO_0000357,
2057,,10618,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,CHO,B,,CHEMBL616701,449.0,BAO_0000219,
2058,,10618,,,1,,,Autocuration,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,,H,CHO,B,,CHEMBL616702,449.0,BAO_0000219,
2059,,10618,,,1,,,Autocuration,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,,H,CHO,B,,CHEMBL616703,449.0,BAO_0000219,
2060,,10618,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,,H,,B,,CHEMBL616704,,BAO_0000357,
2061,,10618,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,,H,CHO,B,,CHEMBL616705,449.0,BAO_0000219,
2062,,10618,,,1,,,Autocuration,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,,H,,B,,CHEMBL616706,,BAO_0000357,
2063,,10618,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,,H,CHO,B,,CHEMBL616707,449.0,BAO_0000219,
2064,,10618,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,,H,,B,,CHEMBL616708,,BAO_0000357,
2065,,10618,,,1,,,Autocuration,12146,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL616709,,BAO_0000357,
2066,,10618,,,1,,,Autocuration,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,,H,CHO,B,,CHEMBL616710,449.0,BAO_0000219,
2067,,10618,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,,H,CHO,B,,CHEMBL616711,449.0,BAO_0000219,
2068,,10618,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL616712,449.0,BAO_0000219,
2069,,10618,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,,H,,B,,CHEMBL616713,,BAO_0000357,
2070,,10618,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,,H,,B,,CHEMBL616714,,BAO_0000357,
2071,,10618,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,,H,,B,,CHEMBL616715,,BAO_0000357,
2072,,10618,,,1,,,Autocuration,16633,Binding affinity towards 5-hydroxytryptamine 1E receptor,,H,,B,,CHEMBL616716,,BAO_0000357,
2073,,279,,,1,,,Autocuration,17085,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",,H,,F,,CHEMBL616717,,BAO_0000019,
2074,,279,,,1,,,Expert,17085,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",,H,,F,,CHEMBL616718,,BAO_0000019,
2075,,279,,,1,,,Autocuration,16209,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,,H,,F,,CHEMBL875905,,BAO_0000019,
2076,,279,,,1,,,Autocuration,16209,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,,H,,F,,CHEMBL616719,,BAO_0000019,
2077,,279,,,1,,,Expert,17085,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",,H,,F,,CHEMBL616720,,BAO_0000019,
2078,,279,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL616721,,BAO_0000357,
2079,,279,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL616722,449.0,BAO_0000219,
2080,,279,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),,H,,B,,CHEMBL616723,,BAO_0000357,
2081,,279,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,,H,CHO,B,,CHEMBL616724,449.0,BAO_0000219,
2082,,279,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,,H,,B,,CHEMBL616725,,BAO_0000357,
2083,,279,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL616726,,BAO_0000357,
2084,,279,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,,H,,B,,CHEMBL616727,,BAO_0000357,
2085,,279,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,,H,,B,,CHEMBL616728,,BAO_0000357,
2086,,279,,,1,,,Autocuration,6866,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL616729,,BAO_0000357,
2087,,279,,,1,,,Expert,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL616730,,BAO_0000019,
2088,,279,,,1,,,Autocuration,16312,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL617125,,BAO_0000357,
2089,,279,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,,H,,B,,CHEMBL857977,,BAO_0000357,
2090,,279,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,H,CHO,B,,CHEMBL617126,449.0,BAO_0000219,
2091,,279,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,,H,CHO,B,,CHEMBL617127,449.0,BAO_0000219,
2092,,279,,,1,,,Autocuration,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL617128,,BAO_0000357,
2093,,279,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,,H,CHO,B,,CHEMBL617129,449.0,BAO_0000219,
2094,,279,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,,H,,B,,CHEMBL617130,,BAO_0000357,
2095,,279,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,,H,CHO,B,,CHEMBL617131,449.0,BAO_0000219,
2096,,279,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL617132,449.0,BAO_0000219,
2097,,279,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,H,CHO,B,,CHEMBL617133,449.0,BAO_0000219,
2098,,279,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,,H,,B,,CHEMBL617134,,BAO_0000357,
2099,,279,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,,H,,B,,CHEMBL617135,,BAO_0000357,
2100,,279,,,1,,,Autocuration,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,,H,,B,,CHEMBL617136,,BAO_0000357,
2101,,104686,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",,H,,B,,CHEMBL617137,,BAO_0000019,
2102,,104686,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,H,,B,,CHEMBL617138,,BAO_0000019,
2103,,104686,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,H,,B,,CHEMBL617139,,BAO_0000019,
2104,,12687,,,1,,,Autocuration,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617140,,BAO_0000019,
2105,,104686,,,1,In vivo,,Autocuration,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",,H,,F,,CHEMBL617141,,BAO_0000218,
2106,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,,F,,CHEMBL858112,,BAO_0000019,
2107,,17005,,,1,,,Intermediate,12352,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,,H,,B,,CHEMBL617142,,BAO_0000019,
2108,Bos taurus,22226,,,1,,,Autocuration,13657,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",,U,,B,,CHEMBL617143,,BAO_0000019,
2109,Bos taurus,22226,,,1,,,Autocuration,14331,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,,U,,B,,CHEMBL617144,,BAO_0000019,
2110,Bos taurus,22226,,,1,,,Autocuration,14331,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,,U,,B,,CHEMBL617145,,BAO_0000019,
2111,,22226,,,1,,,Autocuration,14331,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,,U,,B,,CHEMBL617146,,BAO_0000019,
2112,Cavia porcellus,104784,,,1,,,Autocuration,12685,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,,H,,B,,CHEMBL617147,,BAO_0000019,
2113,Cavia porcellus,104784,,,1,,,Autocuration,14389,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,,H,,B,,CHEMBL617148,,BAO_0000019,
2114,Cavia porcellus,104784,,,1,,,Autocuration,14386,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,,H,,B,,CHEMBL617149,,BAO_0000019,
2115,,104784,,,1,,,Autocuration,5732,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,,H,,B,,CHEMBL617150,,BAO_0000224,
2116,,104784,,,1,,,Autocuration,16293,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,H,,B,,CHEMBL617151,,BAO_0000224,
2117,,104784,,,1,,,Autocuration,2078,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617201,,BAO_0000224,
2118,,10209,,,1,,,Autocuration,5486,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,H,,B,,CHEMBL617202,,BAO_0000357,
2119,,104826,,,1,In vivo,,Autocuration,11820,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,H,,B,,CHEMBL617203,,BAO_0000218,
2120,,104826,,,1,,,Autocuration,10297,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,H,,B,,CHEMBL617204,,BAO_0000019,
2121,,104826,,,1,,,Autocuration,13704,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,,H,,B,,CHEMBL617205,,BAO_0000224,
2122,Mus musculus,104826,,,1,,,Autocuration,10297,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,,D,,B,,CHEMBL617206,,BAO_0000019,
2123,,104826,,,1,In vivo,,Autocuration,11820,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,H,,B,,CHEMBL617207,,BAO_0000218,
2124,Mus musculus,104826,,,1,,,Autocuration,10297,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,,D,,B,,CHEMBL617208,,BAO_0000019,
2125,,104826,,,1,,,Autocuration,11555,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617209,,BAO_0000224,
2126,,104826,,,1,,,Autocuration,11555,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,,H,,B,,CHEMBL617210,,BAO_0000224,
2127,,104826,,,1,,,Autocuration,11555,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,,H,,B,,CHEMBL617211,,BAO_0000224,
2128,Mus musculus,104826,,,1,,,Autocuration,10297,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,D,,B,,CHEMBL617212,,BAO_0000019,
2129,Sus scrofa,104784,,,1,,,Autocuration,16688,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,,H,,B,,CHEMBL617213,,BAO_0000224,
2130,Sus scrofa,104784,,,1,,,Autocuration,16688,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,,H,,B,,CHEMBL617214,,BAO_0000224,
2131,,22226,,,1,,,Autocuration,5333,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,U,,B,,CHEMBL617215,,BAO_0000221,
2132,,22226,,,1,,,Autocuration,4437,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,U,,B,,CHEMBL617216,,BAO_0000221,
2133,Sus scrofa,17005,,,1,,,Autocuration,5033,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617217,,BAO_0000357,
2134,,104686,,,1,,,Autocuration,15267,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617218,,BAO_0000019,
2135,,104686,,,1,,,Autocuration,15267,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL872913,,BAO_0000019,
2136,,104826,,,1,,,Autocuration,11820,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,,H,,B,,CHEMBL617219,,BAO_0000019,
2137,,104686,,,1,,,Autocuration,9069,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL873482,,BAO_0000224,
2138,Rattus norvegicus,104686,,,1,,,Autocuration,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,,D,,B,,CHEMBL617220,,BAO_0000019,
2139,,104686,,,1,,,Autocuration,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,,H,,B,,CHEMBL617221,,BAO_0000019,
2140,,104686,,,1,,,Autocuration,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,,H,,B,,CHEMBL617222,,BAO_0000019,
2141,,104686,,,1,,,Autocuration,10428,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,,H,,F,,CHEMBL875906,,BAO_0000019,
2142,,104686,,,1,,,Autocuration,9628,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,,H,,B,,CHEMBL617223,,BAO_0000019,
2143,,104686,,,1,,,Autocuration,12704,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617224,,BAO_0000224,
2144,Rattus norvegicus,104686,,,1,,,Autocuration,15453,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,D,,B,,CHEMBL617225,,BAO_0000224,
2145,,104686,,,1,,,Autocuration,188,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,,H,,B,,CHEMBL617226,,BAO_0000224,
2146,,104686,,,1,,,Autocuration,10349,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,,H,,B,,CHEMBL617227,,BAO_0000224,
2147,,104686,,,1,,,Autocuration,10349,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,,H,,B,,CHEMBL617228,,BAO_0000224,
2148,,104686,,,1,,,Autocuration,8868,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,H,,B,,CHEMBL617229,,BAO_0000224,
2149,,104686,,,1,,,Autocuration,10025,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,H,,B,,CHEMBL617230,,BAO_0000224,
2150,,104686,,,1,,,Autocuration,10025,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,H,,B,,CHEMBL617231,,BAO_0000224,
2151,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,,H,,B,,CHEMBL617232,,BAO_0000224,
2152,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617233,,BAO_0000224,
2153,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,,H,,B,,CHEMBL617234,,BAO_0000224,
2154,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of quipazine induced head twitches in rats,,H,,F,,CHEMBL617235,,BAO_0000019,
2155,,104686,,,1,,,Autocuration,11702,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,,H,,F,,CHEMBL617236,,BAO_0000019,
2156,,104686,10000000.0,,1,,,Autocuration,10085,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,,H,,B,,CHEMBL617237,,BAO_0000221,
2157,,104686,10000000.0,,1,,,Autocuration,10085,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,,H,,B,,CHEMBL617238,,BAO_0000221,
2158,Rattus norvegicus,104686,955.0,,1,,,Autocuration,9630,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,,D,,B,,CHEMBL617239,,BAO_0000221,
2159,,104686,,,1,,,Autocuration,11070,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,,H,,B,,CHEMBL617240,,BAO_0000019,
2160,,104686,,,1,,,Autocuration,9841,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,Membranes,H,,B,,CHEMBL617241,,BAO_0000249,
2161,,104686,,,1,,,Autocuration,9841,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,Membranes,H,,B,,CHEMBL875907,,BAO_0000249,
2162,,104686,,,1,,,Autocuration,13291,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,,H,,B,,CHEMBL617242,,BAO_0000019,
2163,,104686,,,1,,,Autocuration,10590,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,,H,,F,,CHEMBL617152,,BAO_0000019,
2164,Rattus norvegicus,104686,955.0,,1,,,Autocuration,9064,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,,D,,B,,CHEMBL617153,,BAO_0000221,
2165,Rattus norvegicus,104686,,,1,,,Autocuration,12268,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,Membranes,D,,B,,CHEMBL617154,,BAO_0000249,
2166,,104686,955.0,,1,,,Autocuration,13508,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617155,,BAO_0000221,
2167,,104686,,,1,,,Autocuration,11279,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,H,,F,,CHEMBL617156,,BAO_0000019,
2168,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,,H,,F,,CHEMBL617157,,BAO_0000019,
2169,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,,F,,CHEMBL617158,,BAO_0000019,
2170,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,H,,F,,CHEMBL617159,,BAO_0000019,
2171,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,H,,F,,CHEMBL617160,,BAO_0000019,
2172,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,,F,,CHEMBL858113,,BAO_0000019,
2173,,104686,955.0,,1,,,Autocuration,9231,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,,H,,B,,CHEMBL617247,,BAO_0000220,
2174,,104686,,,1,,,Autocuration,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617248,,BAO_0000019,
2175,,104686,955.0,,1,,,Autocuration,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,H,,B,,CHEMBL617249,,BAO_0000249,
2176,,104686,,,1,,,Autocuration,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,,H,,B,,CHEMBL617250,,BAO_0000019,
2177,,104686,,,1,,,Autocuration,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617251,,BAO_0000019,
2178,Rattus norvegicus,104686,,,1,,,Autocuration,11828,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617252,,BAO_0000019,
2179,,104686,,,1,,,Autocuration,12253,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,,H,,B,,CHEMBL617006,,BAO_0000019,
2180,,104686,,,1,,,Autocuration,12253,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,,H,,B,,CHEMBL617007,,BAO_0000019,
2181,,104686,,,1,,,Autocuration,11279,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",,H,,F,,CHEMBL617008,,BAO_0000019,
2182,,104686,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,,H,,B,,CHEMBL617009,,BAO_0000019,
2183,Rattus norvegicus,104686,,,1,,,Autocuration,14424,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,,D,,B,,CHEMBL617010,,BAO_0000224,
2184,Rattus norvegicus,104686,,,1,,,Autocuration,15180,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL857978,,BAO_0000019,
2185,Rattus norvegicus,104686,,,1,,,Autocuration,15180,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617011,,BAO_0000019,
2186,Rattus norvegicus,104686,,,1,,,Autocuration,9786,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,,D,,B,,CHEMBL617012,,BAO_0000019,
2187,,104686,,,1,,,Autocuration,12132,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,,H,,B,,CHEMBL617013,,BAO_0000224,
2188,,104686,,,1,,,Autocuration,5486,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,,H,,B,,CHEMBL617014,,BAO_0000249,
2189,,104686,,,1,,,Autocuration,15316,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617015,,BAO_0000019,
2190,,104686,,,1,,,Autocuration,16429,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,,H,,B,,CHEMBL617016,,BAO_0000019,
2191,,104686,,,1,,,Autocuration,14617,pKi value for 5-hydroxytryptamine 2 receptor binding site,,H,,B,,CHEMBL617017,,BAO_0000224,
2192,,104686,955.0,,1,,,Autocuration,11351,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,,H,,B,,CHEMBL617018,,BAO_0000221,
2193,,104686,,,1,,,Autocuration,11279,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,H,,F,,CHEMBL617019,,BAO_0000019,
2194,,105075,,,1,,,Autocuration,9523,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,H,,B,,CHEMBL617020,,BAO_0000019,
2195,,105075,,,1,,,Autocuration,9523,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,H,,B,,CHEMBL617021,,BAO_0000019,
2196,,105075,,,1,,,Autocuration,9523,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,H,,B,,CHEMBL617022,,BAO_0000019,
2197,,105075,,,1,,,Autocuration,9523,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,H,,B,,CHEMBL617023,,BAO_0000019,
2198,,105075,,,1,,,Autocuration,9523,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,H,,B,,CHEMBL617024,,BAO_0000019,
2199,,105075,,,1,,,Autocuration,9523,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,H,,B,,CHEMBL617025,,BAO_0000019,
2200,,105075,,,1,,,Autocuration,9523,Hill coefficient of compound was determined,,H,,B,,CHEMBL617026,,BAO_0000224,
2201,,22226,,,1,,,Autocuration,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,,U,,B,,CHEMBL617027,,BAO_0000019,
2202,Rattus norvegicus,104686,,,1,,,Autocuration,5033,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,,D,,B,,CHEMBL617028,,BAO_0000019,
2203,,12687,,,1,,,Expert,10845,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,,H,,B,,CHEMBL617029,,BAO_0000019,
2204,,12687,,,1,,,Expert,10845,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,,H,,B,,CHEMBL875908,,BAO_0000019,
2205,,12687,,,1,,,Autocuration,16288,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),,H,,B,,CHEMBL617030,,BAO_0000357,
2206,,12687,,,1,,,Autocuration,16288,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),,H,,B,,CHEMBL617031,,BAO_0000019,
2207,,12687,,,1,,,Autocuration,16190,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,,H,,B,,CHEMBL617032,,BAO_0000019,
2208,Rattus norvegicus,104686,,,1,,,Autocuration,12463,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,,D,,B,,CHEMBL617033,,BAO_0000224,
2209,,104686,,,1,,,Autocuration,9699,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",,H,,B,,CHEMBL617034,,BAO_0000224,
2210,,104686,,,1,,,Autocuration,9699,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,,H,,B,,CHEMBL617035,,BAO_0000224,
2211,,104686,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,H,,B,,CHEMBL617036,,BAO_0000019,
2212,,104784,,,1,,,Autocuration,1205,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617037,,BAO_0000224,
2213,,22226,,,1,,,Autocuration,11376,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,,U,,B,,CHEMBL617038,,BAO_0000219,
2214,,104784,,,1,,,Autocuration,11376,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",,H,,B,,CHEMBL617039,,BAO_0000219,
2215,,104784,,,1,,,Autocuration,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617161,,BAO_0000224,
2216,,104784,,,1,,,Autocuration,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617162,,BAO_0000224,
2217,,104784,,,1,,,Autocuration,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617163,,BAO_0000224,
2218,,104784,,,1,,,Autocuration,1089,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617164,,BAO_0000224,
2219,,104784,,,1,,,Autocuration,386,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,Brain membranes,H,,B,,CHEMBL617165,,BAO_0000249,
2220,,104784,,,1,,,Autocuration,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617166,,BAO_0000224,
2221,,104784,,,1,,,Autocuration,17066,Binding affinity towards 5-HT2 receptor,,H,,B,,CHEMBL617167,,BAO_0000224,
2222,,104784,,,1,,,Autocuration,959,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL872912,,BAO_0000224,
2223,,104784,,,1,,,Autocuration,6398,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,,H,,B,,CHEMBL617168,,BAO_0000224,
2224,,104686,,,1,,,Autocuration,11889,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,,H,,B,,CHEMBL617169,,BAO_0000224,
2225,,104784,,,1,,,Autocuration,4221,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617170,,BAO_0000224,
2226,,104784,,,1,,,Autocuration,11026,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,,H,,B,,CHEMBL617171,,BAO_0000224,
2227,,104784,,,1,,,Autocuration,11866,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,,H,,B,,CHEMBL617172,,BAO_0000224,
2228,,104784,,,1,,,Autocuration,4221,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617173,,BAO_0000224,
2229,,22226,,,1,,,Autocuration,13950,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,,U,,B,,CHEMBL617174,,BAO_0000019,
2230,,104784,,,1,,,Autocuration,1263,5-hydroxytryptamine 2 receptor binding affinity,,H,,B,,CHEMBL617175,,BAO_0000224,
2231,,17005,,,1,,,Autocuration,13291,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,,H,,B,,CHEMBL617176,,BAO_0000357,
2232,,17005,,,1,,,Autocuration,10812,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617177,,BAO_0000357,
2233,,104784,,,1,,,Autocuration,13020,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,H,,B,,CHEMBL617178,,BAO_0000224,
2234,,104784,,,1,,,Autocuration,13021,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,,H,,B,,CHEMBL617179,,BAO_0000224,
2235,,104784,,,1,,,Autocuration,13020,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,H,,B,,CHEMBL617180,,BAO_0000224,
2236,,17005,,,1,,,Autocuration,14532,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,,H,,B,,CHEMBL617181,,BAO_0000357,
2237,,17005,,,1,,,Autocuration,13944,Binding affinity against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617182,,BAO_0000357,
2238,,17005,,,1,,,Autocuration,14331,Binding affinity against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617183,,BAO_0000357,
2239,,17005,,,1,,,Autocuration,14118,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617184,,BAO_0000357,
2240,,17005,,,1,,,Autocuration,13033,Binding affinity against serotonergic 5-HT2 receptor,,H,,B,,CHEMBL617185,,BAO_0000357,
2241,,17005,,,1,,,Autocuration,10321,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617186,,BAO_0000357,
2242,,17005,,,1,,,Autocuration,12918,Compound was evaluated for the binding affinity at 5- HT2 receptor,,H,,B,,CHEMBL617187,,BAO_0000357,
2243,,17005,,,1,,,Autocuration,15120,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617188,,BAO_0000357,
2244,,17005,,,1,,,Autocuration,2613,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617189,,BAO_0000218,
2245,Homo sapiens,104784,,,1,,,Autocuration,13378,Inhibitory activity against cloned human 5-HT2 receptor,,D,,B,,CHEMBL617190,,BAO_0000224,
2246,Homo sapiens,104784,,,1,,,Autocuration,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",,D,CHO,B,,CHEMBL617191,449.0,BAO_0000219,
2247,Homo sapiens,104784,,,1,,,Autocuration,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",,D,CHO,B,,CHEMBL617192,449.0,BAO_0000219,
2248,Homo sapiens,104784,,,1,,,Autocuration,2331,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",,D,CHO,B,,CHEMBL617193,449.0,BAO_0000219,
2249,Homo sapiens,104784,,,1,,,Autocuration,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",,D,CHO,B,,CHEMBL617194,449.0,BAO_0000219,
2250,,104784,,,1,,,Autocuration,4170,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617195,,BAO_0000224,
2251,,104784,,,1,,,Autocuration,15453,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,H,,B,,CHEMBL881830,,BAO_0000224,
2252,,17005,,,1,,,Autocuration,1479,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617196,,BAO_0000357,
2253,,104686,,,1,,,Autocuration,11139,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,,H,,B,,CHEMBL617197,,BAO_0000224,
2254,,17005,,,1,,,Expert,13969,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617198,,BAO_0000357,
2255,,17005,,,1,,,Expert,13392,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL873476,,BAO_0000357,
2256,,17005,,,1,,,Expert,14430,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,,H,,B,,CHEMBL617199,,BAO_0000019,
2257,Cavia porcellus,107,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617200,,BAO_0000357,
2258,,51,,,1,,,Autocuration,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,,B,,CHEMBL617484,,BAO_0000357,
2259,,107,,,1,,,Autocuration,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,,B,,CHEMBL617485,,BAO_0000357,
2260,,51,,,1,,,Autocuration,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,,B,,CHEMBL617486,,BAO_0000357,
2261,,107,,,1,,,Autocuration,13463,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,,H,,B,,CHEMBL858022,,BAO_0000357,
2262,,107,,,1,,,Autocuration,6347,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,H,CHO,B,,CHEMBL617049,449.0,BAO_0000219,
2263,Homo sapiens,107,,,1,,,Expert,6857,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,,D,CHO,F,,CHEMBL617050,449.0,BAO_0000219,
2264,,107,,,1,,,Autocuration,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,H,,F,,CHEMBL617051,,BAO_0000219,
2265,,107,,,1,,,Autocuration,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,,H,,F,,CHEMBL617052,,BAO_0000219,
2266,,107,,,1,,,Autocuration,4176,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,H,,F,,CHEMBL617053,,BAO_0000219,
2267,,107,,,1,,,Autocuration,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",,H,CHO,B,,CHEMBL617054,449.0,BAO_0000219,
2268,,107,,,1,,,Autocuration,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",,H,CHO,B,,CHEMBL617055,449.0,BAO_0000219,
2269,,107,,,1,,,Autocuration,15331,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,,H,,B,,CHEMBL882924,,BAO_0000357,
2270,Homo sapiens,107,,,1,,,Expert,16146,Inhibition of human 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617056,,BAO_0000357,
2271,,107,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL617057,449.0,BAO_0000219,
2272,,107,,,1,,,Expert,13631,Inhibitory concentration against human 5-HT2A receptor in BEK cells,,H,,B,,CHEMBL617058,,BAO_0000219,
2273,,107,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),,H,,B,,CHEMBL617059,,BAO_0000357,
2274,,107,,,1,,,Autocuration,4011,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,,H,CHO,B,,CHEMBL617060,449.0,BAO_0000219,
2275,,107,,,1,,,Expert,4012,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,,H,CHO,B,,CHEMBL617061,449.0,BAO_0000219,
2276,,107,,,1,,,Expert,6366,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,,H,L929,B,,CHEMBL617062,307.0,BAO_0000219,
2277,,107,,,1,,,Expert,15949,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL617063,449.0,BAO_0000219,
2278,,107,,,1,,,Autocuration,14093,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,,H,,F,,CHEMBL617064,,BAO_0000019,
2279,,107,,,1,,,Autocuration,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,,F,,CHEMBL617065,,BAO_0000019,
2280,,107,,,1,,,Autocuration,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,H,CHO,B,,CHEMBL617066,449.0,BAO_0000219,
2281,,107,,,1,,,Autocuration,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,,H,CHO,B,,CHEMBL617067,449.0,BAO_0000219,
2282,,107,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,,H,,F,,CHEMBL617068,,BAO_0000019,
2283,,107,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,,H,,F,,CHEMBL617069,,BAO_0000019,
2284,,107,,,1,,,Autocuration,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,,F,,CHEMBL617070,,BAO_0000019,
2285,,107,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,,H,,B,,CHEMBL617071,,BAO_0000357,
2286,,107,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL872915,,BAO_0000357,
2287,,107,,,1,,,Autocuration,14755,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,,H,,B,,CHEMBL617072,,BAO_0000357,
2288,,107,,,1,,,Autocuration,16441,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,,H,,B,,CHEMBL617073,,BAO_0000357,
2289,,107,,,1,,,Autocuration,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,,H,,B,,CHEMBL617074,,BAO_0000357,
2290,,107,,,1,,,Expert,16659,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL617075,449.0,BAO_0000219,
2291,,107,,,1,,,Autocuration,3307,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617076,,BAO_0000357,
2292,Homo sapiens,107,,,1,,,Expert,6857,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,,D,,B,,CHEMBL617077,,BAO_0000019,
2293,,107,,,1,,,Expert,5635,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,,H,,B,,CHEMBL617078,,BAO_0000357,
2294,Homo sapiens,107,,,1,,,Expert,4234,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617079,,BAO_0000357,
2295,,107,,,1,,,Autocuration,15527,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL617080,,BAO_0000357,
2296,,107,,,1,,,Expert,6588,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,,H,CHO,B,,CHEMBL617081,449.0,BAO_0000219,
2297,,107,,,1,,,Expert,13631,Binding affinity towards human 5-HT2A receptor in BEK cells,,H,,B,,CHEMBL617082,,BAO_0000219,
2298,,107,,,1,,,Autocuration,17723,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617083,,BAO_0000357,
2299,,107,,,1,,,Autocuration,14770,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,H,,B,,CHEMBL617084,,BAO_0000357,
2300,Homo sapiens,107,,,1,,,Expert,16293,Binding affinity for human 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617085,,BAO_0000357,
2301,,107,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,,B,,CHEMBL617086,,BAO_0000357,
2302,,107,,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,,H,,B,,CHEMBL617087,,BAO_0000219,
2303,,107,,,1,,,Autocuration,15363,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617088,,BAO_0000357,
2304,,107,,,1,,,Autocuration,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617089,,BAO_0000357,
2305,,107,,,1,,,Expert,16441,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",,H,,B,,CHEMBL617090,,BAO_0000019,
2306,,107,,,1,,,Autocuration,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617513,,BAO_0000357,
2307,,107,,,1,,,Autocuration,4176,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL617514,722.0,BAO_0000219,
2308,,107,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617515,,BAO_0000019,
2309,,107,,,1,,,Autocuration,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,H,,B,,CHEMBL617516,,BAO_0000357,
2310,Homo sapiens,107,,,1,,,Expert,17200,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,D,,B,,CHEMBL617517,,BAO_0000357,
2311,Homo sapiens,107,,,1,,,Expert,4013,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,,D,CHO,B,,CHEMBL617518,449.0,BAO_0000219,
2312,,107,,,1,,,Autocuration,5088,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617519,,BAO_0000357,
2313,Homo sapiens,107,,,1,,,Expert,5088,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617520,,BAO_0000357,
2314,,107,,,1,,,Autocuration,5088,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,,H,,B,,CHEMBL617521,,BAO_0000357,
2315,Homo sapiens,107,,,1,,,Expert,5088,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617522,,BAO_0000357,
2316,,107,,,1,,,Autocuration,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL617523,,BAO_0000357,
2317,,107,,,1,,,Autocuration,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,,B,,CHEMBL617524,,BAO_0000357,
2318,,104686,,,1,,,Autocuration,9786,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,,H,,B,,CHEMBL617525,,BAO_0000019,
2319,Rattus norvegicus,104686,,,1,,,Autocuration,9205,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,,D,,B,,CHEMBL617526,,BAO_0000019,
2320,,104686,,,1,,,Autocuration,11257,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,,H,,B,,CHEMBL617527,,BAO_0000224,
2321,,104686,,,1,,,Autocuration,9362,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,H,,B,,CHEMBL617528,,BAO_0000019,
2322,,104686,,,1,,,Autocuration,9362,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,H,,B,,CHEMBL617529,,BAO_0000019,
2323,,104686,,,1,,,Autocuration,10590,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,,H,,B,,CHEMBL617530,,BAO_0000224,
2324,,104686,,,1,,,Autocuration,10468,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,H,,B,,CHEMBL617531,,BAO_0000019,
2325,,104686,,,1,,,Autocuration,13050,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,,H,,B,,CHEMBL617532,,BAO_0000019,
2326,,104686,,,1,,,Autocuration,11624,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617533,,BAO_0000019,
2327,,104686,,,1,,,Autocuration,10468,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,H,,B,,CHEMBL617534,,BAO_0000019,
2328,,104686,,,1,,,Autocuration,10330,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617535,,BAO_0000224,
2329,,104686,,,1,,,Autocuration,10062,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,H,,B,,CHEMBL617536,,BAO_0000224,
2330,,104686,,,1,,,Autocuration,11642,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617537,,BAO_0000224,
2331,,104686,,,1,,,Autocuration,10062,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617538,,BAO_0000224,
2332,,104686,,,1,In vitro,,Autocuration,13427,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,H,,B,,CHEMBL617539,,BAO_0000219,
2333,Rattus norvegicus,104686,,,1,,,Autocuration,12280,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617540,,BAO_0000224,
2334,Rattus norvegicus,104686,,,1,,,Autocuration,4101,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,,D,,B,,CHEMBL617541,,BAO_0000224,
2335,,104686,,,1,,,Autocuration,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617542,,BAO_0000224,
2336,,104686,,,1,,,Autocuration,11147,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,,H,,B,,CHEMBL617543,,BAO_0000224,
2337,Rattus norvegicus,104686,,,1,,,Autocuration,2395,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,D,CHO-K1,B,,CHEMBL617544,485.0,BAO_0000219,
2338,Rattus norvegicus,104686,,,1,,,Autocuration,2395,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,,D,CHO-K1,B,,CHEMBL617545,485.0,BAO_0000219,
2339,Rattus norvegicus,104686,,,1,,,Autocuration,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,,D,,B,,CHEMBL617413,,BAO_0000019,
2340,,104686,,,1,,,Autocuration,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,,H,,B,,CHEMBL617414,,BAO_0000019,
2341,Rattus norvegicus,104686,,,1,,,Autocuration,9098,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,,D,,B,,CHEMBL617415,,BAO_0000019,
2342,,104686,,,1,,,Autocuration,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617416,,BAO_0000224,
2343,,104686,,,1,,,Autocuration,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,H,,B,,CHEMBL617417,,BAO_0000224,
2344,,104686,,,1,,,Autocuration,9699,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",,H,,B,,CHEMBL617418,,BAO_0000019,
2345,,104686,,,1,,,Autocuration,9699,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,,H,,B,,CHEMBL617419,,BAO_0000019,
2346,,104686,,,1,,,Autocuration,9098,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,H,,B,,CHEMBL617420,,BAO_0000224,
2347,Rattus norvegicus,104686,,,1,,,Autocuration,3070,Affinity for 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617421,,BAO_0000224,
2348,,104686,,,1,,,Autocuration,9547,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,,H,,B,,CHEMBL617422,,BAO_0000224,
2349,,104686,,,1,,,Autocuration,10444,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,,H,,B,,CHEMBL617423,,BAO_0000019,
2350,,104686,,,1,,,Autocuration,14617,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,,H,,B,,CHEMBL617424,,BAO_0000019,
2351,,104686,,,1,,,Autocuration,14617,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,,H,,B,,CHEMBL617425,,BAO_0000019,
2352,,104686,,,1,,,Autocuration,11130,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),,H,,B,,CHEMBL617426,,BAO_0000224,
2353,,104686,,,1,In vivo,,Autocuration,11130,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),,H,,B,,CHEMBL617427,,BAO_0000218,
2354,,104686,955.0,,1,,,Autocuration,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,,H,,B,,CHEMBL617428,,BAO_0000221,
2355,,104686,,,1,,,Autocuration,2797,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,,H,,B,,CHEMBL617429,,BAO_0000224,
2356,,104686,,,1,,,Autocuration,11332,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,H,,B,,CHEMBL617430,,BAO_0000019,
2357,,104686,,,1,,,Autocuration,11332,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,H,,B,,CHEMBL617431,,BAO_0000019,
2358,,104686,1870.0,,1,,,Autocuration,10752,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,,H,,B,,CHEMBL617432,,BAO_0000019,
2359,,104686,,,1,,,Autocuration,1185,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617433,,BAO_0000224,
2360,,104686,,,1,,,Autocuration,1185,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617434,,BAO_0000224,
2361,Rattus norvegicus,104686,,,1,,,Autocuration,11624,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,,D,,B,,CHEMBL617435,,BAO_0000224,
2362,,104686,,,1,,,Autocuration,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,,H,,B,,CHEMBL617436,,BAO_0000019,
2363,Rattus norvegicus,104686,2435.0,,1,,,Autocuration,15453,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,,D,,B,,CHEMBL617437,,BAO_0000019,
2364,,104686,,,1,,,Autocuration,11662,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,H,,B,,CHEMBL617438,,BAO_0000019,
2365,,104686,,,1,,,Autocuration,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,H,,B,,CHEMBL617439,,BAO_0000019,
2366,,104686,,,1,,,Autocuration,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617440,,BAO_0000224,
2367,,104686,,,1,,,Autocuration,9069,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617441,,BAO_0000224,
2368,Rattus norvegicus,104686,,,1,,,Autocuration,8814,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,,D,,B,,CHEMBL872918,,BAO_0000019,
2369,Rattus norvegicus,104686,,,1,,,Autocuration,8908,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,,D,,B,,CHEMBL617442,,BAO_0000019,
2370,,104686,,,1,,,Autocuration,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,H,,B,,CHEMBL617443,,BAO_0000019,
2371,,104686,,,1,,,Autocuration,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,,H,,B,,CHEMBL617444,,BAO_0000019,
2372,,104686,,,1,,,Autocuration,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,H,,B,,CHEMBL617445,,BAO_0000019,
2373,,104686,,,1,,,Autocuration,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,,H,,B,,CHEMBL617446,,BAO_0000019,
2374,,104686,,,1,,,Autocuration,9098,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,,H,,B,,CHEMBL617447,,BAO_0000249,
2375,,104686,,,1,,,Autocuration,9098,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,,H,,B,,CHEMBL617448,,BAO_0000019,
2376,,104686,,,1,,,Autocuration,9098,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,,H,,B,,CHEMBL617449,,BAO_0000019,
2377,,104686,,,1,,,Autocuration,9161,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,,H,,B,,CHEMBL617450,,BAO_0000019,
2378,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,,H,,B,,CHEMBL617451,,BAO_0000019,
2379,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,,H,,B,,CHEMBL617452,,BAO_0000019,
2380,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,,H,,B,,CHEMBL617453,,BAO_0000019,
2381,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,,H,,B,,CHEMBL617660,,BAO_0000019,
2382,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,,H,,B,,CHEMBL617661,,BAO_0000019,
2383,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,,H,,B,,CHEMBL617662,,BAO_0000019,
2384,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,,H,,B,,CHEMBL872919,,BAO_0000019,
2385,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,,H,,B,,CHEMBL617663,,BAO_0000019,
2386,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,,H,,B,,CHEMBL617664,,BAO_0000019,
2387,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,,H,,B,,CHEMBL617665,,BAO_0000019,
2388,,104686,,,1,,,Autocuration,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,,H,,B,,CHEMBL617666,,BAO_0000019,
2389,,104686,,,1,,,Autocuration,12094,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,,H,,B,,CHEMBL617667,,BAO_0000019,
2390,,104686,,,1,,,Autocuration,12018,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,,H,,B,,CHEMBL617668,,BAO_0000249,
2391,,104686,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,,H,,B,,CHEMBL617669,,BAO_0000249,
2392,,104686,,,1,,,Autocuration,15260,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617670,,BAO_0000224,
2393,Rattus norvegicus,104686,,,1,,,Autocuration,11624,Inhibitory constant against 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617671,,BAO_0000224,
2394,,104686,,,1,,,Autocuration,13654,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617672,,BAO_0000224,
2395,,104686,,,1,,,Autocuration,9541,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,,H,,B,,CHEMBL617673,,BAO_0000019,
2396,,104686,,,1,,,Autocuration,11933,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617674,,BAO_0000224,
2397,,104686,,,1,,,Autocuration,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,,H,,B,,CHEMBL617675,,BAO_0000019,
2398,,104686,,,1,,,Autocuration,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,,H,,B,,CHEMBL617676,,BAO_0000019,
2399,,104686,,,1,,,Autocuration,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,,H,,B,,CHEMBL617677,,BAO_0000019,
2400,,104686,,,1,,,Autocuration,8841,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617678,,BAO_0000019,
2401,,104686,,,1,,,Autocuration,1455,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,,H,,B,,CHEMBL617679,,BAO_0000224,
2402,,104686,,,1,,,Autocuration,1455,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,,H,,B,,CHEMBL617680,,BAO_0000224,
2403,,104686,,,1,,,Autocuration,11752,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,,H,,B,,CHEMBL617681,,BAO_0000019,
2404,,104686,955.0,,1,,,Autocuration,11642,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,,H,,B,,CHEMBL617682,,BAO_0000221,
2405,,104686,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,,H,,B,,CHEMBL617683,,BAO_0000224,
2406,,104686,,,1,,,Autocuration,3967,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,,H,,B,,CHEMBL617684,,BAO_0000224,
2407,Rattus norvegicus,104686,,,1,,,Autocuration,12771,Binding affinity towards 5-hydroxytryptamine 2 receptor,,D,,B,,CHEMBL617685,,BAO_0000224,
2408,,104686,,,1,,,Autocuration,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,,H,,B,,CHEMBL617686,,BAO_0000019,
2409,,104686,,,1,,,Autocuration,11628,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,,H,,B,,CHEMBL617687,,BAO_0000224,
2410,,104686,,,1,,,Autocuration,13654,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,H,,B,,CHEMBL617688,,BAO_0000224,
2411,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,,F,,CHEMBL617689,,BAO_0000019,
2412,,104686,,,1,,,Autocuration,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,H,,F,,CHEMBL617690,,BAO_0000019,
2413,,104686,,,1,In vivo,,Autocuration,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,H,,F,,CHEMBL617691,,BAO_0000218,
2414,,104686,,,1,In vivo,,Autocuration,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,H,,F,,CHEMBL617692,,BAO_0000218,
2415,,104686,,,1,In vivo,,Autocuration,11200,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,H,,F,,CHEMBL617693,,BAO_0000218,
2416,,104686,,,1,In vivo,,Autocuration,11200,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,H,,F,,CHEMBL617694,,BAO_0000218,
2417,,12687,955.0,,1,,,Expert,15436,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,,H,,B,,CHEMBL857985,,BAO_0000221,
2418,Rattus norvegicus,12687,,,1,,,Expert,15436,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,D,,B,,CHEMBL617695,,BAO_0000019,
2419,,12687,,,1,,,Autocuration,14025,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,,H,,B,,CHEMBL617696,,BAO_0000019,
2420,,12687,,,1,,,Autocuration,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,,H,,B,,CHEMBL617697,,BAO_0000357,
2421,Rattus norvegicus,12687,,,1,,,Expert,13735,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,,D,,B,,CHEMBL617257,,BAO_0000019,
2422,Rattus norvegicus,12687,,,1,,,Expert,5816,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,D,,B,,CHEMBL617258,,BAO_0000357,
2423,,12687,,,1,,,Expert,14287,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,,H,,B,,CHEMBL617259,,BAO_0000019,
2424,,12687,,,1,,,Autocuration,15738,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,,H,,B,,CHEMBL617260,,BAO_0000357,
2425,Rattus norvegicus,12687,,,1,,,Expert,15738,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617261,,BAO_0000357,
2426,,12687,,,1,,,Autocuration,15026,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,,H,,B,,CHEMBL617262,,BAO_0000019,
2427,,12687,,,1,,,Expert,16647,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,H,,B,,CHEMBL617263,,BAO_0000019,
2428,,12687,,,1,,,Autocuration,16647,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,,H,,B,,CHEMBL617264,,BAO_0000019,
2429,Rattus norvegicus,12687,,,1,,,Expert,13345,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617265,,BAO_0000019,
2430,,12687,,,1,,,Autocuration,1543,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,Membranes,H,,B,,CHEMBL617266,,BAO_0000249,
2431,,12687,,,1,,,Autocuration,12444,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,,H,,B,,CHEMBL617267,,BAO_0000019,
2432,,12687,,,1,,,Expert,16404,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,,H,,B,,CHEMBL617268,,BAO_0000019,
2433,,12687,,,1,,,Autocuration,16404,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,H,CHO,B,,CHEMBL617269,449.0,BAO_0000219,
2434,,12687,,,1,,,Expert,15577,Kinetic inhibition constant evaluated by measuring serotonergic activity,,H,,B,,CHEMBL617323,,BAO_0000357,
2435,,12687,,,1,,,Autocuration,15577,Serotonergic activity of the compound.,,H,,B,,CHEMBL617324,,BAO_0000357,
2436,,12687,,,1,,,Autocuration,2495,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,,H,,B,,CHEMBL617325,,BAO_0000249,
2437,Rattus norvegicus,12687,,,1,,,Expert,15042,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,,D,,B,,CHEMBL617326,,BAO_0000019,
2438,,12687,,,1,,,Expert,15026,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,,H,,B,,CHEMBL617327,,BAO_0000249,
2439,Rattus norvegicus,12687,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,,F,,CHEMBL617328,,BAO_0000019,
2440,Rattus norvegicus,12687,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,,F,,CHEMBL617329,,BAO_0000019,
2441,Rattus norvegicus,12687,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,,F,,CHEMBL617330,,BAO_0000019,
2442,,12687,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617331,,BAO_0000357,
2443,,12687,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL617332,,BAO_0000357,
2444,,107,,,1,,,Expert,4820,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617333,,BAO_0000357,
2445,,107,,,1,,,Autocuration,6736,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,,H,,B,,CHEMBL617334,,BAO_0000357,
2446,,107,,,1,,,Autocuration,5163,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,,H,,B,,CHEMBL617335,,BAO_0000357,
2447,,107,,,1,,,Autocuration,5163,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,,H,,B,,CHEMBL617336,,BAO_0000357,
2448,,107,,,1,,,Autocuration,6011,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,,H,,B,,CHEMBL617337,,BAO_0000357,
2449,Homo sapiens,107,,,1,,,Expert,14294,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,,D,,B,,CHEMBL617338,,BAO_0000357,
2450,,107,,,1,,,Autocuration,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617339,,BAO_0000357,
2451,,107,,,1,,,Expert,17066,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617340,,BAO_0000357,
2452,,107,,,1,,,Autocuration,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,,H,,B,,CHEMBL617341,,BAO_0000357,
2453,,107,,,1,,,Expert,6736,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617342,,BAO_0000357,
2454,,107,,,1,,,Expert,5163,Affinity for 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617343,,BAO_0000357,
2455,,107,,,1,,,Expert,16911,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,,H,NIH3T3,B,,CHEMBL617344,723.0,BAO_0000219,
2456,,107,,,1,,,Expert,6841,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,H,,B,,CHEMBL617345,,BAO_0000357,
2457,,107,,,1,,,Expert,6119,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,,H,,B,,CHEMBL617346,,BAO_0000357,
2458,,107,,,1,,,Autocuration,3962,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617347,,BAO_0000357,
2459,,107,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,,H,,B,,CHEMBL617348,,BAO_0000357,
2460,,107,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,,H,,B,,CHEMBL617349,,BAO_0000357,
2461,,107,,,1,,,Autocuration,3962,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,,H,,F,,CHEMBL617350,,BAO_0000019,
2462,,107,,,1,,,Expert,1633,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,,H,,B,,CHEMBL872339,,BAO_0000357,
2463,,107,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,,H,,B,,CHEMBL617351,,BAO_0000357,
2464,,107,,,1,,,Expert,6576,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617352,,BAO_0000357,
2465,,107,,,1,,,Autocuration,4687,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617353,,BAO_0000357,
2466,,107,,,1,,,Autocuration,16946,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617354,,BAO_0000357,
2467,,107,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617355,,BAO_0000357,
2468,Mus musculus,107,,,1,,,Expert,3032,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,,H,CHO,B,,CHEMBL617356,449.0,BAO_0000219,
2469,,107,,,1,,,Autocuration,16655,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617357,,BAO_0000357,
2470,,107,,,1,,,Autocuration,13964,Binding affinity at 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617358,,BAO_0000357,
2471,,107,,,1,,,Expert,16989,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617359,,BAO_0000357,
2472,,107,,,1,,,Autocuration,16117,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,,H,,B,,CHEMBL617360,,BAO_0000357,
2473,,107,,,1,,,Autocuration,16700,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,,H,,B,,CHEMBL875913,,BAO_0000357,
2474,,107,,,1,,,Autocuration,3269,Affinity against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617361,,BAO_0000357,
2475,Homo sapiens,107,,,1,,,Expert,1274,Binding affinity against 5-Hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617362,,BAO_0000357,
2476,,107,,,1,,,Autocuration,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,,H,,B,,CHEMBL617363,,BAO_0000357,
2477,,107,,,1,,,Autocuration,12146,Tested against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617364,,BAO_0000357,
2478,,105075,,,1,,,Autocuration,12652,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,H,,B,,CHEMBL617365,,BAO_0000224,
2479,,105075,,,1,,,Autocuration,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,,H,,B,,CHEMBL617366,,BAO_0000224,
2480,,105075,,,1,,,Autocuration,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,,H,,B,,CHEMBL617367,,BAO_0000224,
2481,,105075,,,1,,,Autocuration,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,H,,B,,CHEMBL617368,,BAO_0000224,
2482,,107,,,1,,,Autocuration,16647,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),,H,,B,,CHEMBL617369,,BAO_0000357,
2483,Homo sapiens,227,,,1,,,Expert,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,,D,HEK293,B,,CHEMBL617370,722.0,BAO_0000219,
2484,Homo sapiens,227,,,1,,,Expert,6857,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,,D,CHO,F,,CHEMBL617371,449.0,BAO_0000219,
2485,,227,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),,H,,B,,CHEMBL617372,,BAO_0000357,
2486,Homo sapiens,227,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,,D,,B,,CHEMBL617373,,BAO_0000357,
2487,,227,,,1,,,Autocuration,14093,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,,H,,F,,CHEMBL617374,,BAO_0000019,
2488,,227,,,1,,,Autocuration,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,,H,,F,,CHEMBL617375,,BAO_0000019,
2489,,227,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,,H,,F,,CHEMBL617376,,BAO_0000019,
2490,,227,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,,H,,F,,CHEMBL617377,,BAO_0000019,
2491,,227,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,,H,,F,,CHEMBL617378,,BAO_0000019,
2492,,227,,,1,,,Autocuration,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,H,,F,,CHEMBL617379,,BAO_0000019,
2493,,227,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,,H,,B,,CHEMBL617380,,BAO_0000357,
2494,,227,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,,H,,B,,CHEMBL617381,,BAO_0000357,
2495,,227,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,H,,B,,CHEMBL617382,,BAO_0000357,
2496,,107,,,1,,,Autocuration,12369,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617383,,BAO_0000357,
2497,,107,,,1,,,Expert,12369,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,,H,,B,,CHEMBL617384,,BAO_0000357,
2498,,107,,,1,,,Expert,12369,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,,H,,B,,CHEMBL617385,,BAO_0000357,
2499,,107,,,1,,,Autocuration,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,,H,,B,,CHEMBL617386,,BAO_0000019,
2500,,107,,,1,,,Autocuration,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,,H,,B,,CHEMBL617387,,BAO_0000019,
2501,,107,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,NIH3T3,B,,CHEMBL617388,723.0,BAO_0000219,
2502,,107,,,1,,,Autocuration,6857,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,H,CHO,F,,CHEMBL617389,449.0,BAO_0000219,
2503,Homo sapiens,107,,,1,,,Expert,6857,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,CHO,F,,CHEMBL617390,449.0,BAO_0000219,
2504,,104817,,,1,,,Autocuration,5635,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,,H,,B,,CHEMBL617391,,BAO_0000224,
2505,,107,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL617392,,BAO_0000357,
2506,,107,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,H,,B,,CHEMBL617393,,BAO_0000019,
2507,,107,,,1,,,Autocuration,5105,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,H,L929,B,,CHEMBL617394,307.0,BAO_0000219,
2508,,107,,,1,,,Expert,5104,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,H,L929,B,,CHEMBL617395,307.0,BAO_0000219,
2509,,107,,,1,,,Expert,5105,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,,H,L929,B,,CHEMBL617396,307.0,BAO_0000219,
2510,,107,,,1,,,Autocuration,5105,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,,H,L929,B,,CHEMBL617397,307.0,BAO_0000219,
2511,,107,,,1,,,Autocuration,5254,Binding affinity against 5-HT2A receptor,,H,,B,,CHEMBL617398,,BAO_0000357,
2512,,107,,,1,,,Autocuration,5254,Binding affinity against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617399,,BAO_0000357,
2513,,107,,,1,,,Autocuration,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL617400,722.0,BAO_0000219,
2514,,107,,,1,,,Autocuration,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,H,HEK293,B,,CHEMBL617401,722.0,BAO_0000219,
2515,Homo sapiens,107,,,1,,,Expert,14157,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,,D,HEK293,B,,CHEMBL617402,722.0,BAO_0000219,
2516,Homo sapiens,107,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,HEK293,B,,CHEMBL617403,722.0,BAO_0000219,
2517,,107,,,1,,,Expert,14068,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,,H,,B,,CHEMBL617404,,BAO_0000357,
2518,Homo sapiens,107,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,HEK293,B,,CHEMBL857981,722.0,BAO_0000219,
2519,Homo sapiens,107,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,HEK293,B,,CHEMBL617405,722.0,BAO_0000219,
2520,Homo sapiens,107,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,,D,HEK293,B,,CHEMBL617253,722.0,BAO_0000219,
2521,,107,,,1,,,Expert,6166,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,,H,,B,,CHEMBL617254,,BAO_0000357,
2522,,107,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL617255,722.0,BAO_0000219,
2523,,107,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL617256,722.0,BAO_0000219,
2524,,107,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL616874,722.0,BAO_0000219,
2525,Homo sapiens,107,,,1,,,Expert,15779,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,,D,HEK293,B,,CHEMBL616875,722.0,BAO_0000219,
2526,,107,,,1,,,Expert,14391,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,,H,HEK293,B,,CHEMBL616876,722.0,BAO_0000219,
2527,,107,,,1,,,Expert,15851,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",,H,HEK293,B,,CHEMBL616877,722.0,BAO_0000219,
2528,Homo sapiens,107,,,1,,,Expert,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,,D,HEK293,B,,CHEMBL616878,722.0,BAO_0000219,
2529,,107,,,1,,,Expert,3832,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,,H,HEK293,B,,CHEMBL616879,722.0,BAO_0000219,
2530,,107,,,1,,,Expert,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,,H,HEK293,B,,CHEMBL616880,722.0,BAO_0000219,
2531,Homo sapiens,107,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,,D,HEK293,B,,CHEMBL616881,722.0,BAO_0000219,
2532,,107,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,H,NIH3T3,B,,CHEMBL616882,723.0,BAO_0000219,
2533,,107,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,NIH3T3,B,,CHEMBL616883,723.0,BAO_0000219,
2534,,107,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,NIH3T3,B,,CHEMBL616884,723.0,BAO_0000219,
2535,,107,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,,H,HEK293,B,,CHEMBL616885,722.0,BAO_0000219,
2536,,107,,,1,,,Autocuration,1883,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,,H,CHO-K1,B,,CHEMBL616886,485.0,BAO_0000219,
2537,,107,,,1,,,Expert,1883,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL616887,485.0,BAO_0000219,
2538,Homo sapiens,107,,,1,,,Expert,14875,Binding affinity for human 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL616888,,BAO_0000357,
2539,,107,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,,H,HEK293,B,,CHEMBL616889,722.0,BAO_0000219,
2540,,107,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,,H,HEK293,B,,CHEMBL616890,722.0,BAO_0000219,
2541,Homo sapiens,107,,,1,,,Expert,16404,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,D,CHO,B,,CHEMBL616891,449.0,BAO_0000219,
2542,,107,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,,H,HEK293,B,,CHEMBL616892,722.0,BAO_0000219,
2543,,107,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",,H,HEK293,B,,CHEMBL616893,722.0,BAO_0000219,
2544,,10620,,,1,,,Autocuration,12652,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,,H,NIH3T3,F,,CHEMBL616894,723.0,BAO_0000219,
2545,,107,,,1,,,Expert,4682,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,,H,NIH3T3,B,,CHEMBL616895,723.0,BAO_0000219,
2546,,10620,,,1,,,Autocuration,12652,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,,H,,F,,CHEMBL616896,,BAO_0000019,
2547,,10621,,,1,,,Autocuration,4921,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617099,,BAO_0000357,
2548,,10621,,,1,,,Autocuration,4921,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,,H,,B,,CHEMBL617100,,BAO_0000357,
2549,Oryctolagus cuniculus,107,,,1,,,Autocuration,16312,Binding affinity against rabbit aorta 5-HT2A receptor,,H,,B,,CHEMBL884532,,BAO_0000357,
2550,Oryctolagus cuniculus,107,,,1,,,Expert,14998,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,,H,,B,,CHEMBL617101,,BAO_0000357,
2551,Oryctolagus cuniculus,107,,,1,,,Expert,14025,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,,H,,B,,CHEMBL617102,,BAO_0000357,
2552,Oryctolagus cuniculus,107,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,,H,,B,,CHEMBL617103,,BAO_0000019,
2553,Oryctolagus cuniculus,107,,,1,,,Expert,13047,The compound was tested for binding affinity against 5-HT2A receptor,,H,,B,,CHEMBL617104,,BAO_0000357,
2554,,10576,,,1,,,Autocuration,1883,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL857979,485.0,BAO_0000219,
2555,,12687,,,1,,,Autocuration,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein,,H,,B,,CHEMBL857502,,BAO_0000019,
2556,,12687,,,1,,,Autocuration,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,H,,B,,CHEMBL617105,,BAO_0000019,
2557,,12687,945.0,,1,,,Autocuration,13463,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,,H,,B,,CHEMBL858021,,BAO_0000019,
2558,Rattus norvegicus,12687,945.0,,1,,,Expert,13463,Binding affinity for 5-HT 2A in rat stomach fundus,,D,,B,,CHEMBL875910,,BAO_0000019,
2559,,12687,,,1,,,Autocuration,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,H,,B,,CHEMBL617106,,BAO_0000019,
2560,,12687,,,1,,,Expert,16326,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,,H,NIH3T3,B,,CHEMBL617107,723.0,BAO_0000219,
2561,,12687,,,1,,,Autocuration,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,,H,,F,,CHEMBL617108,,BAO_0000019,
2562,,12687,,,1,,,Autocuration,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,,H,,F,,CHEMBL617109,,BAO_0000019,
2563,,12687,,,1,,,Autocuration,15740,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617110,,BAO_0000357,
2564,,12687,,,1,,,Autocuration,16633,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,,H,,B,,CHEMBL617111,,BAO_0000357,
2565,Rattus norvegicus,12687,,,1,,,Expert,17200,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,,D,,F,,CHEMBL617112,,BAO_0000019,
2566,,12687,,,1,,,Autocuration,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617113,,BAO_0000357,
2567,,12687,,,1,,,Autocuration,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617114,,BAO_0000357,
2568,,12687,,,1,,,Autocuration,17133,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617115,,BAO_0000357,
2569,,12687,,,1,,,Autocuration,17200,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,H,,F,,CHEMBL617116,,BAO_0000219,
2570,,12687,,,1,,,Autocuration,15363,Efficacy at 5-hydroxytryptamine 2A receptor,,H,,F,,CHEMBL617117,,BAO_0000019,
2571,,12687,,,1,,,Autocuration,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,H,,B,,CHEMBL617118,,BAO_0000357,
2572,Rattus norvegicus,12687,,,1,,,Expert,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,D,,B,,CHEMBL617119,,BAO_0000357,
2573,Rattus norvegicus,12687,,,1,,,Expert,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),,D,,B,,CHEMBL617120,,BAO_0000357,
2574,Rattus norvegicus,12687,,,1,,,Expert,17200,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,D,,F,,CHEMBL617121,,BAO_0000219,
2575,,12687,,,1,,,Autocuration,17200,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,H,,F,,CHEMBL617122,,BAO_0000219,
2576,,12687,,,1,,,Autocuration,17211,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617123,,BAO_0000019,
2577,,12687,,,1,,,Expert,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,,H,,B,,CHEMBL617124,,BAO_0000019,
2578,,12687,,,1,,,Expert,13565,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,,H,,B,,CHEMBL617600,,BAO_0000249,
2579,,12687,,,1,,,Expert,13730,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,,H,,B,,CHEMBL617601,,BAO_0000357,
2580,,12687,,,1,,,Expert,12416,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,,H,,B,,CHEMBL882923,,BAO_0000019,
2581,,12687,,,1,,,Autocuration,15295,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617602,,BAO_0000357,
2582,,12687,,,1,,,Autocuration,1742,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,,H,,B,,CHEMBL617603,,BAO_0000019,
2583,,12687,,,1,,,Autocuration,15295,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617604,,BAO_0000357,
2584,,12687,,,1,,,Expert,14970,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617605,,BAO_0000019,
2585,,12687,,,1,,,Expert,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617606,,BAO_0000019,
2586,Rattus norvegicus,12687,,,1,,,Expert,14776,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617607,,BAO_0000019,
2587,,12687,,,1,,,Autocuration,14286,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,,B,,CHEMBL617455,,BAO_0000249,
2588,Rattus norvegicus,12687,,,1,,,Expert,17200,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,D,,B,,CHEMBL617456,,BAO_0000019,
2589,,12687,,,1,,,Expert,15306,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),,H,,B,,CHEMBL617457,,BAO_0000357,
2590,Rattus norvegicus,12687,,,1,,,Expert,14178,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617458,,BAO_0000357,
2591,Rattus norvegicus,12687,,,1,,,Expert,14229,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,,D,,B,,CHEMBL617459,,BAO_0000019,
2592,,12687,,,1,,,Expert,12884,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,,H,,B,,CHEMBL617460,,BAO_0000357,
2593,,12687,,,1,,,Expert,13149,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",,H,,B,,CHEMBL617461,,BAO_0000357,
2594,Rattus norvegicus,12687,,,1,,,Expert,15295,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,,D,,B,,CHEMBL617462,,BAO_0000019,
2595,,12687,,,1,,,Autocuration,15740,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,,H,,B,,CHEMBL617463,,BAO_0000357,
2596,,12687,,,1,,,Autocuration,15185,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",,H,,B,,CHEMBL617464,,BAO_0000019,
2597,,12687,,,1,,,Autocuration,15185,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",,H,,B,,CHEMBL617465,,BAO_0000019,
2598,,12687,,,1,,,Expert,17529,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,,H,,B,,CHEMBL617466,,BAO_0000019,
2599,,12687,,,1,,,Autocuration,14826,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,H,,B,,CHEMBL617467,,BAO_0000019,
2600,,12687,,,1,,,Expert,17211,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,,H,,B,,CHEMBL617468,,BAO_0000019,
2601,,12687,,,1,,,Autocuration,14826,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,H,,B,,CHEMBL617469,,BAO_0000019,
2602,,12687,,,1,,,Autocuration,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617470,,BAO_0000019,
2603,,12687,,,1,,,Autocuration,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,,H,,B,,CHEMBL617471,,BAO_0000019,
2604,,12687,,,1,,,Expert,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,,H,NIH3T3,B,,CHEMBL617472,723.0,BAO_0000219,
2605,,12687,,,1,,,Expert,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,,H,,B,,CHEMBL617473,,BAO_0000357,
2606,Rattus norvegicus,12687,,,1,,,Expert,15436,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,D,,B,,CHEMBL617474,,BAO_0000019,
2607,Rattus norvegicus,12687,,,1,,,Expert,15436,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,,D,,B,,CHEMBL617475,,BAO_0000019,
2608,,12687,955.0,,1,,,Autocuration,14442,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,,H,,B,,CHEMBL617476,,BAO_0000221,
2609,,12687,,,1,,,Expert,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617477,,BAO_0000357,
2610,,12687,,,1,,,Expert,12457,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,,H,NIH3T3,B,,CHEMBL617478,723.0,BAO_0000219,
2611,,12687,,,1,,,Autocuration,14755,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",,H,,F,,CHEMBL617479,,BAO_0000221,
2612,,12687,,,1,,,Autocuration,4707,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,,H,,B,,CHEMBL617480,,BAO_0000357,
2613,,12687,,,1,,,Expert,13297,Binding affinity against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617481,,BAO_0000357,
2614,,12687,,,1,,,Expert,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,,H,,B,,CHEMBL617482,,BAO_0000019,
2615,,12687,,,1,,,Autocuration,4664,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617483,,BAO_0000019,
2616,,12687,,,1,,,Autocuration,16633,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,,B,,CHEMBL621528,,BAO_0000357,
2617,Rattus norvegicus,12687,,,1,,,Expert,4664,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,,D,NIH3T3,B,,CHEMBL621529,723.0,BAO_0000219,
2618,,12687,,,1,,,Expert,16133,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,,B,,CHEMBL621530,,BAO_0000357,
2619,,12687,,,1,,,Expert,16133,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL621531,,BAO_0000357,
2620,Rattus norvegicus,12687,,,1,,,Expert,14060,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL621532,,BAO_0000019,
2621,,12687,,,1,,,Expert,16326,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,,B,,CHEMBL621533,,BAO_0000357,
2622,,12687,,,1,,,Expert,16659,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL621534,449.0,BAO_0000219,
2623,,12687,,,1,,,Autocuration,14776,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,,H,,B,,CHEMBL621535,,BAO_0000019,
2624,,12687,,,1,,,Autocuration,13481,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,,H,,B,,CHEMBL621536,,BAO_0000357,
2625,,12687,,,1,,,Autocuration,17386,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL621537,,BAO_0000357,
2626,Rattus norvegicus,12687,,,1,,,Expert,6611,Binding affinity for 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL621538,,BAO_0000357,
2627,,12687,,,1,,,Autocuration,14423,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,,H,,B,,CHEMBL621539,,BAO_0000019,
2628,,12687,,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,,H,,B,,CHEMBL621540,,BAO_0000019,
2629,,12687,,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,,H,,B,,CHEMBL621541,,BAO_0000019,
2630,,12687,,,1,,,Autocuration,6238,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,,H,,B,,CHEMBL621542,,BAO_0000019,
2631,,12687,,,1,,,Expert,6648,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,,H,,B,,CHEMBL621543,,BAO_0000357,
2632,,12687,,,1,,,Expert,5667,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,,H,,B,,CHEMBL621544,,BAO_0000357,
2633,Rattus norvegicus,12687,,,1,,,Expert,6611,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,,D,,B,,CHEMBL621545,,BAO_0000357,
2634,,12687,,,1,,,Autocuration,13481,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL621546,,BAO_0000357,
2635,,12687,,,1,,,Autocuration,13481,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,,H,,B,,CHEMBL621547,,BAO_0000357,
2636,,12687,,,1,,,Expert,15558,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,,H,NIH3T3,B,,CHEMBL618692,723.0,BAO_0000219,
2637,,12687,,,1,,,Autocuration,6013,Binding affinity towards 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL618693,,BAO_0000357,
2638,,12687,,,1,,,Autocuration,16633,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,H,,B,,CHEMBL872922,,BAO_0000357,
2639,,12687,,,1,,,Autocuration,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,,H,,B,,CHEMBL618694,,BAO_0000357,
2640,Rattus norvegicus,12687,,,1,,,Expert,6013,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,,D,,B,,CHEMBL618695,,BAO_0000357,
2641,,12687,,,1,,,Autocuration,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,,H,,B,,CHEMBL618696,,BAO_0000357,
2642,,12687,,,1,,,Expert,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,,H,,B,,CHEMBL618697,,BAO_0000357,
2643,,12687,,,1,,,Autocuration,6013,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,,H,,B,,CHEMBL618892,,BAO_0000357,
2644,,12687,,,1,,,Autocuration,6013,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,,H,,B,,CHEMBL618893,,BAO_0000357,
2645,,12687,,,1,,,Autocuration,16293,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL618894,,BAO_0000357,
2646,,12687,,,1,,,Expert,17175,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,,H,NIH3T3,B,,CHEMBL618895,723.0,BAO_0000219,
2647,Rattus norvegicus,12687,,,1,,,Expert,13278,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,,D,,B,,CHEMBL618896,,BAO_0000357,
2648,,12687,5383.0,,1,,,Autocuration,3682,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,,H,,B,,CHEMBL618897,,BAO_0000019,
2649,,12687,,,1,,,Autocuration,2014,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,,H,,B,,CHEMBL618898,,BAO_0000357,
2650,,12687,,,1,,,Autocuration,2014,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,,H,,B,,CHEMBL618899,,BAO_0000357,
2651,,12687,,,1,,,Autocuration,4932,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,,H,,B,,CHEMBL618900,,BAO_0000357,
2652,,12687,,,1,,,Autocuration,4932,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,,H,,B,,CHEMBL618901,,BAO_0000019,
2653,,12687,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL618902,,BAO_0000357,
2654,Rattus norvegicus,12687,10000000.0,,1,,,Expert,5432,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL618903,,BAO_0000221,
2655,,12687,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL618904,,BAO_0000357,
2656,,12687,,,1,,,Autocuration,13672,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,,H,,B,,CHEMBL618905,,BAO_0000357,
2657,,12687,,,1,,,Autocuration,13672,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,,H,,B,,CHEMBL618906,,BAO_0000357,
2658,,12687,,,1,,,Expert,14749,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,,H,NIH3T3,B,,CHEMBL618907,723.0,BAO_0000219,
2659,,12687,,,1,,,Autocuration,13462,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,,H,,B,,CHEMBL618908,,BAO_0000019,
2660,,12687,,,1,,,Autocuration,15740,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617909,,BAO_0000357,
2661,,12687,,,1,,,Expert,16647,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,H,,B,,CHEMBL617910,,BAO_0000019,
2662,,12687,955.0,,1,,,Autocuration,13345,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,,H,,B,,CHEMBL617911,,BAO_0000221,
2663,,12687,,,1,,,Autocuration,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,,B,,CHEMBL872923,,BAO_0000249,
2664,,12687,,,1,,,Autocuration,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,,B,,CHEMBL617912,,BAO_0000249,
2665,Rattus norvegicus,12687,,,1,,,Expert,15535,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,,D,,B,,CHEMBL617913,,BAO_0000019,
2666,,12687,,,1,,,Expert,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,,B,,CHEMBL617914,,BAO_0000249,
2667,,12687,,,1,,,Autocuration,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,,B,,CHEMBL617915,,BAO_0000249,
2668,,12687,,,1,,,Autocuration,16740,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,,H,,B,,CHEMBL617916,,BAO_0000249,
2669,Rattus norvegicus,12687,,,1,,,Expert,4795,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,,D,,B,,CHEMBL617917,,BAO_0000019,
2670,,12687,,,1,,,Expert,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617918,,BAO_0000019,
2671,,12687,,,1,,,Autocuration,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,,H,,B,,CHEMBL617919,,BAO_0000019,
2672,Rattus norvegicus,12687,,,1,,,Expert,17200,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,,D,,B,,CHEMBL617920,,BAO_0000019,
2673,Rattus norvegicus,12687,,,1,,,Expert,2148,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,,D,,B,,CHEMBL617921,,BAO_0000019,
2674,Rattus norvegicus,105102,,,1,,,Expert,13345,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",,D,,B,,CHEMBL617922,,BAO_0000224,
2675,,12687,,,1,,,Autocuration,5088,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,H,,B,,CHEMBL617923,,BAO_0000357,
2676,,12687,,,1,,,Autocuration,5088,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,H,,B,,CHEMBL617924,,BAO_0000357,
2677,,12687,,,1,,,Autocuration,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,,H,,B,,CHEMBL617925,,BAO_0000357,
2678,Rattus norvegicus,12687,,,1,,,Expert,17133,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,,D,,B,,CHEMBL617926,,BAO_0000357,
2679,,12687,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,,H,,B,,CHEMBL617927,,BAO_0000357,
2680,,12687,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,,H,,B,,CHEMBL617928,,BAO_0000357,
2681,Rattus norvegicus,12687,,,1,,,Expert,2309,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,,D,,B,,CHEMBL617929,,BAO_0000019,
2682,,12687,,,1,,,Expert,12953,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,,H,,B,,CHEMBL617930,,BAO_0000019,
2683,,12687,,,1,,,Autocuration,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,,H,,B,,CHEMBL617931,,BAO_0000019,
2684,,12687,,,1,,,Autocuration,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,,H,,B,,CHEMBL617932,,BAO_0000019,
2685,,12687,,,1,,,Autocuration,16659,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,,H,CHO,B,,CHEMBL617933,449.0,BAO_0000219,
2686,,12687,,,1,,,Autocuration,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,H,,B,,CHEMBL617934,,BAO_0000019,
2687,,12687,,,1,,,Autocuration,16740,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,H,,B,,CHEMBL617935,,BAO_0000019,
2688,,12687,,,1,,,Autocuration,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,,H,,B,,CHEMBL617936,,BAO_0000357,
2689,,12687,,,1,,,Autocuration,17211,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,,H,,B,,CHEMBL617937,,BAO_0000019,
2690,,12687,,,1,,,Autocuration,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,,H,,B,,CHEMBL617938,,BAO_0000019,
2691,,12687,,,1,,,Autocuration,16633,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,,H,,B,,CHEMBL617939,,BAO_0000218,
2692,,12687,,,1,,,Autocuration,16633,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,,H,,B,,CHEMBL617940,,BAO_0000218,
2693,,12687,,,1,,,Autocuration,16633,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,,H,,B,,CHEMBL617941,,BAO_0000218,
2694,,12687,,,1,,,Expert,15026,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,,H,,B,,CHEMBL617942,,BAO_0000357,
2695,,12687,,,1,,,Expert,15026,Ratio of pKi of 5-HT2A to that of D2 receptor,,H,,B,,CHEMBL617943,,BAO_0000357,
2696,,105093,,,1,,,Expert,16404,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617944,,BAO_0000224,
2697,,105093,,,1,,,Expert,16404,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617945,,BAO_0000224,
2698,,105075,,,1,,,Expert,16404,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617946,,BAO_0000224,
2699,,12687,,,1,,,Autocuration,16404,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,,H,,B,,CHEMBL617947,,BAO_0000357,
2700,,12687,,,1,,,Expert,16326,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,,H,,B,,CHEMBL617948,,BAO_0000357,
2701,,12687,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,,H,,F,,CHEMBL858116,,BAO_0000019,
2702,,12687,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,,H,,F,,CHEMBL617949,,BAO_0000019,
2703,,12687,,,1,,,Autocuration,15329,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,,H,,F,,CHEMBL617950,,BAO_0000019,
2704,,12687,1515.0,,1,,,Expert,16404,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,,H,,F,,CHEMBL617951,,BAO_0000019,
2705,,12687,1515.0,,1,,,Expert,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,,H,,F,,CHEMBL617952,,BAO_0000019,
2706,,12687,1515.0,,1,,,Autocuration,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,,H,,F,,CHEMBL617953,,BAO_0000019,
2707,,12687,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL617954,,BAO_0000357,
2708,,12687,,,1,,,Expert,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,H,,B,,CHEMBL617955,,BAO_0000019,
2709,,12687,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,H,,B,,CHEMBL857071,,BAO_0000019,
2710,,12687,,,1,,,Expert,12490,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,,H,,B,,CHEMBL617270,,BAO_0000019,
2711,,12687,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,,H,N1E-115,B,,CHEMBL617271,339.0,BAO_0000219,
2712,,12687,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,,H,N1E-115,B,,CHEMBL617272,339.0,BAO_0000219,
2713,,12687,,,1,,,Autocuration,12918,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,,H,,B,,CHEMBL617273,,BAO_0000019,
2714,Rattus norvegicus,12687,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,,D,,F,,CHEMBL617274,,BAO_0000019,
2715,,108,,,1,,,Autocuration,17723,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617275,,BAO_0000357,
2716,,108,,,1,,,Autocuration,6013,Binding affinity towards 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617276,,BAO_0000357,
2717,,108,,,1,,,Autocuration,16293,Binding affinity towards human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617277,,BAO_0000357,
2718,,108,,,1,,,Expert,3857,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617278,,BAO_0000019,
2719,,108,,,1,,,Expert,3857,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,,H,,B,,CHEMBL617279,,BAO_0000019,
2720,,108,,,1,,,Expert,3857,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617280,,BAO_0000019,
2721,,108,,,1,,,Autocuration,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617281,,BAO_0000357,
2722,,108,,,1,,,Autocuration,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617282,,BAO_0000357,
2723,,108,,,1,,,Expert,16441,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,,H,,B,,CHEMBL617283,,BAO_0000019,
2724,,108,,,1,,,Expert,16441,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,,H,,B,,CHEMBL617284,,BAO_0000019,
2725,,108,,,1,,,Autocuration,4176,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,,H,HEK293,B,,CHEMBL617285,722.0,BAO_0000219,
2726,,108,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617286,,BAO_0000019,
2727,Homo sapiens,108,,,1,,,Expert,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,,D,,B,,CHEMBL617287,,BAO_0000357,
2728,,108,,,1,,,Expert,5088,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,,H,,B,,CHEMBL617288,,BAO_0000357,
2729,,108,,,1,,,Autocuration,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,,H,,B,,CHEMBL617289,,BAO_0000357,
2730,,108,,,1,,,Autocuration,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,,B,,CHEMBL872917,,BAO_0000357,
2731,,108,,,1,,,Autocuration,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL617290,,BAO_0000357,
2732,,108,,,1,,,Autocuration,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL617291,449.0,BAO_0000219,
2733,,108,,,1,,,Autocuration,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,,H,CHO,B,,CHEMBL617292,449.0,BAO_0000219,
2734,,108,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,H,NIH3T3,B,,CHEMBL617293,723.0,BAO_0000219,
2735,Homo sapiens,108,,,1,,,Expert,6857,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,CHO,F,,CHEMBL617294,449.0,BAO_0000219,
2736,,108,,,1,,,Expert,3857,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,H,,B,,CHEMBL617295,,BAO_0000019,
2737,,108,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL617296,,BAO_0000357,
2738,,108,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,H,,B,,CHEMBL617297,,BAO_0000019,
2739,,108,,,1,,,Expert,5104,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,,H,CHO,B,,CHEMBL617298,449.0,BAO_0000219,
2740,,108,,,1,,,Expert,5105,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,,H,CHO,B,,CHEMBL617299,449.0,BAO_0000219,
2741,,108,,,1,,,Autocuration,5105,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,,H,CHO,B,,CHEMBL617300,449.0,BAO_0000219,
2742,,108,,,1,,,Autocuration,5254,Binding affinity against 5-HT2C receptor,,H,,B,,CHEMBL617454,,BAO_0000357,
2743,,108,,,1,,,Autocuration,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,H,HEK293,B,,CHEMBL617505,722.0,BAO_0000219,
2744,Homo sapiens,108,,,1,,,Expert,14157,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,,D,HEK293,B,,CHEMBL617506,722.0,BAO_0000219,
2745,Homo sapiens,108,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,,D,HEK293,B,,CHEMBL617507,722.0,BAO_0000219,
2746,,108,,,1,,,Expert,14068,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,,H,,B,,CHEMBL617508,,BAO_0000357,
2747,Homo sapiens,108,,,1,,,Expert,12936,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,,D,HEK293,B,,CHEMBL857982,722.0,BAO_0000219,
2748,Homo sapiens,108,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,,D,HEK293,B,,CHEMBL617509,722.0,BAO_0000219,
2749,Homo sapiens,108,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,,D,HEK293,B,,CHEMBL617510,722.0,BAO_0000219,
2750,,108,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,,H,,B,,CHEMBL617511,,BAO_0000357,
2751,,108,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,,H,HEK293,B,,CHEMBL617512,722.0,BAO_0000219,
2752,,108,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,,H,HEK293,B,,CHEMBL617749,722.0,BAO_0000219,
2753,,108,,,1,,,Autocuration,15779,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,HEK293,B,,CHEMBL617750,722.0,BAO_0000219,
2754,,108,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,HEK293,B,,CHEMBL617751,722.0,BAO_0000219,
2755,,108,,,1,,,Expert,14391,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,,H,HEK293,B,,CHEMBL617752,722.0,BAO_0000219,
2756,,108,,,1,,,Autocuration,15779,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",,H,HEK293,B,,CHEMBL617753,722.0,BAO_0000219,
2757,,108,,,1,,,Expert,15851,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",,H,HEK293,B,,CHEMBL617754,722.0,BAO_0000219,
2758,Homo sapiens,108,,,1,,,Expert,15851,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,,D,HEK293,B,,CHEMBL617755,722.0,BAO_0000219,
2759,,108,,,1,,,Autocuration,15779,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",,H,HEK293,B,,CHEMBL617756,722.0,BAO_0000219,
2760,,108,,,1,,,Expert,3832,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,,H,HEK293,B,,CHEMBL617757,722.0,BAO_0000219,
2761,,108,,,1,,,Expert,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,,H,HEK293,B,,CHEMBL617758,722.0,BAO_0000219,
2762,,108,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,H,NIH3T3,B,,CHEMBL617759,723.0,BAO_0000219,
2763,,108,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,,H,HEK293,B,,CHEMBL617760,722.0,BAO_0000219,
2764,,108,,,1,,,Expert,1883,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,,H,CHO-K1,B,,CHEMBL617761,485.0,BAO_0000219,
2765,Homo sapiens,108,,,1,,,Expert,4321,Binding affinity against 5-hydroxytryptamine 2C receptor,,D,,B,,CHEMBL617762,,BAO_0000357,
2766,,108,,,1,,,Autocuration,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617763,,BAO_0000357,
2767,,108,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,,H,HEK293,B,,CHEMBL857983,722.0,BAO_0000219,
2768,,108,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,,H,HEK293,B,,CHEMBL617764,722.0,BAO_0000219,
2769,,108,,,1,,,Autocuration,16404,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,,H,HeLa,B,,CHEMBL617765,308.0,BAO_0000219,
2770,,108,,,1,,,Autocuration,13267,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,,H,,F,,CHEMBL617766,,BAO_0000019,
2771,,108,10000000.0,,1,,,Autocuration,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,,H,,F,,CHEMBL617767,,BAO_0000221,
2772,,108,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,,H,HEK293,B,,CHEMBL617768,722.0,BAO_0000219,
2773,,108,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",,H,HEK293,B,,CHEMBL617769,722.0,BAO_0000219,
2774,,11864,,,1,,,Autocuration,13463,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,,H,,B,,CHEMBL858023,,BAO_0000357,
2775,,11864,945.0,,1,,,Autocuration,13463,Binding affinity analysed on 5-HT 2C in rat stomach fundus,,H,,B,,CHEMBL617770,,BAO_0000019,
2776,,11864,945.0,,1,,,Autocuration,13463,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,,H,,B,,CHEMBL617771,,BAO_0000019,
2777,,11864,,,1,,,Autocuration,12652,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,,H,A9,F,,CHEMBL617772,625.0,BAO_0000219,
2778,,11864,,,1,,,Autocuration,4682,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,H,NIH3T3,B,,CHEMBL617773,723.0,BAO_0000219,
2779,,11864,,,1,,,Autocuration,4682,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,,H,NIH3T3,B,,CHEMBL617850,723.0,BAO_0000219,
2780,,11864,,,1,,,Autocuration,4682,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,H,NIH3T3,B,,CHEMBL617851,723.0,BAO_0000219,
2781,,11864,,,1,,,Autocuration,12652,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,,H,,F,,CHEMBL617852,,BAO_0000019,
2782,Mus musculus,12689,945.0,,1,,,Autocuration,13463,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,,H,,B,,CHEMBL858024,,BAO_0000019,
2783,Rattus norvegicus,12689,945.0,,1,,,Expert,13463,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,,D,,B,,CHEMBL617853,,BAO_0000019,
2784,,108,,,1,,,Expert,13969,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,,H,,B,,CHEMBL617854,,BAO_0000357,
2785,Sus scrofa,108,,,1,,,Expert,13392,Binding affinity for 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL873477,,BAO_0000357,
2786,,108,,,1,,,Expert,13392,Binding affinity towards 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617855,,BAO_0000357,
2787,,108,,,1,,,Expert,14430,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,,H,,B,,CHEMBL617856,,BAO_0000019,
2788,,108,,,1,,,Autocuration,1742,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,,H,,B,,CHEMBL617857,,BAO_0000019,
2789,,108,,,1,,,Autocuration,14286,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,,H,,B,,CHEMBL617858,,BAO_0000249,
2790,,108,,,1,,,Autocuration,5619,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617859,,BAO_0000357,
2791,,108,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617860,,BAO_0000357,
2792,,108,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL617861,,BAO_0000357,
2793,,108,,,1,,,Expert,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,H,,B,,CHEMBL617862,,BAO_0000019,
2794,,108,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,H,,B,,CHEMBL617863,,BAO_0000019,
2795,,108,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,,H,,B,,CHEMBL617864,,BAO_0000249,
2796,,108,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,,H,,B,,CHEMBL617649,,BAO_0000249,
2797,Sus scrofa,108,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,H,,F,,CHEMBL617650,,BAO_0000019,
2798,Sus scrofa,108,,,1,,,Expert,12919,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,,H,,F,,CHEMBL617651,,BAO_0000019,
2799,Sus scrofa,108,,,1,,,Autocuration,16429,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,,H,,B,,CHEMBL617652,,BAO_0000357,
2800,Sus scrofa,108,,,1,,,Autocuration,773,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,,H,,B,,CHEMBL857072,,BAO_0000019,
2801,Sus scrofa,108,,,1,,,Autocuration,5033,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617653,,BAO_0000357,
2802,,12687,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,H,,B,,CHEMBL617654,,BAO_0000019,
2803,,12689,,,1,,,Autocuration,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,,H,,F,,CHEMBL617655,,BAO_0000019,
2804,,12689,,,1,,,Expert,14970,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,,H,,B,,CHEMBL617656,,BAO_0000357,
2805,,12689,,,1,,,Autocuration,14970,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,,H,,B,,CHEMBL617657,,BAO_0000357,
2806,,12689,,,1,,,Autocuration,14970,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,,H,,B,,CHEMBL617658,,BAO_0000357,
2807,Rattus norvegicus,12689,,,1,,,Expert,14178,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,,D,,B,,CHEMBL617659,,BAO_0000357,
2808,Rattus norvegicus,12689,,,1,,,Expert,14178,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,,D,,B,,CHEMBL617838,,BAO_0000357,
2809,Rattus norvegicus,12689,,,1,,,Expert,14229,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,Brain membranes,D,,B,,CHEMBL617839,,BAO_0000249,
2810,,12689,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,,H,,B,,CHEMBL617840,,BAO_0000357,
2811,,12689,,,1,,,Autocuration,14826,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,,H,,B,,CHEMBL617841,,BAO_0000019,
2812,,12689,,,1,,,Autocuration,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,,H,,B,,CHEMBL875915,,BAO_0000019,
2813,,12689,,,1,In vitro,,Expert,17211,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,,H,,B,,CHEMBL617842,,BAO_0000219,
2814,,12689,,,1,,,Expert,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,,H,NIH3T3,B,,CHEMBL617843,723.0,BAO_0000219,
2815,,12689,,,1,,,Expert,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,,H,,B,,CHEMBL617844,,BAO_0000357,
2816,,12689,,,1,,,Expert,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617845,,BAO_0000357,
2817,,12689,,,1,,,Expert,12457,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,,H,NIH3T3,B,,CHEMBL617846,723.0,BAO_0000219,
2818,,12689,,,1,,,Autocuration,4707,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,,H,,B,,CHEMBL617847,,BAO_0000357,
2819,,12689,,,1,,,Expert,13297,Binding affinity against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617848,,BAO_0000357,
2820,,12689,,,1,,,Autocuration,16633,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,H,,B,,CHEMBL617849,,BAO_0000357,
2821,,12689,,,1,,,Expert,16133,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,,B,,CHEMBL621507,,BAO_0000357,
2822,,12689,,,1,,,Expert,16326,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,,H,,B,,CHEMBL621508,,BAO_0000357,
2823,,12689,,,1,,,Autocuration,14423,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,,H,,B,,CHEMBL621509,,BAO_0000019,
2824,,12689,,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,,H,,B,,CHEMBL621510,,BAO_0000019,
2825,,12689,,,1,,,Autocuration,15412,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,,H,,B,,CHEMBL621511,,BAO_0000019,
2826,,12689,,,1,,,Expert,15558,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,,H,A9,B,,CHEMBL621512,625.0,BAO_0000219,
2827,,12689,,,1,,,Autocuration,16633,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,H,,B,,CHEMBL621513,,BAO_0000357,
2828,,12689,,,1,,,Expert,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,,H,,B,,CHEMBL621514,,BAO_0000357,
2829,,12689,,,1,In vitro,,Expert,17175,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,,H,,B,,CHEMBL621515,,BAO_0000219,
2830,,12689,,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,,H,,B,,CHEMBL621516,,BAO_0000219,
2831,,12689,5383.0,,1,,,Autocuration,3682,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,,H,,B,,CHEMBL621517,,BAO_0000019,
2832,,12689,,,1,,,Autocuration,4932,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,,H,,B,,CHEMBL621518,,BAO_0000357,
2833,,12689,,,1,,,Autocuration,4932,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,,H,,B,,CHEMBL621519,,BAO_0000019,
2834,,12689,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL621520,,BAO_0000357,
2835,,12689,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL621521,,BAO_0000357,
2836,,12689,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL621522,,BAO_0000357,
2837,,12689,,,1,,,Expert,14749,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,,H,,B,,CHEMBL621523,,BAO_0000219,
2838,,12689,,,1,,,Autocuration,15740,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL621524,,BAO_0000357,
2839,Rattus norvegicus,12689,,,1,,,Expert,17133,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,,D,,B,,CHEMBL621525,,BAO_0000357,
2840,,12689,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,,H,,B,,CHEMBL872921,,BAO_0000357,
2841,,12689,,,1,,,Autocuration,12369,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL621526,,BAO_0000357,
2842,,12689,,,1,,,Expert,12369,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,,H,,B,,CHEMBL621527,,BAO_0000219,
2843,Rattus norvegicus,12689,,,1,,,Expert,2309,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,,D,,B,,CHEMBL617865,,BAO_0000019,
2844,,12689,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617866,,BAO_0000357,
2845,,12689,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,,H,,B,,CHEMBL617867,,BAO_0000019,
2846,,12689,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,,H,,B,,CHEMBL617487,,BAO_0000357,
2847,,12689,,,1,,,Expert,12953,Binding affinity for 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617488,,BAO_0000357,
2848,,12689,,,1,,,Autocuration,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,,H,,B,,CHEMBL617489,,BAO_0000357,
2849,,12689,,,1,,,Autocuration,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,,H,,B,,CHEMBL617490,,BAO_0000019,
2850,,12689,,,1,,,Autocuration,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,,H,,B,,CHEMBL617491,,BAO_0000019,
2851,,12689,,,1,,,Autocuration,14025,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,,H,,B,,CHEMBL617492,,BAO_0000019,
2852,,12689,,,1,,,Autocuration,14998,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,,H,,B,,CHEMBL617493,,BAO_0000019,
2853,,12689,,,1,,,Autocuration,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,,H,,B,,CHEMBL617494,,BAO_0000357,
2854,Rattus norvegicus,12689,,,1,,,Expert,13735,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,,D,,B,,CHEMBL617495,,BAO_0000019,
2855,,12689,,,1,,,Autocuration,13181,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL617496,,BAO_0000357,
2856,,12689,,,1,,,Autocuration,1883,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,,H,CHO-K1,B,,CHEMBL617497,485.0,BAO_0000219,
2857,,12689,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,,B,,CHEMBL617498,,BAO_0000357,
2858,,12689,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,,H,,B,,CHEMBL617499,,BAO_0000357,
2859,,12689,,,1,,,Autocuration,14579,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,,H,,F,,CHEMBL617500,,BAO_0000019,
2860,,108,,,1,,,Autocuration,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617501,,BAO_0000357,
2861,,108,,,1,,,Expert,4820,Binding affinity towards 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617502,,BAO_0000357,
2862,,227,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,,H,,B,,CHEMBL617503,,BAO_0000357,
2863,,227,,,1,,,Autocuration,14755,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,,H,,B,,CHEMBL617504,,BAO_0000357,
2864,,227,,,1,,,Autocuration,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,,H,,B,,CHEMBL617406,,BAO_0000357,
2865,Homo sapiens,227,,,1,,,Expert,6857,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,,D,,B,,CHEMBL617407,,BAO_0000019,
2866,,227,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL617408,,BAO_0000357,
2867,,227,,,1,,,Autocuration,15363,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617409,,BAO_0000357,
2868,,227,,,1,,,Autocuration,15363,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617410,,BAO_0000357,
2869,,227,,,1,,,Autocuration,15363,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617411,,BAO_0000357,
2870,,227,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617412,,BAO_0000019,
2871,Homo sapiens,227,,,1,,,Expert,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,,D,,B,,CHEMBL617774,,BAO_0000357,
2872,Homo sapiens,227,,,1,,,Expert,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,,D,HEK293,B,,CHEMBL617775,722.0,BAO_0000219,
2873,Homo sapiens,227,,,1,,,Expert,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,,D,HEK293,B,,CHEMBL617776,722.0,BAO_0000219,
2874,Homo sapiens,227,,,1,,,Expert,6857,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,CHO,F,,CHEMBL617777,449.0,BAO_0000219,
2875,Homo sapiens,227,,,1,,,Expert,6857,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,D,CHO,F,,CHEMBL617778,449.0,BAO_0000219,
2876,,227,,,1,,,Autocuration,15779,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,H,HEK293,B,,CHEMBL617779,722.0,BAO_0000219,
2877,,227,,,1,,,Expert,15851,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,,H,HEK293,B,,CHEMBL617780,722.0,BAO_0000219,
2878,,227,,,1,,,Autocuration,15779,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",,H,HEK293,B,,CHEMBL617781,722.0,BAO_0000219,
2879,Homo sapiens,227,,,1,,,Expert,14157,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,,D,HEK293,B,,CHEMBL617782,722.0,BAO_0000219,
2880,Homo sapiens,227,,,1,,,Expert,4540,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,,D,HEK293,B,,CHEMBL617783,722.0,BAO_0000219,
2881,,227,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,,H,,B,,CHEMBL617784,,BAO_0000357,
2882,,227,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,,H,HEK293,B,,CHEMBL617785,722.0,BAO_0000219,
2883,,227,,,1,,,Expert,14391,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,,H,HEK293,B,,CHEMBL857984,722.0,BAO_0000219,
2884,,227,,,1,,,Expert,3832,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,,H,HEK293,B,,CHEMBL617786,722.0,BAO_0000219,
2885,,227,,,1,,,Expert,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,,H,HEK293,B,,CHEMBL617787,722.0,BAO_0000219,
2886,Homo sapiens,227,,,1,,,Expert,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,,D,HEK293,B,,CHEMBL617788,722.0,BAO_0000219,
2887,Homo sapiens,227,,,1,,,Expert,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,,D,HEK293,B,,CHEMBL617789,722.0,BAO_0000219,
2888,,227,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,,H,HEK293,B,,CHEMBL617790,722.0,BAO_0000219,
2889,,227,,,1,,,Expert,1883,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,,H,CHO-K1,B,,CHEMBL617791,485.0,BAO_0000219,
2890,,227,,,1,,,Expert,4321,Binding affinity against 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617608,,BAO_0000357,
2891,,227,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,,H,HEK293,B,,CHEMBL617609,722.0,BAO_0000219,
2892,,227,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,,H,HEK293,B,,CHEMBL617610,722.0,BAO_0000219,
2893,,227,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,,H,HEK293,B,,CHEMBL617611,722.0,BAO_0000219,
2894,,227,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,H,HEK293,B,,CHEMBL617612,722.0,BAO_0000219,
2895,,227,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,H,HEK293,B,,CHEMBL617613,722.0,BAO_0000219,
2896,Oryctolagus cuniculus,227,,,1,,,Autocuration,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,,H,,B,,CHEMBL617614,,BAO_0000019,
2897,,12688,945.0,,1,,,Expert,13463,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,,H,,B,,CHEMBL617615,,BAO_0000019,
2898,,12688,945.0,,1,,,Expert,7259,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,,H,,B,,CHEMBL858114,,BAO_0000357,
2899,,12688,945.0,,1,,,Autocuration,7259,Affinity against serotonergic receptor in the isolated rat stomach fundus,,H,,B,,CHEMBL617616,,BAO_0000357,
2900,Rattus norvegicus,12688,945.0,,1,,,Expert,7185,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,,D,,F,,CHEMBL617617,,BAO_0000019,
2901,Rattus norvegicus,12688,,,1,,,Expert,7185,Antagonistic against 5-hydroxytryptamine 2B receptor,,D,,F,,CHEMBL875914,,BAO_0000019,
2902,,12688,945.0,,1,,,Autocuration,13267,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,,H,,F,,CHEMBL617618,,BAO_0000019,
2903,Rattus norvegicus,12688,945.0,,1,,,Expert,13735,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,,D,,B,,CHEMBL617619,,BAO_0000357,
2904,,12688,,,1,,,Autocuration,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,,H,,F,,CHEMBL617620,,BAO_0000019,
2905,,12688,,,1,,,Autocuration,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,,H,,F,,CHEMBL617621,,BAO_0000019,
2906,,12688,,,1,,,Autocuration,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,,H,,F,,CHEMBL617622,,BAO_0000019,
2907,Rattus norvegicus,12688,945.0,,1,,,Expert,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,,B,,CHEMBL617623,,BAO_0000357,
2908,Rattus norvegicus,12688,945.0,,1,,,Expert,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,,B,,CHEMBL617624,,BAO_0000357,
2909,Rattus norvegicus,12688,945.0,,1,,,Expert,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,,B,,CHEMBL617625,,BAO_0000357,
2910,Rattus norvegicus,12688,945.0,,1,,,Expert,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,,D,,B,,CHEMBL617626,,BAO_0000357,
2911,,12688,945.0,,1,,,Autocuration,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,H,,F,,CHEMBL617627,,BAO_0000019,
2912,,12688,945.0,,1,,,Expert,16404,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,H,,F,,CHEMBL617628,,BAO_0000019,
2913,,12688,945.0,,1,,,Autocuration,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,,H,,F,,CHEMBL617629,,BAO_0000019,
2914,,12688,945.0,,1,,,Autocuration,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,,H,,F,,CHEMBL858115,,BAO_0000019,
2915,Rattus norvegicus,12688,945.0,,1,,,Expert,16404,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,,D,,F,,CHEMBL617630,,BAO_0000019,
2916,,12688,1515.0,,1,,,Autocuration,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,,H,,F,,CHEMBL617631,,BAO_0000019,
2917,,12688,,,1,,,Autocuration,7483,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,H,,B,,CHEMBL617632,,BAO_0000357,
2918,,12688,,,1,,,Expert,7483,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,,H,,B,,CHEMBL617633,,BAO_0000357,
2919,,12688,,,1,,,Autocuration,7483,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,H,,B,,CHEMBL617634,,BAO_0000357,
2920,,12688,,,1,,,Autocuration,7483,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,,H,,B,,CHEMBL617635,,BAO_0000357,
2922,Rattus norvegicus,12688,945.0,,1,,,Autocuration,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,D,,F,,CHEMBL617637,,BAO_0000019,
2923,,227,,,1,,,Autocuration,6347,Binding affinity against 5-hydroxytryptamine 1A receptor,,H,,B,,CHEMBL617638,,BAO_0000357,
2924,,227,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,,H,,B,,CHEMBL617639,,BAO_0000357,
2925,,227,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,,H,,B,,CHEMBL617640,,BAO_0000357,
2926,,227,,,1,,,Autocuration,4687,Evaluated for the binding affinity to 5-HT 2B receptor,,H,,B,,CHEMBL617641,,BAO_0000357,
2927,,227,,,1,,,Autocuration,16946,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617642,,BAO_0000357,
2928,,227,,,1,,,Autocuration,16633,Binding affinities against 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617643,,BAO_0000357,
2929,,227,,,1,,,Autocuration,16633,Binding affinities towards 5-hydroxytryptamine 2B receptor,,H,,B,,CHEMBL617644,,BAO_0000357,
2930,,227,,,1,,,Autocuration,16633,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,,H,,B,,CHEMBL617645,,BAO_0000357,
2931,,108,,,1,,,Expert,15026,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,H,,B,,CHEMBL617646,,BAO_0000357,
2932,Bos taurus,108,,,1,,,Autocuration,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,H,,B,,CHEMBL617647,,BAO_0000357,
2933,Bos taurus,108,,,1,,,Autocuration,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,,H,,B,,CHEMBL617648,,BAO_0000357,
2934,Bos taurus,108,,,1,,,Autocuration,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,,H,,B,,CHEMBL617875,,BAO_0000357,
2935,Bos taurus,108,,,1,,,Autocuration,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,,H,,B,,CHEMBL617876,,BAO_0000357,
2936,Bos taurus,108,,,1,,,Expert,16404,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,,H,,B,,CHEMBL617877,,BAO_0000357,
2937,Bos taurus,108,,,1,,,Expert,15026,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,H,,B,,CHEMBL617878,,BAO_0000357,
2938,Bos taurus,108,,,1,,,Autocuration,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,,H,,B,,CHEMBL617879,,BAO_0000357,
2939,Cavia porcellus,108,,,1,,,Autocuration,16312,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,,H,,B,,CHEMBL617880,,BAO_0000019,
2940,Cavia porcellus,20033,2435.0,,1,,,Intermediate,5486,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,,D,,B,,CHEMBL617881,,BAO_0000357,
2941,,51,,,1,,,Autocuration,5254,Binding affinity against 5-HT1A receptor,,H,,B,,CHEMBL857073,,BAO_0000357,
2942,,108,,,1,,,Expert,3857,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,,H,CHO,F,,CHEMBL617882,449.0,BAO_0000219,
2943,Homo sapiens,108,,,1,,,Expert,6857,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,,D,CHO,F,,CHEMBL617883,449.0,BAO_0000219,
2944,,108,,,1,,,Autocuration,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,,H,,F,,CHEMBL617884,,BAO_0000219,
2945,,108,,,1,,,Autocuration,6347,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,,H,CHO,B,,CHEMBL617885,449.0,BAO_0000219,
2946,,108,,,1,,,Autocuration,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",,H,CHO,B,,CHEMBL617886,449.0,BAO_0000219,
2947,Homo sapiens,108,,,1,,,Expert,16146,Inhibition of human 5-hydroxytryptamine 2C receptor,,D,,B,,CHEMBL617887,,BAO_0000357,
2948,,108,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),,H,,B,,CHEMBL617888,,BAO_0000357,
2949,,108,,,1,,,Autocuration,3857,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,H,,B,,CHEMBL617889,,BAO_0000019,
2950,,108,,,1,,,Autocuration,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL617890,,BAO_0000357,
2951,,108,,,1,,,Autocuration,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,H,,B,,CHEMBL617891,,BAO_0000357,
2952,,108,,,1,,,Autocuration,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,H,,B,,CHEMBL617892,,BAO_0000357,
2953,,108,,,1,,,Expert,4012,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,,H,CHO,B,,CHEMBL617893,449.0,BAO_0000219,
2954,,108,,,1,,,Expert,6366,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,,H,CHO,B,,CHEMBL617894,449.0,BAO_0000219,
2955,,108,,,1,,,Expert,15949,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL617895,449.0,BAO_0000219,
2956,,108,,,1,,,Autocuration,17211,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,,H,CHO,B,,CHEMBL617896,449.0,BAO_0000219,
2957,Homo sapiens,108,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,,D,,B,,CHEMBL617897,,BAO_0000357,
2958,,108,,,1,,,Autocuration,14093,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,,H,,F,,CHEMBL617898,,BAO_0000019,
2959,,108,,,1,,,Autocuration,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,H,,F,,CHEMBL617899,,BAO_0000019,
2960,Rattus norvegicus,108,,,1,,,Expert,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,,H,CHO,B,,CHEMBL617900,449.0,BAO_0000219,
2961,,108,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,,H,,F,,CHEMBL617901,,BAO_0000019,
2962,,108,,,1,,,Autocuration,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,,H,,F,,CHEMBL617902,,BAO_0000019,
2963,,108,,,1,,,Autocuration,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,,F,,CHEMBL617903,,BAO_0000019,
2964,,108,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,,H,,B,,CHEMBL617904,,BAO_0000357,
2965,,108,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,,H,,B,,CHEMBL617905,,BAO_0000357,
2966,,108,,,1,,,Autocuration,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,,H,,B,,CHEMBL617906,,BAO_0000357,
2967,,108,,,1,,,Autocuration,14755,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,,H,,B,,CHEMBL617907,,BAO_0000357,
2968,,108,,,1,,,Autocuration,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,,H,,B,,CHEMBL617908,,BAO_0000357,
2969,,108,,,1,,,Expert,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL620617,449.0,BAO_0000219,
2970,Homo sapiens,108,,,1,,,Expert,6857,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,,D,,B,,CHEMBL620618,,BAO_0000019,
2971,,108,,,1,,,Expert,5635,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,,H,,B,,CHEMBL620619,,BAO_0000357,
2972,Homo sapiens,108,,,1,,,Expert,4234,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,,D,,B,,CHEMBL620620,,BAO_0000357,
2973,,108,,,1,,,Autocuration,16209,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,,H,,B,,CHEMBL620621,,BAO_0000357,
2974,Rattus norvegicus,104698,,,1,,,Autocuration,5778,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,Membranes,D,,B,,CHEMBL872920,,BAO_0000249,
2975,,104698,,,1,,,Autocuration,5094,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,,H,,B,,CHEMBL620622,,BAO_0000223,
2976,Rattus norvegicus,104698,,,1,,,Autocuration,809,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,,D,,B,,CHEMBL620623,,BAO_0000019,
2977,,104698,,,1,,,Autocuration,1578,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,,H,,B,,CHEMBL620624,,BAO_0000019,
2978,,104698,,,1,,,Autocuration,809,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,,H,,B,,CHEMBL620625,,BAO_0000019,
2979,,104698,,,1,,,Autocuration,12469,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,,H,,B,,CHEMBL620626,,BAO_0000219,
2980,,104698,,,1,,,Autocuration,14290,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,,H,,B,,CHEMBL621307,,BAO_0000019,
2981,,104698,,,1,,,Autocuration,14290,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,,H,,B,,CHEMBL621308,,BAO_0000019,
2982,,104698,,,1,,,Autocuration,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,,H,,B,,CHEMBL621309,,BAO_0000223,
2983,,104698,,,1,,,Autocuration,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,,H,,B,,CHEMBL621310,,BAO_0000223,
2984,,104698,,,1,,,Autocuration,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,,H,,B,,CHEMBL621311,,BAO_0000223,
2985,,104698,,,1,,,Autocuration,15253,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,H,,B,,CHEMBL621502,,BAO_0000249,
2986,,104698,,,1,,,Autocuration,15253,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,H,,B,,CHEMBL621503,,BAO_0000249,
2987,,104698,,,1,,,Autocuration,11683,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,Membranes,H,,B,,CHEMBL621504,,BAO_0000249,
2988,,104698,,,1,,,Autocuration,12092,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL621505,,BAO_0000223,
2989,,104698,,,1,,,Autocuration,1946,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,H,,B,,CHEMBL621506,,BAO_0000019,
2990,,104698,,,1,,,Autocuration,11623,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,,H,,B,,CHEMBL619781,,BAO_0000223,
2991,,104698,,,1,,,Autocuration,11623,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,,H,,B,,CHEMBL619782,,BAO_0000223,
2992,,104698,,,1,,,Autocuration,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,,H,,B,,CHEMBL619783,,BAO_0000019,
2993,Rattus norvegicus,104698,,,1,,,Autocuration,5432,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,,D,,B,,CHEMBL619784,,BAO_0000019,
2994,,104698,,,1,,,Autocuration,14826,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,H,,B,,CHEMBL619785,,BAO_0000249,
2995,,104698,,,1,,,Autocuration,2222,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL619786,,BAO_0000223,
2996,,104698,,,1,,,Autocuration,11963,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,,H,,B,,CHEMBL619787,,BAO_0000019,
2997,,104698,,,1,,,Autocuration,14145,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,,H,,B,,CHEMBL872925,,BAO_0000019,
2998,,104698,,,1,,,Autocuration,17819,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,,H,,B,,CHEMBL619788,,BAO_0000019,
2999,,104698,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,H,,B,,CHEMBL619789,,BAO_0000249,
3000,,104698,,,1,,,Autocuration,10394,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,H,,B,,CHEMBL619790,,BAO_0000249,
3001,,104698,,,1,,,Autocuration,15034,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,H,,B,,CHEMBL619791,,BAO_0000019,
3002,,104698,,,1,,,Autocuration,691,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,H,,B,,CHEMBL619792,,BAO_0000019,
3003,,104698,,,1,,,Autocuration,12092,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,Membranes,H,,B,,CHEMBL619793,,BAO_0000249,
3004,Rattus norvegicus,104698,,,1,,,Autocuration,11752,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL619794,,BAO_0000223,
3005,,104698,955.0,,1,,,Autocuration,11752,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,,H,,B,,CHEMBL619795,,BAO_0000221,
3006,,104698,,,1,,,Autocuration,301,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,,H,,B,,CHEMBL619796,,BAO_0000019,
3007,,104698,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,,H,,B,,CHEMBL620448,,BAO_0000223,
3008,,104698,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,H,,B,,CHEMBL620449,,BAO_0000223,
3009,,104698,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,,H,,B,,CHEMBL620450,,BAO_0000223,
3010,,104698,,,1,,,Autocuration,11684,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,,H,,B,,CHEMBL620451,,BAO_0000223,
3011,,104698,,,1,,,Autocuration,11684,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,,H,,B,,CHEMBL620631,,BAO_0000223,
3012,,104698,,,1,,,Autocuration,12953,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,,H,,B,,CHEMBL620632,,BAO_0000019,
3013,,104698,,,1,,,Autocuration,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,,H,,B,,CHEMBL620633,,BAO_0000019,
3014,,104698,,,1,,,Autocuration,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,,H,,B,,CHEMBL620634,,BAO_0000223,
3015,,104698,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,H,,B,,CHEMBL620635,,BAO_0000019,
3016,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620636,,BAO_0000218,
3017,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,,H,,F,,CHEMBL620637,,BAO_0000218,
3018,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620638,,BAO_0000218,
3019,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620639,,BAO_0000218,
3020,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620640,,BAO_0000218,
3021,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,,H,,F,,CHEMBL620641,,BAO_0000218,
3022,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620642,,BAO_0000218,
3023,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620643,,BAO_0000218,
3024,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620644,,BAO_0000218,
3025,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620645,,BAO_0000218,
3026,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,,H,,F,,CHEMBL620646,,BAO_0000218,
3027,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620647,,BAO_0000218,
3028,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620648,,BAO_0000218,
3029,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620649,,BAO_0000218,
3030,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,,H,,F,,CHEMBL620650,,BAO_0000218,
3031,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,,H,,F,,CHEMBL620651,,BAO_0000218,
3032,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,,H,,F,,CHEMBL872875,,BAO_0000218,
3033,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,,H,,F,,CHEMBL620652,,BAO_0000218,
3034,,104698,,,1,,,Autocuration,10609,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,,H,,F,,CHEMBL620653,,BAO_0000019,
3035,,104698,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,,H,,B,,CHEMBL857076,,BAO_0000019,
3036,Rattus norvegicus,104698,,,1,,,Autocuration,12861,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL620654,,BAO_0000019,
3037,,104698,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL620655,,BAO_0000223,
3038,,104698,,,1,,,Autocuration,10728,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,Brain membranes,H,,B,,CHEMBL620656,,BAO_0000249,
3039,,104698,,,1,,,Autocuration,10728,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,Brain membranes,H,,B,,CHEMBL620657,,BAO_0000249,
3040,,108,,,1,,,Autocuration,5163,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,,H,,B,,CHEMBL620658,,BAO_0000357,
3041,,108,,,1,,,Autocuration,5163,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,,H,,B,,CHEMBL620659,,BAO_0000357,
3042,,108,,,1,,,Autocuration,6011,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,,H,,B,,CHEMBL620660,,BAO_0000357,
3043,,108,,,1,,,Autocuration,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620661,,BAO_0000357,
3044,,108,,,1,,,Autocuration,5635,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620662,,BAO_0000357,
3045,,108,,,1,,,Expert,5163,Affinity for 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620663,,BAO_0000357,
3046,,108,,,1,,,Autocuration,6841,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,H,,B,,CHEMBL620664,,BAO_0000357,
3047,,108,,,1,,,Expert,6119,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,,H,,B,,CHEMBL620665,,BAO_0000357,
3048,,108,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,,H,,B,,CHEMBL620666,,BAO_0000357,
3049,,108,,,1,,,Autocuration,1633,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,,H,,B,,CHEMBL620667,,BAO_0000357,
3050,,108,,,1,,,Expert,1633,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,,H,,B,,CHEMBL620668,,BAO_0000357,
3051,,108,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,,H,,B,,CHEMBL620669,,BAO_0000357,
3052,,108,,,1,,,Expert,6576,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620670,,BAO_0000357,
3053,,108,,,1,,,Autocuration,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620671,,BAO_0000357,
3054,,108,,,1,,,Autocuration,12146,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,,H,,B,,CHEMBL620672,,BAO_0000357,
3055,,108,,,1,,,Autocuration,12146,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,,H,,B,,CHEMBL620673,,BAO_0000357,
3056,,108,,,1,,,Autocuration,16946,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620674,,BAO_0000357,
3057,,108,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL620675,,BAO_0000357,
3058,,108,,,1,,,Autocuration,16700,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,,H,,B,,CHEMBL620676,,BAO_0000357,
3059,,108,,,1,,,Autocuration,3269,Affinity against 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL621382,,BAO_0000357,
3060,Homo sapiens,108,,,1,,,Expert,1274,Binding affinity against 5-hydroxytryptamine 2C receptor,,D,,B,,CHEMBL621383,,BAO_0000357,
3061,,108,,,1,,,Autocuration,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,,H,,B,,CHEMBL621384,,BAO_0000357,
3062,Bos taurus,144,,,1,,,Autocuration,5834,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,H,,B,,CHEMBL621385,,BAO_0000357,
3063,Bos taurus,144,,,1,,,Autocuration,11147,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,,H,,B,,CHEMBL617989,,BAO_0000357,
3064,Cavia porcellus,104714,,,1,,,Expert,14145,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,,H,,F,,CHEMBL617990,,BAO_0000019,
3065,Cavia porcellus,104714,2116.0,,1,,,Autocuration,10561,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,H,,B,,CHEMBL875085,,BAO_0000221,
3066,Cavia porcellus,104714,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,,H,,F,,CHEMBL617991,,BAO_0000019,
3067,Cavia porcellus,104714,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,,H,,F,,CHEMBL617992,,BAO_0000019,
3068,Cavia porcellus,104714,2116.0,,1,,,Autocuration,10561,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,,H,,B,,CHEMBL617993,,BAO_0000221,
3069,Cavia porcellus,104714,2116.0,,1,,,Autocuration,11454,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,,H,,B,,CHEMBL617994,,BAO_0000221,
3070,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,,H,,F,,CHEMBL617995,,BAO_0000019,
3071,Cavia porcellus,104714,,,1,,,Autocuration,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,,H,,F,,CHEMBL617996,,BAO_0000019,
3072,Cavia porcellus,104714,,,1,,,Autocuration,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,,H,,F,,CHEMBL617997,,BAO_0000019,
3073,Cavia porcellus,104714,,,1,,,Autocuration,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,,H,,F,,CHEMBL617998,,BAO_0000019,
3074,Cavia porcellus,104714,,,1,,,Autocuration,4639,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,,H,,F,,CHEMBL617999,,BAO_0000019,
3075,Cavia porcellus,104714,,,1,,,Autocuration,4639,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,,H,,F,,CHEMBL618000,,BAO_0000019,
3076,Cavia porcellus,104714,2116.0,,1,,,Autocuration,15253,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",,H,,F,,CHEMBL617815,,BAO_0000221,
3077,Cavia porcellus,104714,2116.0,,1,,,Autocuration,15253,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",,H,,F,,CHEMBL617816,,BAO_0000221,
3078,Cavia porcellus,104714,2116.0,,1,,,Autocuration,11963,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,,H,,F,,CHEMBL617817,,BAO_0000221,
3079,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1946,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,,H,,B,,CHEMBL617818,,BAO_0000221,
3080,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1946,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,,H,,B,,CHEMBL617819,,BAO_0000221,
3081,Cavia porcellus,104714,,,1,,,Autocuration,12045,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,,H,,B,,CHEMBL617820,,BAO_0000223,
3082,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,H,,B,,CHEMBL617821,,BAO_0000221,
3083,Cavia porcellus,104714,2116.0,,1,,,Autocuration,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,H,,F,,CHEMBL617822,,BAO_0000221,
3084,Cavia porcellus,104714,2116.0,,1,,,Autocuration,273,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),,H,,F,,CHEMBL617823,,BAO_0000221,
3085,Cavia porcellus,104714,2116.0,,1,,,Autocuration,188,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,,H,,F,,CHEMBL617824,,BAO_0000221,
3086,Cavia porcellus,104714,2116.0,,1,,,Autocuration,12919,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,,H,,F,,CHEMBL617825,,BAO_0000221,
3087,Cavia porcellus,104714,2116.0,,1,,,Autocuration,12918,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,,H,,F,,CHEMBL617826,,BAO_0000221,
3088,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,H,,B,,CHEMBL617827,,BAO_0000221,
3089,Cavia porcellus,104714,2116.0,,1,,,Autocuration,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,H,,F,,CHEMBL617828,,BAO_0000221,
3090,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,,H,,B,,CHEMBL617829,,BAO_0000221,
3091,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,,H,,B,,CHEMBL617830,,BAO_0000221,
3092,Cavia porcellus,104714,2116.0,,1,,,Autocuration,1559,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,,H,,B,,CHEMBL617831,,BAO_0000221,
3093,Cavia porcellus,104714,2116.0,,1,,,Autocuration,14424,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,,H,,B,,CHEMBL617832,,BAO_0000221,
3094,Cavia porcellus,22226,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,,U,,B,,CHEMBL617833,,BAO_0000019,
3095,,51,,,1,,,Autocuration,5486,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,,H,,B,,CHEMBL617834,,BAO_0000357,
3096,Homo sapiens,104714,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,,D,,B,,CHEMBL617835,,BAO_0000223,
3097,,104714,,,1,,,Autocuration,6013,Binding affinity towards 5-HT3 receptor,,H,,B,,CHEMBL617836,,BAO_0000223,
3098,,104714,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL617837,,BAO_0000223,
3099,,104714,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,,H,,B,,CHEMBL620392,,BAO_0000019,
3100,,104714,,,1,,,Autocuration,5104,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL620393,,BAO_0000223,
3101,,104714,,,1,,,Autocuration,5105,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL620394,,BAO_0000223,
3102,,104714,,,1,,,Autocuration,5104,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,,H,,B,,CHEMBL620395,,BAO_0000223,
3103,,22226,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,,U,,B,,CHEMBL620396,,BAO_0000019,
3104,,105030,,,1,,,Expert,13657,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,,H,NG108-15,B,,CHEMBL620582,433.0,BAO_0000219,
3105,,105030,,,1,In vivo,,Autocuration,10369,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",,H,,B,,CHEMBL620583,,BAO_0000218,
3106,,105030,,,1,,,Autocuration,10369,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,H,,B,,CHEMBL620584,,BAO_0000019,
3107,,105030,,,1,,,Autocuration,12918,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,,H,,B,,CHEMBL620585,,BAO_0000224,
3108,,105030,,,1,,,Autocuration,12918,Compound was evaluated for the binding affinity at 5- HT3 receptor,,H,,B,,CHEMBL620586,,BAO_0000224,
3109,,105030,,,1,,,Autocuration,10369,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,H,,B,,CHEMBL620587,,BAO_0000019,
3110,,105030,,,1,,,Autocuration,773,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,H,,B,,CHEMBL620588,,BAO_0000019,
3111,,105030,,,1,,,Autocuration,12918,5-hydroxytryptamine 3 receptor agonism in mouse,,H,,F,,CHEMBL620589,,BAO_0000218,
3112,,105030,,,1,,,Autocuration,10561,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,,H,,B,,CHEMBL620590,,BAO_0000219,
3113,,105030,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,H,,B,,CHEMBL617956,,BAO_0000019,
3114,,105030,,,1,,,Autocuration,12827,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,H,,B,,CHEMBL617957,,BAO_0000019,
3115,,105030,,,1,,,Autocuration,12918,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,,H,,B,,CHEMBL617958,,BAO_0000224,
3116,,105030,,,1,,,Autocuration,273,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,H,,B,,CHEMBL617959,,BAO_0000219,
3117,,105030,,,1,,,Autocuration,273,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,H,,B,,CHEMBL617960,,BAO_0000219,
3118,,105030,,,1,,,Autocuration,10561,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,H,,B,,CHEMBL617961,,BAO_0000224,
3119,,105030,,,1,In vitro,,Autocuration,5033,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,,H,,B,,CHEMBL617962,,BAO_0000219,
3120,,105030,,,1,,,Autocuration,16429,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,,H,N1E-115,B,,CHEMBL617963,339.0,BAO_0000219,
3121,,11765,,,1,,,Autocuration,10322,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,H,,B,,CHEMBL617964,,BAO_0000019,
3122,,11765,,,1,,,Autocuration,14331,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,,H,,B,,CHEMBL617965,,BAO_0000219,
3123,Mus musculus,10630,,,1,,,Autocuration,13462,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,,D,,B,,CHEMBL617966,,BAO_0000357,
3124,,17106,,,1,,,Autocuration,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,H,,B,,CHEMBL857074,,BAO_0000019,
3125,Sus scrofa,144,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL617967,,BAO_0000357,
3126,Sus scrofa,144,,,1,,,Autocuration,12861,Binding activity radioligand.,,H,,B,,CHEMBL617968,,BAO_0000357,
3127,Oryctolagus cuniculus,104714,,,1,,,Autocuration,10561,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,,H,,B,,CHEMBL617969,,BAO_0000223,
3128,Oryctolagus cuniculus,104714,,,1,,,Autocuration,10561,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,H,,B,,CHEMBL617970,,BAO_0000223,
3129,Oryctolagus cuniculus,104714,,,1,,,Autocuration,10561,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,,H,,B,,CHEMBL617971,,BAO_0000223,
3130,Oryctolagus cuniculus,104714,,,1,,,Autocuration,10561,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,H,,B,,CHEMBL617972,,BAO_0000019,
3131,Oryctolagus cuniculus,104714,,,1,,,Autocuration,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,H,,F,,CHEMBL617973,,BAO_0000019,
3132,Oryctolagus cuniculus,104714,,,1,,,Autocuration,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,H,,F,,CHEMBL617974,,BAO_0000019,
3133,Oryctolagus cuniculus,104714,2116.0,,1,,,Autocuration,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),,H,,F,,CHEMBL617975,,BAO_0000221,
3134,Oryctolagus cuniculus,104714,,,1,,,Autocuration,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,H,,F,,CHEMBL617976,,BAO_0000019,
3135,Oryctolagus cuniculus,104714,,,1,,,Autocuration,273,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,H,,F,,CHEMBL617977,,BAO_0000019,
3136,Oryctolagus cuniculus,104714,,,1,,,Autocuration,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),,H,,F,,CHEMBL617978,,BAO_0000019,
3137,Oryctolagus cuniculus,104714,,,1,,,Autocuration,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),,H,,F,,CHEMBL617979,,BAO_0000019,
3138,Oryctolagus cuniculus,104714,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,,H,CHO,B,,CHEMBL617980,449.0,BAO_0000219,
3139,Rattus norvegicus,104698,,,1,,,Autocuration,1650,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL617981,,BAO_0000019,
3140,,12020,,,1,,,Autocuration,16288,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),,H,,B,,CHEMBL617982,,BAO_0000019,
3141,,12020,,,1,,,Autocuration,16288,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),,H,,B,,CHEMBL617983,,BAO_0000357,
3142,Rattus norvegicus,104698,,,1,,,Autocuration,10254,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,,D,,B,,CHEMBL617984,,BAO_0000019,
3143,,104698,,,1,,,Autocuration,14532,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",,H,,B,,CHEMBL617985,,BAO_0000019,
3144,,104698,948.0,,1,In vivo,,Autocuration,13392,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,H,,F,,CHEMBL617986,,BAO_0000218,
3145,,104698,948.0,,1,,,Autocuration,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,H,,F,,CHEMBL617987,,BAO_0000019,
3146,,104698,948.0,,1,,,Autocuration,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,H,,F,,CHEMBL617988,,BAO_0000019,
3147,,104698,948.0,,1,,,Autocuration,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",,H,,F,,CHEMBL617792,,BAO_0000019,
3148,,104698,948.0,,1,,,Autocuration,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,H,,F,,CHEMBL617793,,BAO_0000019,
3149,,104698,,,1,,,Autocuration,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",,H,,F,,CHEMBL617794,,BAO_0000019,
3150,,104698,,,1,,,Autocuration,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,H,,F,,CHEMBL617795,,BAO_0000019,
3151,,104698,,,1,,,Autocuration,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,H,,F,,CHEMBL617796,,BAO_0000019,
3152,,104698,,,1,,,Autocuration,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",,H,,F,,CHEMBL617797,,BAO_0000019,
3153,Rattus norvegicus,104698,,,1,In vivo,,Autocuration,1089,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),,D,,F,,CHEMBL617798,,BAO_0000218,
3154,,104698,,,1,In vivo,,Autocuration,1089,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),,H,,F,,CHEMBL617799,,BAO_0000218,
3155,Rattus norvegicus,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,D,,F,,CHEMBL617800,,BAO_0000218,
3156,Rattus norvegicus,104698,,,1,,,Autocuration,11454,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,,D,,F,,CHEMBL617801,,BAO_0000019,
3157,Rattus norvegicus,104698,,,1,In vivo,,Autocuration,12205,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,,D,,F,,CHEMBL617802,,BAO_0000218,
3158,Rattus norvegicus,104698,,,1,,,Autocuration,1089,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),,D,,F,,CHEMBL617803,,BAO_0000019,
3159,,104698,,,1,,,Autocuration,5094,Binding affinity towards 5-HT3 receptor in rat was evaluated,,H,,B,,CHEMBL617804,,BAO_0000019,
3160,Rattus norvegicus,104698,,,1,,,Autocuration,2622,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL617805,,BAO_0000019,
3161,,104698,,,1,,,Autocuration,245,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL617806,,BAO_0000223,
3162,,104698,,,1,,,Autocuration,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,,H,,B,,CHEMBL617807,,BAO_0000019,
3163,,104698,,,1,,,Autocuration,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,,H,,B,,CHEMBL617808,,BAO_0000019,
3164,,104698,,,1,,,Autocuration,3020,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,,H,,B,,CHEMBL617809,,BAO_0000249,
3165,,104698,,,1,,,Autocuration,1742,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,,H,,B,,CHEMBL617810,,BAO_0000019,
3166,,104698,955.0,,1,,,Autocuration,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,,H,,B,,CHEMBL617811,,BAO_0000249,
3167,,104698,955.0,,1,,,Autocuration,17394,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,,H,,B,,CHEMBL617812,,BAO_0000221,
3168,,104698,,,1,,,Autocuration,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,,H,,B,,CHEMBL617813,,BAO_0000249,
3169,,104698,,,1,,,Autocuration,14286,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,H,,B,,CHEMBL617814,,BAO_0000249,
3170,,104698,,,1,,,Autocuration,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,,H,,B,,CHEMBL617698,,BAO_0000019,
3171,Rattus norvegicus,104698,,,1,,,Autocuration,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,,D,,B,,CHEMBL617699,,BAO_0000019,
3172,Rattus norvegicus,104698,,,1,,,Autocuration,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,,D,,B,,CHEMBL617700,,BAO_0000019,
3173,Rattus norvegicus,104698,,,1,,,Autocuration,14178,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL617701,,BAO_0000223,
3174,,104698,,,1,,,Autocuration,15034,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,H,,B,,CHEMBL617702,,BAO_0000019,
3175,,104698,,,1,,,Autocuration,1089,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",Membranes,H,,B,,CHEMBL617703,,BAO_0000249,
3176,Rattus norvegicus,104698,,,1,,,Autocuration,1089,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,,D,,B,,CHEMBL617704,,BAO_0000019,
3177,,104698,,,1,,,Autocuration,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,H,,B,,CHEMBL617705,,BAO_0000223,
3178,Rattus norvegicus,104698,,,1,,,Autocuration,12801,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL617706,,BAO_0000223,
3179,,104698,,,1,,,Autocuration,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),,H,NG108-15,B,,CHEMBL617707,433.0,BAO_0000219,
3180,,104698,,,1,,,Autocuration,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,,H,NG108-15,B,,CHEMBL617708,433.0,BAO_0000219,
3181,,104698,,,1,,,Autocuration,15194,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,,H,,B,,CHEMBL617709,,BAO_0000019,
3182,,104698,,,1,,,Autocuration,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,,H,,B,,CHEMBL617710,,BAO_0000019,
3183,,104698,,,1,,,Autocuration,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,,H,,B,,CHEMBL882925,,BAO_0000019,
3184,,104698,,,1,,,Autocuration,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,,H,,B,,CHEMBL617711,,BAO_0000019,
3185,,104698,,,1,,,Autocuration,10610,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,,H,,F,,CHEMBL617712,,BAO_0000019,
3186,Rattus norvegicus,104698,,,1,,,Autocuration,10355,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,,D,,F,,CHEMBL617713,,BAO_0000019,
3187,,104698,,,1,,,Autocuration,691,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",,H,,F,,CHEMBL617714,,BAO_0000019,
3188,,104698,,,1,,,Autocuration,10611,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,,H,,F,,CHEMBL617715,,BAO_0000218,
3189,,104698,,,1,In vivo,,Autocuration,12801,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,,H,,F,,CHEMBL617716,,BAO_0000218,
3190,,104698,,,1,,,Autocuration,10609,Inhibition of 5-HT evoked reflex bradycardia in rat.,,H,,F,,CHEMBL617717,,BAO_0000218,
3191,,104698,,,1,In vivo,,Autocuration,11454,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617718,,BAO_0000218,
3192,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617719,,BAO_0000218,
3193,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),,H,,F,,CHEMBL617720,,BAO_0000218,
3194,Rattus norvegicus,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,,D,,F,,CHEMBL617721,,BAO_0000218,
3195,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617722,,BAO_0000218,
3196,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,,H,,F,,CHEMBL617723,,BAO_0000218,
3197,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617724,,BAO_0000218,
3198,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617725,,BAO_0000218,
3199,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617726,,BAO_0000218,
3200,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617727,,BAO_0000218,
3201,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617728,,BAO_0000218,
3202,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617729,,BAO_0000218,
3203,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617730,,BAO_0000218,
3204,,104698,,,1,In vivo,,Autocuration,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617731,,BAO_0000218,
3205,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617732,,BAO_0000218,
3206,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617733,,BAO_0000218,
3207,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617734,,BAO_0000218,
3208,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,,H,,F,,CHEMBL872874,,BAO_0000218,
3209,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,,H,,F,,CHEMBL617735,,BAO_0000218,
3210,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,,H,,F,,CHEMBL617736,,BAO_0000218,
3211,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,,H,,F,,CHEMBL617737,,BAO_0000218,
3212,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,,H,,F,,CHEMBL617738,,BAO_0000218,
3213,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617739,,BAO_0000218,
3214,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617740,,BAO_0000218,
3215,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617741,,BAO_0000218,
3216,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617742,,BAO_0000218,
3217,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617743,,BAO_0000218,
3218,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617744,,BAO_0000218,
3219,,104698,,,1,In vivo,,Autocuration,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,,H,,F,,CHEMBL617745,,BAO_0000218,
3220,,104698,,,1,,,Autocuration,670,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",,H,,F,,CHEMBL617746,,BAO_0000218,
3221,,104698,,,1,,,Autocuration,670,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",,H,,F,,CHEMBL617747,,BAO_0000218,
3222,,104698,,,1,In vivo,,Autocuration,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,,H,,F,,CHEMBL617748,,BAO_0000218,
3223,,104698,,,1,In vivo,,Autocuration,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,,H,,F,,CHEMBL618909,,BAO_0000218,
3224,,104698,,,1,In vivo,,Autocuration,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,,H,,F,,CHEMBL618910,,BAO_0000218,
3225,,104698,,,1,In vivo,,Autocuration,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,,H,,F,,CHEMBL618911,,BAO_0000218,
3226,,104698,,,1,In vivo,,Autocuration,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,,H,,F,,CHEMBL618912,,BAO_0000218,
3227,,104698,,,1,In vivo,,Autocuration,10322,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),,H,,F,,CHEMBL618913,,BAO_0000218,
3228,,104698,,,1,,,Autocuration,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,H,,F,,CHEMBL618914,,BAO_0000019,
3229,,104698,,,1,,,Autocuration,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,H,,F,,CHEMBL618915,,BAO_0000019,
3230,Rattus norvegicus,104698,,,1,,,Autocuration,15412,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL618916,,BAO_0000223,
3231,,104698,,,1,,,Autocuration,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,,H,,F,,CHEMBL618917,,BAO_0000019,
3232,,104698,10000000.0,,1,,,Intermediate,15412,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,,D,,B,,CHEMBL618918,,BAO_0000221,
3233,Rattus norvegicus,104698,,,1,,,Autocuration,15412,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,,D,,B,,CHEMBL618919,,BAO_0000019,
3234,Rattus norvegicus,104698,,,1,,,Autocuration,17394,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL618920,,BAO_0000019,
3235,,104698,,,1,,,Autocuration,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618921,,BAO_0000223,
3236,,104698,,,1,,,Autocuration,12457,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618922,,BAO_0000019,
3237,,104698,,,1,,,Autocuration,12205,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,,H,,B,,CHEMBL618923,,BAO_0000019,
3238,,104698,,,1,,,Autocuration,14532,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,,H,,B,,CHEMBL618924,,BAO_0000019,
3239,,104698,,,1,,,Autocuration,1122,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,,H,,B,,CHEMBL618925,,BAO_0000019,
3240,,104698,,,1,,,Autocuration,5094,Binding affinity towards 5-HT3 receptor in rat was evaluated,,H,,B,,CHEMBL618926,,BAO_0000019,
3241,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,,D,,F,,CHEMBL618927,,BAO_0000221,
3242,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,,D,,F,,CHEMBL618928,,BAO_0000221,
3243,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",,D,,F,,CHEMBL618929,,BAO_0000221,
3244,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",,D,,F,,CHEMBL618930,,BAO_0000221,
3245,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,D,,F,,CHEMBL618931,,BAO_0000221,
3246,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",,D,,F,,CHEMBL619594,,BAO_0000221,
3247,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",,D,,F,,CHEMBL619595,,BAO_0000221,
3248,Cavia porcellus,20033,2116.0,,1,,,Intermediate,13961,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,,D,,F,,CHEMBL619596,,BAO_0000221,
3249,Cavia porcellus,20033,2116.0,,1,,,Intermediate,13961,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,,D,,F,,CHEMBL619755,,BAO_0000221,
3250,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,,D,,F,,CHEMBL619756,,BAO_0000221,
3251,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,,D,,F,,CHEMBL619757,,BAO_0000221,
3252,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,,D,,F,,CHEMBL619758,,BAO_0000221,
3253,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",,D,,F,,CHEMBL619759,,BAO_0000221,
3254,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",,D,,F,,CHEMBL619760,,BAO_0000221,
3255,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",,D,,F,,CHEMBL619761,,BAO_0000221,
3256,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,,D,,F,,CHEMBL619762,,BAO_0000221,
3257,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,D,,F,,CHEMBL619763,,BAO_0000221,
3258,Cavia porcellus,20033,2116.0,,1,,,Intermediate,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",,D,,F,,CHEMBL617868,,BAO_0000221,
3259,Cavia porcellus,20033,,,1,,,Intermediate,15034,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,,D,,B,,CHEMBL617869,,BAO_0000357,
3260,Cavia porcellus,20033,2435.0,,1,,,Intermediate,5094,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,,B,,CHEMBL882926,,BAO_0000249,
3261,Cavia porcellus,20033,2435.0,,1,,,Intermediate,5094,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,,B,,CHEMBL617870,,BAO_0000249,
3262,Cavia porcellus,20033,2435.0,,1,,,Intermediate,5399,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,,D,,B,,CHEMBL617871,,BAO_0000357,
3263,Cavia porcellus,20033,2435.0,,1,,,Intermediate,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,,D,,B,,CHEMBL617872,,BAO_0000357,
3264,Cavia porcellus,20033,2435.0,,1,,,Intermediate,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,D,,B,,CHEMBL617873,,BAO_0000357,
3265,Cavia porcellus,20033,2435.0,,1,,,Intermediate,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,,D,,B,,CHEMBL617874,,BAO_0000357,
3266,Cavia porcellus,20033,2116.0,,1,,,Intermediate,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,,D,,F,,CHEMBL619067,,BAO_0000221,
3267,Cavia porcellus,20033,2116.0,,1,,,Intermediate,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,,D,,F,,CHEMBL619068,,BAO_0000221,
3268,Cavia porcellus,20033,2116.0,,1,,,Intermediate,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,D,,F,,CHEMBL619069,,BAO_0000221,
3269,Cavia porcellus,20033,,,1,,,Intermediate,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,,D,,B,,CHEMBL619070,,BAO_0000357,
3270,Cavia porcellus,20033,,,1,,,Intermediate,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,,D,,B,,CHEMBL619071,,BAO_0000357,
3271,Cavia porcellus,20033,,,1,,,Intermediate,15034,Agonistic activity against 5-hydroxytryptamine 4 receptor,,D,,F,,CHEMBL619072,,BAO_0000019,
3272,Cavia porcellus,20033,,,1,,,Intermediate,15034,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,,D,,F,,CHEMBL619073,,BAO_0000019,
3273,Cavia porcellus,20033,,,1,,,Intermediate,12918,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,,D,,F,,CHEMBL619074,,BAO_0000019,
3274,Cavia porcellus,20033,,,1,,,Intermediate,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,,D,,B,,CHEMBL619075,,BAO_0000357,
3275,Cavia porcellus,20033,2435.0,,1,,,Intermediate,17394,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,,D,,B,,CHEMBL619076,,BAO_0000357,
3276,Cavia porcellus,20033,2435.0,,1,,,Intermediate,15034,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,,D,,B,,CHEMBL619077,,BAO_0000357,
3277,Cavia porcellus,20033,2435.0,,1,,,Intermediate,5094,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,,B,,CHEMBL619078,,BAO_0000249,
3278,Cavia porcellus,20033,2435.0,,1,,,Intermediate,5094,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,,D,,B,,CHEMBL619079,,BAO_0000249,
3279,Cavia porcellus,20033,2116.0,,1,,,Intermediate,17358,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,,D,,B,,CHEMBL619080,,BAO_0000221,
3280,Cavia porcellus,20033,,,1,,,Expert,12953,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,,D,,B,,CHEMBL619081,,BAO_0000357,
3281,Cavia porcellus,20033,,,1,,,Intermediate,12953,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,D,,B,,CHEMBL619082,,BAO_0000357,
3282,Cavia porcellus,20033,,,1,,,Intermediate,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,,D,,B,,CHEMBL619083,,BAO_0000357,
3283,Cavia porcellus,20033,,,1,,,Intermediate,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,,D,,B,,CHEMBL619084,,BAO_0000357,
3284,Cavia porcellus,20033,2116.0,,1,,,Intermediate,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,D,,F,,CHEMBL859397,,BAO_0000221,
3285,Cavia porcellus,20033,2116.0,,1,,,Intermediate,12918,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,,D,,F,,CHEMBL619085,,BAO_0000221,
3286,Cavia porcellus,20033,2116.0,,1,,,Intermediate,12919,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,,D,,F,,CHEMBL619086,,BAO_0000221,
3287,Cavia porcellus,20033,2116.0,,1,,,Intermediate,273,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,,D,,F,,CHEMBL619087,,BAO_0000221,
3288,Cavia porcellus,20033,2116.0,,1,,,Intermediate,273,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,,D,,F,,CHEMBL619088,,BAO_0000221,
3289,Cavia porcellus,20033,,,1,,,Intermediate,13181,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,,D,,B,,CHEMBL619089,,BAO_0000357,
3290,Cavia porcellus,168,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL619090,,BAO_0000357,
3291,Cavia porcellus,20033,,,1,,,Intermediate,15034,Antagonistic activity against 5-hydroxytryptamine 4 receptor,,D,,F,,CHEMBL619091,,BAO_0000019,
3292,Cavia porcellus,20033,,,1,,,Intermediate,5033,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,,D,,B,,CHEMBL619092,,BAO_0000357,
3293,Cavia porcellus,20033,,,1,,,Intermediate,1980,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,,D,,B,,CHEMBL619093,,BAO_0000019,
3294,Cavia porcellus,168,,,1,,,Autocuration,13181,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,,H,HEK293,B,,CHEMBL619094,722.0,BAO_0000219,
3295,Cavia porcellus,20033,,,1,,,Intermediate,14287,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,,D,,B,,CHEMBL619095,,BAO_0000019,
3296,Cavia porcellus,20033,,,1,,,Intermediate,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,,D,,B,,CHEMBL857988,,BAO_0000357,
3297,Cavia porcellus,20033,,,1,,,Intermediate,15316,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,,D,,B,,CHEMBL619096,,BAO_0000357,
3298,Cavia porcellus,20033,2435.0,,1,,,Intermediate,16429,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,,D,,B,,CHEMBL619097,,BAO_0000357,
3299,Cavia porcellus,20033,10000000.0,,1,,,Intermediate,14818,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,,D,,B,,CHEMBL619098,,BAO_0000221,
3300,Cavia porcellus,20033,,,1,,,Intermediate,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,,D,,B,,CHEMBL619751,,BAO_0000357,
3301,Cavia porcellus,20033,,,1,,,Intermediate,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,,D,,B,,CHEMBL619752,,BAO_0000357,
3302,Cavia porcellus,20033,2116.0,,1,,,Intermediate,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,,D,,F,,CHEMBL875096,,BAO_0000221,
3303,,108,,,1,,,Autocuration,5486,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,,H,,B,,CHEMBL619004,,BAO_0000357,
3304,,168,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL619005,,BAO_0000357,
3305,,168,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL619006,,BAO_0000019,
3306,,168,,,1,,,Autocuration,4199,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,,H,HeLa,B,,CHEMBL619007,308.0,BAO_0000219,
3307,,168,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL619008,,BAO_0000357,
3308,,168,,,1,,,Autocuration,5213,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL619009,,BAO_0000357,
3309,,168,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",,H,HeLa,B,,CHEMBL619010,308.0,BAO_0000219,
3310,,10622,,,1,,,Autocuration,17358,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,,H,,B,,CHEMBL619011,,BAO_0000357,
3311,,10622,,,1,,,Autocuration,17358,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,,H,,B,,CHEMBL619012,,BAO_0000357,
3312,,10622,,,1,,,Autocuration,16946,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,,H,,B,,CHEMBL619013,,BAO_0000219,
3313,,10622,,,1,,,Autocuration,17358,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,,H,,B,,CHEMBL619014,,BAO_0000357,
3314,,11249,2081.0,,1,,,Autocuration,268,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,,H,,F,,CHEMBL857503,,BAO_0000019,
3315,,11249,2081.0,,1,,,Autocuration,268,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,,H,,F,,CHEMBL619015,,BAO_0000019,
3316,,11249,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL619016,,BAO_0000357,
3317,,11249,10000000.0,,1,,,Autocuration,14875,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL619017,,BAO_0000221,
3318,Sus scrofa,168,10000000.0,,1,,,Autocuration,13267,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,,H,,B,,CHEMBL619018,,BAO_0000221,
3319,Oryctolagus cuniculus,168,,,1,,,Autocuration,13047,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,,H,,B,,CHEMBL619019,,BAO_0000019,
3320,Rattus norvegicus,10623,,,1,,,Expert,1650,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,,D,,B,,CHEMBL619020,,BAO_0000357,
3321,,10623,,,1,,,Autocuration,567,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,H,,F,,CHEMBL619021,,BAO_0000019,
3322,,10623,,,1,,,Autocuration,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,,H,,B,,CHEMBL619022,,BAO_0000357,
3323,,10623,,,1,,,Autocuration,188,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,,H,,B,,CHEMBL619023,,BAO_0000357,
3324,,10623,,,1,,,Autocuration,670,lntrinsic activity relative to 5-HT receptor,,H,,F,,CHEMBL619024,,BAO_0000019,
3325,,10623,,,1,,,Autocuration,204,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,,H,,F,,CHEMBL619025,,BAO_0000019,
3326,,10623,,,1,,,Expert,1946,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,,H,,F,,CHEMBL619026,,BAO_0000019,
3327,,10623,,,1,,,Autocuration,6398,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,,H,,F,,CHEMBL619027,,BAO_0000019,
3328,,10623,,,1,,,Autocuration,6398,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,,H,,F,,CHEMBL619028,,BAO_0000019,
3329,,10623,,,1,,,Autocuration,17358,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,,H,,F,,CHEMBL619029,,BAO_0000019,
3330,,10623,,,1,,,Autocuration,6398,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,,H,,F,,CHEMBL619030,,BAO_0000019,
3331,,10623,,,1,,,Expert,11752,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,,H,,B,,CHEMBL619031,,BAO_0000357,
3332,,10623,,,1,,,Autocuration,809,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,,H,,F,,CHEMBL619032,,BAO_0000019,
3333,Rattus norvegicus,10623,,,1,,,Expert,14178,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,,D,,B,,CHEMBL619033,,BAO_0000357,
3334,,10623,,,1,,,Autocuration,567,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,H,,B,,CHEMBL619034,,BAO_0000357,
3335,,10623,,,1,,,Autocuration,1946,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,,H,,B,,CHEMBL619035,,BAO_0000357,
3336,,10623,,,1,,,Autocuration,1946,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,,H,,B,,CHEMBL619036,,BAO_0000357,
3337,Rattus norvegicus,10623,,,1,,,Expert,13961,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,,D,,B,,CHEMBL619037,,BAO_0000019,
3338,,10623,2435.0,,1,,,Autocuration,6238,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,,H,,B,,CHEMBL619038,,BAO_0000249,
3339,,10623,,,1,,,Autocuration,14290,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,,H,,B,,CHEMBL619039,,BAO_0000249,
3340,,10623,,,1,,,Expert,14290,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,,H,,B,,CHEMBL619040,,BAO_0000249,
3341,Rattus norvegicus,10623,2435.0,,1,,,Expert,809,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,D,,B,,CHEMBL619041,,BAO_0000019,
3342,,10623,2435.0,,1,,,Autocuration,1578,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,H,,B,,CHEMBL619042,,BAO_0000019,
3343,,10623,2435.0,,1,,,Expert,16709,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,,H,,B,,CHEMBL619043,,BAO_0000249,
3344,,10623,2435.0,,1,,,Expert,1946,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,,H,,B,,CHEMBL619044,,BAO_0000019,
3345,,10623,2435.0,,1,,,Expert,15253,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,,H,,B,,CHEMBL619045,,BAO_0000249,
3346,,10623,2435.0,,1,,,Expert,4535,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,,H,,B,,CHEMBL619046,,BAO_0000249,
3347,,10623,,,1,,,Expert,13961,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,,H,,B,,CHEMBL619047,,BAO_0000249,
3348,,10623,955.0,,1,,,Autocuration,17358,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,,H,,F,,CHEMBL619048,,BAO_0000221,
3349,,10623,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,,H,,F,,CHEMBL859398,,BAO_0000019,
3350,,10623,,,1,,,Autocuration,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,,H,,F,,CHEMBL619049,,BAO_0000019,
3351,,10623,,,1,,,Autocuration,670,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,,H,,F,,CHEMBL857886,,BAO_0000019,
3352,,10623,,,1,,,Autocuration,670,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,,H,,F,,CHEMBL619050,,BAO_0000019,
3353,,10623,,,1,,,Autocuration,1317,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,H,,F,,CHEMBL620591,,BAO_0000019,
3354,Rattus norvegicus,10623,,,1,,,Expert,12936,Binding affinity against rat 5-hydroxytryptamine 4 receptor,,D,,B,,CHEMBL620592,,BAO_0000357,
3355,,10623,2435.0,,1,,,Expert,4535,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,,H,,B,,CHEMBL620593,,BAO_0000249,
3356,Rattus norvegicus,10623,,,1,,,Expert,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,,D,,F,,CHEMBL620594,,BAO_0000019,
3357,,10623,,,1,,,Expert,14424,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,,H,,F,,CHEMBL875079,,BAO_0000019,
3358,,10623,,,1,,,Expert,14424,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,H,,F,,CHEMBL620595,,BAO_0000019,
3359,Rattus norvegicus,10623,,,1,,,Expert,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,,D,,F,,CHEMBL620596,,BAO_0000019,
3360,,10623,,,1,,,Autocuration,14424,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,,H,,F,,CHEMBL620597,,BAO_0000019,
3361,,10623,,,1,,,Expert,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,,H,,F,,CHEMBL620598,,BAO_0000019,
3362,,10623,,,1,,,Expert,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),,H,,F,,CHEMBL620599,,BAO_0000218,
3363,,10623,,,1,,,Autocuration,14424,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,H,,F,,CHEMBL620600,,BAO_0000019,
3364,Rattus norvegicus,168,,,1,,,Autocuration,1980,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,,H,,F,,CHEMBL620601,,BAO_0000019,
3365,,168,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,,H,,F,,CHEMBL620602,,BAO_0000019,
3366,,168,,,1,,,Autocuration,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620603,,BAO_0000357,
3367,,168,,,1,,,Autocuration,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,,H,,B,,CHEMBL620604,,BAO_0000357,
3368,,168,,,1,,,Autocuration,17358,Compound was tested for 5-hydroxytryptamine 4 binding affinity,,H,,B,,CHEMBL620605,,BAO_0000357,
3369,,168,,,1,,,Autocuration,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620606,,BAO_0000357,
3370,,168,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,H,,F,,CHEMBL620607,,BAO_0000019,
3371,,168,,,1,,,Autocuration,16117,In vitro binding affinity towards 5-HT4 receptor was determined,,H,,B,,CHEMBL620608,,BAO_0000357,
3372,,168,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,H,,F,,CHEMBL620609,,BAO_0000019,
3373,,168,,,1,,,Autocuration,17358,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,,H,,F,,CHEMBL620610,,BAO_0000019,
3374,,168,,,1,,,Autocuration,17358,Tested for selectivity for 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620611,,BAO_0000357,
3375,,168,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,,H,,B,,CHEMBL620612,,BAO_0000357,
3376,,168,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,,H,,B,,CHEMBL620613,,BAO_0000357,
3377,,168,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,,H,,B,,CHEMBL620614,,BAO_0000357,
3378,,168,,,1,,,Expert,1274,Binding affinity against 5-Hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620615,,BAO_0000357,
3379,,104698,,,1,,,Autocuration,10728,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,Brain membranes,H,,B,,CHEMBL857075,,BAO_0000249,
3380,,104698,,,1,,,Autocuration,11695,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,Brain membranes,H,,B,,CHEMBL620616,,BAO_0000249,
3381,,104698,,,1,,,Autocuration,11695,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,Brain membranes,H,,B,,CHEMBL619411,,BAO_0000249,
3382,,104698,,,1,,,Autocuration,12490,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,,H,,B,,CHEMBL619412,,BAO_0000019,
3383,Rattus norvegicus,104698,,,1,,,Autocuration,11828,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL619413,,BAO_0000019,
3384,,104698,10000000.0,,1,,,Autocuration,12253,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,,H,,B,,CHEMBL619414,,BAO_0000221,
3385,,104698,,,1,,,Autocuration,10561,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,H,,B,,CHEMBL619415,,BAO_0000019,
3386,,104698,,,1,,,Autocuration,10561,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,,H,,B,,CHEMBL619416,,BAO_0000019,
3387,,104698,,,1,,,Autocuration,14432,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,,H,,F,,CHEMBL619417,,BAO_0000019,
3388,Rattus norvegicus,104698,,,1,,,Autocuration,12936,Binding affinity against rat 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL619418,,BAO_0000223,
3389,Rattus norvegicus,104698,,,1,,,Autocuration,1274,Binding affinity against 5-Hydroxytryptamine 3 receptor,,D,,B,,CHEMBL619419,,BAO_0000223,
3390,,104698,,,1,,,Autocuration,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,,H,,B,,CHEMBL619420,,BAO_0000019,
3391,,104698,,,1,,,Autocuration,670,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,,H,,B,,CHEMBL619421,,BAO_0000249,
3392,Rattus norvegicus,104698,,,1,,,Autocuration,968,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,,D,,B,,CHEMBL619422,,BAO_0000019,
3393,,104698,,,1,,,Autocuration,14287,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,,H,,B,,CHEMBL619423,,BAO_0000019,
3394,,104698,,,1,,,Autocuration,567,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,,H,,B,,CHEMBL875080,,BAO_0000019,
3395,,104698,,,1,,,Autocuration,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,,H,,B,,CHEMBL619424,,BAO_0000019,
3396,,104698,,,1,,,Autocuration,14826,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,,H,,B,,CHEMBL619425,,BAO_0000249,
3397,,104698,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,,H,,B,,CHEMBL619426,,BAO_0000223,
3398,,104698,,,1,,,Autocuration,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,,H,,B,,CHEMBL619427,,BAO_0000223,
3399,Rattus norvegicus,104698,,,1,,,Autocuration,10394,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,,D,,B,,CHEMBL619645,,BAO_0000223,
3400,,10576,,,1,,,Expert,13657,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",,D,,B,,CHEMBL619646,,BAO_0000249,
3401,,12020,955.0,,1,,,Autocuration,1879,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,,H,,F,,CHEMBL619647,,BAO_0000221,
3402,,12020,,,1,,,Autocuration,1879,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,,H,,F,,CHEMBL619648,,BAO_0000019,
3403,,12020,,,1,,,Autocuration,1879,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,,H,,F,,CHEMBL619165,,BAO_0000019,
3404,,12020,,,1,In vivo,,Autocuration,204,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,,H,,F,,CHEMBL620719,,BAO_0000218,
3405,,12020,,,1,,,Autocuration,1879,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,H,,B,,CHEMBL872924,,BAO_0000019,
3406,,12020,,,1,,,Autocuration,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL620720,,BAO_0000357,
3407,,12020,,,1,,,Autocuration,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,H,,B,,CHEMBL620721,,BAO_0000019,
3408,,12020,,,1,,,Autocuration,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,,H,,B,,CHEMBL620722,,BAO_0000019,
3409,,104698,,,1,,,Autocuration,10641,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",,H,,B,,CHEMBL620723,,BAO_0000019,
3410,,12020,,,1,,,Autocuration,773,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,H,,B,,CHEMBL620724,,BAO_0000019,
3411,,104698,,,1,,,Autocuration,11952,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,,H,,B,,CHEMBL620725,,BAO_0000249,
3412,Rattus norvegicus,12020,,,1,,,Autocuration,14145,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,,D,,F,,CHEMBL620726,,BAO_0000019,
3413,,144,,,1,,,Expert,17066,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL620727,,BAO_0000357,
3414,,104714,,,1,,,Autocuration,6398,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,,H,,B,,CHEMBL620728,,BAO_0000223,
3415,,22226,,,1,,,Autocuration,10321,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,U,,B,,CHEMBL620729,,BAO_0000019,
3416,,104714,,,1,,,Autocuration,511,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,,H,,F,,CHEMBL858288,,BAO_0000019,
3417,,104714,,,1,,,Autocuration,4639,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL620730,,BAO_0000223,
3418,,104714,,,1,,,Autocuration,4639,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL620731,,BAO_0000223,
3419,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,,H,,F,,CHEMBL620732,,BAO_0000019,
3420,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,H,,F,,CHEMBL618042,,BAO_0000019,
3421,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,,H,,F,,CHEMBL618043,,BAO_0000019,
3422,,104714,,,1,,,Autocuration,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618044,,BAO_0000223,
3423,,104714,,,1,,,Autocuration,268,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,,H,,F,,CHEMBL618045,,BAO_0000019,
3424,,104714,,,1,,,Autocuration,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,,H,,B,,CHEMBL618046,,BAO_0000223,
3425,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,,H,,F,,CHEMBL618047,,BAO_0000019,
3426,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,,H,,F,,CHEMBL875084,,BAO_0000019,
3427,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,,H,,F,,CHEMBL618048,,BAO_0000019,
3428,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,,H,,B,,CHEMBL618049,,BAO_0000223,
3429,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,,H,,F,,CHEMBL619764,,BAO_0000019,
3430,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,,H,,F,,CHEMBL619765,,BAO_0000019,
3431,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,,H,,F,,CHEMBL619766,,BAO_0000019,
3432,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,,H,,B,,CHEMBL619767,,BAO_0000223,
3433,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,,H,,B,,CHEMBL619768,,BAO_0000223,
3434,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,,H,,F,,CHEMBL619769,,BAO_0000019,
3435,,104714,,,1,,,Autocuration,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,,H,,B,,CHEMBL619770,,BAO_0000223,
3436,,104714,,,1,,,Autocuration,5067,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL619771,,BAO_0000223,
3437,,104714,,,1,,,Autocuration,14331,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,,H,,B,,CHEMBL619772,,BAO_0000219,
3438,,104714,,,1,,,Autocuration,5067,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,,H,,B,,CHEMBL619773,,BAO_0000223,
3439,,104714,,,1,,,Autocuration,6179,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,,H,NG108-15,B,,CHEMBL619774,433.0,BAO_0000219,
3440,,104714,,,1,,,Autocuration,4265,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,,H,,B,,CHEMBL875083,,BAO_0000019,
3441,,104714,,,1,,,Autocuration,4265,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,,H,NG108-15,B,,CHEMBL620718,433.0,BAO_0000219,
3442,,104714,,,1,,,Autocuration,17358,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,H,,B,,CHEMBL618127,,BAO_0000223,
3443,,104714,,,1,,,Autocuration,17358,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,,H,,B,,CHEMBL618128,,BAO_0000223,
3444,,104714,,,1,In vitro,,Autocuration,13628,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,,H,,B,,CHEMBL618129,,BAO_0000219,
3445,,104714,,,1,,,Autocuration,4612,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,H,,B,,CHEMBL618130,,BAO_0000223,
3446,,104714,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,,H,,F,,CHEMBL618131,,BAO_0000019,
3447,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,,H,,F,,CHEMBL618132,,BAO_0000019,
3448,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,,H,,F,,CHEMBL618133,,BAO_0000019,
3449,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,,H,,F,,CHEMBL618134,,BAO_0000019,
3450,Cavia porcellus,104714,,,1,,,Autocuration,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,,H,,F,,CHEMBL618135,,BAO_0000019,
3451,,104714,,,1,,,Autocuration,511,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,,H,,B,,CHEMBL618136,,BAO_0000223,
3452,,104714,,,1,,,Autocuration,1479,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618137,,BAO_0000223,
3453,,104714,,,1,,,Autocuration,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,,H,,B,,CHEMBL618138,,BAO_0000223,
3454,,104714,,,1,,,Autocuration,12146,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,,H,,B,,CHEMBL618139,,BAO_0000223,
3455,,104714,,,1,,,Autocuration,12146,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,,H,,B,,CHEMBL618140,,BAO_0000223,
3456,,104714,,,1,,,Autocuration,13969,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,,H,,B,,CHEMBL618141,,BAO_0000223,
3457,,108,,,1,,,Expert,13392,Binding affinity for 5-hydroxytryptamine 2C receptor,,H,,B,,CHEMBL873478,,BAO_0000357,
3458,,104698,,,1,,,Autocuration,13392,Binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618142,,BAO_0000223,
3459,,144,,,1,,,Autocuration,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618143,,BAO_0000357,
3460,,144,,,1,,,Autocuration,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618144,,BAO_0000357,
3461,,144,,,1,,,Autocuration,16655,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618145,,BAO_0000357,
3462,,104714,,,1,,,Autocuration,13020,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,H,,B,,CHEMBL618146,,BAO_0000223,
3463,,104714,,,1,,,Autocuration,13021,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,,H,,B,,CHEMBL618147,,BAO_0000223,
3464,,104714,,,1,,,Autocuration,13020,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,H,,B,,CHEMBL618148,,BAO_0000223,
3465,,144,,,1,,,Autocuration,10321,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,H,,B,,CHEMBL618149,,BAO_0000019,
3466,,144,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL872927,,BAO_0000357,
3467,,144,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL618150,,BAO_0000357,
3468,,144,,,1,,,Autocuration,17358,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,H,,B,,CHEMBL618151,,BAO_0000357,
3469,,144,,,1,,,Autocuration,2222,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL875094,,BAO_0000357,
3470,,144,,,1,,,Autocuration,10322,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,H,,B,,CHEMBL618152,,BAO_0000019,
3471,,144,,,1,,,Autocuration,16117,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,H,,B,,CHEMBL618153,,BAO_0000357,
3472,,144,,,1,,,Autocuration,17200,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,H,,B,,CHEMBL618888,,BAO_0000357,
3473,,144,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,H,,F,,CHEMBL618889,,BAO_0000019,
3474,,144,,,1,,,Autocuration,16700,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,H,,B,,CHEMBL618890,,BAO_0000357,
3475,,144,,,1,,,Autocuration,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,H,,B,,CHEMBL618891,,BAO_0000019,
3476,,144,,,1,,,Autocuration,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,H,,B,,CHEMBL619054,,BAO_0000019,
3477,,104714,,,1,,,Autocuration,12409,Binding affinity against the 5-hydroxytryptamine 3 receptor,,H,,B,,CHEMBL619055,,BAO_0000223,
3478,,144,,,1,,,Autocuration,4365,Binding affinity against human 5-hydroxytryptamine 3A receptor,,H,,B,,CHEMBL619056,,BAO_0000357,
3479,,144,,,1,,,Autocuration,4365,Percent efficacy against 5-hydroxytryptamine 3A receptor,,H,,F,,CHEMBL619057,,BAO_0000019,
3480,,144,,,1,,,Autocuration,4365,Binding affinity against human 5-hydroxytryptamine 3A receptor,,H,,B,,CHEMBL619058,,BAO_0000357,
3481,Rattus norvegicus,12020,,,1,,,Expert,6769,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,,D,Oocytes,F,,CHEMBL619059,,BAO_0000219,
3482,Rattus norvegicus,12020,,,1,,,Expert,6769,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,,D,Oocytes,F,,CHEMBL619060,,BAO_0000219,
3483,Rattus norvegicus,12020,,,1,,,Expert,6769,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,,D,Oocytes,F,,CHEMBL875095,,BAO_0000219,
3484,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,,D,,F,,CHEMBL619061,,BAO_0000221,
3485,Cavia porcellus,20033,2116.0,,1,,,Intermediate,809,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,,D,,F,,CHEMBL619062,,BAO_0000221,
3486,Cavia porcellus,20033,,,1,,,Intermediate,14290,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,,D,,F,,CHEMBL619063,,BAO_0000019,
3487,Cavia porcellus,20033,2116.0,,1,,,Intermediate,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,,D,,B,,CHEMBL619064,,BAO_0000221,
3488,Cavia porcellus,20033,,,1,,,Intermediate,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,,D,,B,,CHEMBL619065,,BAO_0000357,
3489,Cavia porcellus,20033,2116.0,,1,,,Intermediate,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,,D,,B,,CHEMBL619066,,BAO_0000221,
3490,,10209,2116.0,,1,,,Autocuration,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,,H,,B,,CHEMBL619775,,BAO_0000221,
3491,,10209,,,1,,,Autocuration,3269,Affinity against 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL619776,,BAO_0000357,
3492,Cavia porcellus,104841,,,1,,,Autocuration,7721,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,H,,B,,CHEMBL619777,,BAO_0000224,
3493,Cavia porcellus,104841,,,1,,,Autocuration,7721,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,,H,,B,,CHEMBL619778,,BAO_0000224,
3494,Cavia porcellus,104841,2116.0,,1,,,Autocuration,9117,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,,H,,B,,CHEMBL619779,,BAO_0000221,
3495,Cavia porcellus,104841,,,1,,,Autocuration,7721,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",,H,,B,,CHEMBL619780,,BAO_0000224,
3496,Cavia porcellus,104841,,,1,,,Autocuration,7721,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",,H,,B,,CHEMBL619166,,BAO_0000224,
3497,Cavia porcellus,104841,,,1,,,Autocuration,15796,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,H,,F,,CHEMBL619167,,BAO_0000019,
3498,Cavia porcellus,104841,,,1,,,Autocuration,15796,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,,H,,F,,CHEMBL619168,,BAO_0000019,
3499,Homo sapiens,168,2081.0,,1,,,Expert,15650,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,,D,,B,,CHEMBL619169,,BAO_0000219,
3500,Homo sapiens,168,2081.0,,1,,,Expert,15650,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,,D,,B,,CHEMBL619170,,BAO_0000219,
3501,Homo sapiens,104841,,,1,,,Autocuration,6866,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",,D,,F,,CHEMBL619171,,BAO_0000019,
3502,Homo sapiens,168,2081.0,,1,,,Expert,15650,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",,D,,F,,CHEMBL619172,,BAO_0000219,
3503,Mus musculus,22226,,,1,,,Autocuration,10063,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,,U,,B,,CHEMBL619173,,BAO_0000019,
3504,Mus musculus,22226,,,1,,,Autocuration,12665,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,,U,,B,,CHEMBL619174,,BAO_0000019,
3505,,104705,,,1,,,Autocuration,7504,5-hydroxytryptamine receptor binding affinity was determined in rats,,H,,B,,CHEMBL619175,,BAO_0000019,
3506,,104705,,,1,,,Autocuration,7504,Binding affinity at rat 5-hydroxytryptamine receptor.,,H,,B,,CHEMBL619176,,BAO_0000224,
3507,,104705,,,1,,,Autocuration,7038,Affinity against 5-hydroxytryptamine receptors in rat fundus model,,H,,B,,CHEMBL619177,,BAO_0000019,
3508,,104705,,,1,,,Autocuration,7626,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,,H,,B,,CHEMBL619178,,BAO_0000224,
3509,,104705,,,1,,,Autocuration,7626,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,,H,,B,,CHEMBL619179,,BAO_0000224,
3510,,104705,945.0,,1,,,Autocuration,7185,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,,H,,F,,CHEMBL619180,,BAO_0000019,
3511,,104705,945.0,,1,,,Autocuration,7185,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,,H,,F,,CHEMBL619181,,BAO_0000019,
3512,,104705,,,1,,,Autocuration,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,H,,F,,CHEMBL619182,,BAO_0000019,
3513,,104705,,,1,,,Autocuration,6960,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,,H,,B,,CHEMBL619183,,BAO_0000224,
3514,,104705,,,1,,,Autocuration,6960,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",,H,,B,,CHEMBL619184,,BAO_0000224,
3515,,10576,10000000.0,,1,,,Autocuration,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,H,,B,,CHEMBL619185,,BAO_0000221,
3516,,12198,,,1,,,Expert,15753,Binding affinity for rat 5-hydroxytryptamine transporter.,,H,,B,,CHEMBL619186,,BAO_0000357,
3517,,104705,,,1,,,Autocuration,8062,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,,H,,B,,CHEMBL619187,,BAO_0000019,
3518,Rattus norvegicus,104705,,,1,,,Autocuration,9036,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,,D,,B,,CHEMBL619188,,BAO_0000019,
3519,Rattus norvegicus,104705,,,1,,,Autocuration,15067,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,,D,,B,,CHEMBL619189,,BAO_0000224,
3520,Rattus norvegicus,12198,955.0,,1,,,Expert,15753,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,,D,,F,,CHEMBL619190,,BAO_0000019,
3521,Rattus norvegicus,12198,2037.0,,1,,,Expert,15753,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,,D,,F,,CHEMBL619191,,BAO_0000221,
3522,Rattus norvegicus,104705,,,1,,,Autocuration,15295,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,,D,,B,,CHEMBL619192,,BAO_0000019,
3523,Rattus norvegicus,104705,,,1,,,Autocuration,6347,Percent binding affinity against 5-hydroxytryptamine receptor,,D,,B,,CHEMBL619193,,BAO_0000224,
3524,,22226,,,1,,,Autocuration,6763,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,,U,,B,,CHEMBL619194,,BAO_0000019,
3525,Rattus norvegicus,104705,,,1,,,Autocuration,12092,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,,D,,B,,CHEMBL619195,,BAO_0000224,
3526,Rattus norvegicus,104705,,,1,,,Autocuration,1579,Affinity against 5-hydroxytryptamine receptor was determined,,D,,B,,CHEMBL619196,,BAO_0000224,
3527,Rattus norvegicus,104705,945.0,,1,,,Autocuration,1579,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,,D,,B,,CHEMBL619197,,BAO_0000019,
3528,Homo sapiens,121,,,1,In vitro,,Expert,5963,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,D,,B,,CHEMBL619198,,BAO_0000219,
3529,Homo sapiens,121,,,1,In vitro,,Expert,5963,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,,D,,B,,CHEMBL875081,,BAO_0000219,
3530,,18065,,,1,,,Autocuration,5030,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,,H,,B,,CHEMBL884712,,BAO_0000357,
3531,,121,,,1,,,Expert,15796,Inhibition of 5-hydroxytryptamine reuptake,,H,,B,,CHEMBL884710,,BAO_0000357,
3532,,18065,,,1,,,Autocuration,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",,H,,F,,CHEMBL619199,,BAO_0000019,
3533,,18065,,,1,,,Autocuration,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",,H,,F,,CHEMBL619200,,BAO_0000019,
3534,,18065,,,1,,,Autocuration,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",,H,,F,,CHEMBL619201,,BAO_0000019,
3535,,18065,,,1,,,Autocuration,12409,Tested for 5-hydroxytryptamine receptor uptake,,H,,F,,CHEMBL619202,,BAO_0000019,
3536,Homo sapiens,51,,,1,,,Expert,16909,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,,D,CHO,B,,CHEMBL619203,449.0,BAO_0000219,
3537,Homo sapiens,51,,,1,,,Expert,16909,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,,D,,F,,CHEMBL619204,,BAO_0000019,
3538,Homo sapiens,10576,,,1,,,Autocuration,15629,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,,H,,B,,CHEMBL619205,,BAO_0000249,
3539,,10576,,,1,,,Autocuration,15629,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,,H,,B,,CHEMBL619206,,BAO_0000357,
3540,,10576,,,1,,,Expert,15629,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,,H,,B,,CHEMBL619207,,BAO_0000249,
3541,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,,H,,F,,CHEMBL619208,,BAO_0000019,
3542,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,,H,,F,,CHEMBL619209,,BAO_0000019,
3543,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,,H,,F,,CHEMBL619210,,BAO_0000019,
3544,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,,H,,F,,CHEMBL619211,,BAO_0000019,
3545,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,,H,,F,,CHEMBL619212,,BAO_0000019,
3546,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,,H,,F,,CHEMBL620681,,BAO_0000019,
3547,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,,H,,F,,CHEMBL620682,,BAO_0000019,
3548,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,,H,,F,,CHEMBL620683,,BAO_0000019,
3549,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,,H,,F,,CHEMBL620684,,BAO_0000019,
3550,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,,H,,F,,CHEMBL620685,,BAO_0000019,
3551,,10825,2435.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,,H,,F,,CHEMBL620686,,BAO_0000019,
3552,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,,H,,F,,CHEMBL620687,,BAO_0000019,
3553,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,,H,,F,,CHEMBL620688,,BAO_0000019,
3554,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,,H,,F,,CHEMBL620689,,BAO_0000019,
3555,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,,H,,F,,CHEMBL620690,,BAO_0000019,
3556,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,,H,,F,,CHEMBL620691,,BAO_0000019,
3557,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,,H,,F,,CHEMBL620692,,BAO_0000019,
3558,,10825,349.0,,1,,,Autocuration,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,,H,,F,,CHEMBL620693,,BAO_0000019,
3559,,168,,,1,,,Expert,1274,Binding affinity against 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620694,,BAO_0000357,
3560,,168,,,1,,,Autocuration,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,H,,F,,CHEMBL857986,,BAO_0000019,
3561,,168,,,1,,,Autocuration,14532,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,,H,,B,,CHEMBL620695,,BAO_0000357,
3562,,168,,,1,,,Expert,16989,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620696,,BAO_0000357,
3563,,168,,,1,,,Autocuration,17200,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,,H,,B,,CHEMBL620697,,BAO_0000357,
3564,,168,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor,,H,,B,,CHEMBL620698,,BAO_0000357,
3565,,168,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,H,,B,,CHEMBL620699,,BAO_0000357,
3566,,168,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,H,,B,,CHEMBL620700,,BAO_0000357,
3567,,168,,,1,,,Autocuration,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,,H,COS-7,B,,CHEMBL620701,643.0,BAO_0000219,
3568,,168,,,1,,,Autocuration,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,,H,COS-7,B,,CHEMBL875082,643.0,BAO_0000219,
3569,,168,,,1,,,Autocuration,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,,H,COS-7,B,,CHEMBL620702,643.0,BAO_0000219,
3570,,168,,,1,,,Autocuration,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,,H,COS-7,B,,CHEMBL620703,643.0,BAO_0000219,
3571,,168,,,1,,,Autocuration,17046,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,H,C6,B,,CHEMBL620704,673.0,BAO_0000219,
3572,,168,,,1,,,Expert,17046,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,H,C6,B,,CHEMBL620705,673.0,BAO_0000219,
3573,,168,,,1,,,Expert,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,,H,C6,B,,CHEMBL620706,673.0,BAO_0000219,
3574,,168,,,1,,,Expert,17046,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,,H,C6,B,,CHEMBL620707,673.0,BAO_0000219,
3575,,10624,,,1,,,Expert,17066,Binding affinity towards 5-hydroxytryptamine 5 receptor,,H,,B,,CHEMBL620708,,BAO_0000357,
3576,,105,,,1,,,Autocuration,17200,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,,H,,B,,CHEMBL620709,,BAO_0000357,
3577,Homo sapiens,10624,,,1,,,Expert,16146,Binding affinity against 5-hydroxytryptamine 5A receptor,,D,,B,,CHEMBL620710,,BAO_0000357,
3578,,10624,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL620711,449.0,BAO_0000219,
3579,Homo sapiens,10624,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,,D,,B,,CHEMBL620712,,BAO_0000357,
3580,Homo sapiens,10624,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 5A receptor,,D,,B,,CHEMBL620713,,BAO_0000357,
3581,Homo sapiens,10624,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,,D,,B,,CHEMBL620714,,BAO_0000357,
3582,Homo sapiens,10624,,,1,,,Expert,4234,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,,D,,B,,CHEMBL620715,,BAO_0000357,
3583,,10624,,,1,,,Autocuration,6013,Binding affinity towards 5-HT5A receptor,,H,,B,,CHEMBL620716,,BAO_0000357,
3584,,10624,,,1,,,Expert,17175,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,,H,,B,,CHEMBL620717,,BAO_0000357,
3585,,10624,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,,H,,B,,CHEMBL618072,,BAO_0000357,
3586,,10624,,,1,,,Autocuration,6166,Binding affinity towards cloned human 5-HT5A receptor was determined,,H,,B,,CHEMBL857987,,BAO_0000357,
3587,,10624,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,HEK293,B,,CHEMBL618073,722.0,BAO_0000219,
3588,,10624,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,H,HEK293,B,,CHEMBL618074,722.0,BAO_0000219,
3589,,10624,,,1,,,Autocuration,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),,H,HEK293,B,,CHEMBL618075,722.0,BAO_0000219,
3590,Mus musculus,10625,,,1,,,Expert,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,,D,,B,,CHEMBL618076,,BAO_0000357,
3591,Mus musculus,10625,,,1,,,Expert,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,,D,,B,,CHEMBL618077,,BAO_0000357,
3592,Mus musculus,10625,,,1,,,Expert,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,,D,,B,,CHEMBL618078,,BAO_0000357,
3593,Mus musculus,10625,,,1,,,Expert,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,,D,,B,,CHEMBL881821,,BAO_0000357,
3594,Mus musculus,10625,,,1,,,Expert,17066,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,,D,,B,,CHEMBL618079,,BAO_0000357,
3595,,10625,,,1,,,Expert,17175,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,,H,,B,,CHEMBL618080,,BAO_0000357,
3596,,10576,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,H,HEK293,B,,CHEMBL618081,722.0,BAO_0000219,
3597,,10626,,,1,,,Autocuration,16190,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,H,HEK293,B,,CHEMBL618082,722.0,BAO_0000219,
3598,,10624,,,1,,,Expert,4820,Binding affinity towards 5-HT5a receptor,,H,,B,,CHEMBL618083,,BAO_0000357,
3599,Homo sapiens,10624,,,1,,,Expert,17066,Binding affinity towards 5-hydroxytryptamine 5A receptor,,D,,B,,CHEMBL618084,,BAO_0000357,
3600,,10624,,,1,,,Expert,17066,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,,H,,B,,CHEMBL618085,,BAO_0000357,
3601,,10624,,,1,,,Expert,17175,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,,H,,B,,CHEMBL618086,,BAO_0000357,
3602,,10624,,,1,,,Autocuration,16633,Binding affinities against 5-hydroxytryptamine 5A receptor,,H,,B,,CHEMBL875092,,BAO_0000357,
3603,,10624,,,1,,,Autocuration,16633,Binding affinities towards 5-hydroxytryptamine 5A receptor,,H,,B,,CHEMBL618087,,BAO_0000357,
3604,,10624,,,1,,,Autocuration,16700,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,,H,,B,,CHEMBL872926,,BAO_0000357,
3605,Cavia porcellus,104714,,,1,,,Autocuration,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,,H,,F,,CHEMBL618088,,BAO_0000019,
3606,,104714,,,1,,,Autocuration,5486,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,,H,,B,,CHEMBL618089,,BAO_0000223,
3607,Homo sapiens,10627,,,1,,,Expert,16146,Inhibition of human 5-hydroxytryptamine 6 receptor,,D,,B,,CHEMBL618090,,BAO_0000357,
3608,Homo sapiens,10627,,,1,,,Expert,17273,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,,D,,B,,CHEMBL618091,,BAO_0000357,
3609,,10627,,,1,,,Autocuration,17687,Inhibition against human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL618092,,BAO_0000357,
3610,Homo sapiens,10627,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,,D,,B,,CHEMBL618093,,BAO_0000357,
3611,,10627,,,1,,,Expert,16190,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,,H,HeLa,B,,CHEMBL618094,308.0,BAO_0000219,
3612,Homo sapiens,10627,,,1,,,Expert,17066,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,,D,,B,,CHEMBL618095,,BAO_0000357,
3613,Homo sapiens,10627,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,D,,B,,CHEMBL875093,,BAO_0000357,
3614,Homo sapiens,10627,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,,D,,B,,CHEMBL618096,,BAO_0000357,
3615,Homo sapiens,10627,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,,D,,B,,CHEMBL618118,,BAO_0000357,
3616,Homo sapiens,10627,,,1,,,Expert,3555,Binding affinity against 5-hydroxytryptamine 6 receptor,,D,,B,,CHEMBL618119,,BAO_0000357,
3617,,10627,,,1,,,Expert,5808,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL618120,,BAO_0000357,
3618,,10627,,,1,,,Autocuration,6013,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL618121,,BAO_0000357,
3619,,10627,,,1,,,Expert,15818,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",,H,HEK293,B,,CHEMBL618122,722.0,BAO_0000219,
3620,,10627,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,,H,,B,,CHEMBL618123,,BAO_0000357,
3621,,10627,,,1,,,Expert,3935,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,,H,HEK293,B,,CHEMBL618124,722.0,BAO_0000219,
3622,,10627,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL618125,,BAO_0000357,
3623,Homo sapiens,10627,,,1,,,Expert,3805,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,D,HEK293,B,,CHEMBL618126,722.0,BAO_0000219,
3624,,10627,,,1,,,Expert,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,,H,,B,,CHEMBL618236,,BAO_0000019,
3625,,10627,,,1,,,Expert,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,H,,B,,CHEMBL618237,,BAO_0000019,
3626,,10627,,,1,,,Expert,6786,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,,H,COS-7,B,,CHEMBL618238,643.0,BAO_0000219,
3627,Homo sapiens,10627,,,1,,,Expert,4234,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,,D,,B,,CHEMBL618239,,BAO_0000357,
3628,,10627,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL618240,,BAO_0000019,
3629,,10627,,,1,,,Autocuration,17200,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,,H,,B,,CHEMBL618241,,BAO_0000357,
3630,,10627,,,1,,,Autocuration,17451,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,H,HEK293,B,,CHEMBL859399,722.0,BAO_0000219,
3631,,10627,,,1,,,Autocuration,3935,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,,H,,F,,CHEMBL618242,,BAO_0000019,
3632,,10627,,,1,,,Autocuration,5033,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL857991,,BAO_0000357,
3633,,10627,,,1,,,Expert,4540,Binding affinity against human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL619951,,BAO_0000357,
3634,Homo sapiens,10627,,,1,,,Expert,4540,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,,D,HeLa,B,,CHEMBL619952,308.0,BAO_0000219,
3635,Homo sapiens,10627,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,,D,HeLa,B,,CHEMBL619953,308.0,BAO_0000219,
3636,,10627,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,,H,HeLa,B,,CHEMBL619954,308.0,BAO_0000219,
3637,,10627,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,H,HeLa,B,,CHEMBL619955,308.0,BAO_0000219,
3638,,10627,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,H,HeLa,B,,CHEMBL619956,308.0,BAO_0000219,
3639,,10627,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,H,CHO,B,,CHEMBL619957,449.0,BAO_0000219,
3640,,10627,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,H,HEK293,B,,CHEMBL619958,722.0,BAO_0000219,
3641,,10627,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,,H,HEK293,B,,CHEMBL620627,722.0,BAO_0000219,
3642,,10627,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,H,HEK293,B,,CHEMBL620628,722.0,BAO_0000219,
3643,,10627,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,,H,HeLa,B,,CHEMBL620629,308.0,BAO_0000219,
3644,,10627,,,1,,,Autocuration,6166,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620630,,BAO_0000357,
3645,,10627,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,,H,HeLa,B,,CHEMBL620782,308.0,BAO_0000219,
3646,,10627,,,1,,,Autocuration,15316,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620783,,BAO_0000357,
3647,,10627,,,1,,,Expert,4199,Binding affinity against human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620784,,BAO_0000357,
3648,,10627,,,1,,,Expert,15146,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,,H,HeLa,B,,CHEMBL620785,308.0,BAO_0000219,
3649,,10627,,,1,,,Autocuration,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),,H,,B,,CHEMBL857992,,BAO_0000357,
3650,,10627,,,1,,,Autocuration,16429,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,,H,,B,,CHEMBL620786,,BAO_0000219,
3651,,10627,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,,H,HeLa,B,,CHEMBL620787,308.0,BAO_0000219,
3652,,10627,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",,H,HeLa,B,,CHEMBL620788,308.0,BAO_0000219,
3653,,10627,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",,H,HeLa,B,,CHEMBL620789,308.0,BAO_0000219,
3654,,10627,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",,H,HeLa,B,,CHEMBL620790,308.0,BAO_0000219,
3655,,10628,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL620791,449.0,BAO_0000219,
3656,,10628,,,1,,,Autocuration,14423,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,,H,,B,,CHEMBL620792,,BAO_0000019,
3657,,10628,,,1,,,Autocuration,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620793,,BAO_0000357,
3658,,10628,,,1,,,Autocuration,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,,H,,B,,CHEMBL620794,,BAO_0000357,
3659,Homo sapiens,10627,,,1,,,Autocuration,16190,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,,D,HeLa,B,,CHEMBL620795,308.0,BAO_0000219,
3660,,10627,,,1,,,Expert,4820,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620796,,BAO_0000357,
3661,,10627,,,1,,,Autocuration,4639,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,,H,,B,,CHEMBL620797,,BAO_0000357,
3662,Homo sapiens,10627,,,1,,,Expert,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,D,,F,,CHEMBL620798,,BAO_0000019,
3663,,10627,,,1,,,Autocuration,6011,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,,H,,B,,CHEMBL620799,,BAO_0000357,
3664,,10627,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620800,,BAO_0000357,
3665,,10627,,,1,,,Autocuration,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,,H,,B,,CHEMBL620801,,BAO_0000357,
3666,,10627,,,1,,,Autocuration,5014,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL875100,,BAO_0000357,
3667,,10627,,,1,,,Autocuration,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,,H,,B,,CHEMBL620802,,BAO_0000357,
3668,,10627,,,1,,,Expert,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,,H,,F,,CHEMBL620803,,BAO_0000019,
3669,,10627,,,1,,,Expert,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,H,,F,,CHEMBL620804,,BAO_0000019,
3670,,10627,,,1,,,Autocuration,4373,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,,H,,B,,CHEMBL620805,,BAO_0000357,
3671,,10627,,,1,,,Autocuration,4687,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620806,,BAO_0000357,
3672,,10627,,,1,,,Autocuration,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,,H,,B,,CHEMBL620807,,BAO_0000357,
3673,,10627,,,1,,,Autocuration,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,,H,,B,,CHEMBL620808,,BAO_0000357,
3674,,10627,,,1,,,Autocuration,16633,Binding affinities against 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620809,,BAO_0000357,
3675,,10627,,,1,,,Autocuration,16633,Binding affinities towards 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620810,,BAO_0000357,
3676,Homo sapiens,10627,,,1,,,Expert,17066,Binding affinity towards 5-hydroxytryptamine 6 receptor,,D,,B,,CHEMBL620811,,BAO_0000357,
3677,,10627,,,1,,,Autocuration,16700,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,,H,,B,,CHEMBL620812,,BAO_0000357,
3678,,10627,,,1,,,Autocuration,3269,Affinity against 5-hydroxytryptamine 6 receptor,,H,,B,,CHEMBL620813,,BAO_0000357,
3679,,10627,,,1,,,Autocuration,5486,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],,H,,B,,CHEMBL620814,,BAO_0000357,
3680,Homo sapiens,10209,,,1,,,Expert,16146,Inhibition of human 5-hydroxytryptamine 7 receptor,,D,,B,,CHEMBL620815,,BAO_0000357,
3681,,10209,,,1,,,Autocuration,5014,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,,H,HEK293,B,,CHEMBL620816,722.0,BAO_0000219,
3682,,10209,,,1,,,Autocuration,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL620817,,BAO_0000357,
3683,,10209,,,1,,,Autocuration,3805,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),,H,,B,,CHEMBL620818,,BAO_0000357,
3684,,10209,,,1,,,Expert,5014,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,,H,HEK293,B,,CHEMBL620819,722.0,BAO_0000219,
3685,Homo sapiens,10209,,,1,,,Expert,6491,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,,D,,B,,CHEMBL620820,,BAO_0000357,
3686,,10209,,,1,,,Autocuration,16190,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,,H,CHO,B,,CHEMBL620821,449.0,BAO_0000219,
3687,Homo sapiens,10209,,,1,,,Expert,17066,Binding affinity towards human 5-hydroxytryptamine 7 receptor,,D,,B,,CHEMBL620822,,BAO_0000357,
3688,Homo sapiens,10209,,,1,,,Expert,17066,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,,D,,B,,CHEMBL620823,,BAO_0000357,
3689,Homo sapiens,10209,,,1,,,Expert,3555,Binding affinity against 5-hydroxytryptamine 7 receptor,,D,,B,,CHEMBL620824,,BAO_0000357,
3690,,10209,,,1,,,Expert,6588,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,,H,CHO,B,,CHEMBL620825,449.0,BAO_0000219,
3691,,10209,,,1,,,Autocuration,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,,H,,B,,CHEMBL872930,,BAO_0000357,
3692,,10209,,,1,,,Autocuration,6013,Binding affinity towards 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL620826,,BAO_0000357,
3693,,10209,,,1,,,Autocuration,16209,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,,H,,B,,CHEMBL620827,,BAO_0000357,
3694,,10209,,,1,,,Autocuration,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL620828,,BAO_0000357,
3695,,10209,,,1,,,Autocuration,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL620829,,BAO_0000357,
3696,,10209,,,1,,,Expert,5014,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,,H,HEK293,B,,CHEMBL620830,722.0,BAO_0000219,
3697,,10209,,,1,,,Expert,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,,H,,B,,CHEMBL620831,,BAO_0000019,
3698,,10209,,,1,,,Expert,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,H,,B,,CHEMBL620832,,BAO_0000019,
3699,Homo sapiens,10209,,,1,,,Expert,4234,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,,D,,B,,CHEMBL621548,,BAO_0000357,
3700,,10209,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL621549,,BAO_0000019,
3701,,10209,,,1,,,Autocuration,17200,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,,H,,B,,CHEMBL621550,,BAO_0000357,
3702,,10209,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,,H,CHO,B,,CHEMBL621551,449.0,BAO_0000219,
3703,,10209,,,1,,,Autocuration,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,,H,,B,,CHEMBL621552,,BAO_0000019,
3704,,10209,,,1,,,Autocuration,5104,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL857077,,BAO_0000357,
3705,,10209,,,1,,,Autocuration,5104,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,,H,,B,,CHEMBL618158,,BAO_0000357,
3706,Homo sapiens,10209,,,1,,,Expert,5033,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,D,COS-7,B,,CHEMBL618159,643.0,BAO_0000219,
3707,,10209,,,1,,,Autocuration,5486,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,H,COS-7,B,,CHEMBL875101,643.0,BAO_0000219,
3708,Homo sapiens,10209,,,1,,,Expert,4540,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,,D,HEK293,B,,CHEMBL618160,722.0,BAO_0000219,
3709,,10209,,,1,,,Expert,6166,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,,H,,B,,CHEMBL618161,,BAO_0000357,
3710,,10209,,,1,,,Expert,17342,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,,H,HEK293,B,,CHEMBL618162,722.0,BAO_0000219,
3711,,10209,,,1,,,Expert,17342,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,,H,,B,,CHEMBL618163,,BAO_0000357,
3712,,10209,,,1,,,Autocuration,17296,Binding affinity against 5-hydroxytryptamine 7 human receptors,,H,,B,,CHEMBL618164,,BAO_0000357,
3713,,10209,,,1,,,Expert,16429,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,,H,,B,,CHEMBL618165,,BAO_0000219,
3714,,10209,,,1,,,Autocuration,15779,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,,H,HEK293,B,,CHEMBL618166,722.0,BAO_0000219,
3715,,10209,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,H,HEK293,B,,CHEMBL857989,722.0,BAO_0000219,
3716,,10209,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,H,HEK293,B,,CHEMBL619888,722.0,BAO_0000219,
3717,,10209,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,H,HEK293,B,,CHEMBL619889,722.0,BAO_0000219,
3718,,10209,,,1,,,Autocuration,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,,H,HEK293,B,,CHEMBL619890,722.0,BAO_0000219,
3719,,10209,,,1,,,Autocuration,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,,H,CHO,B,,CHEMBL619891,449.0,BAO_0000219,
3720,,10209,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),,H,HEK293,B,,CHEMBL619892,722.0,BAO_0000219,
3721,,10209,,,1,,,Expert,4199,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,,D,HEK293,B,,CHEMBL619893,722.0,BAO_0000219,
3722,,10209,,,1,,,Autocuration,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),,H,HEK293,B,,CHEMBL619894,722.0,BAO_0000219,
3723,,10209,,,1,,,Intermediate,3680,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,,D,HEK293,B,,CHEMBL619895,722.0,BAO_0000219,
3724,,10209,,,1,,,Intermediate,3680,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,,D,,B,,CHEMBL619896,,BAO_0000357,
3725,,10209,,,1,,,Autocuration,15316,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,,H,COS-7,B,,CHEMBL619897,643.0,BAO_0000219,
3726,,10209,,,1,,,Autocuration,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,,H,HEK293,B,,CHEMBL619898,722.0,BAO_0000219,
3727,,10209,,,1,,,Expert,5213,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,,H,HEK293,B,,CHEMBL619899,722.0,BAO_0000219,
3728,,10209,,,1,,,Autocuration,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),,H,HEK293,B,,CHEMBL619900,722.0,BAO_0000219,
3729,Homo sapiens,10209,,,1,,,Expert,14818,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,,D,HEK293,B,,CHEMBL619901,722.0,BAO_0000219,
3730,,10209,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,,H,HEK293,B,,CHEMBL620580,722.0,BAO_0000219,
3731,,10209,,,1,,,Autocuration,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,,H,HEK293,B,,CHEMBL620581,722.0,BAO_0000219,
3732,,10209,,,1,,,Autocuration,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",,H,HEK293,B,,CHEMBL620733,722.0,BAO_0000219,
3733,Homo sapiens,10209,,,1,,,Autocuration,17200,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,,D,,B,,CHEMBL620734,,BAO_0000357,
3734,Mus musculus,10022,,,1,,,Expert,17066,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,D,,B,,CHEMBL620735,,BAO_0000357,
3735,Oryctolagus cuniculus,10209,,,1,,,Autocuration,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,,H,,B,,CHEMBL620736,,BAO_0000019,
3736,,11923,,,1,,,Autocuration,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,,H,CHO,B,,CHEMBL620737,449.0,BAO_0000219,
3737,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,,H,CHO,B,,CHEMBL620738,449.0,BAO_0000219,
3738,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,,H,CHO,B,,CHEMBL620739,449.0,BAO_0000219,
3739,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,,H,CHO,B,,CHEMBL620740,449.0,BAO_0000219,
3740,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,,H,CHO,B,,CHEMBL620741,449.0,BAO_0000219,
3741,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,,H,CHO,B,,CHEMBL620742,449.0,BAO_0000219,
3742,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,,H,CHO,B,,CHEMBL620743,449.0,BAO_0000219,
3743,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,,H,CHO,B,,CHEMBL620744,449.0,BAO_0000219,
3744,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,,H,CHO,B,,CHEMBL620745,449.0,BAO_0000219,
3745,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,,H,CHO,B,,CHEMBL620746,449.0,BAO_0000219,
3746,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,,H,CHO,B,,CHEMBL620747,449.0,BAO_0000219,
3747,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,,H,CHO,B,,CHEMBL620748,449.0,BAO_0000219,
3748,,11923,,,1,,,Autocuration,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,,H,CHO,B,,CHEMBL620749,449.0,BAO_0000219,
3749,,11923,,,1,,,Expert,17066,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL620750,,BAO_0000357,
3750,Rattus norvegicus,11923,,,1,,,Expert,17066,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,,D,,B,,CHEMBL620751,,BAO_0000357,
3751,,11923,,,1,,,Expert,17386,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,,H,,B,,CHEMBL620752,,BAO_0000357,
